<!DOCTYPE html>
<html><head>
		<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
		<meta http-equiv="Content-Security-Policy" content="script-src 'none'; media-src 'none'">
		<title>Zotero Report</title>
		<link rel="stylesheet" type="text/css" href="data:text/css;base64,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">
		<link rel="stylesheet" type="text/css" media="screen,projection" href="data:text/css;base64,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">
		<link rel="stylesheet" type="text/css" media="print" href="data:text/css;base64,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">
	</head>
	<body>
		<ul class="report combineChildItems">
			<li id="item_CYKFY5EN" class="item journalArticle">
			<h2>A counseling intervention to address HIV stigma at entry into 
antenatal care in Tanzania (Maisha): study protocol for a pilot 
randomized controlled trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Watt MH</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Knippler ET</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Minja L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kisigo G</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Knettel BA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ngocho JS</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Renju J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Osaki H</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mwamba R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Rogathi JJ</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mmbaga BT</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: HIV-related stigma significantly impacts HIV care 
engagement, including in prevention of mother-to-child transmission of 
HIV (PMTCT) programs. Maisha is a stigma-based counseling intervention 
delivered during the first antenatal care (ANC) visit, complementing 
routine HIV counseling and testing. The goal of Maisha is to promote 
readiness to initiate and sustain treatment among those who are 
HIV-positive, and to reduce HIV stigmatizing attitudes among those who 
test negative. METHODS: A pilot randomized control trial will assess the
 feasibility and acceptability of delivering Maisha in a clinical 
setting, and the potential efficacy of the intervention on HIV care 
engagement outcomes (for HIV-positive participants) and HIV stigma 
constructs (for all participants). A total of 1000 women and 
approximately 700 male partners will be recruited from two study clinics
 in the Moshi municipality of Tanzania. Participants will be enrolled at
 their first ANC visit, prior to HIV testing. It is estimated that 50 
women (5%) will be identified as HIV-positive. Following consent and a 
baseline survey, participants will be randomly assigned to either the 
control (standard of care) or the Maisha intervention. The Maisha 
intervention includes a video and counseling session prior to HIV 
testing, and two additional counseling sessions if the participant tests
 positive for HIV or has an established HIV diagnosis. A subset of 
approximately 500 enrolled participants (all HIV-positive participants, 
and a random selection of HIV-negative participants who have elevated 
stigma attitude scores) will complete a follow-up assessment at 3 
months. Measures will include health outcomes (care engagement, 
antiretroviral adherence, depression) and HIV stigma outcomes. Quality 
assurance data will be collected and the feasibility and acceptability 
of the intervention will be described. Statistical analysis will examine
 potential differences between conditions in health outcomes and stigma 
measures, stratified by HIV status. DISCUSSION: ANC provides a unique 
and important entry point to address HIV stigma. Interventions are 
needed to improve retention in PMTCT care and to improve community 
attitudes toward people living with HIV. Results of the Maisha pilot 
trial will be used to generate parameter estimates and potential ranges 
of values to estimate power for a full cluster-randomized trial in PMTCT
 settings, with extended follow-up and enhanced adherence measurement 
using a biomarker. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03600142. 
Registered on 25 July 2018.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2019-12</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>20</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>807</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Trials</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/s13063-019-3933-z">10.1186/s13063-019-3933-z</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1745-6215 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>*HIV</li>
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Young Adult</li>
					<li>Male</li>
					<li>Infectious Disease Transmission, Vertical/*prevention &amp; control</li>
					<li>Middle Aged</li>
					<li>Follow-Up Studies</li>
					<li>Adolescent</li>
					<li>Anti-HIV Agents/therapeutic use</li>
					<li>Tanzania</li>
					<li>HIV</li>
					<li>Sexual Partners</li>
					<li>Feasibility Studies</li>
					<li>Tanzania/epidemiology</li>
					<li>Pilot Projects</li>
					<li>Prenatal Care/*methods</li>
					<li>Stigma</li>
					<li>*Social Stigma</li>
					<li>Counseling/*methods</li>
					<li>HIV Infections/drug therapy/*epidemiology/*transmission/virology</li>
					<li>Intervention</li>
					<li>Pilot randomized control trial</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_HC8AGYB3">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location Name :</strong> </p>
<p><span style="color: var(--tw-prose-bold)">Majengo Health Center and Pasua Health Center</span></p>
<p><strong>Location Type</strong> :</p>
<p> Healthy Facility</p>
<p><strong><span style="color: var(--tw-prose-bold)">Description: </span></strong></p>
<p><span style="color: var(--tw-prose-bold)">Two government health facilities in Moshi municipality, Tanzania (Majengo Health Center and Pasua Health Center)</span></p>
<p><strong><span style="color: var(--tw-prose-bold)">Sample size : </span></strong><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">&nbsp;</span></span>1039 women and 492 male partners</p>
<p></p>
<p>&nbsp;</p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_ULCEA2BE" class="item journalArticle">
			<h2>A Liftless Intervention to Prevent Preterm Birth and Low 
Birthweight Among Pregnant Ghanaian Women: Protocol of a Stepped-Wedge 
Cluster Randomized Controlled Trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kwegyir-Afful E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Verbeek J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Aziato L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Seffah JD</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Rasanen K</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Preterm birth (PTB) is a leading cause of infant 
morbidity and mortality worldwide. Every year, 20 million babies are 
born with low birthweight (LBW), about 96% of which occur in low-income 
countries. Despite the associated dangers, in about 40%-50% of PTB and 
LBW cases, the causes remain unexplained. Existing evidence is 
inconclusive as to whether occupational physical activities such as 
heavy lifting are implicated. African women bear the transport burden of
 accessing basic needs for their families. Ghana's PTB rate is 14.5%, 
whereas the global average is 9.6%. The proposed liftless intervention 
aims to decrease lifting exposure during pregnancy among Ghanaian women.
 We hypothesize that a reduction in heavy lifting among pregnant women 
in Ghana will increase gestational age and birthweight. OBJECTIVE: To 
investigate the effects of the liftless intervention on the incidence of
 PTB and LBW among pregnant Ghanaian women. METHODS: A cohort 
stepped-wedge cluster randomized controlled trial in 10 antenatal 
clinics will be carried out in Ghana. A total of 1000 pregnant 
participants will be recruited for a 60-week period. To be eligible, the
 participant should have a singleton pregnancy between 12 and 16 weeks 
gestation, be attending any of the 10 antenatal clinics, and be exposed 
to heavy lifting. All participants will receive standard antenatal care 
within the control phase; by random allocation, two clusters will 
transit into the intervention phase. The midwife-led 3-component 
liftless intervention consists of health education, a take-home reminder
 card mimicking the colors of a traffic light, and a shopping voucher. 
The primary outcome are gestational ages of &lt;28, 28-32, and 33-37 
weeks. The secondary outcomes are LBW (preterm LBW, term but LBW, and 
postterm), compliance, prevalence of low back and pelvic pain, and 
premature uterine contractions. Study midwives and participants will not
 be blinded to the treatment allocation. RESULTS: Permission to conduct 
the study at all 10 antenatal clinics has been granted by the Ghana 
Health Service. Application for funding to begin the trial is ongoing. 
Findings from the main trial are expected to be published by the end of 
2019. CONCLUSIONS: To the best of our knowledge, there has been no 
randomized trial of this nature in Ghana. Minimizing heavy lifting among
 pregnant African women can reduce the soaring rates of PTB and LBW. The
 findings will increase the knowledge of the prevention of PTB and LBW 
worldwide. TRIAL REGISTRATION: Pan African Clinical Trial Register 
(PACTR201602001301205); http://apps.who.int/trialsearch/ 
Trial2.aspx?TrialID=PACTR201602001301205 (Archived by WebCite at 
http://www.webcitation.org/71TCYkHzu). REGISTERED REPORT IDENTIFIER: 
RR1-10.2196/10095.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2018-08</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: Canada</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>7</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e10095</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>JMIR research protocols</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.2196/10095">10.2196/10095</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>8</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1929-0748 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Ghana</li>
					<li>randomized controlled trial</li>
					<li>heavy lifting</li>
					<li>liftless intervention</li>
					<li>low birthweight</li>
					<li>low-and middle-income countries</li>
					<li>physical activity</li>
					<li>preterm birth</li>
					<li>stepped-wedge</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_C4L6SGGD">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location names:</strong></p>
<p><img alt="" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAACNkAAAMqCAIAAAA68ZJOAAAgAElEQVR4nOzdb2gcaYLn+WBfbCyds6MRbDJN59aqjSnEIIRnsI/RuLrotShcPXhbY9/VrdAi3QwjVKiaFazEdMNpQJqG8W4nLIbpkWhxzUgM2ptaVepAjO3qam+JdWFKXqrLXoTrUI2pKl+WzCL0IlmafBHv4l5ISkXE80TEExFP/MmM74d4ZSsjIyIjnnji+cXzPIYNAAAAAAAAAAAApMPIewMAAAAAAAAAAADQs8iiAAAAAAAAAAAAkBayKAAAAAAAAAAAAKSFLAoAAAAAAAAAAABpIYsCAAAAAAAAAABAWsiiAAAAAAAAAAAAkBayKAAAAAAAAAAAAKSFLAoAAAAAAAAAAABpIYsCAAAAAAAAAABAWsiiAAAAAAAAAAAAkBayKAAAAAAAAAAAAKSFLAoAAAAAAAAAAABpIYsCAAAAAAAAAABAWsiiAAAAAAAAAAAAkBayKAAAAAAAAAAAAKSFLAoAAAAAAAAAAABpIYsCAAAAAAAAAABAWsiiAAAAAAAAAAAAkBayKAAAAAAAAAAAAKSFLAoAAAAAAAAAAABpIYsCAAAAAAAAAABAWsiiAAAAAAAAAAAAkBayKAAAAAAAAAAAAKSFLAoAAAAAAAAAAABpIYsCAAAAAAAAAABAWsiiAAAAAAAAAAAAkBayKAAAAAAAAAAAAKSFLAoAAAAAAAAAAABpIYsCAAAAAAAAAABAWsiiAAAAAAAAAAAAkBZtWdRbb/2bb3/7d1jSW771rYv/+B//1re+dTH3LWFhYWFhYWFhcS7/4l8M/pN/0v/P/tkruW8JCwtL2RaeklhYWFhyX37zN7/5W7/1rdw3g4WFhYUljeV73xt78eL/0xIhacuihof/l8HBS4bxDZaUlr6+b/7e7/1B7pvBwsLCwsLCwiIuV69ey30bWFhYyrl85ztv5L4NLCwsLGVefu/3/uA3f/O3c98MFhYWFhbty+Dgpb6+b/73/76vJULSlkV9+9u/09f3zT/909k/+ZO3WdJYJib+2DC+MT7+f+S+JSwsLCwsLCwszuWtt/5NX983v/OdN3LfEhYWlrItExN/wlMSCwsLS77L4OClf/7PX819M1hYWFhYtC+/+7u/bxjfKGIWpXGzIPp3/+5HhvGN5eW/zHtDAAAAXP7rf/3IML7x7W//Tt4bAqB0lpf/0jC+8Sd/8nbeGwIA5XXy7ryuEZwAAMWhN/Qhi+oaZFEAAKCYyKIA5IUsCgByRxYFAL2KLKqkyKIAAEAxkUUByAtZFADkjiwKAHoVWVRJkUUBAIBiIosCkBeyKADIHVkUAPQqsqiSIosCAADFRBYFIC9kUQCQO7IoAOhVZFElRRYFAACKiSwKQF7IogAgd2RRANCryKJKiiwKAAAUE1kUgLyQRQFA7siiAKBXkUWVFFkUAAAoJrIoAHkhiwKA3JFFAUCvIosqKbIoAABQTGRRAPJCFgUAuSOLAoBeRRZVUmRRAACgmMiiAOSFLAoAckcWBQC9iiyqpMiiAABAMZFFAcgLWRQA5I4sCgB6FVlUSZFFAUhTa/+DhscH+628tyrEVx97t7nx8Vd5bxRQRmRRAPJCFgUAuSOLSg/PvADyRRZVUmRR0MpqvWw2m8ftvLejZKzWs91Go9Fo7D5rWXlvjMdn9UuGx6X6ZwlW2NnZRqPR+PD//bW2LXXYmfJuszG1E7gxmR759ou9e41Go3Fv7wWXGnocWVR8Rb4zAN2ALAoAckcWlR7lZ16gR4j5a/Hfk+5tZFElRRaF5KzWs62lsZFan+moxlSqf/izz/PeslI42pmuOY585Wr9SZECCr1Z1NGDucHzne2f2kmn5qBWL8/lyFv7d65Wzr/UrE1vH9LKjN5FFhVTwe8MQDcgiwKA3JFFpYcsCmUjnvPJ3pNGUmRRJUUWhWTaT1ZuONu7HK7cIYtK35dr14TDX52+X5yXO3RmUdbuXNWxnovLn6p/tPWyeeKlQgcBlXp5LkfecwQMwzAM88od6k/oWWRRsRT+zgB0A7IoZKt9fFpXZYgJ4BxZVHrIohREa0ZAwZFFFU15sqjPf/aHAx1Do0vvR3yl3PX5gYGBge7u/JFCFvXLecfRGZlcj/omruvzAwMDA/O/1Ldx0Mrar1+R51BRKzLCr678uwtXZLlOGUnSYxiGMbZZmCZHjVlU691bjtPNHNs8Cv57q/Xsbn3e22PPMAzD7KuNjC2t+w5xp1Avz+XIWztTsgvulcXHKX4pkKcUsijZXUMwNDoxM7O02th92o0tgsW/MwDdIIUsiqektHz6kxGhIB/5ifo7S7n9NO0Xe+tLE6ND1Yq3yK5Uh0bfrt9lkFWUnb4sSqkGqKB3Ct7Us6huLZrjNyMk0tr+U/F0+9Ntqu8akUUVTXmyKOEB/eLi4yg1POHz3X3qppBFea/u8Bbj4M/zbkZRybpoOH/46fvq64pfD5I1uZXolJEcuKBi6bO//u55hSqbsktfFvXp8kXHSqpzu/4lt3X4yfrssPBULzlLa68vbB0IVUmF8zHikdfDp4G5TGc8yiaFLMrvOvItJvpevbl8VywnCiyX8gnoOSlkUTwlpcRdRzzTP7ervIbsf5r2wd1lv8ElXCrDkysPGZAZpaUvi4paA/STSsHbuv9vL1TS/QpR2llUFxbNSZsRknC/eNtxbe3rKCuJdCLl0DqUM7KooilxFmUY1akd9QKNLCqMeHWbV+r76vVnnrK6hLQyZ/ZdHpuZr280GruR7sxkUTF9vXZN/BUMc2pHesV9fudK5mWXriyqtTPV71jHaytf+vyhdfj+gkr90XG4ajdW3O9YKZyP0Y68Lrtz/ZJv7e67EBCkAFnUqcrwQtSe9LnJp3wCek0GWRRPSXrIq0eG0f/OA9WDm+1PEzDGuY9uugcBWpUki7o/bab9FaKUs6huK5p1NCMkIK++G0ENH6LW5liEnzOP1qGckUUVTamzKMMwr62pXt5kUWGkr+MG9mEI+TxPWYUkeculOrUd9yGJLCqu1v1pb+803wqatT2efdmlKYv6cuU1xxr6p3bkfdWt/TtXI1UgOwdtcO7B+TsJKudjlCOvz2d3hGExI71NAXSZ4mRRXXW15VM+AT0mkyzK4CkpMevBO/L2zigZfIY/zdHOdLQcqrM519cox1E+5cii9m8Ppf0VEqlmUV1WNGtqRojP3dzhEqH15PHiK0q7a9t2Tq1DOSOLKpqSZ1ERntHJosL4DA2j3ILDU1ZXcL9DYRiGYd56N/5QtmRR8VnPNyc7HbHNvu8uP/K70jxVky7KojxV2YvL0lGmg+cvC2FeW/mHzj1A7XxUP/I6HT1aPu9KX7kwufmcZgn0sGJlUV2U6ORTPgE9JassiqekZALaOyM8nmT10xztTAUNcR6s+s6DbhovFtCiFFmUpzdLL2RRXVU062tGiC0givJt/RB5+1YF/5y5tA7ljCyqaEqfRRmGUZ2+r1AgkkWF8blfGIZ55Y7KoeIpqyu4e5EbRtSBbD3IohKyWi+bzWbzOOgJ1Vs16Z4s6mhzzHG6+dRd/ecvq1wYfbu+cW/voNlsPt1tNFYXRi943nrqH9921mcjnI8qR16/9nGz2Wy+ZDpr9LyMsqi3NpouT3c36pOXhfmKA0qgQsqnfAJ6RXZZFE9JCfhMsBG1zM7mp/ly7Zp8Y82+y2NLq43dp81m82DvXkN2D7p0uzvehQD00pdFtfY/aMj9dOIV70X5ysRPff648fFXGnbLzTuaXfdnUd1UNOtsRohLPrVWh2oY5W2kC/w582kdyhlZVNGQRRmGWrxOFhXG936h+D4xT1ldQfyZE/1OZFEZ8NZxuyaLclfNLi4+lpQiPlVIc3BaPqeodfiwfv3sE0LRn/Y8rgAUZZRFyS/w9sH6LUnBkujNCwBdI8ssiqekuIT2ztde87xbrlZmZ/HT+CRR1ev1h9JRztsHW9ODZoSNAHqRvizKn64JjuMSZgrq+iyqi4pmvc0IMXmjqFdee80dj/bP7SqsxjPUY8jP6Q2uurtlWxFZVNGQRakWaGRRYQLuF0qldcKnrPYxbwBngSwqbe1jzSeyMKxi7LIr0kWWuGrvqcnK5+6UdmoPLc/bT9YnR0Ym/1b4K7IooCByzaJs227tTAkDjJjT9/VtDYDCyjaLMjJ4SupB3oGtjGtrv/I26ipN+57+TyMfsCpszdbh+0ujI6NLWqYjAbpRGbIoYciZ2GW71XoZYeSM1J55u6ho1tyMEI9nsDyjf27X+xpx/zsPQr9LOOyBP6cQXHV3y7aM1Tr2Xg2Js6holxhCkUWdn4rB3d+jZ1Ht46d36/NjIwNVR3dOs682MDK2tLr7LN/zOPMsKrwXa8SnLKv1xd579bdHh2rugQwq1aHRt+t3pe8yOPzq5zPn5lfO51OwWs+2lsZGquezLbw6uiB7NaJ9cNfz9WZfbWRsaX3vRYQowWo9E8+SSnUg8ooUv+2LvfWlCc9Bq1QHhkbfrr8X8H1ffXzWNf1Hwj37tR8l6L2ebRYVe/9F7Rd760vu383sqwWt5+t7P3acc0uuc+r0ZHKt7NXRhfVPpG9LytY3MzMzM/Pje663jNrHzae7jY0feA+UOPLAB/vSvvKJLrKkVXv35+WVMOnTvTm2GfuxXel8DD/ytu0pYmaWth2zOwk/90nRsRV4V3Cvb2ZmZmbm578K2her9Wx3VX6O3s35/gOEyzuLEp8OVcowPbf09ouTO5W4ktXdsMqNWvnk/cKk9VXd5R2Qr8yzKO1PSbZtnxclzkpcYD3gf370V57iw3U1C44ercyr//GT9SXXun+w8TR0F/wJjYiX6p+J/6jS4pn6TyNt75R39gfgUOwsKlndyWq9PNi71/j3Y95HWaFlxbdppX38VHjUMzotUkGtCHZ6WVT3FM3amxHiEDbCnNqxhH8MCqPax82DvXsbi9fCT6RzQoOeZFzKgBa9yJWLc6k+MFiHn6w723FP1zG58uGLth0ni0pyibkfyJzNzWfb6Th8lerQ6Nunm6m4r0kberJthZYji3IIjNejZFHW4cP6Te+AooLK8Oz6k7xedcohiwp7zUD5Kcs6fLjiM52D+/AGPRJ5vu2k72v7ycqNmny91etr59se8Hen373wfvDt37Ztu32wNTscfJaYtRs+gzdE1j7Ymg09aGbtxvIvZEct/Md1iFKRySyLSrb/wqqCf7jKhZt1Ybp47wafliDW8+2AtZm1G2s+F01w1fmXs2EFkM8HT2i4yJJlUZ5KmPyT1s6UuIWJ3utROh/V9syzKnNqx7Jt++hRPaDsMGvjm34HNMqlYh0+DPoawzDMvssqhRSQm/yzKPEVw8DiRc8tvf1kJaT6aPbVBgTzvwzYyaCt1lRf1V3eAfnKIYvS9pRk27ZKNcAwKsOzwqt2ktQkoADxvrsd8Y/HNhNMwSdt75T8s8JMG2n/NLJbT//UTtfMPwjkpqhZVNK60+d/fTXkGTuoSLFtu32wJc5e5GXWbojtER0pZVHdUzTrb0aIQRpFyf5ZPsdWtPaeiKSnQ9zKRUdqDwzBqzAqV5cfrUfIopJfYvKmv+CWP6Nyddn/mlX/EUIaerJthQ5Q4iyqvz9SEq6aRVmH788Nqt9dlM63FGSQRckOcNBbYEpPWe2D9fGQ4s8h4Abl/bah2w93poPXfJpVHoX9neuvfVj7a9d9JkoUVK7eSdgHuP1kRfnb5MV9d2dRyff/3NED1evbFV/KNnhss3X0aPFK6Np8TuPgqnOkX8xdmmm6yBJlUe4aq0/9S1aHVJ0O1Ud6WZTRP/dA6ar3u96VL5X2k/pVtYqpOTjHyC8oqq7KojTd0hWrFxLnuxGh5NVYX9Vd3gH5yiCLSuUp6YR6TdUwa9PupxVJCeI7s4eYLgW87C52NE0URQlzvZ+VczFaPFP+aWR3HtW56IFyK2IWpaPupPCOvG+RYh0+XFZ80DOMgBapdLKo7imaU2hGiE6YWus0mlENo6K190Qkng5JKhd+m6zlgcF6vimb5te7Taaw8dJLXdMlJlzl19b2VQ6g76E7kbShJ9tW6BAlzqLG/mpzSvwd1BtWpafu0Y5knbFOk5RlkEW98sP1uqSdXf2OKBSAh9uTkZtpqtP3pfcU4dskpZO4srndf5BPPitjXluTP5BZ+7IDE7iqBNPWRv82Q8xRZM+bvoqVRWnZ/zNHm2Pq6/L0HBc22LxyVXXLqnO7wuakk0Xpu8gSZFHW40VnRdavlik7KxM1baSaRSkVMSd/eOWO5DipXSpRT/fKzf/7fyQ5YEBa8s+iJGP0jW/LxgrVc0uPda8Sd0O55NVaX9Vd3gH5yiCL0v+UdCL6le3+SkkRIi34pEWk4ZtcCVOXKk5e78O3vVPS4hk67Xu6P83X3olSDMN4ZfFx/H0HyqN4WZSeulPsLOrXn/4kQiP56dfL61mpZFFdVDSn0IwQmW8UJRtAUHbPzDKLSlq58Nvk5A8McS7KU+Klru8SE5v+VPfUtwE7cUNPtq3Q4UqcRV2qfyb/NWTNvkpZlO+Pez6iSk0+6FXWI5NmM0bf1I68aPDJaBSesnxu3JVq0MGVv3URVHSf/F6y1ZnVqvu2cPLVPt8sH9tVXlxWhsfm6xuNRqPRWF0aEwdHi9tc41s4nx60gQHP+Kcd7gDAev6L+rx3oiUfRcqidO3/yUGQDCts9l0em69vNFaXZjyj03ov6pBqZ/CpJClvgqvOX/7dv46QKTk+qO0ii59FuStmvpmu2LBhGFfufK7yDb7SzKJc/AsZw5C/+6SyaZ4Qz/ltQ6MTE6ND3tGO/Y4tkLvcsyjhgVr+HKjrlv6l+KJLZXiy/t7eQbPZfLq7sewzGoPZV3NNoKxWPumur+ou74B8ZTFGn/6nJL8r26y9PrG02mg0Go2N+tuSQWdczR5i0SdvMfSr1Uob88RupomiKCEGc1ZDxRbPkGnf0/1p7k+L795P34+/70CJFCyL0lZ3sh7/OGSELL8ipbUzJXs/+GwD5K0a0npWGllUFxXNaTQjRCXcGJ0/lNjsJOl2fLQzGzpUZGzOw6WjcnFC+wPD0fa49JV5s+/V0YmZmZmZidFXfdsvJZe6tktMqenPpx1S3oCdtKEn21ZoFeXOovyuK1mIG55FSc+36nXPSIvtFx/KOv1lnUZllEX5nPPSgFXlKcvanXOszazdWHbNzWYdPpQMeSa90cnLwcrwrGN6PKv1bN23v2fl6rJjejnr8GFd0t1R/OrW/Wnhz6q3hDHhJD1N4zTXSAtTc3DaPYar1XomHZRN2h0l+qR/gdLNojTvv/ACjXAiW4efrM9e7jNlnWv9bkjuk873rBPOJdWqc9RfTNdFFjuLcjeD+NdT03i8Tz+LqgzPOueD9Pm5JVe7wqbJZsc2a+PrztO9/eLDs6IqeBxRIF85Z1GSTrDm9b8R2k613dIlHWe99aT2ox96HkF+e/5hxB6zAUciUX1Vd3kH5CujLEr3U9Jnd4T6mXllURgfSjI+tLPZQ+zvNHRbfCCX1ThOvrHzXvc5cTAklYnr/YhNdO5WG3FY/uAWz1R/miI0eALdqlhZVBptfZJ1hrSEuF9d8tSzbLt9IKtoSUpc/VlUVxXNBXhLQLiLuqvD0e6b0U6kqK1DeioXPl9tGEb8BwZpPONt/bDt9ou/l46OJ91tTZeYT9Oft22t/eJD2ZQdkjAqYUNPtq3QasqeRdm+BZo3/wvLomSt3p4xujqkCVi2Q0dnlkX55n1CTK42+oT1fHt2ZGBgaHTBZ048SQOS7IU+sRz0GVJTnj/LYhpZrxnvKAxiGeLb8dHavy0MMhrxHUJZEXjptvzrZNeBWu8M3VlUAgqzBSfYf3F1kXpyy7bGZ0BY6TXjfbpPK4vSdZHFzKI8Jan/R6ztceF4Jp5wNN0syryyKJsEUlbIiNXh0E2TdtuTP/i0D3Yb9z5JfT5KIIH8siifd0tkfea13dLFdyMlzbniWE+SFk2F8imF+qru8g7IV2ZZlM6nJEktwPedE+FFYmctTgyjxAcQ2chzklWdEt7lSlJdE/fT+7AlZvuBDSmp/jT7t4eEVWiYlAUohSJlUem09UXPomz76FH95tDAwMjkiqyaJa9oiYW49iyqq4rmVJoRohEfITwNS2IYFdBcnGYWpa1yIf/qJA8MwiiHhn8XD/FBzHe3tVxisqfO6q11WeOabBYQ7yNe0oaebFuhFZFF2d5+AD4/TkgWJbsQArJr2QkcOmiqThlmUbZ07BmxDIswK28gyUyEkuYa9SJYNh66TwYROruEZOCLgBdChMapiMWAZIShoK+TlYIqFZfCZlG6919/FvXmul+/FNntxlNCpJdFhVO5yOJlUe77ZFAVVZo0FjqLkr1YfELSVCEcz9BNk4x7zeTY6F4ZZVGv/ahxbnVpZkIyxIRh+IzerO+WrjYlqXCVS/4qvHxKo76qu7wD8pVhFmXrekqSXNlBL1F7H1mcV7VYn/BOGeUuzl65eNH51cJsSMJFn6R2ItZAxdmXorV4pvrTyJ5zyKIANQXKolJq64uTRcXZpxgvOUbUXUVzKs0IkSi0K0UJo1LMojRWLqRfneCBQRz+N3DbNDaKKVxi6rNvSrNR7/oSNvRk2wqtiizKtm2lofqCGwokTbMh7dSSdvIsZzLNNotS6k6rK4uSXPiSIk69LJIUcn5/KnlL0PWnYlYVHEB69yTau8OSAjD4FJNVsoSzuHuyKO37L1lh9frKE2nPIYlodQRZkeK+++aZRalcZHGyKE8EF3iH7b4sKmDrFP44bNMkSXjG73cBOmWURSmpTm3L3ovTeEtXzKK8Q4rEyaJSqa/qLu+AfGWbRWl5SpI8rQS3HXhX6KxjCm0enrLNM6/n1NqK6/nHc0ULT0dJHnjFurpsbWKpFVDKpfrTkEUB8RUni0qrrS+dLEpS8Ait4JqzqC4rmnPPopSOhNpBtW07zSxKa+VC7wOD7KoM2jadzx/hl1iknyT0jxM29GTbCq2MLOqMrFOEM40K/nyMs0OSbabV+00i6yzKbzRPxx0jxSxKsqoIZZG2P5VEVSPzf9fw93fzI/HPENmLAiGHVLKBCm8/FzSLSmH/JSMLG4ZRuTC6sL73Rcv3zYJTESubkhHm3XeBgmVRws7EyKLcpXDIJHpkUa5NU7l4gS5SkCzKrN2oCwOin9B6SxduL7Knc2EHJH8UWj6lUl8li0JvyTqL0vCUJF6mv/3Wfwwojxr/8a3fdv25s84gNvC4Xjjy/PfYZstT8LgKCKE+niiKEir38rWJ7Xz+70qn+tOQRQHxFSeLSqutL7MsKvJLjtF0W9GcdxYlnk/SUE4Mo/w6s6SXRWmtXOh9YJD0m/LvZBX1u0OEr0trFpWwoSfbVmh1ZFHnguP14H5VkiFHw0pzyRmXYdNh9llUaO+zZFlU+7jZbDYP9u41Gj+dECoLxciiZGOGRxOlvJR8W+jHJbUSb8GTfhZ18Y0ZFW9dFip4YSO0J91/2cB55yrVkcm6cypCj6iVTcnGuN63yD6LinaRRc+i3NXTkPlMpQcosP6honuzKIa9Qo/JP4vqvzy3HjStmtZbuvi4efEH/8WdgQljsEsfDMLKp3Tqq2RR6C3ZZ1FJn5JkV3ZEzhWKYZSzuHE3TV1b+1ooJZytat6kPcnTrtie4rc2saXPt8Uz1Z9Gdt/xHaYHgEthsqjU2vo0ZlFW62Wz2Ww+3W00Gj/yTg2TchbVfUVzGs0I6sR8x6epX8z4fBpIUsuiNFcutD4whDWWJdht+bGIdIlpzaISNvRk2wqtjizKSV6gXbq9b4V8XnL2hHdk0z5jYBR5ZFG2T953Ou1j1CzKan2x9159fmxkoCqd3SF4VXlkUcn7AEUpBSTfFlpkKdTG0s+iFK+CsFnoU9l/6QnsURme3ZLNSqghi3JtTBZZVJKLLGoW5WmKDRqI+ITkdbPEz/fdm0Xlej8B9Ms/izIqwwsPAjpn6r2lS97vNGuvv13faDQajcZGfXLYWwhLp7AKLZ/Sqa+SRaG35JFF2YmekmIPQeqzQjEeP69gudsST1vQ3P9oTu3I/zpZFCXOve2/NrHF06+gSfWnkbyNnGWLJ9DVCpNFpdbWlyyLah8/3V1dmhgdqvXJxm4J3CedT45dWDSn0YygSvJ2s2+vEzGMctxeHVLLonRXLjQ+MEgGEYrauBb6/JHgEtOaRSW8XLNthVZHFuXmH69HzaLCf68yZlFBvc+Usyir9WxrwWd6cR89kkXJ7z0+4pxfPZ5F6dh/a3/temgcZRjVW5vPrdCVFzeL0nCRRSwV3X/eP7UTNAS3bdvy5/ukk+6RRQEFkVEW9dZG89TT9VthQ8+76b6lyyugfqrT96WFZIwsSkN9lSwKvSWnLCrBU1Ly5iLPZSg0gHWaFt0tiZ2P+YRR3g0L7fQeQLKTAWMpvCEM3+QzC2m6P42sxTN4mhkAp4qcRelp64uZRbVffLgyeTm0dTxoczU+OXZj0ZxGM4IiySxH/ZffUh8JyLz1rsIo3sXJotyr1vjAENYYmGS3NVxiPZVFRWqFVkcWJZAXaNeW/s9r/p+P865EnL6++uSWRfnmfXNL3jcEZJ+3nm+O1yIUCr6ryiOLEt8DCRlu1WNX1tvGV5x+QQrj2nVzFqVj/23bttsHW7Ph9ybvO+sasijXOzOpZVGaLrJItXbPC0I+dVIPydDdip/0RRYFFERGWZRrVCrZ0POnfeMlUrilHz1avqrwCoA5OOfbYSuNflHh9VWyKPSW3LKo2E9JkklSgycD8LgnDEgqrPG0N4+7DHFcvO7Q5TS68rb3JWnPECcaiUre0pjuTyObvlbalAjAq8hZlJ62vhhZlGJVMWyf9D05dmfRnEIzghqx13FkarPF6smidFcuuiGL0nOJFSmLyrYVWh1ZlETr/rQkjTLNgM/HOD0kZ1xGYbxt55pF2bb92R3JHUM4wsLn/V8arlQHRsZmZmbm6xsFns9W9RoAACAASURBVC9K0pE0xb7AcV7gkZzH3ptd12RRKe1/h9X6Ym99aSwok3J3t45Y2ZQ9vLr+Pp0sSt9FFuUH+HLtmuNLzbHNgHGxHNsqm78rWS2ye7OoOPOjAQWWQxblV/27tiYdMTSVW3r7YMMz5697W/ouT648DJjEKrx8SqW+ShaF3pJjFmXHfEryzsqUfCQ44bXxa2tfe8dicpYEnne9X1l8LDbG5htF+YwblfJPI45eRRgFqClMFpVaW1/ULMp3ugCzrzY0OjEzM7O02sh2vqguLZpTaEZQoiGKkg3pl1oWpbtyofGBIXLPDqXv1naJpT1fVJRnp2xbodWRRUmpjJTi+rzk9Ai7SsXr2n+kUP3yzaLU5t3xfN7anRM+UhmerN991nJfSUoXfh5ZlOQ3TzF+lBXPIYWOpJgSqgZdk0WltP8iq/XsrmQqD8PwBFkRK5uSt3XcZUoaWZTOi0w9i/J0RpBPgiL9oKwWqZpkSXVvFiXJLsMHMgeKK5csyraPNsckj7PyUkX7Ld1dM6reWq7PdwbpWFpt7D49Dn8tLbR8SqW+ShaF3pJvFhXrKUlShU06EpzQp2n6vuff3EWeJ4y6VP/MO0BdkghGNtZddLIhAtP+aWRhlHFx8XEB2oGAYitOFpVWW1+05gH3y5uGYRiGWXt9YX3vhad6mPzBUlnXFs36mxFUyMYGjEGYVzu9LEpz5ULnA4PkEgt8oFD4bo2XmNYsKmlDT6at0OrIovxI2yN8Py8Z9zMkWQptaU5X3lmU32A4/p8XXyIwr616p+SxbbvIWZSkFEnx9QvJcQhOVmQ9cYT0pmuyqJT239fRo0UhwA4bGSlgV8O3PoUsSutFppxFeb5VqFwFkNYiz2YsDflo62VTbNft3ixKdkspRCUDiCenLMrn5UppqaL5lu7+4rjdB0LLp1Tqq2RR6C15Z1HRn5JkF2rizjfeEGXo9iNXqeetVXvKxGtrH3nasOI3YEnqe2ZfbSCMONu4pGhN/aeRhlH+4786tY+bL1uEViir4mRRabX1RWoeEHsgXfzBf5E+82aWRXVz0ay9GUGB5G5QqYYeroGq8M5zouAjWkVcb+VC5wODJCYLbLsL/26dl5jWLCppQ0+2rdDKyKL8hcTr4Q/3Ad8gK/syPR/yz6LCe5+5Py+kub65QnGzKGmknd7rF7I4Y2rH99YhuTlK7jTdk0Wls/8BxJ5YsbMoWW3KW0dLIYvSepGpbp/7ph91Umv5A755ZfFR0GV1tDNdM2V/1sVZlOy9NPUuZkDR5JZF+TzNVqfvC7cDrbd07xV86S+exHnMDS+f0qivkkWht+SfRUV9SrKlLRVJO994y5M3x5wvaoo1Ns8b32+++abr4/HH/5C1dyrl9WLVSKzap//TyJs8jeqtTen7Xp2vuXO1Ev5nQO8qThaVVltflOYBseXdt0zNKovq8qJZczNCOMkXKtWAJb2pPGdTilmU3sqF1gcGyZb5t95Z+7fDLnWtl5jeLCppQ0+2rdCqyKKCyM5Yv8/L7jjmlbr0lSfpeqP0BkiuCFmUbdtH2+P+3XpDZsb2i4Jl6yxKFhXpNLFt224f3F2+OVSrvTq7E6OskN1gq1PyNckOm1J36eJmUansf/u46feKophFud7MkFV1fyitw0hrUsLGxM+ifBMmrReZ2va1dqaca4qeyPu+BFW9Xv/Q253atu32iw/r18/fMvBcfd2cRcnG65YXLkePlt+o1V69uabwSi6Qk/yyKJ9po2QPXhpv6bKX+zrT9J2N0tdoNBq7T5tBL2MqlE8p1FfJotBbipBF2ZGekmw7Wq3Xtm3r8JP12ZFarfbGHd8yS1ZqdkoNSYujvGXvVPwoSjLBhurbYgotnhn8NL7DrZiD01veYbBt27Zaz7amB88/EfAzAj2sQFlUSm19km/3LSnFv/XpaqrQ6K4ni+r6ollvM0IoyaO6YtNHaBglOZECeghFaB2ybb2VC70PDLIRIqU5WfvJynXJo51ndVovMc1ZVNKGnmxboRWRRQULiNdVhpc0jMrVP7t74CjIvJXLM7I3btNUkCwqsPdZSBYlK2iOHtVlxUxxsii/uRUHp9f3vnA+i7SPn95dvnnhvENu1Judbdvy6X8Msza++olz6nPPbfX8G+8knH1IQapZlPb9PztbzdqNunf2eElZ4a5LSh/oJRvz9wuyuafEo6xadZbcpM1rf3XQPtnxm6MLDzo3GK0XmdL2ues28Xp8B3XJr1RHxk6acFeXZmYmRofEPu5G9fr5rbqrsyj5Pah6feW/nRct1uHD+o3a2V9lfd8B1OWZRfm1G0qGVNJ3S5dc4kEqF0YX1j85FKoFaiWv7voqWRR6S0GyqAhPSbZt+8Xo1evLd12TzVmtL/bWZy/3qUQd/rPSy6tsAeFV/JcuE7R3Sptfwua7S+GnCRz83+x7dXRiZr6+0dioz8/MjI2I41cZ5uDcA+IolE2Rsqh02vpk0wdd/MEvDi3baj3bmh11tieLWyrp2GA935Z9fSpZVC8UzTqbEcLEj6KkcZArPpKcxuaVxYenJ9LC2KRrM2X9ia7cftK2z067v3GfLRorF5ofGKR1FHNwequzYe3jp3eXzxs/Alen9RLTnUUlbujJtBVaDVlUKL8CTfJ56Q9sGOfjpkrqlicnSuavOxUmiwrI+9yfl92qK8Ozq/f2DprNg717G/W3X/cpZQqVRQV2Hz4dMFZyozMMw7j4w0eRR+yR3zoc3+X3ZX6lTldlUXr337Mus+/y2Ol76o3VpTEhQPJWxgKezzsDK/tsjLQLrmrVWTYNlnvlnfuU1otM5e18d1YYu7t3WJf8kP13FL/dnUX5d+X1Pdt51RZFlW8W5VdjF19R0HZLlzzShxObJxXvDJrrq2RR6C2FyaKUn5JOBbTCnV7bPpe2ObYuRtu2LW2yOuHztrDv38e/zGX1WPWZp2Qtnu5YLJufJnTw/2ApNgYBhVWsLCqVtj7fIrNz6Z9XPGXvl9ZuLG/sPm02m093pe0RvvuUPIvqkaJZXzNCiGQz/sjCKOegObIeQi7O9+lCW4fMa2vul0e0VS50PzBIAxpl3tXpvMS0Z1GJG3qybYVWQRalQN6cLf386fihkeRSuyxQFmX73dg9nw94ocx7RCsVz18WKYuy4z6NRHnvwuFsuPFo3+V7X+2yLErf/kv7WPkTmyyDBjoJWZW0hFCuOoe3cHaiLp0XWfj2eb4t0TClsX5mQxiFv8uzqMj1ad6zRWHlnUX5vCopPJ3Z+m7pcWqQws1G+c6gtb5KFoXeUqAsylZ8SjoTr1ktoDbg01LqO4yUz9/Hv8plowOpt3fKp3lx1Tiz+mnsuKV8rHlJgB5QtCwqjbY+/86nZx/vVDyD+vB4VCqex2L9WVQPFc2amhGCd1eSvUWIouQToTvCKJ9pCR2czwvhrUNChyBNlQvtDwzq21W9fsP7l8J70hovMf1ZlIaGnkxbocORRSmR/ex+nz96tKxemJm1G/lM2VGsLEp+XQif930XxalydfnRkfdBqGBZlB3xNDGMyvDC+/IXFlVYzzfH1etNleGFgObprsuibE373z5YV16J9Jle1nfaDF2h//OnetVZ4bbV6ZKk7yIL3T533Vs2OVc01uH70uENg3fDvY6uz6Js224/qauVLZL9Bwoj9yzK70Wk/vFt8brRcUtvH2y5BrZQFjZKh2/Ro6++ShaF3lKsLErxKakjWq3XMGs3Vp4EvPEqfds6YO4n6d9Hnw70TNL2TnmLp3N7MvxpbNtuP1nxGy3I5+cZV2/tBHpL8bIoW39bX3jr8Hks4D/gi7fQOPL0fNGeRfVY0ayjGSFwZ5NGUfKmJOcoPIFzZZ38ueN9uvAmn/6pHc/PqaNykcYDg0LAcnInFYYAElen7xJLI4uyNTT0ZNoKHYIsSpVwjgd9XqVFwazdWP5FbpXLomVRsvZyyeeDK/Bm7Ub99JLzvGJSvCzKtm3r8OHKZOhNz+y7PLt1EPCMqMg6fFh3jvwpVRmeXX8SfFvtxizKtjXtv8pPVhn2+b1k95htnwFnz1YVVPZHqjofPZjz/R7P7Fe6LrKQ7fO8j6OrKbJ9sLUwGvY7+19VvZBF2Qr1ad+zFCiKAmRRfk838kH/E93Sreebt1xjwA7O/f1Bs9k8GRKi0Wg0Ghv1+ZmJ0VdlVUtncRG1UUVPfZUsCr2laFmU4lOSQ/tga8F/VOUzlQs3helPRZJwKeia1dDk5iAp0iLPdSkb2cDR4pnxT2Of3i7CXz1Q+3mA3lXILMq2dbf1Wftr0rmYT8oB9zNbyDNeZXh2++Q7w560E2ZRPVk0J2xGCNoYMXeTz8weRDIcnXtKiMD+XcLDf1DrkONEkhyjJJWLlB4YggKWyoXJ9dM99562stXpusRSyqLCtzC8oSfbVugA5cmivr734xmXH9/zfaNLzjr8ZH0pyufbL/beq8+PjZyPvGj21QaGRieWVndd87zlIIUs6lc/dx/gmZ//KuIa2gd36/Ohn7cOP1lfGhvpDEpaqQ4MjU4sre+9cB5S6/kvHOsSVyVsrf8Pms6fdja09Wx3dWlidOj8NKlUBwYGRsbm6xvaz5Pzb+uM6VqpnnzZe+5p6/zE2MVoq1M9b4QrWuWjyfffPpmX8eTKPlvJ+YX9zH8dvveY9sHd+tujQ2e/f6U6MDT6dv1uwKr8DkDgT3F24Ti/RrhuPH+b5CIL3j73y1TKE50qOvmdZ8ZGBly/UXjpq3Q+qh35SFeKwh9HvlSs1jPviRV+lgJFkUIWFeeu4an5nVr8f77w+/tYt3TP24mSmXLPtZ/8hfdecnHpfC+i3hlOV5qwvqq7vAPylUIWldVTkvsjnStbrAzdU6/2Pv6Ze9OX5E1UHUcPfuL+wPzfxY2b/8cH/96zqpU46Yx1+HBl3r2iH753cPqfufw0tn3288jvF+pPJUDvyiKLildtsm1bb1vfaXPAaVFt9tUGRsbm/ZoDPG0HPn999MRRgU3+YOnSy0Vz7GaEAE83fuDel6VYjfztgy3vM8lfffQ/PX8iO5Hekzb42Fbr2ZajxeesVSy0FSpB5SLFB4b2i731hc5lcbLrS6u7B+7Wq+0lldVpuMQkJYv/GRjpj0/2JHFDT7at0FLlyaLgkkIWBSBApPcdepz7pdno7wUB6HUpZFGF5R3xdHw78CkiaT9/ACFSyKIAANFkkUUBAPJAFlVSZFFAtsiiOr7ceOvVgRMjk/X8hioFUFhlyqK8Y1AEzMRiSwbAcs0XBSA5sigAyB1ZFAD0KrKokiKLArJFFgUAqsqURQmzsVSntn2GOrEOHy56xr+vzu2S5wNakUUBQO7IogCgV5FFlRRZFJAtsigAUFWmLEoypbFh9l0em69vNM6tLk2MvirMlN0/vu0/txSAWMiiACB3ZFEA0KvIokqKLArIFlkUAKgqUxZl25/duSKkUQrM2vQOSRSgHVkUAOSOLAoAehVZVEmRRQHZIosCAFXlyqJs++jB3GC0OKpydfkRQRSQBrIoAMgdWRQA9CqyqJIiiwKyRRYFAKrKlkXZtm0dPqzfvFBR6A7Vd3l266Cd9/YCPYssCgByRxYFAL2KLKqkyKKAbLX2P2h4fPxV3hsFAIVUwizqRPv46e7q0sTo0EC14kmgakOjE0vre1+0rLw3EuhtZFEAkDuyKADoVWRRJUUWBQAAiqm0WRSA3JFFAUDuyKIAoFeRRZUUWRQAACgmsigAeSGLAoDckUUBQK8iiyopsigAAFBMZFEA8kIWBQC5I4sCgF5FFlVSZFEAAKCYyKIA5IUsCgByRxYFAL2KLKqkyKIAAEAxkUUByAtZFADkjiwKAHoVWVRJkUUBAIBiIosCkBeyKADIHVkUAPQqsqiSIosCAADFRBYFIC9kUQCQO7IoAOhVZFElRRYFAACKiSwKQF7IogAgd2RRANCryKJKiiwKAAAUE1kUgLyQRQFA7siiAKBXkUWVFFkUAAAoJrIoAHkhiwKA3JFFAUCvIosqKbIoAABQTGRRAPJCFgUAuSOLAoBeRRZVUmRRAACgmMiiAOSFLAoAckcWBQC9iiyqpMiiAABAMZFFAcgLWRQA5I4sCgB6FVlUSZFFAQCAYiKLApAXsigAyB1ZFAD0KrKokiKLAgAAxUQWBSAvZFEAkDuyKADoVWRRJUUWBQAAiimjLOro8NBK9xvQU9qHh628twHpI4sCgNyRRQFAryKLKimyKAAAUEyZZFGt+9NVs3aj/pBAKnXt42az+bLVxQe6fbA1O1wxLi4+7uKdgBqyKADIHVkUAPQqsqiSIosCAADFlEEWZT1evGicMGs31vZJGFJy9GDhcp95cqQrF26uPGnnvUWRHT1YGK6cnSxX7nyW9/YgZWRRCVitl81uT56hrn3cbDabzePuK9dRfCllURRSAJA7sqiSIosCAADFlH4W9Vn9kuF05c7nqX1XiTkSP6Nrw5xPl137YI5tHuW9SUgVWVRMztTWqFy4Scbf06z9tRs186xc7Lu88ICSEVqlkEVRSAFAIZBFlRRZFAAAKKa0s6jWzlS/KyDpf+cB7RH6td69ZRqCbjvYwl4wUF+PI4uK5bM7V7yXe//4NvFEj2rdn656y/ZLt2nYh0basygKKQAoCLKokiKLAgAAxZRyFuXtFGVcqnu66vzq5zNeP/9VOhvTfY4ercyPjQyc+MOfBXQouz8tiaIkh7vghN5d5q13W3lvFNKjP4v6+t6PhRJFMF/faDR2n3brcGe7c/09cLFD0ddr1yQ/tzm1U7gwqv1i7736/NjIwED1rD9MpTowNDqxtLr7LOIobe0Xe+tLYyMDtc64s9WBodG36+/tvUhy1Vr7fzuvXN2Q1E4i6p7KjO4sqmsKKZ0nLWctgEIiiyopsigAAFBMqWZR1oN33M0RkmRhZ0porpjaSWNjutDnd66otuI8XnxF0vDThQMifrnymnsXLi5/mvc2ITX6sygh/g5WuTD69sqHidoJM+e3i9oLzqMHS6NDAypZeE8qyu5L7pGhN4SsWYcP6zcvVKQbesrsuzy7/Vyhbd86fFg/H5FQtqbajfrDwxhJ3NGDuUHveoOuGp8jH0H3VGY0Z1GZFVIJ6DxpOWsBFBhZVEmRRQEAgGJKM4tSGnGNLMqXtT3uPCzBTY8fLQijOBnGaytfZra1ughnTbcNNIgIcs+iTlWGFVsci8DamZI1eb6y+Fjv97j74xQq+shCYXbf55Qe2yxKl9GjR8tXA1v0z5mDc8FTXSmvq3K1/iRKhGw937wluUfSqn9KcxaVVSEVm86TlrMWQLGRRZUUWRQAACimFLMotR4uZFG+9m8POQ9LSGNoa3fB/fJs5eqdrpxRROxNV8DBqKBHUbIowzAM80q9Sy4Ya3dOaJ80r9zRHZa4B/4sXRZVnN3/cu2a0K5fnb5fjCjK2q8L8wLFvc4irkv9ij16tOi3Ylr1T+geoy+jQioenSctZy2AwiOLKimyKAAAUEzpZVFCFCXvpEMW5ae1OeY6LOGNoe2Du/XJkYGBgaHRhfVP4owGUwzeAQeZNKpnFSmLMgyjOrUT/P57UVj7a9cdLb3hL+7HEC0L7zmF2n3PMF3V62sFiU1b96dl3TZCyHpIB6yrUj2ff8d7xYZHcn5dS04FVTd8pmFU10UXje4sKptCKhadJy1nLYAuQBZVUmRRAACgmFLLohSjKLIoX965v0vUQEAYVRbZZFGv/ajhsro0MeozTUgXjQhptZ7tNhqNxr29VKa7ip6F95Ti7X77xd69RqPR2H3WKsopaj1evOi9gszajeW7Z5totb74UDaLjqREl/ajqY2vd/a2/UK6Kp+I4FRA15JTgdWNowc/mVH3x9/1zNrYTYPk6s+ibDv1QioOnSctZy2ArkAWVVJkUQAAoJjSyqLcc20Y/k15ZFE+Pr9zRe0I9iIhjGKYvt6UTRYlLVGs59vTwpTw5J4d3muwTOWPXfrdVyLM7efTs/Boe7zf83fCbFfCyyvydR3tTHnb/s1ra/K2c+v55riYAigVDrGOhreDTHcVJelkUcWj86TlrAXQHciiSoosCgAAFFNKWZT3pXJj6LZPTZMsSq69Pe5pjxj684+akbwszOvz0Xk7hfXP7ea9SUhBjlmUbcsn4uFUs207wtsEvanku69EuMsb1bld+T3Hm+wZhjl93/kHny57+6r0T+1I28SPNse816xsJsqjR8tX5V0fVQuHaMQOMsFdXwqnJFmUzpOWsxZAlyCLKimyKAAAUEwpZVHqUYLuLMpqPdvdqM9PjA4NdIyMzczX39v7Ino2Y7W+2HvPvbaRsZmlVcVhktrHT3dXl2bGRgYGBgZqfabZVxsYGBqd8F3BZ383PzE6NFBVao4Io9J62n6xd6+zhSeGRidmllZ3nx4rjKnz1cfOoc92D5wfab/Ye68+f77mk/0+UBupx9oej74z6Do5Z1G29eAd4eX3K3c+D/sSyWUTpVw4/e6TokpcicKl577wGo1Go/HxV8EbLC3H5F/VPm4e/F/etlMxC3eG3f4lgdV6trU0NjIwUKvVBgZGJlceySeNiVxYnmvtf+D48nuuqfKs1rPd1SXHno+MzdffC5xNL8buxz/WStw72Gg0Go0P9r1t3qkVxn6EeWlkreunxPv8tbWvz/9bbNQPWJeYEXj/+HB7Uta1pHprc1243vW06ovFTreNdKY/i1IqpLI+azWetJy1ALoFWVRJkUUBAIBiSieLEsaXG9/2a/rTl0W1D7YWXg8e3KRy4Wb9Q8V5C9oHW7PDAZlQZdi3VdW22wd365NBnzYMs3aj/tDbIio5GvEFxjfW4cOVsC3suzy7FdwM7Nne08jROnxYv+kzH49h1m6sPAn/CYR+CcLwOOgBeWdR4nkWct20D7ZmL/vMSG8YxkkZI1zXXkePgi++yoXRCXFij5//qrMC9WLTOnwom6/EcT2+vrB11rz7q/8wEiEIdx4ozwadDaope8/fu6FxC8tz3t/8tMU48LeqDC+8711j/N2PcayjkJzU4renVxjL/fqjn8443pwwa7P3/Yto8YR17oC4f68sPvb/ZrFZ33s0PrvjnW/HvLL46Ei2HTpa9Vs7U56woIvmnTulP4tSKqQyPms1nrSctQC6BllUSZFFAQCAYkoni/I+Ogf0NNCTRSkPbWIotWRY+2vXhRmpZSpXl715lHX4/kJww6rr83f2nQ//2WRRajMSnG2ipM3Wd3tfWXys8lOYg3MP/GK8M96Wm8BmHnSp3LMooQNewHWjXsoEneDKhUvQbigWm0ePFr2tm/LtrY1vPreilj8BWZQxdHvftvbrkm93DteaqLAM+M3HNo9Uyrjq9bUExa/nPIl6rKOIk0XpLIyTEw+t4+UCcdw072BoHkLnFvFVBdd0P+c/dCqt+uKsQV3YjbcYWVShztrAk5azFkD3IIsqKbIoAABQTKlkUd6Ws6BHdA1ZlGRi6DCnr5tKyVtQ/Vc1/B+edj56+P7cYITPGoZnqusMsqiIu3eyjbd8Wk+F7a3WFEOu/vHt4KYkoaWHjlE9KPcsav/2kPev5Sfa0c60cn5rGIZh1qbFOexjFVay3VAqNmWzYfmqzv7y1xqzKGNq+/GidwQrwzDOX0xIXFgG/Ob9tZpiwnXptiONSpBFRT/WUcTKojQWxokFdyHxDukbOk6m0PFaNgrw0YOF4Yph9l1eeBB0h03cqi+O82neerf77lUFyaIKdNaG9HvirAXQNciiSoosCgAAFFMqWZT3/c+g1y2TZlFxopWTJ+9ra7KR8cXJnDsqVckATubYpqNBJFKL5BnH3NnW8+2lk/G43hDacfsvvyUO23VO/IDssMduCpdP8J0kO/OdMvyUt2MUL+32oLyzKPHdcOl55lPKVKpDp2PpjY1IxnYTG0vFUZEMo3Jh9O36RqPRWF2aCBhjtHJhNji09u5k691b4srMvtrI2MzE6FDNPXbd6aZ++pe/E6H8CsyiqlWfgqaznUkLy+DfXJXzPhB79+Mc6yjiZVERhBXGCYmX2dkgjrYt62ASWgcI7rES6YNJW/XFfbu4+LgLRzorShYVQbpnbfBJy1kLoIuQRZUUWRQAACimNLIo4SE96Lk5WRZlSd+9rwzPbjkmim+/2FuflryBL0ujxNmoDcOoXnfMMmUdfrLemUhKeE/fu0GV4cn63adns9y3j59uSbZE9kJqyFQFKgdS/MDR5pjkMNRu1D/8ojMtlNV6dndZNoiYrOHHryHJudtW6wv58Q+ZnEB4i1jPdN0oknyzKFnwLLnMrP3bwjrNwbm/d888J+vn47lmxMmpvAWI9Xx9zJNW/fYfNw5eemdtCy82JSNIXbntHJvUaj07m2DPsRVW62Wz2Ww2N97yrn/ozz9qujm3SrlJ2dG1QFth6ZdFmbXXF9b3Dk5uBe3jp/KC7bWV89tAvN2PeazVJcqidBTGyYh3VdfXiXvnHMdRSvyI4qsKulv1Jd1L5C+5FF7Bsqjcz9qQk5azFkAXIYsqKbIoAABQTGlkUd4n7sCZfhJlUbJspTq1LZveSNqzwduUIXu9XfoWu3X4cGV+ZmlbMnKdtb92o2YaRuXCTUeC5dxo55QAp8TXY1PIomTBnafN9HwjZf2nnI22fl9qGNXrdcn4h7K9loxQE7Ty8W3e2+01+WVR1uFDyawksqRDUir4BQrCZeNanzg3ley1eGEHrq19LfxReLEpTE7ic7W1j5vHkhIgavnj16RsDk6v7x28bFlW62WzeXBw4PoyTYWl7Dc3B6clxbMsVpQd4Gi7n/BYh4udRWkrjBOQ3KXdG+/tAavQRC8eEMXt19yqL/btSzXUS1OBsqgCnLWhJy1nLYAuQhZVUmRRAACgmLLIogIf0ZNkUZIBttxD5gVvl+FtepaMuiLJX5ITWzHEJgn9WZT4LmzguCyy4cQuLn8a9qWv/PCRzxrFvZa2sp/zzsfAe7SrqQAAIABJREFUIH29J5ss6q0NR3eWp7uNjfrk5T7JaGzS0kMyVFPAxBrev3b+rbBp8jNaZYjT8GJT+IvQt/ZDviBGFmVeqe8nbeJUKSwlv/mb6z73AUkhL2kQjrb7CY91uJhZlMbCODZJo763h23ke530gKhVG7S26kv6VXbvTaowWVQBzlqFk5azFkAXIYsqKbIoAABQTGlkUVGmi0qSRYkjXoW83in5gHMGAGtnSmifVhzPPyKFpgX9WZQ41XZI0Cb5gHcbomyl2CskZJciZZroStlkUUrMK4uSl/El63PNGiLYvz3k+mtH0KGYRalksDGyKKN6a1PSj9OHjixKzwWrUFhGauP1/kDSP06YRUU71uFiZlEaC+N4ZL2RxbFeu7VVX0wsglLqoitMFpX3Wat20nLWAugiZFElRRYFAACKKY0syvvgnFIWJWmYCBvGTZiCyDWAoOSt2yt3Plfc6UgUmjG0Z1GSJtiwt/eFoaeEbC7SVkbdJbKo3leQLMqs3ViRjlUp60Yz+tNnTX/Pfjrqd8kIJZY01RIS83hj9Emu97MJlGSD4YV/QdQsStewTwpbEqmNV+mPo+1+wmMdTnsWFaclPTLJQK/SnnLd2aovGfI2oJtx8XVBFpXFWat60nLWAugiZFElRRYFAACKqYuzKMmDfejQSJJvO28qTjR1lar2cbPZ3HgrtBlDexYl2buwCZgkR9gz9xdZFBLJPYsy+y5PrjyUzTAXa3USjtNWiJnMayv/4P5qsa1QetorlFWfLguzw3VULoy+Xb/7rOV//SfPojRcrqqFZd5ZVMJjHa4LsyjZjIM+06yJHXBjtOqb0/dVNktbq76ke8m1Nf3j+WaHLCrSSctZC6CLkEWVFFkUAAAopi7OoiSfDG0MkLzA3vmMUntfRO3jp7sb9fmJ0aGBmmyCGv9v0p1FydrUww60rOeZ+zNkUUgk/yxqcHo7aDQ16TxIkThPW8kkbNXry+/tHTSbzWbzYG99drji2T75BHgqxaasYdWjcuFmXR7E5ZBFxS8sc8+ikh3rcN2WRR09mBsUhjnzHbZQ3LsYrfqKm6+rVV9MH3X1A8xL6bOoaCctZy2ALkIWVVJkUQAAoJjSyKIiZQhas6jQTwa16enMoqzDT9YXRi9UvCv0lUcWFb53oYc41YYklXlz0N2yyaJe+1Hj1Oq00Nzo/+a7bevIotzDWiqEFg6+L62rFX7W/p2r4WWQWZveFjKSDLOo5IVl/llUomMdrquyqKNHi8J8O/Jhzk5J5nEMu5OLmy8byVLpg3Fa9Vvv3vLuYdffncqdRUU+aTlrAXQRsqiSIosCAADFlEUW5RnXzU1rFhX6ZJ9BFmUdvr/g7dwQLo8sqn9uN2Rf8s2ivH8fNqQguk82WZTzpD3aHvd2TfLtfWTLRmLqv/zWjLolodeVtb92XSmOqlyty+ewsiMUm9bhw/qNWlAvI8MwDKM6fb8V8gVpZFGaCssiZFF2/GMdrnuyqPaT2xHb9G3ZxIQhd3IxB1Ac7ExPq77YvcS89W7U37RoSpxFxTppOWsBdA+yqJIiiwIAAMWURhbV2hxTf26On0UFjbcX4ds67QfCZqs3FXQEvRxv9tUGBgZGxmZmZt4QZhdJPYsKH29PFJ5fpdmQJLTc6J+8C3nLPouy7S/Xrol5Qf/UjrRZLvZ084GO70/XhE1wCB3PLWKx2T7YXV0YfTVo5LuLy58Gf4H2LEpfYVmQLOpE9GMdrkuyKGu/LmnTX3zk2+vwlNhIH/KehJgQK3Yw0dGqLxloM/IPWkBlzaLinrSctQC6B1lUSZFFAQCAYkojixKenK/c+Vz5b9Ufs2NkR5JhVRwfEZsKlNsKTrfo/rTQ4cHsuzxZv/v0pWvqeoUmFd1ZlP148RXvHwT9Lj4HxPORNBuSvBs8dJuHlZ6TRxblM6dUdW5XbeKkhCeiO4IxB18fHRo4MzI2s7S6+6wV2gEwZrHZPn56tz55WZqTuC/G1LMonYVlobKoM+rHOlw3ZFHSNv3atP/wlw7izSnSrSGk77VT8lZ98bfwHUmzq5Qyi0py0nLWAugaZFElRRYFAACKKZUsyvvcGxQRxc+iZOlK8MO9tTMlNAw6ZnORJVVTO+rjwn258prn4/3XVqTjvOSRRUmiO89UNl6SBlDv8U2xIUnoyBW8sehK+WRRtrU7Jxkm7+LiY/FqlZQKr63Eb8TzzBf15rpSq6cgQbFp27Z1+P6cOG+WawVpZ1FaC8tCZlGnFI51uMJnUdI+bkHzsHmIrz0EbI442Fj4cLNnkrbqS7qX9L/zoBcGjy1fFpX0pOWsBdAtypdFWa2XzWbzZfi7Xb2NLAoAABRTKllUlI5RSRpVJWGUtDn5lGTqZnezsmxMOp+huyTERmvfhok8sihpPzLfaXJsWduJ2H6RYkOS98dVfocYXSSnLEraOmcYxqXbYhwipiZ+XagUeC6qwAswSLIsyrZlhWeWWZTewrLIWZRthx7rcMXOoqQzoEVp07dlzfp+F5n14B3vn0a4NyRs1ZcUBkmS6SIpWRal46TlrAXQJUqVRVn7azcvnL1pULkwuemdt7VEyKIAAEAxpZNFCU1n49t+FcFEjaqSuMR3ymnr8aL4x565myXP7NLmadtuP1l/e2JiadtRwRXbC/32+mj9TeFbwrOokKaL8GYaWRbn2/hytDkm/LE4v0B6DUlCYzXdonpRblmUz7RRsoGLZJdCYKNl+8WHK/MTE2//rVBySDpZVaojYzNLq41Tu0+bzWazedwO3svkWZRwnNzlS9TyJ2Irsd7CMossKkkWHnKsY6ygOFmU9Xzzltimfyty04/kXi679cpu41G2PFGrviRQ8FYhuleZsihdJy1nLYDuUKIsSjICdHX6flnLPLIoAABQTOlkUcL7ov5tb5L2itd+1Ajx8Venn5Y1ExvV6yv/zd0r3zp8uCyOxiJ5h1UW1whtFO2DremzUZccbdJie6FsGJT2wfp4TfwOoWFCMldT//h/etG27fbB1sLY5Jq3wUOhmUbWImKYg3N//8Ld8i3fRlkzfWoNScJwiswW1ZNyzKJ8po2SdFWSjuhn1sbXhYmd2i8+XJkc7pQ0QmIlDDwZpFIdGJms35XOHqXSzHu0M10zDaMyPLt14I22rP3bnn33DEd6f1rM39550LZt27YOH67Ut58n6CGpu7DUn0VF3f1ExzpcUbMo63B7Srg0Kpf+fOejexv1+ZkA8yuPPJeZrKdi9Xr94aF1/m2y23iErsvS/VZv1Ze8qiK+ntG1SpNF6TxpOWsBdIXyZFGSd76MqLM/9xCyKAAAUEwpZVHCeHARRmBS4HgQl/ZuMAyzrzYydtKAMDZSFWMow+89qc/uCHNZG4ZhVC6MTszMzMzMTIxecK+t094sm42qer3+4cFx27bt9nHz6e7qrHwqe8nxkU3v5P6E5/VbpWYa+Tw5hlGpDnX271XpJppX7kh+wdQakrxRnPrUCugmuWZRPpdD//i20OIovmZ5ell0ypmxkQFJOeMNcGU9L8OYtXHhhf3wZt6j7XHHJVQZnqy/t3fQbDabzYO995aF4am8UZD8ab5SHTjbS0/5E7GVWG9hqT+Lirb7CY91uGJmUZ65zyIyr/+Np2nI515eqQ4MDAwM1OT3paBRLr++92NvnPCG8DbGxTfcf/Hje/IWK1n3krhDbBZRSbIo3SctZy2ALlCeLEr6llmyGTG7GVkUAAAoppSyKLEtz++dpKRZVMzGBd+h/Gxrvy5No3zXVJs9zbTkU9CoEavJoWvzNHMrNtNE3b0TfkOSpdWQ5J1gJXJHAnSHfLMov6tMElPHu24MszbtvnJirsd7AYY18/qGZz6bKfZ5DE3N3Ol01FZirYWl/iwqyu4nP9ahiphFSfsQRyIe9qj38pD5feRNUiF8joMkcoieKRZZKbKoNE5azloAhVeeLEr+Jif9ovLeEAAAAJe0sijxgdqnIpg8i7Jt++jB3GCEJobK1fqToPlYjh4tKrYXm4NzDxzNCj6vyEo+9MTT1ClrSjh695a0Q9f5ipwvuKo300hn7Q74ltr09qFP60VKDUnCLAxMFtWj8s6i/K7Zi4uPxRHjnqxEuW4Mo3J1WRjTyW4f/Kfp3/mnUVZzukWucZVCmnl//elfq2+qkJedCI9YnKlK9FZijYVlClmU+u7rONZhiphFSYYxjEh22KUz+UgF3Zf8D1s4+Ssckh6Ur61EzhSLrBRZVDonLWctgIIrTxYlK/mYL4osCgAAFExqWZT4RC1/CNaSRdm2bR0+rN+QzC3iURmeXA/Moc5W93xTNlOJg1m74ZwV4NTRI9nEVM7vX3j/0LKF9+7lTSrW/prvPlUu3HR9f7RmmvbB1uxwcNJlGIZZe33p/aCWk3QakrxRFDNt96z8syi/YTllU9Db9tGj+s0LodeNz8RBdvtJ3VU6VK7+2cbJDHirSzOnQ2QO+QzrZFy58/n5mhSaedsHW76j3HWYtRt1MS87Ze3fCSjM3AVgnFZibYVlGllUpN1PfqyDFTGLinXndvH7jY4ehd3KzdqNFYXbuLZWfXFeSv+O1d2qFFlUeictZy2AAitRFmXb1uH7C2dVMrPv8kLgc2yPI4sCAADFlF4WJY5yJA2jfjk/EN38L32+s/1ib31pbERoza1Uh0bfrr+390IhhuqwWs/u1ie9s02drOrus5Zv1bZ9sLXgnXWpUh0aXVh3fr+1/7eTI509+sOffe6zNqv17G59fmJ06OQPR8Zm5usbu+LXiwfSf53OVb89OuSd58bsq42MLa1KvsQr0peq/rEwQB9RVM/Sn0V9/rM/VC8vTh09WnFci6defWvD5w1yv1LmZNo13wvHPauQX9pl27ZttZ6tC+/ZuzpGSYpN6U5arWe7q5JtDS/FTj9/+HDFUwSafbWRSeGjMYof27Y1FZaS39z/J4/yx8q7b9vJj3UAyTaLhzeVwthfrDu34m/UuTeFnhmBZGVBKMlxePbTUedfDI2+vRIzVCww/VmUUiGV7Vmb7knLWQugoEqVRZ2wWi+bLxNUvHoDWRQAACimFLMocWx+9zBTKbNaL5vNZrPZPI6SPwWuK2qltn3cjPOxXJxua/4bK0y2zfwGPUx/FpWxs+smvJTxvu4eMu7k/u0hdxaVeOZl9U31/7CGwjT4C3Ivf+Si7n6iYw23k4PJoUyX/iyq3DhrARRHCbMo2DZZFAAAKKo0syhiBUQmjCuTaYCJjHV9FqXOOzxUSBYl9A6c2qHsBJAOsigA6FVkUSVFFgUAAIop1SxKnPmHmZMRSJgq6toaJ0wPK1EWdX/aHbIGzd1hHW65x/NjoEoAKSKLAoBeRRZVUmRRAACgmFLOosRx+ugaBV/C2VKd2+Vs6WUlyqJam2OGh1l7fWH13t5B89zT3Y3626/XhDnn7yQcoA8A/JFFAUCvIosqKbIoAABQTGlnUeI0KVfuRJsiHeXx0ULV1QI/tslc272tRFmUbe3OuU5vZUE9qAAgObIoAOhVZFElRRYFAACKKf0sytUEW7m6/Ih4AX6OHiwMV85Olkt1+oL0ujJlUbZt7d+5WpHnTb6q19cIogCkiywKAHoVWVRJkUUBAIBiyiCLsu2j7fF+ozI8u3XQTvNr0BPaB1uzwxXj4uJjmuB7XrmyKNu2rcOH9RveIfh8UGQCyAZZFAD0KrKokiKLAgAAxZRJFmXbRy9e0KYKdUeHhyRRJVC6LOpE+2B3dWlspNYnC6XMvtrIZP29T7gCAGSELAoAehVZVEmRRQEAgGLKKIsCAEFJsyiH9nHT6WWLBApA1siiAKBXkUWVFFkUAAAoJrIoAHkhiwKA3JFFAUCvIosqKbIoAABQTGRRAPJCFgUAuSOLAoBeRRZVUmRRAACgmMiiAOSFLAoAckcWBQC9qqBZ1Le+dXFw8NJ3vvPGv/yXb7KksXz/+2/19X3ze98by31LWFhYWFhYWFicy40b/5thfOO7381/S1hYWMq2fP/7bxnGN65f5ymJhYWFJbdlcPASTYIsLCwsPbl85ztvGMY37t//QEuEpC2L+o3fqA4O/u7JqxAsKS3f+97N3LeBhYWFhYWFhUVc/tW/+l/7+r6Z+2awsLCUcPmjP/rfc98GFhYWljIvf/AH16gHsrCwsPTkMjh46R/9o9/4z/95W0uERL+orln+6I/+tWF8g35RLCwsLCwsLEVbrl//fl/fN998k1oKCwtL1stJv6jvf/+t3LeEhYWFpbTL7/7u7w8OXsp9M1hYWFhYtC+///vfNQrYL4r5otLGfFEAAKCYmC8KQF6YLwoAcnfy7jzzRQFA7ynofFFkUWkjiwIAAMVEFgUgL2RRAJA7sigA6FVkUSVFFgUAAIqJLApAXsiiACB3ZFEA0KvIokqKLAoAABQTWRSAvJBFAUDuyKIAoFeRRZUUWRQAACgmsigAeSGLAoDckUUBQK8iiyopsigAAFBMZFEA8kIWBQC5I4sCgF5FFlVSZFEAAKCYyKIA5IUsCgByRxYFAL2KLKqkyKIAAEAxkUUByAtZFADkjiwKAHoVWVRJkUUBAIBiIosCkBeyKADIHVkUAPQqsqiSIosCAADFRBYFIC9kUQCQO7IoAOhVZFElRRYFAACKiSwKQF7IogAgd2RRANCryKJKiiwKAAAUE1kUgLyQRQFA7siiAKBXkUWVFFkUgEJoHzc7XrasvDcHQBGQRQHIC1kUAOSOLAoAehVZVEmVJ4tq7X/Q6Phgv6Vjne3jZrN53NaxKiA7xTxxd6aMjkv1z/LeHABFQBYFIC9kUdq0j5/uNhqrSzMzMzMzS6uNxu5TXjsCoIQsysVqvTx/fzPSE73V+mLvXmOjPj8zMzMzX99o3Ns7iNsioHNdAEqMLKqkypNFfVa/pLOl23q+OV4zDcMwDLN2Y22fxyl0hQKfuGRRAARkUQDyQhaVXPtga2H0QsWQqVwYXdg6oPESQCCyqDPW/tqN0wf5k6f5K3Wlh3nr8OHK5OU+U1YQm32XJ1ceHiq3CehcFwCQRZ2ynn+kue9MsWWbRbn6JmV8gPVmUa61GYZxcflTPZsJdV997DibPv4qykfT6CXXFYp84pJFARBknUVZrS/27q0uzUyMDg04jYzNzNc3eJO/B7nqEhErE+hxuWVRRw9+MnPmx/e+TrQua/9v5zsr+/mvslxX+8nK9ao0hXKqXq8/Okq0WQB6WuZZ1NGTe4lqBVbr2e7q0szYiLMaOV9/b+9Fouzd2r/tepA3r9xReGC2Dt+fG5QmR651DU5vPw+t4epcFwDYNlnUifaT+tXzF7dK0RqaaRb15cprrvvUtbVkT1eRaM2iPr9zxXPP7fGzxdqdO32YnNrJe1s6nNlFxO3S3Euua6ifuDn84mRRAASZZVHtg7t1v/c8XSoXRhfWPynFS59frl0ze71Ith680+/8efvndvPeJBRHTlnU0c6UI8FJdvlZ+/UrjmItUZ0u2ro8f20YhlGpnrbKVj39pMwry4/L814YgGgyzaKsw+1pR9ejiIWmdfhwZXJY3hPUMAzD7Ls8GzOnsR4vXnSuqjq1o5Diu+8nJ5tQOymIa946b/XWu4HJm851AcAJsij76IEn5e/hR+9zWWZR3ijKMF5b+TKD7z2hNX1obY55diXTXC1750ePLKqbqZ+4OfziZFEABFlkUe0nKzd9hpDyZdZu1Ht+FJJOqdy7RbI3ijKM/nce9PjPCnW5ZFGdDFjD5Xf+YlHyOl20dXnaLCtX/+yuazC+9osP664+U2rNqgBKKLssytpfux6/0Dx6tHxVpTZp1qa3o9YgYyVRnlcCzNr4qutdKqv1bGt6UG3MP53rAoCOkmdR1vPNW8IYAr376O2QYRb16fJF7yHO8hjrTR+s3QXnWL3V6fu9/TrfeUxAFtXVlE/cHH5xsigAgrSzKHeH+IgqV5d7eWip8ztlzxbJrXdvCT3hzKkdGk9wIvssStKZKP7lJ77DHr9OF3Fdroe+6pS82dU63Hau9OLiYy49AKKMsqijR4ve8jdCoXm04+xOZRiGUamOjJ0OaTo24u04FC1+974LcOm2SszjquOYV24/kY4Q2H5y27Hb5timdLt0rgsAzpU5i/JriOjZR2+n7LIoWRSV5XQ12tOH9sHWwujQwNDowvqTXr/Nfr12LXKFLH1kUbEonbh5/OJkUQAEqWZRQod4wzDMvstjS6u7T5uOmaGs1svm090NyRh+5tW//jyNLSuE3bn+Hi+SZVGUYZi33u3t14ugLOssyjsZSKLL72h7vF9YWcw6XcR1ufobBrZGHm2OnV+DdEoEIJNBFuUZmS9yoekqy8ROQ7Zt2+0Dd7+h/vFtxSak1v1pZxKl2uHINSZRUNjv7nMlHbhI57oAwKG0WZSsIeJUrz56u2SVRTmfSvrfmZvqHPPMRuYvc/qQ2OPFVyJWyLJAFpWePH5xsigAgvSyKLH/gTk4vfWsFfx8337xYf1Gp7lC7cXULuUY1LVHi2Rn08q1ubnzekGPD7sMZdlmUc7mxurFi/800eX32Z1O+WZevJisThd5XY5KpGGMbQZlu9b2+PmfMl0bAIm0syhxZL6ITQytnSlH/u7Xacj2Vj3VOoN6kyjVzkauoflfWXwc9Lf7t4fO/1ZSB9K5LgBwKmUW5RkawDAqV6fHz8vOHn30dssoi3JGUebUzpHjdpbVS3CkD/E5HxTJosogl1+cLAqAIK0syjvcSaTB+63nv1i+OTTwxp0eTqJcrQm9WSQ7o6hL9c+czee8yQvbtrPNopyD4FWn729OJbj8nM2d5pU7O+eV3uh1ujjrilKhc9XIx7d7uUwFEE+qWZR7WDnDMGvTU29Ga2JwdRqKUuYptIN5xkeNMLSfq3AN2w1nqT10W2h71bkuAHAqXxblff/hpBmidK2h2WRRzlFQzKkdS/yH9JE+xOc8dmRRZZDLL1660hdAuHSyqFhTQJeNo0zuySLZOXT0pfpnkn9A6WWXRX25dq3zYHRx8bHluP4in4zOpN0c2zxyVuqi1ulircsxznPELIoLD4AovSzKO0RS5Wr9STtS8GK7izyFUX6d7WBhnUG9SdTcrnqz2flAywq7EdKsonNdAOBUsizKOzNhZ/rp0rWGZpJFtcRuUNbO+TB9sUfmbx83n+42TrkndxAFPetYrZcHe/dO1nNv7yBwPZ2d2v+g0fHxV5K/sFovmyeO2+5/f7a7UZ8/mclyvr6x6zckkNV6tttYXZo5s7R6b+8LlW3zaB8f7N3rfOPJmhq7T4/9eo8LnJdFxApF+/ipax9mZubr78Xai+DNyiCLslovPfsyX9+I/ou0j5/uOn+M0N+ifXx6GgnnZfvF3j3n9iyt+p5L58JPXDunX7x0pS+AcKlkUc5mX0N1kBRl5zd/d6ltHX7yXqfwX1rdPQgo+K3WF+779nx9Y/epUu3ELX6R7LxPxumYEW8PdBw8NZJuUM5djj2daaSqqchZIW3c2ztoBtQPEh+sNKtovSGjLMrd9ehkIpDYWZSrf9VJyh47i4q7rtj9omi1BCBKJ4uynm/ecr+ZPr753LKjl0rOEk9lTDpndhVYQrpn6lOdJupM7L5Mkm3SuS4AcCpXFuUeqbV66+S2Y9slLDqzyKKc3ZY7PZFd09pGHEm2fXBXMoO4YRiG2Xd5cuXDF7Knbmn6YB0+XJGtqXJhdGEruKUj/JZ8/hedrl/tg63Z4Yq42bUbK65xha3Dh/WbF8Q/PNnF2e3nahURv907382by3d9drO1/8FGfX5mZmxkYKDq2JJKdUAw/0vx8+2Du8s+u2AYhlEZng05wOEyy6LaB1sLo/77YvZdnl0X5ieVrmbW79cw+y77HZDz3Tx/dSpgVWFH1vfEzf0XL13pCyBcGlmUs/+LYfRP7cR7H8aPo5TtBBrtJys3vJNiy2dRaR9sLbwunT/bMAyjcuFm/aHSWILxiuSvPm6sLs3MTIwODdQc9xizrybcB/7wZ5/7fXOCPUh28NS5KqGdEflc9dWIM9fEqpo6Nujwk3WfmkblwuiCdCKz+Acrgypab8gki7L2b3d+yPO2xphZlLPpstPfM2YWFX9drulCIswXxWhOACTSyaJcfY7MK4uPzjrIR8yiPr9zJcqf265nXnP6vu/2eZKoO1G7yDpL1yhzPEkGS9W5LgBwKlcWZXemYXXedmy7hK2hGWRRPo/28naAMNbh+wuSMMejer3+yDvcjpA+yJ7XXYJnj4iSRRlDt/eFd2+839Z5/LT271wN2UVzcO5ByHhCobvXITtanv0L4dl96/m2LHGLsxeBssii1E64k72ZDsoIj3amw3+OytW6ONepYzfHNlu2be2vhf2yZm3ad7wp3xM391+8dKUvgHApZFHODjEJ+r/4EgY5db8A1SkQhfYH1RtO59VdHwmKZNd9NZismE6+B7EPXjR+70NJX54KX1vsqukJpQqbpJIR62BlVUXrDRlkUc5Z6c1ra53HoVhZ1OnT7ckJdz6WU6wsKtG6nKVs4PAXzsGqIgfAAMohrTH6zspf55vpduQsKnrnTpUBSI42xxz38/7x7eh3ZOfQRMG1Xdc7WtKXxHWuCwAcSpdF2Xb7xd6u0JehdK2h6WdRzvuR+y0K58CzSo1B3jm+AlVnf/lr54fd6cMP6wrJgBE0ck+kLMoYv+3Y9LMXjGue92cv1T/zDh101ifF+6eno7b78Y59fLaqodGx0SF3r5eTlYnZhesVnxDO3Zd9deeNamE3nI/dkaWeRclOOLOvNjAwMjY2IvtRKlflM9l7m4fMvldHJ07Gw5lwvwZdnb7vfWJ37ObQ7SeuNXW6LAm/qH83ft8TN/dfvHSlL4Bw+rMod+6eQmHj/IJra197Bvv3+2bxhlOpjozNzCytNhqrS957hf8MV8mK5PvTSu+wSI+clj2Id/CicrV/u3ptRJz1QbrbAbxVU1v+g/kxr/61szNa9IOlLxpIAAAgAElEQVSVYRWtN6SeRTl/NHdbY/QsylXXvHTbUQmMnkUlXpcz1g0orlznLFU/AFLpzRdltZ7tCgPZRgyXXDFN1DH6fF6tcSdRjjK0faw+y4L7vRvftgF3O4XfYAE61wUA50qYRUmVrjU09SzK+WacN3AK+j+R881BwzAMs3Zj+a5jop328dO79cmzlz2F5x5prw+z9vrCumNo/PbxU+8gen6nQbQs6lRleNY1zop1+LDuaMPof2d786x9pHq97hrRxfOnRsAru85XGU8OVN07OEz7xd76tKtBQqhTnM9D8NGfO3pav7XRFDjqRO6aU2V4sn7XNbCM1Xq2Pu6MAWPPFpZ6FuU94bw/3sne3F12/yqyB25XvmheWfQOT9Q+uLt8o2b6vPPk3M1qtXq2Let7rt+0/WJvddydr8qDVP8TN+9fvHSlL4Bw2rMoV5tB2EAjsbgmWrq9Nnd2j6hcOHsJYWZidGjo3zrfPHDfcMzaDck4dp5qgHy4lqRFcmeGwubGW+d/NPTnHwn3Ac88SJr2IM7Bi8x5DnhvSUH/J1tVsqqpt8J2cnc/r5VarS/21jsjHnorapEPVpZVtN6Qchbl/EG8J0fULMp6vNh59y/gTFGqLetYl7tF0hyc9g772D7Ycj6IRJ0JBUB5pJdFSUXt6OR8v7ozM4O/o/U3z1cvLeDdN+uLP7y7t74wOuQeQn9odMHTGCD9LlfgX73urZp5G5h83xzQvC4AOEMWdaJ0raEpZ1GuNyjEuMnZZypkYAZrd875uO/pSu1w9GhlcvTmmvBAIyRD5uDc+9Ih+JwDt/tvWOQsyu/7nE9r/f39p/du+eiA7pqJvI3A3bEq6NnO8zKv7zDE0SpkZ8Nf1sbX/WYbcG9i7M7bqWZR3hMuqGbmfs9Y6NrkevnJtzub1Xopn+HcO2SSd2BR55a4X4qWniAqv2Y+v3jpSl8A4bRnUe4R+qLdOtQ4S9DTu3rIIK7uG07Q/cY63DqfPkBeCcilSNa2B9EPXnTOHhviFrj6TIVUUJJWTb0VNr+7u/V8e2F0dME7Zl6Mg5VdFa03pJlFucIaxyB4p6JlUc76n9ifLVoWpW1d3m54Zl9tZGxmZmZmZmzE3QuPESEBBCh4FmXtTDly9aCha2x31i/vFtXamep3lo9mQN/pynDYPOJC5+1KdejkfZUJd7xlGNXrYgtaausCgBNkUSdK1xqabhbliqJkx9MVRgWNzO8a6yFg5Dx/7mTIbzA1yXb7vDYdMYsKbJlxfV1wHcY1BK+k+uJeV+jYwu43en1+gsgVstZL7wvTgVsZdwpyV0gj673jz9XxR3Zmuk841/AkMu43mz3Tnzm3M0arjms3zSu3xRmlHDwNY5Kv059F6frFS1f6AginPYtyFampFDXCqy9hr4a6bjihFRznSyny7c++SNa3B5EPXnSuKEryArMrjAqczjRh1dT9K4Q1X0nEOlhZVdF6Q3pZlOu9N1ktM0oW5ZzhXlbzj5JF6VzXyXvyNy8EzU9WGZ5cEftQAsC5gmdRnufvgDeBrcNt92C6klusq7FHRXiv0vbB1uxlYW4B5ypqry94+65msC4AIIs6U7rW0FSzKIXneee9PmAoEFeVIN6QIWozBJ1x9rWWP4hHzKKCB7LYHnfewQP7drte6b5y53P3/7oOeXAbyilXU4rPS9aRZ+QM57zS4s5VHGGO9UCSs8FVC1SZv9zddOPuAqgxixq6HVoWutumxHM3jSxKRfgvXrrSF0A43VmUe2a8LLKo0IzBecNRqeA4X8AVagGqtBbJGvcg6sGLLvwlKNcbzgEjSCesmrq+Rm3a1KAN0HmwdFTRekNaWZTzTTCfZkT1LMr5OlToNGwhdTqd67Jt2zp8uDIZ2GppmH2XCaMABCp6FuUdu8ZnZH/vTBCymoO7LadTStbf2zs4eaH26e7G+ci/wcX1mfbB1sJo4EsBRuXCqFqApHNdAGCTRZ0pXWtomlmUa1IGv1gkeKiUU662I4VheGWiZVHhf60zi7L3b4d00znnOqreP3W3bKjlHq4VSg9uGsmEjnWml0W5tk6xHcYVErpW6Qo2L/1FYL+mkN1UKZRcJ5PYdS6vLCp8naUrfQGE051FuZvvM8iiQnvLuG4eSp1QnLft8e14bbg6i2SdexDx4EXn3Fi/N01Cxpc+lbRqen/aUWGLdSamdrDSqAR0p3SyKNcgeH7jYytmUe6R/ryDRJ9SzI90rsu2209WbtQ8bapmX21gYGBgoOaNp8zajZWo1WMAZVH8LEoYKf+sxBsZm5kYHfr/2Xv/0DiyPMEz9q+AzmlyvWwudWTVClP4xK4QLs46Sutqb611de4tvK2xb4sRBmnmGJFGNYyZkdhuOM+stHW0mc5/DNct0eaalq8xtz2ytKxAdl2XscA9plXgbosVLsjCVI3JklmE/kiaIf+I/+L+SEn5Xvx8kfEiIzLi8+H9U+XUy5cvIl689/28H+5GzzA8OyHizv6G4X/GQ7uxelU+R3xm06vJtvY/XXCKK6NUGRoaGhoaqrj+YXTB+wQL7XkBAByDi+pQuGhogi5KWnDjr0UUPiYvG+pxu5BoLkr6yuRdVJTCBU1XlQJCCmto3F/uJV4K56Lko+1VI31SccQ7WTaEhlm9XH8cetSod75KjZJUENekeVwUAAwQmXBRn80P+TP/WdBXhL6JpbiD4jInobXstbHU2CRr/QXRKi8ykmXyn2mi8rG4XVNp3oj3ZtBhJFZZuKhjknBR4vT5gLVsSi5KOnjE30Yq+SOdeclayzCMyvjC2u6h2PVtH+461giE7zMFAMVkEFyUbVv7G7NOAS9jVirdzoX7OD6Xigpe7iSf7ug18dt5kvTwHy0//kpcrmW1vnpcl2cN+H2nzrwAALrgojoULhqanIuS3uJBg3RJRnkun9Iy2o7mosLvhEy4KEe2cmREeba0lKPHpRoIFxUtj+AKlyJEyjeclKccV3Kd6WAYpcr4dP3+joKTitwoBT8vuCgAGCAycV5U4MwHV3sWrbshzSGJTgZclNZfELGvFhFpakiQ/5FllOfyqbhdU+mm6m15W2KVhYs6RruLkpceBYXpFFyUvL4qQOQo+COdebnOTrn51O93Hjy6MSxELv0WYwFAoRkMF2Xb/huTmuVz08uP1z7uNo1e5wTK02HDTwlwnG/teFfIrqpy9d5Lv1Os9u5cktps93JdnXkBAIjgojoULhqamIuKcHqANAPEazMULSeNF8FFycpDuevkv7tc5B/iidV6vbu9vr6yWKvVapPj7u05suaiervh5O6jwxLK/TKR0umJhdVnAWvY47koV8X0w0X1dsUL1/oCQDjaXZS0a6piA5eki4q5wlelsUy4Sdb6CxJ1UdIxDCEHNIn3iWcvNmbXtMcOm38evVZWUl20fKDZRVl7t7qXLGTCeKiLOtiYOrlHQ5YUhfojnXmFhUcdSHWidtItABSMwXFRRxy9WTts7zYP246FRd5rT6UeqsoxknL0QZpRLJ9l7bOF3wniS8BtwXTmBQAgg4vqULhoaFIuSt4s7vrP14P4+XVhGYrHe1fD5FFcVIxv761DZrVebK8sTIy4tg92kw8XFVaeg6d11875XUqjcxveM4wGxkXFveKFa30BIBztLkreAEWtrbFebizWBD46dyqgPevdRX179EotGvO/8I0a961J1voLknRRUszm2x9+EtgzXf/kw2+ffNhLRsXsmupY8R+jspLvouUDrS6q9XC2G4is3NgOvmdCXNQXt7vrq7x2epI/HOyPdOZlO09SC56OaNsOR0z/DwBcDJyLciOZKL8XgNixUNu71//McelMSgWvJc4jd56BqTMvAAAZXFSHwkVDk3FR8uSJiLh35mddlF/JMuqi2o21OY/V6SeY5WoO10Uplaf9amd1YeK0d/DHey5qPBdlzj4M+FddLkrLFS9c6wsA4Wh3UY43pf9plqpZ6FwXpSnk0d8mWesvSNBFyYs1IuK+TwZ2XVSfumj5QKeL+u8/v9T7Dei80L9e8FlsH42ZTc152b2cpCZPEOh1ziEA5JZBd1HyCXq+UxF+/5+vdr9XsXvq1wWLfialtChLmiKjMy8AAAe4qA6Fi4Ym4qKkDfmj41rK6z/jIwJFcFFBu8Sp5uhx7nikDpl7N7pSZXxyvn73wU6j+frkhMtMnxcVtmmhQp4uBeSg/Wrnft1jO2mPFfuRG6Xg4mt3UdqueOFaXwAIR7+Lcpxv1MuWUDpdlPRpDVHY/jfJWn9Bci7K4+DGKLjuk5hdUzlg3y8X1ccuWj7Qui4q5slq0oWWO/w9M7OpOS+7J82qZc4hAOSWwXZRiibKlttCxe8V/0QMP0RvVv3bbp15AQA4wEV1KFw0NAkXJW+20APODR20TJgrgouSJ6F4WCVPpOr1cigRfoi0/twojc6tvWh5Xq5Mu6jQGvGkp8pvN9ZmxWObQ5YFKp0MEjwjVbOL0njFC9f6AkA4CbgoefMQn037A9HpoqQ4sNqWLAGk0SRr/QWJuSj5oveAc1eauF1TDbOGo1ZWX7to+UCri7K2b2hYgHTUv5QPku+Rox6uzrxwUQCgnUF2UdLurCHbs4p74ak1hVJXRPwTXBQADAi4qA6Fi4Ym4KKkd6LycYWSwHLKKGkqoTtYr0QhXJQ8t1EtNCKvYvNaD678Q6S9GYMPZc60i3Icd6YWIpKyjHSTWp/ffDugNFEbJSm+5f4DrS5K6xUvXOsLAOEk4aIcoVdz7HbEBkeni9JpX1JqknX6o6RclPRmVF4LJwksp4yK2TWVO2zx94oMraw+d9HygVYXZdt2+7Cpyt2Pjq/AyF/9uvu/D9vHeVmt16p5/fqvThbxfXS3+7+7K+F05iUdF6V0+8hzqFQncwFAYRhcFyXPAQmb/CQ2n0qzYeUwjhj6kY54UupNSau9pW/XmRcAgANcVIfCRUP1uyhpQ35lFRWiRKQgQoRMBQrhohwresIPDHae7dXjTz0iwmSebLso+YZTOKLTcd9HPaRT7LDFdFHy9fSYoa7VRWm94oVrfQEgnERclGMKgM9hff5odVHBwiMSaTXJ+n5BQi5KfjNG2JYxcJZJzK6pvLAq9l6RoZXV5y5aPtDtoiLQfQDjPwfCBY19OcPzkh4MlZWS0h8QtQQAJ4Pqor64LWzOp7IMX5zkotCtkDs3UvhM7mIonNwn/4E0KUBnXgAADnBRHQoXDdXuouRxe5SheWCoQAp0RJ/D7CxYbl2UY4PE8N8pzw73joWo/pAoHTdpukz2XJR8w52a2QzpdMkbr0QOSYnFcfXXxJ8Zukbr4N6k2Of1CAnqdFF6r3jhWl8ACCcZF+XeLqty6Y66jtLrohxzGSbvBSxYiVEsGb1Nsq5fkJCLkic7RbI+gfOrYnZN5Q5bZfZh+PQhmUiV1e8uWj7ARfWQl3xjh3aJ5eGf0jQ6ACgWA+mi5GOiFDeEFvsVYb0pa+/WWf/GU96ZOLTnI/V2nCEEnXkBAMjgojoULhqq20XJIfxoW5bIoxHHe8u5o86t523vXA6eLp0vmdVZ5+4jBXFRjvha8GRvRx/JbwdjqXQBNkTacCboVxw8vSl+bxZdlOOGC97NRl5+b1684+qhtQ+FbVVciBUXfF5U8AV1XE/vHmxkF9W3K1641hcAwknKRblaTMMwq1OrDf+WuvuHrcfzbwW0Z9F1SmtzRgzG+vdwjkuw/2R5euKK054l1ySH7vmr6Rck46Lk0HjE3fBkzeYI9cTsmjqEaGVmY9+7mq2X96aqZun8bbm+IlVWv7to+QAX1Ute8nguuAst96B73PoCAPLNALooxwte+WhSudMRMO53NJ7uMI5shKKEENy2SWdeAAASuKgOhYuGanZRkfdlCPhzh4xyvtjM6uX6E2nUbrVerM2NlnzekkVxUc4jMg1zeHbNI7pm7T9ZOl8SPuc/VpTXWYt9qXZjbfFHj07+TDo8wafP1W6sTlUdZyRn0UU5l9UblUuO+83793j0zo4uSGl04VOvMJPUlfSYOiT9TMMwSueXPApi7T+pX5Kuu083UeW2TOeKF671BYBwknNRtm0fPLox7GidzOqFhdWdr1qerdnh7lZ9+lzZDG7PetEpjpiCWZ1afeFVBqv1Ym3upATO97bWJlneN0uY22DtP1le/IXzBaPnFyThoiJvLhPw504ZFbdr6qg1ozQ65+ixtV89rl8+uWByfUWrrD530fIBLqq3vGRL6+f5Xbeb12QuAICBc1GOl7uyibLdm0h7BHLarx7Lo37vldXODQB8QwhySMhzdrLOvAAARIrooj6bH3JREVpPs1x1/vP8Z0kUJE20uqjAhU1KyCdBOyfHOcfs0kWqOqJDzgBHcVyUx2xvo1QZn5yv311fX19fv1ufvzZxWuonGObYzaf+sxal4hmGWb1wrVar1SY70RUhRCWv4DaHZ1d3Gp31QO3D5u72ysLx95rV9893P5pNF+Vxw5nlMxPXFlfW19fX19dXFmuTzphk5eq9l44el9R3M8vn5la2d5vNw7bdPmw2dla7ISrDME5NbbivgtNFdS7o6W5B7tbnXQXxn7CkdFumcsVxUQDgIlEXZdt2+/nyJWfPotPKVoaGRiau1Wq1Wm1y3N3JOP7Y6N/81pFlbzrFuRrF6Ly5a0ct/d36/LWJM84yVOY++wcxE51NsryxnWGURidrtVrt2oVO8NgdWdHyC/S7qMCFTSpIC4rcM3xjdU29Omyde889KjFcr/aIldXfLlo+wEX1mpf7uRC70CuLXo1B4BYEAFBcEnRRX/70Q1dAUHp1d9/Ix3z405Dzjxw2PoqJsm2vfoFZro5P1o46pK7uqP+o36OHIcSE7tbnJ8cd3Qz/zHTmBQDQpYguyjPEG0z+BmQ6XZQct+htb1h5jz/XTg3W/qeuScwelM4vucxKkVyUHRBeU6wuGfkUIhfd85Q8YjJ+3yd4x6y6KOUbzjAMwzCrUy4RZUe4EubwjUdel0E6L2rqhkJmrn18fH+6b62lccVxUQDgImkXZdu23W6sSdMCFCmdvlL3enn2rFMOnjrmkyo0rM4sNL6EHXNzXXj8tPi/QLuLkjLs7SwaeY8/93YzMbqmtm2rdhM8+hhRK6uvXbR8gIvqPa/OzpKhN5zv7Q0AcESCLsox/1KF4DbZ6WyimijbtqP0pkrn64GbIkfql4XEhHTmBQBwBC5KifwNyDS6KHmw3uvIST4J2itqYO0/qV857f0iNMtnrixteZ73UDAXZdtK4bXS6PSy185zLjx2MjrJYm5DGD8Gjz2F0J2gLrPromy7c8NdDh5Om9ULC14bIR7TbghbEvlUou/fO25F9+p3uSTO/YECf3pArfX/iuOiAMBFP1yUbdu23W547L/n09CWz03Xvbsath1Tpxw8XZ4O82Kl0xP+rxydL2Fr746PJDGrlz09XOxfoNtFyZ3Kmc2eot1y/9ZzqlWPXdMTgroJpcr43Oozjzd79MrqYxctH+Ci4uVlvdxYuBAipMK60ABQeAbHRTn2souxMig8AFEanV5W0j1K/TLFmJDOvAAA7GK6qN/+rBaVnzl3Yhl49Lmo3//6/zqpp/n6/9fz7Dbr5cbiSUZ/tvKb3/t8rPXVzoP1leOPLq6sPzjea8Sbbx580r2QnzwIO7pavDs8Py3l53ljhH+ip8JJ9234HWm1XmyvLF6bGDnZ6+Vo46HFlW3Psxz8c9p/snx9YqSzMNwsV4fGJxdXd1551Lm1/2x1cXL8eIW7Wa4OjUxcc364e6V7fK4i1oRIxLvBtu32q5379XlhoyazXB0aGp+cr9/3rAM3nSsxOX5yIXzqxYmXojmu4aOsSpWhofFJtSsa4bbs8xUPfeYAoHj0zUUd0T7c3b5bn69Njgs7pHX2XBufrC2uPPA5S0og+gvGie+Le75+P/z79b6E2421xcnx7stmZOJ6fSv0XdPzL4hfeRKN+98/yW1x9XnPU3QPni7Pn2R087985fOxyF1TB+3D3e31u/Wjr5qv313f3n3tX1u9VVafumj5IEUX1e0TxX8OhDsl9uXsIS9XDzp6FxoAikyCLkp6kaoR0CZ/9V9udj83HzBrSZX2q53VxWsTIyetZ2fQP6/QEXPg7pf1HBPSmhcAFJ0iuiiwNZ8XBQDaYbkQABSXfrsoAIBjUnRRAADQIUEXBQAAqYKLKii4KIBsg4sCgOKCiwKAtMBFAQCkDi4KACCv4KIKCi4KINvgogCguOCiACAtcFEAAKmDiwIAyCu4qIKCiwLINrgoACguuCgASAtcFABA6uCiAADyCi6qoOCiALINLgoAigsuCgDSAhcFAJA6uCgAgLyCiyoouCiAbIOLAoDigosCgLTARQEApA4uCgAgr+CiCgouCiDb4KIAoLjgogAgLXBRAACpg4sCAMgruKiCgosCyDa//VnthE8efJN2cQAA+gguCgDSAhcFAJA6uCgAgLyCiyoouCgAAADIJrgoAEgLXBQAQOrgogAA8gouqqDgogAAACCb4KIAIC1wUQAAqYOLAgDIK7iogoKLAgAAgGyCiwKAtMBFAQCkDi4KACCv4KIKCi4KAAAAsgkuCgDSAhcFAJA6uCgAgLySURf1xhunh4fPjo7+z++8M05KIn3vex+Vy2985zv/S+olIZFIJBKJRBLTd77zQbn8xvvvfzf1kpBIpKKlf/tvJ8vlN9599/3US0IikUiFTcPDZ995511CgiQSiZS/NDHxoWF86+HDX2lRSNpc1B/8QeXNN//HzlQIUkLp3/27f596GUgkEolEIpHc6fLl/y31MpBIpGImRkkkEomUbvpX/+oiIUESiUTKZRoePvuP/lHpb/92Q4tC0uai3nzzzJtvnrl8+d9fuTJFSiL94R/+kWF8a2rqj1MvCYlEIpFIJJKYLl36Xrn8xne+80HqJSGRSEVL3/veR4ySSCQSKd30zjvvDg+fTb0YJBKJRNKe3nnnXSOD66I4LyppOC8KAAAAsgnnRQFAWnBeFABA6nTmznNeFABA/sjoeVG4qKTBRQEAAEA2wUUBQFrgogAAUgcXBQCQV3BRBQUXBQAAANkEFwUAaYGLAgBIHVwUAEBewUUVFFwUAAAAZBNcFACkBS4KACB1cFEAAHkFF1VQcFEAAACQTXBRAJAWuCgAgNTBRQEA5BVcVEHBRQEAAEA2wUUBQFrgogAAUgcXBQCQV3BRBQUXBQAAANkEFwUAaYGLAgBIHVwUAEBewUUVFFwUAAAAZBNcFACkBS4KACB1cFEAAHkFF1VQcFEAAACQTXBRAJAWuCgAgNTBRQEA5BVcVEHBRQEAAEA2wUUBQFrgogAAUgcXBQCQV3BRBQUXBQAAANkEFwUAaYGLAgBIHVwUAEBewUUVFFwUAAAAZBNcFACkBS4KACB1cFEAAHkFF1VQcFEAAACQTXBRAJAWuCgAgNTBRQEA5BVcVEHJr4uy9p+tLtZqi6vP9i2vf//ypx8OnfDhT7/sd/kAAEALn83TmucWXBQApAUuCgAgdXBRttV63Ww2m69bnnEtAICBBRdVUHLqoqzPF4dN4whzeGG75frIF/Wzxgln61/E/sqXGwsTI0NDIxMLa4123NwAALLGwdPl6fGhoaHx6eUn3o4/JTZntLbmkCVwUQCQFrgoAIDUScFFWftPlq9PjJxMdTvz0d2v+/ftx4VovdiqX584UzYNAbNcHZ+ub71ASwFAHii6i2ofNne310/Y3i3KpIN8uijJMxmGYby99LvAz8SOXn5956LQSTDHbmc8Gto+bDZ2HqyLbO8y1QYA/LC2b1SERrUy+9Ct+NMCF5VjcFEAkBb9clFW67XYK3+w0zjsfVabzjFtYcfHAJAh+u6iHIMew5y8dxA3z/Zh8xiVhrT9fPlyVXJQTszq5eXn8SdARywXAIBeiuqirP1nqwsTp0tezXv5zJWlrbyvcOmri7IefXxKqOFTHz+K9r47ePSjWq1Wq9U+efBN4AfFwGSHmU3nZ7S6qM9vviV/36kb27EyTAbvyTUSpcrIxMLqzquc3/cwcJw8/T/7rYbc4jz+UvPiblnySuvepKOxuHjHpx229n4xr9RSawMXlWMScVGuCSuqZPOJ19s8AsAxibuodmOrPn3Os1teqozP+e0z7onOMW2MvHpuXo/gJQ4ADvrsoloPZyUTVZnZjG2iDu5NmurN3MHmbLCH0la2aOUCANBOEV2U9fLeVHgrXzq/9DT22ye79NNFWZszcnVHlFHf3Lmo+KL8evm90IGNVhf1cNZ5I2UsYGXtP1udG/UaU/pgVi/Xs7ULFxSaL2+P6Xy0cFGR6V6B0Ho7aQ/7NqTBReUYXFQomptHADgmURd18HTpfGjH3KxO3XsZ3hvXOaaNmRcuCgA001cX5TJRN7bjRkSsvfqYqdzMOT9dOn1l6f5Oo7N0qbFzvz4tx3TO3trrsYDRygUAkASFc1HOpjcQHZMhMkofXVTrl1edNW5e/WWEXZ66i49CX5TW3u3u+K50/rbHG1qri2ptzpzq/YcljPVyI5KGEn6G2ggYIHG2bxw/YbiolHCGlzx2Pu2gPmtAG7ioHIOLCkVz8wgAxyTnog42ZyqBjY2AOVYPjDTqHNPGz8s9cyUavMQBwEEfXZSjbQ5rflVwN6uBzdzvlt4Wvn/4xqcek4MPHt0YFrL0HZPpLBcAQCIUzEU5RwCl0bmV4z2w24fN3S3nfAPz4p3+H1fYD/rnotw7PBnRnI21MRXlRWm1Xmyvr6+vb/sc7Kj3vChhT1+z/H6GltK1n9e9Zl2WKuOTtfn63eMd4O/W52uT41WPXULM8z/5Mu0fAYVHePpxUWlh7X+6cPRiLJ2e9tfUe7dG+j2kwUXlmD64qLc/qKmSxU3wdDePAHBMQi7KGQE0q5eX7h+dEWW1Xjd2VhcuyCuTAibm6xzTasnrZNNQZf7k/e5O573FVAEgz/TNRblMVPwjwHh2O8kAACAASURBVJ1HT4WMVaQjLYIikNJh5ebMZlRjFrFcAAAJUSgXJS9iqVzyPvXv4OlNcaAQ+XCjwaBvLkrcNu/s2W4U6L1lVcknxI50vCg1uyjbtjtnP8Y4bVg7HrMbS6PTy4/9T4Nqv3IMgHNrYWGgEB5XXFSqWK3XYSfbdisIFwXx6YOLGvDHWHfzCADHJOOipAbIZ9a7bb28d1UMFPqMl3SOaVMaH1uf3zxZBWBO3svMbD4AyAp9clEHG1PiRjdajokS5JZpHjedAWMV8eCHYMMkW6uIMipyuQAAEqJILko6TChwg1V5sJClbde00S8XJVblxTvb9R5klPBqzqqLyhau/T8ql+pqC7as/SdL75dNPbOBAOIjuAZcVMbRPGtACVxUjsFFhaG7eQSAY5JwUVL88NTUhn/HXHZDnguGdI5pUxofi5lpOJcFAPJHX1xUEiZKyPLtmzcVtviRWtfJe4GNq7TpUKThT/RyAQAkRYFclNjEh03mkpr4Uze2NRYjI/TJRYkb3763/LX034q7MXTPIMFFqeA6d3Nmw2vepT9W63WmFnlBgRFPH8BFZRzNswaUwEXlGFxUCNqbRwA4JgEXZW3OdGe9h83H656UaxjGxTvfOP9d55g2nfGx5NvU98oAgCLRBxd1cG9S3EwmUMerIe5PY47V9yyVjSO6J4AqdOrE4Y85+zDJcgEAJEVxXJSoNN66+XnIp6V4hccgYODpj4sSX6udgYY4+U5NRonjsT64qPZh84iQ/ajiYrVeN/V/lbjhhaHn3E2VbxV+SxY8VvciaijOSWYRr5JQKfGr5CSz0EIIvz3m12qtRTlD5aoUW5DBdVFiTfb8rIsPWczLkUzbE3fWgNSKqP5EXFSOGTAX1dMN7EBoKhSeTA3No962oNeXZd+6XQDKJOCixCc2ZNK7Lb/d3M5H55g2nfFxFAEGAEUlcRclHb6kJXDiMj5qm5hLbWsUFxXebMcqFwBAUhTHRTXufjQyVCkZhlE6/5Pw5jbvIa5+uChpN4rjAYsoo4JGH1brdbO5u72+/gNh54i3rv14PQK/2vMY6/kEo9uNtYWJM2X5lKVSZXxu9VnwsqKId0r71ePl664vMoxSZWRiIey7Qmn98qqY8ds3P09weGe1XmzVp8errt9ilCrjk4u+P+bFjyeGjhm5ckelz3fwaGH85G8mf+Y9fdJqvVhbnByvlBylMcvV8en6ViMoNvjZ/HHuH3Rbh3ZjbU46q9k8/dc7wh99+dMP3X9ktxtb9WlnKczymYmFtcAieGfXbqwtTJyWMiudvlJ/4qxba//ZqvODhmGWz1xZCv7lTuLUYrcaR/784cmz1ymax7M1vez6GSeF8Hj63/uB+xH/zd9H+Gm23VcX1X61s7owMeKqScMsn5m4HlaV3Wy87qdO/fnn0b2Xxj/ptgF+N8k5/yvRIXB81D5sNhs7D9Z/fK07a8CrpfZsjju/z6tFDL5Djsn7i7rQDIaLincDd/BuIzuvDfeLVEPzGKcf0tPLUterAaBf6HdRv//1X40PVcumYZjVuYehm9sFxyV1jmnTGB+zKAoAVEjYRTlMlIZj66ztG93jmI4P31ZxPuKsgDDPH+WzccsFAJAUxXFR0RD3PmFdVG9Iu1F0pwCKr09fGSVFfXvG873qDkZbLzfkKIoDszp176VvYER9VOaK1nh+12XFs528kLomSZ50Zu0/qV+uuoJvTkqjC14HM4s7NSpNh5SumdegVak8pdG5Db/rKFzFo4t4sDnrzlC+wK7zcaz9TxcCr3DlUoB6E7Ibu/2lbdsHj/xzK52/fZKT9fLeVOCP9zuHWnctuo8vaT9fDszRHL7xyHm7y8HiYCKHkvvjolQedcMwq5dDrsvB06Xzwdn4XA730U3txmrgTRLYyvnHxCK01K7aVrrfzOps0CajuKgck3UXpeMGVmi+5V5B7OYxdj+kp5elllcDQB9J4ryoSIjH2MfdK17nmFZLXtKiqJnNHJ7KDABaSNRFfXF7TOiIaDkmSjizWzgUUMn5SOGRwLWz0tRjpWVRccoFAJAQuChvxJ0U1LdhHSCSd1Hie1KyIuJm4366pH8u6unTm2OhTiWof6IWDLX2NzyiNUapMjTkXjfRa2dI2sY9uT0v2s/rIQFyEXPspiuoJR2THF7OkNM8vctjlqtD7iVbfmvvhas4cmtPWsYuMrUh/rFQLnP2oWK1+F9cKbvN/Y2ZSlA+xyc9W3t3LoV8sPPDbwd3MnXUoliNY7e/8L7n3SVzZDbgLsrnUfejctVPAfndhC5KV/7f/x7wM2c27YNHN4bjtHL6XZS1/6lSkYLLhYvKNVl2UbpuYDE6EMTJMqNYzaOWfkhPL0strwaAPpK2i5LmlnXmJ/WOzjGthrykXTMUzw4GgEKSoItymKjZ8OWqYRxsTJ20bVInSs35yGNU32OrrL1bwudUmtCY5QIASAZclCfizIQEV5ekSOIuShxGOapQms3hPe/j4NGPah0+Oiec5Hjq3Ee1YKSPh7uoU5VKpyhm+dx0/f5Oo3NmQWPnfn3aMXXYL5ivEgx1xJvM6uWlrV3hPAmr9WJrSZwk3FsQRpxFaZgzm0mEcVyBJ7N6YWFle7fZfN1qd7YOWnFuA+b+NZFklHjFXE+jszyl0bnVna+EMyfar3ZWpWngnhE28SrObMiHbgk/RB52iwWrVI8vn1k+N12/u717cistOaZ/+7UoUnaVyvHv6d6XrrzeW/6625E+uRB+X3u8IF/hqvZYi2I1mtXq8T1fOj2xsPLg+OHa3V5xTsuX+9HW3i/mvR7ntz9wP+8/+63fT/IhaRflCi2fXMDDdmczu/v16XOy3fOsS/nkN7N6uf745IJYrRfbK3PHuXScpP/PPDszO+bbyjmK4tPK+buobktd+0Bc7ejRUn/y4GT+9O8f/3lVrqXTE92bt7m7vbJwQbp7fUeIuKgck10XpesGls/LLo3OrXX7Be1XO/eXrhy9Srutd4zmUVM/pKeXpZZXA0AfSdlFSQOluA+CzjGthrzEEUA+h9gAoIvEXJRkosyx+l7r1c6DlcVarTY5Pj5Zq9UWVx7svIqyy72Yo6Pbp+h8Wg9nhX5aZcZjXb0lz1VVMWjxywUAkAi4KA+kGVs57Scn7aKkoYbTikhjrJB9wiPGjsM/7p5WbA7f8NpJzm4/vyUF6L1vhfBgqDgbxadnYdu2c4VL9E6B/MvCD0buAXkqjmGO3fQ51uHAsdzMeXKVtIQrWEZJA1/HrSSXxxy75bflmbQwxGNDEPEqvnexs3e0WZ1aEXqh7UPncfTuW6lyyX2Sk23b1svVSeEW8Lm2ruw8t9aTtNHZixdPHX3UY/M/6+W9q2Ls0S+coa0W3atkzOFZz1OyDp5+X7qRfMRppHNclUjWRcmPulG5uup9oJPzyrg3KJd2OPVZoGDtP1men7/zedipeIZhGEbp/JLns6rUyildhyhaqGvazOplz2fGbj//T+Jv8HlP4KJyTHZdlKYbWJpm4TP/pN1YW6wtbnqd/BStedTWD+npZan71QCQNOm6KGnCVkwVpXNMqyEveVFUoqfaAsDAk5CLks+J+vbIxXHv5dpm+dxcyHHPHeThuXNNk7LzcUwONasXTqbsNHYeOCY6qcxc1lQuAIAEwEW5kV5Pee0nJ+yipK3A3aZBCrQGy6ikXVTwe9wxkdirqGHBUPGsyNBegzghJvIW6lK0R2n34KjIPbeQrQTlhR3OupN8ZJCMElWU83NSecJ2NhSnBbkulDtSptC/k2+l4PMt5AnwCndmwM+RghSG4b0yxutrvW8KfbXoqMbA07Ec6368I46D5aKkRz30DpIvjfPWFnfBGbkV+UXoaOUCr4TToHm0ctpdlG1bLzcWa7XFoAGeFLHyOZYCF5VjMuyitNzA0h5c8pZ2SkRpHjX2Q3p6Wep+NQAkTZouSn5eXXNVoqFzTKshL2mmYsByfQAAOyEX1dqcEQc+oQQPo2y50fbqFEVxPmHHmHcIPL45kXIBAOgGF+VEihDq2Ds2myTrooL8gW3bUTYLT9ZFCcc3+iDH/UMmCXv8s7zPRvjITfi+iFMO5dOikuhTSIdqKqgyORTnuMySj/SXUdKt5Di9WVoxFT5aF4vjvOcc4TW1AbJ0K313Nfj75cvjFXiUsguMTEoxzGCbK1Wz52I5jbUoVeNb338afLN/fvOt7qe9fUvCLsosV4ciIJ2o4i6N9KirPIBS2+J42sWajBul9t9y3LMkHkHzBFyUEtIt4lkNuKgc0wcXFU6suyr4BhaL0oNwjtI86uyH9PSy1P1qAEia9FyUpGNDz/oMQeeYVkNe0rAgsVNtASA3JOGiPHuCZvnMxLXODseT4+6jkoPmaoozl73b7IjOp/1q+5ML33aX8ZhvT/zNrxW2D9ReLgAAreCiJOSVsWFLBAaZRF2UOKff6Q+OkMYjQWt4knVRCm9eOe7vDuYHB0Olv1Z6zwvl86m78D9Mpk8hBYjU1l1J9srxJ0pDUjEDp/mQDlBWmTwtehlHvN0xa9t3nZFENFMSeuNFyE786SGxui9vjwV+rc5ajGgGwve8S9hFxcFVGlk2Km2RKdsr6U/EuukhXhO14mQZ5Sp8Wi5KqlPPPHFROWbwXVTwDSwVJWSz4tCfEviUa+2H9PSy1P1qAEiatFyUtB1Db2fHnqBzTKslL6mr0UOjBwBFQ7+LkmfKGoZhVC7VHzvVTrux5lid5Df1Rtxdwm9Op7rzcX+vH6XR4N0D9ZYLAEA/uCgBeUM2xSH2gJKgi1LUTJKw8g+2pu6i7L1bI90/cOuhwBiLtTHV/VfFbfOEDMduf6nyFx16clF//5t1f34jnVEhSQ1VTSb5K2eZwm8BUUU5/1q6LmqnYwlV5H+yuvoAOVrAPzSuHiG7KDex+NPc2kprLUYMOEo3x8C7qIezglfy3lDOhXRPSCZQVuB+hz2p/UyVigsWzWm5qPA8cVE5ZvBdVMj9Kc0pMKtTPsfLKf2UoKdcbz+kp5el7lcDQNKk4qJk4RNzCzudY1otebEoCgCiot1FOVVUgFl3Hvfs1WyJe9f7Z6XofA42Z6Vjq8zqhev1u9u7zWaz2Wzubt+tX7/g+MCsz1dqLRcAQCLgoo5xTPkK2xh20EnORcmbwQRsv6cmo9J3UVIcxx0XCYyxSF/21vt/UlPgA3/9EkhPe/S5jn4QkX+r9FHFWLujUM7KC9vLUfx3V8xLLM+3R6+oVO1H5075lKWnedgRA/5h0bg+uKjg2zd2LUYMOIb/4IRd1FvXfhygYl38QFw75CyNvPen6opGf1crHydldI7PXdl+0VJ6L0WuuOAHFRcFKdAHF/X2B2HN3ScP1F513gTfn44zFQ3DKJ2+snR/R2HjFddPCXrK9fZDenpZ6n41ACRNCi5KXhIVeARpKDrHtJrykhZF8b4GABW0uyhpGlDoNubykbrOXYulxjFouaiK85FbWqN0fumpV37W/pOb4ue8ls9qLRcAQFLgomzbtm1r7/b5UmCrnjcSc1HKKkqOw/qejZS+i5JDL66/CIyxBKqecKJ1DKQvU4yGq7soaVmUenhIWi0S6OrcMkpUUS75FXeBCy7KlVHsWhw0FxWx4x1Yk8E3uh9BT5U4pU3ALJ+bXFwNCVdHrzjpxzkXZPbRRVmt181ms7HzwKX/cFFFow8uSr/niHYDtx7OCosNupROT1yvb4WYZ+WnXG8/BBcFhaDfLkqeDx93Pz19Y1pdeVnbNwTRFu04XAAoLLpdlLQfiEpTJB03IO0HIrVqwctFFZzP13cuCqO+4JM9pW92TdfVWy4AgMTARdm2tXfnktBD9l3tmiuSclGRziWQXu8++4MV2UWZl34eZUq2HGRT3G/tJ+f9NyWWYkA9hvBCqlucJ+mUUYKr9OgsxrQolYVfi7nhonTUYpFdVHAr0Vue1st7U1UvH2UYhmFWLyz4bhQe00U5y5+si7JaL7bv1ue9jgoWwUUVjUFxUXFuYNs+eLrk/xIujU4v+27P2ScX5eyH4KKgEPTVRR08ujHcbT1K52/Hkkf6xrT68pLCrMHzFAEATtDtosTuiNIxyfJCqm4PRlrIGra8Ktz5yMor1JHJJw6LbarmcgEAJEfhXZT18t5VcRPsWFPRBoiEXJS0BUNEvA8eyI+Lcp6tox/59AmlDpYT/xhQMi5KkpeyjApWUXLGkQ7W8gIXpaMWcVGRMw698az9Z6sLE6f9gtU+u+UMhouy9p+tzp0LjN+HVSouKsdk3kVpuIE7tBtb9WnfjPz26urJRcXvh+CioBD0z0UdPBU3XIq5iknjmFZjXvKiqMl7xRhoA0B8NLso6eAFtXGDtIv58bYzrc0ZIeYSuvtxd9/jU+c+8toHWprLrRLCkU+QOBnB6y4XAECCFNtFWfsbM0UUUXZSLkqa1BEZTxmVNRcV7byo/h7BbW3OCMGsng4G9o8B9bhHn89soi7izB6xyELVef4SqWsYOwpdVBeltxaL7KJ626NPGnsE/UKr9WJ7ZWHijEe4ujL7MNjURndRUxvyA5eAi2o/X77sWvNVqgyNT9Zqiyvr6+vr69u7zbsfheSJi8oxmXZRmm5gOc9XO/fr0+MVt3k2x27HeGPo7YfgoqAQ9MlFtZ/f0ieiNI5ptY6PpUVRwTtGAQCIJLkuSrF/4dntkYZ9PXPSIYo+ipR6St15RprLBQCQIEV2UdIiVqNy9d7LAnWPE3FR8VSU97YN6bso6Q/cxzAFxlgkgRN/2UkY8ortXjZkD4gBSV0xtR0AndN2nCFuV6G71ilMRcm9rdhzvYvqovTWYpFdlJTxWzc/V8tS2rZ85JbCC6/9amd1blQOVrt/R+SK8xnSRMkuwsV3nM9rVi8srO585XE4TmieuKgck10Xpe8G9s6+9WJryWG6PGbJKj/levshuCgoBP1wUXJLYo7d9DypXhGdY1qt42N5UdTFO15bYAAAeJKki3KdRe2JFMo4GarJkwl75aRDFH13DZ/urOZyAQAkSGFdlKOj7b3RUY5JwEVZjz4Wl8D82d11FVb+RPBXHiHc1F2UbFPcDiY4xiItC1IVOL0jX4OQky+9CIgBSfEst5PzRpqQ7RNrFwt97J2Ev/OL60u9LeXgvw+FdVFaa7HILkqeiaY2vJGXpXmrWm/kPX3cXxe14uQllb1lp3zx5cDU2E3f83BwUcUmqy5K5w0c9DXyBlnud676U661H4KLgkKQuItyiCifrTgV0Tmm1Tw+lhZF9bRhAwAUF90uSpwEqDbslUIZ3RGS9XJjMXgDvPC98BY3jj2/NheluVwAAAlSTBd1sDlb1bUnwoCi30XJGkQxFms7jphyD1PSdlEOw+b+fHCMRYrx9rJQKSrSqC/80EonQTEgqTOmdvRwyJqyI9wySgid+X+RlHnMo5AL66K01mKhXZTkldQe9RADFPy3YsPk+iERKy6sldPqoqTVm96nBKrniYvKMRl1UVpv4GCk3pGrrOpPudZ+CC4KCkGyLsrau31eWN8cbws8nWNa3eNj6/ObwoTDkAYTAMCBbhcldYhUmqTe9r1w0O0E+XSBpH0yVCb8ykNIpZ01eikXAECCFNBFHTy6MVxwEWUn4KLk7eGihFWDZVTKLkr+WV4fD4mxhLos3Vh7t8RYm1GZ2fCfte0iMAYk7cGoMLtRHoMG/YFjRz5BRQV1E+U7Z2YzRoCtuC5KZy0W2kU52gqF8c3BvclofyAh/pKYLkouuYeQ1OqixDUaYYMnXFSRyaiL0noDhxB4rkGEp1xnPwQXBYUgQRdl7d25pO0sJp1jWv3jY6mbE7ODCQAFRLeLksc8oXMwpZXwvU/ZDHc+0u4a4TEWuVvnsY2zrnIBACRH0VyUvLWROXbreVv3VwwGul2UHM2MtgmMtE2Yc85usi7q1NRG0BBQ7oF4b3MeGmORDI7S2M5qvdh5FkEgOf9cPsvCMCqX6qqb0AfHgCRtEbbmylGM4GsnVNKpG/WumQoO0Mt3ndJ4vv1qZ6fhfugL7KI01mKyLirauiGV79TrohwDg5C2xbENTvQYjRgRd+3uJ/3MkEsqF8SzlYvsooKm9InDreAJhnLJcFFFI6MuSusNHIzYN3Jrr0jNo75+CC4KCkFSLsqx+Wa06WJOdI5pExgfyxPS4i68B4ACot1FyaO14P6Q3I2LsbIz3Pk45FJwN80RYul981NcFACkSaFcVPv5LX2bcw84ml2UJCkibwEjn5oiiyz5DMbvrgqXzGodug4Lj+iiDMMcvvGp90Cw/bwubqFhVG5se30uPMbSejgr9mRK55f8zVC7cXxmeayZko7Ok2EYpdHp5cevAkaWVuvF1tKV0+IvdseA5IGlUbm07DNYdYy2/Sqvi3BZKpWTvwyVml/clo+Qn/I/Ydnaf7Y6N1oyPHt4RXZR+moxWRflaFfah4c9BEqSdFHOlU7+bYvzvCcPAXTwaGF8aHxuzUv52bZ9sDF1MmbxaHCdrZzvkejyS9HvQY3sohxBJ6mplg6e8w1OOVsQXFTxyKiL0ncDW3t3royMXKn7HDglrXEOW64Y2jxq64fgoqAQJOKirP0NfWcx6RzTJjI+lnpE/dikHAByh34X5Rz2+gQzrP1PxYWivRzC3UXF+TiGbpWrPoNxV/8yxvAHFwUAaVIcF+VcLHLmo+/PX5sYGVJgfCF/0kqvi4qnooJ3t5JOKTJK55ceN5rNZmNnZapqGpXZh/J3RXZRhmEYpdHp+tbu6+NoafuwsXMUbxe6BM5vOkYlxmJtL1SllUql0xMLK9u7zaNwkdV63di5X78+Iakgc2rjHyJWpIC818ZxluUzE9cWV9bXH+w0ms1ms7m7vb5+tz4/OV4pOT/rHQNyLboqjc6tbJ9UntV63dhZXbgg/VyzuhBiomznmqvO36ncSV///JJUdLN8brp+f6dxXKL2YXN3e2Vx8lxZLNK/+OF/k3IptovSVYv6A47i4h/DqFyqP240m83m7trcaMkwx25H7jgn66LcFtisXl66v9M4jgu3D5u7W/VpuXEpXfq5y0SdqCazenlpSxZS7cbarPBse+mjXls5H2WsdGvK0wbM4dm13Waz2Ww8rl+Wm2p5hYZL2FmtF8eBcMM0u78TF1U0+uCi3v5A+YDnn/32OAtNN7Cgmkqjc6vyEiRr/0ld2MXLe1F2xOZRUz8EFwWFIAEX5egffPuD2v9RmxxXGYaOXHFKK51j2mTGx45FUTGiuABQXJJwUV7BjOn63e3d5lFs5G59Wh7wxt2zVMn5uEplVi8sdGMsVuv17vaKI8QSs2C4KABIk6K4KHmztcjkbzCs1UXJoZle9qwNOpZJyt2FI3oazUWd/X7duX7Ik9L5274vesUYi3wecDiBi1MUsV5uOIPNEb5+1WdFhrflCshpVm2BlxzKNtTvJMcZ0OF4zAgvuovSU4v6A44hDbd3hFb5OxNwUa6TIMKr0aNt+WrlguMJK1WGhsYna5PjQ1V5dOQtyeU9+ipK5fGdgad6a35952JQu9Btql0fLFVGJq7VarVrEyPCzyudrz9/3v1mXFTR6IOLioBw32u5gX//+M+r8jeY5erQyMS1axMjQ/LcED/rHr151NEPwUVBIdDuokLekCHIj43OMW1C42N5UdTkvdxN6QSAfpCIi7Kj9YfiLxVVdT4Re2nKMZa45QIASIKiuCh5cU1k8jcY1umiJFnU45611uaM8O6Vt6Nx7C3jeAtP/fLvhc9Gc1GT91qhZsUcnt0IkkLqMZZ2Y3VKqYdRGvXdmis67cbanGNyTyBm+dzc2gvX5ocyipbLrF7228TPA1lIRrqTrP0nS0omxaxe9twQCRdla6jFJAKO7u0mBUrnf/h5tEWYybso27btg6f1ywqPeml0wW8TP6UnrDTqNyXZUbUHjxaCMwsoiUd2fh9zzegTkZrq0MFW6fxS5w7rLv3ARRWNzLooXTewSjthVi8H7OLVQ/MYux+Ci4JCoNtFyZuRR0Z+bHSOaRMZH8uLokJ36QYA8CYpF2Xbdvv5cvhgLWhyrjoRnI9qLy1ajCV+uQAAtFMUFyWNnqOTv8GwPhclHrZolt/3X0AUko20LOOt7z+VsvGI2ZjlM1ecm1dFc1Hmv/hhR3lZ+0/q8klJhmF0NrBZ9Tq7WyJiMLTd2KpPe+6IZ5jlMxPX61thHqgn2q92Vhcnx6u+UqpUGZm4Xr+/E3SklPpPKVXGp+uuixOGJCRP3diO+But/WerCxNnPH9iqTI+ubjq/+twUcfEqcWEAo5eEdvS6YmFXoRtf1yUbQdWpFk+o9K02O1Xj5e9n7Cwn++uWmv/2aqHlDbLZxQqUv3W9HJoZvnc9LLLXfpIcrN8TjrZrruvGC6qaGTYRdm6bmDbar1Y824nvJ8bFz01j3H6IbgoKAS6XVTPTY/XY6NzTJvE+FhYFBWs0wEAAknQRdn28WDNHQM62q0+cijDh6jOJ6CX1mOMRU+5AAB0UhQXBQ70nhfVH6zW68bOg/X19Qfdc2x00j7snJ+0vr6922w6T/7WjNV6ffxt69u7zWYSP8ib9mHz5JuPzo2K91vT+yk+tA+bzc6d0vl9CV/KnJKxWhSf/rTLEo34FdltmdYf7DRUHjDfWK7Vet3s1mNSj2r7sNuSBn+H1Xotth0DdWEhYRJxUZrRdgN3n8xecuq1eczcyxsgKyRwXhQAAEQjYRd1TLxOWGKIvTS6aQCQN3BRBWUQXRQAAITDugIYfAbBRQFAPsFFAQCkTp9cFAAA9B1cVEHBRQEA5BNcFAw+uCgASAtcFABA6uCiAADyCi6qoOCiAADyCS4KBh9cFACkBS4KACB1cFEAAHkFF1VQcFEAAPkEFwWDDy4KANICFwUAkDq4KACAvIKLKii4KACAfIKLgsEHFwUAaYGLAgBIHVwUAEBewUUVFFwUAEA+wUXB4IOLAoC0wEUBAKQOLgoAIK/gogoKrD5p0AAAIABJREFULgoAIJ/gomDwwUUBQFrgogAAUgcXBQCQV3BRBQUXBQAAANkEFwUAaYGLAgBIHVwUAEBewUUVFFwUAAAAZBNcFACkBS4KACB1cFEAAHkFF1VQcFEAAACQTXBRAJAWuCgAgNTBRQEA5BVcVEHBRQEAAEA2wUUBQFrgogAAUgcXBQCQVzLqov75Px8ul9/4j//x/1xa+iEpiTQ19ceG8a0//dO51EtCIpFIJBKJJKa/+Iv/YBjfGht7L/WSkEikoqU//dM5w/jW1NQfp14SEolEKmwql98gJEgikUi5TP/yX/5PhvGtv/u732hRSNpc1D/5J9V3332/MxWClEQql9+4dOl7qReDRCKRSCQSyZ0+/PBqufxG6sUgkUgFTLQ/JBKJlG761//6fyUkSCKRSLlM4+P/xjC+9bd/u6FFIWlzUf/0n771zjvvpl47OU7vvPPu8PA7jLJIJBKJRCJlLZXLbwwPn/3Odz5IvSQkEqloaXj47JtvnhkePpt6SUgkEqmw6f33v/v++99NvRgkEolE0p46zXvmXBTnRSUN50UBAABANuG8KABIiyXOiwIASJtOvJLzogAA8kdGz4vCRSUNLgoAAACyCS4KANICFwUAkDq4KACAvIKLKii4KAAAAMgmuCgASAtcFABA6uCiAADyCi6qoOCiAAAAIJvgogAgLXBRAACpg4sCAMgruKiCgosCAACAbIKLAoC0wEUBAKQOLgoAIK/gogoKLgoAAACyCS4KANICFwUAkDq4KACAvIKLKii4KAAAAMgmuCgASAtcFABA6uCiAADyCi6qoOCiAAAAIJvgogAgLXBRAACpg4sCAMgruKiCgosCAACAbIKLAoC0wEUBAKQOLgoAIK/gogoKLgoAAACyCS4KANICFwUAkDq4KACAvIKLKii4KAAAAMgmuCgASAtcFABA6uCiAADyCi6qoOCiAAAAIJvgogAgLXBRAACpg4sCAMgruKiCgosCAACAbIKLAoC0wEUBAKQOLgoAIK/gogoKLgoAAMCLz+aHTvjwp1+mXZxCgosqBl/+9MPuwzb/WdrFAbBtGxcFAJABcFEAAHkFF1VQcFEAEMrmjNFlZjNudtbLjYWJkaGhkYmFtUZbRwFhoDl4ujw9PjQ0ND69/GTfSrs0AuKNf7b+RdrFKSS4qGLwRf2szpcMgBZwUQAAqYOLAgDIK4V3Ue3D5u72+gnbu83DQkRI++yirNbrxs6D9QJWdHI4bt31BzuN160sRXMhB2h1UV/fuWh2czPHbhPiLzTW9o2KcHtVZh+20i7SCbio9Om3i6Kbkg64KMgig+ii5GHB9m6cMYHOvJyN64OdBk0rAKgwkC7KFV3stQGV2864Tae2YgEAaKGwLspqvVhbmDhdMjwonZ5YWHuR7+a5Ty6q/erx8nWfajaMUmV8ur7F8ohIWK0Xa4uT58qmZ5Wa5TMTC6vPMrXCIHkOHv2oVqvVarWf/bbnPKR4WM/kLpCm00V9fvMtubZO3djWVMz0iVFR0q1XIO/RujfpeHwu3vnG+6M6nvBo4KLSp18uKs/dFGvvF/O1Wq1W++SBz7OVPrgoyCL9dlEHT2+Omb0+B+3G1tIVrzbMLJ+5shSt/dKZl91+9Xh52nvAUjpdwNEKAEREt4uShms9ENg6B0QXzfK5KJ1Ja//Z6pxn21mqjM9FbDr1FQsAQCeFdFHWy43ZYe9Qvtg6D9/4NL+d5ORdVLuxNjfqE91xvFVH59ivSwVr/0n9cjX0zjUMw6xermdry6sk+fL22NHvjhHHwkV5otNFPZx13rs5qi5cVGS6z23Yj9fyhEcDF5U+fXBRue+mnDS6Gb6JcVGQRfrpoqz9jVmpbx/lOTh4unQ+rBErnV96etDnvJQyM8zh2Y2XRRmsAEBkBsZFWS/vTYXHaCqX6qENqEpOZnXqnlLTqa9YAAC6KZ6LsvbqYyrR/E7TPLOZ05Y5WRfVfr58qRJevb28U4uKtf/pjXCBKqE8YBx0tm+cOvrJuCjd6HRRrc2ZU2JlmVd/mZ092eKCi4qO85l7e+l33h/U8oRHAxeVPgm7qCJ0U765czH7NzEuCrJI31yUtXfH1RIpPwcHmzOqrVjogFZnXtbLe1eVm9fS+dt7A9WwAkDf0O2i3PMio+HdOksLW0Mwq7MBDWiEOKU5Vg9pOvUVCwAgAYrmopxd7dLodH3r6EyA9mFzd3tl4YI0e8C8eOdr3YXIAgm6KM8XX6kyPjlfv3u0Q+3KYs1jl7nSBz/LZV3Hx3NUZ5bPTFxbXDmq0rv1+Wvu5dfm6fntf0i79EljbUwd/94YcaxvHnxS8+Ojc6JDefsD3w/2bwuxfqH1vCi7/Xz5aGGfWX4/X6YUF9UD1v6nC0erUkqnp33D/Hqe8GjgotInSRdVkG7K3q2R7N/EuCjIIv1xUT6RQrXnwBmz7IxoO8eJWK3Xu1v1aWnZZ1DgUmdeduvhrDhkMcvn5lZ3vjre+d5qvd7dWpI3eajc2MZGAYAb3S7qZOtida6MfvukNfOcRfnFbbn5PH1l6bj5tG27fdjYWZXX4PtGFx1xSrN6YeGk8WwfNnZWHWHKwHkB+ooFAJAIxXJR8lHp5tit515brrSf3xLb7lMfP8phDzkxF+V48XW2tvE+fKv96rG45Vx+F6HFxDGq6+zA9/iV171rtV6IWw6Fz5jJA0IkK6E4lrx+o1DBMr0uyrZt224fNpv5O7YaF9UrVut1M/j03OSfcDe4qPRJzkUVppvSvY0zfBPjoiCLJO+iXDvzRXsOrM9vvi2MC4ZvPPJom5xbKrx983Ovdk5nXo6hduXSsudQ2znJznddNAAUGd0uKjIH9ybNwFbv6zsXuw2j/wkf8swDT6klfpVhVC7d8QriOBb1m5P3vLul+ooFAJAQhXJR3/z8Ure1DZyE9fXye91W/tSNba3FyATJuCjnxDqFM7eO97FlUpwPzqV8vuM64U86m7QXZXqLEDXGRekmAReVT3BRyZH8Ex74nVyTlEjIRRWomyI0LRm+iXFRkEUSdlGunfkqlUqk50COM/pFI12fNN5bdg8MdOYlD6D9fFUHSYGZM5sD1bwCQD9I2UWJ28t7xlWsRx93904JbD4drsnVLZM1flDjKX/Sc9K8vmIBACRGkVxUd+f8cO/fujdp5LpZTsRFyYMU9RnEVut1/tZJ6EHubkRY6NQ+DF5qkB++vD12Uj+4KN3gohTBRSVGH55wN7io9EnGRRWpmyIci5DhmxgXBVkkSRfVfl4/L22MNHzj0+fLF6M8B79bEhYyeTohAUkPuZW6zryk5zl8in3rl1dPGilkFAC4SNdFiQ2at/PZnOn2KcOXd4qtraNfJraGoZsyyarJ7cj0FQsAIDkK5KJEvRTe4xVfPnlslRNwUdJ7MakZxFbrdbOLjtCQmGMcfdM+1Fsu27Ydg74EFzqJhY/rsMS8estMyEHh77dvdG+7bLqoJG6x2JdJkWy5KKEme3zGdF0LF2m4KKk17LnRifa4qWalcRvGuE94T88NLip9knBRfemm2HYCz0IPjZ84/yrWTXzyY0Ifn156aLgoyCKJuaiDR9JOd0bpfP15O+JzIDVkCjvJBwU5deYltzrG1EZo+yocB5nPXUgAIBZpuihxUZSPpxeHKCO3wuOW3WM8DePinW+6/yBFfMLmBNhhcwi0FQsAIEEK5KK+/H8+GhmqlAzDMKsLofEHXFRUpOFJ2HLgqLQbW/XrE2dc54gbpcr49PKT4A12vvzph0Mdxj/pLni29p+tLkycLsn5meVzofmJWK0Xa4uT4xVHNoZZro5P17ca8WJQUkcjZK+LHmi/2lldmBhxFd4wy2cmrkcrvbX/bNWrIgyzfGZiYU0lq84VcV1ks3xmYmH1mfOaWK3Xzebu9vr6D8TO2w/WXfzm76PVige9uaj2q8fLXjdtqTLi9YP80FCzJ1m1XmzV5yfHh7qZlSpDIxPX61veZ6X4Kpb2q53VRTGjUmVofNo/G6/sPNvV7sP6wU+6/9xubNWnnVUQ5ff73FtGqaLhMXX9smRdlNV6sVWfHq96toaTi6p3VrTH7ZjP5o8uz8j0f+4OfNqNrfr0OWdWpdOh1yco+hbzCY/53OCi0icBF5VoN8WO2SHQ1vi1D5vNxs6D9R9fe+vkL9669mPXk/OrPXHNwsmzLX59u7HmONn69F/veHxjnB4aLgqySEIu6sXfjIrPU3V24+jxiPQciHFGpUONpUnysvPRmZdtf36z2+oovTrF3z15j5NKAEAiRRcVuijKsY+SUgdGGF68dfPzk/8taXwFFeV4Zzj8kbZiAQAkSYFcVDTEFj6PEwS0uyjptac2nlHC2n8inhzujTCc88B9ZkK7sToVlKdZnbr3MuwHKJWsNDq3EZqTH+KYTrFnooorwuRTD5dDD6dSzOto5qcfx+dxBJal/vQ4cCjLoWA0xLYiuyiVKpF+UO/ZhNWsalZm+dyCx6kpbsUSnFPIoxMa4Xc9rNb+pwuBBfc527VL+L3lQWT90BcXpdTmGEZp1OtSivlEe9y8f2bnR1r7T5bOB12f0vkl/9vcN/oW6wnX8dzgotJHv4tKqpti2zo6BHoaP6klCka+sYU/PPqHg81Z9w9yPA16e2i4KMgMSa2L6p6RJL8cozwH0uBAYfGR7Wj8xFCjzrzsHl6deZ/5CQCxSM1FSYui/Bqn6B0YsY3s/oHUqqosZLIdjbds8nUVCwAgUXBR3ojvhFx2jnW7KGmenK6NFqz9T+WtLILwP/ZBfCPPbLr2x4icn227d3vvYJarQ+7lCuqHPPmXW6cRtfY3PCJM/hVxNUAutJ8vy8cvB+BfDwebM0qZnEzJzrKL8qneUmVoyL1Gw/8u01OzQSXyymj4xiO5PLJi2VDSOqXzP/FrMqO4KHP2ofdj5iLgWbX2bp93riioDg0NDXk8qCIZdFGKlXH8M8du+imgyI+b9888W//Cdfq6X1n87k/9LkrXc4OLSh/tLiqRbopt25o6BHoaPx0uauTWnm3t1ce8mkghWJ1AD40QCGSF5M6LsvZ+MT0+7tTSEZ4DaQL92O0vlb5VPHhRGFDozMu2pUPq1AKq4tZQvGsBwEFaLkrcM8//6DupMVSR+eK2pEJLL65PNWcfqhVRbG7lLq2uYgEAJAouyovutLUkz+hJFd0uSnyJqr9FA/n94z+vGiKl0xMLK9u7RycR7G6vLFyQ4uKV2YeeXQVp1t3M7FF8xSyfm67f32l0cmvs3HdtMmWO3fYeFjmDNKXRudWdr4TdydqvdlalifnK56MLSCNE5SFiKK5AdGn0qB4O252tfdw14Vf8r1YuyDXmrlN5ex/PGj24NynkUhqdW9s9OWai/Wrn/tKVo50Uu8+itfeL+VqHj84Jd97bH9Rc/Oy3sessgotyVK9Zvby0tSucmmG1XmwtidPIvQOTemrWq0SGYZbPTS6uHG/TtLI4KV5t5/kpUmCzUql45XG3fl1+Ev1bzSguyqhUj3M1y+em63ePn/3Gzv0lx0x8v2GCdOVKo3PSrlZW68XarCOUWqoMDY1MXFvcjLqzY8IuyhUYNqsXOq3h61a7s5ndinPLUe9bq4fHzftnmpOzx3eWu2l27n7q0zj7Rt96fML1PTe4qPTR7qIS6KbYtr4OgZ7G7+DRj46fjA+EPX5PnfvI9eR88kCMIUuTYjeETrBEt9oS6aERAoGskJyL8ibCcyDOhldvyMQnvBu21JmX62co7LkX9XwpACgW6bgo6Ry9t5d+5/tBsTFU2dzO+yAnaVmUcsQnYJc+PcUCAEgWXJQLaV51r0taMo9mFyV7E01LeLpK0KxernseOdB+/p9ES+C9jZ17in3p/JJPdrekmJJnhNvauyXkZ47d8tvpSVqAdWpmM+I+6FLcTNcU7oONKenk9qur3kdOWC/vXZWcivfBGt24tjPOf5LR/pr4jR67IomXx+95azfWFmvefqAfcSxlFyVXb2XGb18ieT2JV6hbR826S+R35x9tWulR/e5J9ubwrEd5rP0NSXn5FCeSizqqxUuez771cnVS/GVeuUmHw/gctyapuqDhRgiJuii5zTHMsZs+J7AcPL0ptWDuHx3zcXPdD2Z1yrMNcd4Q3nWr8vRGesJ1PTe4qAyg20Ul0k3R2CHQ2vjZdtSbWPz0excvmkeP98rOq5Mf1D5sihMrkuih4aIgI2TYRfX2epK+4MT66MzLtm3H9H7fxQTHSKfickoJADhJxUVJi6ICjxaVepaho0j50NKure+xHyS237JB0lMsAIBkwUUdY7VeO6dzBx50MeBodlHyyUbaognWy43FWm0x6Jx5aeaKd3jJEeEJPl/GEbt3x06+vnNRWEUSst7pi9vdyHDEgKZ8soWeaKi1fUMID4eJVnkBhZ/reLo8X5sPPJxc7NG5pVrcSZEZclFS9YbVbuvh7MmHPUVl7Jp1liisSO1Wy/2vDvcQtGGjtLO2jz2N6KLcewaKyDeoOztxR66AkIhYi70/Z0m6KKnNCWt0LHlBg6MFi/u4yfdD8PVxGDSvFkS7i9Lz3Ni4qCyg20Ul0k3R2CHQ2fjZth3HRXVKEDoVK4EeGi4KMkJ2XVTQifWqf3bcIOjMq4P8yAe2iY4lpebMZi7nfgJADFJwUVIr5twvxIk0pAjuNzk2KhGaTv+lpoEEDD21FAsAIFlwUZ4HU5jlc3NrLzwis7lBs4uS3oZ9fouFHrwrD5puhS10k17frrGZOIkveKqMbdtyfybaootIZxSpIc97UbhMck8mdIKj7/cGncgp/s5eloVnx0WprMIREWq317oNOetUvuAKRXIjPdnf/b8DAvy241H0vL+iuajvrgY/X7KvdT37Yl5BOx6IxxX0fAdJFVWqDEVAOlHGo1akicMKCyzlUJDc7MR93KTh0tRGSPsnl8RjeJWAi1JB4YxgXFT66HZRSXRTdHYIdDZ+tm3HdFHatqeO1kPDRUFGGBAXFeGJ8WoQdOZ1jDx7xmcdt7X/ZEk+Ea/3MQYA5Jf+uygp+OG9nltEnvbpt+PM0QYkAmInsMcxR1ADrqNYAADJgovycFFm+dzk4uqz4LDrgJMjFyXFZLy+O+pYS5ZR8lJlafcJlTl84tqMSJsC6XdRcvBKaQm2plXbUjDK8VOk3xne5XORGRclrThRegaEbHvdgzGoZh1Xr4e6taMu9wn9dDQXFfp9wSuKxH8Nykr1c4G4NzPsDXetSNdYbQ8b/21v4j5uEYdLsoxyFz4lFxX83Ni2jYvKAgPgorR2CHQ2frZtx3NRYTOB1dHeQwPoB7ioqHmd4D7fsnPC6IOdRnN323VMaQe//XIBoND020VJAxe1dsl9Evfpiev1u+vbu83GzoP1u/XrzkN0DccQLAEXpaNYAADJgovyXBd11Gb7nCqUB3LkokLf4JHHWv7BX3EFhaKaEb490mHp+l3Uw1lh7KfoxaQwUs8baAReAfk8eZ/TZ3rMWxMq18LamPK5afwR7lzlk0oDShZYsz0+ldFclPSNfXBRwVHO9NZFxcD1K768Pdb9V1Vn6b9CLebjFnW4FCLA03JR4XniotIn+y5Kb4dAZ+Nn23YsF6UzGqG9hwbQB3BRUfMSkY7HU4HXLAB40WcXFXFR1BHyMdAKODa5SMRFxS8WAECy4KKOaB82m42dB67ZWmH7/w8qSbqoXrZ+0vXlWiIdcvxU/Avxq749eqWmwEfnTkX6cs9S93KyS2CGyutwwrddi/rVzkpwnG9jGEbp9JWl+8KB6b3nrQkVFyV95q33/0Tl3vig+8N7rNqgX9+TxHASzUWFXgzNLiokP8G7KJ4XFWnpom9JjPd+sB6BH18LesakjFXL59+ExXzcIg+XghsQXBT4k6iL0tJN0dsh0Nr4qX3C79NaX6W4KBhEcFFR83LQbqzNjbom3R9RGp39qz8ZORlt61uHCQD5oq8uSl4UFUnMWPtP6perPgrerF7+/vxEd0zq3AQ5IRcVt1gAAMmCi3Jj7T+5KWwvYI7dzmEgSrOLSuRQcH+s1utms9nYebC+vr6+/gNhCoueSIcUlBFWVPivoVMjSsXI0WQN0VBpWZRyfpLQiPAD2ofNZrO5u+0OtrvzaD2c9Zy2Uzo9cb2+FXJuW1ZcVMx1MeoXWLlmdSyLGmwXJY0pfI7LkrYwiLEYIEYgN3CzrR4fwICnPdbjFnm4JP0418rQPrqoKC2SjYvKArpdlPZuiuYOQX5cVNI9NIDkGRAXpT6BxrOnoTMvL6zWi+2VxWsTI0fHY45MXJuvb71otcVt/CqzD5mKDwCe9NNFSYfd9XRwUvvVzv36/OT48YnA45O1xdWdV21xsOkRWJQO41WfPKrcb+uxWAAAyYKL8kYKUObxQFXNLko6K6fX/cYCsVovtu/W5yfHq65dxkUScFFCljFDT5WFX0f4xfJmWlG294v2o6L8WWDttV/tPFhZvDYxUvGbCemfx8FTxynGIqXR6WXf3TLz4aLMSz8PiAH0VrM9LagJ/FmD5qIcw4rS+aXH0vKfdmNtVthGJtbM3KRcVI97dQZHinp/3OK5KFf5k3VRcVokXFT66HZR2rspmjsEA+2i+tpDA0ie7LqoHl9P3l+gMy9lpPXZp6Y2crn9CADooH8uytq+kVDs7+DeZLdndPbWnmuI1WOTGnOoElosAIBkwUX5Ib4Wej4nJ7todlGyONGxo9wJ1v6z1Tn3Mbc+9NFFJWHcROTAWfwdhZJzUe3G1tIV9/mXPvhegXZjqz7te6XN4RuPvMarWXRRGsxhh1g1i4uybds+2JyV9yYoVY5mhcmCwhyrx+qFD5SLsu1eH7fBcFEaWiRcVProdlHauymaOwSD6aLS6KEBJE+GXZS4xFO9uyk+4d0zTXXmpYg02RMTBQBB9M1FyYuivPfS6AVLXAXqo3ykvXCUu5PSW0PtzNJoxQIASBZclC9i2CJ/sSjdLkreUe7Ux4+0vNLaz5fdm9yWKkPjk7Xa4sr6+vr6+vZu8+5HuiMdUlBGiFgpnBauEXlHodhnife2R59sxFy1Z+1/uuDaEN4sV0cmrtXm63fX19fXH+w0fv1XIwF5OGi/2rlfnx73WMrguXw8Ky5KuloayhG/Ztmj74iDp/Xgs1tLo3MbL2O2WBnbo0/54kd83OK5KJdR1++idLVIuKj00e6idHdTNHcIBs9FpdVDA0ieDLuonsKWPlFLnXkpIc3Ex0QBQDB9clHyoih9ByfJp/T6Kp+eZgXEmBSgWCwAgETBRfmS7/GxbhflcBY6ljbLMzYMs3phYXXnK4/TTLSfjO1/xInoc7QtfvFFnsXd08bFAtKvUu6z7N0SgrbOULI0u9EwSqPT9a3dw7Yrk56eJav1YmvJEejyWKGYFRclOYPYU+R11Kz0bxG2n5bIgYs6eHQsJ0oVef+oUmVkYmF155W7XqOTlIuSM1YN+lgbU8JfqSwAUXzcIisav7P3Ouh2UfpaJFxU+mh3Udq7KXo7BAPmotLroQH0gQy7KLljrtYtkJyT2JfXmVcocquBiQKAMPrjoqRFUbG2bJeQRyUBykcatinGaKRJsJGW+isXCwAgUQrjoqz9Z6sLE2fKZun0n6sdkir2zyNvQZB5tLsoR5Qn9jIeeYLK2E3fA0z0RzqszRkhwiJtbib9yOTvCllGxZ3GLS2MUtyzTZ5ILvd05I7b1dWGb0g/RqzJennvqtBhciuVrLgo+WJFXSovo6lme1sJJzPoLqr1cPbo9qnMbBy3Ie3DpoefiEdiLkqSnKpKURqgRAgVhT5uURVNiBDV66J0tki4qPTR76J0d1P0dggGykWl2EMD6AdZdlFSf1NpF3lpXCO/inXmFfKHe7eE31iZ2cREAUAI/XBRUo8m/kY0xxxsTAmta/BW8FJ/Mvq+E1F24o9SLACAJCmKi2r98qqwCazKApPetm4dGPS7KLmODcOcvBdjmCFlFtIr0BzpsB597L+9lZRX3JVK4fxuSVhCHXf7YumWVpsSHqDlpLKFaLJ4saavl98L+OvMuCiprmLNuNdVs7JI7K1vPeAuqluV8Q9cUy+JVhcleyW1NifOkrjgxy2iopEy63FVo/ItobVFwkWlTwIuSm83RXOHYJBcVIo9NIC+kGkXJQuk8P6m9MA6+wQ68wpAnomPiQIAFfrgouSdQzUdMyGvAg1XPpKMUuhPShEidRUVtVgAAAlSFBflCBSHxx+kGFr+lkUl4aKcIXv1N9zBox/V5n8hfVYcG4VFkfVGOuRYlas3IN0Yp2Y2Y29FGFKazRlxaZTy8M3a+8V87UeP5M/KP03BTUi9M8cfSJ2mkKXhMWNN4gXOrosKlpgR0Fezjnu5F5M52C5KyC3pzWCSc1HyeENhkCTvAh55VBX4uEWLbksl94px6XRRelskXFT6JOGitHZTbL0dgkFyUen10AD6Q7ZdlPx2DXu8Q6S5zrz8kGbiY6IAQJHEXZTj6CQ9PX55FahST1PW/CH9SSk8pD7/tYdiAQAkR2FclONVE9wPtvZXJ4N8RA5IxEU5FjkbhlG5tPw8eDMsa39jtnNISeXSne4rUdxeLFgFOja9DYt0hIyA5Ny8Dq+U4/tKA6r2q50d/+2iQpD2nTIMwxy+8an/bjid73teP186+qyko2RbEhadl+vC2S2Stg4L3JLOcaxE5FiTGGN2R716XqMeATUX5Qy9q3TxrNaLnWeOy6mxZuULHrgltPVyY3F++anzjsiNizIMozQ6ubjyYKfRbDYHaI8+2xHvDtvY23FTRB5VBT9u4s8MucMdBfHcfj2yiwp4wvW2SLio9EnGRWnspti21g5Boi4qfPlCpCYssR4aLgoyQsZdlDxXLOht7JgG7zUXU2de4X+GiQIAZZJ2UXLzp+G4c9sVTFJUPuqRSjl/5ammvRULACAxiuOinIs8fEP67caqeGJG7E1cskkyLso14jAMw6xerj9+5RVd/7XMAAAgAElEQVTpsfafrc4Oi58e/ZsXR/8mxRV9ZaDjdBNDIdJhGObYTVfEvUP7+S2p8D6HV35xWz6xe+reS99x2/6z1bnRUrxXvtx3MAzDKI3Orb3wOCPcttuNraVL4qdL0//192Jeag+BbR88vSn9SreVk45t9+28OfIx3GNsa+/OlZGRK3Wf8yakOTwed4J0dR3laB/qUQ6qLko4nahT+eeXfG41u3OpLldNw93f1FWztu1SmaXzSx713G6sHT2Irtt0sF2U/esFx6PjwixXh4ZGJq7VFlce7Hi2U2ok6aIc45OA2LmzRXQ3YTEfN+lnGkblqk/jZ+1vSK2Wl9Z3/nQVFxX0hOt8bnBRGSAhF6Wvm9JBW4cgURfleJqt1qGzBxGpCUush4aLgoyQdRflbHq838aOZ9B3JKIzL9ffYaIAoFeSdVHy+ErP5PPelY8cRfCJVzmGMcotKiYKADJHkVyUxxKT6oWFle3d5hGNnfv16dGSNHLOa6c5KRdle6kTwzDM8pmJa/P1u+vr6+vrK4u1axMjlZLjI9JrUV5i4nImVuvFcSTfMM3uVVVwUYZhGKXR6frW7uvjYEz7sLFzFCISLr23ibJt2/7655ekz5rlc9P1+zuN4wzbh83d7ZXFyXNl8X77Fz/8bz1WqTt0ZhiGUaqMT9YWV9bX19fX79bna5Pj1bLjUx63r/PymNXLS/d3Gsch3fZhc3fL+RiULv3cHUh2zAd3hcfbr7p1Kl4ieYwtxL5Lo3Or8hoha/9JXTBr3vFscbMgw6hcqj9uNJvN5u7a3GjJMMduawgjK7so27a2F6rSRSidnlhY2d49XohjtV43du7Xr0+cFmvYnNr4h24eemr2GNfzaFYvXD96EtfX7zqLUpn7TCjKoLso++DRjWH3o+OLWb0ctkRCoSTaXZRHE1AanVvZPmnCrNbrxs7qwgXp3jOrC24TFfNxc7goo/MWXe02IFbr9e5J0xyYleun+9Wa6hOu9bnBRaVPYi7K1tVNOUJTh0C7i5K2rTTM4dm13Waz2Ww8rl+umkZl9mHLL7/wr0+qh4aLgoyQpItq7f1q3cmPrwknQ773A+c//2rPPb3C2S84HtO+brVbr5u72yvOPoHyiqd4eUk42tq8DqoBIBkSdVHyoigdk88dTWlU5ePsnJZGp+v3dxrNw3b70CtOqX50Q6xiAQAkQrFcVNTIZOn87bw21Qm6KNu2Dx4tOMROGO7AoVMcGqXKyMS1Wq12bWJEcC6l8/Xnz7uhjPA9+iphCyU6H/Ob73+EtXf7fKRfGLhERgFr744jvhuG76Ina+/OJaVKOC65z1Pg2urILFfHJ2u1Wm1yfKgbwjOrsxuvNrrHtUmxpt8//vOq4cxkaGTi2rWJkSE5DOinlVzFcOTnFwaPQAQXZdv2weZspCvlnkivo2bF7FQvuMeU/kF3Uba1v/M3E99W+fUntdBTDz1hF2VHfXmZ1Vn3+CT+4ybt+lWpqJTHfyGq4uVWfsJ1Pje4qPRJ0kXZeropx2jpEGhv/Ny9KMfvkebbRGzCEuqh4aIgIyTpojxmyIXh84y7F/r6EfQm1p/XSZ6YKACIQ4IuyrEoqpdTlZ05xlc+7gXlvoTFqnQWCwAgAYrmomzbbj9fVgjqm+X3vTazyg3Juii7M8deTZ6UTl/xDvCExvRPNhzrTpxXiHSERqBKowthJzId/cIlpfCTWb3styNWNNqNNefiLZ9vLJ8L+QkHT5WuTkhVhAbgzOrUaqNtSxO0nbEmlaKY1ct3/PtNnlPcT37C+R9+Hnfz52guyrbtdmN1Su3mH51b8zo5REvNioTVslk+51mSgXZR1st7J5ehcqn+5KvXzWaz2dzdPp5pvLJY81z7cOnnkc8dS95F2bZtvdxQaQGCVnfFfNzkCt8LM+Rh68wUL7fyE67vucFFpU/CLsrW0k0R84rZIdDvonyWVHcfhl/+vXd+Sk1YQj208C8G6AOD4aJspf7myYsvDJ15udsfTBQARCU5FyUvitIwc9UxWOlZ+aj0J7333E+0WAAAuimgi7Ltzq79CxNnnDuaGUZnl5YFx95FOSRxF2Xbdmeflvr0uDPU263p68veZzQc026szZ1zXyazfG5a/MvuxmhqkQ5r/9mqR75m+czEgqca8P+F/neSUaqMTy6uxjmDxov2qx3fb+x8pc9RUlHKrv4UWPtP6ldOuy9w6fTEgliQ7i5GXrEmq/VizbsoZvnc9HJ4d8srwl46HfVq+hHZRdm2bdvthu/Nb5bPTFyvbwVeKD01K+XYerFVvy6ugClVhkYmri2u7nzlV5IBdlFC5zssAmK1XsinBEYPiPbFRdm2HXhflSrj0/Wt0Hs+xuPmrvB2Y2vJ4z4tVcYVHlz1y638hGt6bnBR6ZO8i7JtW0M3RcwrTocgARdlewtsz+e8lyYsoR4aQPoMjIuybf+WpzOqURwTaM5LNlGl01cCZpQBAHiTlIsSF0WVRhcexRblkvIxy+diZuk32CtVxqfVe6XaiwUAoJGCuqgT2ofNZmPnwfr6+vqDnUazeajXG2SX/rioLs6Kfh1laGS1Xh+vZdjejX6RfCMdVuv1UaEe7DSiFclF/+8kq/W6KVZL71+poeztQzGHnquye0V6udRW63X3cmbnUXZeqGi1o6lmC4f16OOTU4Ym7ymsjLM2u7u2DYR9iHdfHecQ8XHzjX+3D48L00sbrV5g1Sec52bw6ZOL6hKrmxKcVdrvo/Zh9/HU/jTE7KEBZJEkXVRi6BzV6MwLAKA3Ej0vagDoy/AKACAViu6iCku/XVSaMOsWoGjs3RqJKJbEdoJmwgeWC0Hf6LuLAgA4YiBdFABAvii6iwIAyC+4qIKCiwKA/PJw9mSV06kb2wp/0Lo3edJKXLwT+byogoCLgr6BiwKAtMBFAQCkDi4KACCv4KIKCi4KAPLLN3cunjz0p6Y2wnbHFvfTNq/+UmFPv2KCi4K+gYsCgLTARQEApA4uCgAgr+CiCgouCgByzMG9SeHo7cqlus9Jr1brxdbSJeFg17HbKBZfcFHQN3BRAJAWuCgAgNTBRQEA5BVcVEHBRQFArvniJ+dLhohZro5P1gSuTYxUpI+YwzcehS2hKjS4KOgbuCgASAtcFABA6uCiAADyCi6qoOCiACDnWC/vTVVNQw2zenn5uefSKTgBFwV9AxcFAGmBiwIASB1cFABAXsFFFRRcFAAUAGv/2erCxOmSWz6dUDo9sbD2omWlXdQBABcFfQMXBQBpgYsCAEgdXBQAQF7BRRWUIrkoACg87cPm7vb6+sriyQ598/W76w92GoeshQLIILgoAEgLXBQAQOrgogAA8gouqqDgogAAACCb4KIAIC1wUQAAqYOLAgDIK7iogoKLAgAAgGyCiwKAtMBFAQCkDi4KACCv4KIKCi4KAAAAsgkuCgDSAhcFAJA6uCgAgLySURf15ptnyuU3/uIv/sNf/uUPSEmkqak/NoxvXbv2v6deEhKJRCKRSCQxffzxXxrGt77znQ9SLwmJRCpamp39M8P41h/+4R+lXhISiUQqbHrzzTNvvnnm44//MvWSkEgkEklvGht7zzC+9Xd/9xstCkmbi/qDP6i8++77nakQpITShx9eTb0MJBKJRCKRSO704YdXy+U3Ui8GiUQqYGKURCKRSOmm8fF/8+abZ1IvBolEIpG0p+HhdwzjW3/7txtaFJI2F/XP/tnQO++8+4//8f9ASii9++775fIbY2PfSb0kJBKJRCKRSGIql98YHj576dJk6iUhkUhFS8PDZ9988wyjJBKJREoxvfvu+4QESSQSKZfp/fe/m0UXxXlRSfOXnBcFAAAAmYTzogAgLTgvCgAgdTpz5zkvCgAgf2T0vChcVNLgogAAACCb4KIAIC1wUQAAqYOLAgDIK7iogoKLAgAAgGyCiwKAtMBFAQCkDi4KACCv4KIKCi4KAAAAsgkuCgDSAhcFAJA6uCgAgLyCiyoouCgAAADIJrgoAEgLXBQAQOrgogAA8gouqqDgogAAACCb4KIAIC1wUQAAqYOLAgDIK7iogoKLAgAAgGyCiwKAtMBFAQCkDi4KACCv4KIKCi4KAAAAsgkuCgDSAhcFAJA6uCgAgLyCiyoouCgAAADIJrgoAEgLXBQAQOrgogAA8gouqqDgogAAACCb4KIAIC1wUQAAqYOLAgDIK7iogoKLAgAAgGyCiwKAtMBFAQCkDi4KACCv4KIKCi4KAAAAsgkuCgDSAhcFAJA6uCgAgLyCiyoouCgAAADIJrgoAEgLXBQAQOrgogAA8gouqqDgogAyyW9/VjvhkwffpF0cL7558Em3jD/7bdrFAYAcgosCgLTARQEApA4uCgAgr+CiCgouCiCTbM4YJ5ytf5F2cbz4on62W8aZTc/PWPvPVhdrtdri6rN9qx+Faje26vO12nx9q9Hux/cBQKLgogAgLXBRAACpg4sCAMgruKiCgosCyCS5cFFf/OR86eQT5lh9L2Ed1Xo4VzVPvrAys3mQ7PcBQNKk5aKs1uumyCFyG6Bw9NVFtQ9pcAAA3PTRRYm9v9etvsyjBAAoMrgoma/vXDSDg6w5IQkX9dn8kBrjk7XFlQc7X/Geh7T48qcfqtyn8/W727v9jQzkwEVZmzPdZtQwDMO8+stW3wpkGIbx9tLvkvw+AEicvrqo9qud+/XrEyOVkuGBWa6OT87Xt14Up9Ny8PzB+vr6+vqv9hJtu1OltfGn4hv/Tzfy+1MhMv1wUe3GVn163NXomOUzEwurO6/8u54qPdggPvzpl5ELW5jxMQBkiORdlLX/bHVh4kzZ9GyJNWzuYW3fqEQa2f/6r0fUm/P5zyKXZ39jbqT3PwcA0AUuSsDaq4+JL6I897WTcFFiEF2N0umJhTV21IL+47IXQZjlc3N9u09z4KLclZvwD3E3PXluvAEKQX9clNV6sTZ3zhWD8O+0XKk/6c+2o6myfeNUpl9COvjmzkX54k7eQ0bBMQm7qPbz5cvVkGandH7Jp7GJ1IP1IPJjXaTxMQBkiERdlLX/ZOm85xQkuSV+GmO3jYPNmYqQm0Lr6+qcBBKxNbb27lyq9P7nAAAawUWdYO3dOhurdR8osuGijl7yo/0L9APYtt3TSD5mZ1SVHLgo+9cLFanqTn38KNHg7Tc/vyTHdN5b/jrJ7wOAxEneRbUba7PDqhZKwKxeXn6e6z5L695ktl9CGvh6+T3nheXFASck6KL+f/beLzSOLM/zjbeASmqEB5JpyK7WmMKIWSFq+1rLCNfU1ji3r4Zag7ChWKF7JXZokV7V7hXdEv2HUd0rbUP7zuR90DDTEu3dpqRpBFMjpy4jVnJ1t3HSdptKX9xt7Qr5orqmqrUqmUXoIRmafIi3uA8pZZ7fiRMnzok4kRGZ8f0QL+VKRZ4TcfL8+X1/f5yTrekgHeqC/OhdQY7jDmtR2TofAwBSRHxalLO/HKhDtWbisMnfT7fGL+nOvi1nIBXs6fsarXmyMMytPZjMAQDJAS3qnPr96Tw/vffy9By7FmX3FXyCiQsiD2S7ML2VAV9jkBbISf7S1fdLHBPFwX5vtia7MB17JaJe0KLc0ydtRzN7YPZB3A/Nebkx3jLtiG03AICuImYt6vTBrFCHyuX7B4sT8pWgQ4tBcrTn+JQuQtERWvMhRoELYtOiOCd5yy68M79a3TsvUrJXXS9PDpEpJz993xOw9+JH39DNy8fMY3ruQVk7HwMAUkRcWpRnJu67Olle360dHh8f1nbXy7eLl8lEbA8v6++GXizz0o/CpooJi8rl5dP6YHFR+YTt4wSByRwAkBzQolzX9S5IvT89x65FSdfaxtneDn/aiuB0AoAuxA7lO1gbRw/LXBqVS+Nb8Y7SntCiXNd1G0e13cqurOSBWZz6QbVSqWaoogsAvUycWpRgz5e7fHNpx6c6oFM/2ClP0kx+by487d2ppr0MpXQRisxvlt5sLer5fOvFotQgOCcmLYoKO37h9o3nK2wWpfxsNepkw1Z70vpRZ+98DABIEfFoUfXtKSb2yB5eEOVD5aKIdGsf86lNVeffdljU4B1ThlA+Mx8mcwBAGoAW5bru6cZYe4s+NfVWFqbnZLWoc7jTlmXZw2UENIBOoKZFua7ruo3nd8hmMmZjVc9oUQAAEJ7YtCiPfUA1555z8qh8vmcxYBxOMZ8tD6d8EYoKkwLHntpYG2uNhTcWnibdNpAK4tGiGA3Ust66IznxkLx49uhHX0b5WvaYq2VPzeL5GACQImLRosg59s3vPvHdALJToF5RSefpQtvjZXyqdZvATRUTFjW+ZWSjyWfms23mvzCZAwCSA1oUa5Wwh8v7++VM7LVToUW5rtflrqd9jUFq0NCi+E9bl2arMbYMWhQAAMSlRfGlT+zhBa1CgM7Js93K45c9vU9hlJqULkLRcB580Jaibn1cZwuFx13dEHQJsWhRbBmQwJHGDlPr+t3wYhRrE9Xxpsro+RgAkCLi0KJYp4CAmZjMw+q1mVjrVn5q+1Qj2NxwWBSfjzp3belnf9P2v8FkDgBIkKxrUaxVopkJ9kU29tqp0aI8Psr29btI2A/iRk+LYiq5G9sd+gEtCgAAYtKi2FRVFlIDC2HXu5QuQpGof3yLCxJh/wViFHDdeLSopwtvtH5ZKhF47Od1HPIpJChqbEO5uEhWz8cAgBQRgxbFnmIDZ2Jna1z7yHu6Nd4SsJoF/9S1KJNhUc7LjVvE4Tt/a+Olg1M8ACAtZFuLYvN2X2zQM7LXTpEW5fFTDrIEOPWD6uri2AitKG73XSneLu8cBiTa+fVPzkuSz/2USY7h1A92yreLg+072n2FkbHFtWeC/MFeGke1tcWxkQJTTSKX7x8ZW1xTrpbTOKqtLU4UB9l7nN9kVakEjrBjzsmztXmmW7n8YHF+U/CMGke1tXny7c0HsKlefSfSa/ly9wfnzf8rtgqn98Hm8oMq9wtEU4ticxbJpwanfrBTnuMeg91XGCzeLt9TGQ6+WtThve+WWixuKfnlO/s/nWv9zcL//bnwQ42j2u7qYmls5KIW6shYaU7WWIVd7Gc/fq9dW3XuF94PmH7jv5hrf997P/5M/uHmaF0vz00UB1v1XydKij81AEAHiEOLIh6ulnVpajusfVdIe1qj6/Cj8s0rrTktlx/5ftXna52TZ/fKt+lGwO4rjIzNlXd0Jqfwy7FTf3X8+MPB1t8Mfvj4mOeVpCXhexD54alCpKipbcfzb5o1IVzXDbGMUnRXpEgPK9JmLTPEoEURm6aKlZH9g7A+UDQoSjnzRIbPxwCAFGFei3LuT7fWPoVAUfZYrjTzvVhuu1hfzLnqWtT96Ys/jur4+tmP3yVrfCsJALQoAEBKyLIWxcfPNv81I3vtVGlR1A7Qtg54aRxuztD64R5yQ/MPJG5/7UZeRFqfPinfKPje0i6Mb8is/s7JJ/NDOb+/tiwrNzQjEn/YOzySNaDZir6rMwHiQ7tj5ynkJP3Kj95lrRfSHgQ9ANc18VqYn93w8meu67rOy60ZSbP8Kj6roqtF0dEtzpbSONyUNbnZ7ss3y/KG+2pR1IqqZC77YuXt9l+8veIJOAx4cXbhnXnRsFPYxQZ+xPQbVw4nc04elW9elnzP0ORKpKEFADBBDFoU3WmI5sRoMNNaa4PBpUfxnRKD1w+7cKMsKq/tvU+Y5fgXc1SakOAzw0bsQZSHp4M4IZ+zPdX+Jq0QlJDL6AXhVqSwDyv6Zi0zxKBF6RsAtY2gHkhQlHLaiUyfjwEAKSKWelFNv5vj4zMF5wtmGlbI0cenNnX4mwSYHBjX18hhUUx4FjH8QIsCAKSE7GpR7P6czdKSkb12yrQo3s4uEqNOnyxdU7SUSNLuMI28fvdLZ//uaF5yo6Db8dWufLAH5n08eYXWA7+7FKa3/O1QtGOn29NyeasZM+4N3xZ/c3s3FdNrYX52l2arao9F1qpAomlR5+oJg9pIOid3rfzcd/srEVVI1WuF8gHk87zZVbXFAjHSsBZl5I2raVGqv7eoUicAICrmtSiiN4QLf5HDzntT254MxBd4csJorB+5a8v+616U5ZgscXIEM6yBHoR9eJqwHhpsED7ZhKqqlBGWUdd1I6xIYR6Wmc1aZugNLUqjLEqbjJ+PAQApIiYtShl23g70U2HjUMmZVVmLMhcW5bque7o9cznncTCBFgUASAkZ1aLIsS0/W2W25xnZa6dNi+KMROehPW1Otsa5A3/ucvF2eb1SqVQqlfXy7SL1K700viU+STONvHR9tO270nd1bO7idquLY5xzr9ibkBaesAs3lu7VDps5bA5ra8xNfDK0e5Qsu+/q2OJqpbJb26vtViqri2O8A6u/hYDp2BvDw3l6Q1Gv3lz6DZsckX2eggcwvCx6n8ZeC7svemu0bdzJXS5OXHRgvXz7HU5go79dHYzm6POagS4eQ3Vvryp6EBJZRSaqkDinQHMZa4TgzK4Cw1UuPzJ2kc1vbITm7hnf+p3vw4uuRRl54wpalFc5tvuuFCfO+zxRvEJ+bH/0w/8mfboAgFgxr0W1K0JbVpT6K76Qaa28X50V6xR0huJnY7vwzvxqda/psNs4Oz6src2TidBnGxBxOX7xo29cpJfjEsz28/BZUM30INTD04bY5slGk4hRKt8SbRmNtiJpPyxjm7XMEEe9KHafomJn1K0vxUMCQRUFVpyPAQApIlktymFW10AHJnZR5wxHqloUFxbVjN7aq1YqlUp1T54hWR1oUQCAlJBJLconfrZJRvbaqdOiOGO/J/CEeS+5oRlRGaPTJwusXcAnBbDX91ecRK/xfIW4u+bnH/MfYe1aYmnBOXlUvjk4OPn3ohMg63loWVZ+VJy7hm+IX5INT8dy15Y8N2w8v9N+Rpemps+PqaI4Hf57xR6Vpl4L2Rc1+ylM5uOcfELciO3Rj4KCg8RoalFsLXfehkCy8VuWPTAtTMrIN91PVpGKKjTFlDzNNWvFoG+Pa7Fw7Dn1g83pAdsSmQ1Na1Em3nigFsX93oSvqXH0sDyatyLG3AEADGBci6KbjODAUn2IQjA1df4f+ZH5tQs3lePD2u7uc2ZGpbOxPbwgzmHnnGwxsc5i9xZTy7F6xlOjPQjx8PRhpSiPcZ/d0wUWkYi6jEZbkfQflrHRkRXi0KLIvidQG3KIxBhiwiLCq1ptPJyPAQCpIkEtiuSO8XHKbSNObXqOqhbVDouycjlhIHMuPzIZsbIjtCgAQErIoBZFCrJ6LY4Z2WunT4ti119RSl5n/+7Nwf5BWbUdahsQOxFSyUaa9o7Js2sJQrWiOSzWt6fYpIRS07dzsjkeWCmIdiw/5dcvzgBiSYoZc20UVvEy9Fo4ZUKWxI4N5rJCGxT1tCgaj0SHAm26PLVN4/l/ZD8stPXIzYA0maXMWORvVlNvsVM/qD3zDqQYtKjIbzzAeqrxe2sc1Woo3w5A0hjXosgew7Oim0AgsQ/f8U/Iyv9FQGY0NhJbuGwbWo71tChjPdB/ePoEqE0au7qIy2jUFSnEwzI1OrJCHFoUTZws/7VwYXchThms65KasojzMQAgZSShRTn1z2k4tz0wG1BH8cUyE1DqndsVtSjqMiXDHpgOqCMuaSu0KABAOsicFiWJn22Skb12CrUoerYO9/CJZuAt6sM1MjAJCcnow/eIvZN2fUnSUIV6wlRBErlTss1547tPJMoWyYYoDzlnLTMRMhcHvxYqDd2Rx6SwpcfDjhQNLYpPxEPO9FQbCs4ZSG09omCzIDMgsWX42lP90w3RFiv6ylKMa1EG3rj8sVExMWKSJwBABzCtRTlb43HPArxC4JOet90kdjZWmIyZ2V+59gtP8HKso0UZ7IHuw9OHNFZonFetrhN1GY28IsX1sBRGR1aIRYvi9vK+AiKfmCCEdi5J0uzXNpyPAQBpo4Na1C/mPGmKmxUYfhag+khSm56jqEURl6lAwubwgBYFAEgJGdOi2FOAjxCRkb126rWokIYioh6JXqCWwy+1XXG3I+KPpsci6auSTYmaPgQtV+8Y9bqR18wg7zT8DyLwtejti/bvDEYdKYpaVOPoIVftm84bVNhTSsdPZUhvsFngiyQ38Bk8/mXY1QOr/DGuRRl449LHRp+5klUGAJAsprUoI1sMna8InF9J4ILSLoJxDwkdtRK4HGvsJkz2QPPh6UMa69MvYsAXxoK7bvRlNPqKFNvDCh4dWSEeLYp6z1uWZeWGJsv3aofHZw3Xqb86PqzdK08O8amZtF8wDYryS37AgvMxACCFdFCL8pZx+IO3v/d3taOA+GziZerjXKmoRTWOavfKt4tXCleKE4uru7XDZt1N97z0pnd1CAhGFwMtCgCQErKkRVGvBb/JOyN77V7VogLXV71CCLJjOfkqe2D2E99kfx5ImIe/vUPSFm+eMo2OaQhMhvYrhpUJ8vwMaFGDHz4+Zjms7VYqq4sTXDFvyztvSCPnVFrvdXYNfpHEyCAcPuwnOEMXCXULac3svBYV/MZlj41W+5KrrwCAdJAKLapxduzPmTRzWrDGwHrAKsY9MBNd2IJXwXOv+m7CZA80H542ZOH0dRxhW+HbiIjLqIEVKbaHBRvVBXFpUa57us1UTlNBIXcCB9FUFWLmcD4GAKSTRLWoJrnLN1d8c+CSgFLfQCXVelHBeOqZB2Zk8YB1HgCQErKjRdGd9vR9v5NbRvbaqdeitLPeCW4SXYuS3s6TJKXwzvzmnsc6JYDEYKumQQnIU9YBLSr8/smwMqH5FgNbpIZdGN/govRJiJm3xpkPcgFLoW8kGktghmJtblzgFJVBVVvM0XktKvipyD5AHni20w4B0DWY1qLoEqq4cPiZJsQTl96CST0ibn9UUeB7b6vfX+Vro2lRRntgaLfhB4lFksQwk2aIdaKoy6iBFSm2hwUb1QXxaVGu654+Kd/w16Pswuh48Q9a/6kU1sRCZPJQiRMAACAASURBVFcFQyXOxwCAtNJBLapxxrqjXukjc7RYpKdK1LLvWmxOi3L5Msr63ihY5wEAKSErWhRbkFW+r8/IXjuFWhQ5nms//HPv5ccfDsrvYVCLcp3qLEnofr4p6LtSnF+tHtR9B1nIekfk+XrsF+nUolRfS9q1qNzQzKaneni4sCjeo5k3ZKn0jWYI4s1lrNM177JN/Lnjs2WmSouiTui9PK0D0EOY1qLoyqcYzRKnFqVXGMCD9vytuhyrL7BGexCvFkWkKGlIWbBoFXEZNbEimX9YyqMjK8SqRbmu6zr1g53y7eJguzZJLt8/MlneOTh7zhga9Z3eyeAITh2N8zEAIL10UIviaRxuTg8wvp+eqCc25ao8AtWoFhVkBggCWhQAICVkQ4tSi59tkpG9dvq0KHo8H7wjffdO/dVedb08NzbC15hkiVuLcl3n5JPZAT9jTO7yzaUdgYDB6SDKw0xufEiDFhX+taRUi8rlB4u3yzu+umLIIS99AWp9YzOwcMYGVur0FBmQC5qKdJkWJdf+AACpxLgWRcrOKcZeP54XOJz4Tlx6C6ZU5womYP4OvxyrL7BGexCrFkVWzAC7DRGjRA2JuIyaWJGiPqwIoyMrxK5F+UG83CRRSj7Ut6faNsrgcrQ4HwMA0kyCWpTr0imS5ktVS216jmEtiiZIiVS0HJM5ACA5sqBFsQVZrde/sfj30vwhfzvRcnh8+3vs//j0tyYakxbSp0XRsCg/M1Hj6OHK5Ij/0TnwHG1Wi3Jd13VOHq1MXu3zVaSuLT05ldy1J7SoyK8lWS2Krxd1fHx8fPzKP7BN2I7OalH+vtvs//B6xJKvDls5qZu1qJAlsgAAHca4FkXO7qrljbiKUfKwkfBa1Ov/9p6kMJUI3xUq8nIcTouK3IM4tSgiRdl9hX4pBXY/53HoiLyMmliRQj+s6KMjKySkRRHDZ4iy9HojA+djAEC6SViL4nylW1HVztMFZltx5Zt3VbMTvzHxt8y//3w/ZLXHKHoStCgAQErIghZFfWFD01uTdeq0KGIqEGZQcV5uzQx5D9B2X6F/sDhRKpVKc+V15qjUKS3qnMZRbW1xTKhJ8b6GIbUoeV6YpLQoM68lWS0qtNkr3JCXZ+hR7RupCNA2lzEdE6WQJjmVMpKjj1T16rGJHICexbgWxU29oVQA+cSlt64QBxwjE5OZ5Vh9gTXag/i0KJrNRhfvOIm4jJpYkcI8LEOjIyskokV9cfc6U+lJX4kiQVEKVURwPgYApJvEtSi6Zl/Mds7WuInJM/ReB1oUAKAHyIIWFTWlfU9O1mnToqgU5Q3nIJHQlmXlLhfnV6t7Hs/gwPU1Ni2q1dL6wU55kjvw26MfseIaeVJqmYL4v/L44iaiRRl7LV2qRdHoKnleSZ+/8ti5lPtG7GsXt2F+SMLkLEZihLpMizITDAYA6CjmtSiuVmNw/iovJrUo8mlpCSMljC3H6ouQ0R7EpkVFk6IE4yTqMmpgRdJ+WOZGR1bovBZF31EIJYq+PUFEnxecjwEAqSZ5LYqs2a20vNSrJCzQogAAWSYTWpSzf/fmoDwlhzA5Ry7f/ufBmx8ZrqScLOnSoogrHy/cuFxpXXtgelNUhcl13TRoUec0nq+MsnUmiL2BuCKqWjIC/igBLcrga+lSLYq6RSnalAL+SKNvrILbNJexUpQwAxX98pDGw27ToshPRzUzFwAgUWLQomg4KU39r4ZJLYrYge2pbW1hjMXgcqyxCJnsQVxaFHnn9sB7JSW+wSb143oWdRk1sCJpPiyToyMrdFqLohmfwihRukFRrovzMQAg5ZjXopqJbEYGi4sP1KZZdk/UXvFPH8yPqE6eTF1GkiV45PvVkP6RbFi6si/sOVjnAQApIRNalBYZqc2aJi2KFOoV+SqzFXDssQ3ZziE1WpTLWUDod5HMNt4oMBHEoVtg9Om8FmXytXSpFkXfiqKXPXn53q/W6Rv7Ci598MBhbu3nEksDAwy4ZHeBFkUfOSpGAdANxKFFcQbfoJXLi1EtiuQMDBOl1cbkcqyxCBnsQVxaFGmiul5GFSzOrh91GY2+Iuk9LKOjIyt0VosiZaKs/PR9/a0ZKSL65sLTSMqwkIycjwEAKcK0FlX7fqE91c5WFSZK4j4Scu5rb6vM7G5YZ1RtRyCs8wCAlAAtiicje+30aFH0BCZyVCamhIBTf5q0KPLX9LtozhiVTBrklClyeOy4FmX0tXSrFhX8XngCX71W31h7mT012761v8BJWqwohHJ0nRZFH3pEiykAoBPEokVxISLeco4BGNWiOMFDVxdjb2RyOdZZhIz1IC4tii7RGhYbGkLHPdOIy2j0FUnrYZkdHVmhk1rU6cYYM9hCKVFkTIWI+FQhI+djAECKMB4XxVbfVpkrSRWJsMmIzWpRxIlbMQiWAes8ACAlQIviycheOx1alPNyY7zAJisXbgrImimvrnS6NR5QSruTWhS73eHP/2RrE2jBof0S+vF0XIsy+lq6VoviDFZBvqjO/h3me4XDXa9v9OtbN5ZtTLksVdKx1zis7j474bvUdVoUX5BO+pqck2e7Vd8MRgCAzhCTFuVxgLHs4YVHnlnOB7NaFCdKKOblatT5Ij9ml2MymwZF7ZjqQUxaFBGN9EQfZ3uKWSk5vSnqMhp1RdJ6WGZHR1bomBbFlfIKpURFGejqZOR8DABIEeZz9JEl8dL4lnTX8sXd6/47AXUUtSin/uos8PxJTQlqsV0EaFEAgJQALYonI3vtxLWoxtHD8o0CNaP7mTHYG/ufsZyTrWl6w5i1KOfl1mJp0TfvPskF5N290CO/PbzwxG8z1Hh+ZzjY6tH5HH0mX0v3alHcntDK39p46f8oiAlUbH/S7JuoLHuAIYLPUjUw+4nIENs4XGsqxZ7fZRdqUZzfsZUfXXku+OE6J4+WruUs7WAJAIBpYtOiPNZfy7JyQzNrXtmd0jh6uPJvBpi/i65F8XYOv9m43YLyjYItmJ9MLsd0ixBoejHUg1i0KCL56Fro6eLKtSjqMhpxRdJ7WEZHR1bokBbF7yBDKVF0qIa2lgaRkfMxACBFmNei+CrlvhYY/th+aWo7ZHUnJS3qfGdqF26U/f2jGs/L13JM48OEo0OLAgCkBGhRPBnZa8euRb0x8bcVIauLpbERpgJu6wQ2teW38tJSSYI9g1M/2JwZyvG3jFWLalsi8qPlh0ecFaFxuHYrKH6ad87ODc1s7hF/GKd+sLNEFTvfXUfntSiTr6WLtSivXdMu3Cg//Jz4fTeOamvco/DzhNbuG3WwtlQsbh5LrF24sXSvdnjc5LB2rzzJtjY3+Y//xPx5N2pR3t+blRuaWa3unff5eK+6Ov8O+1sb+suDoFYBAGIjRi3K9Zznz+eEy8Xb5fXq3vHxq/MJvHF2fHxY211dHLvq3bWY0KI8qoSVG5os7/Bbgc/5SZlzhTW5HNNuWPlba02PG+fkUflGIedVkYz0IA4tio1Nty7NVjX/XJ5RN+IyGm1F0ntYRkdHVuiIFsUNgnBKFBcUFd5aGkRGzscAgBQRgxYl2rXMrNWYg3vjbI+3v6jGfYsJ1qJo8XS77+pkeWfvVatJTv3V3g7dVCg1yam/OuZ5/CFTAOv9df5/vxIErgMAQBxAi+LJyF47di1Ki/xo2TcqyHW9ichyl4sTi6stZSt/sTLbwws/+5t2Yvw4tagvfnSNdCGXHxkrlRZXK6uLpYniZXav4J+N2Nlf9lrD7L5Cf39/f79Ar5MFa3ReizL5Wrpai3Jd93Sb8ydujon+/v7+/v685x3Lto/6faOlK5TKj/m0WIg9MPug++OiXNfn9yYmP3oXcVEAJEm8WpTrus7JJ/Ne+7si9sC0Nyg65LriDdOyLKu1ggi2AoJZ2eByLHBwoF8+vMz3zEQPjGtRVEoKSjYopDrL1nXyiFlRllE30oqk+bCMjo6M0AEtiqZHCKtESeP3jJKR8zEAIEXEokXpLN/ni2O0bBnBWpRmgywrd21ZoUnUt0iJOFcRAABggRbFk5G9dlq0KLvwzrxvljsGjwep904D01svHdf9bHlY9gLNxUWpmbFy18qizCu6t7EsuzDum/xNs2OmtCiDr6XbtSjXdRvPV/ikk2Jy15ZkymuIvpHK5OrpWRRanBua2fKOum7Volyl35tduCGXxgEAHSB2Lcp1XddtHIoCQoKmRZ98fuHXFefl1vSAmhlCPCsbXI5d163fn5bcyx76yz3zPTC9KMujmhShkVWCkOPQy+h5I0OuSNoPy+ToyAZxa1G8fhtSiaLOSPpF7HXIyPkYAJAiYtKiXNc9fbKk5A5ysThGQalelPNyS3E/mhual2VDZoAWBQBIMdCieDKy105Yi8rlB4u3y/dqfGo7GadPPAWmmth9V1nLUNujN+Z6Ua7rNg53lm5eFu8b7L6rMyoym+u6jcPN+aLPbSwrd7k4v3kQFDGdiBblmnotPaBFua7rOiePViYFqZxaT2RyxZPOkSdE3xgndl1LhHPybG2+eIVrst1XGJks3/Mrn9LFWpTruq7bONwpT47w4Wq5/GBxftVTIx4AkAid0aJc122mwxXMCfwEfqV4u7wjW4ujrStO/UC2E7D7rhTn16S7JjPLcbMxYpEkd/mmpJBBpB4YXpRJKJAglEuRF8uMYGBPbYu6HmoZZQixIoV5WAZHRxaIV4viykSpObiL7sMornZhOkIKKQUycj4GAKSI+LQo11UywBg5FippUc0WHdXW/JvUzN2n0SRoUQCAFAMtiodJrHrWw0bJOLSoxpknJa2ISI+1cbZXrayX50qlUmmuvF7ZrR1673fRENE3sY0MzohL0uz6N7xxtletVFYXS9JmKXTusLbbus/iakXnPhodIy9Kfn/yAPxvG/m1KD5oUQ/C5TVW7Fg4nPqrvWqFfSCV6p7ql2j3jTW5+ZjKtL43+PErvK3Aj5h+46GGRKsRSI4NQNrooBbVwqm/Ot6rVlrLcHP6rlT31DYuZtYV4U5A/W6Rl2PuVs12LK5WdmufK69iIXpgeFFml4RIu06dtUpjGZV+VWD3Qz8sg6Ojx4lXiyLb8AijnblP/NuYjJyPAQApIl4t6pxIBhi1L9CdqUmTNC0JDKJ6UQHgSAwA6BTQojJKHFoUAKDjsAlaRCmEAACgC0lCiwIAANftSL0oAAAAcjqiRQEAAEgAaFEZBVoUAL0AW2Q+ZEUMAABIHdCiAABJAS0KAAASB1oUAAD0KtCiMgq0KAC6H1Kd/e2VL5JuDwAAmAFaFAAgKaBFAQBA4kCLAgCAXgVaVEaBFgVA10NKRd36uJ50ewAAwBDQogAASQEtCgAAEgdaFAAA9CrQojIKtCgAuh02Px+kKABALwEtCgCQFNCiAAAgcaBFAQBArwItKqNAiwKguyH5+S598MBJukEAAGAMaFEAgKSAFgUAAIkDLQoAAHoVaFEZBVoUAF0Nyc83vPwi6fYAAIBBoEUBAJICWhQAACQOtCgAAOhVoEVlFGhRAHQ1jbPjFmeNpFsDAABGgRYFAEgKaFEAAJA40KIAAKBXgRaVUaBFAQAAACCdQIsCACQFtCgAAEgcaFEAANCrQIvKKNCiAAAAAJBOoEUBAJICWhQAACQOtCgAAOhVoEVlFGhRAAAAAEgn0KIAAEkBLQoAABIHWhQAAPQq0KIyCrQoAAAAAKQTaFEAgKSAFgUAAIkDLQoAAHqVVGtR//APW7/85WNccVzf/OaMZb32ne/8ReItwYULFy5cuHDhYq+f/GTdsl772tcGEm8JLly4snZ961vftazX3n//f0m8Jbhw4cKV2aupRX388b3EW4ILFy5cuMxeKdWifu/3vvLuu3/WXH5wxXH19X3ln//zP+7r+0riLcGFCxcuXLhw4eKukZE//eM/fjfxZuDChStrV1/fV77+9RGcknDhwoUrwevdd//sT/7kG4k3AxcuXLhwGb+ax/x/+IctIxKSMS3q93+/gIUn1uurX70yMvKniTcDFy5cuHDhwoXLe/3Lf/k/Dwy8lXgzcOHClbWrqUUl3gxcuHDhyvL17rujMAniwoULV09e7747aqVQi2qGayEgN77r3/27Wct67Vvf+m7iLcGFCxcuXLhw4WKvv/7rH1nWa3/4h3+UeEtw4cKVtes73/kLy3rtm9+cSbwluHDhwpXZqxmcurPzSeItwYULFy5cZq+vfW3Asl771a8+NSIhGdaiTKUOBF6+/e3vWdZrS0s/TLohAAAAAACEX/7ycVOLSrohAIDMsbT0Q8t67c///HbSDQEAgOzS9J0/OvrvSTcEAACAYVJaLwpaVNxAiwIAAABAOoEWBQBICmhRAACQONCiAACgV4EWlVGgRQEAAAAgnUCLAgAkBbQoAABIHGhRAADQq0CLyijQogAAAACQTqBFAQCSAloUAAAkDrQoAADoVaBFZRRoUQAAAABIJ9CiAABJAS0KAAASB1oUAAD0KtCiMgq0KAAAAACkE2hRAICkgBYFAACJAy0KAAB6FWhRGQVaFAAAAADSCbQoAEBSQIsCAIDEgRYFAAC9CrSojAItCgAAAADpBFoUACApoEUBAEDiQIsCAIBeBVpURoEWBQAAAIB0Ai0KAJAU0KIAACBxoEUBAECvAi0qo0CLAgAAAEA6gRYFAEgKaFEAAJA40KIAAKBXgRaVUaBFAQAAACCdQIsCACQFtCgAAEgcaFEAANCrQIvKKNCiAAAAAJBOoEUBAJICWhQAACQOtCgAAOhVoEVlFGhRAGjx5e4PSi1+8uukmyPk1z9pN/EHu18m3RwAAAgLtCgAQFJAiwIAgMSBFgUAAL0KtKiMAi2qe/nFXH+buV9Evp9z8mxtsVQqLa49O3EMtK9HeVF+y2oxtZ10c4RsT7Wb+Fb5hegjHX/bjcOd8lypNFfeOWx04vsAAD0BtCgAQFJAi2JpHFZXF9u+Tv9+9dN/SsW9AAA9Tma1qMZR7V75dnGwv9BnW5Zl2X2F/sHixOJa7SjR43Ra2wUA6EKgRWUUaFHdCys4RBdFXvzoWq51N3u4vA85SkxPaFGdftv1+zMFu/WF+ant03i/DwDQKySlRTn1V8csZzhdA5A5ulaLapyZnrzq96fzzLHDujS+FXorZ/JeAIDep3NaFLv5e1VP0hpy+qR8gzk9e7ALN8pPws2ckRaIGNsFAMgkWdSivvy79/uVee/Hn8XRhsSJQYsi4ToKz815uTUzwvzJ8IePf2euNT2MSS3K2Z6imwr71sd1Q+0MBxlGYgaLE6XF1d3a5x3dKfaAFtXxt02emWVZ1ptLv4nz+wAAPUNHtagLR898zhJg9xVGxubKOweJWic6yunz3UqlUqn8fD/ZHUGc1Le+ye4svrnVu10F2sSqRT3+3wfVz6Fq6Q8ahzvlyRHvBJbLj0xGCks/3Z4i6lEUpyKT9wIAZIHYtajGUW1tvnilj9dYcvmRscXNCNs+52RrZlBvHndd19m/O5q3FMhdW1Z3KPVZIOy+K8V5tYCmeNoFAMg2WdSiqrOXVObSJj6JrrqeGLQoIpEEPjfn6cKb7IPOz1axcqlhUovyiAWJj3jSu8ANz+Wb5UcdSizYA1pUx9+292Wm9MEBANJGZ7Qop36wOXPVY4RIw5qTJK19ctI7ghj58u51+nLHNiBGgQvi1KI8Q09K4Lapcbg2LvNVtyzLsgvjGy9DTFy8evTmwtPQ05/JewEAskGcWpRz8sn8kNADiZ07b6w81xfzeelG8fjLz5J24Z3b5fVKpVKpVNbLt4uXSWtztz4OVvMbz1ekwUyWZVm5a0vynW0M7QIAgCxqUXpngOFlxEUpoqNFOdVZsqa9dQc+FMoYzdH3eJ56uVz64EGyb0JLi7IsK/wRW5Me0KI6/ra//GiUbn/fXvkizu8DAPQM8WtRjcPN6QFVFYqsOaFME11EfWNMspD0Bl+svM2/WCxQoEWcWpSWS6Q9fV92r9Pt6SAzY+tO2nmZOftjpMTOJu8FAMgKsWlRzv7ytQAdqjVdFaa1QjhPnywMc9Oykt3gi7vXmT/LXVvyJrxrPC+zrbav35VtW5yTLeUFIj96129ONt4uAABwXTeTWlT7DGD3FeSJEUYmf9qrW+VEtSguXzhOJHqYrRd1+mSptXuwB2YfJO3JQnr35jdKPGMjF9UyWToQEd4LWlTH37bzcqPtrivZ5gIAACVmLer0waxQh8rl+weLExcLzkRxsF+Yt0/XNNFdtJe7ntWivGHCFsQo0CZGLYpxiczlg1JSL8r2ac5+mVo8c5eL86uV6t7x8fFetbK6OMbFfOan76sH/51ujbOaWSTjosl7AQCyQ0xalDjQp7p3fHx8WNtdL09yc6c9vKy2GfKRf1TsBr9ZYjIG+ceN0sxC+fnHGn2cX63unVeL2quulydpVJjPAmG6XQAAcE72tCjmDDC+lV3DaIJaFJSoiJjVolzXdRtHtd3KrlK+4NhR6p1TP9ic4cLq446t6wktynU7/7ad+kG1UqlmqNIKACA6cWpR/Andsqzc5ZtLO3viUs5O/WCHt0z0dH6p9lLSq1oUY1u5lM+3XixKGoJzYtSi2i6Rg3ciHXOpoJq/tSYoC+W83LjFTnbKQ/x0Y4yd8CKVdjJ5LwBAlohFi6JTkjhDnXPyCfFYUimx7F9UScFuQAJmpTmD6x/fajfs0mxV/CFibhMGM7mu23i+wrZYVDHDcLsAAKBF9rQoY2eA7iYxLYrP0gDfOG3Ma1FpQr13zskWHUsKu8QI9IwWBQAA6Sc2LcoTS6Cac885eVQ+P7T3doXLz5aHe3whYWwr9tTG2lhrLLyx8DTptoFUEJ8WZcolsr491bYQ2mNrvtU+qLe62hDn1SOdeKo47wUAyBZxaFFsoI/UJZompwuInOYz89k281/BdgNm42VZ1+9+KfssqTci3qaRYCapu66zf6dt4LBHP+K+2XC7AACgTea0KIRFNUlIi+KUqEvjW/CN0wZaVAtyFA/cIkUDWhQAAHSMmLQocuq2LMseXhA6i/r+/cmz3crjDpQoTBBGqenJhcR58EFbirr1cZ01nyReMxOkg/i0KEMukcQDPcBGSoqjKdRBpgbYaOkrTN4LAJA1YtCi2ECfgBB3drcgDQri0z7nri397G/abi4KdoOnC2+of5w97wsDkNg+Bm5rSC95W4rZdgEAAEPmtCiERTVJRIvi8oUjS0M4oEUxkC1SrPoytCgAAOgY8WhR1DCKbYiI+sZYTy8krBG/GU/N/gvEKOC6MWpRhlwine2p9kwmTZvkuq67f2dQ/Tf9YnnYmHpk8l4AgOxhXotiLQeBRSKdrfH2DOYTVcpnQrXytzZeOrp2A3aWjqz5sH1UiYVlP8+tJ0bbBQAALFnTophA00yHRSWhRYXN0tA4qt0r3y4OFkithlx+ZGxx7ZlvTopzfv2T8wrkcz9lDkBO/WCnfLs42C5JbvcVlO5HW3ZYXV0cGyGVzXP5weLE4ppqNZ7GUW1tcWyE7Vsu3z8yJruDn1rj1A+qq4ulsZHzmscjYyWVhnz24/fadZLnftGJXsvQVdruTzPDQnbEbhzV1hYnuHHUfNirKsWMfPeU//T4b0ot5lbUXOxPH/xV62/+/eqn/yT6jFM/qK6X5yaKg60q1hMlaWODtajgt234J/OLufb3vffjQG9ct3FU22VHcf/IWGmufC8dxcwAAB0jDi2Kurhal6a2jSaL+nL3B4Lp0zl5VL55pbXw5PIj36/6fK1z8syz3bH7CiNjc+UdnZJ7zd0At05bdt+V4u3yjqCmDPuXr44ff9i2PAx++PiY55WkJeF7EPnhqUKkqKltx/NvYdL9Rly5dFf7SA8r/OjIErFpUe1NaySXSEbkURix7AY2QIui6lG09BUm7wUAyCLGtajfbU9eLH0qhSICpZjPfvwuWUpbsfaaWhTJhRfgX8B6DIlCXYmCpmLwZP+AW5lMtgsAAAhZ06IMnQG6n45rUbwSpVJswTl5VL55mV3hPdiFG3dlXnbtRtnT95sNeVK+UbD97ze+oZB8xzl5JLuLZVlWbmhmU27yOflkfkjWOb87CNSaxuHmjN+9gkphqO+VTPQ6EF0tijRf7IOj0G7L7rs6syV98/7PiWQ/USoMTQyiAi/soJGfG5oUal7BWlTw2zb8k1EP1Wocbs5c7ZN8zzvz8jcEAOghYtCiSFYrBYdYXZj5tTV9cnlbfKde2Sp+MQfeKAvqawvuI5lILcuyckPzDzzrxy/mqDQhwWcmj9iDKA9PB3FCPr0oE77bEVaucKt92IcVdnRkkLi0KKMukY2zAG34AnbrJzMQcsX0IsWNmrwXACCjxFEvqul2ozR3kmR3F8sthcn6kx9ljFK6+VTIN537yfi0nlgRBKYP/VQu7Gmd+wOD7QIAAELGtCiERV3QYS2KS4sjraHYxHm5MR4gH7QWRknSB6ZR1+9+6ezfHc1L7tQk6MAkPPGLW1aY9rsVVznL9w4D8x63Vk6taTxfCeyUPTDra1xQ3LAY6bUCkbQowS5Rvd2WZRemt3wtfZLnRA2cwbsv8nmPFKXa4ty1Jd5CZVaLMvKTUdOi1L5GWSsGAHQ95rUoojeEC3+Rw86vU9seY+wFnoQpqhOgZVm5a8v+26fTJ0vXFPUkz6RNll45gpncQA/CPjxNWN8RdvUlNhRVlTLqyhV6tQ/zsKKMjgwSlxaViEskO/VJfkG8eqTiNNiJewEAMks8WpQyJNLH7xh7uj1zOefx49AWhB7Pt/cT9tiG7ypM3LuFaYWNalEG2wUAAISMaVHcGaBxdnx8fFjbrVQqu7XD4+Oz7OSm6KgWpZ0v/He/+SF3rLb7ro4trlaarC6OcY6dvuIW06hL10fbGS36ro7Nlddbt+N8eSVB27yGlBuaLN+rHR6/qjuuU391vLdTnmTvJu4tV8u3cGPpXu2wmf3msLbGtEe05tMHPdx+Urn8yNh5qMz5mQAAIABJREFU2paJ4hXO9dU3J6LKhsVMr5UwmqPPo/hdjKPd2l5tVzSS/G0wsudEEz8F7b+IFMWFUXk1SrvvSnHC57X+0Q//m+/DM6BFmfjJKGhRAisaM5RLYyM0kdD41u9kTxcA0BOY16JY507N4Bc1aCKs/eqsWKegMyE/AdqFd+ZXq3vNHWnj7Piwtjb/DuuZ47NInWyNc1+Xu1y8fTFpr5dvF2n0DZcw68WPvnGRXo6dce2+Qj8Pn23VTA9CPTxtfrP0ZvsJEL8RsoyrfEvUlSvKaq/9sCKOjgwSkxbFuUQ69VfHx8d71UqlUqnuKfrpa8MeOfxD9+mAtofL+07j7LC2W6mslxfL65XKbu1Q9Zhs8l4AgAyTrBYVJdJHXxAi1iEfUwo3ufqcvtnDt4rbg7y+lLl2AQAAS7a0KOYMYOdyImdEu+9KcV6zalBX0kEtileilhUMCfXtqYu13y7cKD/0ptznCkX6eTh7XX3FWeT44KL8/GPR7WimwfytNXE+usbzMuN++ubCU248kXBn4ZrunDwq3xwcnPx7wVIucF/ODc1s8nUFnJNHC8RQ4nMCDd4rGeq1GppaFLt74qMd+byQo+LsQPy799lAyZ8Ta+AK8LcnPlbU/ZprsT0w7R2rjaOH5dG8eOQY1qLOifSTCWyS83ThTfbbRK/JqR9sTg/YFty1AcgMxrUokvTeun73S1M3bkEUgqmp8//Ij8yvXTibHB/WdnefM5MYnQDt4QVxDjvnZGu6reaIHVOZbxdtCVzXPX1CNgV+Vmn1zKomexDi4enDrtQeewu7MwtMtht15Yq22us/LGOjIyvEpEUx7lO5nDBMLZcfmTRZt4u8V0mlXnpW+4P3vyvM5mj3XZ1cCUwVavJeAIAsk6gWRfOYaCad09eieB8Vu3BjaWfv3EXBqb/a21m6oeCZxH93YKS3Q/xZRLtjU+0CAACWbGlRJIRCSn60LCrH0jt0SotqPL9DlChJaC/l9MH8SH//iKyGDz3Ki32cqWFdmoONyfdriXccjEIWGPrDrut8r+XeJ4FwYoE9MPuJX6do/JX4u4L2SqZ6HaZ3QVs3rhA92T6Rdgc03DnZZF++UEsKeE6kaJRMjGKLVdDPabS4cVSrCUwV5rWoiD+Z4CaRBkm3r079oJYBNwEAgOu6MWhRZAcYSyZ7Op015/E7snKN9C8Cju8kuEHk7OHs37052D94U7J9pQqKz/5DS4sy1gP9h6dPgNqksTeLuHJFXe1DPCxToyMrxKNFUUFchj0wHbFCZuOMS1lASplwcNpoUOOk6ZJN3gsAkG2S1KLISqsdlB1Gi1KoJn5Obmje1/rjci6y8q0ZF+Pts/QbahcAADBkSotSPwMozNxdTtxaVDOvC62EHa2OkACiRIgLSrKNCsw5QhL4ePccRG0I3pKwzjTUJYVtVIi6ZVT0+65UNKVijbBisY7GEqXXimhoUVyGGyrsUG0oOFacHp4FTQ/U7EjRKF+fe7ZdtAQoaXG4RESmtaioP5nAJnHJDae2jSfNAgB0J6a1KGdrPOoMGwSvEAR5ZNDsL8HzH2NcCJ2Knyw0wj2BjhZlsAe6D08f0lhh2A/J4Cd5wlFXrsirfVwPS2F0ZIV4tCh1l0jLCpfu+rMfv9ff399foHFIuaGZNUlIIR/l1/qzfDMtZ0EQ1eR3RjZ5LwBA1klOiyL+vCFK3oXTolzXdd36r8vvvu6/NLx+Y+UgaNdBzRq+3iqeouNSRy0D7QIAgDaZ0qKc+kF1dXHsaqEwMjZXXmdSczv1V8d71VWa0T5S1Zu0E7cWJeDK//Zz044SbIhJGEs4BzVV8dsG4mKiUmmCzcVGPs82KmpcVGDkENsnoV6nkXsuUq8VUeudUz9YG6e/VlozjPRKyWpHjUvewRK4p6Q38BHi/OqmawRWSTCtRUX8yQTejj6yrKcEAgAwmNaiqPm+E1pU0JRGHBiU9gJM4E7oqBXiQRBxETDZA82Hpw9prE+/2B0PdRZhibpyRV/tY3tYwaMjK8SjRTWOavfKt4tXCleKE4urbKXixtnxYe0eLb1qhVBpvCFzr7858Ze/ECRlbENdqSyrqV3VSHb0xtHD8g3+jCzIuW7yXgCAzJOQFkWDhSTZTf0Jp0U1Djdn1OKPRPnzyfcvD3MuCc1a32cN16m/Ei44kt2EuXYBAMAFmdKiFHBOPpkdYP0IerX2XgJalGVZuWvLZsW9QJOJXt0D2SmcRNWpVZpgdiHEzYTsTmQp9sToVVQiXpiiT0v3SgZ7rQjp3fvrx4S9aqWyXp4b82Se52VjolL6W5Qo5PV7OquwpyTCnXC4sZ+g+z1SRSqUiucmoEUFG66ktyPVvjKeEAgAQEiFFtU4O/bnTJo5LVhjYFdnxdWSmVDDFrwyuQiY7IHmw9OG2Mh9o7bZVvg2IuLKZWC1j+1hRXDk7jFiqhcVjKcWp547vleLOh8lfVf9MifRAWlZ+Sm/1MzO/t1R/3QEpu8FAACJaFE08UrICtj6yyk/K1p235XixOJqpVKpVCqrixPFK9T+IUu86rru6fZ0QScU18/sabpdAADQBFqUF1oEpUd99ePWoi5dfb9UKpVKpTHOiSLkgq7wnQa0KNm2gb3T6+/9oKLA3068Ib6bJ71K4Z35zT2PXUuh08Gbm8CtkPQDJnsdondq5K4t8YkKiQKnmmiGCFietqvsKclnBFMHK0VxtjAi6oRNjdN5LSrwfrLbUcVQmGQTAJBRTGtRdIJX1KKkC5JnxtOrLUA+PXj7I5X19Xtvq99f5WujLQJGexCtMEMgJBZJkkCYNEOsE0VduQys9rE9LGhRFySmRbmu6+zfCa01OvVXjOPWCJcqXZTtg8pHQQlBuOTY3E/J5L0AACABLYqGRIV3o9ZdTrkJMT+68v9441mdk0dl6q0gj509fcIHoZIloTA6XvyD1n+KbXSxtAsAAFxoUWLImbU3vfXj1qLaZ2Pn/1u5LsmlFo7mYev4eP190Vf6NCqSYV2z2JgHejenOpv3fsbuu1KcX61KU2m4HdWizPZaCT0tyi7cKD/yOl3KVSW17+YtREp7SvnUwTpTczYueoAPawHqMi2KOJfHkjILANCtmNai6ASvuLOLU4vSKx3jQXvKPI/xevzhoHzSVl8EjPYgXi2KrM3SkLJg0SriymVitTf/sJRHR1ZIUovi00CGjJRv3omzEHoNhORnrJDSmlY7oz8mk/cCAIBOa1E0BChSsQ49Laq+PcWWoZTVa3ZO1kgtqCB3Bad+sFO+XRxsuybk8v0jk+Wdg7PnjN+DOAY3xnYBADIPtCghCo6RXU7ntCiXq/5ohVCjGmeHtd3VxYnioLDqreArRY2KZFj3S3uhiMd1ls8GSchdvrm045ttt4NalOleK6CkRdl9hZGxRS4DvW+7le0pUvOO2p6SpAHiDuKMM7Rng0Yz7oQNEeoyLUqq/QEAMo1xLWr/DmNmt8a3VLYhj+cFbiO+M56eQhAiCJglYMp06q/2quvlubGR/v68b47/aIuA0R7EqkXpVL4k5nFRQyKuXCZW+6gPK8LoyArJalGusz2lWYpNdjNa+YQaHMlYUvom4qVGRrDJewEAQGe1KOflxi2pcq+FlhZFdfnAIFHNj4shjtE+JbGSaBcAIDNAixKjZ4/tQjqqRbnu6cZYGDXKqR9szvNJaP3ooBY1/H8+k9SQUKor4bqu65w8Wpn0lD5qIUg95+lTJ7UoQ70OQFovSvWuyWlR1JuVFaPY/+H1FtU/wYvoZi2qJzV/AEBYjGtRxLqrXM6QVoySh42E16Je/7f3NJfXV34B1I2jhyuTI/4CA8GcFhW5B3FqUUSKsvsK/VKIy5Mg2W7ElcvEah/6YUUfHVkhYS3KdLZENpiPzn0hvohkmWR/ASbvBQAAHdSinJOtKXNClKs3H2qXkaR/ECamlKTe8+ttAu0CAGQIaFFioEXpI9OiQqhRPhluc/n+/pGxUqlUKi2uspUHYtaiSNY3s0OicVRbWxwTalLC4PAOalEx9toPvd75EFKLkmbeUd5TslavdvwTawYVGLdoNsSM5Ogj2Vx6cp4FAITFuBbFnZFDqQDyGU9PISBGWCNmf+fl1syQV2aw+wr9g8WJUqlUmiuvsyUdIy4CRnsQnxZF853p4h0nEVcuE6t9mIdlaHRkhR7TosioJSOGjRcdvKN07PYdfibvBQAAHdOiaFGk/NSWN/+/LjqTONlNKU2EJNJf1bmqDUlZ5K+7dbxdAIBMAS1KDLQofeRalJ4axdVJtPuuTpbv1Q49ETGB78mcYZ29Uzxrq1M/2ClPcqYCe/Qj3qekg1pUB3rNY0SLondRy8XE/xXv/aO+pyQR6ue3YXP3CWPWjcQIdZkWZSYYDADQi5jXorhKggrVTDyY1KLIp6N7j9I8XJaVu1ycX63ueeKnDC4CRnsQm006mhQlGCdRVy4Dq732wzI3OrJCr2lR7P188+opjmbfPPYm7wUAAJ3RojghavRu9MLmrt4kHmRDC7i75hrBpW2VRIB1tl0AgKwBLUoIMVgoW7K7iQS0KHU16sUyu0SOlh/5Oqd0UIsirqxx6pON5ytsnWHv2ayTWlTHet3CjBZF3HJUbUXyP9LYU5KiUW+vfEH/RWyxM+JI1GValLM1zrxsRPIDANrEoEXRudmyr9/VzWVvUosikQr21HaknWb9/jRTbntgetO34qTJRcBkD+LSosg7twfeKynxDTapH9ezqCuXgdVe82GZHB1ZIWktinVHF4QYXRSjH5n8qZrVlH2zZNCRcFGlAy/5ARBdy+S9AACgA1rU6fY0k4Ynd23ZiBDlpleLcp4uMBsceS5CaFEAgDiBFiWCHF17MiwqGS1KTY0iPqxvLjyVbQk6qEXRBG7xlmOUD8BOalGd7HUTM1oUjSpXazdRoL1mNZ09JRnDb698wdy6nbVP1uKQQUJdpkVxUQrwiAUAtIhDi+LO4JY9tqFXEMCoFkUMt2GitNqw0bgBnTK5CBjsQVxaFGmiul5GFSxu2Y66ckVf7fUeltHRkRUS1qJIsmfPsP0ff3ejNTzVJHWi+dARw27zlUYjGb9UizV5LwAAiFmLOn0wO8Cs9aLKCKHRWU6JtUV/7tTYR3AxYNP3pRuYzrULAJBFoEUJIDlUBaVdeoGEtCiPGiVY9nWOMp3Uomj16wCRLCJsQ5LVojrZa9d1jWlRNCuPyq+YZNYTKEZ6Jhr2sb01O9syXPlb62iLw1n1uk2Log+9I1onAKA7iEWL4kJEtE0PRrUoTvDQ1cXYG7GCS4A2YnQRMNaDuLQourBrhG7REDrumUZcuaKv9loPy+zoyAqJalFOdZYJZBN4MJF3mp+tBo0gMpz5WDzWdhg8GuvbUxJXL5P3AgCAGLWo0ycLw6wQdee5X8RwKLR8WEm4tYLVgohE6i4x1AoXpER1rl0AgGySLS2qcebJje7ldGu8vTUOkcKlO0hMiwpWo9j7yGvfOvt3go7jRg3r1KihZsFy6vUQOxt2KU80R5/byV67rmtMi+JEtEAbGfnZC0/2miYa8vUtpNs4+idS3c85ebZb9WbZ6Totik+ZJX1NjcPq7rPoxWQBAN1ATFqUpx6lZQ8v+CcC5jCrRXGihDxVSotG3bORJV8sT41F17rARSDIIchUD2LSosj+RU/0cbanmMWJM5NHXbmirvZaD8vs6MgK8WhRTv2Vp/Ct90PkbCNWmqiKI6u/63LSluB3QIKw5Lt8OnsKZDKT9wIAZJ64tKjG8ztEiFp4EsGXRoiW3YBuKi6Nb0lbQ5dq1cmTqxsZrER1qF0AgMySIS3qfNObG5rxz5TunGyxSWM7EQaSEAlqUUFqFFm7/d3kGs/L13JW0FeaNazT85yVH12RuNA49YPNmaGcyDrjvNxaLC36jkOSRcj7BDqsRRnrtRrGtCh+RyTZZtINqY9dSdddmDpOBw3nZovpD8PnSTsnj5au5SzRMb/7tChPyqyB2U9EVuHG4dp4wbbCjysAQHcRmxblOZBblpUbmlkLUrobRw9X/g2TzcWAFsXF4ftOgO0WlG8U7IC5XxJ9y21xFRaB4FgFQz2IRYsiko9u/BGV2bgWRV25Iq72eg/L6OjICjFoUefzjl24ISmDy51t/HVOWpUjf2vjpfiW3AZXOFzoj9j3XjSKwEcCM3kvAEDWiUWLoptAuzAdx9FSz27AGVskUVr8nK4QGeu6vJODmhLViXYBADJMZrQoujnOXS7Or9UO295pjbPD2tr8OwVpwE4vkagWFaBGkVSzonPMhTWD0gEtymN/sOzCO/Nrtc+Jj2/jbK+6SgYTDa9r3yM/Wn54xC3pjcO1W/LcHJ3Wosz0WhVzWpTX/T03NLO5R3xSnfrBzhIdS34nf+3UNdSXyLJUEpDwLbZyQzOr1b3jc/hHbA395QH7512oRQnMwnbhxtK92uF5nw9r98qTQ4xpJjf5j/8U0CoAQNcToxblCrxZLMuycpeLt8vr1b3j44sY+sbZ8fFhbXd1cexqH7/nMKJFecto5oYmyzv8QvU5Pw9yh3xa7lDgedFyEwnogqcbVv7WWtNvxjl5VL5RyHl3xkZ6EIcWRZLF8InJgpGn+o26ckVa7fUeltHRkRWMa1HUomf3XZ0s7+y1k3U49Vd7O3TIBDjfeHfmN5bY351T/7y2xr1W34Pti2Uympv3umidsG3+Z2ST9wIAZBvzWhS3eL/+3g+2KquLJQXmVvy8Wp36q2Oexx8Otr/l/XX+f3tSNXli9rkp3XUbZ3u80ULVRZO7uaoSFXu7AACZJitalLO/7DU7yIjJRyI1JKxFydUoLr2Z3Xd1bK68XqlU1stzE8UrLYtQ/tbGve++If1K01qUKzAgnDey0N/f39+fFwyz/Ohd5pT1xY+ukf+by4+MlUqLq5XVxdJE8TL792I1p/NalIFeK2NSi/L54V+0uuC1LUoOxPplFKghSzFWXWOq8j7hrtSiXNc93Z72aMti7IHZB708MQMAzolXi3Jd1zn5ZN5rf1fEHpj2hjaHlFO8YVqWZVlWLu+3UAkmQt73IXe5OLG4WqlUKquLpbGR1hptDy/87G/apWbES5k4xWzry4eX+Z6Z6IFxLYquwKFKaBPPKK+YFXHlirDaaz4so6MjIxjXotRHy8VburYcsInWPdpKjYPiXb4PAWdkk/cCAGQZ01oUVzNUE7/llrrwhL2VeCt1brUQ7qQUZXyaKUZLiYq1XQCAjJMVLcp1Xff0iSCYRoRduCHLQtYTJK5FCdSotnnDx67Bkh8tPzl1Xff+9MUHO6VFua57+qQ8qraTsQs3yrwTjaIBLHetLB6FiWhRkXutilktytWwN9qFcb8cJ64brqQ365Wtnh9IocU+T7hbtSjXdRvPV4Km59zQzJbkBQEAeonYtSjXdV23cSgKCAmaiXzy+YWXU5yXW9MDaoZqv4kw2PxrD0xvvXRc97Pl4Yt/8lnK5MYae+gv98z3wLQWJY9qUoRGVgkW8YgrV9jVXvthmRwd2SCOelHOyy3F2SY3NC/LdcnecmNc6WR7cWiScfpkSUXbUrmV0XsBADKLYS3K2RpXmC99iVeLcnW2UgFWC+aWnFFNV4mKq10AAJAlLcp1mym5ypOCXCtNcpeL84E1A3qCFGhRHi9B4mzrf2TLXb65tNPyR267e3ZQi3LdZukI/5Fk5fIjk+WdA0GB7vM/P9xZunlZfFCz+65KipolpkUZ6LUCxrWoZrsPN+eLPo+7+bvfDGp1CC2K9UXWtYQ1DnfKkyN8wFkuP1icX/XUMb+gi7Uo13Vd5+TZ2jwT+NjE7iuMTJbvZWJeBgBc0BktynXdi52hZ761uJnoSvG2fH2LJqc49QPZOmX3XSnOr9X4tL4svh5Xdt9VVj9rxz35LmU+Iknu8k1JqZtIPTCsRZFQIEEolyIk3Zg9tS3qetSVK8RqH+ZhGRwdWSAOLcp1XddtHNXW/H8lzdx9/gcAEc7JI8nG3O67Orni/6P1NE+yW7b7rk6ueDKLd+ZeAIBMYliLCiEascSuRblu4FZKzWrRuhktExUcbyu5lcl2AQBA9rSoC5z6q71qpbJeniuVSqXF1Uplly0f1fvEoEU1zmRZcH3gEuxyr8Cpf17bvUjiu7haqVT3vDe+uIXwK9lGBbeJtEZtONCRNFder1Sqe4p/6zarLFUuejhXXlcZh+RBB35TYJ9CdDpqr2Xo9U775oe13Qo7otR/9/rPic1zFN6y1vpehd9U8HAP7oXhn4ze7Tx/laVJGQDA0EEtqoVTf3W8V620Fonm6qa8vJH5UH2+4xCuUzqz516VXZyFi9zFFCvvVuNsr3rejsXVyi5XJNJwD8w8PKYNhnYSOkt/xJVLfbUP/bAMjo4eJzYt6gLyKznfRkca98KNecg7nt9L73DSgXsBADKG6bgoQWEnDfxm1BC3DZ6c6VYqpLUylHWuA+0CAIDsalGZJwYtCgDQhiQIentFUPgLAACAD0loUQAA4Lod0KIAAAAEYbpeFAAAgLQALSqjQIsCIE7YBEH2rY/1UzMDAECGgRYFAEgKaFEAAJA40KIAAKBXgRaVUaBFARAjX6y83QqKEhU8BwAAIAFaFAAgKaBFAQBA4kCLAgCAXgVaVEaBFgVAfLClot5c+k3SzQEAgC4DWhQAICmgRQEAQOJAiwIAgF4FWlRGgRYFQFyw+fkgRQEAgD7QogAASQEtCgAAEgdaFAAA9CrQojIKtCgAYoLNz2e9vfJF0u0BAICuA1oUACApoEUBAEDiQIsCAIBeBVpURoEWBUA8sPn58tP360m3BwAAug9oUQCApIAWBQAAiQMtCgAAehVoURkFWhQAseDUXx1f8KruJN0cAADoRqBFAQCSAloUAAAkDrQoAADoVaBFZRRoUQAAAABIJ9CiAABJAS0KAAASB1oUAAD0KtCiMgq0KAAAAACkE2hRAICkgBYFAACJAy0KAAB6FWhRGQVaFAAAAADSCbQoAEBSQIsCAIDEgRYFAAC9Skq1qK99bcCyXvtP/+mjf/zH/4Irjuub35yxrNf+w3/4duItwYULFy5cuHDhYq+f/GTdsl77Z//sf0q8Jbhw4cra9a1vfdeyXnv//f818ZbgwoULV2Yvy3qtr+8rMAniwoULV+9dQ0P/wrJe+9WvPjUiIRnTon7v977yJ3/yjaYrBK44rr6+r1y//q/7+r6SeEtw4cKFCxcuXLi461/9qxtf/eqVxJuBCxeurF19fV95991RnJJw4cKFK8Hr+vV//cd//G7izcCFCxcuXMav5vT+D/+wZURCMqZF/f7vF959dzTxp9PD11e/euXrXx9JvBm4cOHChQsXLlzea2TkTwcG3kq8Gbhw4cra1df3la9/fQRaFC5cuHAleL377p/BPR0XLly4evJqKj6p06KaqQPv3//5f/2v+7jiuJo5+r7//f8j8ZbgwoULFy5cuHCxVzNH3x/+4R8l3hJcuHBl7frOd/7Csl774INvJd4SXLhw4crs1XQI+NWvPk28Jbhw4cKFy+zVLMyUuhx9ZstYAS/f/vb3LOu1paUfJt0QAAAAAADCL3/5uKlFJd0QAEDmWFr6oWW99ud/fjvphgAAQHZp+s4fHf33pBsCAADAMGZFH2hRXQO0KAAAAACkE2hRAICkgBYFAACJAy0KAAB6FWhRGQVaFAAAAADSCbQoAEBSQIsCAIDEgRYFAAC9CrSojAItCgAAAADpBFoUACApoEUBAEDiQIsCAIBeBVpURoEWBQAAAIB0Ai0KAJAU0KIAACBxoEUBAECvAi0qo0CLAgAAAEA6gRYFAEgKaFEAAJA40KIAAKBXgRaVUaBFAQAAACCdQIsCACQFtCgAAEgcaFEAANCrQIvKKNCiAAAAAJBOoEUBAJICWhQAACQOtCgAAOhVoEVlFGhRAAAAAEgn0KIAAEkBLQoAABIHWhQAAPQq0KIyCrQoAAAAAKQTaFEAgKSAFgUAAIkDLQoAAHoVaFEZBVoUAAAAANIJtCgAQFJAiwIAgMSBFgUAAL0KtKiMAi0KAAAAAOkEWhQAICmgRQEAQOJAiwIAgF4FWlRGgRYFsoZTf3Xc4lXdSbo9AAAQP2TmO2sk3RxloEUBAJICWhQAACQOtCgAAOhVoEVRGmfH2TBXQ4tKgsZRbXd1sXTB4urus5PeHWNp40X5LavFW+UXSbcHdJj6/s8rLX6+XzdwS6f+qrcXCqBFOscDmfmmtpNujjIZ0aJimJd6gNMn5ZuXc5aVu3yz/OQ06daADJJxLapxtletVM4PLIurlUp1L/TSZvJeAIBsAS0KAAB6FWhRLU4fzA/l2hYbKz+13cMHYGhRncU5+WT+ap9t8XSRYbDrgRaVcQwPgNMnS9fOV4zc0PyDHl4tgArpHQ/QolINFiYPzv4d5plY1psLT2G4Bh0mq1pU43BzvniZPQ23yV0uzm8eqsfWmrwXACCTQIsCAIBeBVrUOadb45fYXXJ++n5Pu6fGoEX99tOKpndv47DK/Enl4f/7O3OtSRPO/vI18WEsjYZB8h4rn/426fYYI0MmP+JpH5oeeveu6xoeAPXtKbJi2Lc+7pkVI0qgBpk+em0ESUjzeIAWpQSdNTsXoJShhUmV6iz5MVmWPX0/6TaBrNF5Ler0+W6EtdOpH1RXF0tjI/0XjIzNle/VPteIQGo8XxnNiw8r7Pl4VCVW0eS9JJ0M0UsAQBfRES3Kd2o5MqKXnz74q1ZOnB/sfqn+h42j2r3y3ERxsNWsweJEuHbF3EUAAAgBtCjXdV33dGOMDVmxh8v7Pb6tjUGL2p5iHmGwRaV+f5ocU96606PPnO+olcsPFieaO5K/SpP3vOu6rus8+IBYgS7NVpNukikyZPIjXQ1NF1mtlTA6AO5P81GOvfO4ojwosgz0ziMJRH08fHH3ut3ZOQhalApfrLxN3t/1uxrmgihkZ2F6PJ9X66Xn1wRQPbF5AAAgAElEQVQtCnSczmpRzsnWdKE97PXm6cbh5owo8cL5r6fv6oxKAJKzXx7m7pHLn5ss85w7nT289FSm1pu81/kdTx4103ZG7CUAoLuIWYtyTh6tTA7Jp5atl5EMVKfbU4wdSHGb57zcmn+n4DetW5ZdeGdesV0d6CIAAIQCWpSbRSUqeS2KLsy9/MypLJC/tZbqwxIvRVnWpQ8e9MibyY7JD1qUEKMD4OnCG9wPBaqt62ZXi1IfD60nBC0qgI5qUbwUZVlvr3zRiS/OzsLU7mhQL53qLHHg6fU8BSCNdFCLcvbvciFE6vO083JjXGKvvMAujG9IbY3coSx37Ts75LDSOHpYJo2U5LE3ea/mDdsZcKP1EgDQbcSpRalPLdNbYet7txzQzlHY5ilO65ZlD8wG+TR3oosAABASaFH8InFpfCttoSpxkKwW5VGilnvW/vKbpTeZp5L22K/6x7c8mx97ajvdjVYlMyY/aFFizA6ALz4aZXb3PTWHQYsKgep4UDfIGwNaVDBkoe7sC8rMwtSOdgrupfNyY7IZA5G7PAnrMkiATmlRp08W+BAi9XmaO0xZlpXLj4yVSqXSRHGQD0CSKT5kBsxPiW2SzskW+3V+ddxM3sv1ibFqZpcYG/FEWfV4rWcAMkdsWtTp9jQn+FxMn6VSaWykwMWahppaBNNX4AbIO63bfYXB4kSpNFEc5Fsld+buRBcBACA8mdeiXiyTRSIz03CSWhRXm8u+frcz7sdJ8NnycLunHUv6ExaRFJWuyidRyIzJz3Wd+qtjPx5/OMi83PfXfT94fJbmCL4QmB4AzsmjlcmR/v6RyfLPespYCi0qFGrjoV0KB1pUAB3UokRSlGW9ufSb+L86MwvTl3evZ6CXoGfohBbFZebTnKc5K6c9ML15QMomOfWDNeJd72e1JBkR7LEN/3MwySMiTJtg8l6uJ8t5bojPxOfUDzanB4hL6dR2T5xZAABubFoUzYlkF8ZXn/GyeeOQzi3a3urO/h2vZ2jABoh6yNuFG+WHR/yUR+d13zt2oosAABCFjGtRnBIlcczqNZLTojglqseXPbbuwRsLT5Nujhw2S9H12dn2Bir1IpoSWTH5BUBjprrIMh0ZDABFoEXFR31jrONDEFpUAKzx9NIHs1OtRbsjiTezMi/t3xnMQC9BzxC7FuXNzKc3TxOTpT1857nYe6jx/M4w+zlRyC7JMTu2Ia0EtTXe/qhohjR5L8UYK4/Jt1MJVgEAsROLFlXfnmI0c9/pk5f8teyErJCef/PN11U2QFTL98/AR2OnhLNnJ7oIAADRyLIWxbuU9W7JIgFJaVFcba6ej0NjH0ra7S+sFPVW+QV7oOyJg11WTH4BQIvK+AAIBlpUfCRhkIcWJYc9+9tT26dtubAj5RKzMi8xU0MP9xL0DPFqUVQhsiy7MD31ZzrzNDVZSpME08OuaFLTOamQCWt8K9Z7kU7mZ6uS2ZgWux1e/kz6xQCAbiEOLYpUCNWZp9Q3haxalJ++vzGl8nWMu1pQXQfSBYGzcwe6CAAAUcmuFsUrUb2cKE5AMloUV5srAwWpu0iLYt0P3yq/EPxDl5MVk18A0KIyPgCCgRYVH0kY5KFFSWFT09pT2473H+IlI/MS283e7SXoHWLUok4fzJKkcrlr5ecNvXmaZNSWqzQuL9R4Mh0w+TM19SPvh03ei0lpq+ASx364mxY6AICMGLQodppSqEPATreK4fKsvevNhacOs/mXTIusFBXYLjLXema8+LsIAADRyaoWxcXz93x4jocktKhIGREbZ4e13fXyXKnF4mqluqdW0qZdPod+3qkfVFv3nCuvV2mudfrByuoi8927tc99PksIrUVF6m8YBGFQ7DFRrXJG4+z8Ob/iHo5T/7y2236Ac+X1cH1x6q/2yJsozZXXFd+FssmPVlv6/KTO/RPfOV9aj0P6R079c/qq58rr1T3lL9ElvBZlqKGe25RKi6shh7ZTf3VY26002a0dSmtcyQYAe6Pd2qFSp377aaXFz/cFG/0Yfw7id2Foeui0FmVmsuMeavDM4LcscAtDqVSaK9+rHQW2JnA8uJEM8uF/N9CiZNS9YVDOdjtNn3a5RO1xaHpeIjTOuAWzNFe+p7ZgGp6+2HzF0KJA+olJi3JebtxiM/PZhfGNl46rOU9rKT6uy+W684hRoWOZBO00eC/2fwenCtd+JgCALiAGLYqdpVSqELCTi8Lcwnq7XyRdUtKimH2Swt6T7YVn+oy5iwAAYIRsalG8EtX74TkeOq9FcUqUPPSYwTl5tDJ5tU9U3deyLMvKXb65tHMoN4S0DzQtL+fG4ebMUM5zN7twY4Wk1HVOHpVvXvZ+0LIsu+/qzJaoRv1nP36v/5x8jv18oZ/jvR978kiY6K8+xGuy5X7IRngr+cm0x0BLu5I9wMKN8hNVEbhxuDlfFN/n4mWseYpyEtQs7FzA5IVMTTwu1cyTJApQ6NLZONycf0dYuPr8TZcfSXsUijBalJmGOifP1mb8h7ZduKHcX+fk2ZrPcMhdLs5vCkVl4QDw+73lLhfnN+W/s0CTSyw/B8kdmj+D1QqPnzDiR8e0KEOTnfSR+I9Opputg1rA+5GOT9/x8NtPK6uLpdJEcbC/wHRWsCCIVoTovxtoURLIIneRmYSsh8rlEqOPQyPzUpPG4c6Sb2MsKzc0E3QbE9PXbz9dL8+VSmMjgXshGaJfBQAxE5MWRcp82MMLrV+NzjxNEzkprdHSMk5M7litGk+Dd7yndIP3ahzVdptS+qLwrCW5G4ypAPQI5rWoz5aHlSfbJsz+3p6+L/8sa2Nsl/9Q0aJ+d/q8Wmm6nKlMeTItKt4uAgCAIbKoRTlPFxj/MHVRpKfosBYVsjZX4/nKDV8LOCE/KjPjMme8wTv7Hr9EjnbrnP3la77GnPMPCypLUmu/DO4xmeqvNn6mN6GdTgIzBsa3HNc5+YRmIhH1JDgm0Tn5ZF6gGwqwB6b9t28qFnZaDZQdp8SrVKWAltwNVbVPLZ9ZY2hqUYYaevqkrDS086N3g6YGpV+JaCR4BkDgnezCtF+pbFdLizL1c2g8LwfNSAJ0rTId0aJMTXYKk7TPi2S62Uy1fvogcKjnri37jk/f8UCeiRz+aRv53UCL8sfH30LsnCHDyDg0Mi+5zsstkaON9zb+ZbFd18z0pTH0JcCsDBIgthx9FwXt87fInklnnmajDFXzKbEOVR5TI6tUSZ2tSG5A8VebvJcOQcWnAADdiHktSn9TLA1BIlzM75ZFy38oxUVpwbokeO4ZZxcBAMAY2dOiqBLFGJud+llcWbFSSEe1KI8SJauy24LPqG5ZlpXL9/cPFseKg9TLtnnbwrSfGZddk8fv3B1t7xPO3XMLnP/xW+UXfHWrXL5f+FHLssc26Pd+WZlUM7KSx2Swv7qQEyHxY9RMOMyMgcH/uMk8aMYT2tsRqTLp7JPbtO81MjY2InodvtbiQAs7P07peyVlQIPNk7LjuLdPufzIWKm0uFqprC6WJriAH7MpRHW0KDMNFb3C1u/JOx6kpQ9EvxI/7Gs/Iu70dAB8tzyt9Cv1zyWqo0UZ+TlwsaW5obG58nqlUqlU1su3JUGDyoEdwgcVhxZlbLKj4vHF+CyVSqXSGIkqEaw6ZFnYOiHe6hevxzu/+P8cfccDazcMgP07Y78baFG+sB4DtPYza7gNzlBrahxGn5dEPy3/4SwrlGpi+tIY+hKgRYEEiLFelFM/qFb5uESNeZp8VB561EYeS0U2uL6LHJ3o/H6YJu+lDgmLorM5AKB7Ma9FkclQN4GdNGiIndYujW8xc59xLep0Y6xdkcqzSY2viwAAYJCsaVGcEjX2n2s75ckRLm/OyGR5x69wUK/QQS2Ky4joUW7EcGZXu3Cj/JCr2NE4qq1NE7OLnxlXEKiUG5ohibyck0dlxthy6YOtjQt9Jj9Kv5r7qOUTMtQ4Oz4+XP0z5mPvrx9ztAsxGO2vJrJimVqFNIVe0LmhmTVabKVxuMn1w3dMsA5Gotfmuq5TP9hZou9DfPgNsLD7JOdj2sIqdkHmSdaSyQ0P2idxhi1ujCnKt0qoa1GGGspNuoV35vnxcPRwiYQU+D5b7lfSHFvt2idO/fPaWiuZoOfXIYxXbLanfY/G2R6fvdPv3KCjRdEmh/o5sOcOK39rzZNhq/H8Dvt43nj3L1Yrld3aoXYVqbi1KGOTnVOdZUao95k4J8/Wmi9TFP7MdvNSPm+ft2WJrv5O/WDnOzTixecF+Y+HduG49ffbnxn88DG/ILClecz9bqBF+cF6DPBPT/b/OMyNQ+59689LZJawckP8ZtapH6yNs2KX/6puZPpqDf3HHzKJu0RDn0I+Di0KJECMWpQQjXma1XjVVReSadrzBXQHbA9M80k8uZ+67Phh8l6qkA06pCgAeoYY6kWRKNGL2g3+nK4xthzJhoTdgPFGBMNaFCt6Cc8kMXURAACMkjEtijv027a/z6ZWLZvuo2NaFF+bSy3Eg4Ykyc881F9XaLTn3/vA7CeiDDfs+enSpUvnDRYnw6EmH197jmLGKsP91YP1YfR2hBzwgnxreOtVfpRW32L6Qax3PmFG3Idkg4fzBhfVgJNa2P2T8zHNYfM2SQ+75JPUjsmZLSVdck42x1t3UStRpYKqFmWwoReiVu7akl9hG/pt4mwt/K9kwWeCdl5uzReL88G5M/0mAn7W8kkeo61FRfo5EOVkals8GthpSeHw4UO8WpTByY7ErvjGrzXOjoVynGc8cCmTSEuIUC3WJlRKtuuUdTf1u4EW5YNkmnZdGjMlzx9leBxGm5fOlV67MO6Vq8+hP0G/Vd3saq45qUSZgwAwQXq1qBDVojxfIPrZ80GVdl/hPL5zbITGVAbk9zR8LxVILFZwJCsAoFuIQYtytqcYLTzARZpzDPOLGSLnBG+iAnNaVOPoIesD6peRJIYuAgCAaTKlRdG4BhXMJsdKE3FrUW9M/G2lUlldHCOevIrPk9r8aZSzABq+IYpRIkcwqVWdfLN8+Sb1gPxWbiUtynh/tSBSlMB8TX42AanpSHf9ZLyL+7LHaeHBmGbFCyzsRqMtvC31t24FhkRdQN65/5OXFBuhB2Zfs+U5rLRgyh6nqEUZbmjj7FhsiBV/oUDoo78SxfBKAu25rPKPmu6op0VF/Dmw6RMkMih7+ghdf4E8qOAQBgIb+CMaXSYnOyLP6XeWjoeA98PZ70VfZ1yLck38blxoUT6QoSh6GUSMkqyzRsdh9HnJdeqv2AC7wNv45Pgyu5pDiwJdRnq1qJCFkdhNhN+Pyjl5VL7pn+/Xsqzc0OSKn29EfPcK4HRrnMlE4OerAwDoQmLQojgPGolTnHOyRTMw+2yYiKuQyF4RSYv67aeVSqVSWV2cKF4hmZzeXfL1mjfeRQAAME+WtChiRz7fCF8uzq9W95pGtMPa7morv5PC7N3VxK1FCXhj+r+onTmoZqhSN5yY4wSBGepnPJJxPCCygM3hYw0vfyb6jIoWZb6/OgTb24hzjdzfUMvSSg7GAhOeovDDNJQY2Dwt9bNuKe/XXO7J+7WJPDD6Ptk+qbw49lY+Q0wXNS0qgYbKnXbJQw3n9qpn3iT5bIQ7cy0tKurPgW287JzAfi6s7CBMGhYGbwOMTnYmNYBggx4dgQIZIA4tSrcbwhgXaFEiFJws2AcnmQVNjkMD85IS7EAMG/fJErSaQ4sC3UaXaFEaM3rwT9o5ebQyedVbJZHB7ruqJiCZvJccktYgjJ8SACC9xKFF8dltfCoA8KmR/XaCrNucjxUhkhblNbD9wfC3//OzgLnTaBcBACAOMqRFkSO85ZtwxDl5tEBrkvTkOTgBLcqyC+N+KZBYqMlPpeIi55XrVZA0Tm77d5TLFKjkyVDQomLorwasoOarrchTGTHoWVrlD4e8NEULH5EH+QaIrVt8cr6AnIfEgCnesbEf4T5B2qdkR2TftLr/qwwlLSqRhkpHD1sgIeScrGfeDP60WS1K4+cge77p1qLMTnbU/j2+qWnS0jXoUUcFr+KakBYVfE9oUQLIsPITReX5ay8wOQ4NzEv6XyoeEyanL2hRoOvImhbVeL5yg3PGtOy+Qn9/f39/gZeU7MINv5Sdpu8VAE1r0LvJTADIKvFoUfzxvzVLjYyVJoqD3onKsvzMJKR2k58VwbAWZVmW3Xd1Zk2uRxnrIgAAxEN2tCgqRcmDH7js9704MSehRVmWuI4PBzGDD95RGwNy4ULj5KZjAtF0Lfb55hj6qwxRmfxvo/gxXeuV9LXQpD+q6gZ53pypW/BqlZPztSHPQlgciWk4N3UQm6Vi9BDTIzMWORUtKpmGykYP0YhD1qXWM28S5aETWpR8lmJfiWyWYBY6Mzn6ouDpheHJjmuowOlP+b4qBj3yB960rNCiDBOnFkXC7fxFUbWPGRyHBuYl/S81oUUF3RBaFOgyMqVF8SUR8yPzm3skPWzjbI9zoPc7R5u8VxDU1AolCoDeIy4tynWdk61pXjSn2Pk8c+S/flfgtkTq9PqHZUbSon79k1KpNFEc7O/P81lPc0Pe6simuwgAAHGRGS2K2MCCUwNxtUmiBJ6kk7i1qNZS23j+19dJQJq3oCOFOp8rR1iQb+cDOTqgRSmYc8QfiaO/qpAoBZmBn4pR/tqsQesVER9Urdb0llyPqCW5r9BPN3X50btKZ2E6N3jMk6xmwMeQ0VlIm85pUck0VDZ6yHgPGXelad6MLjUZNeay/9u3fhc7OMMvW1HswNIZz/hkV9+eouHOlmX3XSnOr1YVtAB9g558FEKLMkyMWhR5JLL1k4hRvhtHc+PQwLykBLQoAOT0nBbln8qBT1S94FuC5PTB7ADrv+X1LjR5rwAaz++QkCh5yUcAQFcSnxbluv7JRO2+q5MrDzc/aE9noipQRHmXiuGRtCjylfXPa2tEyw+S8qN1EQAAYiQrWhTx81fKhUqssSH98FNMx7Qol6sqawWpUWrlbDyoZ2dLmRYVR38VIfnmAirwsHGF/j8gg9Yr3+Ek7xKJpqL3lEZ7vP7+prI/JSlkxZknWdOl55EqhQ760zktKv6GNs4Oa7uV9fLcha8Xpwxytwj5K5H0vOu0KPeLu9fbvnfDdwQ5bYiLcJDor9oSk1pUDJMdZ85isPuuTpZ3Dv1T/0TUojwPphNalObvJmxH00F8WpRGOTyyd/RfJU2Nwzi0KKf+aq9aqawulkql0tiIN08WtCgAPKRXiyKTkvqvw7e0IFHcg27o7N9hl3FeoDd5Lyk0+qpXSzsDAOLVos453yc1qe4dnzW4M5XIB5DMYAFhmca0qHNoTKivhyLb2jBdBACAWMmKFqXsBduCenB3kf1GjU5qUd6MtTIzaUhzpdR00YNalAFTDdFtXn/vBxUpP3jv9daHfa13iWtRsgcekHlM4yxLTtukbez/8Z6r2ca9PnSzpMfcT42ctXW1KJMNbRzV7pUnR4Q5qikyLUo5Sk7W8+7TonjbS+Gd+dXq3nGTveoqcZOLlKsmbVpUQHucl1t87V0Gu3CjLHbM7h4tKvTvJmxH00FsWhRNFXn7I+nK99FtJkJX5rJhZBya06Kc+kF1db446Mno4gVaFAAe0qtFkd+m+n6IzHvMF3y2PMxMVMG+msSLjft1mryXBF6I8g++AgB0OR3RorwEevfV709ruP+Z1qJc13m6wHhVhcmEYcqBEQAAwpIVLerXi+0JW7GKRm+fhTurRemoUdCilIg+PKn7oiY+lTO6R4sa/PDx8fHx3totdlgq5wjxiyhj3O1Fp3CFARM/2nFRRhrqnDwq37wssYrm8oiLCp6lTp8sDAfqEcrpJpVakn4tynVd13XqBztlURKK5hMRSXMRtShPHbU4tKiIv5uwHU0HMWlRNMuqJkHbx6jj0IgW1TjcnPFrgmVZlt1XQFwUAHJSrEWRj6omu/VL0UcdL1V8NUlcFvl+k/fyxdlfvtZe9OyBWVm1FABAl5OEFkXlbqHJ6n98NMrvrcIQZX/D+hdoVwhW6CIAAMRNVrQodueuOO+Tzb7H7NTtdFqLUlejZFnWVL+df11p1qLi6K8KAVFCQYiTaRi0XoVLQkhrQk3f9/1/F3fkcoSoqlG0gNbFDpCRooRFtUIZEEyjogcYbqgnf5Xdd6U4sbhaqe4dH7dLWssKa5sIU+0BLcp13frj+SuWH3bf1ZlNSTowNWLTojow2Z1Hg3jkG0FFYW2JJqD5xrWo6L+bkB1NCfFoUaRKoj6SconkW0KOw8jzkrN/d5TstKxcfmRsrry+Wzs8ftWqXoV6UQDISbEW5d6fViv1ysLuqdnNcQgXEd/Tnsl7ieEmuEgR4ACALqDzWpSaTBOxsrLypCdpJ3s01qscDiUKAJAKsqJFkbwBasYYtkBON9lv1Oi8FqWsRpEHr6qy0IJgVINItxYVR38VIDWPwiBMVmTQehWuh7KH6fNqQ6pR7AM8N08y+1KxdYDYspMqQqdiLDDZUD6z3I3ywyOxWCIbPeTFhkzS1/1alPNy4zyQzy6M/1/NqkFjI/0jY6VSaXF1t+bzYHWJTYvq4GTnnDwqU5u8J5ZTW6LZv8Nka/P+LMxqUWZ+N+E6mhJi0aJoTqgQKNUbbaE7DiPOS3STlRua2TyoCy0M0KIAkJNmLSpExSjfalFdpEW1d0CWZUGIAiATdFqLIrn3JDKNU52ljj+h4E5CjbO9qvphLmwJWtUuAgBAzGRFiyJeZEomMCMFStJLElqUohpFnc/VgjKoq3MUo2PntagY+hsMsQkrFwwmApZIjDJpvaI1PdR+geSOfMC676vl1Si18y2b49Ce2nbYUCm/qiJpMLApGQvMNZQ8JnlJLtnoob+SECPe7X4tqp0bXBBcYZL4tKgOT3anG2OSTGS6Eg3VxLy52Y1qUYZ+N6E6mhbi0KLIS1SMceIELD0xynW1xmGkeYmE68rXMWhRAMhJsxZFc2yrbOH9/4C4aiotEDROnT1Rm7yX55MnW1NEiNo6gf0UgN6ns1oUNVS9ufBUNs00zo5VWX//4p7NGgHntFMcuL/dbiVXVjzkkQ2t+uZeq4sAABAnmdGiiA1MYeNO9u3aWVjTTzJalFeNEq2B1OSnYvehBSC8351qLSqG/ur9vbIUFaD1uIatV0Qvk9WMb0F+tR5jseTVhlKjWPukfWtjq/1M/Z9ooJoXP2qOq6YaypomgkqrSkcPrSqgMWbbdLkWxYy3mG2z8WlRnZ7siJ0rohZFC+wJsmGY1KKM/W5CdDQ1xKBF0Y2dqhQV2ftDfRxGmpdYl6uAG0GLAkBOqrUoOpUFb9HIjo7bP5GttkocPPkDGqps8l4EenaMWhMTANA1dFKLerHM1uQ1KdO0d1R+OxpaiVrhq8kfKKcwia+LAACgTWa0KL05/nRrXNcM3mUkpUUpqVE0i06wHeKLu9eZzwvM1OnWosz3NwBqV9P6+wBTnlnrFTk9X5raDrBb03B5b+OkrzaMGsU+Rzufv5gypBZ2KpfFG94iRjGJiqGGaowIYq/1fpb+SlRTKbJ0uRbF/v/8rbXIVaEUW2JWi+r0ZMc0R566NShGqx2UZlk+v3GTWpS53w3f0UxrUdSZQl2KiuC/0UR5HEaZl3TeM8k3CS0KAA/p1qK4YE35Fo1EZnpWL7ooB86LdC7k7mbyXkz7ae7Ra8sQogDIDB3TomhqbMMyTbAWxU3q1+/K95nUbPH/s/dGsZEc+Z1mYneBBFTWFvqhDMElTS3RaBA2QfR4yYPo1vTKXSe0LHCnzL7TDcFdEjaGqAZlmFiQZ3lw9Jr0HNw+J+5Awx4S0zhhyB1wvRp20VhiydZo+lQANYSqjdaQOKL7UEKjpT6KjT2CD7WDQT3kW95DkVURkZGZEZmRlVmZvw/xolYxKzIqMiIyvoh/CC6aD/UWAQBAmvS4KGbM6zLXzLTUnt1BTxKdixKxUbRVcI9QxPxc3LB/MXdRyu/XHfplUXKJN60o2DdHxUHJ6Hlodz9E1yreU+vx0/qwUXSbco7H23dje4p89x6+c+DuFMyTvZXJ4pi6RaCiAf3VZJQ6LttlfwdzDgCv9jChuZ0jtJhPN8bzun2+osddFL0zTNO0TG6gOFEul8uLq5UWu7X68fEL/gExEoTpohQ3dmbjhdv9ktXPPXSr+wPP9Fn81zdZF+XmvxQ+N3BRbejVDXLb3enGnl2gpKweBmmXqN3/rkOw/QXyueq+i/JewAsXBaIm5i6K+QPnrpSdfLQvrmRGsjJ9oW28q/JaF5+azhMTtO4RawEASaNLLop5x1StaQRcFDNIdW3sTh/M9ru36xxCvkUAAJAmRS6KDdqv5W4ae8xkptl4vDlNtu6aPrycyLfgKF2UiI2iz1XU9P7pTc4+APNkb+laxvu9J+4uSvX9ukJPaXNCTUn8OSujFLsodi8575m1LMtq1tfG86Q/5g7gPH9axkZdGt/yLFxq3Nj6K88ZTqb26/nxNe758mbj8WY7eLS6U5rFD5dWkVFqetRh7a6tWjvVHrbdyAzOMI9J8/knxmi7KjBl1uMuiu3A3MjkBorza498HqcQqotS2di1mgc9P7rCE6XUFBxnxTX9JLQqOCcjzTozKHB6FEV+bjogEfE8mCd7K4s/bjdbSp8buKgW0uGjXP6cevFXWA8DtUvUGYsOswxsZ+lcJ9Q2X/SxMLn3HlyUFFPzeZeDiwIREHsXxezW1TLXlmzvtGwn4dAs0Ou+nPtCpvHgLtVUeS1mwlUfvnPQaLwQOZzljNMUAwB6kK64KKEVZ0EQclFC70fmyR7xoqtpopFCQr9FAACQJlUuyj6XSSwtL08UB3LMvI66+d/YEa2LEtobRa/l0zQtkxspzRnrlUqlUlk35iaKffTvpQ8v7PN/rvi7KLX364b7xiYBqFlSJliRchfFeWb17JXixMVOkNXFcqltQc7J3dp4yhtgCfy08jaKPvOU9i4AACAASURBVERGcG0Suyz9/Me+2N+ybsxNFK8wd6XlZn72K+9LeyPuopRklN6Fp+VuLu0ctnYQmI0X9do9Y/Li98tce7PzZQ61x/6UaFomVzgnxz4gtJLsdRdlWc2DlVF2HtkNvX/2gY8eLGQXpaqxo6a8Mn1jS/dq9eMXDdNsvDg+3FmiSurqHbudZl1U64uyQ+2MVFYXbRlxGRSI/Nx0fFRNywyWyuVyeeJ6K7OdflDlcwMXZVleG5tEoFRPZw2/0noYrF2i10bo/dNrtXprTrZ5dnxYXZ2/qM56/s1rnY92w0Wx+zr1/PWJcrl88YCxI0C4KBA1YbqoL374ToElTw6lOsOaC9754Rf26/C70vKcsWrMlUsjHkMiEvvbMTnUXl3kDfWc+kJV17LdXSbL/p0zuflPA/xAAIC40AUXxRj0MDSNmItybD7L59iaddG9ol24RQAAkCZlLuoifJPIQFbPTzvFgEoAUbsooXOjmgcrN5ku2ZHMtSVnMdMLLkrl/Yrenx8Vxc6SUjIqBBdlWebJR9RWdDf0/DhfRLFf5zhXLGujXErDjdN925YGF/z+2jxkXJSKjPL0kY3W70ZoTufaI/aU8CpCr7so82TPGGvPJV8Z4Pk3e0H4iDEbuouyVDR24u2Cwznn1G2+/Z7AxfT8tMvqFKGfm1nJbqP9hwqfG7goi7WA/g4BpWP8ncsotfUwYLtkn8Xg0HqeCLPWFRfFRH214XL2FVwUiIAwXRR3IYQ7zmPWZaEhmucpS+Jvx5r7UFvVtWxhieXooa4OAOBM2C6KHW2Ho2lEXZRlmSdb06LNp+DsQHduEQAApEmdi7Isy2rWN2cG3cbuev76/JbLMDsBRO+i7NMmvCXD3j+WpmUGJ1d4kds69IiLUna/ztCxiF3OIXGD1i/krF4oLsqyeFvSbej56/O8WF/8r3POnayNIqb0JN3e6f7KpMdvrWX6iu53JY2ki1KRUVefpWeHZi5a207e3GtPs04EBWQzkhuZ4Uen62kXRUw46f2zH/EiVZ4dH9dru529D+fIByPrhouyLBWNHannuOj5UW5YT9ttTm1zo5eROWEDQrrdukupmUd3HSycnh81yLdKVc8NXBTbafmVG3T/2Wnu1dXDwO2S+yRwpm/soooRcq47Lsp2wAGZL3Y+BS4KRE2PuCjLsqzTfdfxMfHYe2A+3Zq/7jEL6jnUVnWt+9MSm8Dt9FBXBwBwJlwXxZyhFNqJdOIuyrIEX49m1g7E2vUu3SIAAEiTShdlWZZlmY3HO8ZcaaS9sFzP5gsDxYnFtdrzFMSZDsFFff5BucP3d7/2/gvLPNlbmSP+6s5PX/A/13hcXV2cKA60f61MrlAYKE4srla5J9gwfL37/c6XfPC58Ec97oK6Y/5lBT7CIej9OlK/9347N4uCgxgep/vE77bwD88u/p28Xe8qIPGztGg+r91rPbTn0Uz0bL5QGCnNGfcEnlrhn5apln+0+tkvHT9LrvV2OHnZHcffes64V3sW5Md2gCoG8ToZNKPN+o5xuzhA/u1Iac7Yoetzu2KJNCDNs8NqZd04/6nmjPVK9TyMGR+ZZ9sSqMzBP+CcPeZ3IUKIixxjRmt++TPh5AqKQrrFU9DYNZ/X7hm3iwPtIEcOtYuBO3t+UU9bl2qNCm4LtS8yP3ezvrlYGjm/4UyuMFC87ZBZFc+NdEMbExS6qF9++rftEpgzfup7pZH5dGvRsWfwWQ9Vt0uWZZ48WlssjZDdJGds27kX78GLst7cPNlbuV0caD9eA8Xbxj3O0oEgbRAAKgjTRdHDMCE8nwKm/ZHqvDhXIkfackNtVdeiBhPy9FBXBwBwJlQX9ewfFjqNxpyxo3TtJ0mnPRMe0SiaC+raLQIAgDTpdVEpJwQXBUDqII+L8qWiAPCGiFVzabYq8hfk0TY37mIml0evbhdKDWrPiwIAAHHCdFEAAACE6MJ5UQAAACIBLiqlwEUBEBgyZJO/E0gA8KY62958JxiuinBRgvYqfcBFxRy4KABAVMBFAQBA5MBFAQBAUoGLSilwUQAExHzwXucs9jdWvow6PyCpkLucRCLumQ8X2pIU2/WcgIuKOXBRAICogIsCAIDIgYsCAICkAheVUuCiAAhG48Nb7ZOViWPsAVCNuT3VOcQ7d2vD9bgb8+nGrc5pUYL7qNIIXFTMgYsCAEQFXBQAAEQOXBQAACQVuKiUAhcFQCDImWx9aht7T0CIUN5E0/PX59dq9TPqAFqz8eJwx5gcyna0lT5sHKFiOgEXFXPgogAAUQEXBQAAkQMXBQAASQUuKqXARQEQACo+H8KggbChdzuJkLlmHDS9L5xe4KJiDlwUACAq4KIAACBy4KIAACCpwEWlFLgoAPxDxufTLi/9Iur8gDRwum+M5nWOdrJpqL4xY+8EftQduKiYAxcFAIgKuCgAAIgcuCgAAEgqcFEpBS4KAN/88tO/LV8w92OEQQPdo/m8trZYGinkMjYFpWfzI6XFtdpzbIcS4evd77ef4vIHn0edHcACFwUAiAq4KAAAiBy4KAAASCpwUSkFLgoAAHqa5tnxBS8aMKIgWcBFAQCiAi4KAAAiBy4KAACSClxUSoGLAgAAAEA8gYsCAEQFXBQAAEQOXBQAACQVuKiUAhcFAAAAgHgCFwUAiAq4KAAAiBy4KAAASCpwUSkFLgoAAAAA8QQuCgAQFXBRAAAQOXBRAACQVGLqon791wvf+tZ/n82+0uqBkJSnb37z9VdfvfLqq1cizwkSEhISEhISEpmy2VdeffXKt771VuQ5QUJCSlt69dUr2ewrr7/+ZuQ5QUJCQkptev31N998821MCSIhISElL7355tua9tL9+x8rUUjKXNSlS7/x27/9O5GXToJTNvvKO+/cijwbSEhISEhISEj2hFEKEhJSJCmbfeXb33438mwgISEhpTmNjPwupgSRkJCQEpkGB/+7f/pPX/7JT7aUKCRlLuob3+jPZl/5d//uT5aW/hIpjPTd785o2kvf/e5M5DlBQkJCQkJCQiLTn/zJ/5LNvjI8/EbkOUFCQkpbmp7+I017aWLiDyLPCRISElJqUzb7Sjb7yve+9+eR5wQJCQkJSW36rd/6l5r20s9//pkShYTzonoGnBcFAAAAgHiC86IAAFGxhPOiAAAgalpr53FeFAAAJI+YnhcFFxU2cFEAAAAAiCdwUQCAqICLAgCAyIGLAgCApAIXlVLgogAAAAAQT+CiAABRARcFAACRAxcFAABJBS4qpcBFAQAAACCewEUBAKICLgoAACIHLgoAAJIKXFRKgYsCAAAAQDyBiwIARAVcFAAARA5cFAAAJBW4qJQCFwUAAACAeAIXBQCICrgoAACIHLgoAABIKnBRKQUuCgAAAADxBC4KABAVcFEAABA5cFEAAJBU4KJSClwUAAAAAOIJXBQAICrgogAAIHLgogAAIKnARaUUuCgAAAAAxBO4KABAVMBFAQBA5MBFAQBAUoGLSilwUQAAAACIJ3BRAICogIsCAIDIgYsCAICkAheVUuCiAAAAABBP4KIAAFEBFwUAAJEDFwUAAEkFLiqlwEUBAAAAIJ7ARQEAogIuCgAAIgcuCgAAkgpcVEqBi/Lkq88qbT4+akSdHQAASBCNo487TexnX0WdHRA34KIAAFEBFwUAAJEDFwUAAEkFLiqlwEV5sj2ltblqPIk6OyC5fP5BucMHnwe/YPN5bbdS2a09bwa/Fuh5YlodnhhXO03s1HbU2QFxAy4KABAVqXZRzbPD6upiuVwaKRQKhcJIqVxeXI3dGAIAkHx6zEWZjWe1e8ZceaI4UCgUCgPFifKcsV593DCTcy0AAFAEXFRKgYvyBC4KdAmyqgWelDeP7t7MXVwsc235CMPMNBPj6gAXBVyBiwIAREVKXVSzvjkzlNU1Pnp2aGazDiMFAOgWPeOizJM9Y6wv49B4apm+MWPvRPAdLK7XAgAApaTFRX29+/1yEL6/+7WqrMSDEFwUtblDpMCa9c1F4k/+aPWzX6rLTXBi7KIEq/PiaqV6+CJOS16CPoctVOwcihUqXdTXP7pJzyK8sfKlomxGToD9Y1TNS1xz7oxUdWieHR8fHx8fn3VnpgkuCrjSXRd1vma0NFLIMxOxmVxhoDiRtl0BZuPF8fHx8XGsRhCKMR/+kBxZ/PBhcm8VSNN1F2Ue/XhO2Sj39MFfyw94zKcb43knDdVBz4/eFVjV0qj+H+LD+gCjssb9Px4oXDD3M7+XAQDEkm67KH8t8en+0jVH3UOMJwfnH5z26rXcefKDt9oN8Ts//CLYxQAAKSEtLoqa9fJBzFxEcEJwUdSEuneBfXn3BvnKo5c2AvaCqomxi5Krznp2aNLYicVKxqDPYYvETVurdFHUtRJWXAHKiap5MXucw0SiOjQ+vKV3tcbARQFXuuWimvXN+aLzmlESPTs0uZKKBaS/WLqc+Nay0+Sd/7pT2yn4ZYEg3XVRp/sLw0RtDNQhmk83buU61xJ9hE+3p3Lk86BlciOl8xnZ0kiObiFzt/6T1yqnhwuviTSqAdsZJtcYSQCQMLrqovy1xOaRMUyPJrJXihOtxnOieIVe36T3L7qte4nrtaRKIMEDRwCAUuCixEhcqxq1i3qyTHWPuantmJmoBLmoizK+KbKSMYYZt5G4l02VLspWxJeXfqEom5EDFyWNRHU4ujPQ3QcMLgq40gUX1ayviewDYNDzo8Z+7EYsSjG3xhPfWrIqStP0Wx82os4ViAvdc1HmydY00wz57xCbBwazCl7sEaZfyvT+2f/CbAM1T/aoSVp9eNn1uo2NkkSj6rOdOd0oqSo4AEAs6ZqL8tsSN+5Pk0I8d3PlH5n95M362i3qI9P3HcYacb2WO+bDhcsqGnQAQOpIi4syq7P0ei85kveGGqmLYhdqxNFE9ZCLyuQKdnK8Vd76sBGtjoKL4qL0vKhGdb6//XTp+ek4Pls+gYuSR7w6dEoXLgrEgZBdFLN5gETP5i96UjZgX5s4LO4Ij87DmdjW8uu7N+y/amkjYUN94JsuuSjqSMegHeLpg9l+W4Ml8gibD967RPzFHYe2zTy6Q/Tal6a2XR4XiW1Rmb4ZPwNV25p//wUHAIgr3XFR/lviL1feIFrF8S2Htux0a5xsZPnNclyv5YptS22CB44AAMWkxUXJQy4nyM1WkzbnEKGLspkon8swwqZnXJTTUKl5drizNEqv8dFv3I3r6UFiN5VIlLooy7LMk0dri+Xy4lrCzjeBi/KFWHX4Ynm4yw8fXBRwJUwXZR4t20Lo6/nr86vVQ/txac2zem3NFsbP+dU+Adyfvhg4JLW1JKZpdL0zSkrQ+YogGN1wUUw8qEAdoqNcF3iEqT2Cl9574PzGS0krt2WaxLaocAwvz0RhJAFA4uiCiwrSErcDGnuOICg5xA1SEddrucExUckdOAIAVAMXxYfaR5XEl9PIXBT7+nB5Ia7HRfe8i2phK/C4hmyDi0rhncsBFxUi1dlLXa6CcFHAlfBclO3dWc+Pr3kfqWie7BkXqzvid8KlSog9QwltLclpmpJhdLZIJfR+gTRhuyhOPCj/HaI9Mp/UgIfo/j2PTet4ak3Tp+87fayzLeq1hYdyNyMC+ZKeu3HjIsAwRhIAJI2QXVTAlpjaYe3R2BJr/jRtePmLXrmWC8TZ7/rwjTdeFu91AADAgotygFwj4LpErGeJyEXRAR6ijxnnRkJclMUsjpEcZnQPuKgU3rkccFHhQZ7tABcF4kBYLoo9YkQu2l7z+Scrc+W/fpBgE0WF10pma0kOim7c/Zpsi2K7XAd0l1BdlG0TU+7myl+867NDZNf06/2zfzPXtjMCj3DneDiBj1Mdt+OWp3C3RZGrCXJT2/udLGEkAUDCCNNFBW+JO0ftCnycfIvlSPq4XssJcrGzPmwcbbUvk8yBIwBAPXBRHKgYBAltTyNxUczhhrE2UUlyUUzc9pi+q8FFpfDO5YCLCg/ytQUuCsSBcFxUY3uKiI0f92FINJBT00lsLakx/o27X9Prz0LZxgF6jvBcFLuJSe+ffXDqs0O0relvqXW59xdyKYqci3Jc2xbmtihyNUFutmqSWcJIAoCEEZqLUtISUxMsMs6Hs6s0rtfiQ87ptQ6A2IaLAgBIAhdlh9oU5Xo0aw8TgYui4h5KnlxkNh5X1425ieJAoc1IqbzIPdzBxlefVc759Ckx69Ssby6WRs6vNlC8vbJPrXSWd1HNs8Pq6mK5fc1CoTBSmjPWq48baie7ZLUN9aLJ+XyngCqVymdfeV3t6OPOpz8+UvWA+HVRZuNZ7R5dNwaKE4uru5KHJXF+vcJA8bZxT/7QpeZZvba7bsyVW8wZ6xXXiursWJpnh9XK6uL5hRZXKyJ16fMPym2+v/u1/QOdX5B6ICyz8bi6ukiU5EhpTu7+m8+5v4WiJ6CrLipYm0NfhyrU86s4F0n7cdx9dML8PDvGHN28CJwJ5lkdLMuiy1aqaP0/N3BRwJVQXBS9S1j1AYqdpnX3gBhOmCd7K7fbTcBIaXHrqdPTr6o/C9ShkY+m9JSC7zsIXniiOSRV1PmmDTKejb9gCGbjBdlblxdXK7u1Z+I9n9ywIWBhKRzuJJaQXNTpg9l+2h2tHDQty1eHaB7dvUm9VvXPftQaNEi+v5AfH7jj/uYttNyeeJ4Ub4uiwo5fvXNkWhZcFAAJJhwXpaolpj4+vuXa43vtQI3rtXiQm1MvTk+FiwIAyAIXxUK9pSY3WEfXXRRrokQPWzBP9oyxPqc46JrWOnB80/WoByJnN+625mJP95dswdWZNzCZdznPXGYGZ9zzKIW0tvGYxJeb4w9pi4kPF9Wsb84MZZ3CPGuanh819k4854Ka9c35647Rolu/ntj0l3mytzLplCM9OzSz9oiXHV75O99bpm/M2Hd7ejxrLlHUFw9Es745M+hUgTOD8x95FuPpfvsoFf41SmUWZzPifWMhuigVbU7rQk+3nAvVuVHo3GZ7eZrrlTyqp3N1+Hr3+xPFgUIh53avzsUd9LmBiwKuhOCiqPFdCMdVEnX60my19ZVPN8ZtTwl3YkBRf+b3wfz8g3JppFDIu+TgAqcWNNgdBCo8CRof3mpfUr/14flEOblix+vEHPttzxedeoxM39jSjmtn4WvY4Luw1A13kk5ILoqKapSf3mr/tn46RHI6MHPNOGjXM0kXRR0XcjEq5EMtbXPcFtU5gErttig2JlSr8OCiAEgu4bgoZS0xeYLeRW/sALlXibv9KK7XssGEST2fkoCLAgDIAhfFQG6K6rylJo8uu6jG/WnSRHU6Lle4r9Z89Pyo85EPRM6uGk+YdXUdmBcw0Xc58VzKHUvhgqy2odYxcl4ee9FF8Wwil9amewfMk4/mXWwBQebasvuPJ1gPeF6HLX+Be8vd2nCcLpJxUa8tPBTLuesza4u4LYZs5emCi1LV5ji2MiycH5Jx567n6rYz4xxpzLk60I+cO3RxK3lu4KKAKyG4qM4MqaZp2hsrSjdFWXSdntq26Bf2DvZ5ATX9WaAHk2pe3eG1oMHvwHfhycFXUc7/7o7Ybev50ZUDno/yPWzwU1gKhztpILQYfedjA8odWX47xNbvTk2lWpZ8XAfqy90aRvId2Xm5Zkjbosg1jfrwcvu24KIASC5hxehT1BKb21OE9HHZVU2theIPMuJ6LYYv797ohEmdvt/+A7goAIAscFEU1OYd5Utm40RXXRTzkixmosyjZfYVP5MbKZXLc8aqMVcul0bY1fyO07FEzvTp+4wX68AMOYTe5Wy5zPQVbxvrld1a/bhe262sMstlBS2cB5Lahnp55L1l9pyLOt2mZ+f17FBpcbVSqR4eHx9WK+sGvcrYoWawoaI1TdOzV4oTrU07E8UrzEpllxaBU1s1PZs/j33DrjTv//4h9ddU+b89RT4tmZzDNdrRSezIuCjt7feJqTQ9mx8pOd0++epP3zy95zEzOLO6W6sfHx8fH9dr94xJp9mvzPiW3CRF2C5KYZvDtDJ6/vptY70VUmndmCSvY/8Zidt8beGn5Lrn3MWvw8mKY9visi/qRzfFtBtd3KqeG7go4Ip6F0WfnOi+/N8XZJ0eXv7iyTLfRzMtkJr+LOiD+em88HoCWwuq5A78FZ4s1Hozav8TKaPEKgd725pGdNnsflP9O5Vf0n8eZNggXVgKhzspIbzzoizLap7Zwi/67hDNxpktFKR0jHGq9js1MfQKG5fwFrxtUWbjxfHx8Qv/8ZrJN0n6u+GiAEguoZ0XZSlqianQz06vYvRMmGMHG9drdaC6AfrzcFEAAFngokhI06/6HIGY0UUXxZqo2arAqwgb0o8b2sVsPF6j15SS6zP4ORtfuDhrMdNXnF+9OPZodbH818xaXYF3OTqXev80N+RWs75GbBpRUbGkXNTp1nhnxYt3AfWAiyKfU03L3eRG/TFP9haIt2ZetaN+vszgjP3onebBChWN32G5KFNbtczgzCZ9HJDZeLyzdB7Czj4g5C1It+fHPNkzboocuSbloi6ulR81PmFu3zzZo5d884/PI6+mD9/hrP6mm4CB29uH/mYkwnVRKtsc5g1gy3ad5vNPjNG8rv/mkn3cTx0iq+v8GmVZZuMf6drp8PsITUrJvHypem7gooAryl0UeSZQOO/K1EFL7y+UWi2Fnh2avFDRlXVjbu7H5ESvqv5MXYcmO5Gt6A78FJ401HmwzEphahmx96Y5+rZ5fWjzeW3tPLiqfXY/2LBBurDU1Y60EKqL4qC0Q5Q/75YZp7HV0Ww8puM4uy2sI1raS/1DA7YwwJncQPG2sSN1jij5JuPyNGAkAUDCCNNFcfB1ch9l6dmxwPkLX+cDzoEs4nut9iXvXHX8PFwUAEAWuKgO1Kuav8OLe4euuSjGRDnu5aAwHy6Q54u7biY63ScnOLhzNPa5XX14wfPcBc93OTqX7jueTjdK7UwGr1ui2oaZOBfZOBZ/F0UWpcfIifqFeBMrrWXNjvFzLMuyGttTl9xv11Zb7ebhnGZ9xzA4RzGwLipzbcnhQCjmu/ilL+2iXAL+0ft7eJv3ya0GjiuqeIfFyxOmi1La5pDfJv+4s9XBpUaxgQC9dj0qcVGKnhu4KOCOchdFRegTC4ovCSXmWx45d2vN7bQglf2ZogdTciJb2R3IF5485CoBe9NM9VMeN07dtsMqjNZFTx6tGStsjx502OCjsFTVjrSQNhfFjRh5vs2P3eOXH3cOEm2xsVCd0bNvLokcgUePdOzrf+CiAEgu8XdRFi9c7/kmZ3aHs/MLfuyvxWxOtcdKgYsCAMgCF9WGWuOY+AWBYbuoS0Pv2gNJiSy5sCwmWIT3jmFylQZ3upyd2700viUQKM/rXY7KpfduL3I5btAA6rRLeONPK3bWjdtU0BXRA7Vi76LIuSTvPWbk3JLfI5SpPS72yD10bRXb9sdAlb/HqWL013EDCcm5KK+wkdSH7fO35JnXA3ecW2xicsL3JDBVTtxq78jfTRDBuTiForbNITMq/7DT1cErqif93HBuLQQXJYTHcwMXBTxQ7qLczrRUg23Lqdfqm+73Z94PptxEtro7kC48eSgVxTl3ipJRjofhsFfysds98LAhrMISqB1pIX0uyrIsyzzZ+5tRMpQpy2vj/+cjD31Eb0D1wvtwMpeYUC3gogBILj3hoizLspr1zfcGX3Zu615+4/0d0dU1cbyWc5jUc+CiAACywEWdQ2+K4oY6ShRhuygOV75XE+s2qfcYoWMUPebnmZwJikaPdznPQ5jcbmt8K9CsASfGmjOZvuL8mvu7Y++4KGqqSGjHCeFA3FSJG/enCafHepTGRkm+bjFIlT/1hdxj3OVclOfvTZ2xMrz8hfO13Kq17ah1H3g1MaLYC0Vxm+N7HsjPX9PzPvbZw6hclPtzE9J3ggSh2kV5alvVX+HZRUXSn3k+mDJNkMo7kCw8eajMOrg8ckcHt3ttQfWK8jkNPmwIrbC8a0daSKGLMk/2jLE+hwM+22T6xrhhONs0jjYWWysRM7mB4sTiaqVyfoRovbZbWV0sDTEr8l2X3JBv5w4LGuGiAEguveGimvXNGbZls6Fnh2a4hzn0wLXIFfsOTTZcFABAFrioFtSmqDQ0oRG4KE3T+2cfeG9Iot/SxXYVUHH+bX9D79gSfWd3f5ejJoDFaszRnYGLPyCnQT7/oOzFB5/TV5JyUa0Tqm8bLqteesdFkRNF9LnjTphb45KVyT1nTMbIy/teRixX/p6fVuyiyJ1P9uuR13Ir31i7KNVtDjVR6RIB0fs2RZ4v6geyF25kLsrrmnBRwJWed1GejiGS/kzgwRNvglTegWThSSO26YlsvB1Hi8RgzlVZOeUk+LAhtMJCs3xBylwUN0DfQHGiXC6XyxPFAckwfZZlmabzMSZih5FabEwoh9AacFEAJJf4uyhuILyRUmsGpzQiFQ4vnteiw6Q6LR6AiwIAyAIXZVnMpiihRfE9T9gu6jwerT3MuHcsEyrSuGh3Rk3Hsos5/R0z4/4uRy4effkP7h0L8OmfDfByITDBzuaZnoY4D+jOwg4yNC0zOMM5rEi6gCJ0UdTPPPxXj0SKff3doJl1G5hS1sHvQvUA5d8FF+V+PVLjuESNIs2N7+BSVDk5VHsHqKfBdhPK25xP56lT6fX86JJwNAX5WSSyMbL/BVwU6E1Uuyha2go+5679s63WynWO0fRnKl2U0jsIaWRxAbWV1SX+HtmnO+g1evGC/DZ3BcOG0AoLzfIFqXJRzMm+mWt/Yh+xNOubM4PkG51nBGFXmNMu+SfgbY13gjs7vz3CRQGQXGLuopiWTM+Pr9pC0Zgne8Yo6fodxHpMr0WFpXeJKQwXBQCQBS7KYs4gdg0RnxzCdlGdbuj0//oj8ohmfoxZAvot35c5couYpchFycVDt6PSRTnfkdl4VlujXx65odl7xkWJnojsJk8iGAAAIABJREFUgHoXRa9vVrLfp8dcFPUoOK9tJdpY+VXkvIxIFrZrpQ2hzaEPtj8n01e8bewcnnlIKWkXRd2czfTBRYHeJNzzogQVQJguKpr+TKWLUnoH4booqpV3vTp1AhZ3bRq1LUo+pyqGDXBRoZMiF0WPV3JTW44R+MynayXimZc/KY262MOFyy7ZpKZSXY/5hYsCILnE2kXRrZg+fOfA8Q3vdP99cprD7nRiei1qpYLryZRwUQAAWeCi6PbaS5Qkhu65KLZH9CpkUc/C4DY5EIKLkoySZ6M7LqqFebJFrnjUh5fZIULPuKiAQdo8M9s8q9d2VxfL5dIIZ1MfJ2M+a6vbbfWai7Ia21OduQleQLrmwZ1hJSFQw3JRIbQ5vNgIbfTs0OTKJ8+dXgyCuShb/rvgoqSfGwXfCRKPchdFbUcRrHLUpkPPWi3XOYbdn/l8MCWaIKV3EKqLkjngk5RR3Ah6joNdMVQMGxQUlt/akRbS46KoCu/5FkyLq2DLN6kmmd5gKBYTqgVcFADJJc4uij46+PLCQ/cjQmlBxCx1iee1hMKkngMXBQCQBS6KGla77DxNGN10Ucz2Xo+XHZ+v6W5v5mG7qIHbP6rI8ancATKuNyu0hZw8KMG+MaUnXdTL73xfstR3D5wCIZ88WrMfp8zHxUX5Pku+t10UG95Fzw6VFlfPy3x1sUTuy/MayIpnJAYuyvNB8DgIPDM4/xFv+XHPuCj/z43/7wTpQbmLojdACsYKbdarZC/ydxOvudRa/y5KYX8W9MH06aIC30GYLopSUS8Pjrmf0Dk2+HLn0xxxRfVE8iH6VAwb/BdW4NqRFlLjoujTz7xP1KXfJ3zHXHbNJxU5/+XSB49d434SAdDfXSf/h9cmdABA7Imxi6I3OQsc3EgNRegjM2N5rS/v3ugMFa78aVU0AvPAn31K/PuLRkrmVgEA0qTdRdFrAdQflhxbuuuiZGxUb+yLoo5J6Pr6Dx9lRC0/ZF8ee8ZFUWvUlUyT2CLgd6po68izgeLEu0OXnL4V+6JamCdb03mvuS3XI1ZFiJmLEgzUZDYe7xiTI7xV5/zlvsFclKtpVuaiAj43vr4TpAzlLoqJreur83KvtXKdo/r+TMmDKdEEKb2DEF0UtfFDFntWenVflJrakRbS4qLkTz+j/4KaAlWVT3oPq29SXYEBSAYxdlHyZz86T8bE8Vp0W+8b7JICADiRchdFbYoSWA6WHLrtosRtlM9Q+l0+L4r6v8HWBfrAx1SG65E4PeOiqM8EegO2LMuyTrdpgdLa0bNbq9NreNwGpgEXSHMu0pMuyrKa9f847jh5kOkrzm/aTsKWJiwXFUKbw8FsPKutzRfZfVL2M7akXRR1aIvtL9S7KAXPjfR3gvSh3kUxvYyf8FIqXZTi/kzVgynRBCm9g/BcVMCJbVs9CbqxScGwQb6wlNWOtJAWF+XjfSKgjBXIJz0o802qKzAAySDGLkq+KXRub2N5LWrNpW/gogAATqTaRaV2U5QVhYsStlHyyzksZp8SuzMgDBdF9c/e89Bq8bOs1q0QesZFUe+ntg0gclDR6LXM4IyjLHEbmLruNxOl513U6YPZ/lZZ5m6ufFav7VYqldXF8uJqpVKpHirbnR+WiwqhzXGhWV8bJ+cE9altunxkXZTHsmbFLkrNcyP3nSCVhOCimEAkdhHsiUoXpbI/U/hgSjRBSu8gLBdFhxTL5ApCkBtZ2TsLui9EwbBBsrBU1o60ABcldPVAjyr1JFEPUuP+jOdWey/0/Pc+9Z01AEA8gIuK8FpPfuB08rE4mdH/0N1JMgBA75BmF0Wd7OdjTqKnicJFCdooc3uKeAMRe813nxoIw0XRexEULGmWwce7o+ufyAXaidBF0TGWAu1Hox7/q3fcTjFyG5jStdVnafS4i2psT50/CyHvLQ3NRalvczygZsTZ7Ei6KDrzdi+u1kUpem6kvhOkkzBcFNFaaZrm44xQlS5KYX+m8sGUaYIU3kFYIws/rbvFtNFsz0Zl1baaQDJLwWNFel5Bae1IC2lxUXTkUvkYfQHW4lGaOEDzQRRdqqssAEkkxi6KmgmSj4VHLXOJ67Uk6PQ72AkFABAjxS6KCiDvJ1ZLTxONi7LbqEvjWzYbRb02C+1Xo//C9mYUioui19p2d1edvIui3x2Hl79wvp7nqCVKF+U+QSQBtZ7b413adWBK1z1/DUlvuyhiJsPnMeyihOai1Lc5MvkJ5qLojHA+r9RFKXtuJL4TpJRQXBRzFjP/yDYXlLooZf2Z0gdTqglSdgdhjSzoBlJi0QA1Rc/6Jur9Qb/1oeRipODDBqnCUls70kJaXBQzCen9DNMqNcB2SGphQJBtlXBRACSXGLsoem5F4N2RnumgeuO4XksCuCgAgCypdVHUq6D8m2TPE5WLErJRtObxXLhMx1rk/JihuChmNoIn1UJD1kXRJWSf+aBDs7uPWuhYL113UezUu+sKX9Fvcy9Bc//911w+S9dW/cZd19JrvDizh8bpbRdFXk3vn9485NyhGsJzUcrbHC/IGJ/sqJ86i+79fdecMM0p79mVd1EuK6PVPTeY9AQehOSiLOvJMtmHaXp+eutEtB9R66JU9WdKH0y6zfBaYKDqDkJyUdSUjFxL7fqndLBHjx6jecYGqg08bJAqLLW1Iy2kxkUxldHhKN821DnLAfwzPYoKtCAULgqA5BJjF8WMBC4vPHR/Y6MnY5g3trheSxy4KACALGl1UfSmKI9GOolE56KEbBQ9V5SbcpkpOt2eynl8cUguinkl04cX9l1f4Zr1zZmhbPbasv/JmnOkXFTzYOUmWUK8aQ96CY3zvMrp/hITObjrLoodM+VubTx1K0/zZM8Y68vmp+nF75R+c4kNYh7dpUrPc07duR6YJx/N9uu8dfi97aLoytMqg2y+UCgURkrlFnPGeqWyW6sfB9NUIboo1W1Os16tVJ1O5KBfE2xzMNRtum7bYDLCnxWSd1Fuz0NYzw1mkABLaC7K9uS0LPpjz4PtzJNHf1u65FJr5XWKmv5M6YPJNEFeW4kU3UE4LoqakJFdNOC6+ZUN9uh02+cDMH3YoAd+AYcN/vdFBa4daSE1Lop5I7bXVQJmMRpPIZlHy9cyenbI+Uwyy1bVAkbJh4sCILnE2UUxwwSZNzb7gCSu1xIGLgoAIEs6XRS9Kcp9RWJCidJFidgo9oWHe9Zy8/knBv3mzF+UG5aLsqzTrXFyOkLL3VzasU9oNc8Od5ZGO+fw5qbvB9uHR89ivLt+zOewujpf7KPdkcNbJjNqyVxb2qOn4s2TR2szg/YTLLvvojjHjvVPr9Wes7XDbDyrkVnWh5fJrFJfd2l8k2MemvXN6X729GRextjaqmUGZ8jtQWwF0K/9gAqS2NsuyjKrs/S8rht6dmhyZU94F4JjRpS7KJVtzkUUMPtzZFmW1Ty4Q3yRfQEa7aI0TcvdND5h67d5smeMUmd7O23NFJqUooUi8Tw065szI291/LnC5wYuCrgSoouyLPPpxi222dKzQ5PGvVqdVeZm4wWvM1XiohT1Z0o7NDpol3b1Lw7Oc2Oe7BljIzPsnIaaOwjDRQU818k9disrNPX8qPHJs/b4j71fLTfzs18Rfx5s2CBXWEprR1pIkYuyGven6brMcfNm4zFbRTjvMtSVMoOTBvtKZDYeU/Vak46TagcuCoDkEmsXZdtoz31js7862gZAsb6WIHBRAABZUumiqCVg0kdXJ4NoXZTQ3ijbymVNy+QGihPlcrlcnigO5LPMe7PjVobwXBQ7r3zelWfzF/ksjRRy7PyVzlkRLAetbcRx+2Z21NIpbbqs9fz08sKwQMkEuymPODInW7bKoWVyFxtxeLVDyzAb0ugd7FpmcNJYrx62HF5ldbE0dHGF3M3F9zofdcgYp7aK/wo97qIsyzrd/4s3Xha8f02z/xhihOuiLFVtDr1fUssMlhZXK5Xq4fFhtbJuTFJGl7cp1+aiNE3TND2bv9hnNlEcYFsVl0dbrCGjzy9vb227+J6OcVP33MBFAVdCdVGWxdvna3sA7P03UfVntr9iruhPp6joz9R2aNTB163MFAqFi1xwFg+puAP1LoqOo+wjmBh9Mo49ujGrk1zg9XkBhg2ShaV2uJMOwnRRPsbwzj8yf8Tgiv2H5dXlzqCjNGJ/gLkL2371sxlOlW61H/z21G0Xlo/iTHWVBSCJhOii1LTEvJ68/e7IeWFz8+9xvZYQcFEAAFlS6KLkT6lPIlG7KCEb5TpVRKP3z37kuNciTBdlWVbzYIVe5OeWz/zoygG7XlgaPy5Kz48a7jEEBeZFMteW9k8t6/50+3ajcVGWZZknH81z9mk55Htw3l49ROaRzv+QON3HOWMitZX/+/e4izrdb+/Q0fOjt+cuLKzj5IOmab5Co4buoiw1bY7oNRzCOlHl/f7agmct1ftnHzg/2oINmcfutszY3//X8w+qem7gooArobsoy2pt/BPuSDr122Fzp2+dErw/U9uhXWztdKDv3z9SfwfKXRS1vcvfuTb0UTq8gGRPN8Y9h3/8H8yyLP/DBtnCUj3cSQHpclGW3KtM7qbjm4zEZfT8uHtET/niTHWVBSCJxN5FyY1/XOerYnwtAeCiAACypM9FkQslVazH6lGid1H2l2P+eozWKUvOLzZ6dmhm7ZFr/xmyi2rlcmdpzBbBhyTTV5z3yKcwUqOnTG6ktChwFIZlWebJ3tKbDmWd6Rtru6wvltsboyJzUa38PlpzrRytoEs7jlHr3V6aqenGzjJx94w165ucSE6tjDj/Cr3sogiD6XJQiNl4cbjDbAm6NFv1+maXjITloixLSZtjNeub89edJ2S4AQA5t3nVeGKZJx/NO2VHz48aHhEPhRsyx1lVW2bVPDdwUcCVrrgoy7Isq/m8tsZvuJnHLXulOM8JP9cmkE4J3J8p7dCcJIlbkxPsDhS7KFoj5eY/9XcVytHzOy3zZG9lknvbmb7i7RVbWBwWP8MGH4WlfLiTcFLnoixL7FVmbMmlDWphnjxyb1GDBGu2AxcFQHLpARdlWYLjH893x3hfywO4KACALKlzUSf/+J8r5+wqEgM9SQgu6qvPKh0+PhI6Eck8ebRL/NXOwf/n8MHm2WF13Zhrb7cYKZXLc8Z69ZA92cEzZ5+xUXVE/kr0dhrParuri+XyRHGgUCgUBooT5fLiakUsm+I0jj6uCFA9PH4hoqDYm3hcXV0kb2Fxlb0B8+mnciUjfVPCP5PlWDl2a8+EBJztfueM9So7/dOsVyUy1jw7rtfOa/ZurX7s8fPLVVCqoHif9qy5nlcQvh6xel5knxO9GZI5C94bfw+yZVnMLYtV2kBtDnGN1cX2JZxqFw1XHp1X0/MrjZTKnMeSj1RDZp48umfMtR6G82ffIbPBnxvJagjSRvdc1AXNs3ptt7K6SGzsbIUzWVytVA8FelMf7QwnE0H6M6UdWrNeXV3stDlzxj0XDxf4DlQUHgEx2K94NLmuUKPU//yPJ84fbLw4PqxefKP86Etq2OCzsMIY7iSVMF2U4BiexPlHpgZGYnj8sOyrzMW7jGgj5HQdP4MoEYjiTHWVBSCJhOiilLbELdjxT5BmL67XcqLTF6mbGwIAJJvUuSjQIgQXBQBIF8QGudcWHor8BRH+RyttYKzKQ/LUcQCSSfddFAAAtAjTRQEAABAiRBcFAAAgUuCiUgpcFAAgIMTBYQN3hFrrTvQfUXuVPuCiALDgogAA0QEXBQAAkQMXBQAASQUuKqXARQEAAkLucnpj5UvPz59ujbdVFOcYeGBZFlwUAJZlwUUBAKIDLgoAACIHLgoAAJIKXFRKgYsCAATl0/nOue56/+xHLkfwmScfzfa3t1HppY3TLuazp4CLAsCCiwIARAdcFAAARA5cFAAAJBW4qJQCFwUACMzpRknvmBNNzw5NGuvVw2OCem13db7YlyE+lpvaholyBC4KAAsuCgAQHXBRAAAQOXBRAACQVOCiUgpcFABAAc0D4xrpmbzQ+2cfQES5ARcFgAUXBQCIDrgoAACIHLgoAABIKnBRKQUuCgCgBvNkzxjr8xZSmcHJlT2XMH7Asiy4KAAsy4KLAgBEB1wUAABEDlwUAAAkFbiolAIXBQBQidl4XF1dLJdGCoVcx0vp2XxhoDixuFp93ICFEuKrzyptPj5qRJ0dAKIBLgoAEBVwUQAAEDlwUQAAkFTgolIKXBQAAAAA4glcFAAgKuCiAAAgcuCiAAAgqcBFpRS4KAAAAADEE7goAEBUwEUBAEDkwEUBAEBSgYtKKXBRAAAAAIgncFEAgKiAiwIAgMiBiwIAgKQSaxf1859/9t/+2y+RwkgtF/W97/155DlBQkJCQkJCQiJTy0V94xv9kecECQkpbanlov7Nv/nDyHOChISElNrUclFHR48jzwkSEhISktoUUxf1679eePPNt7PZV1o9EJLy9OqrV/r7r7766pXIc4KEhISEhISExKTf/u2R119/M/JsICEhpS29+uqVVoo8J0hISEipTa+//uabb74deTaQkJCQkJSnVvN+//7HShSSMhf1z//5KyMjvxt56SQ4ZbOvvPPOWOTZQEJCQkJCQkKyp5s3v401SUhISN1P2ewrb79dijwbSEhISGlO/+pf3ezvvxp5NpCQkJCQlKfXX3/zn/2zl3/yky0lCkmZi/rGN/o17aU///P/9W/+5gdIYaTvfndG016anf2fI88JEhISEhISEhKZvve9f69pLw0PvxF5TpCQkNKWWm9J//bffjfynCAhISGlNmWzr2Szr/zVX/3vkecECQkJCUlt+q3f+pea9tLPf/6ZEoWk+LwoVaEDgZ3WeVFLS38ZdUYAAAAAACha50X9i3/xm1FnBACQOlrnRf3hH96OOiMAAJBeWmvnnz//f6POCAAAAMXE9LwouKiwgYsCAAAAQDyBiwIARAVcFAAARA5cFAAAJBW4qJQCFwUAAACAeAIXBQCICrgoAACIHLgoAABIKnBRKQUuCgAAAADxBC4KABAVcFEAABA5cFEAAJBU4KJSClwUAAAAAOIJXBQAICrgogAAIHLgogAAIKnARaUUuCgAAAAAxBO4KABAVMBFAQBA5MBFAQBAUoGLSilwUQAAAACIJ3BRAICogIsCAIDIgYsCAICkAheVUuCiAAAAABBP4KIAAFEBFwUAAJEDFwUAAEkFLiqlwEUBAAAAIJ7ARQEAogIuCgAAIgcuCgAAkgpcVEqBiwIAAABAPIGLAgBEBVwUAABEDlwUAAAkFbiolAIXBQAAAIB4AhcFAIgKuCgAAIgcuCgAAEgqcFEpBS4KAAAAAPEELgoAEBVwUQAAEDlwUQAAkFTgolIKXBQAAAAA4glcFAAgKuCiAAAgcuCiAAAgqaTdRTXPjo8Pq5VKpVKpHh4fnzXD/sK4ABcFQG+xPaW1uWo8iTo7AAAQInBRAICogIsCAIDI6UEXZTZeHNdru5VKpbJbqx+/aJhR5wgAAGJJWl1Us75jTI7kMhqLnh2aNHbqiXdScFEA8GgerIz1ZTRNy/SNGfunUWeHAC4KAJAe4KIAAFERhYs63TfGrmT19kgvN7Udp0EoAAB0mx5yUebJo7X5ItmGX5DpK86vPTqJkZNCbwMAiAFpdFGn+0vX7BKK6TSuLe3FqctQThguqnl23AGrQCKH+j3ktvyZjRfp/ClPN0rkEFK/cffLqLPUBi4KAJAeuu+izMaLw2pl3ZgrkyyuVnZr9fTsmk8R1CApRYERgADdd1HM+FPLzValBt/Ns8NqZXWRaLl2a88kx+/0I+FOmt4NAAAR0RUXZTae1XbJwd+csV49lBkUmE83xvN2CUWvd8+PrzmudpdpfHlIjWCC9jYAAKCE1Lmo0+2pnIeHajfMU1vJ1VFhuChyrhyT5dFD/R5T2zJ/+sS4msqf8uu7N5hWYHj5C/5Hn/zgrUKhUCgU5n7WpczBRQEA0kP3XFTzec1hLSs1i5AdmjR2Hqdj/rVx/48HCoVCofDODx26wATwi6XL5A98eekXUecIxIduu6gv796gVkING0fCTU2zvjl/3WEaVM9fn98UDfZBjf29wDgUABA6IbuoZn1zvtjntEQ9Mzi5IrA23Twyhj08VKdpv3PAbY+pSRsfSMzzBOltAABAIelyUWxfkRuZ3+ysemieHe4sjZKj+QS3znBRyQcuShpxF9UpIbmSDQBcFAAgPXTFRZ3ur0wOem2Up9Dzo0ayt81bFtHdJLivebjwGv3TQkaBDt11Uba5wWXR5655sHLTe4ll7uYKf/6TRmo2NMFtAwAgLoToosRaT03vn/3IbdDHLHPX+7+z8kl7S6rZeFZbm6GGmfxweF1zUf57GwAAUEyqXNSXK2+Qbe8C9zCY0/0F0le9sRKfGF0qgYtKPnBR8gjH6Ls/rfsq2QDARQEA0kPoLur0wbychiK6Bo+piV7ni+XhpPc15oP3LrE/66XZatTZAnGhmy7qyTK9TlL44A7eavxMrlAoFPK2bZ4CqyultkXlpu83gt86AAC4EZaL4u5lyuS4radbq0yPJXK3Np5y2lnz6cYtwlddeu+B7UPVWduQRAZ9+r7QbfvubQAAQD1pclFUOA6392tqNP7awkOVmYgLcFHJBy7KD+bTrZmhrK7p2aHJNcd1pI2Nkr+SDQBcFAAgPYTqopiJgXMyuZFS63ioiwj89dpuZXVxghfBZfB/exxGzmJBZ8tQUvsanoriTxCBdNI1F2WL2CE8N8isxs8MzqzVnndGrc3ntbXpfplLd0aZl/9gteJKNSXRSgEA0RKOi2L3MuVHjU+I4/XMxmMmVJKmlzZ4zWfjw1udT12a2nY09I3tKWLQUdqwffD0YNe91WX5T4tvvSw3ePHf2wAAQBikyEUd3RnotL437n7t8lFiojmpMgouKvnARYUH0ZrARQEAgHJCdFH2g0MzgzNrj9x2OrEzE4neFGBujSe8ryGnj66WSu1gffqtD5P7swIZuuSi2LnBq3dEQ8PTM5sOq/Fty/HHt5ynHjsjf9El9gAAEC5huCizOpvzbj2t5sEdsnnmhfElRkueW6upuMAcGSV5D0d3OlM1QlGc/Pc2AAAQDilyUeRM7sAd9ytT3qprc83dBC4q+cBFhQdRtnBRAACgnNBcFBOiRNOHF0QPgDJPPlq8nteTvpiUGAEks68hF5y9tvCQiI0DGQVadMVFMXODMocUU6E+crNV579r3J8mpl1dTkXrDDKdTkoFAIDuEoKLovYyXV546Nx6mg8XiIaW45qo+ZLxLdf2m/JWQcdW5KlPbtuxOt/uv7cBAICQSI+L+vIH18R7gORPxcNFJR+4qNAgywcuCgAAlBOSi7Id24z3cRtEZ5PIvoY8PPa1hYd0wD73sAkgLXTBRVHr2h1DQPH/lKyyngKVmnl1/DS2RQEAYod6F0UuRvFsPakJEbul/9kMEcDZa0IgwLwMA7Wxy2WBQecP/Pc2AAAQGulxUVIzuTLLHHqTHnFRZuNFvdaJn7tbq585neAT8kXOaZ4dH1Yr5LVeKIiZ3jwjMlg9VHFJKwoXpaZ0qNKoVA+Pff9cZuMFmZ/qocCVzMaL4zZOn78/rfssWctWHwXzBRcFAEgTobgoOq6Ve8QqhZiNZ+1G37PBVzZkYXrkym7tmVCP/MXycLC+RuWgS7LwRCAHOOeTOGTsHKFgNw40z7xGD650xh9+h4HiheW3dqSF0F0UveBebq8lJZcEIsmLqCtizT62RQEAYoJ6F0W8w+tT217dHvnGb9f01HyJjIvyitDkCrmmSmQzd5DeBgAAwiNFLop81fTqe8iOB+dFiaLSRTXrO0tjV7JUIJ2LHy87NLkiFFHHPNlbmRziXiTTV5zfPDxmcXz9b9Z3DIdLaXr2SnF+0+sc385whQim0axvzvMORdezQzOb9YBTLt1zUcFL5/wy/NI4/7kcyqN9m/pv/uUvvC7lXbCOw8qL2bXVxXL5LWJMd/mtso0PPudc2Ww83pwv8iu1lukbMzwqNVwUACA9hOGiyA0xmqbfuOvfOvAgNhZ0Ln26b9AnYGvazR/9V96fKxn3WJbVfP7JyuRIjteXOveB52pi3ZgrvzvUmbe+NPSurYP7/q7TzqEgdxCw8MQhg5u11xNz/1GU5vPa2nxxgC1xPXulOO9+DJllWa2zyIzJkTxbbpncyKSxwx2wBCgsX7UjhYTsoti5Qbcge/Y/3p6SfUkl4lA6vAJ3gtNjWxQAIC4od1G/+n8+XCxPFAcKhYGxu9774t1tE3XCvMe7ObnMJ8h5UbKbogL1NgAAECIpclHUsrBL7z1wiQ5LLSDzXjLRi8TYRZlPt2YGua/J1CtzfnTlwO2N+fTBbD931t8NXq7F8qNpen58zeUd3nYAw+n+0jXXy+r56UALV7riohSVjmUe3b2Z87hGZnD+gb1AiNtsbWE83Tc8LpW76Tz6dBx0Uv/DA7a0zZM92xwRB314Yd/5F4eLAgCkhxBcFN2Ku44DA1+/1Qucbk9xeiN7f6xo3GM165siPTLnqG5qwOAOt/8JfAf+C08Ocl0acSc+ZZTIbWeuLTlKOI4/speZffTkr7D8144UEqqLouYS5QOFUmJJTBxR+opz6gm2RQEA4kgI50VJQY6NOOafWuHkuqua+mSA13hqU5R3rL2AvQ0AAIRIilwUvS7AuTGmD/dL6uqBuLqo0/2FYdvS0EJhpFQul0YKzLJR5x+RfSvP5AaKE+VyuVyecNqYwn8D4+Tn/ILcVaV6/yzHlliWxUwdbD3duOVlXtzvUIDwXZSy0rHNoujZfKFQKBRsP/nof2BX+dInW5xuT3s7H81lg7p6F+UpHakbHF52Km24KABAelDvor6+e4NobEPY8072EqWNBnNUtGP7rWjcYz7dGBfq/jRN07Tc9H1qVW4gF6XiDnwWniTUWjNq3oj8fkFN6TR4RrdPAAAgAElEQVQE4pC5tmy7aVNwIKjZlybJF1aw2pFCQnRRQecGqdX1ouebUa0fxzZhWxQAIIZE7KI8m9vTjRIxa+gY/Y6a6AiwKZ+azPSepISJAgDEmTS5KHbGO3fLvlGjWV8jXw2TG1E1li6KeZ3W86PGJ8/pn6j5/BNqESn3F6J6Xr1/mg05wvzKWiY3UiqX54z1Kv1B2+t9ZnBmjQypbzae1dbmr1Pv904dPTl1oOv6xS1en1/rHKVgNp59wq6R9X90QcguSl3p0Cd45G7SweqaZ4eb51fhihpK0QyfZykzOGnsdM5KaJ4d7hjfoffJOYwEnTfjnx5cnMLwdxOdddXaG39asfHZV+2/+tXPZsi6pmeHbDlborZxOY5Q4aIAAOlBuYsiFv5r/K0BQSG7j6vGdue/2qsrCvmsrt/8ETGdoWrcY335g2tUh9xXnCd6ZLPxrLY2TXWC9CyG+fTTiw7sT4nFu69N/J2tg/v4iPIUiu7AT+FJQ+0OYUZX5KJlARllGwLp+evzq9V27OfD6ioRKdg+erEtwckMThr3avXzP6/X7pGhjxk5JF1YAWtHCgnNRdFzg5fGN5893jHmSiOFQiGXyeQKhcJIac7YcYlsTW6LEm/H3E89IVrHgbm/362sLpbLrTBWhYHiRLm8uIoDxQAA3SdaFyWw7YkeC+jDC7Z90ObJ3gL1Ef9GiDJfnjNEwXsbAAAIk3S5KMsyj5apLQqZvuLE4mqlUqlUVhcn6ANmeMsYE0McXdSTZcGemlqLan9hJlf/OU3sm0d3iCWw/Hc5Kj+aPnzHKTZO88CgatXVO5ys27bVOIZtae6/Twb29b14O1wXpa506GDLvLKzLMs8ebS7yz13wbaaO3fTIQYQO3XEnW0SOYZU6qjSzm561rJ1oMaWTvGB4KIAAOlBuYvqLPzXtIuQrmohu4bXLl/WNU3TMoPz/+W5Q+9oqRv3WMSsA2cFzsVHqGMDnI68lutrVN2Bj8KTpvHhrU5ebSucyUknz+PAmSFQ/+xH/PHcwcpYX9YecLlxf5o0UU7DFvPko/mhbNb2NiJfWMpqR1oIyUUxJ3e8nLMdE9YmM8g/vIuS6uKDQWrgajurhG4dncj0jS39FAEcAQBdI1IXRQbvdVE/TEwWPTtUmjPWK5VKZd2YK1HnaQc6f4HqPzyXzCjobQAAIFTS5qIssaNbMn1jTrPGCSF+LoqaI7g0vuXaU5MqiV0mS6oNl46a/BhP91D58dwhx2yC5rzD0y7KPR4/FUXGt4wK00WpLB1ysaaPMPW0i/I46ICWPp6/kxIXZVnNerVSqbqO8qjhLv/hgYsCAKQH5S6K6isG7oQwvrQtOfFa/qps3HP+iZNHuxX+og3uNzqchyrT16i7A+nCk4da+MI5OZxayOSqYughkNd926F6fMc1OM74KSxFtSMthOOiyJM+RODNW7pLJUeoUFPsc01vGvXK0zgOFAMAdIcIXRQdfs99r7DAcYx6diiY8aHy4zkRoKK3AQCAUEmhi7LMk0dr8yNuQdpzI/Nrru9rvU/sXJT44Y8tyDkFenUr+ZrmFkjdfvazY34EzoZkpibsd0C9PXqtyKbiyEi8a1JIHP/gCuenVFo6ZD593Cp1quj7+16PLXluOW+uJQwXJQK1KJVbDHBRAID0oNpF0adFhdKGsobA60vUjXvEoSad+StdJPoahXcgW3jyeO97omSVy+3QdUk+kjIZZE30cCqKsApLoHakhTBcFL0u65xMX/F2awU9J0CHxtGMfkegbs/1Fz98k4oLkjsPzdeK02c/ATa5EewBALEiMhd1ujVOREP1XHHSrNsOA2Ca8v7vGDsBVBR97L3XxmU1vQ0AAIRK2lzU6b7nnqh2g5wfNfYTO9aOm4ui3q2E5liIuQA68rm7YxL8HDXTILY6lN7MZLsHubdHkQObvAjPRaktHSqIvYDXcrlNkZKiZJQ9PGNULso76gpcFAAgPah2UfT0fRdc1KWpbY8wb+rGPRJQ6x64/Zd4X6PyDiQLTx7q0E6HeRxq2YyjY6JVlPwSGkpF+TI+oRWWd+1ICyG4KHpRluYUqrtZ36TP7tIuLzwkPhWGi7Ks1vGl6+vVwxecs0PYE99cjjYFAAB1ROOi6Kj+HvLdfLrltSeq0+oPzmz52ldKbYpyCObfQVFvAwAAoZIqF8WcFKxnh2ZWO6Nus/HisLrKdCaJXfoVMxdFLUYVjJ1DfB31ZWQcCrdcEE7CNqlDh6sQnGlw/yO5t0ef8eApQnNRikuH+vHdTlXyvk2RkqIz4ssZhuGivO8DLgoAkB5i4aI+/6DszAefu32Fp2NQOe6RwLv/Eu5rlN6BXOHJQ4bFc15CQ03gOE33kAtofGxQo4KlOZxX6kFohRXK6KYnUe+imMlB1xXozLmxlDsNy0V50jy4Qx6S5mdDHwAASBGFi6InDHPT910mOtizqDN9Y0v3avWz8w1QzbN67d4SY/Lltx/JbYpS1tsAAECopMhF0QcNOx0UbFnNA+NaRrD97l1i5qKopZiZXEEEImgE/WXkxhfn2CnkvIRNp/h7z6fugp2XkXx7VCAeqN/j3fVjCT79swGXr1ddOpyN5JnB0uJa7RlndabrbQqVFJUR95uDiwIAgEhQ7aLoZQiCbajrkg5b4y+3oVnpuEcchS5K6R2o2A3uArkXyW0SXUBGBRVBVKXyF4M5tMKCi7pAuYuiY297BgFgjp0nlKfP30jFEjf6BBLMWQIAwqbrLorZEuV+DHXj/jR5IHb/7Ef81bTmydY06aMk17rTAxPPrUvKehsAAAiV1LgoeoWAxwGETM+SxNF2zFxUwC08zJeRmokf4ZcaaHB+YH+3QsdtYd4QI3ZRcnMK7vMc6kvndHuaHzozkxuZNHYeuzkp6ZKiV8ezBdMlF2U2XhzXa7uVSmXdmCuXy+XyW8RAEC4KAJByVLsoejeLYIi7MF2U2nGPE82z4+PDaut0gHK5XC6/O0QEiAvmopTeQaguiooS7L6fg5rE4X6UqkjyOaW2RfkcQagqLB+1Iy0od1F0fGiBPUXUYWzEMbNUBRpe/kLw+6k6I/5nDNTj4TtQKAAAiNFdF0WLKM/16OSEk2fgUnpRvGeYPYevEQmPqqy3AQCAUEmLi5I9aJhulBO4QiDGLkrP5oVW13YY+GNm9zQtE3M3l3YOLzZLW82zw00yEqM+vGzPqc9bcbM/qXdRHvlpHqw4H+WmZ4dmNh0O/OwhF2U2ntXWFieKA/aDoGngogAAKUe5i6IdgNi47vTB/Ag52shniV5KoYtSMO4haZ4d7hhzpREquzzUuajAdxCmi6Im0F/+g3uu+8K//PuJl9sf5s3iBNzXpCK+XqDCClY70oJyF0VWG7HIjNR8IvEr+xsMKjoKjArM6VtpAQCAEF10UebRMhEZSe+ffeCxd4k6+9Hb+dBHZwsH6KWW0wvFRlXX2wAAQJikxUVJR3dXsXAxzsTYRSkpbfPo7k027hsHPT/N3SQNF9V1F2VZlmU2Hu8Yk0MO8yMOP1ZPuCjzZG9lUvRgU7goAEDqUe6i6Jdtf8HR3Bv/APuiVI0ym/XN+euOyzpsKNwXFfQOQnRRtlO8JfDaOC8/G0/dqM+dJT4LS0XtSAuqXdSvPrwlW2uoqHpETfFllaiLCR7uxgVDUQBA9+iWi6Injpzmhyjkz370s6ua2nvlvZreUtrbAABAmKTERbnPPnMJIFZ6gZi5KEXr9SjMk4//+IrmTGbQcasNvdJF+FZcBWaCXFQIpUPTPDvcMW4X+2zuhrczPfbnRZlPN8aZyR89mx8plRdXK5Xq4fHx8fHxWRPnRQEAQAf1Loruu3yFX1bpopSPe073l64xvWYmN1CcmDPWK7u1+vHx8fGLhhnWeVHxdVF0YARZ7PUk4AJiamNJ92L0qaodaSHUfVGCJeswivellaiHNUgIJgxFAQDdoysuyny6cYsMqCN2mpP8vJf8fCS9KWpqW2jYqq63AQCAMIGLcgIuSpoARUZNFQRZsNemeWCcv3br/e9MFAcKhUIu0zpce6Q053EEkY+lLpblMUGRIBcVQunwMRuPqXiKGi+gjXRJUeVi2ySp2kWdbk+Rh8/lR5cc6h5cFAAAtAnBRdEBUsQWmNKodFFqxz30KQdaZnBmrfact9pGoYtSegehuSg65rYP2HpCDYF8LCCmVkb7i3ImW1gKa0daCNVFif3qlLUkf2WqBopFG6We1UCh9eTvAwAA/BK+izJPtqYoEbV1Iibru+CiqE1RwgMjhb0NAACECFyUE3BR0gQpMkpUBD+f68u7N85fu6/ecT920gFq+bTg2xb1qmebn0iQiwqhdFwwTzbH3b5OtqSoqmZXW2pdFLWeyX14CxcFAABtQnBRzHu9dml8S2TtK4FKF6V03EMdbT1858Bhz7fnLViWTF+j8g7CclHUT375/U9cz4pq8w/TxLCDlVHUEEj+xCd6n1bwWJHehaWydqQF5S6KLFqxRVxUPaPqCVWpRWoQNdF4eekX/m+D3F+FSE4AgJAJ20XRS0ZztzaeCk8bhe6iqEkEib38KnsbAAAIj5S4KPkArfS5Asl7IYubi6J7QR+rlUmItc9+JzSok67F8kPHXbF15ElyUepLxx3yaXQ9vUqgpKhXeM4ITamLoqacPG4aLgoAANqE4qKsxvYUuTVKMBJLG6UuSuG4h7yShxxR6aJUjtxCclG0ihKfhKdeApi/o4dA8jP79IlRgWNFehaW0tqRFpS7KOpnEKk0bsEEJE8QofYGBlJRVAXBjCUAIGRCdVG0iMpcW5Zav0zvkZ7a9vxbei7Es+ummluphltlbwMAAKGRFhdFL0P0bpbptbPB9+nEjti5KLrIc7NV/8HMyc7bfQWoC3Qsn8sLD73y4zW5kCQXpb50xP86mIuiM37pvQe2jCt1UaQD98obXBQAALQJx0VZ1ulGiTy/Tx9e2BfXUWpdlLJxDzUj4tHbK3VRCkdu4bgoSpZJzeW4SSxmJCG9vY4OG+hj+75UYamtHWlBvYuiag1v+ElBt1M23URVIY8Hz6zO5lwuJQGl8n1ZVAAAkCE8F3W6PU2c5qwPG9I9seQZpNQ2J88NS3RzW9qQGWYo7W0AACAs0uKimPbfvcNhAqsncrgdPxdFxNXTNKHVyubJozVjhTOLRL14a1omN1KaM9YrlUqlengef+WF63FRlmUxExEeQxSmyvDkTKJclPLScYVcg2wPCULdpnu1odc/8W9M2kW5xSgkR6mug87mwZ1hr62bcFEAgPQQlouy9QSanh9dEVy0QgaoUuCiVI17qOVWbqunmHMRvF2UZxQuZSO3MFwU7YwkL0pvomYmc+gFay63bZ58ND8yMHaXHiOJv5I0D1bGBkbmH9DXlyostbUjLah3Uay5dXlWBF5DacHkcjG6uePPSppPtxbnjJ26ayvIVA/poTwAAEgTkos6fTDbH0xEWZbESMCyjTy91sZQvbz8Qh+VvQ0AAIREalyUZT5cIPsLLXeTP/fQPFi5Sc1SJHO4HUMXxXaHjj+RZVnN+ub89dZqFt74gY7H64iezRdGSnPGzmOumaLf9LTMtaU97nE/bJXJTd/n9OMJc1EKS8c8Wr6W0TKDM1vcGM1UteC8RlO3qWl6/+xHvIyYJ3sLdPXi/kxCvxMtO6kVRM169dPObVBTQE4Lk8yTj8gBsWORw0UBANJDeC7qotehyPSNLTmMBSzLsprPa2sXow7HDsKHTlE07hGKlWcb3jr0cVRQa6rjMk8eVQ+YKQ1VI7cQXBRtfKQX+1I5Yjvwxv1pqixzNw3bGKhZ35wZPK9n7FzQk2Wq1PT+6U3WBJgne8boeZVjyst/jL7AtSMthOGirNMt8vhTPT++Ztc/5sneEtU66Tfucn8y5mK8sS87vORv4etMkWYGZza5jaB5smcIvOgAAIBawnBRp/vkjIDc7njmSsxGe8c5COZN32ufEx1O2s9WJaW9DQAAhEJ6XJT9hVnTMn3F28b6+V6Zw+q6cbvYR09P+F0oEXtCd1FC2N6gn/yIeRfWs0OlxdWL/Uz12u66cbt4JUv9jvp3Kr9ksmI+3RinJ43c0fPjvMMqbVVGz1/v1Jjjw2pldZ6pMnr/fJX7gpY0F6WsdIgZGT1/fX7z8Kw9WDIbjzszOZqm6cPL9qxwqp2eHZrsZKRe211l5xCd36OFfif6ODk9P7q0XqlUKqutzBLLl+hIPJlrS5887wwFzcYzYnYzl+tUfbgoAEDKCdNFWY6jBD2bHymVy+dbqSuri+XyRHEgl7F9UNMyMz9jrulPp6gY99AbgPT8+Bo5o9w8O9wxJs/7Uj2X63yU28fRRxpomcGZ1UqlUllfGs3r3LkKJSM39S4qoIpiOnDbamH7O4WevVKcKLeYYO7X/jbBbs9rbeI///NyaYSudLTLkisspbUjLYTioji/eqavOLG4WjlvbibYt1DXBe22HZ6t5263dljbrawuloboR45/qV/dn75EfyWZJW6mEvtqDACIG8pdFNt1vzw4MlLgDvJs6PkZ2+SBrU1vtcO7tfrFFIStKfbeQe66EkYUpb0NAACEQJpclMXuyPXscvpnHyS1UY6pi7Is8+guuzTTFf4SXPNkb+U75z+1rov95Hw7cbq/xC6fdsatxiTPRVlKSudka5IzH5jJ2ceFDmeKkrf52vA1EQWZm9ri7uGy3bpjqXnsvOtspmTXTmut7XiFQp4cmOr9sw9OiU1UcFEAgJQTsouyLHrfihQOUf386hQV4x5mn42maVomVygU6K40d/PukUlsk+H3cfSKXPvd2xf0KrgD5S6KPifW17mv9GqS0oZtEkpwCOSwV0x01ZR9qbVsYamsHSkhJBcl96zkbvGWyZEXY8IqulzKcdxrPt2alng1zlxb8r2HAAAA5FDtouiwerLwulvJ8U/u5l0Plx98U5SPnHn2NgAAoJyUuSirFbudXZ9gR88OOUQMSwixdVGW1YqPzy7W4P9GtpgmlkUZRzJyXPPs/Kyo48NqpbJuzNnWqThkh4yT4r/GJNJFWUpKR2A+0DGCn62kTvcNt4GXnh81XF+jBX8nTognIrPzxLyR10iw8+nObiu4KABAyumCi7IsqxU4zrY81LnB7ivOcwcelhVMpwQc91iei606/ozY9+TUx9FnejtcR+0dqHZRXh5JCNpn8aaEPIZAev66c32xLM/xT2ZwcoUT/1i+sFTWjlQQmouyLMs63fccN2f6xgRPsWserLhfTOBAPPNkz/B+evX8qD0SJQAAhIdiF0V36tI4dbdi459M35j7HIRlWexJUUHDoSrtbQAAQCnpc1GWZVmW2Xi8Y9zmxF3J5AaKt53OD0oSYbion80VJHnnh184Xq35vLa2WBrJZ9kYKPmB4m3jXu05v9cktl4LRJFoHtwhF4uObzl+3qnKCNeYL374TufG59jQPjbIwnQrJsFLCHyjY2YFvj5w6bTOM19ko9JoejY/Mul+oDJH0TSff7IyyVwqkxspLa498nyLFv+dzJM9Y4yKwpPJOWS2Wd+cZwMUZXIDxXk6Q09+NDbgXOQKqgQAAPQI3XJRLczG4+rq4kRxgBeqJZMrjJTmjHu1Z+59mWzPacPnuKdzFyd7tr6P04s2qt8b8ezjmvXNGepSevYK22epvIPAhUfz+O+K7auNTP7Yb0gx8+juebdcKBQKpQ8c1ic3n9fuGXPl0sjFN5bKc8Z6VfRdolX7yhPF868aKE6UF1d3nUvLV2GprB3JJ1QXZVnn4+ZJ26PSGhp6Puq8i7FxMPXsleJt9wE09yrsUF7P5kdKi9J5AgCAwCh2UVTnKY9rd+sw/pFrQn9V/dPfbo9dFK2LV9rbAACAMlLqokjMxovj4+Pj4xeJ908kYbio8Djf0nTm3VsS5wPoU9sivyh5qPPwstAb/XmVSVeNESZ46Zz/3IJXcN0u1LqUQMUJQOuGxXIrXpMBACDNdNdFMVzso46wmw/UWygcpfjvRdHfxRSMYQUI3UURXLyHKnlUZIak3nnC0wsAiBLl50V1h4tBZNyaUKW9DQAABAMuKqX0losSpxPmTDTGy9GdgfbClen7YecPKAeh6wAAIHFE6qIAAKmmmy4KAAAAlx51UQAAADyBi0opSXVRxC4nsX1RxJEC+q0Pg8XkBVEAFwUAAIkDLgoAEBVwUQAAEDlwUQAAkFTgolJKUl0Uceqypg/f8TiKkTouKjdbRbySHgQuCgAAEgdcFAAgKuCiAAAgcuCiAAAgqcBFpZSkuijLrM7miOMi86NLO7zTo5vPa2vz1/OdQxxzU9unEWQXBAYuCgAAEgdcFAAgKuCiAAAgcuCiAAAgqcBFpZTEuijLOn0w299xTC0yuQJBPsv8/9ytjafYE9WjwEUBAEDigIsCAEQFXBQAAEQOXBQAACQVuKiUkmAXZVlW82BlNM/6KD56ftTYx46oHgYuCgAAEgdcFAAgKuCiAAAgcuCiAAAgqcBFpZRkuyjLsiyz8XjHmBzJZRwkVCY3Mmns1N0PlALx52dznR1v7/zwi6izAwAAIDhwUQCAqICLAgCAyIGLAgCApAIXlVKS76I6NM+Ojw+rlQt2a/XjF5wjpAAAAAAQC+CiAABRARcFAACRAxcFAABJBS4qpaTJRQEAAACgl4CLAgBEBVwUAABEDlwUAAAkFbiolAIXBQAAAIB4AhcFAIgKuCgAAIgcuCgAAEgqcFEpBS4KAAAAAPEELgoAEBVwUQAAEDlwUQAAkFRi6qJ+4zcu9/df/da33vrd330bKYz07W+/m82+8nu/V4o8J0hISEhISEhIZBod/R817aU334w+J0hISGlL3/72u5r20s2beEtCQkJCiiz191/FlCASEhJSItO3vvWWpr10//7HShSSMhf1a7+W6+//ZmspBFJI6fd+byzyPCAhISEhISEh2dO//tf/Qzb7SuTZQEJCSmH6/d//nyLPAxISElKa0+/8zg2MA5GQkJASmfr7r/6Tf/JrP/nJlhKFhH1RPZN+//e/o2kvYV8UEhISEhISUtzSzZvfzmZfefttjFKQkJC6nVr7or797XcjzwkSEhJSatM3v/l6f//VyLOBhISEhKQ8vf76m1oM90XhvKiwwXlRAAAAAIgnOC8KABAVOC8KAAAip7V2HudFAQBA8ojpeVFwUWEDFwUAAACAeAIXBQCICrgoAACIHLgoAABIKnBRKQUuCgAAAADxBC4KABAVcFEAABA5cFEAAJBU4KJSClwUAAAAAOIJXBQAICrgogAAIHLgogAAIKnARaUUuCgAAAAAxBO4KABAVMBFAQBA5MBFAQBAUoGLSilwUQAAAACIJ3BRAICogIsCAIDIgYsCAICkAheVUuCiAAAAABBP4KIAAFEBFwUAAJEDFwUAAEkFLiqlwEUBAAAAIJ7ARQEAogIuCgAAIgcuCgAAkgpcVEqBiwIAAABAPIGLAgBEBVwUAABEDlwUAAAkFbiolAIXBQAAAIB4AhcFAIgKuCgAAIgcuCgAAEgqcFEpBS4KAAAAAPEELgoAEBVwUQAAEDlwUQAAkFTgolIKXBQAAAAA4glcFAAgKuCiAAAgcuCiAAAgqcBFpRS4KBA2ZuPFcZsXDTPq/MSZ5ln8i4r6Pc+aUWcHAJBo4KIAAFEBFwUAAJEDFwUAAEkFLiqlwEWBsHliXNXaXDWeBL9i8yypFmR7SnFRhQD1e05tO32s2z+S2XgRX38HAPALXBQAICrgogAAIHLgogAAIKnARaUUuCgQNkpdlPl0Yzyva5qmaXp+9O5RwtRDMlxU13+k0/2la5lWhjKD8w9Ow/4+AEDXgIsCAEQFXBQAAEQOXBQAACSVdLuo5vPaPWNuojhQuGCgOLG4Wn2c/EX24biorz6rdKjWFe6NMJ9+Slz6s6/UXRmEhUoXRV1L07TLS7/wcxmqgvLZrdUj2HqVCBel6EcSprE9dYn8Pv3Wh41QvxAA0D267aLMxrPa7upimRwSFgqFwkipPGesVw+x+zJx0CMCDCwBQagu6vRg13MwGqhiEu9MHx+pGRiZRz+eK1/wwecSf5nid20AQEC67qKI5tmr8RWYVVDXuEvki4dTO3wYcM4jYLYAAKkmrS6qWd+cv36+gp9Hpm/M2E/yKvtwXBQ5o65pemlDURGa1dkceWXnAGEgPih0UV8sDzNPqL/r0RXUBT17pTi/9uikWy/KSXBRqn4kYe5Psy04GgYAEkPXXFSzvmNMDmWdB4QXZPq62i1EyZd3b+ix7o8UYD54j1rNcGm2GnWWQHwI00WZW+OCY1FfA5vmgXGxY1zZI2weGcO6dJ5S/64NAAhIV12UebI1TbRYXg2d8KxC0MZdMl80zfrmjNsQN9M3Zuz5GtkGyhYAAKTSRRGBpNzJXDMOkng2jWV1x0VpWm62qmDWxny4cNln5w0iRKGLamyUmIfzxt2vfVxHdtSo50e7856cBBel6kcS5uHCa/T3YSoRgOTQDRfVPFgZ68toUuj5UZ+v7T1Eu0uKa38UHFZFadql9x4k/GcF4oTpoo7uDEi0OHJvPKcPZvupN1wVjzC7IFAkT3jXBgAEp3suyjy6e1OuoeuOi5LPF/G34u3wkuR8R5BsAQCAZVkpdFHm0fI1euJBz14pTrSCDkwUB3LM/xw2knYyTYvuuChNu7zwMGj5tdfnorfrLVTG6DOr8+RYKjd931fQEV+jxtytjadhNwJJcFGqfiRxvvzRTaK91oeX41lwAAAfhO2i6M0Dksi/tvcUndY+rv1RYBof3rLNz+hT24kc8AMfhOiipLZF5aa2hVsa8+nGrRx7geCP8On2FHtVr7cwvGsDAJTQJRd1ur8wbBsTeDV0v1i6zP6JDCIrKH3lq/3HtrZbz+ZHSq1WOM9ulZJphwNlCwAAzkmZi2J22GSu/ckOe6iRebJnUJ7/6p0kjpC75aI0/cbdL4Nc8nRr/JLtosAoYyoAACAASURBVOjtegGVLspqxfooDhQGivNrB37nAKkKyqlFzbPjeu2eMTnIzFCq2eAnmLG4zv15uihLzY8kg3mytzI5UiiMTBo/DV0YAgC6SKguyrZ5QNM0PTtUWlytHh4TJ0OZjRfHh9V1Tgw//doPvggjZ7GgOnsx7oprfxQUnorCoYOgQ4guqrMt6tL0Pxy7InFKnZNcD/oI+3gLw7s2AEARXXBRTKg50YbOag0Rpfi/f/jOyxdX9zxV2X++LMuyrCfLpC7ibOlvPv+EbobFuouA2QIAgDbpclHUZGpuassxygq1kEDdsUcxomsuKlj52eJCoLfrHRS7KBV4uag2zYMVenjmOWJUl7F4FJUdERcFAABqCM9FMUefaJqm909vPvaY9W0+/8QYbb9/J3rmlAi4Gtf+KCBfrrzR/vFvzM52+raQI8uCniE8F0Vsi1JW3XhyXckjTMxm6pcvt+Miuw4B8a4NAFBF2C7KHmouvHfdxv3p9ld5LX0Jmi9qwY0+fMcpEiq92sAzVHE3iwsAkHjS5KKo4PCXprZdu4DG9lTnw2+sBNraE0e66KIC7CqhXmjQ2/UYveyiLNvCznBPkoCLAgAAkrBcFLvERc9PO0+W2v746U+XxgYKby0n2ERRx9nEtT8KBqmirhpPyLMHEzjeB34Iz0UR26KUnHFpnmzRcZgy16bHB8gK7vvKhLXXh5e3O4NAlyEg3rUBAOoI1UU1D+5QK5P0/PTU26G965Ih/dzPsAieL3KU4xGiiPyopk/fDzNbAABAkiYX1Qk6IrTLgewxkrdSMnQX9VrpFtFf+To2ijoo6urUVGcmHL1dL9DjLooN4qNm0kAgY/EoKjtwUQCA7hGOi2IWGUidxpIaiA4prv1RIMjh/VXjCecfQOoJzUWp3RbFLlJvqXUlQ0rS2uuljVNyEOgyBMS7NgBAHeG5KHY7aeaacdAM712XnFRwtUMq8vX13RvtT3supiU/7NxjdLm4AABpIEUuimwuhaaVyfF04prX8PdFTW2RUz7yx0ZRq+Vys9V9YuGq2M/RPDusVlYXyx3mjHu1Z97R15tn/Ejtzee13fb1Fld3a88dNjw3n9d21425zteuVw/PHD7r/bXMF5fL5cXVqlc4oc7Vjulvbtar7UvNGfceua0HNxsvmCKcM9Z3RYrQstxclNl4Rt6QUPk0jj6utPnsK5EM2JFzUWSgIk3ThpfdTgdpntWpH71cXlytiPzstozRw8DO72j7KZ2hAli7/FHz7PiwelGo9DEpdgQGnJ4/UidjbK6aZ4dVovgWV4Xq2Vefdb7v4yOhgz7Mxot6bff8b3ZrdeFCBQB0k1BcFLXExecyGWc6DRzdlponj+61W7fF1Sp7dgp9jWd0VzJnrFcPJY6NucD3CIhq631MZPu8AxWFJwZnGxR5y74j8kp1qHZk+qbAheW/dqSF0FxUp/oFXuHEHh+fuba0f2pZSpY3kfHzzo29kIvCuzYAQCHhuCjz6cYt2uKPbzw1rRDXXZLa3TlekKp8EX2AQDv8/7d3f6FxZAme72P2Jbid0yR+SCjIboQpvOauEFWsvZTW1UVhbeOZwtsa191ihUGegREqNJcxi8R2P3h2pe1lfGfyxRe6JdrcpuVtzL29srRcg+y6U8YCF6ZVUN0Wa1yQhalqo5K4CD8ky5AP8Rb7kMrMc06ciDgRcSIjlfH9EA/TU3Io/inOifM7f8S3sHbng79cAEqhRFnUwzlhkI1J1Vx8v0Y3Q59AA8ii7kvz4iacClzqu+xO3z1S9x2l3dxeuXJat4av4ziOU5lY2Ihszej/qu6D4h08ERaKEHe19IkU5rSbGwuBNc6Pf/b0lcbTqEvQ/7X9ekPU/qJPo7+33pTE3sEnSxPKZfn+jc/1l3BjaSr8ErrVcwvrkTGWH5JFtZsbC+ox9K/Pk/BdWqnuJMyixJmKHGf8pvZ95B08WQ2uay+d10pg2eaoA5PfTlJvJbNGMmkKKm13qHZzu6E/Zrd6bnb1sTZkNbgDsT/S/4H+RNnRz/jWy6inLEGDi3fwxXrIM105PbUUu1gMgIHKI4sSGwPi549KTHgD9t7V7WergcrD9F3d7203N5be0y4I3XlNRZaQ0n7S1ID+8NvNteX5+atT42N14X3sVutjqg9+EVIhznQG2S6eOWkKsd6sYOIkNUkjglQFqnBAKcqm9Bcra/24NPLKooQ+TlmHAckL39U+vNurLmXOosQlRHpjR42yKL61AViUTxYlL1Z3/kavfSancEWaaSViOlJLx+W1Xuxs3mkszs8vrkY2PXVIrR26nQ/6cgEoiRJlUYmr5hm7hg63gWRRvn90d1r4UJp7aNqEIF579/ytL3X71vJeboVEHTL37PVHoYWz8KtmtrxAz0NFf4qfo/tzoa0w3R++dDt0mQnh107fbfm+9/y2Lv+STqM+Fza/UGCSHaki0RP88tMlViG//excVFIQyKKOnq5ciNlx5ULYMhyFZFHygmXBf6Br+9GrXYoMIiPeTspMgfHLVkn/INCoZnZ7dYdrN4vqRHvtZ6uha6Aec883wldmMXyrG92nmMcZwEDlkEWJA2IyjH8JJb4Br9331cbi3rsmMB+/abHb64saIkMNKGS5Tx3duzb7GaS+eMlIUZQQBkhhlPHykOkL1I60ZVOqi2WlflwaeWVRFodF+b7/5a3zriO3Dfp+5izqeK+dh7ffgd8oi+JbG4BFec3R1+0vLab4fl7hitgPKqaCMdDjOia+tkM63hZxWABGXomyKLERIvG8ASPXV2tAWZT8SWM6H46UYHX/jUEWpU5l6zhCp9662mk1fNpAMcb58aqwz0qts6+a/DV/6tr9lrIeeu/X1gIf/qEXQfi14zefSQ0L3V+s2V1YU708PFvfThG8lOrU871zmZyentRcxIjwSMmiftwQgrrwuxK6fEchWZTUcqlWz3SPW6U2NjY+NT01rrlVEcFh5Ne71HQW30gmTSyoNLbqbm+o2sKn/yj+Y8tZlDPzf30iXcDuQx58JsJXdDFp9dDdpzDuhZ+P2JseOKnsZ1Fy54Icmj3FX3Dx9rf6DiCB3xx8L1dqk9Pz88trm5try/NXlSEzoe/DbDUgcThDjMCVs3IG6S5eUlJfDWnUkDgGuT9uN0qmAtXPVDYlv1i26selkVMWZXFYVEf71e5OYJaCLFmU9Lnw1k2hhm+URfGtDcCi/NaL8lovdgIT2eYRrkirTsS/kQd2XF3SsKjQoecDPywAo69EWZTZynw93tMff3+EX68Dy6KU2fY6Y5wiSTP79efQic+ipAjLqUzMNraluU281ov1GbEHalhzQ7B/sFu/3JDmWWk3N+aE7/p3V+93u7y4Z+fkKVWUH3VCB2eLv7ZWqx2fxcK6vCxV+9Xu2ozcj1abbknXa7W3RoZbPTfdXR5genLshz8X74d06Tu/XZ0exmu92F6Rm1/CWsbkdr/ehVwJ3BV11j7tdI5FZFHy/Hhyu4EUsmqeEN/326921+VbHzrGJ7rhQJpXKqaRTDpm+UlTb69bv7yyLaxo1X69t92Y7d6LwG21nUVFPBMHTxryMxYW4MY3uCj3qfMX1V8Uw2t9vbvem1UqcgwWgEGynkXJCwCGzE+bidTD/+btXv+Uyumpq8fF7tWp8fG/FoeIy+9lt35ZM4+d8krUV6Sy1oD6axPe+aj/Q+N/89m+SlkHydIZpLl4iYnPgFqWRv033a6yFajZyqbEF8ta/bg0csqihKjm3WvL81enxnu9zDp9ma6aLAgbJ30WJX6yRTx14fVnvrUBWJRfFqWVQ7gizfWTtmTNMfSRGhkSzoJMFgUgixJlUfL7Mm6EjvzdNnpdtQaXRfnJlo2Soyuha6bJHH3d2SrqM+thE97LK5fruyUqWVTt0uoz3d7EnqinTp1yHMdxz9/U/qh0VmFTA6kRmDrpRsivDqnaiHs7PrqYeeLkkV0Rg1ECPWz1sy8GcoewCxmcXkZzgQrIosQ5e5SWS/kxioowlJ7TIWlsTMOBfCRRFUXxJ+XHQr29H4ZN9XT0dHV26kpwLsk8sij37PVPQtYPkS9xyHCwuAYX9T6F/UV5L7eWpqaWmJcIGBrWsyh5hr48PprFF1y3UhA996f8Xo4qdb2Djf4KLvrmDEs1oGQN2dbOIPnFSy68gPR9ZcxUzKCVrAVqxrIpxcWy9XSURT5ZlByIh6tMzK6H1JdNpM2ixG+L4Ng4oyyKb20AFp30LEoaFJV+aujcQh9p8pXEURlZFIAsypRFKZ9ZEZ/M7Wc3pZbxPPrPFmyQWVSSZaOkeyRNDmG4XlTrUO2zq/6ENOOZtllf/FWRIyXkiCDyq0te9Uf7wSUFJWGpVu805IaQYKNBMNmKGfIhn4x07XXkPr26oV5y7hD3++Uv0mD0MPAsSsn7xPqjMmvezFZ0hCF3n9amKnENB/LjE77qafiSF/LtNZwtU2I9i4p7xqWWY/1cL9HXTb5PcTE4gGFiPYuS3v+5LEwS7IAREc34vvJejn0ti6Wk/vit1IASNWTbO4PEFy85KYq6dj9wrKari2cuUDOXTakulp2noyzyyaLkQDxG1AKz0dJlUUdb/bBYV7E1y6L41gZgzwnPoqRBURm+Q3MKfbznN5W1vYfisACURKmyKHV0in5arccNdSVh+wtcF2+wWZTpslHih5C4YG70vrMcpbaF2/wrTppiN/pnpd6Q2tW3DZaOFMltEYFGAyWLim0rkYZom6zcLTdaxI1kij8hJeBRb8xgs6ijpzfkKfjEDqKmwVCf1G4VN4pN+xjJVyfsd0p9paV7KIdAqaYIsJ5Fxd5FcRkBfR/tyOvm3b8m3KdRfI0DI8x2FvXVrfNOxPvCBiUhiG13EItdk9ey+E5LPYQgtgaUpCHb4hkkvXjJxa8eLhUaEWVGxgI1e9mU28WKfzrKIp8s6nc/mzrTXZyrUhufutpZVW3zeGG1M+rCXSkD2TRZlPiZFrukW2T1jW9tALac6CxKGhSltGsVeVzH5FlpcuqmCgChypVFBecC63wOjI1PXZ2fnuzO2a0waWs+cQadRZksGyUN9Ql8WtvLomILTvOvOG9rxjE9LKk7ZLZf2yEFYYF0Sx5lFdtQIV0UwxYI6YyCRyzt0uCE5OYZtaFtMFmU1zrc2165Ii+0rjyv8nGaTWMjJ5HB/tgG914KC/Xf7OKPyD8htcLq+oMbGHwWFf8ERV63h3NuzD8HMLRsZ1Fy8/0AsqjY73qpCDUahCKWJDNb6Vo14t/C5nURm2eQ8OIlJx5sWH8bqddHaNt41gI1e9mU28WiYakrp/WifN/3vdbXza9DBqgFVphNlTMmzqKkj+Ow2StMsyi+tQHYcpKzKGlQVGDW0+KOq0Oa/yXlgslUGQBkUbYsyvf99rPGBV01WKww177b+x+ZejEMr4FnUfHLRsU0PA9lFpVk0jfp1+oSjMQfj9IvV7Mb6T/GNlrJc9ibtnFJvyNwSkmzKKXbunI17WdRldqYRPt17DhufU7uICq1vhkMYAsefjDrM7n38lxImkYy8cDkr3o5M0058c7gs6j4yxL1A1JWy9wvwAkzFFnUp4tj4RY/jfoVsYXDt7cv9n/acJiT8MpLm6ZZzKKsnkHCkdRJSSlTeH8bkx/LWqBaKJtyu1g0LHXlmEXFUZKcFOOFEn5OSJ0Fw5NN8yzK51sbgBUnN4uSBkWZTDgzoOPyfV8tZlImUVQZAGRTwizK932/3dxYmjodrCVXTk8tbTz+P/tTXccuBXNSFZBFRS8bJU0wrvsoGa0sSrfbxFlUZGtEkqWRlLYR44YN6QACLSqJsyj5mJUGHvtZlAG3fnlVXdJIboYy7poedW6G914Ko4KNZMKMduqcQVbarU5aFpUsjQUwXIZivajIMiPwCktW6CVaOiZoCLIoq2eQvMaQhDSeOSr/kcMobetR1gLVQtmU28WiYamrwCzKTzdVgSDR54TYOT6yRTJRFuX7fGsDyOzEZlHSR3vmcZ9Wy2bvYEsaEhW9evPADgtA6ZQ0izrWft3cfbDZ8WC3edjy5H4CI7zYfSFZVPiyUXLfkWv3Nd1M02VRXutwb2dzc215fn5+fnpybGxsbKwuTsg+MlmU+tuTZVHpFnWXR1OpvyRjFqX8iwFnUZXTU0vrXxzENUOZH0n0hIZm915aqEppJBMb0ALLV6S7vYoTlkWlvE8AhoP1LEpagM7wnZBnFpW0b4TC5E2eqgZkXhexega5ZlFS4RkzzkR8TrRrQWUsUG2UTVYuVrqnoyyKzaLkMYeJ73CCzwlxnd6YvvGJs6hjJf7WBpDRCc2i5G4t2oatQo7LV+bmS7soof3DAlBC5c6iAuTacbaZXYdbQVmUftko+f8ZctmTZFFe68XO2tLUeMisayKyqOBPm3/2Rv6SYc+i3vzhfNDy2uaD3ebriA5CKduRoq+G4b2XqrbSKhXifwl25bYyROgkZ1H2J3wCkC/rWZTUumtYznkvt5bFEuKjc0KeZTGL+u7EFU15FGXx16GtxhlrQOmyqMxnkGcWJfWb+e4HP92M9NMP+lOH6cKojAWqjbIpw8XK+nSURcFZlDxbQdI7YfwnLHYQjP3oTZtFBZTnWxtARiczi4qdVr+g41KDqA/vvhyqqQMBlAtZlEBexG+0a8dFZVHqslEf/qalFNhhM5UbZlHt5sbCuaq6Zm6fW62P5rgod+5h2iNTf3o4sihl/Sn7WVTKnRSZRfn+71eE2LbfSCZ2+tbUeRkXRQUZOGGsZ1HKS0G3amOyXdgcF2XpFWWjBpRyXJTNRb4tZ1FSJTOp4HNyYsdFWXk6yqLoLCpTndf0T/izJaFVMr1kh1emb20AGZ3ELEruOaobXl3McR3dn6sLC2Jcup1ukSjbhwWgtMiiespVOy4ui1KWjXp39b7Quq4sIpVw397z25fk76pKbXJ6sXHnwW5z/7DVLXBHZr2oyGnfkjUSRc8gZ3RKahiWvLEkcsq/ocmioicmNPvVgUXeze+91KjWbSQToyjdnNRSB9uSZFHyul5UkIETxn4WpaxvlGb+fptZlPTTFpa0s1UDSjCowuYZ5JdFyeFPYoHnJGOBaqNsSn6xrD0dZVGKLEquz6aW5PDK9a0NIKMTmEWZ9bEe9HEdPbp+tt/8FjMj6+AOC0CZkUUdkxYyKkHtuMgsSpkVwjWbMzx23/Kw48rEwsaLlraYHZUsSm7QmL4bsURQbPVAmrwokCqFkZbfCOQriRtLpHZCdeaaocmiYs46RMwFTnDvpXUvOo1kYnOC+hwEf3vaJsMTlkXJ94lJ+oATJocsShpYmqqJwGYWJbUDf//G5wkPRWGvBmReHlk9g9yyKPmmp6CONc5aoFoom5JeLItPR1kUnUWJieep6zvJ/rHxn/A3ty+Gj5MzZfzNUL5vbQAZnbgsSh4UZWs1vIzHdfT0xnnrQVT2wwJQcmRRvq9MXV2OVVSLzaLkFaK6or+nY/YtFf3RCzGOShYltWdEzvpmUD2IzIFMzij4rZy0sSQ6rhmeLEruSGrWDuXdvyZ870fP+RN3qaRH/a3Gl2IHrLCZAKTbm7hZo+OkZVHyfUo1HxeAwuSRRSlNr901K83ZzKJspi82a0AJyiOb+VFeWZRUUzIeCycFWGoYlbFAtVA2JbtYVp+Osig4i5IeksTPSIIqpdc63Df02d/04rGP7vT/34f6WFPzq8r3rQ0go5OWRUmDomrXd+xkPpmOq/3sphRE3XwWsSr24A4LAMiilAWMylI7LjiLUq+6QXkds++Hc/1iNubLazSyKKlxQdMjOWnsIrXXGC2zKVW33Gv31duXsGVJ3l0gUxmeLEoJzUzmgZZvluZaJLv3YivZmyv3+xfu1F89Cvkjkm5v+I9FOWlZlNJ5Pc18XAAKk0sWpXaESdo71GoWFR14JGKzBpSkPLJ3BjllUXLhm6AYiOxrk7FAzV42JbtYVp+Osig2izpa/5Msfw2Jp/w2IjwcKR6NUn5rA8joZGVR3s514T1n8csz9XEpfQDOXn9k89VLlQFAFmRR8swVpakdF55FKctGnZrZirnw0ftOUhhKc/0PaRYVOzJJunq6JqDEsYvUpnTq2v2YhEWubukaYxI1lsgNhJqAZ4iyKHmaPJOYTeqKr6uaJmw4EC9Grda7D1EtgdLtTT4awD+BWZRynyIWowMwdPLJotSyK+HyzXazKKULRvr6p9UaUKLyyNYZ5JRFyUOSE7ULSWemVnEyFqiZy6ZEF8vu01EWRWZRmZszhy+LKum3NoCMTlQWJX3vp+v4afW4lCCqPhc1LHpwhwUAHWXPopT5WspTOx6CLMr3j+7P1V3TwjF639J0FlFfXvKMuUObRUX31pbrFvrnNnnsIv8xRM/jonxWaid9l9cLj9xf+9l/En9Wt4rHMGVRSkNBdM965Wbpx/8lbTiQWsm6ohss1LmpQofoHz1duVDR/E2evCxKbXSuXds60N8o7+XdmbpbuXDL0gTaALLKK4sKvJQdx63PrDcN5izxWo8XhdnZsmdRfuv+NWGETfzUKd7Bk9XZqStqema1BiQXlHHT0Fo6g3yyKDnzSTjTWeRY7YwFatayKdHFsvt0lEUeWZT3/PaV8cnZ1Schd7vzQy/vfig8HKnmeBq2LKq039oAMjpBWZRcsNtc9jLVcXnPb12oiPUM20FUusMCgJ5SZ1EmLfqjaiiyKJv7lubvD1mRvN1cn6kry/QOaxblOE7lwormg9U7eNK4JDZihCQhaWIXaVVhx6ldaui+mNXLGBbFyFmU4zi1S6ua5pp2c2PurPhr9WPkhiqLCswx6Z6d29A0ZXoHT1bEimBoTTBxw4HcxOY4Tnw7m9r+6tYvK/fXa73YWJjoHq96X09gFqWGpp012+Ub1X71uHG59zznUlUHkFx+WZTv+0ePrp9VXqFu/b2l9d2vtWuftF/vbTdmz1Xlf2Ihiwq8o9z6zPoL3TF4rRcbC70jUN9UNmtA8gx0Ys3YO3iyuvxrtby3cwZ5ZFHyXHjTdxOOPoqcjjdrgZqtbEp2saw+HWVhP4sSbrlbv7yyHfwrkR8Z7Z+JmaHKosr8rQ0go5OTRUmZu9EM/jkel/f8tthYVLu2ddB6bbIuoPECgKkOCwBEJc6ilG6JJasdj1wWJU+Z4rhn59Z3m6/bvu/77df7eztrS1OnK8ffgO9feDNyV0OSRTmO4ziV01NXl9c2Nzc3NzfvNBan1caw0DE56WIXtXnEcatn+gewtjwfOIDah3df6qst4gmfqtXc4/2dm15s3Onu72r3rvT3F/LlPWRZlKZrvVOpTfbO7U5jMXBu7vkbT0NeMskbDuRVMAxrvYHb6zhutT7WUVfvrHInTmQWpbtPjlOpHZ/zWE29RckWjwGQl1yzKN/3289WL6nvw977YXzq6vz8/Pz89GTw1dj9sYm/+52yy3RxijoaxekUJvPHBe+dxuLVqTPqMdQWPv1HcScWa0DKxHaOU5mYnp+fn7/6XierCIYZVs7AfhYVswhlPGlAUXDkcaYCNVvZlPBi2Xw6ysJ6FvXi7yaUu+1Uat0Xzfz81alx5Z4bVkg+XRwLEPfUfyZ7Fj9NdQapsqhyf2sDyCjHLOqrX3wQeHlKRXe/RO764BdfhexMftVlWj4z+3GptRO3WlWKl3DupV/pu7ZavVwA4Jc4i1I7cpatdjx6WZSuWSCocmHl6ZHYSXRIs6jxmev6VjLlbMLnFEsbu3gHnwT6i4dx6zNhQZRywm81nga7oQeFB1vDl0X5EW2ZGp0nz+TATBvh5AW+DGelNry9uqM9oVmUb3qfop9mAIOVdxbl+77fbirDEMxUTl9p6N7nqeOUo6fyCNqYX68rTezVgNT1G4M0p5b9DKxnUdIO0/VRlgcgB6fBzVCg+r6foWxKerFsPh0lYX9cVGCgfCT9RAIa2m5s0VLe2BRZVNm/tQFklGMWFZi/JV5ocWtzUFTm45IGtycWdo42LxcA+H5psyh56uoyzss0gllUd2L9sAJRaD0Sev0OaRb1VuPL6M/W4Hww6Y8swDt4IkwNE/L731vSzUoXcsLX7vu+3362Gr5Xt3458sN7GLMo3zdqy6xMxCwPkC6LErtsJ+qA5R08aVxRx6N1b0P1zJWVbe2NPblZlO937pM6pq93g2qTC+tfRN8hAIM1iCzK933fbzc18+/pudVzsw39C9L3M8YpR09XZ+NyscrpqfCC11YNyPcD07uIl6B+WZvDZT4D21mU1FvDvXY/1QteDqO0BW3KArUnVdmU/GLZfDpKIY/1onzfbzc3lgLzAahPzTl1vsYoQ5xF8a0NIKMTkUVJg6IyT7GR9bi+unU+6b83OEeyKADWlTKL+h+/Xfvf53uWS9kImU8W9btf9q/rL9XZawazb+/gi/Xl6cnuqGG3Wh8bn7q6vL77Svyw815uLYfvSvxVP30QuQiP+KMxp/ztg59G71bXrt49neMZNyq1sbHJ6eW1He1qDGmPLET71e69xqIwRZFbrY+NTU4vNu7JVzP2hBdvf97tIKQ/ofX4HUqXL+3Dlf2i6HmtFztry1enxntToxzP8mR0q/xEj1yXWCcMdtc2Oeavdx9sri1334Nrmw+6s/boGdyB2B9JeBdjL0vS69Z+vbezeaexePxcNu5s7uwlmxobwGAMLIs61n69t3OnsTg/PSnMcdWZ32pyen557UHIWlKC2FI+VmhZsti4F//77dSAutrNjeXpyX5ZPT71cUOzxo2tM8h+8STNez/u7W15/VnqNvCjp6uLvR3d+G9fh/xY4gJVkbBsSnexbD4dIy+nLKoj8FeSsHotkuq1ZlLeWOGpM9kD39oAMssxi5IKUjP64lZ82S0n6EmQ03Gl+Pfx52jxcgHAsVJmUcgri0IW+Sw2jJEkLReVJooCgGE26CwKALpyzaIAACZyzKIAAIUiiyopsqjhQxYFU+LEQRmnpQaAIUQWBEM7UgAAIABJREFUBaAoZFEAUDiyKAAYVWRRJUUWNXzIomDom9V3e4/Kqb96xLwnAEYNWRSAopBFAUDhyKIAYFSRRZUUWdTwIYuCGXFNdu1i6gBwwpFFASgKWRQAFI4sCgBGFVlUSZFFDR+yKJho3b92igcFwGgjiwJQFLIoACgcWRQAjCqyqJIiixo+ZFEwIM7P57y7+k3RxwMAOSCLAlAUsigAKBxZFACMKrKokiKLGj5kUYgnzs/nfvibVtHHAwB5IIsCUBSyKAAoHFkUAIwqsqiSIosaPr/75XzPTx98W/ThYBg17/2495D8/aOjog8HAPJBFgWgKGRRAFA4sigAGFVkUSVFFgUAAIYTWRSAopBFAUDhyKIAYFSRRZUUWRQAABhOZFEAikIWBQCFI4sCgFFFFlVSZFEAAGA4kUUBKApZFAAUjiwKAEYVWVRJkUUBAIDhRBYFoChkUQBQOLIoABhVQ5pFvfHG6bNn35qY+Bdvvz3Jlsf2ox99VK2+8YMf/KvCj4SNjY2NjY2NTdx+8IMfVqtvvP/+nxR+JGxsbGXb/vRPp6vVN9555/3Cj4SNjY2ttNvZs2+9/fY7NAmysbGxjd42NfWB43zn4cN/sBIhWcui/viPa9/73j/tdIVgy2n71//63xR+DGxsbGxsbGxswe3y5f+t8GNgY2Mr58ZXEhsbG1ux27/8lxdpEmRjY2Mbye3s2bf+6I8q//W/blmJkKxlUd/73pnvfe/M5cv/5sqVGbY8tj/7s3/rON+Zmfnzwo+EjY2NjY2NjU3cLl36UbX6xg9+8MPCj4SNja1s249+9BFfSWxsbGzFbm+//c7Zs28VfhhsbGxsbNa3t99+xxnCcVGsF5U31osCAADDifWiABSF9aIAoHCdvvOsFwUAo2dI14sii8obWRQAABhOZFEAikIWBQCFI4sCgFFFFlVSZFEAAGA4kUUBKApZFAAUjiwKAEYVWVRJkUUBAIDhRBYFoChkUQBQOLIoABhVZFElRRYFAACGE1kUgKKQRQFA4ciiAGBUkUWVFFkUAAAYTmRRAIpCFgUAhSOLAoBRRRZVUmRRAABgOJFFASgKWRQAFI4sCgBGFVlUSZFFAQCA4UQWBaAoZFEAUDiyKAAYVWRRJUUWBQAAhhNZFICikEUBQOHIogBgVJFFlRRZFAAAGE5kUQCKQhYFAIUjiwKAUUUWVVJkUQAAYDiRRQEoClkUABSOLAoARhVZVEmRRQEAgOFEFgWgKGRRAFA4sigAGFVkUSVFFgUAAIYTWRSAopBFAUDhyKIAYFSRRZVUGbOor37xwVjPB7/4qujjAYI+XeQhBQCyKABFIYsCgMKRRQHAqCKLKqkTkkUdPV2dnRwbG5ucXX1y4GXc2ZeNt5yetxpfWjlCnETey62lqfGxsfGppY1mu+ijkdy/xkMKAGRRAIpCFgUAhSOLAoBRRRZlS/v1/t7OZtfO3mEra3SSq5OQRXk712v9dnmnNvewlWl/ZFHwfd/3v7l90e0/Ce75W8P0KJBFAUBBWVT79X5z98GmaGdvf8jrcwBsG40symsd7ne9TtbxSv6qzfZZG9hX0oMBUFInMYvyWodiTfLBbpNaJAAEkUX5vu/73su7H9ZSNgC3m9srV05XnAC3eubKyvaQjbroyiWLEpvRQ1RqY+NTV5fXdl7Elsqtu9PKP754+9sshzeSWZR0za/dT/JPR/J6GPj8xvfl5+rU9Z2wnz169Pfz8/Pz8/O//N2Ajo4sCgAGmkV5rRfbjY+nzlRdJ0ylNj61tL77ajhrdNZ5z3+9OD8/Pz//0weZql1D7ZvVd8Vb/O7qN0UfEYbHoLOoo6c3zvfeP8kq86G8z2+8mfgLwTv4Yn1pSvdVm/yz1mu92AjZl1M5PbW0Ef8pCKDUBpxFZXsTt189Xp09p61KutVzs6uPzeqQD+fCK6MByYuLJOdo0LRn+egAlAhZlO+3nzUuiBXlBA3AR09XLmjr2ILKhZWnR3kefypFZVHihZmYXY26Ml/dOq/8i4xN8yOZvZBFJRas4oVet/4zOLDKFFkUAAwoi/IOvlhfmIirxgnc+uVG9hmDh16vmBzhUkiqAjkOYRREg8yivIOtubpYMbVS4zy6f02cW8Jkp97LuzP12EZQs89a7+XW3NnYfblnr38y+u9TAGkNMIvK9iY+etq4VAt91XXVLq0+i8ujgg1gUZIVF0nPkSwKQI5Kn0UdPbqu1pVNP73Van6E2rX7QxZHDUEW5TiO41Qu3Hoe9hWiNhS8ufL7TIc3ktkLWVRirfvXTonPlfvhb8Imf9y5firVpc2ALAoABpBFeS+3EsVQQqFRn7n7cpTbT7+9fXHkS6Hfr7yp3teslUyMkIFlUd7z24EGTAs1zuAnatxOveeN88ad8WM+a23uC0CJDSqLyvYmTtAm6LjnG6FNX77vJxwWVVv6LM9zTHQsGmRRACKUOouSZubrM/r0VuvZlYnZxvZeZwJsr3W4t92Yldo4YgueAcs/i3r3J5uyO43F+auaSXDc6bshXyHewSdLx1excno2c9PPSGYvZFEptJ+tXu70CnKr70f07/S2ZgZemSKLAoC8syh1QHy3KlebnJ5fbNwR6y3Tk3XNjCvuhZ9/lcuRDYPnN8dHvRQKTNbrOIRR6BtMFiXNlZS2Mq8hL4tqslO1KbUysbDWXSOq/Xo/8FXruBdvh40jDO5rtrF9vEZU+/X+3s7a0ntSz/yIfQEotYFkUdnexGqboFt/b2n9eI0or3XY3L2nvj5r13fC27SEYVFv/nA+0mLj/zNuHEt3jr0Jm81dmfhu70qE9/YFgDJnUSENEY7Rp7c8B7d79vojTXO2d/CJNObqzRufD08alX8WFVq4tV89VmY2jCyqvNahpYXDRzJ7IYtKq/06diln4QqRRQHAAOWYRWk67VcmImfyb7/aXZeaT0e78bRfDo1oKeQ9+qve8Ojvv/VW7/8+9VePhqeejiLln0UF5kpKW5kP7Fh4v7mu0bIg8nwBYbNIKW2ZIX8t3s51IYlyz9/U7qv97KbBvgCUXO5ZVOY3sRz9165t6aYd9Q62pIg+Yk7g/lAkaxWw3EqboKO7071fNFQtnwCGUEmzKHVmPrdW69fC49/8UqkTPqxH/clhmoy+wCzK94MtQQO5MiOZvZBF5Ui4uGRRADBAuWVRgblUapcaZqt6egdPVt6vuo7jnr81yi9noXIwmqWQd/9arwZ66voj8X/RJA7f93PPogJzJdVqwv/MUuP0nt/s/fm60zd+bNKl6pvVd4Wa582IaTykDwdtR8Jvf3Wp/3kX2ftf+q2nru8kO08AZZBvFmXhTfzZUv9fRPZSEvvAOM7F29/qf0wYFmWn7SG/0iZI7NYw2l22ANhQwiwq0Degdmn12SfXE2RR0izzcSmKVNeOrJUPVMFZlK9cmPAi2aKRzF7IovIjLh5KFgUAA5RTFtV6OCd/lOv7sIbzWodxQ2pPOmGBgJEshVq/+VAKn8T/zZQy8H0/3yxKnZjDPXv9k2erF/v/j/Q1TjFpr127f2Q0vF/8GohLY1t3p/vHqQmQ+mvNxf8xSfsayVcNgIxyzKKsvIl3hBbEuGl+pbmBw3Zud1hUjqWNRpKyBABKl0WpfQPc+tzWgZeoAVjq1mDwohU/cofnxVx8FiVHId+/8bmto2i/3u+RJvdLk72IO8va+mRzXz1FZFFe69DGmYi7yXY9crmycv0yTV1NPCzjeSbJogAgpyxKnmB5gCt59ss7kzJKLB0zzVGcqhQSW5PTlkLWzkDemZUCXjy/TqVcrNef9DAqwcVK9XSURW5ZlDoxR+VC41lbqZGnbR1UkyizqabFP4j4jzHpQAP9CMV4yb12P+aZEvdFhRdAUF5ZlKU3sRgvxb/ExG/8kJ3bHBaVZ2mjIc31OkRzQQEYWuXKov7H/ztbCb6SfT9RA7DYQG0ULYmTgQzNLARDkEUZ/Hii0rLd3FiaOqMuMe5Wz1xZ2W621b1F3+V2c7sxO1lTFxRzq2emlta/SNSJ2mu92Fie1u2rPjnb6BxZBoPLorzWi+3GrG4R90ptcnrZ/LKEXNxKLeJ6fLo41jE++/98I+/pnHpAldNTSxvR1zXy791rHe7v7+1sbv5EGLn37k82A377B+11OvhiXXfDO09PzIGRRQGA7+eTRUl9g+zPZf/VLz7ollR//bAbaHgHTxqXpcH4lSv/9/+v/fftV49XPw5WY5xKbTxR1SNlKdR+vb/f3H2w+bOr/baV71/9WaDo+4fnoWFNhjPIevGMiYPyu1VyqZNZ8iYUr/Viu7E4PTnWv+SV2tj41MeN7RcmEU/71e768tWp8X79yq3Wxyanl9d39WuYZblYGesoZZFTFvXi7ybES37cH9K30joozgrfnYbDJItq3vlovPPoVi78PL7WGVlL/eq/dPfl1pdiZwIhiwIQLZ8sytab+B8/+w+TY52Su3LpV7FVB4Msyt5ynXmWNjoMigKQVLmyKGFFPbc+c/dl/zVp3gAsja+d2TJ500qzEFgcAJTFaGVR3sEnSxOB72qpBL58+/lzs+zl6OnKhah9aWkPLtgwoFGZWNh6mb7AHkgWZXQijlOZWPokprEs/uLqr0dg5Sbv4En0nioXVsJXAAn/e5cuSozA5W43NxYin8POgTW0CznHHhoAlEcOWZTY/z+PATBi+XFcUj2/pSmoNEW1Senh1i/HLmyVuhSS6hLR9CVT1jPIcPESEX+PUCEXu5klCaNiT9utnouoGcXXriqnr6wG7lbKi2WjjlIWeY2L6g/NlGupWVsHpWV4+0s+Gc3Rl4g4e3XW+dXFkx7EVO0ATpqcxkXl9SaOJlS0Qjqn23xlD/QcpUFRtF8AMFK2LMr3jx4tT01eUb+GjRuApaaM87e+MvqdNmvulgxBFiVdSv1FNyot9V/gQW6tJqwZGXKXj+7PKa0ClVqn82mwD6koeHDqDL3HB1GtjwVHFmWYJyj/LEp/ImHc8zdC28qkT+Uowb68wmm+1fgysAxn2LGEXdYcsqj2s1WTY4o5MLIoAPD9PLIoqV9QHt02xfJjZsuTZswSjN+U67aBVUw7KjVdxaMz85ZWplIoUxZl4wxSXrykxAVfpbUdxI5mcYs+RJ+2hnv2+qPgSZvXrmqXbku3K8XFslVHKYv81ovynv96dnJS7XWVrXXQe37zLe3ds59FiamtO/cwy67ENzL1XQAaua0XlcebOIZQzQibwtTesCjfH+Q5igPOT/pMxwAGpnxZlJ5xA7D4tWpeCRd3Pxyz9BWfRcnraMX2DgnbofoF7tbfW1rfbR7Pk++1Dpu760vvBVsLtHdZ6tTh1i83noidWduvHjeUT3m3Wh8bm5xevP25XOqqqUtlYmF992thqpb2q911qXtqRPtSpJyzqEB85NbfW1rb2dvfP2y1O3PZrS1NnZZaU0JaMeR1Otz65cbj3hXxWi921ha6s+115xbRn6Y7Pde95ZXTU52D2d/f1x6KU5t7qKsPhf+9e89/vTjf8dE5Ibt884fzAb/8Xe+ffb32nnyZqudmG/d2m50ja+7ea8xKnZHd87dC3jJkUQCQRxbVXxHaMVnLJDl5xqmn3XH4Krkbk1KJceuXV7b3hKV+vNaL7RVx6ExIEZuxFDp69Pfdou2HQlF96txHgaLvpw/kHlV2ziDVxUssYplxMaUymcEgkP+41XPTy2vdmQzXlqfFGYQD9Zpg55zK6amPG3eO//mdxsdifca9eFscq5X4Ytmro5RFflmUXpbWwdbDuVrInbOeRYl/JtlaHMWPAuX5BoCO3LIovRyzqCOhpNa0dKi//trG6/3m7oPNzc215fn5+fnltc3NB70Grizsn6M0zbFhZx4AIIs6ZtwAnK6lWHrrm03sl7OisyixD194/+TY0lL8AHOCXUf7v+7l3Q/lRgPdzZM+sabv6rIhqfUg7DNMPjn3/M2w+U6kRSVPXbuf4qMu1yxKPhHHPX/jiX6mmaOnN6RGFc0qHNKyaSHJm3fwZHUxEOwFTtNxHMetz6zrljXwDrbk5iFtlcjozzhRXa1fw6xMLGgXXPAONmaEcCvsmSeLAoAcsih51Ov0Xfv9NsXfMH7xYqcoqlz498KiQV7r8FBcQehoSywXate2QmZzk0cDa8uGgkohW2eQ4uIlJrWXBA5BrALGjpqTT9upXFjRVY/azfWZuqsJ39Talb5G052MOFBlSn6xrD0dZXFysigxFD01sxX6pNhocpT+grJEUdIwPcbhAQgxGlmUd/CJ0OIT3v/YZIR65fTU0obRUpQhrJ+jNChK334GABpkUR2mn97S69t8tj3zlXkGpdgsSp4JL7w/XFxpKTct9SdI11H6oGrugri38E4d4peYvmO1uHxw7HinL28JM7yneDLyzKKkE4k7E3nYU3C9BbE3cvJJduTKmX66m96RyG08ugYV+1mU7x89XV2cX1wNSet835cra2FjAcmiACCHLEoqRnJZujM4x2tcublzvR/PxDXIin1v9H1XCiiF7J1B4ouXnNQlRrMolPnK29Jpx513uxVoNEpSu/JarUBylOZiWXo6yuKkZFHio6R5COxmUdJzq+l0FstrHapTGEQu7gqg5E52FtV+3dy915gVBkkrC9ZH/PZoBmt0h7F8jlIXhbABXwCgQRbVkSqLSvD6HroG5qKyKK/1Qlk6OeojPuZyi/GGQR/OuOxFnAcuYvpFb2sm8l4ajK6SdicU4SmGNUvXvLu2lRlp3SrNmYgnYjJqS6qMBM5FPNDkQwOlWS7Vfp8xR6JpUMkjizIhLVeiT+SG7lUBAAWwnUXJq0Xl8nZVmxHiPsqlqYoNWnaFqCD1kAS7pZDFM0h68ZKTDlYTRZmveCDtKUWbvFS7StOLOK+LZfB0lMWJyKKkTnbaOaltZlHiDFNhM2CH0TWxutVzC5l69wMYeSc0i9INcKqcvtJ4/Cpqjj3Nvzpu2tGuWp6yw47d9g2pD4u2ZgUAIciiOsiibJCK0OACO9OTUvrhOI7jnr8R1R8u+nKLa3eZdHJOkEWZztOo+TlpWV+TBSnEnrrmQ+00B5NJ8EySXl5faV9R/omUJiWe+yXhH5AcRgUPvqgsSr6o2n0O3asCAApgO4tSxlHnn0XFLoHy7e2LCQ9I+AWpR63YLIVsnkHCi5ecdLAhlS2pUSV0Gkc5ikre9iJ39EkzF15uFyv+6SiLE5BFSZMAhCSi1rIoeW6JxE2gwSzKrZ6bXl7/ImXHfgDlMDJZVOX01MeNbd0EuQKv9fXuvcbHVz9u3NnZU+Yk9lpfK2uNp1za0Wb7htTgUvapfQEkRRbVQRZlQ7JcxGB0ceTl/urW+f5/NGmWGci4qOc3x/u/xGxBCuG4on6vXm5ZVOLL6/tKM4a8S6kZKGxtBaPTNPkDknvAB+5DYVlU/D6H7lUBAAUYiizqD7/dDPfbP0T9itiPcrEuYTpnoFBAnL/1lcm/CLBYClk9g2QXLzmzmEmqqYSlTNKY/OTltPQ7jLosBeR2sXJct/2EGfosSpzxMnyCCUtZlLgmVapheOFTTyX9HABQJiOTRXXf1iHrXRtTluhOMUjeYjnPoCgAWZBFdZBF2WCWi1Rqk6Z94SIvt/TbTFKfuCxKbB8wWy8qZva3705cUceG6Xx0rt+skbhKIF2Fd38S0WwW8LOrocGRumPT8VpyBCSfjDS7h+N0pudY2zGbnyPxH1BEKma6O7IoACjKUMzRF1mrCbzCky0NKv3099//C5Pqwg/fNN+/ya/NVgpZPYOc11WVZk+OaLsxCKNS9dQRPJwT6kLJR8P7fo4Xiyyqa8izKDEcMpzqPPXtVIZEXboduSpclPbr/f3m7oO15elz0jQZ1peGAzAiTmgW5fu+73utw/39vZ07jY/FNfLi19aMI7eoJI6ArJ2jPCgqfjEHAJCRRXWkyqLMPyFz/sZOYZBz9F2dGhenuY1ctVEWVVpKrQFGRWnsXZCWCtDP4C99kmk6oyZYdVIrWxaV7F9HXo/kl9f3faWNRd3nl7fOK3M0di519dz08vqu8QzKSScC0gw3G2QW1X69v7+/v7cTzP/IogAghO0sSi4tDSOEPLOojKOaE5QPeZVCVs8g33qyaRSlZJbabkk2h0WlrFvYvFgJn46yGOos6pvbF3u16egZGjNnUd7zWxf6X3BZm1CF/R48ETv3p5ppCsDIO8lZlKjdXP9QHF2abMU9ldTjNmmXFlvnKBZEaZY8B1B6ZFEdqT69zb//hq+nYf5ZlHSa3sHGjPDxbjrBQ9R1S/4pHv8vvJ3r/XqCW59ZlwbteAdPGpeE/677/suYRdWWPjO4LKK8sij5RIx3HHONvZd3Z+q6PKpzwd9b2ggZt54ti4ocU5dDFtV+tftgbVnJYIPIogAghPUsSi4VDKfQ/fmF8Ld4oVmUe+lXUa0PAymFrJ5BrllUkoU8pdWgdDMPpho13ifPr5du2a+MFyvL01EWw5tFyX3iZrYiRxRly6K857fFr576nN3hS9LMfylmmgIw8kYli/LVIabZwhuxUpO0HmHnHOU2M97fAFIgi+ow/vQWOyKYL+4j7t5wTv2cDTiL8n3/aCt5GjXoLErtAeg4jlutj42NjY2N1aUJJcJmlJB+R9rlHJI4WVmU7/u+d/DF+pI8WF26sNrpP05IFtVubq9cCT01FVkUAISwnkXJ41ksrNNjMYtKvlZkmEGWQlbPIMcsSppHJiHN+PcTnEVZeDrKYmizKOkHY6cCFyYB789WMT8/P//L38UdkffyrtSNP4959MSTSfdKBjDSRiiL8n3v/rV+Y1Kmek6W47RyjvKgqBuf8/YGkBxZVIfxp7c0e4dp1iC99M064+Zt8FlUMI2KH55snEUZfc4bfrx7L7fmzoaN3XEcx3HrlxtPQz7JpOdjEFHCkM3RZz53jdd6sbO2NHWmGrzUmicjWxY1flN5k+SQRXkHnyxNqC08brU+PnV1frFxZ3Nzc/PBbvOzvxmP2SdZFADkkUVJrQC6kCGezSxKmmPFRpPHwEshq2eQXxYlDXRKLPicnMw5+mw9HWUxtFmUXDtPLebmegdb1/IOonxf/mOiygtANVJZlFz+Z9l9wVmUPCgqcqJYAAhFFtVh3gD8/KbwoWaWK0n5RKBZvBhFZFHJ06io0lJeh9zKelG+7/u+9/z25c40cm61Ls1f4lbrk7ONbWnevgBxwSR7PZ3D5ZVFyTs2DVC9rRnhX81smbT0tV/tri8oLSSRR2P0uSodfiA0tp5FSTONOE5lYraxvfc6ON+gxVXjAWCE2c+ilFAizZwiNrMoqU05+zDqAkohq2eQWxaVLYrSPCdZBzZlHFcVOASTi2Xv6SiLoc2i5Cw0tchfIT8utQ9NF/lNjgcOQJTRyqKsfeUXm0VJg6IM190AgACyqI4ERUOSaed931e64qacj8O6YrKoYBoV3dUusrQUUx+j8tzk4/3LW8dT+brnbz47/kz3WoeHkfmTSOrxMoD5GHPLoqRGJtPHVuolnSh2PXoqrmIcaJ5JWneLaSuynEXJdbIP10MWvTLaJ1kUAOSSRamTtSWfVsRmFiW3KWccMl9MKWTzDPLKor5ZfVeoDUz/H5tG/ka4nIEzS1z7lEm1KwtzRcYfgc2noyyGN4vyj56uLkbPzBc7R9/iatjsDoEgSjtvdojOHNxnqm7l9F/Hznzh+77cv3M4prAHMEyGOotqN7cbs5O1ilt9/+dGNQGpz26WSpNYDUlaC8lazkuDopx3VxkUBSAlsqiOJA3AUhgV369W6pI5LFFUYVlUsjQqsrSU5zkxKNDjP96Fe2U2pifut2RbmNJEblmUnCuZnUim3sJSI6F6OAkTGqnxSdPUYzeL+v3Km/2zjp72iSwKAEzkkUUprfKO89ZN83ZW37ecRUkdlbKt/FxQKWTxDPLKouQoyrhaIqeWSluLPCw/eUOMVLvKPldk7MWy+nSUxRBnUSl3a7TTo/tzdeFv+nwjyQtS+t41+mxINe89gPIY5ixKLFvNakDplp0PEtsiE7ctZixtju5OCw2baWowANBBFtWRqAFYLHpif3rA0YSp4rKoJGlUgmaf+DqA/Gu19004gaQtVH1yy8e1+/kuD5ZfFiU/5waVDe/zG8n+QcTxZMuipCPXPRlWsygpFI3JMMmiAMBEPlmU7z2/KbyFHad2bevAvKyymkUpgUeGF35hpZC1M8gri5LrMQlabKLDKGnav+TD6+Q6yvTdxEvxJLpYdp+OsihjFnX06PrZ1EGU76vhdPyDLX0vMSwKQMAwZ1FKI19sVUCuV6QfFpUxDcpU2siNPTRUAMiCLKojWQOwVAZE1da9543zierlA1NkFmWeRsWUltLnfHQdQJkCLj6Lchy3/t7HjTs7e/v7+/vmc/T5aiuF0Yq/7Ve7u+GTpkTJMYuSvxLj0jn5WU9TOxE7+ajNJeJpxnwfKweincY4eRYVsaaDNN9OZM1SOTSyKAAIkVMWFXgRO07tUiN8wiqZ3SxKDSVM2n691ovdL9T0LL9SKDa+sXQGOWVR0tElbOuWJiBUepIpkz1GVY+8l1vLgRnR5NrVqZmt8Ofv6Onq4vKWsl5Pootl9+koi9JlUfJnkjBPeRJyM2X09493sD4tRrpD01kTwPAY6izKvEXQ9/320x/H9JT1Dr54sBO9LLmvTqOaoraUpbSRTzjbaHgApUcW1ZF4OZpbUnO3dl1X7+XdD4XCIkUPsxwVm0UF0qiQL/G40lKZbSekf7P38u5MXWp5CrvL3/7qUtwS15Xa2NjY5PT8YuNOeHVBfjzc+kz4ur/ewRfrCxOV1A9InlmU8lXp1C6thnybKs+6NgA6erQ0OTa5sBGSuYlPRLByI51mxErK3sGWtEC3e/G2bvac5FmUckjt18Ki3+KkzeH1skAcShYFAGFyy6J89VPecRynMjG7+vhVROOr13qxvXLldCXqFZ4imzybAAAK7UlEQVQiTmk9nBOPpHJhJTwWaze3Vy7XXUfTxptbKaS0EHut12q9x9IZ5JFFyYlR4rZuaSo9NchSqp+VCytPgvXPdnNjrjPQRK3gyestOG59RrOIk3fwpHGp82PK9Up2saw+HWVRriyq/eymGESdvf4obddJqaXScc9e/0Q77rTdXJe+GoapsyaA4THcWZRpS4l38EQuYDUdqLsVU7d+uaGpT/i+H3xzajvc2j5H4TSks6UDAYCMyphF/eG3wWWKfyJOE3D1Z+p//u0f1J2oHWvd+ntLazt7+4etdutwf29nbek9Kf4YriSq+CzKLI2KLS2VKoDjuPXLK/d2m8f3obl7rzF7ruoe34ILwi3Tf7x7z29fUlqoIlUmlvSfWd/86pLYZOW41XOzjXu7ze4Aq/br/b2dteXp7sF1/K9/+9/jr7Is1yxK04G8MrGwtrPXPQ2vddjcXVef9fqSJonq3W63fnllW2506bfXOI6jrVkpWZTT+Ytb3212IyGvdbjXbeTq/4w+iTINfKRe0U7tUuNxc39/f39vY2Gi4rjnb3X/nTIQLlAPbb/aPc4bHcd1+z9KFgUAIfLMonx1OqpumVE9M3V1eW1z88Fuc39/f39/b2dz805jcXqyVlF/1k4W5fvezpJccFVOTy2t7eztH5duXuuwuXuv8fGUlIO5M1v/KOzEaikkL8bpnp3b2Nvf399vPm5crrtObe6hEmZYOYMcsqiMUVTcRMWBQLMzmP74s+GOer61hU+l8w3UrpzKxPTyWvezQ60fuhd+Liymk+xiWX06yiLPLKr1/B8Cn6E/uyokn+/+RP3P//A8XfdzkyxKfRTPfPTjxatT42MGJpeCoZUS0/a+j481d+81Zifk96nRBBIASijHLMrOm1jpWeI4lYnZxr3jOuT+vqZNUNsoKMf4x/WoB73dNHcfrC3JlQqjtkWrpY08KIoOBACyKmMWFWzWjqWtwQf7EIZxz98wnQBmUIrPogLFrqZQM+i5Efyc16pcuPXci1qQqKvd3PyLM0Z3tSvkG8p7fuuCpvEq6hAjehOHyjmL8kNa7EK59Tnd5fh67T1lH5Xa2Njk9Pz05FhdyuM0DV3KaZ6q1UyOJ+qvzizwCVQvlV/QS7oCP+hW65PT8/Pz89OTY/0mTLc+t/Vqqz+bPlkUAITIOYvyfd97ubUwkaiY7r/jteNY0sYpR/fnAmO3Y367OjTYZikUaExWaLqLWDgD61mUnMCk2qM8AeG1+8ppG/deChkdb1y7ClQPE14sq09HSeSZRUm3z0zav4j4LCqmphtHt9dknw2VC7eGqq8mgCGSYxZl602crCNzSEOJ9/z25STVKMPhqxZLG2VQVOKFMgFARRZlJOyDrN1cD87+ppQV2haLwg1DFhWfRpmNIj56uhKZ+vQHLwkHqCtphR25Z+c2XhweHndF6fVzXZyfn55UshPHqS19pj0w7+BJ9JH1H5Lw4dgx8s+ifOMWO7d+OWwSP8N9VCY0fSzV03yr8TyuwhZ5JIHdhZ95cCIn8WAv/O3n3dQsNnnsvQeEHudkUQAQIv8syvd93283NxbOqYV61Lu8em5hI2SC3gxxikFt8rjgmQiZ6dZeKRTTycetz/wmMFdA9jOwnUXJUdS7q/pB0jGipurtOHraiKyOuNVzoVMT+wY1o8rpK5rqYeKLZfPpKIfSZFHSVJTJhey1/WzVoF3Vrb6vm9sSAI6dgCzK933v4JMlg4aSyunZqEbBdnPDqINUZWJBXUQy/3OUB0WFTTwDAAmQRRmJ+iDzDr5YX5o6E2jKcKtnppbCWiwKNxxZlO8fPVoSW4Hc6XXxq8R8Rtt2c2MhOIlO5fTUktgI8O1/udz9kUBJK7S9xA56br96LI2Ji/pIDHs+HMdxKrXJ6eX13ag1KuIMJIvyfd/3283txqx2oiKnUpucbWwbRK7tV49X9ftQb1XEaXYOtd1U1+7oHcpq7KdtgsBH19CkPVjv4ElDc0CdHxbeA/3pG8miACDEgLKojvar3fVlTU8ToWgZn/q4cS+6uM4ap0SUsm71zNTHje3oKqWlUqizL01I4lbPxZSvGc7Achb1zWp/6u3K6YW0U4DJA77+ZF27G6/1Yrvx8dR4f4hRpTY2PnV1eX33a5NvgOOnrz9I3K3WxyanFxvbe6/1z1uai2Xz6SiB0mRRKb6JRREPScTnj1s9M7W0/gUxFIBoJyOL8n3fTkPJcYVCv5vOizNRs5G1sV/CoKjQjsMAkEwZs6iceK3D4yE0D3ab+4dDmkF15ZJFFa/9+vge7Ozt74d8w+sJ7RbqEtV6iVd+bL/ujbF6sNtMeHhDxGsddhbROL7MaR719uveLsz+WkITmv6eEt/yBLzWYf9vO/qX9B7BE/EeAIDhNNAsStB+vd8rn47XjRp0aZ2xlLVYCrVf9wvYJDuyUU9ALqijmMkziyqbUfn8ATBwOWZRebFUARJ2w4sTwEgiiyqpEc2iUvO2ZhIFS37shH+widFCAFAmRWVRAEAWBQCFO4FZFADACFlUSZFFyb66db6XdVy8/a3BvxCmWD91fSf3Ayw5sigAKBOyKABFIYsCgMKRRQHAqCKLKimyKMXO9VP9sONm9HJRysLeb678fjDHWGJkUQBQJmRRAIpCFgUAhSOLAoBRRRZVUmRRCnFRRsdxz85thKyw3X61uz53tr8Ub23uYWvQB1s+ZFEAUCZkUQCKQhYFAIUjiwKAUUUWVVJkUQGthwv1fsTkOI5TqY1PXZ0XTE/Wq9KP1C7djhtCBRvIogCgTMiiABSFLAoACkcWBQCjiiyqpMiidI6erlyoOIYqE0ufHBBEDQZZFACUCVkUgKKQRQFA4ciiAGBUkUWVFFlUmHZzuzF7Th7+JHOr52ZXH79qF32kZUIWBQBlQhYFoChkUQBQOLIoABhVZFElRRYVw2sdNncfbN5pLPZm6Fte29zc2TvULyMFAAAsIYsCUBSyKAAoHFkUAIwqsqiSIosCAADDiSwKQFHIogCgcGRRADCqyKJKiiwKAAAMJ7IoAEUhiwKAwpFFAcCoIosqKbIoAAAwnMiiABSFLAoACkcWBQCjanizqGr1jf/4H//zysrfsuWxzcz8ueN85y//cqHwI2FjY2NjY2NjE7d/9+/+veN85/z5dws/EjY2trJtf/mXC47znZmZPy/8SNjY2NhKu1Wrb9AkyMbGxjaS2z/7Z/98GLOoiYl/8c4773e6QrDlsVWrb1y69KPCD4ONjY2NjY2NLbhdvPin1eobhR8GGxtbCTfeP2xsbGzFbufO/YAmQTY2NraR3N5++x1nCLOoP/uzf1v4pRn17X/5J//kj4s+BjY2NjY2NjY2NjY2tiHa/uiPKoUfAxsbGxsbGxsbG9tIbm+//c7QZVEAAAAAAAAAAACAgiwKAAAAAAAAAAAAeSGLAgAAAAAAAAAAQF7IogAAAAAAAAAAAJAXsigAAAAAAAAAAADkhSwKAAAAAAAAAAAAeSGLAgAAAAAAAAAAQF7IogAAAAAAAAAAAJAXsigAAAAAAAAAAADkhSwKAAAAAAAAAAAAeSGLAgAAAAAAAAAAQF7IogAAAAAAAAAAAJAXsigAAAAAAAAAAADkhSwKAAAAAAAAAAAAeSGLAgAAAAAAAAAAQF7IogAAAAAAAAAAAJAXsigAAAAAAAAAAADkhSwKAAAAAAAAAAAAeSGLAgAAAAAAAAAAQF7IogAAAAAAAAAAAJCX/wk/F8SqZuUQaQAAAABJRU5ErkJggg==" width="2265" height="810"> &nbsp;</p>
<p><strong><span style="color: var(--tw-prose-bold)">Location Type:</span></strong></p>
<p>10 Public Antenatal Clinics (health facilities)</p>
<p><strong><span style="color: var(--tw-prose-bold)">Description of Location:</span></strong></p>
<p>10 public antenatal clinics in Ghana, specifically in 4 cities.the 
selected clinics are located in areas where there are sufficient numbers
 of pregnant women to make the trial feasible. </p>
<p><strong>Sample Size</strong>: 1000</p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_PBEDD3ZD" class="item journalArticle">
			<h2>A longitudinal analysis of the completeness of maternal HIV testing, including repeat testing in Cape Town, South Africa.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>de Beer S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kalk E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kroon M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Boulle A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Osler M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Euvrard J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Timmerman V</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Davies MA</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>INTRODUCTION: The virtual elimination of mother-to-child 
transmission of HIV cannot be achieved without complete maternal HIV 
testing. The World Health Organization recommends that women in high HIV
 prevalent settings repeat HIV testing in the third trimester, and at 
delivery or directly thereafter. The Western Cape Province (South 
Africa) prevention of mother-to-child transmission (PMTCT) guidelines 
recommend a repeat maternal HIV test between 32 and 34 weeks gestation 
and at delivery in addition to testing at the first antenatal visit 
(ideally &lt;20 weeks gestation). There are few published longitudinal 
studies on the uptake of initial and repeated maternal HIV testing 
programmes in sub-Saharan Africa. We aimed to investigate the 
implementation of initial and repeat maternal HIV testing guidelines in 
Cape Town, South Africa. METHODS: Between 2013 and 2016 we established 
an electronic PMTCT register that consolidated routine data from a 
primary healthcare facility and its secondary and tertiary referral 
sites in Cape Town. This provided a longitudinal record for each 
participant, from first antenatal visit to delivery. Utilizing these 
data, we conducted a retrospective analysis investigating the 
completeness of maternal HIV testing according to the PMTCT HIV testing 
guidelines in Cape Town, and predictors of complete testing, from 2014 
to 2016. RESULTS: Among 8558 enrolled pregnant women, 7213 (84%) were 
not known to be HIV positive at their first visit and thus eligible for 
HIV testing; 91% of them received &gt;/=1 HIV test during 
pregnancy/delivery. Testing at the first visit was 98% among the 85% of 
women who attended antenatal care. Among women eligible to receive all 
three recommended HIV tests, only 11% achieved all three tests. Delivery
 HIV testing completion among all women without an HIV-positive 
diagnosis was 23%. HIV prevalence at delivery was 21% and HIV incidence 
between first visit and delivery in those with &gt;/=2 HIV tests was 
0.2%. Women who enrolled after 2014 were more likely to receive the 
three recommended tests (aOR: 1.41; 95% CI: 1.10 to 1.81) and retest at 
delivery (aOR: 1.20; 95% CI: 1.05 to 1.39). CONCLUSIONS: Implementation 
of maternal HIV testing in Cape Town improved between 2014 and 2016 but 
major gaps remain, particularly at delivery.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2020-01</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: Switzerland</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>23</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e25441</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Journal of the International AIDS Society</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1002/jia2.25441">10.1002/jia2.25441</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1758-2652 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>*HIV</li>
					<li>*South Africa</li>
					<li>eppi-reviewer4</li>
					<li>*PMTCT</li>
					<li>*guideline implementation</li>
					<li>*maternal HIV testing</li>
					<li>*repeat testing</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_F5AL784X">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Name: &nbsp;</span></span></strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Mitchells
 Plain/Mitchells Plain Sub-Structure, Mitchells Plain Midwife Obstetric 
Unit (MPMOU), MPMOU, including Mitchells Plain District Hospital (MPDH),
 Mowbray Maternity Hospital (MMH), and Groote Schuur Hospital (GSH).</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Type:</span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">health facility</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Description:</span></span></strong></p>
<p><strong><span style="color: black"><span style="background-color: white"> </span></span></strong><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Conducted
 within the Western Cape province of South Africa, specifically focusing
 on the Mitchells Plain/Mitchells Plain Sub-Structure. The primary 
health facility involved in the study is the Mitchells Plain Midwife 
Obstetric Unit (MPMOU), which is located within the Mitchells Plain 
Community Health Centre. Additionally, the study utilized data from 
referral sites associated with MPMOU, including Mitchells Plain District
 Hospital (MPDH), Mowbray Maternity Hospital (MMH), and Groote Schuur 
Hospital (GSH).</span></span></p>
<p><strong>Sample Size</strong>: &nbsp;8558</p>
<p></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_S8XY67RC" class="item journalArticle">
			<h2>A multifaceted intervention to improve syphilis screening and 
treatment in pregnant women in Kinshasa, Democratic Republic of the 
Congo and in Lusaka, Zambia: a cluster randomised controlled trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Althabe F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chomba E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Tshefu AK</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Banda E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Belizan M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bergel E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Berrueta M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bertrand J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bose C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Cafferata ML</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Carlo WA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ciganda A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Donnay F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Garcia Elorrio E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gibbons L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Klein K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Liljestrand J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Lusamba PD</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mavila AK</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mazzoni A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Nkamba DM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mwanakalanga FH</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mwapule Tembo A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mwenechanya M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Pyne-Mercier L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Spira C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Wetshikoy JD</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Xiong X</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Buekens P</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Despite international recommendations, coverage of
 syphilis testing in pregnant women and treatment of those found 
seropositive remains limited in sub-Saharan Africa. We assessed whether 
combining the provision of supplies with a behavioural intervention was 
more effective than providing supplies only, to improve syphilis 
screening and treatment during antenatal care. METHODS: In this 
18-month, cluster randomised controlled trial, we randomly assigned 
(1:1) 26 urban antenatal care clinics in Kinshasa, Democratic Republic 
of the Congo, and Lusaka, Zambia, to receive a behavioural intervention 
(opinion leader selection, academic detailing visits, reminders, audits 
and feedback, and supportive supervision) plus supplies for syphilis 
testing and treatment (intervention group) or to receive supplies only 
(control group). The primary outcomes were proportion of pregnant women 
who had syphilis screening out of the total who attended the clinic; and
 the proportion of women who had treatment with benzathine 
benzylpenicillin out of those who tested positive for syphilis at their 
first antenatal care visit. This trial is registered at 
ClinicalTrials.gov, number NCT02353117. FINDINGS: The 18-month study 
period was Feb 1, 2016, to July 14, 2017. 18 357 women were enrolled at 
the 13 intervention clinics and 17 679 women were enrolled at the 13 
control clinics at their first antenatal care visit. Syphilis screening 
was done in a median of 99.9% (IQR 99.0-100.0) of women in the 
intervention clinics and 93.8% (85.0-98.9) in the control clinics 
(absolute difference 6.1% [95% CI 1.1-14.1]; p=0.00092). Syphilis 
treatment at the first visit was done in a median of 100% (IQR 
99.7-100.0) of seropositive women in intervention clinics and 43.2% 
(2.6-83.2) of seropositive women in control clinics (absolute difference
 56.8% [12.8-99.0]; p=0.0028). INTERPRETATION: A behavioural 
intervention, together with the provision of supplies, can lead to more 
than 95% of women being screened and treated for syphilis. The sole 
provision of supplies is sufficient to reach such levels of screening 
coverage but is not sufficient to ensure high levels of treatment. 
FUNDING: Bill &amp; Melinda Gates Foundation.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2019-05</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 5
Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>7</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e655-e663</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>The Lancet. Global health</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1016/S2214-109X(19)30075-0">10.1016/S2214-109X(19)30075-0</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>5</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>2214-109X (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:35 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:35 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Young Adult</li>
					<li>Adolescent</li>
					<li>Child</li>
					<li>Prenatal Care/*methods</li>
					<li>Democratic Republic of the Congo</li>
					<li>Zambia</li>
					<li>Mass Screening/*methods</li>
					<li>Anti-Bacterial Agents/therapeutic use</li>
					<li>*Quality Improvement/organization &amp; administration</li>
					<li>Penicillin G Benzathine/therapeutic use</li>
					<li>Pregnancy Complications, Infectious/drug therapy/*prevention &amp; control</li>
					<li>Syphilis/drug therapy/*prevention &amp; control</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_L3QRWN4F">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong><span style="color: var(--tw-prose-bold)">Location Name : </span></strong></p>
<p><span style="color: var(--tw-prose-bold)">Facility names not specified</span></p>
<p><strong><span style="color: var(--tw-prose-bold)">Location Type: </span></strong></p>
<p><span style="color: var(--tw-prose-bold)">Health facility</span></p>
<p><strong><span style="color: var(--tw-prose-bold)">Description:</span></strong><span style="color: rgb(55, 65, 81)"> </span></p>
<p><span style="color: rgb(55, 65, 81)">16 antenatal care clinics in Kinshasa, Democratic Republic of the Congo, Lusaka, Zambia. </span><strong><span style="color: var(--tw-prose-bold)">:</span></strong> Kinshasa (Democratic Republic of the Congo) and Lusaka (Zambia).</p>
<p><strong><span style="color: var(--tw-prose-bold)">Sample size &nbsp;: 18 547</span></strong></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_GIQT3XPB" class="item journalArticle">
			<h2>A Non-Inferiority, Individually Randomized Trial of Intermittent 
Screening and Treatment versus Intermittent Preventive Treatment in the 
Control of Malaria in Pregnancy.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Tagbor H</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Cairns M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bojang K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Coulibaly SO</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kayentao K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Williams J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Abubakar I</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Akor F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mohammed K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bationo R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Dabira E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Soulama A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Djimde M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Guirou E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Awine T</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Quaye S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Njie F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ordi J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Doumbo O</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hodgson A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Oduro A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Meshnick S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Taylor S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Magnussen P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>ter Kuile F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Woukeu A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Milligan P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chandramohan D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Greenwood B</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: The efficacy of intermittent preventive treatment 
for malaria with sulfadoxine-pyrimethamine (IPTp-SP) in pregnancy is 
threatened in parts of Africa by the emergence and spread of resistance 
to SP. Intermittent screening with a rapid diagnostic test (RDT) and 
treatment of positive women (ISTp) is an alternative approach. METHODS 
AND FINDINGS: An open, individually randomized, non-inferiority trial of
 IPTp-SP versus ISTp was conducted in 5,354 primi- or secundigravidae in
 four West African countries with a low prevalence of resistance to SP 
(The Gambia, Mali, Burkina Faso and Ghana). Women in the IPTp-SP group 
received SP on two or three occasions whilst women in the ISTp group 
were screened two or three times with a RDT and treated if positive for 
malaria with artemether-lumefantrine (AL). ISTp-AL was non-inferior to 
IPTp-SP in preventing low birth weight (LBW), anemia and placental 
malaria, the primary trial endpoints. The prevalence of LBW was 15.1% 
and 15.6% in the IPTp-SP and ISTp-AL groups respectively (OR = 1.03 [95%
 CI: 0.88, 1.22]). The mean hemoglobin concentration at the last clinic 
attendance before delivery was 10.97g/dL and 10.94g/dL in the IPTp-SP 
and ISTp-AL groups respectively (mean difference: -0.03 g/dL [95% CI: 
-0.13, +0.06]). Active malaria infection of the placenta was found in 
24.5% and in 24.2% of women in the IPTp-SP and ISTp-AL groups 
respectively (OR = 0.95 [95% CI 0.81, 1.12]). More women in the ISTp-AL 
than in the IPTp-SP group presented with malaria parasitemia between 
routine antenatal clinics (310 vs 182 episodes, rate difference: 49.4 
per 1,000 pregnancies [95% CI 30.5, 68.3], but the number of hospital 
admissions for malaria was similar in the two groups. CONCLUSIONS: 
Despite low levels of resistance to SP in the study areas, ISTp-AL 
performed as well as IPTp-SP. In the absence of an effective alternative
 medication to SP for IPTp, ISTp-AL is a potential alternative to IPTp 
in areas where SP resistance is high. It may also have a role in areas 
where malaria transmission is low and for the prevention of malaria in 
HIV positive women receiving cotrimoxazole prophylaxis in whom SP is 
contraindicated. TRIAL REGISTRATION: ClinicalTrials.gov NCT01084213 Pan 
African Clinical trials Registry PACT201202000272122.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2015</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>10</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e0132247</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>PloS one</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1371/journal.pone.0132247">10.1371/journal.pone.0132247</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>8</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1932-6203 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Birth Weight</li>
					<li>Ghana</li>
					<li>Young Adult</li>
					<li>Drug Combinations</li>
					<li>Pregnancy Outcome</li>
					<li>Treatment Outcome</li>
					<li>Antimalarials/*therapeutic use</li>
					<li>Adolescent</li>
					<li>Mass Screening</li>
					<li>Africa</li>
					<li>Hemoglobins/analysis</li>
					<li>Malaria/*drug therapy</li>
					<li>Burkina Faso</li>
					<li>Gambia</li>
					<li>Pyrimethamine/*therapeutic use</li>
					<li>Sulfadoxine/*therapeutic use</li>
					<li>Mali</li>
					<li>Placenta/parasitology</li>
					<li>Pregnancy Complications, Parasitic/diagnosis/*drug therapy</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_UDZ45GW6">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location Name</strong> : </p>
<p>Names of health facilities not specified.</p>
<p><strong><span style="color: var(--tw-prose-bold)">Location Type: </span></strong></p>
<p><span style="color: var(--tw-prose-bold)">Health facilities</span></p>
<p><strong><span style="color: var(--tw-prose-bold)">Description:</span></strong></p>
<p><span style="color: rgb(32, 32, 32)"><span style="background-color: rgb(255, 255, 255)">Conducted in 30 ANC clinics in 4 countries, </span></span>Burkina Faso (Ziniare), Ghana (Navrongo), Mali (San &amp; Kita) and The Gambia (Basse)<span style="color: rgb(32, 32, 32)"><span style="background-color: rgb(255, 255, 255)">, where malaria transmission is moderately high or high and seasonal</span></span></p>
<p><strong><span style="color: var(--tw-prose-bold)">Sample size : </span></strong><span style="color: rgb(32, 32, 32)"><span style="background-color: rgb(255, 255, 255)">5354&nbsp;</span></span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_9Z4TEKZW" class="item journalArticle">
			<h2>A novel intervention combining supplementary food and infection 
control measures to improve birth outcomes in undernourished pregnant 
women in Sierra Leone: A randomized, controlled clinical effectiveness 
trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hendrixson DT</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Smith K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Lasowski P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Callaghan-Gillespie M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Weber J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Papathakis P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Iversen PO</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Koroma AS</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Manary MJ</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Innovations for undernourished pregnant women that
 improve newborn survival and anthropometry are needed to achieve the 
Sustainable Development Goals 1 and 3. This study tested the hypothesis 
that a combination of a nutritious supplementary food and several proven
 chemotherapeutic interventions to control common infections would 
increase newborn weight and length in undernourished pregnant women. 
METHODS AND FINDINGS: This was a prospective, randomized, controlled 
clinical effectiveness trial of a ready-to-use supplementary food (RUSF)
 plus anti-infective therapies compared to standard therapy in 
undernourished pregnant women in rural Sierra Leone. Women with a 
mid-upper arm circumference (MUAC) &lt;/=23.0 cm presenting for 
antenatal care at one of 43 government health clinics in Western Rural 
Area and Pujehun districts were eligible for participation. Standard of 
care included a blended corn/soy flour and intermittent preventive 
treatment for malaria in pregnancy (IPTp). The intervention replaced the
 blended flour with RUSF and added azithromycin and testing and 
treatment for vaginal dysbiosis. Since the study involved different 
foods and testing procedures for the intervention and control groups, no
 one except the authors conducting the data analyses were blinded. The 
primary outcome was birth length. Secondary outcomes included maternal 
weight gain, birth weight, and neonatal survival. Follow-up continued 
until 6 months postpartum. Modified intention to treat analyses was 
undertaken. Participants were enrolled and followed up from February 
2017 until February 2020. Of the 1,489 women enrolled, 752 were 
allocated to the intervention and 737 to the standard of care. The 
median age of these women was 19.5 years, of which 42% were primigravid.
 Twenty-nine women receiving the intervention and 42 women receiving the
 standard of care were lost to follow-up before pregnancy outcomes were 
obtained. There were 687 singleton live births in the intervention group
 and 657 in the standard of care group. Newborns receiving the 
intervention were 0.3 cm longer (95% confidence interval (CI) 0.09 to 
0.6; p = 0.007) and weighed 70 g more (95% CI 20 to 120; p = 0.005) than
 those receiving the standard of care. Those women receiving the 
intervention had greater weekly weight gain (mean difference 40 g; 95% 
CI 9.70 to 71.0, p = 0.010) than those receiving the standard of care. 
There were fewer neonatal deaths in the intervention (n = 13; 1.9%) than
 in the standard of care (n = 28; 4.3%) group (difference 2.4%; 95% CI 
0.3 to 4.4), (HR 0.62 95% CI 0.41 to 0.94, p = 0.026). No differences in
 adverse events or symptoms between the groups was found, and no serious
 adverse events occurred. Key limitations of the study are lack of 
gestational age estimates and unblinded administration of the 
intervention. CONCLUSIONS: In this study, we observed that the addition 
of RUSF, azithromycin, more frequent IPTp, and testing/treatment for 
vaginal dysbiosis in undernourished pregnant women resulted in modest 
improvements in anthropometric status of mother and child at birth, and a
 reduction in neonatal death. Implementation of this combined 
intervention in rural, equatorial Africa may well be an important, 
practical measure to reduce infant mortality in this context. TRIAL 
REGISTRATION: ClinicalTrials.gov NCT03079388.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2021-09</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 9
Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>18</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e1003618</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>PLoS medicine</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1371/journal.pmed.1003618">10.1371/journal.pmed.1003618</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>9</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1549-1277 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:30 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:30 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Prospective Studies</li>
					<li>Young Adult</li>
					<li>Pregnancy Outcome</li>
					<li>Adolescent</li>
					<li>*Prenatal Care</li>
					<li>Anti-Bacterial Agents/therapeutic use</li>
					<li>Azithromycin/therapeutic use</li>
					<li>*Food Assistance</li>
					<li>*Infection Control</li>
					<li>Albendazole/therapeutic use</li>
					<li>Antiprotozoal Agents/therapeutic use</li>
					<li>Dysbiosis/therapy</li>
					<li>Malaria/prevention &amp; control</li>
					<li>Malnutrition/*therapy</li>
					<li>Pregnancy Complications/*therapy</li>
					<li>Sierra Leone</li>
					<li>Vaginal Diseases/therapy</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_P8D3649Z">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location Name</strong> : Clinic names not specified</p>
<p><strong>Location Type</strong> : Health Facility , Regions</p>
<p><strong>Description</strong> : <span style="color: rgb(32, 32, 32)"><span style="background-color: rgb(255, 255, 255)">43 antenatal clinics in Pujehun and Western Rural Area Districts of Sierra Leone.</span></span></p>
<p><strong>Sample size</strong> :1489</p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_NSDBXDDD" class="item journalArticle">
			<h2>A prospective observational description of frequency and timing 
of antenatal care attendance and coverage of selected interventions from
 sites in Argentina, Guatemala, India, Kenya, Pakistan and Zambia.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bucher S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Marete I</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Tenge C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Liechty EA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Esamai F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Patel A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Goudar SS</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kodkany B</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Garces A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chomba E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Althabe F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Barreuta M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Pasha O</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hibberd P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Derman RJ</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Otieno K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hambidge K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Krebs NF</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Carlo WA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chemweno C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Goldenberg RL</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>McClure EM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Moore JL</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Wallace DD</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Saleem S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Koso-Thomas M</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: The Global Network for Women's and Children's 
Health Research is one of the largest international networks for testing
 and generating evidence-based recommendations for improvement of 
maternal-child health in resource-limited settings. Since 2009, Global 
Network sites in six low and middle-income countries have collected 
information on antenatal care practices, which are important as 
indicators of care and have implications for programs to improve 
maternal and child health. We sought to: (1) describe the quantity of 
antenatal care attendance over a four-year period; and (2) explore the 
quality of coverage for selected preventative, screening, and birth 
preparedness components. METHODS: The Maternal Newborn Health Registry 
(MNHR) is a prospective, population-based birth and pregnancy outcomes 
registry in Global Network sites, including: Argentina, Guatemala, India
 (Belgaum and Nagpur), Kenya, Pakistan, and Zambia. MNHR data from these
 sites were prospectively collected from January 1, 2010 - December 31, 
2013 and analyzed for indicators related to quantity and patterns of ANC
 and coverage of key elements of recommended focused antenatal care. 
Descriptive statistics were generated overall by global region (Africa, 
Asia, and Latin America), and for each individual site. RESULTS: 
Overall, 96% of women reported at least one antenatal care visit. Indian
 sites demonstrated the highest percentage of women who initiated 
antenatal care during the first trimester. Women from the Latin American
 and Indian sites reported the highest number of at least 4 visits. 
Overall, 88% of women received tetanus toxoid. Only about half of all 
women reported having been screened for syphilis (49%) or anemia (50%). 
Rates of HIV testing were above 95% in the Argentina, African, and 
Indian sites. The Pakistan site demonstrated relatively high rates for 
birth preparation, but for most other preventative and screening 
interventions, posted lower coverage rates as compared to other Global 
Network sites. CONCLUSIONS: Results from our large, prospective, 
population-based observational study contribute important insight into 
regional and site-specific patterns for antenatal care access and 
coverage. Our findings indicate a quality and coverage gap in antenatal 
care services, particularly in regards to syphilis and hemoglobin 
screening. We have identified site-specific gaps in access to, and 
delivery of, antenatal care services that can be targeted for 
improvement in future research and implementation efforts. TRIAL 
REGISTRATION: Registration at Clinicaltrials.gov (ID# NCT01073475).</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2015</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>12 Suppl 2</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>S12</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Reproductive health</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/1742-4755-12-S2-S12">10.1186/1742-4755-12-S2-S12</a></td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1742-4755 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Prospective Studies</li>
					<li>Pregnancy Outcome</li>
					<li>Developing Countries</li>
					<li>Registries</li>
					<li>Health Services Accessibility/statistics &amp; numerical data</li>
					<li>Patient Acceptance of Health Care/*statistics &amp; numerical data</li>
					<li>Patient Care Planning</li>
					<li>Prenatal Care/methods/standards/*statistics &amp; numerical data</li>
					<li>Quality of Health Care</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_I5LGBU9I">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location Name :</strong></p>
<p>Not specified</p>
<p><strong>Location Type</strong> :</p>
<p><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">Communities/Global Network sites / study cluster</span></span></p>
<p><strong><span style="color: var(--tw-prose-bold)">Description:</span></strong></p>
<p><span style="color: rgb(55, 65, 81)">Sites in six low and middle-income countries, including Argentina, Guatemala, India (Belgaum and Nagpur), <span style="background-color: rgb(255, 212, 0);">Kenya,</span> Pakistan, and <span style="background-color: rgb(255, 212, 0);">Zambia.</span></span></p>
<p><strong><span style="color: var(--tw-prose-bold)">Sample size : </span></strong><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">&nbsp;269,710</span></span></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_BST2RDJ5" class="item journalArticle">
			<h2>A retrospective study of the impact of health worker strikes on maternal and child health care utilization in western Kenya.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Scanlon ML</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Maldonado LY</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ikemeri JE</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Jumah A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Anusu G</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bone JN</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chelagat S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Keter JC</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ruhl L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Songok J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Christoffersen-Deb A</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: There have been dozens of strikes by health 
workers in Kenya in the past decade, but there are few studies of their 
impact on maternal and child health services and outcomes. We conducted a
 retrospective survey study to assess the impact of nationwide strikes 
by health workers in 2017 on utilization of maternal and child health 
services in western Kenya. METHODS: We utilized a parent study to enroll
 women who were pregnant in 2017 when there were prolonged strikes by 
health workers ("strike group") and women who were pregnant in 2018 when
 there were no major strikes ("control group"). Trained research 
assistants administered a close-ended survey to retrospectively collect 
demographic and pregnancy-related health utilization and outcomes data. 
Data were collected between March and July 2019. The primary outcomes of
 interest were antenatal care (ANC) visits, delivery location, and early
 child immunizations. Generalized estimating equations were used to 
estimate risk ratios between the strike and control groups, adjusting 
for socioeconomic status, health insurance status, and clustering. 
Adjusted risk ratios (ARR) were calculated with 95% confidence intervals
 (95%CI). RESULTS: Of 1341 women recruited in the parent study in 2017 
(strike group), we re-consented 843 women (63%) to participate. Of 924 
women recruited in the control arm of the parent study in 2018 (control 
group), we re-consented 728 women (79%). Women in the strike group were 
17% less likely to attend at least four ANC visits during their 
pregnancy (ARR 0.83, 95%CI 0.74, 0.94) and 16% less likely to deliver in
 a health facility (ARR 0.84, 95%CI 0.76, 0.92) compared to women in the
 control group. Whether a child received their first oral polio vaccine 
did not differ significantly between groups, but children of women in 
the strike group received their vaccine significantly longer after birth
 (13 days versus 7 days, p = 0.002). CONCLUSION: We found that women who
 were pregnant during nationwide strikes by health workers in 2017 were 
less likely to receive WHO-recommended maternal child health services. 
Strategies to maintain these services during strikes are urgently 
needed.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2021-09</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 1
Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>21</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>898</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>BMC health services research</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/s12913-021-06939-7">10.1186/s12913-021-06939-7</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1472-6963 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:24 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:24 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Retrospective Studies</li>
					<li>*Maternal Health Services</li>
					<li>Child</li>
					<li>*Prenatal Care</li>
					<li>Child Health</li>
					<li>Kenya/epidemiology</li>
					<li>Kenya</li>
					<li>Patient Acceptance of Health Care</li>
					<li>Health worker strike</li>
					<li>Maternal child health</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_937ZM6QH">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name</strong> : </p>
<p>Trans Nzoia</p>
<p><strong><span style="color: var(--tw-prose-bold)">Location Type:</span></strong> </p>
<p>Region</p>
<p><strong><span style="color: var(--tw-prose-bold)">Description:</span></strong> </p>
<p>Trans Nzoia County is located in the western part of Kenya.</p>
<p><strong>Sample size</strong> : <span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">1341</span></span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_ANL4SCKK" class="item journalArticle">
			<h2>Accessing medical and surgical first-trimester abortion services:
 women's experiences and costs from an operations research study in 
KwaZulu-Natal Province, South Africa.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Lince-Deroche N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Fetters T</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sinanovic E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Blanchard K</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>OBJECTIVE(S): To explore women's experiences accessing 
services and estimate costs incurred for first-trimester abortion at 
four public hospitals in KwaZulu-Natal Province, South Africa. STUDY 
DESIGN: Subanalysis from a prospective cohort study (2009-2011) of women
 aged 18-49years accessing abortion services through 12weeks' gestation.
 Trained study personnel conducted structured interviews with women 
about their reason for having an abortion, experiences accessing 
services and costs incurred. Women who were 9weeks' gestation or less 
were eligible to choose medication abortion or manual vacuum aspiration 
(MVA); women 10-12weeks' gestation all had MVA. RESULTS: We enrolled 
1167 women; 923 (79.1%) were eligible to choose their procedure. The 
median age was 25years; most were black African, single and unemployed. 
Many women reported concerns about the affordability of raising 
a(nother) child (58.9%) or not being ready for (more) children (43.4%) 
as their reason for having an abortion. In total, women incurred a 
median cost of US$9.99 (interquartile range 6.46-14.85) for their 
procedure which usually required two facility visits. Many had to pay 
for transportation, a pregnancy test, sanitary pads or pain medication. 
CONCLUSIONS: Despite the availability of government assistance for 
children through South Africa's "child grant," the affordability of 
raising a child was a major concern for women. Although theoretically 
available free of charge in the public sector, women experienced 
challenges accessing abortion services and incurred costs which may have
 been burdensome given average local earnings. These potential barriers 
could be addressed by reducing the number of required visits and 
improving availability of pregnancy tests and supplies in public 
facilities. IMPLICATIONS: Many women cited concerns about the 
affordability of having a(nother) child when requesting an abortion. 
Although public services are technically free or low-cost in South 
Africa, women incurred costs for first-trimester abortions. Women's 
costs could be lowered by reducing facility visits and improving 
availability of pregnancy tests and supplies.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2017-08</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 2
Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>96</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>72-80</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Contraception</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1016/j.contraception.2017.03.013">10.1016/j.contraception.2017.03.013</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>2</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>0010-7824 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:40 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:40 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Young Adult</li>
					<li>Middle Aged</li>
					<li>South Africa</li>
					<li>Adolescent</li>
					<li>Abortion, Induced/*economics/methods</li>
					<li>Abortion, Legal/*economics/methods</li>
					<li>Access</li>
					<li>Costs</li>
					<li>Economic</li>
					<li>Health Services Accessibility/*economics</li>
					<li>Health Surveys</li>
					<li>Manual vacuum aspiration</li>
					<li>Medication abortion</li>
					<li>Operations Research</li>
					<li>Pregnancy Trimester, First</li>
					<li>Termination of pregnancy</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_H75YG755">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location Name</strong> : </p>
<p>Facility Name not specified</p>
<p><strong>Location Type</strong> : Health facility</p>
<p><strong>Description</strong> : </p>
<p><span style="color: var(--tw-prose-bold)">Public-sector facilities in KwaZulu-Natal,</span><span style="color: rgb(55, 65, 81)"> a province in South Africa</span></p>
<p><strong>Sample size</strong> : <span style="color: rgb(80, 80, 80)"><span style="background-color: rgb(255, 255, 255)">1167</span></span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_SI5J9MTB" class="item journalArticle">
			<h2>Active management of the third stage of labour with and without 
controlled cord traction: a randomised, controlled, non-inferiority 
trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gulmezoglu AM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Lumbiganon P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Landoulsi S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Widmer M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Abdel-Aleem H</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Festin M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Carroli G</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Qureshi Z</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Souza JP</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bergel E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Piaggio G</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Goudar SS</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Yeh J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Armbruster D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Singata M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Pelaez-Crisologo C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Althabe F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sekweyama P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hofmeyr J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Stanton ME</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Derman R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Elbourne D</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Active management of the third stage of labour 
reduces the risk of post-partum haemorrhage. We aimed to assess whether 
controlled cord traction can be omitted from active management of this 
stage without increasing the risk of severe haemorrhage. METHODS: We did
 a multicentre, non-inferiority, randomised controlled trial in 16 
hospitals and two primary health-care centres in Argentina, Egypt, 
India, Kenya, the Philippines, South Africa, Thailand, and Uganda. Women
 expecting to deliver singleton babies vaginally (ie, not planned 
caesarean section) were randomly assigned (in a 1:1 ratio) with a 
centrally generated allocation sequence, stratified by country, to 
placental delivery with gravity and maternal effort (simplified package)
 or controlled cord traction applied immediately after uterine 
contraction and cord clamping (full package). After randomisation, 
allocation could not be concealed from investigators, participants, or 
assessors. Oxytocin 10 IU was administered immediately after birth with 
cord clamping after 1-3 min. Uterine massage was done after placental 
delivery according to local policy. The primary (non-inferiority) 
outcome was blood loss of 1000 mL or more (severe haemorrhage). The 
non-inferiority margin for the risk ratio was 1.3. Analysis was by 
modified intention-to-treat, excluding women who had emergency caesarean
 sections. This trial is registered with the Australian and New Zealand 
Clinical Trials Registry, ACTRN 12608000434392. FINDINGS: Between June 
1, 2009, and Oct 30, 2010, 12,227 women were randomly assigned to the 
simplified package group and 12,163 to the full package group. After 
exclusion of women who had emergency caesarean sections, 11,861 were in 
the simplified package group and 11,820 were in the full package group. 
The primary outcome of blood loss of 1000 mL or more had a risk ratio of
 1.09 (95% CI 0.91-1.31) and the upper 95% CI limit crossed the 
pre-stated non-inferiority margin. One case of uterine inversion 
occurred in the full package group. Other adverse events were 
haemorrhage-related. INTERPRETATION: Although the hypothesis of 
non-inferiority was not met, omission of controlled cord traction has 
very little effect on the risk of severe haemorrhage. Scaling up of 
haemorrhage prevention programmes for non-hospital settings can safely 
focus on use of oxytocin. FUNDING: United States Agency for 
International Development and UN Development Programme/UN Population 
Fund/WHO/World Bank Special Programme of Research, Development and 
Research Training in Human Reproduction, Department of Reproductive 
Health and Research.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2012-05</td>
					</tr>
					<tr>
					<th>URL</th>
						<td><a href="https://doi.org/10.1016/s0140-6736(12)60206-2">https://doi.org/10.1016/s0140-6736(12)60206-2</a></td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 9827
Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>379</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>1721-7</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Lancet</td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>9827</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>0140-6736 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:37 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>3/8/2024, 2:33:17 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_CJDU8JRE">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name</strong> : </p>
<p>Names not specified</p>
<p><strong>Location Type</strong> : </p>
<p>Health facility</p>
<p><strong>Description</strong> : &nbsp;</p>
<p>16 hospitals and two primary health-care centers in Argentina, Egypt,
 India, Kenya, the Philippines, South Africa, Thailand, and Uganda.</p>
<p><strong>Sample size</strong> : 24390</p>
<p></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_C6QRWDWC" class="item journalArticle">
			<h2>Adverse maternal outcomes of adolescent pregnancy in Northwest Ethiopia: A prospective cohort study.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kassa GM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Arowojolu AO</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Odukogbe ATA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Yalew AW</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Adolescent pregnancy is considered a major 
contributor to maternal and child morbidity and mortality, the greatest 
concern of developing countries and an important public health issue 
globally. Adolescents are responsible for eleven percent of births 
worldwide and they face several pregnancy and childbirth related 
complications. However, in low-income countries like Ethiopia, there are
 limited researches conducted to investigate outcomes of adolescent 
pregnancy. Therefore, this study was conducted to assess the adverse 
maternal outcomes of adolescent pregnancy in Northwest Ethiopia. 
METHODS: A prospective cohort study was conducted in 12 health 
facilities from seven districts in East Gojjam zone, Northwest Ethiopia.
 A total of 418 adolescents (15-19 years old) and 836 adult women (20-34
 years old) who attended randomly selected health facilities in East 
Gojjam zone were included. Data were collected starting from admission 
to the maternity ward for labor and delivery, and postnatal depression 
was measured at six weeks' postpartum period using the Edinburgh 
Postnatal Depression Scale. Generalized estimating equations (GEE) was 
used to account for the within subject correlation and assess the effect
 of different known factors that could influence the outcome of this 
study. RESULTS: A lower percentage of adolescent (58.4%) than adult 
(71.2%) women had their first antenatal care booking before 16 weeks of 
gestation. After adjusting for different confounding factors, the 
adverse outcome that was significantly associated with adolescent 
pregnancy was postpartum depression (AOR: 2.29; 95% CI, 1.42, 3.7, 
p-value = 0.001). Assisted vaginal delivery (AOR: 0.44; 95% CI, 0.23, 
0.86, p-value 0.016) and cesarean section (AOR: 0.43; 95% CI, 0.19, 
0.97, p-value = 0.042) were significantly lower among adolescent women. 
CONCLUSIONS: Adolescent pregnancy is associated with higher odds of 
postpartum depression, and lower odds to undergo cesarean section and 
assisted vaginal delivery than adult women. Perinatal care services 
should be more adolescent-friendly to ensure early diagnosis and 
treatment of postpartum depression. School and community-based awareness
 programs regarding use of contraception to prevent unwanted adolescent 
pregnancy, early antenatal care booking and adverse pregnancy outcomes 
of adolescent pregnancy and provision of psychosocial support are 
recommended.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2021</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>16</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e0257485</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>PloS one</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1371/journal.pone.0257485">10.1371/journal.pone.0257485</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>9</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1932-6203 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Prospective Studies</li>
					<li>Young Adult</li>
					<li>*Pregnancy Outcome</li>
					<li>Adolescent</li>
					<li>Prenatal Care</li>
					<li>Odds Ratio</li>
					<li>Ethiopia/epidemiology</li>
					<li>Health Facilities</li>
					<li>Cesarean Section/*statistics &amp; numerical data</li>
					<li>Delivery, Obstetric/*statistics &amp; numerical data</li>
					<li>Depression, Postpartum/diagnosis/*epidemiology</li>
					<li>Pre-Eclampsia/diagnosis/epidemiology</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_SQVHFV4C">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location Name</strong>: </p>
<p>East Gojjam Zone, Amhara Region</p>
<p><strong>Location Type</strong>:</p>
<p> Health facilities, districts, rural areas, urban areas</p>
<p><strong>Description</strong>: </p>
<p>Health facilities of East Gojjam Zone, which is located in the Amhara
 region, Northwest Ethiopia. The main administrative city is Debre 
Markos.</p>
<p><strong>Sample size</strong>: <span style="color: rgb(32, 32, 32)"><span style="background-color: rgb(255, 255, 255)">&nbsp;1,254</span></span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_VSBPBYFL" class="item journalArticle">
			<h2>Adverse Neonatal Outcome are More Common among Babies Born by 
Cesarean Section than Naturally Born Babies at Public Hospitals in 
Eastern Ethiopia: A Comparative Prospective Follow-Up Study at Eastern 
Ethiopia.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Tefera M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Assefa N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Roba KT</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gedefa L</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>The adverse neonatal outcome is defined as the presence of 
birth asphyxia, respiratory distress, birth trauma, hypothermia, 
meconium aspiration syndrome, neonatal intensive care admission, and 
neonatal death. It is a major concern in developing countries, including
 Ethiopia. This study tried to identify predictors of adverse neonatal 
outcomes at selected public hospitals in Eastern Ethiopia. A 
hospital-based prospective follow-up study was conducted in three public
 hospitals in Eastern Ethiopia from June to October 2020. A total of 
2,246 laboring women and neonates born at the hospitals were enrolled in
 the study. Data were collected through interviews, observation 
checklists, and clinical chart review. Reports were presented in 
relative risks with 95% CIs. The overall magnitude of adverse neonatal 
outcome was 20.97% (95% CI: 19.33- 22.71%). It was 24.3% for babies born
 through cesarean section (95% CI: 21.3%, 27.5). The presence of 
meconium in the amniotic fluid increased the risk for neonates delivered
 via cesarean section (ARR, 1.52 95% CI; 1.04, 2.22). Among neonates 
born via vaginal delivery, the risk of adverse neonatal outcome was 
higher among nullipara women (ARR, 1.42 95% CI; 1.02, 1.99) and among 
women diagnosed with abnormal labor or pregnancy such as APH, 
pre-eclampsia, obstructed labor, fetal distress, and mal-presentation at
 admission (ARR, 1.30 95%CI; 1.01, 1.67). The risk of adverse neonatal 
outcome was higher among babies born through the cesarian section than 
those born via vaginal delivery. Abnormal labor or pregnancy and being 
primiparous increased the risk of adverse neonatal outcome in vaginal 
delivery.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2021</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>8</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>2333794X211018350</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Global pediatric health</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1177/2333794X211018350">10.1177/2333794X211018350</a></td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>2333-794X (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>adverse neonatal outcomes</li>
					<li>cesarean section</li>
					<li>Eastern Ethiopia</li>
					<li>vaginal delivery (natural delivery)</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_JLNWXWVT">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Name: </span></span></strong></p>
<p><strong><span style="color: black"><span style="background-color: white">&nbsp;</span></span></strong>Hiwot Fana Hospital, Jegal Hospital, Dil Chora Hospital, Bisidimo Hospital</p>
<p><strong><span style="color: black"><span style="background-color: white">Location Type: </span></span></strong></p>
<p>health facilities</p>
<p><strong><span style="color: black"><span style="background-color: white">Description:</span></span></strong></p>
<p>Public hospitals, specialized hospital, referral hospital, general/secondary hospitals, primary hospitals</p>
<p></p>
<p><strong>Sample Size: &nbsp; &nbsp; &nbsp;2042</strong></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_P88QWNRI" class="item journalArticle">
			<h2>Anemia and pregnancy outcomes: a longitudinal study.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Tunkyi K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Moodley J</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>OBJECTIVES: To determine the prevalence of anemia at the first
 antenatal visit and at 32-34 weeks gestational age, and to evaluate 
perinatal and maternal outcomes. METHODS: Venous blood samples were 
obtained for complete blood counts at both study visits. Maternal and 
perinatal morbidity and mortality were also recorded. The data were 
analyzed using SPSS (version 23). RESULTS: Two thousand pregnant women 
were recruited. The prevalence of anemia was 42.7% (n = 854/2000) at the
 first antenatal visit. Thirty-five percent had mild anemia and 68.9% 
had normocytic normochromic anemia. The prevalence of anemia in HIV 
infected women was higher than that in the noninfected group and 47.2% 
of the study population (n = 2000) was HIV infected. At the 32-34 weeks 
visit, hemoglobin (Hb) levels were available for 1433/2000 (71.7%) of 
the participants. The prevalence of anemia was 28.1% (n = 403/1433); 
19.3% had mild anemia and 65.3% had normocytic normochromic anemia. 
There was a significant difference in Hb levels between that of the 
first visit and that at 32-34 weeks (42.7% vs. 28.1%; p = .001; 95% CI: 
0.11-0.18). There were significant differences in prematurity, birth 
weight and hypertensive disorders of pregnancy between the anemic and 
nonanemic groups. CONCLUSION: The prevalence of anemia decreased from 
42.7% (booking) to 28.1% (32 - 34 weeks). Normocytic normochromic anemia
 was the commonest type of anemia. Attention needs to be focused on 
detailed investigations to establish the exact cause of anemia.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2018-10</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 19
Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>31</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>2594-2598</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>The journal of maternal-fetal &amp; neonatal medicine : the 
official journal of the European Association of Perinatal Medicine, the 
Federation of Asia and Oceania Perinatal Societies, the International 
Society of Perinatal Obstetricians</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1080/14767058.2017.1349746">10.1080/14767058.2017.1349746</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>19</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1476-4954 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:31 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:31 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Infant, Newborn</li>
					<li>Young Adult</li>
					<li>Prevalence</li>
					<li>Longitudinal Studies</li>
					<li>Pregnancy Outcome/*epidemiology</li>
					<li>Infant</li>
					<li>Middle Aged</li>
					<li>South Africa/epidemiology</li>
					<li>Hemoglobins/metabolism</li>
					<li>pregnancy outcomes</li>
					<li>Anemia</li>
					<li>HIV Infections/complications</li>
					<li>Anemia/blood/*epidemiology/therapy/virology</li>
					<li>antenatal visits</li>
					<li>Pregnancy Complications, Hematologic/blood/*epidemiology/therapy/virology</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_JJWHHHRQ">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Name: </span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">&nbsp;Not specified</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Type: </span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">Health facilities</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Description: </span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">kwazulu Natal, South Africa</span></span></p>
<p><strong>Sample Size: 2000</strong></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_CJ7PHVA9" class="item journalArticle">
			<h2>Antenatal depressive symptoms and perinatal complications: a prospective study in rural Ethiopia.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bitew T</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hanlon C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kebede E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Honikman S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Fekadu A</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Antenatal depressive symptoms affect around 12.3% 
of women in in low and middle income countries (LMICs) and data are 
accumulating about associations with adverse outcomes for mother and 
child. Studies from rural, low-income country community samples are 
limited. This paper aims to investigate whether antenatal depressive 
symptoms predict perinatal complications in a rural Ethiopia setting. 
METHODS: A population-based prospective study was conducted in Sodo 
district, southern Ethiopia. A total of 1240 women recruited in the 
second and third trimesters of pregnancy were followed up until 4 to 12 
weeks postpartum. Antenatal depressive symptoms were assessed using a 
locally validated version of the Patient Health Questionnaire (PHQ-9) 
that at a cut-off score of five or more indicates probable depression. 
Self-report of perinatal complications, categorised as maternal and 
neonatal were collected by using structured interviewer administered 
questionnaires at a median of eight weeks post-partum. Multivariate 
analysis was conducted to examine the association between antenatal 
depressive symptoms and self-reported perinatal complications. RESULT: A
 total of 28.7% of women had antenatal depressive symptoms (PHQ-9 score 
&gt;/= 5). Women with antenatal depressive symptoms had more than twice 
the odds of self-reported complications in pregnancy (OR=2.44, 95% CI: 
1.84, 3.23), labour (OR= 1.84 95% CI: 1.34, 2.53) and the postpartum 
period (OR=1.70, 95% CI: 1.23, 2.35) compared to women without these 
symptoms. There was no association between antenatal depressive symptoms
 and pregnancy loss or neonatal death. CONCLUSION: Antenatal depressive 
symptoms are associated prospectively with self-reports of perinatal 
complications. Further research is necessary to further confirm these 
findings in a rural and poor context using objective measures of 
complications and investigating whether early detection and treatment of
 depressive symptoms reduces these complications.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2017-08</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 1
Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>17</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>301</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>BMC psychiatry</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/s12888-017-1462-4">10.1186/s12888-017-1462-4</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1471-244X (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:26 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:26 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Prospective Studies</li>
					<li>Young Adult</li>
					<li>Surveys and Questionnaires</li>
					<li>Rural Population</li>
					<li>Postpartum Period/*psychology</li>
					<li>Ethiopia</li>
					<li>*Ethiopia</li>
					<li>*Antenatal depressive symptoms</li>
					<li>*Perinatal complications</li>
					<li>*Prospective study</li>
					<li>*Rural and low income</li>
					<li>Depression, Postpartum/*diagnosis/psychology</li>
					<li>Depression/*diagnosis/psychology</li>
					<li>Life Change Events</li>
					<li>Parturition/psychology</li>
					<li>Pregnancy Complications/*diagnosis/psychology</li>
					<li>Pregnancy Trimester, Third/psychology</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_RVHN5WTV">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong><span style="color: var(--tw-prose-bold)"><span style="background-color: rgb(255, 255, 255)">Location Name:</span></span></strong><span style="background-color: rgb(255, 255, 255)"> </span></p>
<p><span style="background-color: rgb(255, 255, 255)">Sodo district, southern Ethiopia</span></p>
<p><strong><span style="color: var(--tw-prose-bold)"><span style="background-color: rgb(255, 255, 255)">Location Type:</span></span></strong><span style="background-color: rgb(255, 255, 255)"> &nbsp;</span></p>
<p><span style="background-color: rgb(255, 255, 255)">District</span></p>
<p><strong><span style="color: var(--tw-prose-bold)"><span style="background-color: rgb(255, 255, 255)">Description:</span></span></strong><span style="background-color: rgb(255, 255, 255)"> </span></p>
<p><span style="background-color: rgb(255, 255, 255)">&nbsp;Sodo district southern Ethiopia.</span></p>
<p><strong><span style="color: var(--tw-prose-bold)"><span style="background-color: rgb(255, 255, 255)">Sample size :</span></span></strong><span style="background-color: rgb(255, 255, 255)"> 1240</span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_4N9SM2VQ" class="item journalArticle">
			<h2>Antenatal depressive symptoms and utilisation of delivery and postnatal care: a prospective study in rural Ethiopia.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bitew T</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hanlon C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kebede E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Honikman S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Onah MN</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Fekadu A</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Uptake of delivery and postnatal care remains low 
in Low and Middle-Income Countries (LMICs), where 99% of global maternal
 deaths take place. However, the potential impact of antenatal 
depression on use of institutional delivery and postnatal care has 
seldom been examined. This study aimed to examine whether antenatal 
depressive symptoms are associated with use of maternal health care 
services. METHODS: A population-based prospective study was conducted in
 Sodo District, Southern Ethiopia. Depressive symptoms were assessed 
during pregnancy with a locally validated, Amharic version of the 
Patient Health Questionnaire (PHQ-9). A cut off score of five or more 
indicated possible depression. A total of 1251 women were interviewed at
 a median of 8 weeks (4-12 weeks) after delivery. Postnatal outcome 
variables were: institutional delivery care utilization, type of 
delivery, i.e. spontaneous or assisted, and postnatal care utilization. 
Multivariate logistic regression was used to examine the association 
between antenatal depressive symptoms and the outcome variables. 
RESULTS: High levels of antenatal depressive symptoms (PHQ score 5 or 
higher) were found in 28.7% of participating women. Nearly two-thirds, 
783 women (62.6%), delivered in healthcare institutions. After adjusting
 for potential confounders, women with antenatal depressive symptoms had
 increased odds of reporting institutional birth [adjusted Odds Ratio 
(aOR) =1.42, 95% Confidence Interval (CI): 1.06, 1.92] and increased 
odds of reporting having had an assisted delivery (aOR = 1.72, 95% CI: 
1.10, 2.69) as compared to women without these symptoms. However, the 
increased odds of institutional delivery among women with antenatal 
depressive symptoms was associated with unplanned delivery care use 
mainly due to emergency reasons (aOR = 1.62, 95% CI: 1.09, 2.42) rather 
than planning to deliver in healthcare institutions. CONCLUSION: 
Improved detection and treatment of antenatal depression has the 
potential to increase planned institutional delivery and reduce 
perinatal complications, thus contributing to a reduction in maternal 
morbidity and mortality.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2017-06</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 1
Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>17</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>206</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>BMC pregnancy and childbirth</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/s12884-017-1383-8">10.1186/s12884-017-1383-8</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1471-2393 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:35 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:35 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Prospective Studies</li>
					<li>Ethiopia</li>
					<li>Health Facilities/*statistics &amp; numerical data</li>
					<li>Delivery, Obstetric/*statistics &amp; numerical data</li>
					<li>Obstetric Labor Complications/*epidemiology</li>
					<li>Parity</li>
					<li>Prenatal Care/statistics &amp; numerical data</li>
					<li>Health Services Accessibility/statistics &amp; numerical data</li>
					<li>Patient Acceptance of Health Care/*statistics &amp; numerical data</li>
					<li>Antenatal depressive symptoms</li>
					<li>Assisted delivery</li>
					<li>Delivery care use</li>
					<li>Depression/*epidemiology</li>
					<li>Developing Countries/*statistics &amp; numerical data</li>
					<li>Educational Measurement</li>
					<li>Planned institutional delivery</li>
					<li>Postnatal care use</li>
					<li>Postnatal Care/statistics &amp; numerical data</li>
					<li>Rural Population/statistics &amp; numerical data</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_XDFIT3HL">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong><span style="color: var(--tw-prose-bold)"><span style="background-color: rgb(255, 255, 255)">Location Name:</span></span></strong></p>
<p><span style="background-color: rgb(255, 255, 255)"> Sodo District, Southern Ethiopia</span></p>
<p><strong><span style="color: var(--tw-prose-bold)"><span style="background-color: rgb(255, 255, 255)">Location Type:</span></span></strong><span style="background-color: rgb(255, 255, 255)"> </span></p>
<p><span style="background-color: rgb(255, 255, 255)">District</span></p>
<p><strong><span style="color: var(--tw-prose-bold)"><span style="background-color: rgb(255, 255, 255)">Description:</span></span></strong></p>
<p><span style="background-color: rgb(255, 255, 255)"> Sodo District, located in Southern Ethiopia.</span></p>
<p><strong><span style="color: var(--tw-prose-bold)"><span style="background-color: rgb(255, 255, 255)">Sample size :</span></span></strong><span style="background-color: rgb(255, 255, 255)"> </span><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">&nbsp;1251</span></span></p>
<p><span style="color: rgb(0, 0, 0)"><span style="background-color: rgb(255, 255, 255)"><br></span></span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_H4JQUNZN" class="item journalArticle">
			<h2>Antenatal Dexamethasone for Early Preterm Birth in Low-Resource Countries.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Oladapo OT</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Vogel JP</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Piaggio G</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Nguyen MH</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Althabe F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gulmezoglu AM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bahl R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Rao SPN</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>De Costa A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gupta S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Baqui AH</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Khanam R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Shahidullah M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chowdhury SB</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ahmed S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Begum N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>D Roy A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Shahed MA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Jaben IA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Yasmin F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Rahman MM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ara A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Khatoon S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ara G</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Akter S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Akhter N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Dey PR</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sabur MA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Azad MT</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Choudhury SF</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Matin MA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Goudar SS</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Dhaded SM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Metgud MC</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Pujar YV</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Somannavar MS</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Vernekar SS</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Herekar VR</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bidri SR</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mathapati SS</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Patil PG</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Patil MM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gudadinni MR</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bijapure HR</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mallapur AA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Katageri GM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chikkamath SB</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Yelamali BC</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Pol RR</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Misra SS</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Das L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Nanda S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Nayak RB</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Singh B</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Qureshi Z</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Were F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Osoti A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gwako G</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Laving A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kinuthia J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mohamed H</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Aliyan N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Barassa A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kibaru E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mbuga M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Thuranira L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Githua NJ</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Lusweti B</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ayede AI</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Falade AG</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Adesina OA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Agunloye AM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Iyiola OO</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sanni W</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ejinkeonye IK</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Idris HA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Okoli CV</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Irinyenikan TA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Olubosede OA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bello O</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Omololu OM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Olutekunbi OA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Akintan AL</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Owa OO</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Oluwafemi RO</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Eniowo IP</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Fabamwo AO</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Disu EA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Agbara JO</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Adejuyigbe EA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kuti O</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Anyabolu HC</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Awowole IO</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Fehintola AO</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kuti BP</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Isah AD</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Olateju EK</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Abiodun O</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Dedeke OF</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Akinkunmi FB</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Oyeneyin L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Adesiyun O</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Raji HO</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ande ABA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Okonkwo I</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ariff S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Soofi SB</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sheikh L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Zulfiqar S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Omer S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sikandar R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sheikh S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Giordano D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gamerro H</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Carroli G</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Carvalho J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Neilson J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Molyneux E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Yunis K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mugerwa K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chellani HK</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: The safety and efficacy of antenatal 
glucocorticoids in women in low-resource countries who are at risk for 
preterm birth are uncertain. METHODS: We conducted a multicountry, 
randomized trial involving pregnant women between 26 weeks 0 days and 33
 weeks 6 days of gestation who were at risk for preterm birth. The 
participants were assigned to intramuscular dexamethasone or identical 
placebo. The primary outcomes were neonatal death alone, stillbirth or 
neonatal death, and possible maternal bacterial infection; neonatal 
death alone and stillbirth or neonatal death were evaluated with 
superiority analyses, and possible maternal bacterial infection was 
evaluated with a noninferiority analysis with the use of a prespecified 
margin of 1.25 on the relative scale. RESULTS: A total of 2852 women 
(and their 3070 fetuses) from 29 secondary- and tertiary-level hospitals
 across Bangladesh, India, Kenya, Nigeria, and Pakistan underwent 
randomization. The trial was stopped for benefit at the second interim 
analysis. Neonatal death occurred in 278 of 1417 infants (19.6%) in the 
dexamethasone group and in 331 of 1406 infants (23.5%) in the placebo 
group (relative risk, 0.84; 95% confidence interval [CI], 0.72 to 0.97; P
 = 0.03). Stillbirth or neonatal death occurred in 393 of 1532 fetuses 
and infants (25.7%) and in 444 of 1519 fetuses and infants (29.2%), 
respectively (relative risk, 0.88; 95% CI, 0.78 to 0.99; P = 0.04); the 
incidence of possible maternal bacterial infection was 4.8% and 6.3%, 
respectively (relative risk, 0.76; 95% CI, 0.56 to 1.03). There was no 
significant between-group difference in the incidence of adverse events.
 CONCLUSIONS: Among women in low-resource countries who were at risk for
 early preterm birth, the use of dexamethasone resulted in significantly
 lower risks of neonatal death alone and stillbirth or neonatal death 
than the use of placebo, without an increase in the incidence of 
possible maternal bacterial infection. (Funded by the Bill and Melinda 
Gates Foundation and the World Health Organization; Australian and New 
Zealand Clinical Trials Registry number, ACTRN12617000476336; Clinical 
Trials Registry-India number, CTRI/2017/04/008326.).</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2020-12</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 26
Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>383</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>2514-2525</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>The New England journal of medicine</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1056/NEJMoa2022398">10.1056/NEJMoa2022398</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>26</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>0028-4793 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:42 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:42 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Infant, Newborn</li>
					<li>Infant, Low Birth Weight</li>
					<li>Premature Birth</li>
					<li>Developing Countries</li>
					<li>*Prenatal Care</li>
					<li>Infant, Premature</li>
					<li>Stillbirth/epidemiology</li>
					<li>Dexamethasone/*administration &amp; dosage</li>
					<li>Glucocorticoids/*administration &amp; dosage</li>
					<li>Infant, Premature, Diseases/epidemiology/*prevention &amp; control</li>
					<li>Injections, Intramuscular</li>
					<li>Perinatal Death/*prevention &amp; control</li>
					<li>Risk</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_Y7XMUS2N">
<div><div data-schema-version="8"><p><strong>Location information</strong></p>
<p><strong><span style="color: var(--tw-prose-bold)"><span style="background-color: rgb(255, 255, 255)">Location Name :</span></span></strong></p>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Kenya</strong></p>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; University of Nairobi, Nairobi, Kenya:</p>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;Kenyatta National Hospital, Nairobi, Kenya:</p>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Coast Provincial General Hospital, Mombasa, Kenya:</p>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;Nakuru Level 5 Hospital, Nakuru, Kenya:</p>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Kiambu level 5 Hospital, Kiambu, Kenya:</p>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Thika level 5 Hospital, Thika, Kenya:</p>
<p><strong>Nigeria (Ibadan) site:</strong></p>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; College of Medicine, 
University of Ibadan and University College Hospital, Ibadan, Nigeria:</p>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Kubwa General Hospital, Abuja, Nigeria:</p>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;Nyanya General Hospital, Abuja, Nigeria:</p>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; State Specialist Hospital, Akure, Nigeria:</p>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;Lagos Island Maternity Hospital, Lagos, Nigeria:</p>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mother and Child Hospital, Akure, Nigeria:</p>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria:</p>
<p><strong>Nigeria (Ile-Ife) site:</strong></p>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Obafemi Awolowo University, Ile-Ife, Nigeria:</p>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; University of Benin, Benin City, Nigeria:</p>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; University of Ilorin, Ilorin, Nigeria:</p>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; University of Abuja, Gwagwalada, Federal Capital Territory, Nigeria:</p>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sacred Heart Hospital, Lantoro, Abeokuta, Nigeria:</p>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mother &amp; Child Hospital, Ondo, Nigeria:</p>
<p><img alt="" src="data:image/png;base64,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" width="1055" height="605"></p>
<p><strong><span style="color: var(--tw-prose-bold)"><span style="background-color: rgb(255, 255, 255)">Location Type : </span></span></strong><span style="color: var(--tw-prose-bold)"><span style="background-color: rgb(255, 255, 255)">Health facility</span></span></p>
<p><strong><span style="color: var(--tw-prose-bold)"><span style="background-color: rgb(255, 255, 255)">Description:</span></span></strong><span style="background-color: rgb(255, 255, 255)">
 29 secondary- and tertiary-level hospitals across six trial sites, 
including locations in Bangladesh, India, Kenya, Nigeria, and Pakistan.</span></p>
<p><strong><span style="color: var(--tw-prose-bold)"><span style="background-color: rgb(255, 255, 255)">Sample size :</span></span></strong><span style="background-color: rgb(255, 255, 255)"> </span><span style="color: rgb(77, 77, 77)"><span style="background-color: rgb(255, 255, 255)">2852</span></span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_CPZGZ9IH" class="item journalArticle">
			<h2>Antenatal Doppler screening for fetuses at risk of adverse 
outcomes: a multicountry cohort study of the prevalence of abnormal 
resistance index in low-risk pregnant women.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Vannevel V</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Vogel JP</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Pattinson RC</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Adanu R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Charantimath U</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Goudar SS</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gwako G</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kavi A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Maya E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Osoti A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Pujar Y</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Qureshi ZP</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Rulisa S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Botha T</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Oladapo OT</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>INTRODUCTION: Few interventions exist to address the high 
burden of stillbirths in apparently healthy pregnant women in low- and 
middle-income countries (LMICs). To establish whether a trial on the 
impact of routine Doppler screening in a low-risk obstetric population 
is warranted, we determined the prevalence of abnormal fetal umbilical 
artery resistance indices among low-risk pregnant women using a low-cost
 Doppler device in five LMICs. METHODS: We conducted a multicentre, 
prospective cohort study in Ghana, India, Kenya, Rwanda and South 
Africa. Trained nurses or midwives performed a single, continuous-wave 
Doppler screening using the Umbiflow device for low-risk pregnant women 
(according to local guidelines) between 28 and 34 weeks' gestation. We 
assessed the prevalence of abnormal (raised) resistance index (RI), 
including absent end diastolic flow (AEDF), and compared pregnancy and 
health service utilisation outcomes between women with abnormal RI 
versus those with normal RI. RESULTS: Of 7151 women screened, 495 (6.9%)
 had an abnormal RI, including 14 (0.2%) with AEDF. Caesarean section 
(40.8% vs 28.1%), labour induction (20.5% vs 9.0%) and low birth weight 
(&lt;2500 g) (15.0% vs 6.8%) were significantly more frequent among 
women with abnormal RI compared with women with normal RI. Abnormal RI 
was associated with lower birth weights across all weight centiles. 
Stillbirth and perinatal mortality rates were similar between women with
 normal and abnormal RI. CONCLUSION: A single Doppler screening of 
low-risk pregnant women in LMICs using the Umbiflow device can detect a 
large number of fetuses at risk of growth restriction and consequent 
adverse perinatal outcomes. Many perinatal deaths could potentially be 
averted with appropriate intervention strategies. TRIAL REGISTRATION 
NUMBER: CTRI/2018/07/01486.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2022-03</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>12</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e053622</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>BMJ open</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1136/bmjopen-2021-053622">10.1136/bmjopen-2021-053622</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>3</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>2044-6055 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Cohort Studies</li>
					<li>Prospective Studies</li>
					<li>Prevalence</li>
					<li>Stillbirth/epidemiology</li>
					<li>*Pregnant Women</li>
					<li>*public health</li>
					<li>Ultrasonography, Prenatal</li>
					<li>Fetus/diagnostic imaging</li>
					<li>*Cesarean Section</li>
					<li>*obstetrics</li>
					<li>*primary care</li>
					<li>Fetal Growth Retardation/diagnostic imaging/epidemiology</li>
					<li>Ultrasonography, Doppler</li>
					<li>Umbilical Arteries/diagnostic imaging</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_7HC4YPD9">
<div><div data-schema-version="8"><p><strong><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Location Information</span></span></strong></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Name: &nbsp;</span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">specific names of health facilities not specified</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Type:</span></span></strong></p>
<p><span style="background-color: rgb(255, 255, 255)">Health facility</span></p>
<p><strong><span style="color: black"><span style="background-color: white">Description: </span></span></strong></p>
<p><span style="background-color: rgb(255, 255, 255)"> </span><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Multi-country,
 2 health facilities in each of the following countries Ghana, Kenya, 
Rwanda, and South Africa and 3 health facilities in India.</span></span></p>
<p><strong>Sample Size: &nbsp; 5741</strong></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_UXHUQDFU" class="item journalArticle">
			<h2>Antenatal predictors of incident and persistent postnatal 
depressive symptoms in rural Ethiopia: a population-based prospective 
study.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bitew T</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hanlon C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Medhin G</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Fekadu A</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: There have been few studies to examine antenatal 
predictors of incident postnatal depression, particularly in low- and 
middle-income countries (LMICs). The aim of this study was to 
investigate antenatal predictors of incident and persistent maternal 
depression in a rural Ethiopian community in order to inform development
 of antenatal interventions. METHOD: A population-based prospective 
study was conducted in Sodo district, south central Ethiopia. A locally 
validated version of the Patient Health Questionnaire (PHQ-9) was used 
to assess antenatal (second and third trimesters) and postnatal (4-12 
weeks after childbirth) depressive symptoms, with a PHQ-9 cut-off of 
five or more indicating high depressive symptoms. Poisson regression 
with robust standard errors was used to identify independent predictors 
of persistence and incidence of postnatal depressive symptoms from a 
range of antenatal, clinical and psychosocial risk factors. RESULT: Out 
of 1311 women recruited antenatally, 1240 (356 with and 884 without 
antenatal depressive symptoms) were followed up in the postnatal period.
 Among 356 women with antenatal depressive symptoms, the elevated 
symptoms persisted into postnatal period in 138 women (38.8%). Out of 
884 women without antenatal depressive symptoms, 136 (15.4%) experienced
 incident elevated depressive symptoms postnatally. The prevalence of 
high postnatal depressive symptoms in the follow-up sample was 274 
(22.1%). Higher intimate partner violence scores in pregnancy were 
significantly associated with greater risk of incident depressive 
symptoms [adjusted Risk Ratio (aRR) = 1.06, 95% CI: 1.00, 1.12]. Each 
1-point increment in baseline PHQ-9 score predicted an increased risk of
 incidence of postnatal depressive symptoms (aRR = 1.29, 95% CI: 1.15, 
1.45). There was no association between self-reported pregnancy 
complications, medical conditions or experience of threatening life 
events with either incidence or persistence of depressive symptoms. 
CONCLUSION: Psychological and social interventions to address intimate 
partner violence during pregnancy may be the most important priorities, 
able to address both incident and persistent depression.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2019-03</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 1
Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>16</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>28</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Reproductive health</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/s12978-019-0690-0">10.1186/s12978-019-0690-0</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1742-4755 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:38 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:38 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Incidence</li>
					<li>Pregnancy</li>
					<li>*Pregnancy Complications</li>
					<li>Prospective Studies</li>
					<li>Prevalence</li>
					<li>Rural Population</li>
					<li>Prenatal Care</li>
					<li>Ethiopia</li>
					<li>Ethiopia/epidemiology</li>
					<li>*Intimate Partner Violence</li>
					<li>*Life Change Events</li>
					<li>Depression, Postpartum/*epidemiology/psychology</li>
					<li>Depressive symptoms</li>
					<li>Low and middle income countries</li>
					<li>Perinatal depression</li>
					<li>Persistent depression</li>
					<li>Postnatal depression</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_YK6TSJAJ">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong><span style="color: var(--tw-prose-bold)"><span style="background-color: rgb(255, 255, 255)">Location Name:</span></span></strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Sodo district, Gurage Zone central Ethiopia</span></span></p>
<p><strong><span style="color: var(--tw-prose-bold)"><span style="background-color: rgb(255, 255, 255)">Location Type: </span></span></strong></p>
<p><span style="background-color: rgb(255, 255, 255)">District</span></p>
<p><strong><span style="color: var(--tw-prose-bold)"><span style="background-color: rgb(255, 255, 255)">Description:</span></span></strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Sodo district, Gurage Zone of the Southern Nations, Nationalities and Peoples Region (SNNPR) of Ethiopia.</span></span></p>
<p><strong><span style="color: var(--tw-prose-bold)"><span style="background-color: rgb(255, 255, 255)">Sample size :</span></span></strong><span style="background-color: rgb(255, 255, 255)"> </span><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">1355&nbsp;</span></span></p>
<p></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_8UFWCWRF" class="item journalArticle">
			<h2>Antibiotic prophylaxis in the surgical management of miscarriage 
in low-income countries: a cost-effectiveness analysis of the AIMS 
trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Goranitis I</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Lissauer DM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Coomarasamy A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Wilson A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Daniels J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Middleton L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bishop J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hewitt CA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Weeks AD</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mhango C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mataya R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ahmed I</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Oladapo OT</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Zamora J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Roberts TE</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: There is ongoing debate on the clinical benefits 
of antibiotic prophylaxis for reducing pelvic infection after 
miscarriage surgery. We aimed to study the cost-effectiveness of 
antibiotic prophylaxis in the surgical management of miscarriage in 
low-income countries. METHODS: We did an incremental cost-effectiveness 
analysis using data from 3412 women recruited to the AIMS trial, a 
randomised, double-blind, placebo-controlled trial designed to evaluate 
the effectiveness of antibiotic prophylaxis in the surgical management 
of miscarriage in Malawi, Pakistan, Tanzania, and Uganda. Economic 
evaluation was done from a health-care-provider perspective on the basis
 of the outcome of cost per pelvic infection avoided within 2 weeks of 
surgery. Pelvic infection was broadly defined by the presence of 
clinical features or the clinically identified need to administer 
antibiotics. We used non-parametric bootstrapping and multilevel random 
effects models to estimate incremental mean costs and outcomes. Decision
 uncertainty was shown via cost-effectiveness acceptability frontiers. 
The AIMS trial is registered with the ISRCTN registry, number 
ISRCTN97143849. FINDINGS: Between June 2, 2014, and April 26, 2017, 3412
 women were assigned to receive either antibiotic prophylaxis (1705 
[50%] of 3412) or placebo (1707 [50%] of 3412) in the AIMS trial. 158 
(5%) of 3412 women developed pelvic infection within 2 weeks of surgery,
 of whom 68 (43%) were in the antibiotic prophylaxis group and 90 (57%) 
in the placebo group. There is 97-98% probability that antibiotic 
prophylaxis is a cost-effective intervention at expected thresholds of 
willingness-to-pay per additional pelvic infection avoided. In terms of 
post-surgery antibiotics, the antibiotic prophylaxis group was US$0.27 
(95% CI -0.49 to -0.05) less expensive per woman than the placebo group.
 A secondary analysis, a sensitivity analysis, and all subgroup analyses
 supported these findings. Antibiotic prophylaxis, if implemented 
routinely before miscarriage surgery, could translate to an annual total
 cost saving of up to $1.4 million across the four participating 
countries and up to $8.5 million across the two regions of sub-Saharan 
Africa and south Asia. INTERPRETATION: Antibiotic prophylaxis is more 
effective and less expensive than no antibiotic prophylaxis. Policy 
makers in various settings should be confident that antibiotic 
prophylaxis in miscarriage surgery is cost-effective. FUNDING: UK 
Medical Research Council, Wellcome Trust, and the UK Department for 
International Development.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2019-09</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 9
Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>7</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e1280-e1286</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>The Lancet. Global health</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1016/S2214-109X(19)30336-5">10.1016/S2214-109X(19)30336-5</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>9</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>2214-109X (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:43 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:43 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Young Adult</li>
					<li>Malawi</li>
					<li>Uganda</li>
					<li>Treatment Outcome</li>
					<li>Adolescent</li>
					<li>Abortion, Spontaneous/*surgery</li>
					<li>Antibiotic Prophylaxis/*economics</li>
					<li>Cost-Benefit Analysis</li>
					<li>Developing Countries</li>
					<li>Double-Blind Method</li>
					<li>Pakistan</li>
					<li>Tanzania</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_G8QVBI5J">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong><span style="color: rgb(80, 80, 80)"><span style="background-color: rgb(255, 255, 255)">Location Name</span></span></strong><span style="color: rgb(80, 80, 80)"><span style="background-color: rgb(255, 255, 255)"> : &nbsp;</span></span></p>
<p><span style="color: rgb(80, 80, 80)"><span style="background-color: rgb(255, 255, 255)">Facility Name not specified</span></span></p>
<p><strong>Location Type</strong> : </p>
<p>Health Facility</p>
<p><strong>Description</strong> : </p>
<p><span style="color: rgb(80, 80, 80)"><span style="background-color: rgb(255, 255, 255)">13 hospitals in Malawi, </span></span><strong><span style="color: rgb(80, 80, 80)"><span style="background-color: rgb(255, 212, 0);">Pakistan</span></span></strong><span style="color: rgb(80, 80, 80)"><span style="background-color: rgb(255, 255, 255)">, Tanzania, and Uganda</span></span></p>
<p><strong>Sample size : </strong><span style="color: rgb(80, 80, 80)"><span style="background-color: rgb(255, 255, 255)">3412&nbsp;</span></span></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_D7DKAHAT" class="item journalArticle">
			<h2>Assessment of the safety of antimalarial drug use during early 
pregnancy (ASAP): protocol for a multicenter prospective cohort study in
 Burkina Faso, Kenya and Mozambique.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Tinto H</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sevene E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Dellicour S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Calip GS</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>d'Alessandro U</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Macete E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Nakanabo-Diallo S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kazienga A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Valea I</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sorgho H</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Vala A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Augusto O</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ruperez M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Menendez C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ouma P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Desai M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ter Kuile F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Stergachis A</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: A major unresolved safety concern for malaria case
 management is the use of artemisinin combination therapies (ACTs) in 
the first trimester of pregnancy. There is a need for human data to 
inform policy makers and treatment guidelines on the safety of 
artemisinin combination therapies (ACT) when used during early 
pregnancy. METHODS: The overall goal of this paper is to describe the 
methods and implementation of a study aimed at developing surveillance 
systems for identifying exposures to antimalarials during early 
pregnancy and for monitoring pregnancy outcomes using health and 
demographic surveillance platforms. This was a multi-center prospective 
observational cohort study involving women at health and demographic 
surveillance sites in three countries in Africa: Burkina Faso, Kenya and
 Mozambique [(ClinicalTrials.gov Identifier: NCT01232530)]. The study 
was designed to identify pregnant women with artemisinin exposure in the
 first trimester and compare them to: 1) pregnant women without malaria,
 2) pregnant women treated for malaria, but exposed to other 
antimalarials, and 3) pregnant women with malaria and treated with 
artemisinins in the 2nd or 3rd trimesters from the same settings. 
Pregnant women were recruited through community-based surveys and 
attendance at health facilities, including antenatal care clinics and 
followed until delivery. Data from the three sites will be pooled for 
analysis at the end of the study. Results are forthcoming. DISCUSSION: 
Despite few limitations, the methods described here are relevant to the 
development of sustainable pharmacovigilance systems for drugs used by 
pregnant women in the tropics using health and demographic surveillance 
sites to prospectively ascertain drug safety in early pregnancy. TRIAL 
REGISTRATION: NCT01232530.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2015-12</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>12</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>112</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Reproductive health</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/s12978-015-0101-0">10.1186/s12978-015-0101-0</a></td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1742-4755 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:23 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:23 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Cohort Studies</li>
					<li>Infant, Newborn</li>
					<li>Prospective Studies</li>
					<li>Gestational Age</li>
					<li>Pregnancy Outcome</li>
					<li>Prenatal Exposure Delayed Effects</li>
					<li>Malaria/*drug therapy</li>
					<li>Pregnancy Complications, Parasitic/*drug therapy</li>
					<li>Research Design</li>
					<li>Drug Administration Schedule</li>
					<li>Patient Selection</li>
					<li>Pregnancy Trimester, First</li>
					<li>Clinical Protocols</li>
					<li>Maternal-Fetal Exchange</li>
					<li>Sample Size</li>
					<li>Antimalarials/*adverse effects/therapeutic use</li>
					<li>Artemisinins/adverse effects/therapeutic use</li>
					<li>Pharmacovigilance</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_J8QVIKXM">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Name:</span></span></strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Siaya County Kenya; Nanoro Burkina Faso; &nbsp;Manhia District, Mozambique.</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Type: </span></span></strong></p>
<p><span style="color: var(--tw-prose-bold)"><span style="background-color: rgb(255, 255, 255)">Rural Community</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Description:</span></span></strong></p>
<p><span style="background-color: rgb(255, 255, 255)">Rarieda District 
in Siaya County, Kenya, central Burkina Faso, West Africa &amp; de 
Investigao em Sade de Manhia Mozambique Maputo city.</span></p>
<p><strong>Sample Size: &nbsp; 3176</strong></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_XUH774GS" class="item journalArticle">
			<h2>Association between maternal age at childbirth and child and 
adult outcomes in the offspring: a prospective study in five low-income 
and middle-income countries (COHORTS collaboration).</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Fall CH</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sachdev HS</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Osmond C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Restrepo-Mendez MC</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Victora C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Martorell R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Stein AD</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sinha S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Tandon N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Adair L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bas I</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Norris S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Richter LM</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Both young and advanced maternal age is associated
 with adverse birth and child outcomes. Few studies have examined these 
associations in low-income and middle-income countries (LMICs) and none 
have studied adult outcomes in the offspring. We aimed to examine both 
child and adult outcomes in five LMICs. METHODS: In this prospective 
study, we pooled data from COHORTS (Consortium for Health Orientated 
Research in Transitioning Societies)-a collaboration of five birth 
cohorts from LMICs (Brazil, Guatemala, India, the Philippines, and South
 Africa), in which mothers were recruited before or during pregnancy, 
and the children followed up to adulthood. We examined associations 
between maternal age and offspring birthweight, gestational age at 
birth, height-for-age and weight-for-height Z scores in childhood, 
attained schooling, and adult height, body composition (body-mass index,
 waist circumference, fat, and lean mass), and cardiometabolic risk 
factors (blood pressure and fasting plasma glucose concentration), along
 with binary variables derived from these. Analyses were unadjusted and 
adjusted for maternal socioeconomic status, height and parity, and 
breastfeeding duration. FINDINGS: We obtained data for 22 188 mothers 
from the five cohorts, enrolment into which took place at various times 
between 1969 and 1989. Data for maternal age and at least one outcome 
were available for 19 403 offspring (87%). In unadjusted analyses, 
younger (&lt;/=19 years) and older (&gt;/=35 years) maternal age were 
associated with lower birthweight, gestational age, child nutritional 
status, and schooling. After adjustment, associations with younger 
maternal age remained for low birthweight (odds ratio [OR] 1.18 (95% CI 
1.02-1.36)], preterm birth (1.26 [1.03-1.53]), 2-year stunting (1.46 
[1.25-1.70]), and failure to complete secondary schooling (1.38 
[1.18-1.62]) compared with mothers aged 20-24 years. After adjustment, 
older maternal age remained associated with increased risk of preterm 
birth (OR 1.33 [95% CI 1.05-1.67]), but children of older mothers had 
less 2-year stunting (0.64 [0.54-0.77]) and failure to complete 
secondary schooling (0.59 [0.48-0.71]) than did those with mothers aged 
20-24 years. Offspring of both younger and older mothers had higher 
adult fasting glucose concentrations (roughly 0.05 mmol/L). 
INTERPRETATION: Children of young mothers in LMICs are disadvantaged at 
birth and in childhood nutrition and schooling. Efforts to prevent early
 childbearing should be strengthened. After adjustment for confounders, 
children of older mothers have advantages in nutritional status and 
schooling. Extremes of maternal age could be associated with disturbed 
offspring glucose metabolism. FUNDING: Wellcome Trust and the Bill &amp;
 Melinda Gates Foundation.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2015-07</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>3</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e366-77</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>The Lancet. Global health</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1016/S2214-109X(15)00038-8">10.1016/S2214-109X(15)00038-8</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>7</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>2214-109X (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Mothers</li>
					<li>Pregnancy</li>
					<li>*Premature Birth</li>
					<li>Infant, Newborn</li>
					<li>Prospective Studies</li>
					<li>Young Adult</li>
					<li>Male</li>
					<li>*Developing Countries</li>
					<li>Gestational Age</li>
					<li>Child, Preschool</li>
					<li>Adolescent</li>
					<li>Child</li>
					<li>*Birth Weight</li>
					<li>Age Factors</li>
					<li>Income</li>
					<li>*Maternal Age</li>
					<li>*Educational Status</li>
					<li>*Growth Disorders</li>
					<li>Blood Glucose/metabolism</li>
					<li>Global Health</li>
					<li>Schools</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_EXPFUXJZ">
<div><div data-schema-version="8"><p><strong>Location Information:</strong></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Name:</span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">Specific names of the health facilities not given</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Type:</span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">Health facilities in </span></span><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Johannesburg.</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Description:</span></span></strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">The Birth to Twenty Cohort was conducted in multi countries including Johannesburg(South Africa)</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Sample size : &nbsp;3273</span></span></strong></p>
<p></p>
<p></p>
<p></p>
<p></p>
<p></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_TFUHQU34" class="item journalArticle">
			<h2>Association of maternal prenatal selenium concentration and preterm birth: a multicountry meta-analysis.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Monangi N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Xu H</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Khanam R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Khan W</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Deb S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Pervin J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Price JT</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kennedy SH</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Al Mahmud A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Fan Y</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Le TQ</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Care A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Landero JA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Combs GF</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Belling E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chappell J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kong F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Lacher C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ahmed S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chowdhury NH</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Rahman S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kabir F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Nisar I</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hotwani A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mehmood U</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Nizar A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Khalid J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Dhingra U</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Dutta A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ali S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Aftab F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Juma MH</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Rahman M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Vwalika B</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Musonda P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ahmed T</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Islam MM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ashorn U</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Maleta K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hallman M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Goodfellow L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gupta JK</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Alfirevic A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Murphy S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Rand L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ryckman KK</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Murray JC</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bahl R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Litch JA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Baruch-Gravett C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Alfirevic Z</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ashorn P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Baqui A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hirst J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hoyo C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Jehan F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Jelliffe-Pawlowski LL</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Rahman A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Roth DE</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sazawal S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Stringer J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Zhang G</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Muglia L</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Selenium (Se), an essential trace mineral, has 
been implicated in preterm birth (PTB). We aimed to determine the 
association of maternal Se concentrations during pregnancy with PTB risk
 and gestational duration in a large number of samples collected from 
diverse populations. METHODS: Gestational duration data and maternal 
plasma or serum samples of 9946 singleton live births were obtained from
 17 geographically diverse study cohorts. Maternal Se concentrations 
were determined by inductively coupled plasma mass spectrometry 
analysis. The associations between maternal Se with PTB and gestational 
duration were analysed using logistic and linear regressions. The 
results were then combined using fixed-effect and random-effect 
meta-analysis. FINDINGS: In all study samples, the Se concentrations 
followed a normal distribution with a mean of 93.8 ng/mL (SD: 28.5 
ng/mL) but varied substantially across different sites. The fixed-effect
 meta-analysis across the 17 cohorts showed that Se was significantly 
associated with PTB and gestational duration with effect size estimates 
of an OR=0.95 (95% CI: 0.9 to 1.00) for PTB and 0.66 days (95% CI: 0.38 
to 0.94) longer gestation per 15 ng/mL increase in Se concentration. 
However, there was a substantial heterogeneity among study cohorts and 
the random-effect meta-analysis did not achieve statistical 
significance. The largest effect sizes were observed in UK (Liverpool) 
cohort, and most significant associations were observed in samples from 
Malawi. INTERPRETATION: While our study observed statistically 
significant associations between maternal Se concentration and PTB at 
some sites, this did not generalise across the entire cohort. Whether 
population-specific factors explain the heterogeneity of our findings 
warrants further investigation. Further evidence is needed to understand
 the biologic pathways, clinical efficacy and safety, before changes to 
antenatal nutritional recommendations for Se supplementation are 
considered.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2021-09</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 9
Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>6</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>BMJ global health</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1136/bmjgh-2021-005856">10.1136/bmjgh-2021-005856</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>9</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>2059-7908 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:27 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:27 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Infant, Newborn</li>
					<li>Gestational Age</li>
					<li>*Premature Birth/epidemiology</li>
					<li>*epidemiology</li>
					<li>*maternal health</li>
					<li>*child health</li>
					<li>*environmental health</li>
					<li>*nutrition</li>
					<li>*Selenium</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_7D4U5A7F">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location Name</strong> :</p>
<p>Soweto, Mangochi district Malawi, &nbsp;Pemba island Tanzania and Lusaka Zambia</p>
<p><strong>Location Type</strong> : </p>
<p>City</p>
<p><strong>Description</strong> &nbsp;: </p>
<p>&nbsp;African countries only.</p>
<p>Soweto, Johannesburg <strong>South Africa</strong>; 2 hospitals and 2
 health centers in a rural area in Mangochi district Malawi, &nbsp;Pemba
 island Tanzania; Lusaka district Zambia</p>
<p><strong>Sample size : </strong><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">9946</span></span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_DFBARHF6" class="item journalArticle">
			<h2>Associations between birth kit use and maternal and neonatal 
health outcomes in rural Jigawa state, Nigeria: A secondary analysis of 
data from a cluster randomized controlled trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Leight J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sharma V</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Brown W</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Costica L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Abdulaziz Sule F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bjorkman Nyqvist M</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: The burden of maternal and neonatal mortality 
remains persistently high in Nigeria. Sepsis contributes significantly 
to both maternal and newborn mortality, and safe delivery kits have long
 been promoted as a cost-effective intervention to ensure hygienic 
delivery practices and reduce sepsis. However, there is limited evidence
 on the effectiveness of home birth kit distribution by community health
 workers, and particularly the impact of this intervention on health 
outcomes. This paper reports a secondary analysis of data from a cluster
 randomized trial in rural northern Nigeria in which birth kits were 
distributed by community health workers to pregnant women in their 
homes, analyzing non-experimental variation in receipt and use of birth 
kits. More specifically, associations between pregnant women's baseline 
characteristics and receipt and use of birth kits, and associations 
between birth kit use, care utilization and maternal and newborn 
outcomes were assessed. METHODS AND FINDINGS: Baseline, post-birth and 
endline data related to 3,317 births observed over a period of three 
years in 72 intervention communities in Jigawa state, Nigeria, were 
analyzed using hierarchical, logistic regression models. In total, 140 
women received birth kits, and 72 women used the kits. There were no 
associations between baseline demographic characteristics, health 
history, and knowledge and attitudes and receipt of a kit, suggesting 
that community health workers did not systematically target the 
distribution of birth kits. However, women who used the kit reported 
reduced odds of past pregnancy complications (OR = 0.44, 95% CI: 
0.19-1.00) as well as significantly higher odds of feeling generally 
healthy at baseline (OR = 2.00, 95% CI: 1.06-3.76), of exposure to radio
 media (OR = 1.97, 95% CI: 1.21-3.22), and of perceiving themselves as 
having a low-risk pregnancy (OR = 3.05, 95% CI:1.39-6.68). While there 
were no significant associations between birth kit use and facility 
based delivery, skilled birth attendance or post-natal care, women who 
used a kit exhibited significantly lower odds of completing four or more
 ANC visits (adjusted OR = 0.39, 95% CI: 0.18-0.85) and significantly 
higher odds of reporting prolonged labor (adjusted OR = 4.75, 95% CI: 
1.36-16.59), and post-partum bleeding (adjusted OR = 3.25, 95% CI: 
1.11-9.52). CONCLUSIONS: This evidence suggests that use of birth kits 
is low in a rural population characterized by minimal baseline 
utilization of maternal and neonatal health services, and the use of 
birth kits was not associated with reductions in maternal or neonatal 
morbidity. While further research is required to understand how the 
effectiveness of birth kits may be shaped by the mechanism through which
 women access and utilize the kits, our findings suggest that the 
provision of kits to women outside of the formal health system may be 
associated with increased risk of adverse outcomes.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2018</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 12
Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>13</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e0208885</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>PloS one</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1371/journal.pone.0208885">10.1371/journal.pone.0208885</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>12</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1932-6203 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:43 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:43 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Infant, Newborn</li>
					<li>Nigeria</li>
					<li>Pregnancy Outcome</li>
					<li>*Maternal Health Services</li>
					<li>Pregnant Women</li>
					<li>Rural Population</li>
					<li>*Infant Health</li>
					<li>*Maternal Health</li>
					<li>*Prenatal Care</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_UWH9NTPD">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name</strong> :</p>
<p>Communities not specified in the text</p>
<p><strong>Location Type</strong>:</p>
<p>Community</p>
<p><strong>Description :</strong></p>
<p><span style="color: rgb(32, 32, 32)"><span style="background-color: rgb(255, 255, 255)">72 </span></span><span style="background-color: rgb(255, 255, 255)">Intervention communities within Jigawa state, Nigeria.</span></p>
<p><strong>Sample size : &nbsp;</strong><span style="color: rgb(32, 32, 32)"><span style="background-color: rgb(255, 255, 255)">3,317</span></span></p>
<p></p>
<p></p>
<p></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_EUWQ7W6C" class="item journalArticle">
			<h2>Born too small: who survives in the public hospitals in Lilongwe, Malawi?</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ahlsen AK</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Spong E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kafumba N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kamwendo F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Wolff K</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>OBJECTIVE: Malawi has the highest estimated preterm birth rate
 in the world. The survival rate of these babies is not known. The main 
objective of this study was to demonstrate the short-term survival of 
infants with birth weight below 2500 g nursed in Bwaila Hospital, a 
district hospital, and the tertiary level Kamuzu Central Hospital (KCH) 
in Lilongwe. The specific objectives were to calculate birth weight 
specific survival rates, compare the two hospitals regarding the chances
 of survival and review the use of antenatal corticosteroids. DESIGN: 
1496 babies were included prospectively in the study between June and 
November 2012. Survival was defined as discharge from the nursery or 
postnatal ward. RESULTS: Survival was 7% for extremely low birth weight 
infants, 52% for very low birth weight and 90% for low birth weight 
(1500-2499 g). There was a marked increase in survival from 1100 g. 
Survival was significantly higher in KCH only for babies weighing below 
1200 g. The majority of deaths occurred within the first 3 days of life.
 Only 98 of the babies had a mother who had received antenatal 
corticosteroids. CONCLUSIONS: With the current resources, we suggest 
focusing efforts on preventing early neonatal deaths in low birth weight
 infants above 1100 g in the hospitals in Lilongwe. The coverage of 
antenatal steroids for mothers at risk of preterm delivery can be 
improved. Further studies are needed on the quality of the obstetric and
 neonatal care at the hospitals and how to reduce the high rate of 
preterm birth in Malawi.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2015-03</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>100</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>F150-4</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Archives of disease in childhood. Fetal and neonatal edition</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1136/archdischild-2013-305877">10.1136/archdischild-2013-305877</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>2</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1359-2998 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Malawi/epidemiology</li>
					<li>Birth Weight</li>
					<li>Infant, Newborn</li>
					<li>Prospective Studies</li>
					<li>Young Adult</li>
					<li>Male</li>
					<li>Infant</li>
					<li>Adolescent</li>
					<li>Infant Mortality</li>
					<li>Prognosis</li>
					<li>*Infant, Very Low Birth Weight</li>
					<li>Age Factors</li>
					<li>Hospitals, Public</li>
					<li>Infant, Extremely Low Birth Weight</li>
					<li>low birth weight</li>
					<li>mortality</li>
					<li>neonatology</li>
					<li>Premature</li>
					<li>Premature Birth/*mortality</li>
					<li>survival</li>
					<li>Survival Rate</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_93I9K6E7">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Name: &nbsp;</span></span></strong></p>
<p><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">tertiary level KCH and BH hospitals</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Type: </span></span></strong></p>
<p>City / Health facility</p>
<p><strong><span style="color: black"><span style="background-color: white">Description: </span></span></strong></p>
<p><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">Lilongwe, the capital of Malawi, there are two public hospitals: the tertiary level KCH and BH, a district hospital.</span></span></p>
<p><strong>Sample Size: &nbsp;</strong><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">1496</span></span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_7EYZ96S2" class="item journalArticle">
			<h2>Burden of severe maternal morbidity and association with adverse 
birth outcomes in sub-Saharan Africa and south Asia: protocol for a 
prospective cohort study.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>OBJECTIVES: The AMANHI morbidity study aims to quantify and 
describe severe maternal morbidities and assess their associations with 
adverse maternal, fetal and newborn outcomes in predominantly rural 
areas of nine sites in eight South Asian and sub-Saharan African 
countries. METHODS: AMANHI takes advantage of on-going population-based 
cohort studies covering approximately 2 million women of reproductive 
age with 1- to 3-monthly pregnancy surveillance to enrol pregnant women.
 Morbidity information is collected at five follow-up home visits - 
three during the antenatal period at 24-28 weeks, 32-36 weeks and 37+ 
weeks of pregnancy and two during the postpartum period at 1-6 days and 
after 42-60 days after birth. Structured-questionnaires are used to 
collect self-reported maternal morbidities including hemorrhage, 
hypertensive disorders, infections, difficulty in labor and obstetric 
fistula, as well as care-seeking for these morbidities and outcomes for 
mothers and babies. Additionally, structured questionnaires are used to 
interview birth attendants who attended women's deliveries. All 
protocols were harmonised across the sites including training, 
implementation and operationalising definitions for maternal 
morbidities. IMPORTANCE OF THE AMANHI MORBIDITY STUDY: Availability of 
reliable data to synthesize evidence for policy direction, interventions
 and programmes, remains a crucial step for prioritization and ensuring 
equitable delivery of maternal health interventions especially in high 
burden areas. AMANHI is one of the first large harmonized 
population-based cohort studies being conducted in several rural centres
 in South Asia and sub-Saharan Africa, and is expected to make 
substantial contributions to global knowledge on maternal morbidity 
burden and its implications.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2016-12</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 2
Place: Scotland</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>6</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>020601</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Journal of global health</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.7189/jogh.6.020601">10.7189/jogh.6.020601</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>2</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>2047-2978 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:38 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:38 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Mothers</li>
					<li>Pregnancy</li>
					<li>Prospective Studies</li>
					<li>*Pregnancy Outcome</li>
					<li>Africa South of the Sahara/epidemiology</li>
					<li>Pregnancy Complications/*epidemiology</li>
					<li>Self Report</li>
					<li>Rural Population</li>
					<li>Developing Countries</li>
					<li>*Maternal Health</li>
					<li>*Severity of Illness Index</li>
					<li>Delivery, Obstetric</li>
					<li>Research Design</li>
					<li>Asia/epidemiology</li>
					<li>Morbidity</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_75H7X6T8">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location Name</strong> : </p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Democratic
 Republic of Congo (Equator), Ghana (Kintampo), Kenya (Western 
province), Tanzania (Pemba), and Zambia (Southern Province Zambia).</span></span></p>
<p><strong>Location Type</strong> :</p>
<p> Community and Health Facilities in Zambia</p>
<p><strong>Description</strong> : </p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Democratic
 Republic of Congo (Equator), Ghana (Kintampo), Kenya (Western 
province), Tanzania (Pemba), and Zambia (Southern Province Zambia).</span></span></p>
<p><strong>Sample siz</strong>e : 52232 (combined)</p>
<p><img alt="" src="data:image/png;base64,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" width="2112" height="785"></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_26ZKLGFV" class="item journalArticle">
			<h2>Caesarean section surgical techniques: 3 year follow-up of the 
CORONIS fractional, factorial, unmasked, randomised controlled trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Abalos E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Addo V</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Brocklehurst P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>El Sheikh M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Farrell B</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gray S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hardy P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Juszczak E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mathews JE</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Naz Masood S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Oyarzun E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Oyieke J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sharma JB</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Spark P</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: The CORONIS trial reported differences in 
short-term maternal morbidity when comparing five pairs of alternative 
surgical techniques for caesarean section. Here we report outcomes at 3 
years follow-up. METHODS: The CORONIS trial was a pragmatic 
international 2 x 2 x 2 x 2x 2 non-regular fractional, factorial, 
unmasked, randomised controlled trial done at 19 sites in Argentina, 
Chile, Ghana, India, Kenya, Pakistan, and Sudan. Pregnant women were 
eligible if they were to undergo their first or second caesarean section
 through a planned transverse abdominal incision. Women were randomly 
assigned by a secure web-based allocation system to one intervention 
from each of the three assigned pairs. All investigators, surgeons, and 
participants were unmasked to treatment allocation. In this follow-up 
study, we compared outcomes at 3 years following blunt versus sharp 
abdominal entry, exteriorisation of the uterus for repair versus 
intra-abdominal repair, single versus double layer closure of the 
uterus, closure versus non-closure of the peritoneum, and chromic catgut
 versus polyglactin-910 for uterine repair. Outcomes included pelvic 
pain; deep dyspareunia; hysterectomy and outcomes of subsequent 
pregnancies. Outcomes were assessed masked to the original trial 
allocation. This trial is registered with the Current Controlled Trials 
registry, number ISRCTN31089967. FINDINGS: Between Sept 1, 2011, and 
Sept 30, 2014, 13,153 (84%) women were followed-up for a mean duration 
of 3.8 years (SD 0.86). For blunt versus sharp abdominal entry there was
 no evidence of a difference in risk of abdominal hernias (adjusted RR 
0.66; 95% CI 0.39-1.11). We also recorded no evidence of a difference in
 risk of death or serious morbidity of the children born at the time of 
trial entry (0.99, 0.83-1.17). For exteriorisation of the uterus versus 
intra-abdominal repair there was no evidence of a difference in risk of 
infertility (0.91, 0.71-1.18) or of ectopic pregnancy (0.50, 0.15-1.66).
 For single versus double layer closure of the uterus there was no 
evidence of a difference in maternal death (0.78, 0.46-1.32) or a 
composite of pregnancy complications (1.20, 0.75-1.90). For closure 
versus non-closure of the peritoneum there was no evidence of a 
difference in any outcomes relating to symptoms associated with pelvic 
adhesions such as infertility (0.80, 0.61-1.06). For chromic catgut 
versus polyglactin-910 sutures there was no evidence of a difference in 
the main comparisons for adverse pregnancy outcomes in a subsequent 
pregnancy, such as uterine rupture (3.05, 0.32-29.29). Overall, severe 
adverse outcomes were uncommon in these settings. INTERPRETATION: 
Although our study was not powered to detect modest differences in rare 
but serious events, there was no evidence to favour one technique over 
another. Other considerations will probably affect clinical practice, 
such as the time and cost saving of different approaches. FUNDING: UK 
Medical Research Council and the Department for International 
Development.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2016-07</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 10039
Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>388</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>62-72</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Lancet (London, England)</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1016/S0140-6736(16)00204-X">10.1016/S0140-6736(16)00204-X</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>10039</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>0140-6736 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:35 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:35 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Pregnancy Outcome</li>
					<li>Cesarean Section/*methods</li>
					<li>Dyspareunia/epidemiology</li>
					<li>Pelvic Pain/epidemiology</li>
					<li>Postoperative Complications/*epidemiology</li>
					<li>*Wound Closure Techniques</li>
					<li>Catgut</li>
					<li>Dissection/methods</li>
					<li>Hysterectomy/statistics &amp; numerical data</li>
					<li>Peritoneum/*surgery</li>
					<li>Polyglactin 910</li>
					<li>Postpartum Hemorrhage/*epidemiology</li>
					<li>Uterus/*surgery</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_QUZ8FABH">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name</strong> : </p>
<p>(Argentina--Hospital Dr Jose Maria Cullen, Hospital interzonal 
general de Agudos Dr Jose penna, Hospital J.B iturraspe, Hospital 
nacional profesor Alejandro Posadas, Hospital regional DR Ramon 
carillo); (Ghana --Komfo anokye teaching hospital); (Kenya--Kenyata 
National hospital); (Sudan--Omdurman maternity Hospital, Soba University
 hospital)</p>
<p><strong>Location type</strong> :Health facilities</p>
<p><strong>Description</strong> : <span style="color: rgb(80, 80, 80)"><span style="background-color: rgb(255, 255, 255)">19 sites in Argentina, Chile, Ghana, India, Kenya, Pakistan, and Sudan</span></span></p>
<p><strong>Sample size</strong> : <span style="color: rgb(80, 80, 80)"><span style="background-color: rgb(255, 255, 255)">15935&nbsp;</span></span></p>
<p></p>
<p><img alt="" src="data:image/png;base64,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" width="2462" height="1902"></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_XMBEI9IR" class="item journalArticle">
			<h2>Clinical malaria among pregnant women on combined insecticide 
treated nets (ITNs) and intermittent preventive treatment (IPTp) with 
sulphadoxine-pyrimethamine in Yaounde, Cameroon.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mbu RE</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Takang WA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Fouedjio HJ</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Fouelifack FY</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Tumasang FN</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Tonye R</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Malaria remains a burden for pregnant women and 
the under 5. Intermittent preventive treatment of pregnant women (IPTp) 
for malaria with sulfadoxine - pyrimethamine (SP) has since replaced 
prophylaxis and legislation has been reinforced in the area of 
insecticide treated mosquito nets (ITNs) in Cameroon. Clinical malaria 
despite all these measures remains a problem. We compared the 
socio-obstetrical characteristics of women who developed clinical 
malaria and those who did not though in the same regimen. METHODS: A 5 -
 year nested cohort study (2007 - 2011 inclusive) at the tertiary level 
hospitals in Yaounde. Pregnant women who willingly accepted to 
participate in the study were enrolled at booking and three doses of SP 
were administered between 18 - 20 weeks of gestation, between 26-28 
weeks and between 32 - 34 weeks. Those who developed clinical malaria 
were considered as cases and were compared for socio - obstetrical 
characteristics with those who did not. Venous blood was drawn from the 
women in both arms for parasite density estimation and identification 
and all the clinical cases were treated conventionally. RESULTS: Each 
arm had 166 cases and many women who developed clinical malaria were 
between 15 and 19 years (OR 5.5, 95% CI 3.9 - 5.3, p &lt; 0.001). They 
were of low gravidity (OR 6.5, 95% CI 3.8 - 11.3, p &lt; 0.001) as well 
as low parity (OR 4.6, 95% CI 2.7 - 7.9, p &lt; 0.001). The cases were 
single women (OR 4.58, 95% CI 2.54 - 8.26, p &lt; 0.001) and had 
attained only primary level of education (OR 4.6, 95% CI 2.8 - 7.9, p 
&lt; 0.001). Gestational ages were between 20 to 30 weeks during 
clinical malaria (OR 6.8, 95% CI 4.1 - 11.7, p &lt; 0.001). The time 
between the first and second dose of SP was longer than ten weeks in the
 cases (OR 5.5, 95% CI 3.2 - 9.3, p &lt; 0.001) and parasite density was
 higher also among the cases (OR 6.9, 95% CI 5.9 - 12.1, p &lt; 0.001). 
CONCLUSION: Long spacing between the first and second dose of SP seemed 
to be responsible for clinical malaria in the cases.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2014-05</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>14</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>68</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>BMC women's health</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/1472-6874-14-68">10.1186/1472-6874-14-68</a></td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1472-6874 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Cohort Studies</li>
					<li>Young Adult</li>
					<li>Gestational Age</li>
					<li>Drug Combinations</li>
					<li>Treatment Outcome</li>
					<li>Malaria/*prevention &amp; control</li>
					<li>Adolescent</li>
					<li>Case-Control Studies</li>
					<li>Prenatal Care/*methods</li>
					<li>Age Factors</li>
					<li>Drug Administration Schedule</li>
					<li>Pregnancy Complications, Parasitic/*prevention &amp; control</li>
					<li>Parity</li>
					<li>Gravidity</li>
					<li>*Insecticide-Treated Bednets</li>
					<li>Antimalarials/*administration &amp; dosage/therapeutic use</li>
					<li>Cameroon</li>
					<li>Chemoprevention/methods</li>
					<li>Pyrimethamine/*administration &amp; dosage/therapeutic use</li>
					<li>Sulfadoxine/*administration &amp; dosage/therapeutic use</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_E5U6FY72">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location Name</strong> :</p>
<ol>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Yaounde Central Hospital</span></span>
</li>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Yaounde General Hospital</span></span>
</li>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Yaounde Gynaeco-Obstetric and Pediatric Hospital</span></span>
</li>
</ol>
<p><strong>Location Type</strong> : City / Health Facility</p>
<p><strong>Description</strong> : <span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">three tertiary level hospitals affiliated with the University of Yaounde, </span></span><span style="color: rgb(77, 81, 86)"><span style="background-color: rgb(255, 255, 255)">Cameroon</span></span></p>
<p><strong>Sample size</strong> : <span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">2525&nbsp;</span></span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_JJKEA6YI" class="item journalArticle">
			<h2>Clinical malaria diagnosis in pregnancy in relation to early 
perinatal mother-to-child transmission of HIV: a prospective cohort 
study.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ezeamama AE</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Duggan C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Manji KP</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Spiegelman D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hertzmark E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bosch RJ</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kupka R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Okuma JO</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kisenge R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Aboud S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Fawzi WW</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>OBJECTIVES: We prospectively investigated fever symptoms and 
maternal diagnosis of malaria in pregnancy (MIP) in relation to child 
HIV infection among 2368 pregnant HIV-positive women and their infants, 
followed up from pregnancy until 6 weeks post-delivery in Tanzania. 
METHODS: Doctors clinically diagnosed and treated MIP and fever symptoms
 during prenatal health care. Child HIV status was determined via DNA 
polymerase chain reaction (PCR). Multivariable logistic regression 
models were used to estimate relative risks (RRs) and 95% confidence 
intervals (CIs) for HIV mother-to-child transmission (MTCT) by the 6th 
week of life. RESULTS: Mean gestational age at enrolment was 22.2 weeks.
 During follow-up, 16.6% of mothers had at least one MIP diagnosis, 
15.9% reported fever symptoms and 8.7% had both fever and MIP diagnosis.
 Eleven per cent of HIV-exposed infants were HIV-positive by 6 weeks. 
The RR of HIV MTCT was statistically similar for infants whose mothers 
were ever vs. never clinically diagnosed with MIP (RR 1.24; 95% CI 
0.94-1.64), were diagnosed with one vs. no clinical MIP episodes (RR 
1.07; 95% CI 0.77-1.48) and had ever vs. never reported fever symptoms 
(RR 1.04; 95% CI 0.78-1.38) in pregnancy. However, the HIV MTCT risk 
increased by 29% (95% CI 4-58%) per MIP episode. Infants of women with 
at least two vs. no MIP diagnoses were 2.1 times more likely to be HIV 
infected by 6 weeks old (95% CI 1.31-3.45). CONCLUSIONS: Clinical MIP 
diagnosis, but not fevers, in HIV-positive pregnant women was associated
 with an elevated risk of early HIV MTCT, suggesting that malaria 
prevention and treatment in pregnant HIV-positive women may enhance the 
effectiveness of HIV prevention in MTCT programmes in this setting. 
Future studies using a laboratory-confirmed diagnosis of malaria are 
needed to confirm this association.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2014-05</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>15</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>276-85</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>HIV medicine</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1111/hiv.12111">10.1111/hiv.12111</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>5</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1464-2662 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Infant, Newborn</li>
					<li>Prospective Studies</li>
					<li>Risk Factors</li>
					<li>Malaria/*epidemiology</li>
					<li>Tanzania/epidemiology</li>
					<li>Multivariate Analysis</li>
					<li>malaria</li>
					<li>numerical data</li>
					<li>AIDS</li>
					<li>coinfection</li>
					<li>HIV Infections/epidemiology/prevention &amp; control/*transmission</li>
					<li>HIV mother-to-child transmission</li>
					<li>HIV-exposed infant</li>
					<li>Infectious Disease Transmission, Vertical/prevention &amp; control/*statistics &amp;</li>
					<li>Pregnancy Complications, Infectious/pathology/virology</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_E8R67EH2">
<div><div data-schema-version="8"><p><strong>Location Information </strong><br></p>
<p><strong>Location name : </strong>Dar es Salaam</p>
<p><strong>Location type :</strong> community/ City</p>
<p><strong>Description : </strong>Dar es Salaam, Tanzania</p>
<p>Community</p>
<p><strong>Sample size :</strong> <span style="color: rgb(0, 0, 0)"><span style="background-color: rgb(255, 255, 255)">2368&nbsp;</span></span></p>
<p></p>
<p><br></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_QKI8B23K" class="item journalArticle">
			<h2>Cohort profile: Prematurity Immunology in Mothers living with HIV and their infants Study (PIMS).</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Malaba TR</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Myer L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gray C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Newell ML</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>PURPOSE: Prematurity Immunology in Mothers living with HIV and
 their infants Study (PIMS) is a prospective cohort study in South 
Africa investigating the association between antiretroviral therapy 
(ART) use, preterm delivery (PTD) and small-for-gestational age (SGA) 
live births. PIMS main hypotheses are that ART initiation in pregnancy 
and ART-induced hypertension are associated with PTD and SGA 
respectively and that reconstitution of cellular immune responses in 
women on ART from before pregnancy results in increases in PTD of GA 
infants. PARTICIPANTS: Pregnant women (n=3972) aged &gt;/=18 years 
regardless of HIV status recruited from 2015 to 2016 into the overall 
PIMS cohort (2517 HIV-negative, 1455 living with HIV). A nested cohort 
contained 551 women living with HIV who were &lt;/=24 weeks' GA on 
ultrasound: 261 initiated ART before pregnancy, 290 initiated during the
 pregnancy. FINDINGS TO DATE: Women in the overall cohort were followed 
antenatally through to delivery using routine clinical records; further 
women in the nested cohort were actively followed up until 12 months 
post partum, with data collected on maternal health (HIV care and ART 
use, clinical care and intercurrent clinical history). Other procedures 
conducted on the nested cohort included physical examinations 
(anthropometry, blood pressure measurement), assessment of fetal growth 
(ultrasound), maternal and infant phlebotomy for storage of plasma, RNA 
and peripheral blood mononuclear cells, collection of delivery specimens
 (placenta and cord blood) and infant 12-month developmental assessment.
 Preliminary findings have contributed to our understanding of risk 
factors for adverse birth outcomes, and the relationship between 
pregnancy immunology, HIV/ART and adverse birth outcomes. FUTURE PLANS: 
Using specimens collected from study participants living with HIV 
throughout pregnancy and first year of life, the PIMS provides a 
valuable platform for answering a variety of research questions focused 
on temporal changes of immunology markers in women whose immune status 
is altered by HIV infection, and how ART initiated during the pregnancy 
affects immune responses. The relationship between these immunological 
changes with adverse birth outcomes as well as possible longer-term 
impact of exposure to ART in fetal and early life will be explored. 
Additionally, further active and passive follow-up of mothers and their 
infants is planned at school-going age and beyond to chart growth, 
morbidity and development, as well as changes in family circumstances.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2021-09</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 9
Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>11</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e047133</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>BMJ open</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1136/bmjopen-2020-047133">10.1136/bmjopen-2020-047133</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>9</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>2044-6055 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:34 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:34 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Mothers</li>
					<li>Pregnancy</li>
					<li>Cohort Studies</li>
					<li>Infant, Newborn</li>
					<li>Prospective Studies</li>
					<li>Infant</li>
					<li>Adolescent</li>
					<li>Infectious Disease Transmission, Vertical</li>
					<li>*public health</li>
					<li>*epidemiology</li>
					<li>*HIV Infections/complications/drug therapy</li>
					<li>*Pregnancy Complications, Infectious/drug therapy</li>
					<li>*HIV &amp; AIDS</li>
					<li>*immunology</li>
					<li>*maternal medicine</li>
					<li>Leukocytes, Mononuclear</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_NLHPFFMD">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location Name :</strong></p>
<p><strong> </strong><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">Gugulethu Midwife Obstetric Unit</span></span></p>
<p><strong>Location Type : </strong>Health facility</p>
<p><strong>Description : </strong><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">Public sector primary care facility (Gugulethu Midwife Obstetric Unit (MOU)) subdistrict of Cape Town, South Africa.</span></span></p>
<p><strong>Sample size :</strong> &nbsp;<span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">3972</span></span></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_Y8LR5VE2" class="item journalArticle">
			<h2>Cohort profile: the Hlabisa pregnancy cohort, KwaZulu-Natal, South Africa.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chetty T</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Thorne C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Tanser F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Barnighausen T</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Coutsoudis A</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>PURPOSE: The Hlabisa pregnancy cohort was established to 
evaluate the effectiveness of prevention of mother-to-child transmission
 (PMTCT) guideline revisions. The objectives of the Hlabisa pregnancy 
cohort are to: (1) provide cohort-level information on maternal health 
up to 6 weeks postpartum in a high HIV prevalence setting; and to (2) 
evaluate aspects of PMTCT care that have policy relevance. PARTICIPANTS:
 The pregnancy cohort is located in primary health clinics in the 
Hlabisa subdistrict of rural KwaZulu-Natal, South Africa. Baseline data 
collection between 2010 and 2014 has been completed with the enrolment 
of 25 608 pregnancies; age ranged from 15-49 years. Pregnant women were 
assessed during routine antenatal visits: first visit, follow-up 1 week 
later, 32 weeks (HIV test), infant delivery and 6 weeks postpartum. 
Demographic, pregnancy, clinical, laboratory and HIV data were collected
 through Department of Health interviews, laboratory tests and routine 
data linkage. Treatment data for HIV-infected pregnant women were linked
 to the Africa Centre Hlabisa HIV Treatment and Care Programme for 
detailed antiretroviral therapy (ART) history and laboratory tests. 
FINDINGS TO DATE: The proportion of women initiated on ART post-2013 
were higher (n=437; 100%) than pre-2013 (n=768; 84.2%). The proportion 
of women in care at 6 weeks (73.8%) was also higher post-2013 relative 
to earlier years (58.5%). The majority of HIV-infected pregnant women 
were either on lifelong ART or ART prophylaxis; pre-2013, approximately 
9.6% of women were not on any ART. Pregnancy viral load monitoring was 
inadequate. FUTURE PLANS: This cohort will be used to: (1) determine HIV
 acquisition risk during pregnancy and postpartum; (2) determine the 
effect of HIV and ART on birth outcomes; (3) examine the effect of 
pregnancy on virological response to ART; and (4) characterise the 
effect of sequential pregnancies on access to clinical care, response to
 prolonged ART and birth outcomes.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2016-10</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>6</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e012088</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>BMJ open</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1136/bmjopen-2016-012088">10.1136/bmjopen-2016-012088</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>10</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>2044-6055 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Cohort Studies</li>
					<li>Infant, Newborn</li>
					<li>Infectious Disease Transmission, Vertical/*prevention &amp; control</li>
					<li>Postpartum Period</li>
					<li>South Africa/epidemiology</li>
					<li>Rural Population</li>
					<li>Anti-HIV Agents/*therapeutic use</li>
					<li>control</li>
					<li>Patient Acceptance of Health Care</li>
					<li>Medication Adherence/statistics &amp; numerical data</li>
					<li>*antiretroviral therapy</li>
					<li>*Guideline Adherence</li>
					<li>*pregnancy cohort</li>
					<li>HIV Infections/drug therapy/epidemiology/*prevention &amp; control</li>
					<li>Pregnancy Complications, Infectious/drug therapy/epidemiology/*prevention &amp;</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_ESTZYR8L">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name</strong> : there are 17 health facilities in this district.</p>
<p><img alt="" src="data:image/jpeg;base64,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" width="1280" height="1065"></p>
<p><strong>Location Type</strong> : Health facilities</p>
<p><strong>Description</strong> : <span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">conducted in the predominantly rural Hlabisa subdistrict of uMkhanyakude in northern KwaZulu-Natal, South Africa.</span></span></p>
<p><strong>Sample size</strong> : 26 520</p>
<p></p>
<p></p>
<p></p>
<p></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_QQ9LRLW4" class="item journalArticle">
			<h2>Community-based scheduled screening and treatment of malaria in 
pregnancy for improved maternal and infant health in The Gambia, Burkina
 Faso and Benin: study protocol for a randomized controlled trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Scott S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mens PF</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Tinto H</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Nahum A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ruizendaal E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Pagnoni F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Grietens KP</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kendall L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bojang K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Schallig H</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>D'Alessandro U</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: In sub-Saharan Africa, malaria continues to cause 
over 10,000 maternal deaths and 75,000 to 200,000 infant deaths. 
Successful control of malaria in pregnancy could save lives of mothers 
and babies and is an essential part of antenatal care in endemic areas. 
The primary objective is to determine the protective efficacy of 
community-scheduled screening and treatment (CSST) using community 
health workers (CHW) against the primary outcome of prevalence of 
placental malaria. The secondary objectives are to determine the 
protective efficacy of CSST on maternal anaemia, maternal peripheral 
infection, low birth weight, selection of sulfadoxine-pyrimethamine (SP)
 resistance markers, and on antenatal clinic (ANC) attendance and 
coverage of intermittent preventive treatment during pregnancy 
(IPTp-SP). METHODS/DESIGN: This is a multi-centre cluster-randomised 
controlled trial involving three countries with varying malaria 
endemicity; low (The Gambia) versus high transmission (Burkina Faso and 
Benin), and varying degrees of SP resistance (high in Benin and moderate
 in Gambia and Burkina Faso). CHW and their related catchment population
 who are randomised into the intervention arm will receive specific 
training on community-based case management of malaria in pregnancy. All
 women in both study arms will be enrolled at their first ANC visits in 
their second trimester where they will receive their first dose of 
IPTp-SP. Thereafter, CHW in the intervention arm will perform scheduled 
monthly screening and treatment in the womens homes. At time of 
delivery, a placental biopsy will be collected from all women to 
determine placental malaria. At each contact point, filter paper and 
blood slides will be collected for detection of malaria infection and SP
 resistance markers. DISCUSSION: To reach successful global malaria 
control, there is an urgent need to access those at greatest risk of 
malaria infection. The project is designed to develop a low-cost 
intervention in pregnant women which will have an immediate impact on 
the malaria burden in resource-limited countries. This will be done by 
adding to the standard IPTp-SP delivered through the health facilities: 
an "extension" strategy to the communities in rural areas thus bringing 
health services closer to where women live. TRIAL REGISTRATION: Current 
Controlled Trials: ISRCTN37259296 (5 July 2013), and clinicaltrials.gov:
 NCT01941264 (10 September 2013).</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2014-08</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>15</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>340</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Trials</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/1745-6215-15-340">10.1186/1745-6215-15-340</a></td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1745-6215 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Malaria/*drug therapy</li>
					<li>Pregnancy Complications, Parasitic/*drug therapy</li>
					<li>Community Health Services</li>
					<li>Sample Size</li>
					<li>*Clinical Protocols</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_7FU3XM6H">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location name</strong> &nbsp;:<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)"> </span></span></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Basse
 Health Centre and satellite health facilities- Gambia, Nanoro health 
district_Burkina Faso, Glo-Djigb, Zinvi, and Z district communities 
-Benin</span></span></p>
<p><strong>Location type</strong> : </p>
<p>Community</p>
<p><strong>Description :</strong></p>
<ol>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">The
 Gambia: The study was situated in the eastern part of the country on 
the southern bank of the Upper River Region, centered around the Basse 
Health Centre and satellite health facilities.</span></span>
</li>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Burkina Faso: The study was situated in the center-west of the country in the Nanoro health district catchment area.</span></span>
</li>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Benin:
 The study was situated at the Atlantic Region in the southern part of 
the country, in the Glo-Djigb, Zinvi, and Z district communities.</span></span>
</li>
</ol>
<p><strong>Sample size </strong>: <strong><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">5,400</span></span></strong></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_7FY2AH4B" class="item journalArticle">
			<h2>CORONIS - International study of caesarean section surgical techniques: the follow-up study.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Abalos E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Oyarzun E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Addo V</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sharma JB</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Matthews J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Oyieke J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Masood SN</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>El Sheikh MA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Brocklehurst P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Farrell B</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gray S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hardy P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Jamieson N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Juszczak E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Spark P</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: The CORONIS Trial was a 2x2x2x2x2 non-regular, 
fractional, factorial trial of five pairs of alternative caesarean 
section surgical techniques on a range of short-term outcomes, the 
primary outcome being a composite of maternal death or infectious 
morbidity. The consequences of different surgical techniques on longer 
term outcomes have not been well assessed in previous studies. Such 
outcomes include those related to subsequent pregnancy: mode of 
delivery; abnormal placentation (e.g. accreta); postpartum hysterectomy,
 as well as longer term pelvic problems: pain, urinary problems, 
infertility. The Coronis Follow-up Study aims to measure and compare the
 incidence of these outcomes between the randomised groups at around 
three years after women participated in the CORONIS Trial. 
METHODS/DESIGN: This study will assess the following null hypotheses: In
 women who underwent delivery by caesarean section, no differences will 
be detected with respect to a range of long-term outcomes when comparing
 the following five pairs of alternative surgical techniques evaluated 
in the CORONIS Trial: 1. Blunt versus sharp abdominal entry. 2. 
Exteriorisation of the uterus for repair versus intra-abdominal repair. 
3. Single versus double layer closure of the uterus. 4. Closure versus 
non-closure of the peritoneum (pelvic and parietal). 5. Chromic catgut 
versus Polyglactin-910 for uterine repair. The outcomes will include (1)
 women's health: pelvic pain; dysmenorrhoea; deep dyspareunia; urinary 
symptoms; laparoscopy; hysterectomy; tubal/ovarian surgery; abdominal 
hernias; bowel obstruction; infertility; death. (2) Outcomes of 
subsequent pregnancies: inter-pregnancy interval; pregnancy outcome; 
gestation at delivery; mode of delivery; pregnancy complications; 
surgery during or following delivery. DISCUSSION: The results of this 
follow-up study will have importance for all pregnant women and for 
health professionals who provide care for pregnant women. Although the 
results will have been collected in seven countries with limited health 
care resources (Argentina, Chile, Ghana, India, Kenya, Pakistan, Sudan) 
any differences in outcomes associated with different surgical 
techniques are likely to be generalisable throughout the world. TRIAL 
REGISTRATION: ISRCTN31089967.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2013-11</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>13</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>215</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>BMC pregnancy and childbirth</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/1471-2393-13-215">10.1186/1471-2393-13-215</a></td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1471-2393 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:41 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:41 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Incidence</li>
					<li>Pregnancy</li>
					<li>Infant, Newborn</li>
					<li>Follow-Up Studies</li>
					<li>Pregnancy Outcome</li>
					<li>Pregnancy Complications/*epidemiology</li>
					<li>Infant Mortality</li>
					<li>Abortion, Spontaneous/epidemiology</li>
					<li>Birth Intervals</li>
					<li>Cesarean Section/*methods</li>
					<li>Delivery, Obstetric</li>
					<li>Dysmenorrhea/epidemiology</li>
					<li>Dyspareunia/epidemiology</li>
					<li>Fallopian Tubes/surgery</li>
					<li>Hysterectomy</li>
					<li>Ovary/surgery</li>
					<li>Pelvic Pain/epidemiology</li>
					<li>Postoperative Complications/*epidemiology</li>
					<li>Research Design</li>
					<li>Urination Disorders/epidemiology</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_94N6KXRI">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name</strong> : </p>
<p>Site Name not specified</p>
<p><strong>Location type</strong> :</p>
<p>Study site</p>
<p><strong>Description</strong> : </p>
<p><span style="color: rgb(80, 80, 80)"><span style="background-color: rgb(255, 255, 255)">19 sites in Argentina, Chile, Ghana, </span><span style="background-color: rgb(255, 102, 102);">India,</span><span style="background-color: rgb(255, 255, 255)"> Kenya, </span><span style="background-color: rgb(255, 102, 102);">Pakistan</span><span style="background-color: rgb(255, 255, 255)">, and Sudan</span></span></p>
<p><strong>Sample Size :</strong> &nbsp;<span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">15,492</span></span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_A5H8MQSA" class="item journalArticle">
			<h2>Current respiratory symptoms and risk factors in pregnant women cooking with biomass fuels in rural Ghana.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Van Vliet EDS</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kinney PL</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Owusu-Agyei S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Schluger NW</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ae-Ngibise KA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Whyatt RM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Jack DW</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Agyei O</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chillrud SN</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Boamah EA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mujtaba M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Asante KP</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: More than 75% of the population in Ghana relies on
 biomass fuels for cooking and heating. Household air pollution (HAP) 
emitted from the incomplete combustion of these fuels has been 
associated with adverse health effects including respiratory effects in 
women that can lead to chronic obstructive pulmonary disease (COPD), a 
major contributor to global HAP-related mortality. HAP is a modifiable 
risk factor in the global burden of disease, exposure to which can be 
reduced. OBJECTIVE: This study assessed the prevalence of respiratory 
symptoms, as well as associations between respiratory symptoms and HAP 
exposure, as measured using continuous personal carbon monoxide (CO), in
 nonsmoking pregnant women in rural Ghana. METHODS: We analyzed current 
respiratory health symptoms and CO exposures upon enrollment in a subset
 (n=840) of the population of pregnant women cooking with biomass fuels 
and enrolled in the GRAPHS randomized clinical control trial. Personal 
CO was measured using Lascar continuous monitors. Associations between 
CO concentrations as well as other sources of pollution exposures and 
respiratory health symptoms were estimated using logistic regression 
models. CONCLUSION: There was a positive association between CO exposure
 per 1ppm increase and a composite respiratory symptom score of current 
cough (lasting &gt;5days), wheeze and/or dyspnea (OR: 1.2, p=0.03). CO 
was also positively associated with wheeze (OR: 1.3, p=0.05), phlegm 
(OR: 1.2, p=0.08) and reported clinic visit for respiratory infection in
 past 4weeks (OR: 1.2, p=0.09). Multivariate models showed significant 
associations between second-hand tobacco smoke and a composite outcome 
(OR: 2.1, p&lt;0.01) as well as individual outcomes of cough &gt;5days 
(OR: 3.1, p=0.01), wheeze (OR: 2.7, p&lt;0.01) and dyspnea (OR: 2.2, 
p=0.01). Other covariates found to be significantly associated with 
respiratory outcomes include involvement in charcoal production business
 and dyspnea, and involvement in burning grass/field and wheeze. Results
 suggest that exposure to HAP increases the risk of adverse respiratory 
symptoms among pregnant women using biomass fuels for cooking in rural 
Ghana.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2019-03</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: Netherlands</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>124</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>533-540</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Environment international</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1016/j.envint.2019.01.046">10.1016/j.envint.2019.01.046</a></td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>0160-4120 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:27 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:27 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>*Ghana</li>
					<li>Risk Factors</li>
					<li>Ghana/epidemiology</li>
					<li>Logistic Models</li>
					<li>Rural Population</li>
					<li>*Family Characteristics</li>
					<li>*Pregnant women</li>
					<li>*Biomass</li>
					<li>*Carbon monoxide</li>
					<li>*Household air pollution</li>
					<li>Air Pollution, Indoor/*adverse effects/analysis</li>
					<li>Biomass</li>
					<li>*Cooking</li>
					<li>*Personal exposure</li>
					<li>Carbon Monoxide/analysis</li>
					<li>Heating</li>
					<li>Pregnancy Complications/*chemically induced/epidemiology</li>
					<li>Respiratory Tract Diseases/*chemically induced/epidemiology</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_3KTWIZ7L">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location Name : </strong></p>
<p><span style="color: rgb(31, 31, 31)">Kintampo North &amp; south</span></p>
<p><strong>Location Type : </strong></p>
<p>Community</p>
<p><strong>Description : </strong></p>
<p><span style="color: rgb(31, 31, 31)">Communities in Kintampo North and Kintampo South areas, located in the Brong-Ahafo region of central Ghana</span></p>
<p><strong>sample size :</strong> &nbsp;840</p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_QRYPYS85" class="item journalArticle">
			<h2>Demographic, clinical and behavioural determinants of HIV 
serostatus non-disclosure to sex partners among HIV-infected pregnant 
women in the Eastern Cape, South Africa.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Adeniyi OV</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ajayi AI</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Selanto-Chairman N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Goon DT</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Boon G</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Fuentes YO</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hofmeyr GJ</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Avramovic G</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Carty C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Lambert J</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>OBJECTIVES: Drawing from a baseline sample of a cohort study, 
the study examines the extent and correlates of serostatus 
non-disclosure to sex partners and family members, and reasons for 
non-disclosure among HIV-infected pregnant women in the Eastern Cape 
Province, South Africa. METHODS: This longitudinal cohort study 
recruited 1709 pregnant women living with HIV who attended three of the 
largest maternity centres in the Eastern Cape, South Africa, for 
delivery between September 2015 and May 2016. Relevant items on 
demographics, serostatus awareness, disclosure to sex partners and 
family members, and lifestyle behaviours were obtained using structured 
interviews. Age-stratified binary logistic regression models were used 
to determine the significant correlates of non-disclosure among the 
participants. RESULTS: A higher rate of HIV serostatus non-disclosure to
 sex partners (25.6%) in comparison to family members (20%) was reported
 by the participants. Younger age, not living with partners and alcohol 
use were significantly associated with non-disclosure of HIV serostatus 
to sex partners. Non-disclosure of HIV serostatus to sex partners was 
significantly (p&lt;0.05) associated with poor adherence to the highly 
active anti-retroviral therapy (HAART), failure to keep clinic 
appointments and high viral load at the delivery of the baby. Perceived 
fear of intimate partner violence, fear of rejection, guilt of not 
disclosing at the onset of the relationship, sex partner's 
non-disclosure of HIV serostatus, and guilt of unfaithfulness were some 
of the reasons for non-disclosure of HIV serostatus to sex partners. 
CONCLUSIONS: Non-disclosure of HIV serostatus is a public health concern
 with serious implications for both mother-to-child transmission, as 
well as horizontal transmission, in our setting. Strategic efforts 
toward ending the epidemic of HIV and AIDS in South Africa should 
address the sociocultural and behavioural determinants of 
non-disclosure.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2017</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>12</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e0181730</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>PloS one</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1371/journal.pone.0181730">10.1371/journal.pone.0181730</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>8</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1932-6203 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Young Adult</li>
					<li>Male</li>
					<li>Longitudinal Studies</li>
					<li>South Africa/epidemiology</li>
					<li>*Behavior</li>
					<li>*Demography</li>
					<li>*Self Disclosure</li>
					<li>*Sexual Partners</li>
					<li>HIV Infections/complications/epidemiology/*psychology/transmission</li>
					<li>Pregnancy Complications, Infectious/*psychology</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_CP8N4ST4">
<div><div data-schema-version="8"><p><strong>Location Information:</strong></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Name:</span></span></strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Frere Hospital, Cecilia Makiwane Hospital, Bisho Hospital:</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Type: </span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">Health facility</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Description: </span></span></strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Buffalo/Amathole districts in the Eastern Cape Province, South Africa.</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Sample size : 1709</span></span></strong></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_B5C4I9V8" class="item journalArticle">
			<h2>Determinants of low birth weight in the context of maternal nutrition education in urban informal settlements, Kenya.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Nyamasege CK</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kimani-Murage EW</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Wanjohi M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kaindi DWM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ma E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Fukushige M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Wagatsuma Y</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>Inadequate knowledge in maternal nutrition is one of the 
determinants of low birth weight. However, little evidence is available 
on whether maternal nutrition counselling alone can influence birth 
weight among women from low socioeconomic households. This study 
assessed the effect of prenatal maternal nutritional counselling on 
birth weight and examined the related risk factors. A cluster randomized
 controlled trial was conducted to assess the effectiveness of 
home-based maternal nutritional counselling on nutritional outcomes, 
morbidity, breastfeeding, and infant feeding practices by the African 
Population and Health Research Center in two urban informal settlements 
of Nairobi. The intervention group received monthly antenatal and 
nutritional counselling from trained community health volunteers; 
meanwhile, the control group received routine antenatal care. A total of
 1001 participants were included for analysis. Logistic regression was 
applied to determine associations between low birth weight and maternal 
characteristics. A higher prevalence of low birth weight was observed in
 the control group (6.7%) than in the intervention group (2.5%; 
P&amp;lt;0.001). Logistic regression identified significant associations
 between birth weight and intervention group (adjusted odds ratio 
(AOR)=0.26; 95% confidence interval (CI), 0.10-0.64); maternal height 
&amp;lt;154.5 cm (AOR=3.33; 95% CI, 1.01-10.96); last antenatal care 
visits at 1st or 2nd trimesters (AOR=9.48; 95% CI, 3.72-24.15); pre-term
 delivery (AOR=3.93; 95% CI, 1.93-7.98); maternal mid-upper arm 
circumference &amp;lt;23 cm (AOR=2.57; 95% CI, 1.15-5.78); and cesarean 
delivery (AOR=2.27; 95% CI, 1.04-4.94). Nutrition counselling during 
pregnancy reduced low birth weight and preterm births, which was 
determined by women of short stature, early stoppage of antenatal visit,
 and cesarean delivery.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2019-04</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>10</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>237-245</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Journal of developmental origins of health and disease</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1017/S2040174418000715">10.1017/S2040174418000715</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>2</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>2040-1744 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>*low birth weight</li>
					<li>Infant, Newborn</li>
					<li>*pregnancy</li>
					<li>Young Adult</li>
					<li>Prevalence</li>
					<li>Urban Population</li>
					<li>Middle Aged</li>
					<li>Adolescent</li>
					<li>Health Knowledge, Attitudes, Practice</li>
					<li>Case-Control Studies</li>
					<li>Kenya/epidemiology</li>
					<li>Infant, Low Birth Weight/*physiology</li>
					<li>Maternal Nutritional Physiological Phenomena/*physiology</li>
					<li>*Kenya</li>
					<li>*Nutrition counselling</li>
					<li>*Urban slums</li>
					<li>Counseling/*methods/organization &amp; administration</li>
					<li>Mothers/*education</li>
					<li>Premature Birth/*epidemiology/physiopathology/prevention &amp; control</li>
					<li>Prenatal Care/*methods/organization &amp; administration</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_J8JZF5L8">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location Name</strong> : Nairobi</p>
<p><strong>Location type</strong> : City</p>
<p><strong>Description</strong> : <span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">2 urban informal settlements of Nairobi</span></span></p>
<p><strong>Sample Size</strong> : <span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">1001</span></span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_WNEJCFX4" class="item journalArticle">
			<h2>Determinants of neonatal mortality in rural Northern Ethiopia: A population based nested case control study.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Yirgu R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Molla M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sibley L</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>INTRODUCTION: In low income and middle income countries, 
neonatal mortality remains high despite the gradual reduction in under 
five mortality. Newborn death contributes for about 38% of all under 
five deaths. This study has identified the magnitude and independent 
predictors of neonatal mortality in rural Ethiopia. METHODS: This 
population based nested case control study was conducted in rural West 
Gojam zone, Northern Ethiopia, among a cohort of pregnant women who gave
 birth between March 2011 and Feb 2012. The cohort was established by 
Maternal and Newborn Health in Ethiopia Partnership (MaNHEP) project in 
2010 by recruiting mothers in their third trimester, as identified by 
trained community volunteers. Once identified, women stayed in the 
cohort throughout their pregnancy period receiving Community Maternal 
and Newborn Health (CMNH) training by health extension workers and 
community volunteers till the end of the first 48 hours postpartum. 
Cases were 75 mothers who lost their newborns to neonatal death and 
controls were 150 randomly selected mothers with neonates who survived 
the neonatal period. Data to identify cause of death were collected 
using the WHO standard verbal autopsy questionnaire after the culturally
 appropriate 40 days of bereavement period. Binomial logistic regression
 model was used to identify independent contributors to neonatal 
mortality. RESULT: The neonatal mortality rate was AOR(95%CI) = 18.6 
(14.8, 23.2) per 1000 live births. Neonatal mortality declined with an 
increase in family size, neonates who were born among a family of more 
than two had lesser odds of death in the neonatal period than those who 
were born in a family of two AOR (95% CI) = 0.13 (0.02, 0.71). Mothers 
who gave birth to 2-4 AOR(95%CI) = 0.15 (0.05, 0.48) and 5+ children 
AOR(95%CI) = 0.08 (0.02, 0.26) had lesser odds of losing their newborns 
to neonatal mortality. Previous history of losing a newborn to neonatal 
death also increased the odds of neonatal mortality during the last 
birth AOR (95%CI) = 0.25 (0.11, 0.53). CONCLUSION: The neonatal 
mortality rate in our study was three times lower than the regional 
neonatal mortality rate estimate, indicating community based 
interventions could significantly decrease neonatal mortality. The 
identified determinants, which are amenable for change, emphasize the 
need to improve quality of care during pregnancy, labour and delivery to
 improve pregnancy outcome.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2017</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>12</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e0172875</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>PloS one</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1371/journal.pone.0172875">10.1371/journal.pone.0172875</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>4</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1932-6203 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Infant, Newborn</li>
					<li>Young Adult</li>
					<li>Logistic Models</li>
					<li>Infant</li>
					<li>Adolescent</li>
					<li>*Infant Mortality</li>
					<li>Case-Control Studies</li>
					<li>Ethiopia/epidemiology</li>
					<li>Perinatal Death</li>
					<li>Maternal Age</li>
					<li>Prenatal Care/methods/*statistics &amp; numerical data</li>
					<li>Rural Population/*statistics &amp; numerical data</li>
					<li>Cause of Death</li>
					<li>Delivery, Obstetric/methods/*statistics &amp; numerical data</li>
					<li>Population Surveillance/methods</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_W6FNHUAE">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location Name</strong> : </p>
<p>Actual names of the health facilities is not given</p>
<p><strong><span style="color: var(--tw-prose-bold)">Location Type:</span></strong> </p>
<p>Health facility</p>
<p><strong><span style="color: var(--tw-prose-bold)">Description:</span></strong> </p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Conducted
 in three districts of the West Gojam zone in Ethiopia: North Achefer, 
South Achefer, and Mecha. 24 kebeles (the smallest administrative unit) 
were selected for the study. Each kebele has one health post, staffed 
with two health extension workers, and reports to the next level called 
health centers.</span></span></p>
<p><strong>Sample size</strong> : &nbsp;4097</p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_DKSPV67K" class="item journalArticle">
			<h2>Determinants of postnatal depression in rural ghana: findings from the don population based cohort study.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Weobong B</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ten Asbroek AH</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Soremekun S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Danso S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Owusu-Agyei S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Prince M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kirkwood BR</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Risk factors for postnatal depression (PND), one 
of the most pervasive complications of child bearing, are poorly 
understood in Africa. A recent systematic review of 31 studies found 
that the strongest predictors are social and economic disadvantage and 
gender-based factors; only six of these studies were community based, 
and almost all were in South Asia. METHODS: Cohort study nested within 4
 weekly surveillance of all women of reproductive age to identify 
pregnancies and collect data on births and deaths in the Kintampo Health
 Research Centre study area of Ghana. Women were screened for depression
 during pregnancy and after birth using the Patient Health Questionnaire
 to ascertain DSM-IV major or minor depression. Information was 
collected on determinants relating to the mother, birth, and baby, which
 were examined using logistic regression; effect sizes reported as 
relative risks with 95% confidence intervals. RESULTS: Thirteen thousand
 nine hundred and twenty nine women were screened both during pregnancy 
and after birth, of whom 13,360 (95.9%) had complete data on potential 
determinants. Two hundred and fifty five (3.8%, 95% CI: 3.5%, 4.1%) had 
PND. Antenatal depression (AND) was the strongest determinant accounting
 for 34.4% of PND cases. Other determinants were season of delivery, 
peripartum/postpartum complications, newborn ill health, still birth, or
 neonatal death. Common determinants were observed for onset and 
persistent depression. CONCLUSIONS: Although most AND resolves in this 
setting, more than a third of women with PND also had AND. Adverse 
birth- and baby-related outcomes are the other main determinants. We 
recommend that programs detect and treat depression during pregnancy and
 provide support to women with adverse birth outcomes.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2015-02</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 2
Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>32</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>108-19</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Depression and anxiety</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1002/da.22218">10.1002/da.22218</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>2</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1091-4269 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:33 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:33 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Cohort Studies</li>
					<li>Risk Factors</li>
					<li>Ghana/epidemiology</li>
					<li>Self Report</li>
					<li>Pregnancy Complications/epidemiology</li>
					<li>sub-Saharan Africa</li>
					<li>Rural Population/statistics &amp; numerical data</li>
					<li>depression</li>
					<li>Depression, Postpartum/*epidemiology/etiology</li>
					<li>infant ill health</li>
					<li>onset</li>
					<li>peripartum complications</li>
					<li>postnatal</li>
					<li>postpartum complications</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_CHISIJY9">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name : </strong></p>
<p><span style="color: rgb(0, 0, 0)"><span style="background-color: rgb(255, 255, 255)">Kintampo</span></span></p>
<p><strong>Location Type : </strong></p>
<p>Reaserch center</p>
<p><strong>Description :</strong></p>
<p><span style="color: rgb(0, 0, 0)"><span style="background-color: rgb(255, 255, 255)">Kintampo Health Research Centre study area of Ghana</span></span></p>
<p><strong>sample size :</strong> <span style="color: rgb(0, 0, 0)"><span style="background-color: rgb(255, 255, 255)">&nbsp;13,360</span></span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_82L92XN8" class="item journalArticle">
			<h2>Development and validation of a prediction model for gestational hypertension in a Ghanaian cohort.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Antwi E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Groenwold RH</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Browne JL</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Franx A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Agyepong IA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Koram KA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Klipstein-Grobusch K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Grobbee DE</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>OBJECTIVE: To develop and validate a prediction model for 
identifying women at increased risk of developing gestational 
hypertension (GH) in Ghana. DESIGN: A prospective study. We used 
frequencies for descriptive analysis, chi(2) test for associations and 
logistic regression to derive the prediction model. Discrimination was 
estimated by the c-statistic. Calibration was assessed by calibration 
plot of actual versus predicted probability. SETTING: Primary care 
antenatal clinics in Ghana. PARTICIPANTS: 2529 pregnant women in the 
development cohort and 647 pregnant women in the validation cohort. 
Inclusion criterion was women without chronic hypertension. PRIMARY 
OUTCOME: Gestational hypertension. RESULTS: Predictors of GH were 
diastolic blood pressure, family history of hypertension in parents, 
history of GH in a previous pregnancy, parity, height and weight. The 
c-statistic of the original model was 0.70 (95% CI 0.67-0.74) and 0.68 
(0.60 to 0.77) in the validation cohort. Calibration was good in both 
cohorts. The negative predictive value of women in the development 
cohort at high risk of GH was 92.0% compared to 94.0% in the validation 
cohort. CONCLUSIONS: The prediction model showed adequate performance 
after validation in an independent cohort and can be used to classify 
women into high, moderate or low risk of developing GH. It contributes 
to efforts to provide clinical decision-making support to improve 
maternal health and birth outcomes.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2017-01</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 1
Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>7</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e012670</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>BMJ open</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1136/bmjopen-2016-012670">10.1136/bmjopen-2016-012670</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>2044-6055 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:45 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:45 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Cohort Studies</li>
					<li>Ghana</li>
					<li>Prospective Studies</li>
					<li>Risk Factors</li>
					<li>*gestational hypertension</li>
					<li>*hypertensive disorders of pregnancy</li>
					<li>*prediction model</li>
					<li>*predictors</li>
					<li>*risk scores</li>
					<li>Clinical Decision-Making/*methods</li>
					<li>Hypertension, Pregnancy-Induced/*diagnosis</li>
					<li>Reproducibility of Results</li>
					<li>Risk Assessment</li>
					<li>ROC Curve</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_U6LRMN4C">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name</strong> : </p>
<p>Facility Names not specified in the text</p>
<p><strong>Location Type</strong> : </p>
<p>Health Facility</p>
<p><strong>Description</strong> : &nbsp;</p>
<p><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">Six Primary care antenatal clinics &nbsp;in the Greater Accra region of Ghana</span></span></p>
<p><strong>Sample size</strong> : <span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">2529</span></span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_L7NQTR2P" class="item journalArticle">
			<h2>Development of caesarean section prediction models: secondary 
analysis of a prospective cohort study in two sub-Saharan African 
countries.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>de Souza HCC</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Perdona GSC</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Marcolin AC</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Oyeneyin LO</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Oladapo OT</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mugerwa K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Souza JP</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Caesarean section is recommended in situations in 
which vaginal birth presents a greater likelihood of adverse maternal or
 perinatal outcomes than normal. However, it is associated with a higher
 risk of complications, especially when performed without a clear 
medical indication. Since labour attendants have no standardised 
clinical method to assist in this decision, statistical tools developed 
based on multiple labour variables may be an alternative. The objective 
of this paper was to develop and evaluate the accuracy of models for 
caesarean section prediction using maternal and foetal characteristics 
collected at admission and through labour. METHOD: This is a secondary 
analysis of the World Health Organization's Better Outcomes in Labour 
Difficulty prospective cohort study in two sub-Saharan African 
countries. Data were collected from women admitted for labour and 
childbirth in 13 hospitals in Nigeria as well as Uganda between 2014 and
 2015. We applied logistic regression to develop different models to 
predict caesarean section, based on the time when intrapartum assessment
 was made. To evaluate discriminatory capacity of the various models, we
 calculated: area under the curve, diagnostic accuracy, positive 
predictive value, negative predictive value, sensitivity and 
specificity. RESULTS: A total of 8957 pregnant women with 12.67% of 
caesarean births were used for model development. The model based on 
labour admission characteristics showed an area under the curve of 
78.70%, sensitivity of 63.20%, specificity of 78.68% and accuracy of 
76.62%. On the other hand, the models that applied intrapartum 
assessments performed better, with an area under the curve of 93.66%, 
sensitivity of 80.12%, specificity of 89.26% and accuracy of 88.03%. 
CONCLUSION: It is possible to predict the likelihood of intrapartum 
caesarean section with high accuracy based on labour characteristics and
 events. However, the accuracy of this prediction is considerably higher
 when based on information obtained throughout the course of labour.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2019-11</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 1
Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>16</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>165</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Reproductive health</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/s12978-019-0832-4">10.1186/s12978-019-0832-4</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1742-4755 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:34 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:34 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Prospective Studies</li>
					<li>Nigeria</li>
					<li>Uganda</li>
					<li>Predictive Value of Tests</li>
					<li>*Models, Statistical</li>
					<li>Caesarean section</li>
					<li>Cesarean Section/*psychology/*statistics &amp; numerical data</li>
					<li>Decision support models</li>
					<li>Logistic regression</li>
					<li>Parturition/*psychology</li>
					<li>Prediction models</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_L655AXSJ">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name :</strong> </p>
<p>Facility Name not specified</p>
<p><strong>Location Type</strong> : </p>
<p>Health Facility</p>
<p><strong>Description</strong> : </p>
<p><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">13 hospitals in Nigeria &amp; Uganda</span></span></p>
<p><strong>Sample size :</strong> <span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">8957&nbsp;</span></span></p>
<p></p>
<p></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_GGVZSIQ8" class="item journalArticle">
			<h2>Early childhood wheezing phenotypes and determinants in a South 
African birth cohort: longitudinal analysis of the Drakenstein Child 
Health Study</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Carlyle McCready</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sadia Haider</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Francesca Little</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mark P Nicol</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Lesley Workman</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Diane M Gray</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Raquel Granell</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Dan J Stein</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Adnan Custovic</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Heather J Zar</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>Background Developmental trajectories of childhood wheezing in
 low-income and middle-income countries (LMICs) have not been well 
described. We aimed to derive longitudinal wheeze phenotypes from birth 
to 5 years in a South African birth cohort and compare those with 
phenotypes derived from a UK cohort.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>02/2023</td>
					</tr>
					<tr>
					<th>Language</th>
						<td>en</td>
					</tr>
					<tr>
					<th>Short Title</th>
						<td>Early childhood wheezing phenotypes and determinants in a South African birth cohort</td>
					</tr>
					<tr>
					<th>Library Catalog</th>
						<td>DOI.org (Crossref)</td>
					</tr>
					<tr>
					<th>URL</th>
						<td><a href="https://linkinghub.elsevier.com/retrieve/pii/S2352464222003042">https://linkinghub.elsevier.com/retrieve/pii/S2352464222003042</a></td>
					</tr>
					<tr>
					<th>Accessed</th>
						<td>3/8/2024, 12:48:28 PM</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>7</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>127-135</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>The Lancet Child &amp; Adolescent Health</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1016/S2352-4642(22)00304-2">10.1016/S2352-4642(22)00304-2</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>2</td>
					</tr>
					<tr>
					<th>Journal Abbr</th>
						<td>The Lancet Child &amp; Adolescent Health</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>23524642</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>3/8/2024, 12:48:28 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>3/8/2024, 12:48:28 PM</td>
					</tr>
				</tbody></table>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_53EL2UXT">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name : </strong></p>
<p>Specific names of health facilities not mentioned</p>
<p><strong>Location Type:</strong> &nbsp;Health facility</p>
<p><strong>Descriptin :</strong> <span style="background-color: rgb(255, 255, 255)">Peri-urban area outside Cape Town</span><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">, South Africa at two public clinics.</span></span></p>
<p><strong>Sample size :</strong> <span style="color: rgb(80, 80, 80)"><span style="background-color: rgb(255, 255, 255)">1137</span></span></p>
<p></p>
</div></div>
					</li>
				</ul>
				<h3 class="attachments">Attachments</h3>
				<ul class="attachments">
					<li id="item_8ZV8QRNF">McCready et al. - 2023 - Early childhood wheezing phenotypes and determinan.pdf					</li>
				</ul>
			</li>


			<li id="item_2X6IJZC4" class="item journalArticle">
			<h2>Effect of home-based counselling on newborn care practices in 
southern Tanzania one year after implementation: a cluster-randomised 
controlled trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Penfold S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Manzi F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mkumbo E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Temu S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Jaribu J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Shamba DD</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mshinda H</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Cousens S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Marchant T</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Tanner M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Schellenberg D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Schellenberg JA</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: In Sub-Saharan Africa over one million newborns 
die annually. We developed a sustainable and scalable home-based 
counselling intervention for delivery by community volunteers in rural 
southern Tanzania to improve newborn care practices and survival. Here 
we report the effect on newborn care practices one year after full 
implementation. METHODS: All 132 wards in the 6-district study area were
 randomised to intervention or comparison groups. Starting in 2010, in 
intervention areas trained volunteers made home visits during pregnancy 
and after childbirth to promote recommended newborn care practices 
including hygiene, breastfeeding and identification and extra care for 
low birth weight babies. In 2011, in a representative sample of 5,240 
households, we asked women who had given birth in the previous year both
 about counselling visits and their childbirth and newborn care 
practices. RESULTS: Four of 14 newborn care practices were more commonly
 reported in intervention than comparison areas: delaying the baby's 
first bath by at least six hours (81% versus 68%, OR 2.0 (95% CI 
1.2-3.4)), exclusive breastfeeding in the three days after birth (83% 
versus 71%, OR 1.9 (95% CI 1.3-2.9)), putting nothing on the cord (87% 
versus 70%, OR 2.8 (95% CI 1.7-4.6)), and, for home births, tying the 
cord with a clean thread (69% versus 39%, OR 3.4 (95% CI 1.5-7.5)). For 
other behaviours there was little evidence of differences in reported 
practices between intervention and comparison areas including childbirth
 in a health facility or with a skilled attendant, thermal care 
practices, breastfeeding within an hour of birth and, for home births, 
the birth attendant having clean hands, cutting the cord with a clean 
blade and birth preparedness activities. CONCLUSIONS: A home-based 
counselling strategy using volunteers and designed for scale-up can 
improve newborn care behaviours in rural communities of southern 
Tanzania. Further research is needed to evaluate if, and at what cost, 
these gains will lead to improved newborn survival. TRIAL REGISTRATION: 
Trial Registration Number NCT01022788 (http://www.clinicaltrials.gov, 
2009).</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2014-07</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>14</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>187</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>BMC pediatrics</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/1471-2431-14-187">10.1186/1471-2431-14-187</a></td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1471-2431 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Infant, Newborn</li>
					<li>Young Adult</li>
					<li>Middle Aged</li>
					<li>Surveys and Questionnaires</li>
					<li>Adolescent</li>
					<li>Developing Countries</li>
					<li>Tanzania</li>
					<li>*House Calls</li>
					<li>*Community Health Workers</li>
					<li>*Health Knowledge, Attitudes, Practice</li>
					<li>*Volunteers</li>
					<li>Breast Feeding/methods/statistics &amp; numerical data</li>
					<li>Directive Counseling/methods/*organization &amp; administration</li>
					<li>Infant Care/*methods/organization &amp; administration/statistics &amp; numerical data</li>
					<li>Outcome Assessment, Health Care</li>
					<li>Perinatal Care/methods/organization &amp; administration/statistics &amp; numerical data</li>
					<li>Rural Health Services/*organization &amp; administration</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_LFYIUQYA">
<div><div data-schema-version="8"><p><strong><span style="color: black"><span style="background-color: white">Location information</span></span></strong></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Name: </span></span></strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Newala, Tandahimba, Lindi Rural, Ruangwa, Nachingwea, and Mtwara Rural.</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Type: </span></span></strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Communities</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Description: </span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">Conducted</span></span><strong><span style="color: black"><span style="background-color: white"> &nbsp;</span></span></strong><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">in
 six districts of Southern Tanzania. &nbsp;The districts included in the
 study were Newala, Tandahimba, Lindi Rural, Ruangwa, Nachingwea, and 
Mtwara Rural.</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Sample size : 5240</span></span></strong></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_CDASVXE3" class="item journalArticle">
			<h2>Effect of maternal vitamin D3 supplementation on maternal health,
 birth outcomes, and infant growth among HIV-infected Tanzanian pregnant
 women: study protocol for a randomized controlled trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sudfeld CR</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Manji KP</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Duggan CP</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Aboud S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Muhihi A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sando DM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Al-Beity FMA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Wang M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Fawzi WW</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Vitamin D has significant immunomodulatory effects
 on both adaptive and innate immune responses. Observational studies 
indicate that adults infected with HIV with low vitamin D status may be 
at increased risk of mortality, pulmonary tuberculosis, and HIV disease 
progression. Growing observational evidence also suggests that low 
vitamin D status in pregnancy may increase the risk of adverse birth and
 infant health outcomes. As a result, antiretroviral therapy (ART) 
adjunct vitamin D3 supplementation may improve the health of 
HIV-infected pregnant women and their children. METHODS/DESIGN: The 
Trial of Vitamins-5 (ToV5) is an individually randomized, double-blind, 
placebo-controlled trial of maternal vitamin D3 (cholecalciferol) 
supplementation conducted among 2300 HIV-infected pregnant women 
receiving triple-drug ART under Option B+ in Dar es Salaam, Tanzania. 
HIV-infected pregnant women of 12-27 weeks gestation are randomized to 
either: 1) 3000 IU vitamin D3 taken daily from randomization in 
pregnancy until trial discharge at 12 months postpartum; or 2) a 
matching placebo regimen. Maternal participants are followed-up at 
monthly clinic visits during pregnancy, at delivery, and then with their
 children at monthly postpartum clinic visits. The primary efficacy 
outcomes of the trial are: 1) maternal HIV disease progression or death;
 2) risk of small-for-gestational age (SGA) births; and 3) risk of 
infant stunting at 1 year of age. The primary safety outcome of the 
trial is incident maternal hypercalcemia. Secondary outcomes include a 
range of clinical and biological maternal and child health outcomes. 
DISCUSSION: The ToV5 will provide causal evidence on the effect of 
vitamin D3 supplementation on HIV progression and death, SGA births, and
 infant stunting at 1 year of age. The results of the trial are likely 
generalizable to HIV-infected pregnant women and their children in 
similar resource-limited settings utilizing the Option B+ approach. 
TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT02305927 . 
Registered on 29 October 2014.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2017-09</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>18</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>411</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Trials</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/s13063-017-2157-3">10.1186/s13063-017-2157-3</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1745-6215 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Birth Weight</li>
					<li>Infant, Newborn</li>
					<li>Infant</li>
					<li>Treatment Outcome</li>
					<li>Child Development</li>
					<li>Double-Blind Method</li>
					<li>Tanzania</li>
					<li>Maternal Mortality</li>
					<li>Time Factors</li>
					<li>Anti-HIV Agents/adverse effects/*therapeutic use</li>
					<li>Infant, Small for Gestational Age</li>
					<li>Research Design</li>
					<li>Age Factors</li>
					<li>Maternal Health Services</li>
					<li>Clinical Protocols</li>
					<li>Maternal Health</li>
					<li>Dietary Supplements/adverse effects</li>
					<li>Cholecalciferol/*administration &amp; dosage/adverse effects</li>
					<li>HIV Infections/diagnosis/*drug therapy/mortality/virology</li>
					<li>Pregnancy Complications, Infectious/diagnosis/*drug therapy/mortality/virology</li>
					<li>Vitamin D Deficiency/blood/diagnosis/*drug therapy/mortality</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_IQ2X4WNJ">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name</strong> : </p>
<p>Dar es Salaam, specific health facilities not specified in the text</p>
<p><strong>Location Type</strong> : </p>
<p>Health facility</p>
<p><strong>Description</strong> : </p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Conducted in Dar es Salaam, Tanzania</span></span></p>
<p><strong>Sample size</strong> : <span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">2300</span></span></p>
<p></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_2SGIN6V7" class="item journalArticle">
			<h2>Effectiveness of a Novel Continuous Doppler (Moyo) Versus 
Intermittent Doppler in Intrapartum Detection of Abnormal Foetal Heart 
Rate: A Randomised Controlled Study in Tanzania.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kamala B</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kidanto H</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Dalen I</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ngarina M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Abeid M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Perlman J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ersdal H</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>Background: Intrapartum foetal heart rate (FHR) monitoring is 
crucial for identification of hypoxic foetuses and subsequent 
interventions. We compared continuous monitoring using a novel 
nine-crystal FHR monitor (Moyo) versus intermittent single crystal 
Doppler (Doppler) for the detection of abnormal FHR. Methods: An 
unmasked randomised controlled study was conducted in a tertiary 
hospital in Tanzania (ClinicalTrials.gov Identifier: NCT02790554). A 
total of 2973 low-risk singleton pregnant women in the first stage of 
labour admitted with normal FHR were randomised to either Moyo (n = 
1479) or Doppler (1494) arms. The primary outcome was the proportion of 
abnormal FHR detection. Secondary outcomes were time intervals in 
labour, delivery mode, Apgar scores, and perinatal outcomes. Results: 
Moyo detected abnormal FHR more often (13.3%) compared to Doppler (9.8%)
 (p = 0.002). Time intervals from admission to detection of abnormal FHR
 were 15% shorter in Moyo (p = 0.12) and from the detection of abnormal 
FHR to delivery was 36% longer in Moyo (p = 0.007) compared to the 
Doppler arm. Time from last FHR to delivery was 12% shorter with Moyo (p
 = 0.006) compared to Doppler. Caesarean section rates were higher with 
the Moyo device compared to Doppler (p = 0.001). Low Apgar scores 
(&lt;7) at the 1st and 5th min were comparable between groups (p = 0.555
 and p = 0.800). Perinatal outcomes (fresh stillbirths and 24-h neonatal
 deaths) were comparable at delivery (p = 0.497) and 24-h post-delivery 
(p = 0.345). Conclusions: Abnormal FHR detection rates were higher with 
Moyo compared to Doppler. Moyo detected abnormal FHR earlier than 
Doppler, but time from detection to delivery was longer. Studies powered
 to detect differences in perinatal outcomes with timely responses are 
recommended.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2019-01</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 3
Place: Switzerland</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>16</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>International journal of environmental research and public health</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.3390/ijerph16030315">10.3390/ijerph16030315</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>3</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1660-4601 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:32 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:32 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Infant, Newborn</li>
					<li>Young Adult</li>
					<li>Cesarean Section</li>
					<li>Stillbirth</li>
					<li>Tanzania</li>
					<li>*Doppler</li>
					<li>*foetal heart rate</li>
					<li>*Heart Rate, Fetal</li>
					<li>*Moyo</li>
					<li>*perinatal outcomes</li>
					<li>Apgar Score</li>
					<li>Fetal Monitoring/*instrumentation</li>
					<li>Heart Rate Determination/*instrumentation</li>
					<li>Tertiary Care Centers</li>
					<li>Ultrasonography, Doppler/*instrumentation</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_VEXSHE5I">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name : </strong></p>
<p><span style="color: rgb(34, 34, 34)"><span style="background-color: rgb(255, 255, 255)">Muhimbili National Hospital</span></span></p>
<p><strong>Location Type : </strong></p>
<p>Health facility</p>
<p><strong>Description : </strong></p>
<p><span style="color: rgb(34, 34, 34)"><span style="background-color: rgb(255, 255, 255)">Muhimbili National Hospital (MNH) in Dar es Salaam, Tanzania.</span></span></p>
<p><strong>sample size :</strong> <span style="color: rgb(34, 34, 34)"><span style="background-color: rgb(255, 255, 255)">2973</span></span></p>
<p></p>
<p></p>
<p></p>
<p></p>
<p></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_MCS53WXH" class="item journalArticle">
			<h2>Effectiveness of community-based support for pregnant women living with HIV: a cohort study in South Africa.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Fatti G</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Shaikh N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Eley B</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Grimwood A</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>Antiretroviral treatment (ART) initiation in HIV-infected 
pregnant women in sub-Saharan Africa (SSA) remains inadequate, and there
 is a severe shortage of professional healthcare workers in the region. 
The effectiveness of community support programmes for HIV-infected 
pregnant women and their infants in SSA is unclear. This study compared 
initiation of maternal antiretrovirals and infant outcomes amongst 
HIV-infected pregnant women and their infants who received and did not 
receive community-based support (CBS) in a high HIV-prevalence setting 
in South Africa. A cohort study, including HIV-infected pregnant women 
and their infants, was conducted at three sentinel surveillance 
facilities between January 2009 and June 2012, utilising enhanced 
routine clinical data. Through home visits, CBS workers encouraged 
uptake of interventions in the ART cascade, provided HIV-related 
education, ART initiation counselling and psychosocial support. Outcomes
 were compared using Kaplan-Meier analyses and multivariable Cox and 
log-binomial regression. Amongst 1105 mother-infant pairs included, 264 
(23.9%) received CBS. Amongst women eligible to start ART antenatally, 
women who received CBS had a reduced risk of not initiating antenatal 
ART, 5.4% vs. 30.3%; adjusted risk ratio (aRR) = 0.18 (95% CI: 
0.08-0.44; P &lt; .0001). Women who received CBS initiated antenatal ART
 with less delay after the first antenatal visit, median 26 days vs. 39 
days; adjusted hazard ratio (aHR) = 1.57 (95% CI: 1.15-2.14; P = .004). 
Amongst women who initiated antenatal zidovudine (ZDV) to prevent 
vertical transmission, women who received CBS initiated ZDV with less 
delay, aHR = 1.52 (95% CI: 1.18-2.01; P = .001). Women who received CBS 
had a lower risk of stillbirth, 1.5% vs. 5.4%; aRR = 0.24 (95% CI: 
0.07-1.00; P = .050). Pregnant women living with HIV who received CBS 
had improved antenatal triple ART initiation in eligible women, women 
initiated ART and ZDV with shorter delays, and had a lower risk of 
stillbirth. CBS is an intervention that shows promise in improving 
maternal and infant health in high HIV-prevalence settings.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2016</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>28 Suppl 1</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>114-8</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>AIDS care</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1080/09540121.2016.1148112">10.1080/09540121.2016.1148112</a></td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>0954-0121 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:34 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:34 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Cohort Studies</li>
					<li>Young Adult</li>
					<li>Prevalence</li>
					<li>Urban Population</li>
					<li>Infant</li>
					<li>Infectious Disease Transmission, Vertical/*prevention &amp; control</li>
					<li>South Africa</li>
					<li>Pregnancy Outcome</li>
					<li>Treatment Outcome</li>
					<li>South Africa/epidemiology</li>
					<li>Prenatal Care</li>
					<li>Pregnant Women/*psychology</li>
					<li>Pregnancy Complications, Infectious/*drug therapy</li>
					<li>Anti-HIV Agents/*therapeutic use</li>
					<li>HIV Infections/*drug therapy</li>
					<li>Counseling</li>
					<li>antiretroviral treatment</li>
					<li>Community Health Services</li>
					<li>Community-Based Participatory Research</li>
					<li>community-based support</li>
					<li>lay health workers</li>
					<li>prevention of mother-to-child transmission of HIV</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_3USIFHU4">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location Name :</strong></p>
<p> Facility names not specified</p>
<p><strong>Location Type : </strong></p>
<p>Health Facility </p>
<p><strong>Description : &nbsp;</strong></p>
<p><span style="color: rgb(28, 43, 51)"><span style="background-color: rgb(255, 255, 255)">The study was conducted at three urban public facilities in the Nelson Mandela Bay district of South Africa,</span></span></p>
<p><strong>Sample size : &nbsp;</strong><span style="color: rgb(51, 51, 51)">1105</span></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_GZ3HBJA2" class="item journalArticle">
			<h2>Effectiveness of conditional cash transfers (Afya credits 
incentive) to retain women in the continuum of care during pregnancy, 
birth and the postnatal period in Kenya: a cluster-randomised trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Vanhuyse F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Stirrup O</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Odhiambo A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Palmer T</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Dickin S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Skordis J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Batura N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Haghparast-Bidgoli H</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mwaki A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Copas A</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>OBJECTIVES: Given high maternal and child mortality rates, we 
assessed the impact of conditional cash transfers (CCTs) to retain women
 in the continuum of care (antenatal care (ANC), delivery at facility, 
postnatal care (PNC) and child immunisation). DESIGN: We conducted an 
unblinded 1:1 cluster-randomised controlled trial. SETTING: 48 health 
facilities in Siaya County, Kenya were randomised. The trial ran from 
May 2017 to December 2019. PARTICIPANTS: 2922 women were recruited to 
the control and 2522 to the intervention arm. INTERVENTIONS: An 
electronic system recorded attendance and triggered payments to the 
participant's mobile for the intervention arm (US$4.5), and phone credit
 for the control arm (US$0.5). Eligibility criteria were resident in the
 catchment area and access to a mobile phone. PRIMARY OUTCOMES: Primary 
outcomes were any ANC, delivery, any PNC between 4 and 12 months after 
delivery, childhood immunisation and referral attendance to other 
facilities for ANC or PNC. Given problems with the electronic system, 
primary outcomes were obtained from maternal clinic books if 
participants brought them to data extraction meetings (1257 (50%) of 
intervention and 1053 (36%) control arm participants). Attendance at 
referrals to other facilities is not reported because of limited data. 
RESULTS: We found a significantly higher proportion of appointments 
attended for ANC (67% vs 60%, adjusted OR (aOR) 1.90; 95% CI 1.36 to 
2.66) and child immunisation (88% vs 85%; aOR 1.74; 95% CI 1.10 to 2.77)
 in intervention than control arm. No intervention effect was seen 
considering delivery at the facility (90% vs 92%; aOR 0.58; 95% CI 0.25 
to 1.33) and any PNC attendance (82% vs 81%; aOR 1.25; 95% CI 0.74 to 
2.10) separately. The pooled OR across all attendance types was 1.64 
(1.28 to 2.10). CONCLUSIONS: Demand-side financing incentives, such as 
CCTs, can improve attendance for appointments. However, attention needs 
to be paid to the technology, the barriers that remain for delivery at 
facility and PNC visits and encouraging women to attend ANC visits 
within the recommended WHO timeframe. TRIAL REGISTRATION: NCT03021070.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2022-01</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>12</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e055921</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>BMJ open</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1136/bmjopen-2021-055921">10.1136/bmjopen-2021-055921</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>2044-6055 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Child</li>
					<li>Ambulatory Care Facilities</li>
					<li>Kenya</li>
					<li>*Motivation</li>
					<li>*public health</li>
					<li>*community child health</li>
					<li>*maternal medicine</li>
					<li>*Parturition</li>
					<li>Continuity of Patient Care</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_NRYLECU5">
<div><div data-schema-version="8"><p><strong>Location Information:</strong></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Name:</span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">Names for the health facilities not provided in the text.</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Type: </span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">Health facility</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Description: </span></span></strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Level 2 or 3 health facilities (Dispensaries and Health Centres) in Siaya county, Kenya.</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Sample size :5444</span></span></strong></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_N9UP4KYF" class="item journalArticle">
			<h2>Effectiveness of pregnant women's active participation in their 
antenatal care for the control of malaria and anaemia in pregnancy in 
Ghana: a cluster randomized controlled trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ampofo GD</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Tagbor H</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bates I</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: The burden of malaria and anaemia in pregnancy 
remains high despite the availability of proven efficacious antenatal 
care interventions. Sub-optimal uptake of the interventions may be due 
to inadequate active participation of pregnant women in their antenatal 
care. It was hypothesized that providing opportunities for pregnant 
women to improve upon active participation in their antenatal care 
through malaria and anaemia point-of-care testing would improve 
adherence to ANC recommendations and interventions and lead to better 
pregnancy outcomes. METHODS: Fourteen antenatal clinics in the Ashanti 
region of Ghana were randomized into intervention (pregnant women 
participating in their care plus current routine care) and control 
(current routine care) arms. Pregnant women attending the clinics for 
the first time were recruited and followed up until delivery. 
Haemoglobin levels and malaria parasitaemia were measured at baseline, 
4-8 weeks after recruitment and at 36-40 weeks gestation. Birth weight 
and pregnancy outcomes were also recorded. RESULTS: The overall mean 
age, gestational age and haemoglobin at baseline were 26.4 years, 17.3 
weeks and 110 g/l, respectively, with no significant differences between
 groups; 10.7% had asymptomatic parasitaemia; 74.6% owned an ITN but 
only 48.8% slept under it the night before enrolment. The adjusted risk 
ratio by 8 weeks follow up and at 36-40 weeks gestation in the 
intervention versus the control was 0.97 (95% CI 0.78-1.22) and 0.92 
(95% CI 0.63-1.34) for anaemia and 1.17 (95% CI 0.68-2.04) and 0.83 (95%
 CI 0.27-2.57) for parasitaemia. The adjusted risk ratio for low birth 
weight was 0.93 (95% CI 0.44-1.97) and for pregnancy complications 
(abortions, intrauterine fetal deaths and still births) was 0.77 (95% CI
 0.17-3.52) in the intervention group versus controls. CONCLUSION: 
Although its potential was evident, this study found no significant 
beneficial effect of women participating in their malaria and 
haemoglobin tests on pregnancy outcomes. Exploring factors influencing 
health worker compliance to health intervention implementation and 
patient adherence to health interventions within this context will 
contribute in future to improving intervention effectiveness. Trial 
registration ISRTCTN88917252.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2018-06</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>17</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>238</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Malaria journal</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/s12936-018-2387-1">10.1186/s12936-018-2387-1</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1475-2875 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Ghana</li>
					<li>Young Adult</li>
					<li>Pregnancy Outcome</li>
					<li>Malaria/*prevention &amp; control</li>
					<li>Pregnant Women</li>
					<li>Prenatal Care/*statistics &amp; numerical data</li>
					<li>Cluster Analysis</li>
					<li>Antimalarials/*administration &amp; dosage</li>
					<li>Pregnancy Complications, Parasitic/*prevention &amp; control</li>
					<li>Antenatal care</li>
					<li>Active participation in antenatal care</li>
					<li>ANC</li>
					<li>Anemia/*prevention &amp; control</li>
					<li>Community Participation</li>
					<li>Haemoglobin colour scale</li>
					<li>Malaria and anaemia in pregnancy</li>
					<li>Parasitemia/*prevention &amp; control</li>
					<li>Point-of-Care Testing/*statistics &amp; numerical data</li>
					<li>Rapid diagnostic test</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_KL25RXLM">
<div><div data-schema-version="8"><p><strong>Location Information:</strong></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Name:</span></span></strong></p>
<p><img alt="" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAGcAAACUCAIAAAABJaAZAAAgAElEQVR4nOy9d5Bc13ng26BIuUq7du2qnrdW9j7t2n5rP3utZ3tLXltlm5IIZgUrWGEdZT1JVqYyLYm0LYsiKYoiRZEgQYhEIsJgUuecJ2AyZnq6ezqnm2PfnMN5f9yZQSORAIGhuK/2q1vD5szg9j2/+c754jntm5+fr/5vuRZZXFz0VSoVx3Hc6xNwJXFdAMDL/cKNkEvv/+re8WpG6jhOpVLxVSqV639u27ZlWdZ0zTRNAICqqrIsez9yXAcAYJqmIAiO7ZiGqSgKx3E8zxuG4TiOJMumaTqOzbIsz/OapkmSBABwXBcAIAiCZZmyLFuWtX1Dx9F1XRAEnue93/SE5/khx5mmtftIqqpYlgVc17ItAIDj2KZhKIqiqqrrurqhK4rqiaZpu/d/Rdmmdt264LZazfHx8empyZeOH19cWEin0y+9dGJx8ezaufVUJi3LUqWyWSwUCvl8LBqdGJ9IpRL+gD+VSp+dn3vp+PFg0F/bqqysLCdTqUw2WygWg8Hg2Ph4rV6rbVWXFhcnJyYwHF9aXiptbh49evT48ePBQCCdTk1PT+dyuX6/F48notFIoVg4efIkDEOu62IYNjNTrG5tQYN+KpmYmpqcnJxIJBNLS0vRaLTeqG2UNo4dO57L5WLR6IEDB6rV6lUN1XVvDDXXdc6enfvRY4/97NDBnz711GOPPfbCi4effPLJp5584qGHfvDdBx6oVqtzM4VUMvnCz55/9NFHn3nm6c2Ncwtnz545M/6zQ88/+vDDP3nyx+NnxlRFWS9tHDl6zB8I3n///Q88+E+RaLTX6wQCgVQ6LQjC4z9+/MdPPPmlL335G9/4ZjwamSkWDh16/tFHHjl29OhDD32/WMiXNtYfeeThZCLebrXa7fbk5FQwFEom4k/++Mf3ffnL999//9PPHohGowcOPBtPxKuVzecPHTp+7OjTTz/19a9/fXl5+Wo43EBqAMOwUqlEkaSu67Va7dy5c+VyuVTa2NhYX1hYaDSbm6VSPpdbXlrK5wvz8/Mogti23Ww0K5XyuXPnup3OVm2L53kYQUqlzUwmo+vaAIIpmlo7d67eaLAsKwhiuVJZO3euVqvNnV3o9/owDJdKm+fW1jKZzNraGkkQpY0SwzC1ra1arUaS5NzcfDqdPndubWtrK5/Pz83NLy0vr66ulstlCIIUWZYkqVyurK+vwzDEcdxrSu1S2apW8/nC0vJyu92SZalU2jw9NlaplCcmJ48cOTLt9x86dKjdboeCwc3NzWn/9NLSwuzsTD6fW1hYXFpcqlarhWLh1NiZdCY37Q9MTIyNT4z/9KdPJRIxURRnZ2ZrtXooHHn66WeefvqZEydeWlpaPHnyZLFYXFtbP7uw0Ol0Wq1WZWvr1KlTi4tLkWgUx7FcLn/o0KFnnjlw8uTJXC63ubnZaDRexdD2kFo6k37iiSd+9PjjU1PT8XgiGAo9/cwznU775Njpb3zrG6fHxn74o8ey2WyxmA8EAj/5yU8mJyeOHDl88uSJycnJgD+QyWSefuanX/jilw4fPfbsc8/9+PEfHjx48Etf/PwTT/wYgqDnnnvu9OmxHzz8yLfu/9Zn/uGzD33/+6srS7FYdHJqanraf+r06ZdeOjE+Nvbii4cfeeSHk1PTTz71FARBqXTme//6rw8++MB3vvPdxx9//KmfPn3mzLgoiq8jahzHdTqdRqOBoli/36dpGsdxwzDY4bDT6XAcRzM0y7K2Y5MkSVE0y7LccEiSBIKg3HCIYRiO481mk6JpHMdRFMVQrN1uQRCk6/pg0O/3+91ej6LpwWAAQZBnK3lBgCCIYZhutwdBULvVhmEEhhEUxWzbEUTRuy0EwQiCtFqtwWCgadrriNr/j+V/U3s18lpQ03SNZihd1/fo/q+9XBs1XddZlr3W9zi7Gp+vnNqoF9khbRrmq3rO15dcGzWe56/Sex55B7BYCjc5P2al58+dKNcWJEmwTPtVPu/rQ66NmqZpGIZd2xs4YK0W70hhys0M2GBfii1W/O1eZTR4/F9Oro0aQRDzZ+ev6Q1s291opbtKhHQyAyZIgiwFsk06fK6eQfG+rv0vOWGvlpphGBAMRaKRg88f3NjYoCjKtq9qllmWs1FPtOhpwk4PhkHCzZIgx4ACbMaXt85UmwsYgTjODRrNayVXS01RlEqlMjk5+YMf/KBQyPf7/atMqlims9mIN/AJ3EjBQtSjRoIcbmcgNrDeOLZUmqiUZ3q9liIbN2hQey7XNkNJkkylUtf0BqZhl1uJGnS6i01iRooCeQrkCSfTJf1dKtDFpnro+Gr1xbXGVB062x3UKPKabfRrL9dsDWiavqY3sEx7ZWn83MbztcZxWI6hehI303022EanBnykz4ba6BQN8jAf7PCBLSxchwv1zhqO4692RK+F7LmXaxpWpR1v0ZPN/lifCcBitD8Mo2oS4iN9OkhY2R4dQLUkLMcROU65GcxJ1slgDUlt1mZanYYkXXOQ+BrInlNTZAUW53GQRpV4F5/CrTRupChQIOwMZqQoUMCMFG5lKFBoweMtdIIEuSGYgdVouXu6O8zU0Fy5Oddq1TTldRRa7Dm1brfV4bI0yFOggCjxHh2gQJ4EORLkvRcUyJMgT4LcgI80+2f6wyAJcogUa3ZPomoMNuJdIb7VmVqvhUqN2VarpmuG67rg5xo07zm11VJ+i/QzoOCRgoRojwkSbo7cZnf+IpxMnw4iWmIwDHXwqUZ/rENMI1JsCGZgMdTjgw10qt6fPrtycnEx0u7VVE21bdv9eXgte0vN0K02PjfQojv6laNAHpFiPSZIujnqQnCEk0HVOAlymJEasEHCzvTZYIecJu3sYBjqoJO4kSTdDKTFEDXZl1Pr3dD6Vq7br0uSoGu6Y7926re31AiC7HMzFMhso3G3wQ24cLN/BjczFCjszNA8aWdgPkyCHKIk+kyQBkVESXTw6S7pR7UEaW87ejQokG6WAlnMThFWrkkHZ84eXTmXGKAtSeZVWbHMPVe/vaW2WV3dhAMsKHiqhBtpEuQoUEDkWKVytI1O4noGt9IUyFGgQII8JEYhPtxGJ3Ezg5uZNjbVQiZIO0eBgse3Q0zBcgySYtsLoptD1TiqJQgz02ZDS6XTa+diPagmiENJkixzr7RvD6m5Lqi0ZqvUFAuKFMjjVhrVEhTIY3qyzwZJN4/qyR7l75LTuJUirAymJfvDUKN/pgWPt9HJPhNElDgsxWAphsgJRE0gWqIFj/fogBdgUCCPqglYiFIgNxgG28h4GxnH7XRPjp3rBMrd4gCrMQzGD7kbHrHtITVDtyFuBbbiuJFClDjERzrENCzF+nRgwIUpkKdAjgJ5WIoO+DAkRPpssNY+2WMCLXi8R/kROY6ocVRN9phAsz/WowLlypEeE6TOG98CJEQ62JQXqw2GYYgPI1IMVROYHkf1WBU+s7B2YnMr3W6vYXiHZjGGpocMb193xmAvqy1DfsDOo2oEEsIDLtyjA/Xu6Q421cEmaTDjUfNUBuIjuJlGlTimJ2Ehgihx0s2hagKWogMuPBDCXijW7J8pbx7pElOEk6VBkXSyPdrfQadgKUa6WRrMkG52wIUHXBgSIrAU7dN+VIsjcmS1/MJK4+TmIFLppWv9uS66ARMNlOjhBMbQQ0O/ZlXcQ2rdfnu1MgmLQcLJ0KBAOJl69zSqJgbDECxGyfPOWg5V4riZrrROYmaaATOefaBGriGYYUCRAcUWdKbePQXxkcEw1ByMDbgQC2YRNTHgw7AQhcUoBfLeHfpMEBajJMihWgI3UiyYoUGeBjkaZBvD6Q14vAyHNzux0laiNVhq99chtIWgAwwlDf2Vczl7SK2ytXJ24zDtZj00uJNp9Mf6bLDPBiEuTIM8CfKEk0WUeBefQpT44bF/rSCTmJIgHG/Z2vZIhmBmAxmv4VOIGNlqvoRbWUSOlytHas0TuJ7ycgGIGofFCCxE+kxwwIZa8HitfQLTkrvcR10cGhQYUGBAnnLT/eHUeu3Fla2jNTxSw1INrLjVzDV6y21os9urdrsNCIYQGOOGF9RM94qabbnV+uwWcWYIZnYfF1ESsBwbcOE2OtlngxQo4E6mR/q7RGC1ffrAE5/N5J9Abc+eev8kPwQzm4PxH/zwc6mzz9JWBuLCPSrQJaa7pB+3MvTOb1IgT4ECDQqQGO3gU11yuktOUZc40hddFCh4FglTY6SdZkCeAdkacrqMTtSpUA0Ll+pTG1V/HU63iNkGMruylmMpag+pGbq1sZlMzv2kLUQ8G0qCPGamIT5Cuvk+E+xRARrkKZDvc5H0iW8sfOH3Wn/3n6qf+o2lp/9nV01RoOhZW5gJz2+8+MgTX3zgoX9ILR1sC1FUiXeJqf4wNODCPTYIy3Hv5riVhvgwosYJJ0O6WYgPvzyybdfazZJuDlHjkBDZ/tPKMQpkGVCgQY6wk5geQ+Rwh56YKz13djEsifIeUuN5AUFnSHJifuXQavs05mRoUMTNdBuZpEABVRJ9JkSDIm5mFtYOLXzqt+BbfcxdPvJ2X+k2X/7pv8GdXJcOQEIE05KwmugMIyeCD3/7Xz754ol/Wigd7rFB0s7gRhrXU5AQ6ZKBPhPssyFUTcByrMeGOvikF2ZczUWBPOnk+mwIUROwFIPluOeN76hwnrKzfSm00Yiy7HaWbK+o4TiOoDkACpIUrzVOFFYP9aQY6eQGw3CP8uNmirAysBTDzFz8yBc27r4Zvdv3d//lpiP/4yZ0v6/2md/oMKEOPt3BpxE1QYPCEMxgZnph44XnDv/jj5/9+iM/uW8DniDdHA0KNMjjZgozUpiR8nQHNVKDYQgzU1dJzZuqfTYI8ZEBt22vR36Uo0GugkS6/cZuzLtX1CCo3+lEACgAULDtDC9Els+9sNE5BSlxWIjgVhrmIxAfGbpLieNfXLvzJuxu39/92k0v/dFN6G2+1hd+E7PypJ3DjBQsRgfDUI/2D5ggZWebbKiMTR04+t1v/dMnn3vpgSYXhrUU7mZ5MLfaPt3mIgwo4maqz4RIJ0uNmJSXvfIkyOFWpt49NRiGKfeC1ZAB+SruLzeWbOu8bd0rar1eo9GYAKAAQA6APAB500zByOTixuGtwVgdOtPCpxE9zYLZTehM6b63DW719fb74P2+yh370j/+OA1mvRgLM5KYluhSfogLUyDvmT/KzBdKLz577AF/9ol/+eHnZkpHWbuYWT+4OjhFatkBFcLM9CiRK6vYBYa1RwUQOTaqaDTId8XweiMjS+ro6PaKWrtd3to6AUARgNzOlQcgL8ux1aVDS0tH0nNHlrfGJbDAgLnFmR8ufOFtvb/8D42/fcvMYx+sY5OElb3AArq5Lh3w3DGPHQ3ynD2TXD74+IFvHDr2vYeO/MN35t774PL7Jtf/CVFT9HkrfLVLG2Fn+0wQUxO770uDPOYkN3sxHL+4BLx3ulZqt0/uUMuPsJtxrUJy9ZHvHv+rifIPBlKCBbMUKHak2PLmodX2CdzNQXxkwIVwI0XuFLS8BavPBGE5RjpZL66gQX4IZirQ1N8+9O5f+cub/uCZX9i/ue/e0pteqnybtC/y0fLkFVRsB1lmMAxDfIRwsrvuN+VmK0iw0SxfOro9oea6AEE2CXISgOIOMu9rUTfS09VvfnT1Le9u+u7a+IV/Wv7zujgtgLMUKFCg6DkcFMjjZtoLRakLtCY/4MIDLoTpSQ+KBBbSjaf/cv2tt6763vrxW97+ws13o76PLf3nphJkR/zEUYN40XdoUPC0DJHPa5m3IDbZ0PrWzGXTdntCzTRdiipLUmhnXduensCdq5IH7135t3djvrsqN9/d2ffOhu9g7R9wLjsSk2+PB/dMoZEiL7RosBDpMUFETVAgr4KVE5v/ePv8LR9Q9/2fH7n5d75z892w70OdX1rDjhL6dvLOyzKRIIeqcQ+3900S5FAtAQvRDj414MIMKJKjc9NOn6sl5Cu0VewRNcBxW6YZHZmYOQAKwJrJ9P/5fYLvXcU3/Mqdt/zBEze/T/d9Nv6OtcZpQowTdubClbgIidEBH6ZB8SIFwc10nw3BckwAC7P15/92+dfvHPrelb3ljnNvuIvw/f3cb1ex04iYgMUYLEVhKQpLMYiLeI7FgI/AYhQWY7AYHfCRPhPsEtMDLgwLEdxO06DghWibUBBBB1ca4J5QIwh6MMi6bva8lnnU7Nki/NBdhG//2k2/ff/N7xi/+V7F94XQH0YST7XgCZgL7S4r3nwkrAwkbqdARr9PgTxpZwdcqE8HBkj4dOWbH1r+5XdBvlubvr9aeWu4/hANiqSbg8QILEYhKYqIsS4+3WeDmJ6ExSgkRCExAssxws3SoEC6OViOQUJkMAxBfIQEOQJkVzYzzpXTcjeYmuOAfr/daiU4LgpAYWRR817ModzYZxZ+53bS937dd7fou3v5FybmvjATeiK//HwLmSDd89S8ol+XnG6jk6ie2s0snV+knHyjd7oLTyxsHj+Y/uqB2ide7PxDHnqSdnOeDd2djN6tID6CqvHRVMpFCxyqJmAxCgnhlepJkkRfdovTjaOmaWattjoYRFQ1OmI9R8HlHatQhZ5/eOWuTy38+j9u/FFo82s8NaXy0dWV5wuzT3eZwLY1sDJ9NgQJEVRLQUIUM5KXhuI0KCBybEAH5zaPzW6eJo15CSyKYH7kN/O7X3dvO2qXL2suUC2+vBYz9JdrOrlh1HieL2+koM6E66YuNgIXzVMwxzGBavsABB0HVsGLH3Q1cfbsgXPNE7iRQsToYBhG1QRuZ70VHeIju3bzAo8BzJ1beDL51T/Nf+ntc4c/0+fCNJi9ksNxNd+hQK4ET+MU9PIwbgA113UHg06zGePYkMoFL/TOLgJXcJyszIYMIQ7ceVtO6WLMdb0fFRUlvrhyaL16rEf7CSuzW12mQKFH+zvYFG6lRyuEDFisLD+x8LG39O7yDW73td7zxvyDd7RpP+UWSTe7e0FitEf5vbxenw30mWCX8uPng4eLrsx6I6MoyisO+bqoOQ6o11chKKxrcdtIDpEJS0+5Tha4lwVXsK2MPAw7dgaAvOtkLSO1Qy0HQFHgwrnMkzVimrxw3SHsDG6k+3TAq9eQIM+AmYaYnPvRB4h3+ube5Zt+x77u7b7O3b6N7A+6w+g2IybQYwKwHMPNNG5tX5iR6uCTXWL60qlKg3wJnkTwziuSuF5qJIlzXN6yEqoQYbFJnvLLXEhkg7oUt630JdMz5zpZQ024TvZCfdz9nSzaOb167oVNZAK3M/SIZlGggJvpWusELMYIOzsE8xvIRPor/8O61/cvv+N727+7KXOrT7jXV4o/ANt50skTTpawM4Sd2SlXe3+GPKLEMT2JSDFEjpE76rz9t3EypVbmara6XC+1en2NpsIqH9SkmGNnNDmuiVHXyQInOxK6XwDOVJOaGL1kIucAyFt60tSSHOGvtU6ttE6iRpoZiQ0IJwtx4cEwNGCCpJltysmFpz4K/ZmvfJvv7Lt98B2+2ntu2Sg8AhkZ3MzgVubSYIAEOdLNUiBPWJku5Uf1JG5vV7gZUNhEpwZY42paIK6LmuO4lXJy0DzubKtV3rYyKhcWuHC7c2o4DAFQdOyM42R2wbl2RhWjlp66BFkOuDkOnbSMlMSGAMh1++OL1eOImmJGvFzMSiNSDLcyfTYIK8nVmceLn/yv3ffe0rnb1/zQLxV+8vGeEEW1ZI8KDNgQqiaunGXL40aqS/oHwxCqJSmQJ+x0qZ3mOO5qBn5d1ERR6XcSqhQaUZw8AMX1zWMPPPzF2dXDACzKw5BlpHbXNVNPcfjU5RXNSFL905aRss20yoUBmEUw/1LlGCynGFAknCzp5ggn28GncMtTkDwN5mqDk/OHP730k4/Mhx5oENOkW6B2AvL+MNRngoia2M3NXrSK0dt+XJgBuSox3UMqV9kscl3UGIYRxTkAMqMpDZ4NVsa/NvPoRyqnv4y2jql6etSMGmqSgcYvzCDlXCcLQJ6npqnemDwMS0yIHpzR5bipplB4crX20kBOoOp2yIXqyT4bIs9b2CIN5mmwQIP5HhXwFGfXT8bNdJfyI8p2FmAnMs2TII9qSUxPEk4GFiOIGin3U8xVt4FeFzUY7g6Ho+v6jMj6F/7ljq39PvkuX/NW3/zX/ojHzgAwv7vAOXZGZoMXrWuOldaVODUYw5ov6UpcEaKWmZa5kDwMOVoS6o0tLB2sDM5gplfHy3re3CU+ag7iI7utv9QIuB4dwPUU6WYRJX4+MuUjsBDtMYEB7S/D421ow7aulsB1UduqrWBYcCdyyttusZd8sPluX+NOX+hP9pVv93Vu9TVOf0m353ZjAwDyChemB2MAzIw4wzmFj5Dd03jrhGNndm8IQMEyUqaa6FePLcw/u1w9RrhZBhQxI9XGJi+MAfIkyHs1F0iIwGKUcLPUduEq2meCAy7Uo/xtdGLAhyEhCotR0s0SbhaWYogSLndiBHENncCvnprjgE57jh0GdgZf1K3M1tFPS+/1+d/he/ubbzr09n3SXb6lH32YlpMAzHjq5rpZQ03IXERiw6axG0XkbSOty3FViqlC7BLfuKjy4e65F8qlI6ud0yQoYFqyBZ2hLoznKZDbjsDFaAseh6UYBQqoluzRAUxPoWbK+ylmpnfav3IUyBNWeqN9Yqt91rauoW/h1VPjeRHupg01fF4v3EI38o/Q7b7Sft+RP/Qt3eaD3+1rnvycZs3upCfznvooQkQToyIbNPX0SJBfACAnMEHPBx71WobYJN44YaqJPjy53DiJqIkOOnFJeJSHxUgLmYCECCxEB8MQbmUQJe51/3oeH2FnICFMOBkKFAgn2x+GYCFUGUQGUPeaxv7qqXXaW6XFI6YSHZlQsxx25ux9b4du96nv9xF3+BY//d/6G8+pYkIaBiU2KFB+sneagcehrSO6HBOZIIdPSWzIW8IkNqRwYU2MiUxw1PW1zbQux6jBGUtPAVBE8OnF0pE2Pn1JWFroEtNbzRPNwRnKzWFqojk402MC5IU1pxYy0aX8AzY04MOYlmyy/ho0a5lXe4zHdVGzLNBtn0X6pzQxaqjJ7dnn5FQ50V5/fuXgJ4tf/9Psg+9rLD+tKknLTFtGSpNjdH9MFSLyMER2T9lWRuHDChe29JRlpCwjZekpy0y5Tk4TYzIXNrWESPldO6MKEVNPalKM7I5ZZgaAGQyfnl/5WQObpHa8X2w75g8N+HCzP0Y4adLNIUocN9OecRgMQx1iuscEqrVjbWyyjU/1mAANci020e5c8wkwo9Qcx3Ecx7Vtx7Zd23Ft23UccFmYw6FAknOOkxaZ4KByZIhOymxIYoKqEHVAkeeitcUDrfUXhnTI3l688poUpwfj3gwVmaCuxCUmCNz8iKqevww1waKTLDIuUIEhNmlbGQ6fJjunBMYvDUMqH26UXkxFH60OxjrkdI8KDLhwvXsalmIkyLWRCcJKk9uZtTwJcgMuAvERSIi0sckBH25jk5iZwo10HRmrdJKS9Aqx+hWpbW3VVFWtVtfr9ZVms1SrnqtVN9rtrcGgTZAwyxIsQwxZkmVJlqV4jq3XVvudaUOO8nSAJ/xUf8zcji4L3ph1Nem6OdfJum7WsTMCHZDYkKmnHDvrESG7p1lkwrEyjp117MxO4nd7YmpSjIYmeNKP1I4NsUkAZpnBuC5FHTvr2GnXyRlyrFs+slE9tglP4EaWcvMtZAJR4iTINftjAy6MmSnCzhBmGuLDAz6C21lYjGB6kgS5av04osQZUGhQoVL52rYgXkRtyzCsTqc0GEzpappFp2l4WlVSPBcj8GCvPdZrjXXqpyqrL1ZWXiydPVRd/hneOekt27qSkIdhiQ5aZkbTUoaZ1qW4ZXrLfMHUEhIb4olpgfaLTFCgA5oY06SYQPldO6PwEZEJSGxQ4cO2uR3tq2JUESK6khDoANE5OUQnAChy6JSpJXbttWWkVC5smulq6+T64AzlFjrYJKLEvFbpNjLRRsa7lL8Fj3fJadot9ugAJEZoUMT0JMRH+kwANeJNMjO89q3VYHSGAgA0Xa/X5geNl0w1aukpnpji8EmJDUhswDZT0jDQK70wKB8muqfI7kkWGbeMlGNnXTer8BGB9NPDSG7uYKN1SmFDhpb05prHVOEjjp1x3ZzrZgHIu27O0BKmltwJUQuaFJWHIdtIG3KM7I3pStwy0oaWpHpjzOCMqSeH2KRlpHZscdFQEzQ0bhkZx87UWydXascb/dOoFKNBgQQFWIq10Yla+0QLGsfNNANmOuR0nw3iRqaNTiJynHTSDdK/upl7FcjApdZAEKRavSgIEQBmDDXBYVOaFDP1lKknJTbEDMY25p9bW/yZISVUISIPwxIbssyULid4LtrfejFx6h9n44/g8CRwsgAUAShaeopFJgw1eWHsWRDZIAWd0ZWYocQNLWnqSVWMDvEpgfTrSlxT4vIwTA3ODPEpQ00KlJ/qj8nDoG1lXCfn2FmFjzDwpEAHNClqqonK2osbzVOb7ZOw5LUc5AknA/FhRE3QYIawsh1s0qvg9ZgAqsRRI77VDxDkte2rviI1AADLslvVJMcGDTkmsSGZD8tcWB6GdD4moaGx498+cfJBYJ0FYB6Agqklyd5Yb/Pw2ktfWv7875X+6leXvvDf1ye+Jatpy0gpfERig7adAaA4GgkAUJCGIRadNLWUzIVFJihzYZmLDLEpXYkDkHfsrC7H5GFIoAJk7/QQmxxik0TnlCKENTnm+SveGmrqCVNLADCLoFML8wfOVY7V8WkaFGhQoECBcHOIHO8zgS4ZgIUoqsT7XIiw0pCWWFgOXJNn+wrUAAAURazMj7H4hJfwAiAPwMyQDRxe/OQ3F9/x7dKtp2tfJlm/o6Z1JQFVj84c+era+/4NcaePeo+P3u8795FfruUeMdUsh09x+JQqxHQ5pstxcH7JL2hiVHov1toAACAASURBVGJCOzOuAEBBk2MC5fcmoG2lBTIgMkHLSOtqQubDPDFt6knbSit8eIhNXZoodsy0woVrlWMr6y9WsamBnqJBfsCHe0wAUeKIkuizwQEXws0UCbI9MTGA2q8O2RWpAQAwBNpYG+PpKVWI2EZaZEIHZv76jq1996i+e1TfbZV9Ty/9NdGeELBpojeW/Na7B/fuK77T9+nfuGnm3b7uu3z1Jz6o6kWFDwt0gEWnhtiUKkbATrLbsTOaFDO15E6iPG/pSbJ3WuHDmhhThYg3oyU2JDIBx8p5mRKJDWpiTBqGRrLE5+MHkQmIdMCQ4jwVKJcOr5WPLpWPNLDJIZgdKfHlaZBHrdTKVkjTXv0mwJfzcmGkN4AihhEXEH+z++JHVv/D3Yjvj47e8vbnbr6H931s5VeW6z9xjFmBDYc++4e9O33pW30f+NWbsu/0Dd7t6zz1QUWb8eIBgQkM8WlVjLpuDoCiY2cVPqwMwzzl1+U4ADOum5OHYYWLGGpSk6KqEFP4iGccbCsrsyGZi+DtkwLl16S4oSVGPLvceQdbiDjbS0HeVOIUMlmvvVRqnqig04SbZc538OYQPb3VWr+eXX8vR81xQK0yyxABZP3IeuWn76296Z7Bvv/7a2/8tU/e8n7R9761X5wdPAqMOYENLY99s/KeW5A7fc27fNQdvvX3/dvN8IMALBlqAqkdhyqH6cEZVYwqfEQVo6aW5PEp20irQkQahqVhRObChpocTXU4dkYVo6oQVfkYsnUM2TrKEdMj6ZDcTty6/dp1c+B81WY75gegwA0jXWh8vXGiRga8UjHuZFYaU5IkvHpmrxhRQb0O0ppGNl5Yzjz6d5H/6x7Md8fGTftX33A76btv7fdrtZ8BLaPLcY4JVk5+fvFjv7Lybt/8R/9Teew+jo8qfGSITopUQOEjChfGmifpwbgmREU6KA1D222UVlqVotIwtBOx50cthuNkTC3JohMSE7SMlOe1eFBMLSExwQshjv7b3avoOlmWCXehidXaS20uTIDcZn3OvMbA89qo6bpZqwQ664ckOjhXfvQTi792D+67h/R9LP8Wf/6+YW9C5sJDdNK2MpqZYTtHmM0DRP0FGpv2qnY8PqXLMW8ODtFJenDGdbLyMIy3Tnq20rs4YtpQ4xfmOXIAFAwlzhNThprYsRjnl3/LSAqU3zLSF5rmy4LLe+ZlyEVa/dOFlRcwYnCdfQavHL2vLcbw/hgAM8Ap9JmjyfoDkdI3StUfi7TftbK6FuewKdtMAzADwFkAlgA4a5tpiQ1y+JQqRl3n/AB0OS5Q/iE2pctxTYopfNRxsgAUVCEyUlvIj6TLEzt3GAW6zdrQEtIwaFuZK4DL797KdXO2mdLFCEdMzs28JIrXNT2vilqvW5PltOtmgZsHYA6YM7aUVqmIpSUBKFp6kiemFSFyYYkzb2nJZuUoikwCMDOqAraV0eWYyAYNLaFJMZEJWmba0BKOlblw5AXLSOly3HUvq0H57YBXietqYiR5l/eqEI6d8WpjrpM1tIRIB2QuYpkpy0yiyKZ53ackvTI1WZY6nSCLTbh2dvdxXTfnjcdQEpaeUoSIyARtI70TIRWBO7u1caTZOAGc+R1w+V1dsK20zEVUIaLLcY6Ypnpjl841181rclQRIqPaer7+4GS9ZVFXEraVsa2MY2W8+oPIhEQ2yBPTVO80R0xLbMjS066TA6DQ708Oh+h1Irsqaq7rri0Eid7p3aLnqP5zxLShJbxWBJEJKkIYgIJp5krQc0/kPvrozAdm+j/U9BRwCvYF2pRz3Zwux0Q6iNSO9zZelLnIhUv79lsoQkSX4zs/KrhuzjLShppQ+LBlpE09JfNhkQmKbFBigxIb5IlpRYiaekoVYywyKTJBxz5fz67VEoJwvdPzKqmBwWBLEuISE7hoVI6TpaFxiQ2Zenp3Arr23Gz3sb9Y+Y/v4X3vl3x3lm954dxnBCasCjHn/Ap13lCqQgRrnuitvygxoUvAFTQ5pvARU0+betLUk7oc98IvL0knMUFz233b/WNkZS4sMgFdjgOQ06SowodtKwtAUVGjNF23Xm0UdW3UAAAcx8JwWBFClpEeaVDOATen8hGB9ktsSBWjpp4EYJ4Z+r+7+q47ad+7i2/4s8gb7oZ87139xTJ2AID5S3yL8zrFk360fkKgAjt5ym1qCh8eYpNeIKxu613ukvvkL/V7R7zfqMJHTDWxVT1N0/D1I7taarZtl0ohVY4JpF+XEju5s7zr5kQ6YOkpAAqKEJGGIUvJbfUPfTz/1vfLvt/6ys2/+t6b76zedC96U4l/CoCzL+sfFAw1SXROa2LU3C48FywjJTFBa/t/c5occ+zshUvERabz8n8Sy0wpnL9ZywrCjTn07aqoWZbdaMzpaoLDJhUuIg1Dng+l8BFd3m1Ay7tO1hATg97Jb8y/446h712Zm/8kcPPdmO/epTdtkc8BsABAYSRcv3TMBZEJMtCEJsVsM20ZaYEO6PJ2JtLUk3jrhKEmLnLcLgfuUnYFhvFTZM2+QadXXKWuuYNBSVeTIuUHYMYy0xwxJZABVdx2uEauoiWmY8vf+Yvlt7wL893O++7evOXg0l+x5KQqxGUuJAtRTfeSKLMAzHitC66bBaBoKnEBn1T4iEQHhtCERAZMJQ7AnHdbgfaLlN+xsxf5dJebqpdZPRvNaRy/Yk/3nlBzHBdBGqqcILonZS6silEOnyL7Y/IwrAoRhQ8rfFjmwgofcd2sIcVlNro6ePLQ1v98avMDsda3NC0KzKwuJ7DB2CMPfSocevjs/IHq1rFW63Snc0qWY4nU4xulw4P26fD0D1449M1i4seh8e9Fxr83P/tMu3VSGoYkJrDjglzKK38Jo4vBOU6KJFekC/dC7Tk11wUo3KExv8wHdSVuqAlLT1pG0lAThhr3Ll2Ji0yQJ6c1KQbADAALNp+RsChw53b8tVmSmv785z906ND9P3vum888dd8PHvnc84fuTyQe/9Gjn3vs4c9OjD9035c++qm/f8/Bg9988LufeOD+v/7eP/+/p48/WJ1/ZohO7OjyxWvWlZez3a9FFB1HkMoN3PF0tfVQliF6nfGRZy1cUpErqGJ0sPmiQAflYdjUkwAUNT5qKOcDTNNKQ4Mzvf6Zxtax8uJza4vPVjdeqJePdJsnuu2TMDzRqB+vV46g6FS7daLXOjFTeOrs/AGic4oenDG11BXU6hXB5XvdCALfsOl5DdQ0Td7cHHPdLAAzvBA9t3G41jipbKd3th/UUOMiE7DMlGkkFT4i0kG0cVxigyN9V3kAZrfDAzUJrDQABeDmACjuLHOeVs4AMAestMgEDSOrDEMKF2bgcU2KXnk+XglcQZdDaL8oitdc9LwB1FRVLZWmAcgBMCsK0dLKwdWFZzkhstP2knPdrKHG7Z2Ej22lZS4sMUGJDdpm5lLDJw/DIh28YLRu1lDiu/Gs4+Q0McKik5occ928zIUYaGInyH8FcLvVVV2Js8Q4Ra7pxg1wbq+Nmmma3W653/e7YIbqnzz7vXuWPvDvz37kP64c/HuBC3vgvGYhx8q4bta2MqoY8Rx0FplU+Ihtbds+x87YVkYVoyofkZjdRFsOgJzrZFl4YrQ1xnVzDDQu0AFVill60rGzQ2zSMlOXjb12X7tOVhOjXo+EwoVJcgKCVm/ssRuvTM2y7I2NWQiadKw0g55Z+s6t8J2+3p2+/l2+5h37yoc/rZpZD5yhJSwzpYpRjpjW5JitJStLP2tXTqp8VCD9ppbUlbhIB3jSr3BhAIqmnjTOF4ZzjpMRqMBOSja/7cHRARoa16SY62QdK8Pj0xITNPWUoSVcJ2vbmRFq+V36Gh8x5LhXx+p0xmq11RvJ7GqoKYpaKuURNCZImUbmn8/d5hvc7XvkbTe98PZ9/L2+s3/9n4nGEduaMdQEi07xlH+nD3LO1XPx2MOR7MOykABgRmZDROeUY2W8+evVWBUubBrbuW/HyQhkwNz25rYv00ipYtSxs5aZlodhx8pKbJDuj6lSzOs1ulDd8t7NaxsvdlonNSVhWxkIinS7r+YDM66LmicYhta7y2vBH1Rv8zXv8n3y1/Z973f3ie/zLXz0LdD6s5qSEpkgUj/OQOOGmnDNrCDFg5VvfWvlT7+y8YcHNz8BU2eAWzCUuMQEdSWh8GGRCUpsaIhNSWzIi5NMPSmzIYULX0ihoPARVYhoctSxMwDkRCagDkO6mgAgb+kpQ08AUHCd3E6IMuuAuRNnvv/Cke/iRMjSokNunmGu7dzVG0bNk3Z5o/iJ30fe5cPv8WF3+jq3+pYf/YAoJACYAyBvmykvktfo+ETpq3eVfuE9su/9mm8/7Pvu0u2SHgOgyJPTCh9xrN1mv4LEhHQ17gXwI4va6Ope1KSYF/y6bpajAoPemEAHdDUuMkGOmLKMlKElvAKVBWbh5ScXH/tw5Cvv2hj/BseHZHVdVW/w+cXXRs0BAFrJn/viraU//6XqR/+Ple+8E6m8ANzZ7cyqlpCHQQDmcWLi/tU/vov3/dGJW37vsZvvrO97b+eNG9DTjlnc2WmQ3728ZduxM2Tn1E4nx3n76FgZTY5LbIiBJ2wrDcAcBwdDZx4DYN5QEzIflodhRYhIbFARIpqcrEYfWPrgm9nbfdJdvo27f2Hh6b/sIUvWVbcp7wk1T/rt1vLYw83893k+ZhgZmQt5CVWJCTpOFoCzXeTEF5Z+772K77e/ecuvvu/m/es3/Tl+y1L7MZNLqkJU4SIKH9GkmOeaGVqCHpzRlbg8DMnsdli2a0Ydz+CKUQ6fUugQjQX95+5/OPyxtcEzwPAaV4u2ndakqCrFeTa09unfHOz3ZW/dd+Yd++g7fTPv+cVs+NSNRfYqqbkA9AYlaDBmaSlTTxpqQubCuhyXhyEAcgDMKFL6icqH/mzgu2vr5js3b74T9/3Fwi+34EOukXPdnKEkdDmucCGJCcpcxOsj4bBJx84YSkLhw9IwpCuxEee+CEARgDmoc+r763d+sPLv399+01+u/5fx1leANTsSqxRlOYZ+5q39/b5v/tZNd77lJvwe39I9/2buzIuvC2oAAKjXrqyc1KWQLscUPsITfrx5giend8Y5V4MPfqnw3/dXfX9W83186S3R6v0yH9G3O4sKXp1Yl2O6HPNqw6oY5clpb7uGoSRlLqyKMc87EdmQwkU0Lv6jsx/e3/HdRfjuqNx0G+H78Movz1WeHNnMUDCtzPrnfru/31d8py/wJ/vw23xbf/87rfL664WappmD3iyJjGlS1NCShppSuJDIbHtbjpO15QxGj83A38tC390iDgAnB0DBiwdG6psXRLK65BHMeUxlPizSQVWIGmrS1FKWlvnM1n/dD/v++Mgb33LXTfd0bnp32ffUwt8AsDRiOor1zPeXPvhm6m6feK+vfPctC899XVBv/JnYr74HvNerIFDA0hICHbDMNABFQ4kLlF/hI4aWMJQEcIoALADX69kqApB37Kypp7xSPHDzF5lL2/JKXPkdFz9jblvGPAAFAGbvK/3B/oHvtrmb3/bwzfegvjs2bj6y8FkAlkbuU3DAbG/p6aNfuXf5sY/V0/886OeMPTgI9tVTY1mWpmeBmxIov2UkPbfAMtO6Epe4MANPyMPQSKUytzP4vONkNTHKE9OqFNvxs3KOk+GI6UuahUZfF1Ol73209ua7MN/d0L7ber6vln6fpM5cWDYsOm7uXPPogZe+2W4cp7loq1O8gWdH7Mqrp+a6oNWaJ6kplQ/YZmpkVc45To7Dpzli6sKgfcThcHO2lTXUhEAHFCFiWymB8htq4go7mHeU0cxOFL9839k/+MTyrz2ycm8DOrgbVDh21tZSUO/kQwvv/Wj7zR+Gf+nzq783nn2gtDZ7o4l5Y7+OfVQYhjQaCZYOMdikY1+wS0XhIzJ3ydkxl2TEXCerqwmJ8QKpi5KOlyZ/8kNoUlHDqhmyrKStpVUhauopiQ2JdNCSUo8u/vmdjTfc2ffd2fbdDvv+fuVtG6WVG4prW653L7Km6Z1OZWMlSJNxUYxb1vZKb5tpVYzutnVfAdzOdb6HMv+y1HKOlXG3kwVF20qLTEARoo6ddd28rWa/Bv0/t6O+tz/7xl/725vvgnwfrL7Zv3z8hqEakRtzMoXjgH6/02jMomiKZaOqGgVgRh4GJTZ06WFil519L0Nq9Duuk+Up/4WbE7ZXTEvLfbnzu7fDvrc/e8tvfPrmOyHfhxtvjq7deBcX3PCzYxiGbTRWIChHkgm0/ZLK+XeTt5cDd9HXK07M86GCnabhcc+tu4gaAHPPl/5m/6bvDtZ3j+S7te/72sZtFPsqu7xfXm4wNU9kWWu1K1sbiXZ9QhDCAGQvqNhfDO5q5ubuP8kZSkLmdzcKjt6ziHXGDqx//HNbv/npxlu/vfpn6bXxGzWii2RPqHmiaWZ/0Oz3FyAoxjABzzO4MHS/FNwr/m/edTI8Oa0IYU2K7uROtn9BE+Kukmkhhzd7T6H9iMxf88epXqXsITVPdN1G0QEErfZ6cYKYusQLuXQJy7+SxuUdO6OKEVWMysOwoXjZ4Lxlpq1t43MWuAUMzer6Xn2w2p5T88SyXJLEEKTcasVwfHLX470cuMsahIvBeZe3yUMRoo6T06SYqSUAyAFQEMXI0pJ/7wb0GlHzxHEATZMYVtvaipKkH4CiY2W8nPjLatyVwHn2IcsRU7ocE0j/Tu01LwiRufnA3g3kNaXmieOA4ZDtd0tLs8cIaEwToxIblPnwSBB6TeAKqhjVpZjIBHdrDqIYXVyM7N0Qfg7UPDFNm6bI2tbcoOfXtbgmRrxtFu4FHm/+asC5bk6ToljjOE/6XdebobGl5cTePfzPjZonhmmhaH+zHOW4qCZHJDYoe3sP3FekdoEHY1sZFplg4XEvWydJidXV7N499s+ZGgDAdYFhGM3mer3ul8SYqcc4bFKToiP9tC+DrOA6OUNNSEzIUBMcMe3Fs5KUXFsr7OUz/7ypeeI4Ls/ztfoshoZZfFLhIyONyPlLqdlm2jJTlpFRhajEhGwr7To5enDG22UlScmNjT3JdnjyeqHmiW27rWa9UQ8DUNCVmMgEbGt3b2l+V8sMNSGzIYkNSUxwZ1NMXpNiVP+0V8SR5VS5vLR3z/n6ogYAcF0wHMIcF3KdnMJHFD5sqElDSezoXUFX4vIwvOOveFfO1JKqGHWdrCqEgZtRlPTW1g3uUrjwIV9n1AAAHMeur2+fhm0ZSZkLeacRaFJMk+IyF7roQAYAChw2pUpRb/88ABlVzdRqN77IsiuvR2q6bmJYVVV3u9UKABRUISrQAYUPX86GFhl4XOHDABQVIQLcjKrlWq1rPtvk6uX1SA0AQNNYuXx6d0+K91Uehlznsi0NBa93ZLs47WZ1PT/oN/fu8V6n1ERRgQbLjjN6kGKegcat8x1Hu98vAJC39KTIBGQu7FUedD2PwJ29e7zXKTUAAI53ms2To/vxGNijNlpFLRhqQqQDuhIb4pNE5xSLTplawjALGNbfu2d7/VKj6WG/XwQgu5NWy+pi1HWyrps3tKRlpCU2JFABmQ+bWtJ1cwI5zVPTQ2xKpPw8HSdJaO+e7fVLzXUBApXatSNDZGKITshsyNJTrpNThIh3+IdlpE09ubv12zbT3rZQkZpG25NDltrLZ7sOarZtu64ry7KiKLIs8zzvvVBV9WWOub96gWG4tDquiyHLSNtWRh5GGHjcO5j3kpMDcq6dtYwUADnHTolCVhT563+AK8l11kOxTqf9zIEDhw4devqnP/3Od777s58d+v5D3z9y7BjNMNf/cI7jksSGIHinAhRcOyuQgQvzcfkRs5BTOO+s7CwvZCVpr9Lf4DqpybJUqVYy2ez6+vrMzGw6nd7YWI/FYotLS/YN+qTTrdpmqzW9s0Uwy0Djmhy7UoleYoKaFDO0OIpEFEW+IQ9wWbmAmmma+rWLsSOmaXr/NQxD141XcSvvbqPP12y1O52obaZMPalJUUtPisPgTuvRxRlz20wLpH9ITHTqE4p8YzY1vhy1arUqy3K73UYQBN4RHMdJkiQuFtL7JoqiMAwjlxEUQVAYRmAYgWEYwzByR7x/T1EUQRDw5QXCMNQ0z1dJ1pYXVs8e1sWIyIQ0aVvLRpopL9Y4x047ToqhU6+FrlWrVYqiarWat5x70u12q9VqvV5vNOqtVqvRaNTr9VqtVi5v1uo1lmXlS0RRFPVCQVG0Wq3UarVKpdxqNTud9vr6eqfTUS8vCs/zo1vTzy0XNpafvyTtcVE61zscK6XLMYUPO3aK4zKyvPfrWrVaZVkWRS84f6DVbq+urq6vr5dKpc3NzXJ5s1QqlUobS0tLG5sl9QrddLZlWS6wALAsy3Xdfr8/Pz+/srIyPz+/trZW3ixnc7lqtWrbtjkilmWZpmlZtm3bo2flI8g5nJi4qMV5l5rrZDUppggRTYopfETmIiIdUPiQKOZk+QacCvDK1Hie29raqtfrKIpCyABGIAzDcZxAURTDcARBCYLAccL7iuMESVIkSVIUjWM4hmEYig0Gg1Kp1Gy3oc3VwepstzcolUobG+u1Wq1er3s3r1arm5VyqbTZbDYRBEFR1JvV/f4AhmEIgjudzig1SapJ509nz19EzbEznvumilF3J/erCqEhlZCu+6iTq6ImCMLa2tq5xdIimvpu5UPZwVR1vZ7P52Zmirl8rlDI5/P5VCo1OzuzsrK8uLhQKORnZ4upVLJarbZaTYIkOp3OxORUs92Gj/1r9+G/gTG0XK6Uy5ul0sba2trKykqr3VpfP7e2tloqbVQqZZqmxR1BUXQ4HFIUdfbsWZ7fdrVsGxhG03ESL1t/yV8UY7lOmugHBH74WlDjeb5cLiMDfAiQuHIQceuqpJEkSdMUQRIkSRIkgaIoTVO8wHPckKIohqERBFZV1bIsAICqqolkkqRIa1DRq3Puzlldpmlqmqbruuu6nql1XeciW+n5PYZhrKys7FITRY3jNi480/5SjRtlV/RaNhk8VN/a+/yaR21zcxPu4n1r83n2q3VjkcaGjUaj1Wr1+71up4uhKEVTOIYiMDwYDGq1LRhGvLuw7NB1XUmS4okEQdHKQpAff5SnqXJla+3cuWq1giDIxvpGuVzudDrtdqtWq9XrtZWVFQjajhYZhrYsU9eNlZXVXWr9PtxqJS4H61JwxW7v9MrqIVmOA1AcMsHlRb/j7FWMeAm1Doo5zXH+ka5V4mkJgiAcx2maInCCJEmKpoZDhsBxnMAxDKUoyguqhsMdavEEQTHqUpibetzQVHY4pGmaZVlJkrwXgsDzPD8cDr35KO18kJ2maY7jaJo+Sq3XqzQapwCYlYe7B7RddqrmAZibmTvw5E/uGyCTABQ5YoIiU8oedH9fgVoXG9jlCeEx1G6aqsUwNEWRvCCIoshxHMuwsqxcGkXIsgwA2NE1Sj+XklOHZUWFYaTRbNZqtVqt1m53Op1ur9vt9/soimxtVWv1Wrlc9j70g6EZlmUVRVld3abmOK4o1lUtDNwCT0zrcvxCWLuv8y6YbawdzD7x15kH71md/jbeG7PNlCxnOp3aa0QN7ZJbxvwz9Of69iaNDXv9Po7jEAwTBNFqtdrttiRf7D06juN5WJIkxRNJgqLE1GH68HcsyxxyPMOyHMdRFMVxHEmSDMNIksTzPEVRkiRSNK0oKgDAW/hUVd3VNZ6XUXTFNOOaGNHlhOteOj3zrptznNlO6fnlz/435D1vZD/0xt6H3lT853uG+CTUPbk4H3qNqMEdDHKqEfFZyh7omsHzPMdxgiAoiiIIAsdxkiSqqjqqbq7r6roOXFcUxXg8jpOkhXf05oqmKhRJ4gTO8TzN0DRNsSxL0zSGYTCCYDiuqsruHSRRtGxb07Rda+C6LorB66vTQ8r7nJfiJetawdCSJBOtP/HB3rt8lf2+/K2+7n5f78NvqhZ+2GyHm/XN14ga2qXKeuEJ6pN9a5MluHPnzs3Nza1vbHS73XK5vLq6VtpYb7fbo9Qcx6FI0nWcbV2jaTH+Avn05ySWhGC42+szDINhGIZhoihCENTv91EMQ1GU3vmcFMexJVGwt6mdX9cAACRBlctpkvRbZtp1MuASjSO4WPNfbxvu9z30u/t+59/dVLzVR/z5Pv+PvoQSN+DEsKul1usMFJdr62uSMzR1S5REVVN1XZdlWVFVbxJpmiZJkiRJoih5PofnVYiiGI8ncIrSS3kpc9TQNYZhMQyjKIqiKC8U9WYowzAkSY5+MJuu65Ikja5ru6KqRr2+WK+eVqXwBUubm7OtNCemKo++p/envpXbfKf/eF9rv6/z3psbs3vYGnMZamiXaFkrT1Kf2jLOsrhQqVTa7TYEQa1Wq9Vq9ft9L7qv1WqtVrNWq0uS5LouhmE7nkeSoGkhdpB59ksix9UbzZWVlUq5XKlUNsvlUmmz0WggCFKrbW1ubtIjn8kjCAKKopIkra6uXUTNk1az1O2GdT2x69PaZkrmwgDM9peeWPnkr7ff5ev9ia+8f9/agx/Vru+I0mumBnVRzG0Gxadgs27pjqdRgiComuopl6bpsizLsqTrmiTLXrCpaRoAYEfXaKt9TluOWo6rqIqiKKIkeTG5KIqyLNu2raqqIAi6fv6cX01TvfVx1Mu9SHq9drOVZOhpz5vV5ZhIe2c5L1Vnf1R44C/K3/vbrWOPsjd6v/YrU0N6RMNceor+TNNaoXGm3mh0Om2KIvuDQa/Xb7c7JEmKothud7a2tryAUdd1hmGc3XWNYeSZCfbF+yWGQHCi2+3W6vVqtdJsNuuNxv/X3Pn8tm1Dcbx/b9cdWi9FB3TogO6ywy5BTgN2GLDDgBZJEHROFiQIPKT+JYv6ZVGWJVI/vFm/bEm2fji0ZGsHukmaJml6GLAPeHgCKIJ6IB7f+xKgDNOMoghjPBiovr+R9suyD5CgBwAAA0pJREFUdF2HbqM34toNXNdT5DNN+a2qzi7SehIeVFUjDA+sv/+aZPP/Kj37hJtes/AoKO1G+ru/sqZ+iDEejew4isbj8Wg0siwrjuN8sbBtG2NM0zRCSBiGG68dHrl+sJDfx0e/FNm8KFeEkMuDhdlsfkFIURRZlqdpenmndFmWhCzpmr3fa1VVZdkFFFva4G0S7tK91TTrnU4zij5zUFAWRZokEEKO4/qy7PmeIPCCIFiWdavynCSJbduqOugxDNJ1hPQe05VEcTKZrFZrWZavrTXsoiX4efINWnKRP6eymu/7lmU5juP7vmEYw+EQY2zbdp7nVVUVyyX9zg/5mpc19+K97cXFAhvYtmwdIQihpg2hAmmgVCC0Ldt1x5Io9Fg2CILJJFgWBSHks16jIF0Rubdp9i5NDxwHCAK8XLn3kOc5wzCNRqPVbkMFnpycHB8fy7J8a2fP8wAA5+/Pj/88ZrrdTqdd/+Pd2dmZHwRVVX2crxnOeD3Ynf/0z0pNo5wKtrT6icJpGE49z6PyrOu6NJytVyvqvjRN64dHXhAszt/Eb34siyKKojiKp2Ho+34YhpPpxPO86XQa+P5sNsuy1PM8x3HyPM+yjNb23e6dce0663Xle56unzabv47HxmyW7OzsbG09f/nyu3vaixffPn367MmTr1+9+p7tsZIk8TwPoYKxcaMhhBVlIIqiJPUB4E5PT3f3d/f39+r1w2azlWe5oigbpUiSpF4PIF3X9aFOKyBkYIw1DSGEEcI6QghhjDA2DKRjTUe6hmhHXUeqqrZaLUnqa4qs9UWEMDZMwzANwzRN2zBM07RM06KGYdDiyrZMm05U19FwqGlD7SF/8KRkWRoETlEUi8Vie3v78eOvnt1LrVbb2npeq9Vev/6BYRiqs/I8D26D43hBEERR6nS6LMtKfYkTOAAAwzB5livK4JEsy0mSCILAsgAAjgc8ANz1EQDgWJajBgAc+8EALMeyV4+CwAPAAV4AgggAx27evRoEAMB+POz1ifZ6rKqqhJD1w7h0H1WAw3AaPow4jj4V6+8iyzJCyGq1ovozIaQsy35fftRsNvv9vvD/QN4A5Svg3cYGVVWHX4LyhUBI20BRBrIM2+32v8vgTUfJdgEUAAAAAElFTkSuQmCC" width="103" height="148"></p>
<p><span style="color: black"><span style="background-color: white">Specific names of the health facilities not given</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Type:</span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">Health facilities</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Description:</span></span></strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">conducted in the Ejisu-Juaben municipality and the Sekyere-East district of the Ashanti region of Ghana</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Sample size : &nbsp;1663</span></span></strong></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_96C92LL4" class="item journalArticle">
			<h2>Effects of Essential Newborn Care Training on Fresh Stillbirths and Early Neonatal Deaths by Maternal Education.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chomba E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Carlo WA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Goudar SS</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Jehan I</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Tshefu A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Garces A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Parida S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Althabe F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>McClure EM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Derman RJ</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Goldenberg RL</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bose C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Krebs NF</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Panigrahi P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Buekens P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Wallace D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Moore J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Koso-Thomas M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Wright LL</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Infants of women with lower education levels are 
at higher risk for perinatal mortality. OBJECTIVES: We explored the 
impact of training birth attendants and pregnant women in the Essential 
Newborn Care (ENC) Program on fresh stillbirths (FSBs) and early (7-day)
 neonatal deaths (END) by maternal education level in developing 
countries. METHODS: A train-the-trainer model was used with local 
instructors in rural communities in six countries (Argentina, Democratic
 Republic of the Congo, Guatemala, India, Pakistan, and Zambia). Data 
were collected using a pre-/post-active baseline controlled study 
design. RESULTS: A total of 57,643 infants/mothers were enrolled. The 
follow-up rate at 7 days of age was 99.2%. The risk for FSB and END was 
higher for mothers with 0-7 years of education than for those with 
&gt;/=8 years of education during both the pre- and post-ENC periods in 
unadjusted models and in models adjusted for confounding. The effect of 
ENC differed as a function of maternal education for FSB (interaction p =
 0.041) without evidence that the effect of ENC differed as a function 
of maternal education for END. The model-based estimate of FSB risk was 
reduced among mothers with 0-7 years of education (19.7/1,000 live 
births pre-ENC, CI: 16.3, 23.0 vs. 12.2/1,000 live births post-ENC, CI: 
16.3, 23.0, p &lt; 0.001), but was not significantly different for 
mothers with &gt;/=8 years of education, respectively. CONCLUSION: A low
 level of maternal education was associated with higher risk for FSB and
 END. ENC training was more effective in reducing FSB among mothers with
 low education levels.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2017</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 1
Place: Switzerland</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>111</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>61-67</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Neonatology</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1159/000447421">10.1159/000447421</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1661-7800 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:35 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:35 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Infant, Newborn</li>
					<li>Young Adult</li>
					<li>Male</li>
					<li>Risk Assessment</li>
					<li>Logistic Models</li>
					<li>Infant</li>
					<li>Developing Countries</li>
					<li>Stillbirth/*epidemiology</li>
					<li>Asia</li>
					<li>*Infant Mortality</li>
					<li>Africa</li>
					<li>Multivariate Analysis</li>
					<li>*Educational Status</li>
					<li>Intensive Care, Neonatal/*standards</li>
					<li>Latin America</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_QFA2PNJQ">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name : </strong></p>
<p>Community names not specified in the text</p>
<p><strong>Location Type : </strong></p>
<p>Rural community</p>
<p><strong>Description : </strong></p>
<p><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">Rural communities in six countries (Argentina, Democratic Republic of the Congo, Guatemala, India, Pakistan, and Zambia)</span></span></p>
<p><strong>sample size :</strong></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_HEXLIMK6" class="item journalArticle">
			<h2>Effects of gestational diabetes mellitus on risk of adverse maternal outcomes: a prospective cohort study in Northwest Ethiopia.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Muche AA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Olayemi OO</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gete YK</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Gestational diabetes mellitus is a leading medical
 condition woman encounter during pregnancy with serious short- and 
long-term consequences for maternal morbidity. However, limited evidence
 was available on potential impacts of gestational diabetes mellitus 
using updated international diagnostic criteria on adverse maternal 
outcomes. Therefore, this study aimed to assess the effects of 
gestational diabetes mellitus on the risk of adverse maternal outcomes 
in Northwest Ethiopia. METHODS: A prospective cohort study was conducted
 among pregnant women followed from pregnancy to delivery. Gestational 
diabetes mellitus status was determined by using a two-hour 75 g oral 
glucose tolerance test and based on updated international diagnostic 
criteria. Multivariable log-binomial model was used to examine the 
effects of gestational diabetes mellitus on the risk of adverse maternal
 outcomes. RESULTS: A total of 694 women completed the follow-up and 
included in the analysis. Women with gestational diabetes mellitus had a
 higher risk of composite adverse maternal outcome (ARR=1.58, 95% CI: 
1.22, 2.04), caesarean delivery (ARR=1.67; 95%: 1.15, 2.44), pregnancy 
induced hypertension (ARR= 3.32; 95%: 1.55, 7.11), premature rupture of 
membranes (ARR= 1.83; 95%: 1.02, 3.27), antepartum hemorrhage (ARR= 
2.10; 95%: 1.11, 3.98) and postpartum hemorrhage (ARR= 4.85; 95%:2.28, 
10.30) compared to women without gestational diabetes mellitus. 
CONCLUSIONS: Gestational diabetes mellitus increased the risk of adverse
 maternal outcomes. This implies that maternal care and intervention 
strategies relating to women with gestational diabetes mellitus should 
be strengthened.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2020-02</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 1
Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>20</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>73</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>BMC pregnancy and childbirth</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/s12884-020-2759-8">10.1186/s12884-020-2759-8</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1471-2393 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:27 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:27 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>adverse maternal outcome</li>
					<li>antepartum hemorrhage</li>
					<li>Gestational diabetes mellitus</li>
					<li>postpartum hemorrhage</li>
					<li>pregnancy induced hypertension</li>
					<li>premature rupture of membranes</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_QRUWF9ND">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name</strong> : </p>
<p>(UoGCSH) and Gondar, Woleka, Maraki, Azezo Health Centers)</p>
<p><strong>Location Type</strong> : </p>
<p>Health facility </p>
<p><strong>Description</strong> : </p>
<p>Health facilities, (UoGCSH) and Gondar, Woleka, Maraki, Azezo Health Centers) , Gondar town is located in Northwest Ethiopia</p>
<p><strong>Sample Size</strong> : <span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">694&nbsp;</span></span></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_MZKJNYKH" class="item journalArticle">
			<h2>Effects of prenatal exposure factors on birth outcomes through 
mediation of favorable fetal growth conditions using structural equation
 modeling.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mitku AA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Zewotir T</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>North D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Jeena P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Naidoo RN</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Birth weight, birth length, and gestational age 
are major indicators of newborn health. Several prenatal exposure 
factors influence the fetal environment. The aim of the study was to 
investigate the effect of prenatal exposure factors, including 
socio-demographic, behavioural, dietary, physical activity, clinical and
 environmental on birth outcomes through the mediation of Favourable 
Fetal Growth Conditions (FFGC). METHODS: Data was obtained from six 
hundred and fifty-six Mother and Child in the Environment birth cohort 
study in Durban, South Africa from 2013 to 2017. We adopted structural 
equation models which evaluate the direct and indirect effects by 
allowing multiple simultaneous equations to incorporate confounding and 
mediation. RESULTS: A significant direct and indirect effect of FFGC on 
newborn weight, length, and gestational age was seen. Gestational weight
 gain and maternal body mass index in the first trimester exerted a 
mediation effect between maternal behavioural risk factors and FFGC. 
Similarly, the level of physical activity during pregnancy was 
associated with decreased gestational weight gain. The effects of 
maternal characteristics on newborn weight, length, and gestational age 
were largely indirect, operating through FFGC as a latent variable. 
CONCLUSIONS: Gestational weight gain and maternal pre-gestational BMI 
were observed to mediate the association between prenatal behavioural 
risk factors and favourable fetal growth conditions. TRIAL REGISTRATION:
 Retrospectively registered from 01 March 2013.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2021</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>16</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e0249664</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>PloS one</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1371/journal.pone.0249664">10.1371/journal.pone.0249664</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>4</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1932-6203 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Cohort Studies</li>
					<li>Infant, Newborn</li>
					<li>Male</li>
					<li>Gestational Age</li>
					<li>South Africa/epidemiology</li>
					<li>Body Mass Index</li>
					<li>Birth Weight/*drug effects</li>
					<li>Body Size/drug effects</li>
					<li>Fetal Development/drug effects/physiology</li>
					<li>Gestational Weight Gain</li>
					<li>Latent Class Analysis</li>
					<li>Maternal Exposure/*adverse effects</li>
					<li>Models, Statistical</li>
					<li>Prenatal Exposure Delayed Effects/*epidemiology</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_KVGWC8CR">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location Name</strong> : </p>
<p>names of the antenatal clinics were not given</p>
<p><strong><span style="color: var(--tw-prose-bold)">Location Type: </span></strong></p>
<p>Health facilities</p>
<p><strong><span style="color: var(--tw-prose-bold)">Description: </span></strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">conducted in public sector antenatal clinics in the study areas in Durban, South Africa, </span></span></p>
<p><strong><span style="color: var(--tw-prose-bold)">Sample size : </span></strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">The study initially enrolled </span></span><strong><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">996</span></span></strong><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)"> pregnant women, with </span></span><strong><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">656 mother-child pairs </span></span></strong><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">remaining after exclusions and follow-up.</span></span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_LC6QWUQ7" class="item journalArticle">
			<h2>Efficacy and Safety of Azithromycin-Chloroquine versus 
Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment of 
Plasmodium falciparum Malaria Infection in Pregnant Women in Africa: An 
Open-Label, Randomized Trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kimani J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Phiri K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kamiza S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Duparc S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ayoub A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Rojo R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Robbins J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Orrico R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Vandenbroucke P</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: The World Health Organization recommends 
intermittent preventive treatment in pregnancy (IPTp) with 
sulfadoxine-pyrimethamine (SP) in African regions with moderate to high 
malaria transmission. However, growing resistance to SP threatens the 
effectiveness of IPTp-SP, and alternative drugs are needed. This study 
tested the efficacy, tolerability, and safety of a fixed-dose 
combination azithromycin-chloroquine (AZCQ; 250 mg AZ/155 mg CQ base) 
for IPTp relative to IPTp-SP. METHODS AND FINDINGS: A randomized, Phase 
3, open-label, multi-center study was conducted in sub-Saharan Africa 
(Benin, Kenya, Malawi, Tanzania, and Uganda) between October 2010 and 
November 2013. Pregnant women received 3 IPTp courses with AZCQ (each 
course: 1,000/620 mg AZCQ QD for 3 days) or SP (each course 1,500/75 mg 
SP QD for 1 day) at 4- to 8-week intervals during the second and third 
trimester. Long-lasting insecticide-treated bednets were also provided 
at enrollment. Study participants were followed up until day 28 post 
delivery (time window: day 28-42). The primary endpoint was the 
proportion of participants with sub-optimal pregnancy outcomes (a 
composite endpoint comprising live-borne neonates with low birth weight 
[LBW, &lt;2,500 g], premature birth [&lt;37 weeks], still birth [&gt;28 
weeks], abortion [&lt;/=28 weeks], lost to follow-up prior to 
observation of pregnancy outcome, or missing birth weight). The study 
was terminated early after recruitment of 2,891 of the planned 5,044 
participants, due to futility observed in a pre-specified 35% interim 
analysis. In the final intent-to-treat dataset, 378/1,445 (26.2%) 
participants in the AZCQ and 342/1,445 (23.7%) in the SP group had 
sub-optimal pregnancy outcomes, with an estimated risk ratio (RR) of 
1.11 (95% CI: 0.97, 1.25; p = 0.12). There was no significant difference
 in the incidence of LBW between treatment groups (57/1138 [5.0%] in the
 AZCQ group, 68/1188 [5.7%] in the SP group, RR 0.87 [95% CI: 0.62, 
1.23]; p = 0.44). IPTp-AZCQ was less well-tolerated in mothers than 
IPTp-SP. Occurrences of congenital anomalies, deaths, and serious 
adverse events were comparable in neonates for both groups. Limitations 
included the open-label design and early study termination. CONCLUSIONS:
 IPTp-AZCQ was not superior to IPTp-SP in this study and alternatives 
for IPTp-SP remain to be identified. The proportions of sub-optimal 
pregnancy outcomes and LBW were lower than expected, which may be linked
 to insecticide-treated bednet use throughout the study. Reduced 
incidences of symptomatic malaria infection and peripheral parasitemia 
in the AZCQ group relative to SP suggest that AZCQ warrants further 
investigation as an alternative treatment of uncomplicated malaria. 
TRIAL REGISTRATION: ClinicalTrials.gov (NCT01103063).</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2016</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 6
Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>11</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e0157045</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>PloS one</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1371/journal.pone.0157045">10.1371/journal.pone.0157045</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>6</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1932-6203 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:32 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:32 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Infant, Newborn</li>
					<li>Young Adult</li>
					<li>Drug Combinations</li>
					<li>Pregnancy Outcome</li>
					<li>Treatment Outcome</li>
					<li>Adolescent</li>
					<li>Azithromycin/*adverse effects/*therapeutic use</li>
					<li>Chloroquine/*adverse effects/*therapeutic use</li>
					<li>Intention to Treat Analysis</li>
					<li>Malaria, Falciparum/*drug therapy/*prevention &amp; control</li>
					<li>Pyrimethamine/*adverse effects/*therapeutic use</li>
					<li>Sulfadoxine/*adverse effects/*therapeutic use</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_QLMRFLLB">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location Name</strong> :</p>
<ol>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Centre de Sante d'Ahouansori Agu and Hpital Bethesda in Cotonou, Benin.</span></span>
</li>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Siaya District Hospital in Siaya, Kenya.</span></span>
</li>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Zomba Central Hospital in Zomba, Malawi.</span></span>
</li>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Teule Hospital in Muheza, Tanga, Tanzania.</span></span>
</li>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">National Institute for Medical Research (Mwanza Centre)/Nyamagana District Hospital in Mwanza, Tanzania.</span></span>
</li>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Mulanda Health Centre IV in Kampala, Uganda.</span></span>
</li>
</ol>
<p><strong>Location Type</strong> : </p>
<p>Health facilities</p>
<p><strong>Description :</strong> </p>
<p><span style="color: rgb(32, 32, 32)"><span style="background-color: rgb(255, 255, 255)">Centre
 de Sante d'Ahouansori Agu and Hpital Bethesda in Cotonou, Benin, 
&nbsp;Siaya District Hospital, in Siaya, Kenya, Zomba Central Hospital 
in Zomba, Malawi, Teule Hospital in Muheza, Tanga, Tanzania, National 
Institute for Medical Research (Mwanza Centre)/Nyamagana District 
Hospital, in Mwanza, Tanzania and &nbsp;Mulanda Health Centre IV, in 
Kampala, Uganda</span></span></p>
<p><strong>Sample size : 2891</strong></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_YCTT3BUW" class="item journalArticle">
			<h2>Efficacy of enhanced HIV counseling for risk reduction during 
pregnancy and in the postpartum period: a randomized controlled trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Maman S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Moodley D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>McNaughton-Reyes HL</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Groves AK</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kagee A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Moodley P</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>INTRODUCTION: Pregnancy and the postpartum period present 
important intervention opportunities. Counseling can leverage the 
motivation women have during this time to change behaviors that may 
negatively affect their health and the heath of their infants. METHODS: 
Pregnant women attending an antenatal clinic in South Africa were 
randomly allocated to treatment (n=733) and control arms (n=747). 
Treatment arm participants received enhanced HIV pre- and post-test 
counseling, legal support and access to support groups at baseline, 
which occurred at the first antenatal visit, and then six and ten weeks 
postpartum. Control arm participants received standard HIV testing and 
counseling (HTC) and two postpartum attention control sessions. Outcomes
 were incidence of sexually transmitted infection (STI) by 14 weeks 
postpartum and past 30-day inconsistent condom use at 14 weeks and 9 
months postpartum. RESULTS: There were no intervention effects on 
incident STIs for either HIV-negative (adjusted risk ratio (aRR) 1.01, 
95% CI 0.71-1.44) or HIV-positive participants (aRR 0.86, 95% CI 
0.61-1.23). The intervention was associated with a 28% decrease in risk 
of past 30-day inconsistent condom use at nine-months among HIV-negative
 women (aRR 0.72,95% CI 0.59-0.88), but did not affect inconsistent 
condom use among HIV-positive women (aRR1.08; 95% CI 0.67-1.75). 
DISCUSSION: An enhanced counseling intervention during pregnancy and the
 postpartum period can lead to reductions in inconsistent condom use 
among HIV-negative women. Results underscore the importance of the 
counseling that accompanies HIV HTC. More work is needed to understand 
how to promote and sustain risk reduction among HIV-positive women. 
TRIAL REGISTRATION: ClinicalTrials.gov NCT01683461.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2014</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 5
Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>9</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e97092</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>PloS one</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1371/journal.pone.0097092">10.1371/journal.pone.0097092</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>5</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1932-6203 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:40 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:40 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>South Africa/epidemiology</li>
					<li>Regression Analysis</li>
					<li>Maternal Welfare/*statistics &amp; numerical data</li>
					<li>*Risk Reduction Behavior</li>
					<li>Condoms/statistics &amp; numerical data</li>
					<li>Counseling/*methods/statistics &amp; numerical data</li>
					<li>HIV Infections/*epidemiology/*prevention &amp; control</li>
					<li>Prenatal Education/*methods</li>
					<li>Self-Help Groups/*statistics &amp; numerical data</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_CKSNBTWU">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name : </strong></p>
<p> Facility Name not specified</p>
<p><strong>Location Type : </strong></p>
<p>Health facility, Township</p>
<p><strong>Description : </strong></p>
<p><span style="color: rgb(32, 32, 32)"><span style="background-color: rgb(255, 255, 255)">Primary
 health care clinic in Umlazi Township, Durban. Umlazi, South Africas 
second largest township, is located in the province of KwaZulu Natal 
(KZN)&nbsp;</span></span></p>
<p><strong>Sample size :</strong> 1500</p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_WPJA9JDE" class="item journalArticle">
			<h2>Efficacy, duration of protection, birth outcomes, and infant 
growth associated with influenza vaccination in pregnancy: a pooled 
analysis of three randomised controlled trials.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Omer SB</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Clark DR</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Madhi SA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Tapia MD</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Nunes MC</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Cutland CL</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Simoes EAF</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Aqil AR</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Katz J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Tielsch JM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Steinhoff MC</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Wairagkar N</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Maternal influenza immunisation can reduce 
morbidity and mortality associated with influenza infection in pregnant 
women and young infants. We aimed to determine the vaccine efficacy of 
maternal influenza immunisation against maternal and infant 
PCR-confirmed influenza, duration of protection, and the effect of 
gestational age at vaccination on vaccine efficacy, birth outcomes, and 
infant growth up to 6 months of age. METHODS: We did a pooled analysis 
of three randomised controlled trials done in Nepal (2011-2014), Mali 
(2011-2014), and South Africa (2011-2013). Pregnant women, gestational 
age 17-34 weeks in Nepal, 28 weeks or more in Mali, and 20-36 weeks in 
South Africa, were enrolled. Women were randomly assigned 1:1 to a study
 group, in which they received trivalent inactivated influenza vaccine 
(IIV) in all three trials, or a control group, in which they received 
saline placebo in Nepal and South Africa or quadrivalent meningococcal 
conjugate vaccine in Mali. Enrolment at all sites was complete by April 
24, 2013. Infants and women were assessed for respiratory illness, and 
samples from those that met the case definition were tested for 
influenza by PCR testing. Growth measurements, including length and 
weight, were obtained at birth at all sites, at 24 weeks in South 
Africa, and at 6 months in Nepal and Mali. The three trials are 
registered with ClinicalTrials.gov, numbers NCT01430689, NCT01034254, 
and NCT02465190. FINDINGS: 10 002 women and 9800 liveborn infants were 
included. Pooled efficacy of maternal vaccination to prevent infant 
PCR-confirmed influenza up to 6 months of age was 35% (95% CI 19 to 47).
 The pooled estimate was 56% (28 to 73) within the first 2 months of 
life, 39% (11 to 58) between 2 and 4 months, and 19% (-9 to 40) between 4
 and 6 months. In women, from enrolment during pregnancy to the end of 
follow-up at 6 months postpartum, the vaccine was 50% (95% CI 32-63) 
efficacious against PCR-confirmed influenza. Efficacy was 42% (12 to 61)
 during pregnancy and 60% (36 to 75) postpartum. In women vaccinated 
before 29 weeks gestational age, the estimated efficacy was 30% (-2 to 
52), and in women vaccinated at or after 29 weeks, efficacy was 71% (50 
to 83). Efficacy was similar in infants born to mothers vaccinated 
before or after 29 weeks gestation (34% [95% CI 12 to 51] vs 35% [11 to 
52]). There was no overall association between maternal vaccination and 
low birthweight, stillbirth, preterm birth, and small for gestational 
age. At 6 months of age, the intervention and control groups were 
similar in terms of underweight (weight-for-age), stunted 
(length-for-age), and wasted (weight-for-length). Median centile change 
from birth to 6 months of age was similar between the intervention and 
the control groups for both weight and length. INTERPRETATION: The 
assessment of efficacy for women vaccinated before 29 weeks gestational 
age might have been underpowered, because the point estimate suggests 
that there might be efficacy despite wide CIs. Estimates of efficacy 
against PCR-confirmed influenza and safety in terms of adverse birth 
outcomes should be incorporated into any further consideration of 
maternal influenza immunisation recommendations. FUNDING: Bill &amp; 
Melinda Gates Foundation.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2020-06</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 6
Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>8</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>597-608</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>The Lancet. Respiratory medicine</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1016/S2213-2600(19)30479-5">10.1016/S2213-2600(19)30479-5</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>6</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>2213-2600 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:29 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:29 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>*Pregnancy Outcome</li>
					<li>Gestational Age</li>
					<li>Infant</li>
					<li>Pregnancy Complications, Infectious/*prevention &amp; control</li>
					<li>Treatment Outcome</li>
					<li>South Africa/epidemiology</li>
					<li>Time Factors</li>
					<li>Mali/epidemiology</li>
					<li>Child Development/*drug effects</li>
					<li>Influenza Vaccines/*therapeutic use</li>
					<li>Influenza, Human/epidemiology/*prevention &amp; control</li>
					<li>Nepal/epidemiology</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_B9HQIVZC">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name : </strong></p>
<p><span style="color: rgb(80, 80, 80)"><span style="background-color: rgb(255, 255, 255)">Bamako, Mali ,Soweto, South Africa,</span></span></p>
<p><strong>Location Type : </strong></p>
<p>City</p>
<p><strong>Description : </strong><span style="color: rgb(80, 80, 80)"><span style="background-color: rgb(255, 255, 255)">&nbsp;</span></span></p>
<p><span style="color: rgb(80, 80, 80)"><span style="background-color: rgb(255, 255, 255)">Bamako, Mali ,Soweto, South Africa,</span></span></p>
<p><strong>sample size :</strong> <span style="color: rgb(80, 80, 80)"><span style="background-color: rgb(255, 255, 255)">10000&nbsp;</span></span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_YGU4HM6Y" class="item journalArticle">
			<h2>Efficiency of HAART in the prevention of mother to children HIV-1
 transmission at Saint Camille medical centre in Burkina Faso, West 
Africa.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Linguissi LS</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bisseye C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sagna T</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Nagalo BM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ouermi D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Djigma FW</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Pignatelli S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sia JD</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Pietra V</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Moret R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Nikiema JB</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Simpore J</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>OBJECTIVE: To evaluate efficiency of HAART in the prevention 
of mother to child HIV transmission. METHODS: A longitudinal study was 
conducted on 1 300 women attending the antenatal service at Saint 
Camille Medical Centre from September 2010 to July 2011. The HIV status 
of mothers was determined by rapid tests and ELISA. Discordant results 
were confirmed by real-time PCR. PCR was used to determine HIV status of
 children born from HIV-positive mothers. RESULTS: Among 1 300 pregnant 
women tested for HIV, 378 were seropositive. Mothers were predominantly 
housewives (69.7%), and their mean age was (28.32+/-0.15) years. The 
overall prevalence of HIV transmission from mother to child was 4.8% 
(18/378). This prevalence differed significantly from 0.0% (0/114) to 
6.8% (18/264) in children born from mothers under HAART and those with 
mothers under New Prophylactic Protocol (AZT + 3TC + NVP), respectively 
(P&lt; 0.01). Children's mortality rate during the medical follow up was
 1.3% (5/378). Among 16 women with HIV dubious status by ELISA, the Real
 Time PCR confirmed 2/16 (12.5%) as HIV positive. CONCLUSIONS: The 
protocol of prevention of mother to children HIV transmission (PMTCT) is
 effective. The rate of HIV vertical transmission is significantly 
reduced. Early diagnosis determined by PCR of children born from 
HIV-positive mother is necessary and recommended in the context of PMTCT
 in Burkina Faso. We also found that PCR is an effective tool to confirm
 HIV status in pregnant women.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2012-12</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 12
Place: India</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>5</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>991-4</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Asian Pacific journal of tropical medicine</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1016/S1995-7645(12)60188-6">10.1016/S1995-7645(12)60188-6</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>12</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1995-7645 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:25 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:25 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Prospective Studies</li>
					<li>Prevalence</li>
					<li>Infectious Disease Transmission, Vertical/*prevention &amp; control</li>
					<li>Socioeconomic Factors</li>
					<li>Child</li>
					<li>Anti-HIV Agents/*therapeutic use</li>
					<li>Polymerase Chain Reaction</li>
					<li>Burkina Faso/epidemiology</li>
					<li>Antiretroviral Therapy, Highly Active/*methods</li>
					<li>HIV Infections/*drug therapy/epidemiology/*prevention &amp; control/transmission</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_UZWGRD9E">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name</strong> : </p>
<p>Saint Camille Medical Centre &amp; &nbsp;Biomolecular Research Centre Pietro Annigoni / Ouagadougou</p>
<p><strong>Location Type</strong> :</p>
<p>Healty Facility </p>
<p><strong>Description</strong> : </p>
<p>Saint Camille Medical Centre &amp; &nbsp;Biomolecular Research Centre Pietro Annigoni, Ouagadougou, Burkina Faso.</p>
<p><strong>Geo-coodinates:</strong></p>
<p>Ouagadougou(<strong> </strong>12.3710 N latitude and 1.5247 W)</p>
<p><strong>Sample size &nbsp;: &nbsp;</strong><span style="color: rgb(31, 31, 31)">&nbsp;1 300&nbsp;</span></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_RR9VIIIZ" class="item journalArticle">
			<h2>Episiotomy and obstetric outcomes among women living with type 3 female genital mutilation: a secondary analysis.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Rodriguez MI</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Seuc A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Say L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hindin MJ</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: To investigate the association between type of 
episiotomy and obstetric outcomes among 6,187 women with type 3 Female 
Genital Mutilation (FGM). METHODS: We conducted a secondary analysis of 
women presenting in labor to 28 obstetric centres in Burkina Faso, 
Ghana, Kenya, Nigeria, Senegal and Sudan between November 2001 and March
 2003. Data were analysed using cross tabulations and multivariable 
logistic regression to determine if type of episiotomy by FGM 
classification had a significant impact on key maternal outcomes. Our 
main outcome measures were anal sphincter tears, intrapartum blood loss 
requiring an intervention, and postpartum haemorrhage. RESULTS: Type of 
episiotomy performed varied significantly by FGM status. Among women 
without FGM, the most common type of episiotomy performed was posterior 
lateral (25.4 %). The prevalence of the most extensive type of 
episiotomy, anterior and posterior lateral episiotomy increased with 
type of FGM. Among women without FGM, 0.4 % had this type of episiotomy.
 This increased to 0.6 % for women with FGM Types 1, 2 or 4 and to 54.6 %
 of all women delivering vaginally with FGM Type 3. After adjustment, 
women with an anterior episiotomy, (AOR = 0.15 95 %; CI 0.06-0.40); 
posterior lateral episiotomy (AOR = 0.68 95 %; CI 0.50-0.94) or both 
anterior and posterior lateral episiotomies performed concurrently (AOR =
 0.21 95 % CI 0.12-0.36) were all significantly less likely to have anal
 sphincter tears compared to women without episiotomies. Women with 
anterior episiotomy (AOR = 0.08; 95%CI 0.02-0.24), posterior lateral 
episiotomy (AOR = 0.17 95 %; CI 0.05-0.52) and the combination of the 
two (AOR = 0.04 95 % CI 0.01-0.11) were significantly less likely to 
have postpartum haemorrhage compared with women who had no episiotomy. 
CONCLUSIONS: Among women living with FGM Type 3, episiotomies were 
protective against anal sphincter tears and postpartum haemorrhage. 
Further clinical and research is needed to guide clinical practice of 
when episiotomies should be performed.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2016-10</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 1
Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>13</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>131</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Reproductive health</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/s12978-016-0242-9">10.1186/s12978-016-0242-9</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1742-4755 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:24 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:24 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Young Adult</li>
					<li>Risk Factors</li>
					<li>Pregnancy Outcome/epidemiology</li>
					<li>Socioeconomic Factors</li>
					<li>*Obstetrics</li>
					<li>Delivery, Obstetric/methods</li>
					<li>Africa/epidemiology</li>
					<li>*Circumcision</li>
					<li>*Episiotomy</li>
					<li>*Female genital mutilation</li>
					<li>*FGM</li>
					<li>Anal Canal/injuries</li>
					<li>Cicatrix/etiology/surgery</li>
					<li>Circumcision, Female/*adverse effects</li>
					<li>Episiotomy/adverse effects/*methods</li>
					<li>Hemorrhage/epidemiology/etiology/prevention &amp; control</li>
					<li>Obstetric Labor Complications/*epidemiology/prevention &amp; control</li>
					<li>Postpartum Hemorrhage/epidemiology/etiology/prevention &amp; control</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_T2JBL3XF">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location name</strong> : </p>
<p>Facility Name not specified</p>
<p><strong>Location Type</strong> : </p>
<p>Health Facility</p>
<p><strong>Description</strong> : &nbsp;</p>
<p><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">28 obstetric centers in Burkina Faso, Ghana, Kenya, Nigeria, Senegal and Sudan</span></span></p>
<p><strong>Sample size : </strong><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">26,640&nbsp;</span></span></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_ITUJDEJN" class="item journalArticle">
			<h2>Equity in maternal health outcomes in a middle-income urban setting: a cohort study.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>De Groot A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Van de Munt L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Boateng D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Savitri AI</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Antwi E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bolten N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Klipstein-Grobusch K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Uiterwaal CSPM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Browne JL</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Low socioeconomic status (SES) is associated with 
more adverse perinatal health outcomes, risk factors and lower access to
 and use of maternal health care services. However, evidence for the 
association between SES and maternal health outcomes is limited, 
particularly for middle-income countries like sub-Saharan Ghana. We 
assessed the association between parental SES and adverse maternal and 
perinatal outcomes of Ghanaian women during pregnancy, delivery and the 
postpartum period. METHODS: A prospective cohort study of 1010 women of 
two public hospitals in Accra, Ghana (2012-2014). SES was proxied by 
maternal and paternal education, wealth and employment status. The 
association of SES with maternal and perinatal outcomes was analyzed 
with multivariable logistic and linear regression. RESULTS: The analysis
 included 790 women with information on pregnancy outcomes. Average age 
was 28.2 years (standard deviation, SD 5.0). Over a third (n = 292, 
37.0%) had low SES, 176 (22.3%) were classified to have high SES using 
the assets index. Nearly half (n = 374, 47.3%) of women had lower 
secondary school or vocational training as highest education level. 
Compared to women with middle assets SES, women with low assets SES were
 at higher risk for miscarriage (odds ratio, OR 1.61, 95% CI 1.06 to 
2.45) and instrumental delivery (OR 1.74, 95% CI 1.03 to 2.94), but this
 association was not observed for the other SES proxies. For any of the 
maternal or perinatal outcomes and SES proxies, no other statistically 
significant differences were found. CONCLUSION: Women attending public 
maternal health care services in urban Ghana had overall equitable 
maternal and perinatal health outcomes, with the exception of a higher 
risk of miscarriage and instrumental delivery associated with low assets
 SES. This suggests known associations between SES, risk factors and 
outcomes could be mitigated with universal and accessible maternal 
health services.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2019-06</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 1
Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>16</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>84</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Reproductive health</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/s12978-019-0736-3">10.1186/s12978-019-0736-3</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1742-4755 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:40 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:40 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Prospective Studies</li>
					<li>Risk Factors</li>
					<li>Maternal health</li>
					<li>Ghana/epidemiology</li>
					<li>*Maternal Health</li>
					<li>Delivery, Obstetric</li>
					<li>*Socioeconomic Factors</li>
					<li>Abortion, Spontaneous/*epidemiology</li>
					<li>Equity</li>
					<li>Income</li>
					<li>Low- and middle income countries</li>
					<li>Maternal Health Services/economics/standards/*statistics &amp; numerical data</li>
					<li>Prenatal Care/economics/standards/*statistics &amp; numerical data</li>
					<li>Quality of Health Care/*statistics &amp; numerical data</li>
					<li>Social Class</li>
					<li>Socio-economic status</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_P9AQJVG3">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name</strong>: </p>
<p>Facility names not specified</p>
<p><strong>Location Type</strong>: </p>
<p>Health Facility / City</p>
<p><strong>Description</strong>: </p>
<p>Two public hospitals in Accra, capital city of Ghana</p>
<p><strong>sample size</strong> : 1010</p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_WBQU48H9" class="item journalArticle">
			<h2>Estimates of Stillbirths, Neonatal Mortality, and Medically Vulnerable Live Births in Amhara, Ethiopia.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chan GJ</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Goddard FGB</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hunegnaw BM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mohammed Y</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hunegnaw M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Haneuse S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bekele C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bekele D</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>Importance: Data on birth outcomes and early mortality are 
scarce, especially in settings with limited resources. Total births, 
both stillbirths and live births, are often not counted, yet such data 
are critical to allocate resources and target interventions to improve 
survival. Objective: To estimate the prevalence of stillbirths, neonatal
 deaths, and medically vulnerable phenotypes, such as preterm births, 
small-for-gestational-age (SGA), large-for-gestational-age (LGA), and 
low-birth-weight (LBW) births, in a setting where these key indicators 
remain largely unknown. Design, Setting, and Participants: This 
prospective pregnancy cohort study of women and their newborns was 
conducted between December 12, 2018, and November 5, 2020. The study was
 conducted in North Shewa Zone, Amhara, Ethiopia. Data were analyzed 
from July 2021 to May 2022. Main Outcomes and Measures: Pregnancy 
status, gestational age, birth weight, and vital status were measured to
 estimate the prevalence of stillbirths, live births, and medically 
vulnerable live births (ie, preterm, SGA, LGA, and LBW births). For 
mortality outcomes, the prevalence of neonatal (overall, early, and 
late) and perinatal mortality were estimated. Results: Among the 2801 
enrolled women, the median (IQR) age at conception was 26.5 (22.2-31.0) 
years, and the median (IQR) gestational age at enrollment was 24 (17-31)
 weeks. Of the 2628 women (93.8%) with outcome data, 101 pregnancies 
(3.8%) resulted in an early loss (&lt;28 gestational weeks). Among the 
2527 remaining pregnant women, there were 2518 births between 28 and 
less than 46 weeks' gestation; 2459 (97.7%; 95% CI, 97.0%-98.2%) were 
live births and 59 (2.3%; 95% CI, 1.8%-3.0%) were stillbirths. Many 
newborns (41.7%) were born preterm, SGA, LGA, or LBW. The estimated 
prevalence was 15.1% (95% CI, 13.7%-16.6%) for preterm births, 23.1% 
(95% CI, 21.3%-25.1%) for SGA births, 10.6% (95% CI, 9.3%-12.1%) for LGA
 births, and 9.4% (95% CI, 8.2%-10.8%) for LBW births. Among live 
births, the overall prevalence of neonatal mortality was 3.1% (95% CI, 
2.5%-3.9%); mortality was higher among preterm births (7.2%; 95% CI, 
4.9%-10.4%), LBW births (12.2%; 95% CI, 8.2%-17.7%), and SGA births 
(4.1%; 95% CI, 2.6%-6.5%). The prevalence of early neonatal mortality 
was almost twice as high as the prevalence of late neonatal mortality. 
The perinatal mortality prevalence was 4.3% (95% CI, 3.6%-5.2%), with a 
1.2:1 ratio of stillbirths to first-week deaths. Conclusions and 
Relevance: These findings have important implications for newborn health
 and survival. For policy makers and programmers, accurate data on key 
indicators of neonatal health provide information for resource 
allocation and to evaluate progress. For researchers, the findings 
underlie the importance for further research to develop and deliver 
interventions that improve health outcomes.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2022-06</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>5</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e2218534</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>JAMA network open</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1001/jamanetworkopen.2022.18534">10.1001/jamanetworkopen.2022.18534</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>6</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>2574-3805 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Cohort Studies</li>
					<li>Infant, Newborn</li>
					<li>Prospective Studies</li>
					<li>Infant Mortality</li>
					<li>*Premature Birth/epidemiology</li>
					<li>Stillbirth/epidemiology</li>
					<li>*Perinatal Death</li>
					<li>Ethiopia/epidemiology</li>
					<li>Live Birth/epidemiology</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_7VTHD83Z">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location name : </strong></p>
<p>Birhan field site</p>
<p><strong>Location type :</strong></p>
<p>Community and Health facility</p>
<p><strong>Description : </strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Conducted at the Birhan field site, located in the North Shewa Zone, 130 km north of Addis Ababa, Ethiopia.</span></span></p>
<p><strong>Sample size</strong> : <span style="color: rgb(51, 51, 51)">2628</span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_SQLZHVVG" class="item journalArticle">
			<h2>Evaluation of a community health worker intervention and the 
World Health Organization's Option B versus Option A to improve 
antenatal care and PMTCT outcomes in Dar es Salaam, Tanzania: study 
protocol for a cluster-randomized controlled health systems 
implementation trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sando D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Geldsetzer P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Magesa L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Lema IA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Machumi L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mwanyika-Sando M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Li N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Spiegelman D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mungure E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Siril H</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mujinja P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Naburi H</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chalamilla G</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kilewo C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ekstrom AM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Fawzi WW</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Barnighausen TW</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Mother-to-child transmission of HIV remains an 
important public health problem in sub-Saharan Africa. As HIV testing 
and linkage to PMTCT occurs in antenatal care (ANC), major challenges 
for any PMTCT option in developing countries, including Tanzania, are 
delays in the first ANC visit and a low overall number of visits. 
Community health workers (CHWs) have been effective in various settings 
in increasing the uptake of clinical services and improving treatment 
retention and adherence. At the beginning of this trial in January 2013,
 the World Health Organization recommended either of two medication 
regimens, Option A or B, for prevention of mother-to-child transmission 
of HIV (PMTCT). It is still largely unclear which option is more 
effective when implemented in a public healthcare system. This study 
aims to determine the effectiveness, cost-effectiveness, acceptability, 
and feasibility of: (1) a community health worker (CWH) intervention and
 (2) PMTCT Option B in improving ANC and PMTCT outcomes. METHODS/DESIGN:
 This study is a cluster-randomized controlled health systems 
implementation trial with a two-by-two factorial design. All 60 
administrative wards in the Kinondoni and Ilala districts in Dar es 
Salaam were first randomly allocated to either receiving the CHW 
intervention or not, and then to receiving either Option B or A. Under 
the standard of care, facility-based health workers follow up on 
patients who have missed scheduled appointments for PMTCT, first through
 a telephone call and then with a home visit. In the wards receiving the
 CHW intervention, the CHWs: (1) identify pregnant women through home 
visits and refer them to antenatal care; (2) provide education to 
pregnant women on antenatal care, PMTCT, birth, and postnatal care; (3) 
routinely follow up on all pregnant women to ascertain whether they have
 attended ANC; and (4) follow up on women who have missed ANC or PMTCT 
appointments. TRIAL REGISTRATION: ClinicalTrials.gov: EJF22802. 
Registration date: 14 May 2013.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2014-09</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>15</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>359</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Trials</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/1745-6215-15-359">10.1186/1745-6215-15-359</a></td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1745-6215 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:35 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:35 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Infant, Newborn</li>
					<li>Infectious Disease Transmission, Vertical/*prevention &amp; control</li>
					<li>Treatment Outcome</li>
					<li>Health Knowledge, Attitudes, Practice</li>
					<li>Patient Education as Topic</li>
					<li>Time Factors</li>
					<li>Tanzania/epidemiology</li>
					<li>Anti-HIV Agents/*therapeutic use</li>
					<li>*Research Design</li>
					<li>Community Health Services/*standards</li>
					<li>Patient Acceptance of Health Care</li>
					<li>*World Health Organization</li>
					<li>Health Services Research</li>
					<li>HIV Infections/epidemiology/*prevention &amp; control/transmission</li>
					<li>*Health Systems Plans</li>
					<li>Appointments and Schedules</li>
					<li>Community Health Workers/*standards</li>
					<li>Outcome and Process Assessment, Health Care/*standards</li>
					<li>Perinatal Care/*standards</li>
					<li>Quality Improvement/*standards</li>
					<li>Quality Indicators, Health Care/*standards</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_D5LLQHRX">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name : </strong></p>
<p><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">Wards names not specified</span></span></p>
<p><strong>Location Type : </strong>Wards</p>
<p><strong>Description : </strong></p>
<p><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">Kinondoni and Ilala districts, two of the three administrative districts of the Dar es Salaam region of Tanzania</span></span></p>
<p><strong>Sample Size :</strong></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_J4TWXB6D" class="item journalArticle">
			<h2>Exclusive breastfeeding, diarrhoeal morbidity and all-cause 
mortality in infants of HIV-infected and HIV uninfected mothers: an 
intervention cohort study in KwaZulu Natal, South Africa.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Rollins NC</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ndirangu J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bland RM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Coutsoudis A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Coovadia HM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Newell ML</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>INTRODUCTION: Antiretroviral drug interventions significantly 
reduce the risk of HIV transmission to infants through breastfeeding. We
 report diarrhoea prevalence and all-cause mortality at 12 months of age
 according to infant feeding practices, among infants born to 
HIV-infected and uninfected mothers in South Africa. METHODS: A 
non-randomised intervention cohort study that followed both HIV-infected
 and HIV-uninfected mothers and their infants until 18 months of age. 
Mothers were supported in their infant feeding choice. Detailed 
morbidity and vital status data were collected over the first year. At 
the time, only single dose nevirapine was available to prevent 
mother-to-child transmission of HIV. RESULTS: Among 2,589 infants, 
detailed feeding data and vital status were available for 1,082 
HIV-exposed infants and 1,155 HIV non-exposed infants. Among exclusively
 breastfed (EBF) infants there were 9.4 diarrhoeal days per 1,000 child 
days (95%CI. 9.12-9.82) while among infants who were never breastfed 
there were 15.6 diarrhoeal days per 1,000 child days (95%CI. 
14.62-16.59). Exclusive breastfeeding was associated with fewer acute, 
persistent and total diarrhoeal events than mixed or no breastfeeding in
 both HIV-exposed infants and also infants of HIV uninfected mothers. In
 an adjusted cox regression analysis, the risk of death among all 
infants by 12 months of age was significantly greater in those who were 
never breastfed (aHR 3.5, p&lt;0.001) or mixed fed (aHR 2.65, 
p&lt;0.001) compared with those who were EBF. In separate multivariable 
analyses, infants who were EBF for shorter durations had an increased 
risk of death compared to those EBF for 5-6 months [aHR 2.18 (95% CI, 
1.56-3.01); p&lt;0.001]. DISCUSSION: In the context of antiretroviral 
drugs being scaled-up to eliminate new HIV infections among children, 
there is strong justification for financial and human resource 
investment to promote and support exclusive breastfeeding to improve 
HIV-free survival of HIV-exposed and non-exposed infants.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2013</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 12
Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>8</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e81307</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>PloS one</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1371/journal.pone.0081307">10.1371/journal.pone.0081307</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>12</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1932-6203 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:24 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:24 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Cohort Studies</li>
					<li>Young Adult</li>
					<li>Male</li>
					<li>Infant</li>
					<li>Infectious Disease Transmission, Vertical/*prevention &amp; control</li>
					<li>South Africa/epidemiology</li>
					<li>HIV Infections/*transmission</li>
					<li>Mothers/*statistics &amp; numerical data</li>
					<li>Breast Feeding/*statistics &amp; numerical data</li>
					<li>Rural Population/statistics &amp; numerical data</li>
					<li>Anti-HIV Agents/*pharmacology</li>
					<li>Diarrhea/*epidemiology</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_CSMW35YI">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name : </strong></p>
<p>Facility Name not specified</p>
<p><strong>Location Type : </strong></p>
<p>Health Facility</p>
<p><strong>Description : </strong></p>
<p><span style="color: rgb(32, 32, 32)"><span style="background-color: rgb(255, 255, 255)">Niine antenatal clinics, 7 rural, 1 periurban and 1 in urban KwaZulu Natal, South Africa&nbsp;</span></span></p>
<p><strong>Sample Size :</strong> 2770</p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_STIDGR4C" class="item journalArticle">
			<h2>Factors associated with preterm, early preterm and late preterm birth in Malawi.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>van den Broek NR</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Jean-Baptiste R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Neilson JP</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Assessment of risk factors for preterm birth in a 
population with high incidence of preterm birth and HIV infection. 
METHODS: Secondary analysis of data for 2,149 women included in a 
community based randomized placebo controlled trial for the prevention 
of preterm birth (APPLe trial (ISRCTN84023116) with gestational age at 
birth determined through ultrasound measurement in early pregnancy. 
Multivariate Logistic Regression analyses to obtain models for three 
outcome variables: all preterm, early preterm, and late preterm birth. 
FINDINGS: No statistical differences were noted for the prevalence of 
HIV infection (p = 0.30) or syphilis (p = 0.12) between women who 
delivered preterm versus term. BMI (Adjusted OR 0.91 (0.85-0.97); p = 
0.005) and weight gain (Adjusted OR 0.89 (0.82-0.97); p = 0.006) had an 
independent, protective effect. Previous preterm birth doubled the odds 
of preterm birth (Adjusted OR 2.13 (1.198-3.80); p = 0.01). Persistent 
malaria (despite malaria prophylaxis) increased the risk of late preterm
 birth (Adjusted OR 1.99 (1.05-3.79); p = 0.04). Age &lt;20 (Adjusted OR
 1.73 (1.03-2.90); p = 0.04) and anemia (Adjusted OR 1.95 (1.08-3.52); p
 = 0.03) were associated with early preterm birth (&lt;34 weeks). 
CONCLUSIONS: Despite claims that HIV infection is an important cause of 
preterm birth in Africa, we found no evidence of an association in this 
population (unexposed to anti-retroviral treatment). Persistent malaria 
was associated with late preterm birth. Maternal undernourishment and 
anemia were independently associated with early preterm birth. The study
 did not assess whether the link was direct or whether a common 
precursor such as chronic infection was responsible for both maternal 
effects and early labour.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2014</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>9</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e90128</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>PloS one</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1371/journal.pone.0090128">10.1371/journal.pone.0090128</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>3</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1932-6203 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Infant, Newborn</li>
					<li>Young Adult</li>
					<li>Risk Factors</li>
					<li>Malawi</li>
					<li>Multivariate Analysis</li>
					<li>Malaria/complications</li>
					<li>*Pregnancy Complications, Infectious</li>
					<li>HIV Infections/*complications</li>
					<li>Obstetric Labor, Premature/*etiology</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_7SD5UT4Q">
<div><div data-schema-version="8"><p><strong>Location Information:</strong></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Name: </span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">Specific names not given</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Type:</span></span></strong></p>
<p><strong><span style="color: black"><span style="background-color: white"> </span></span></strong><span style="color: black"><span style="background-color: white">4</span></span><strong><span style="color: black"><span style="background-color: white"> </span></span></strong><span style="color: black"><span style="background-color: white">Health facilities</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Description:</span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">Conducted in </span></span><strong><span style="color: black"><span style="background-color: white">T</span></span></strong><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">hree rural and one Peri-urban health centers in Sourthern malawi</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Sample size : &nbsp;2297</span></span></strong></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_7JXNYHKJ" class="item journalArticle">
			<h2>Factors associated with sub-microscopic placental malaria and its
 association with adverse pregnancy outcomes among HIV-negative women in
 Dar es Salaam, Tanzania: a cohort study.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kalinjuma AV</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Darling AM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mugusi FM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Abioye AI</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Okumu FO</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Aboud S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Masanja H</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hamer DH</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hertzmark E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Fawzi WW</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Malaria infection during pregnancy has negative 
health consequences for both mothers and offspring. Sub-microscopic 
malaria infection during pregnancy is common in most African countries. 
We sought to identify factors associated with sub-microscopic placental 
malaria, and its association with adverse pregnancy outcomes among 
HIV-negative pregnant women in Dar es Salaam, Tanzania. METHODS: We 
recruited a cohort of pregnant women during their first trimester and 
assessed for the occurrence of placental malaria and pregnancy outcomes.
 The follow-up was done monthly from recruitment until delivery. 
Histopathology placental malaria positive results were defined as the 
presence of malaria pigment or parasitized erythrocytes on the slide 
(histology-positive (HP)), and the sub-microscopic placental infection 
was defined as positive Plasmodium falciparum DNA by polymerase chain 
reaction (DNA PCR) amplification in a negative histopathology test. 
Adverse pregnancy outcomes investigated included low birth weight (birth
 weight below 2.5 kg), prematurity (live birth below 37 weeks), and 
small-for-gestational-age (SGA) (live born with a birth weight below 
10th percentile for gestational age and sex). Weighted baseline category
 logit, log-binomial, and log-Poisson models were used to assess factors
 associated with placental malaria, and its association with adverse 
pregnancy outcomes. RESULTS: Among 1115 women who had histopathology and
 DNA PCR performed, 93 (8%) had HP placental infection, and 136 (12%) 
had the sub-microscopic placental infection. The risk of sub-microscopic
 placental malaria was greater in women who did not use mosquito 
prevention methods such as bed nets, fumigation, or mosquito coils (odds
 ratio (OR) = 1.75; 95% confidence interval (CI): 1.05-2.92; P = 0.03) 
and in women who were anemic (OR = 1.59; 95% CI: 1.20-2.11; P = 0.001). 
Women who were underweight had reduced odds of sub-microscopic placental
 malaria infection (OR = 0.33; 95% CI: 0.17-0.62; P = 0.001). Women who 
were overweight/obese had 1.48 times higher the odds of HP placental 
malaria compared to normal weight (OR = 1.48; 95% CI: 1.03-2.11; P = 
0.03). HP placental malaria infection was associated with an increased 
risk of SGA births (RR = 1.30, 95% CI: 0.98-1.72, P = 0.07). In 
contrast, the sub-microscopic infection was associated with a reduced 
risk of SGA births (RR = 0.61, 95% CI: 0.43-0.88, P = 0.01). Placental 
malaria was not associated with low birth weight or prematurity. 
CONCLUSION: Malaria prevention methods and maternal nutrition status 
during early pregnancy were important predictors of sub-microscopic 
placental malaria. More research is needed to understand sub-microscopic
 placental malaria and the possible mechanisms mediating the association
 between placental malaria and SGA.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2020-10</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>20</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>796</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>BMC infectious diseases</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/s12879-020-05521-6">10.1186/s12879-020-05521-6</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1471-2334 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>*HIV</li>
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Birth Weight</li>
					<li>Infant, Newborn</li>
					<li>Young Adult</li>
					<li>*Pregnancy Outcome</li>
					<li>Gestational Age</li>
					<li>Premature Birth</li>
					<li>Follow-Up Studies</li>
					<li>Tanzania/epidemiology</li>
					<li>Infant, Small for Gestational Age</li>
					<li>Risk</li>
					<li>HIV Infections/*epidemiology/virology</li>
					<li>low birth weight</li>
					<li>Premature</li>
					<li>Anemia/etiology</li>
					<li>DNA PCR</li>
					<li>Histopathology</li>
					<li>Malaria/complications/*epidemiology/parasitology</li>
					<li>Placenta/*parasitology</li>
					<li>placental malaria</li>
					<li>Plasmodium falciparum/*genetics</li>
					<li>Pregnancy Complications, Infectious/*epidemiology/parasitology</li>
					<li>Small for gestational age</li>
					<li>Sub-microscopic parasitemia</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_ZP6R2636">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Name: &nbsp;</span></span></strong></p>
<p>names of health facilities not specified</p>
<p><strong><span style="color: black"><span style="background-color: white">Location Type: </span></span></strong></p>
<p>Health facilities</p>
<p><strong><span style="color: black"><span style="background-color: white">Description:</span></span></strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">conducted in Dar es Salaam, Tanzania</span></span></p>
<p><strong>Sample Size</strong>: 2500 </p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_8NSIUWCF" class="item journalArticle">
			<h2>Factors influencing access of pregnant women and their infants to
 their local healthcare system: a prospective, multi-centre, 
observational study.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Madhi SA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Rivera LM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Saez-Llorens X</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Menendez C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Carrim-Ganey N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Cotton MF</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Katzman D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Luttig MM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Candelario R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Baker S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Roychoudhury M</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: The successful implementation of maternal 
vaccination relies on results of clinical trials, considering the 
prenatal and postnatal attendance at selected healthcare institutions. 
This study evaluated factors influencing maternal/infant access to 
healthcare facilities to identify potential barriers to participation in
 future clinical trials on maternal vaccination. METHODS: In this 
prospective, multi-centre, observational study, pregnant women (N = 
3243) were enrolled at ten sites across Panama, the Dominican Republic, 
South Africa, and Mozambique between 2012 and 2014. They completed 
questionnaires at enrolment, delivery, and infant follow-up (90 days 
post-partum) visits, including questions on transportation, phone 
accessibility, alternative childcare, gestational age at enrolment, 
delivery location, and health status of their infant. Logistic 
regression was used to identify factors significantly associated with 
return to study site for delivery or infant follow-up visits. RESULTS: 
Among 3229 enrolled women with delivery information, 63.6% (range across
 sites: 25.3-91.5%) returned to study site for delivery. Older women and
 those at later gestational age at enrolment were more likely to deliver
 at the study site. While heterogeneities were observed at site level, 
shorter travel time at delivery and increased transportation costs at 
enrolment were associated with increased likelihood of women returning 
to study site for delivery. Among 3145 women with live-born infants, 
3077 (95.3%) provided 90-day follow-up information; of these, 68.9% 
(range across sites: 25.6-98.9%) returned to study site for follow-up 
visits. Women with other children and with lower transportation costs at
 delivery were more likely to return to study site for follow-up visits.
 Among 666 infants reported sick, 94.3% were taken to a healthcare 
facility, with only 41.9% (range across sites: 4.9-77.3%) to the study 
site. CONCLUSION: Although high retention was observed from enrolment 
through 90 days after delivery, post-partum surveillance should be 
broadened beyond the study sites and additional follow-up visits should 
be planned within the neonatal period. The factors influencing 
maternal/infant access to healthcare facilities and the issues 
identified in this study should be taken into consideration in planning 
future clinical studies on maternal immunisation in low- and 
middle-income countries. TRIAL REGISTRATION: The study was registered at
 ClinicalTrial.gov ( NCT01734434 ) on November 22, 2012.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2018-01</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>18</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>29</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>BMC pregnancy and childbirth</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/s12884-017-1655-3">10.1186/s12884-017-1655-3</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1471-2393 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Infant, Newborn</li>
					<li>Prospective Studies</li>
					<li>Gestational Age</li>
					<li>Infant</li>
					<li>South Africa</li>
					<li>Mozambique</li>
					<li>Health Facilities/*statistics &amp; numerical data</li>
					<li>*Pregnant women</li>
					<li>Delivery, Obstetric/*statistics &amp; numerical data</li>
					<li>Maternal Age</li>
					<li>*Infants</li>
					<li>Health Services Accessibility/*statistics &amp; numerical data</li>
					<li>Maternal-Child Health Services/*statistics &amp; numerical data</li>
					<li>*Developing countries</li>
					<li>*Group B Streptococcus</li>
					<li>*Healthcare system</li>
					<li>*Immunisation</li>
					<li>Dominican Republic</li>
					<li>Health Status</li>
					<li>Immunization Programs/*statistics &amp; numerical data</li>
					<li>Panama</li>
					<li>Transportation/statistics &amp; numerical data</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_XK5Y8Y6S">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location Names</strong>: </p>
<p>The actual names of the sites were not mentioned</p>
<p><strong>Location Type</strong>:</p>
<p> <span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Study sites</span></span></p>
<p><strong>Description:</strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Conducted
 at ten sites across several countries, three in Panama, two in the 
Dominican Republic, four in South Africa, and one in Mozambique. The 
study sites were predominantly urban, with the exception of one 
semi-rural site in Mozambique.</span></span></p>
<p><strong>Sample size &nbsp;: </strong><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">&nbsp; 3243</span></span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_8GD2PW3C" class="item journalArticle">
			<h2>Factors influencing disclosure among women experiencing intimate 
partner violence during pregnancy in Moshi Municipality, Tanzania.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Katiti V</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sigalla GN</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Rogathi J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Manongi R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mushi D</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Intimate Partner Violence (IPV) has serious 
negative health effects to millions of women around the globe. While 
disclosing IPV could open doors for support and eventually prevent 
partner abuse, the factors associated with IPV disclosure during 
pregnancy are not well known. The aim of this study was to examine 
factors influencing IPV disclosure to any person of interest or 
organization supporting women during pregnancy in Moshi Municipality, 
Tanzania. METHODS: Data were from a prospective cohort study of 1123 
pregnant women followed-up by the project aiming to assess the impact of
 violence in the reproductive health conducted in Moshi Municipality, 
Tanzania from March 2014 to May 2015. Inclusion criteria to the current 
analysis were all 339 pregnant women who reported to have experienced 
physical, sexual and/or emotional violence during the index pregnancy. 
Data analysis used SPSS Version 20. Odds ratio with 95 % Confidence 
Interval (CI) for factors associated with IPV disclosure was estimated 
using multivariate logistic regression models while controlling for age,
 education and parity. A p-value of less than 0.05 was considered for a 
statistically significant difference. RESULTS: IPV disclosure was found 
to be 23.3 % (n = 79). Disclosure of IPV was less likely among 
unemployed (OR = 0.5, 95 % CI 0.30-0.90) and women whose index pregnancy
 was unplanned (OR = 0.53, 95 % CI 0.29-0.98). Women who regularly 
participated in women's or community groups, religious groups or 
political associations at least once a month had 2 times higher odds of 
IPV disclosure compared to those who did not attend regularly (OR = 
2.12, 95 % CI 1.13-3.95). Most of the abused women during pregnancy who 
disclosed their experience of IPV (69 %) disclosed to a member of the 
family of birth followed by friends (14 %) and a member of family of the
 partner (11 %). CONCLUSIONS: Most of the women who experienced IPV 
during pregnancy kept suffering in silence while less than a quarter of 
all the abused (23.3 %) disclosed their experience to someone. 
Identification of the women experiencing IPV during pregnancy should be 
done as a starting point for supporting victim of IPV. Women empowerment
 in economical and reproductive health will reduce their vulnerability 
and facilitate disclosure of IPV for support. Key individuals who 
informally support victims of IPV should be targeted in interventions.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2016-08</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>15</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>715</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>BMC public health</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/s12889-016-3345-x">10.1186/s12889-016-3345-x</a></td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1471-2458 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:28 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:28 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>*Pregnancy Complications</li>
					<li>Prospective Studies</li>
					<li>Young Adult</li>
					<li>Logistic Models</li>
					<li>Adolescent</li>
					<li>Tanzania</li>
					<li>Sexual Partners</li>
					<li>Odds Ratio</li>
					<li>Social Support</li>
					<li>*Pregnant Women</li>
					<li>*Battered Women</li>
					<li>*Disclosure</li>
					<li>*Intimate Partner Violence</li>
					<li>*IPV disclosure</li>
					<li>*Partner violence during pregnancy</li>
					<li>*Risk and protective factors</li>
					<li>*Violence</li>
					<li>Sexual Behavior</li>
					<li>Spouse Abuse</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_R93K93CL">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name</strong> : </p>
<p><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">Moshi</span></span></p>
<p><strong>Location Type</strong> :</p>
<p> Administrative unit</p>
<p><strong>Description</strong> : </p>
<p><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">Moshi Municipality, Tanzania from March 2014 to May 2015</span></span></p>
<p>Sample Size : <span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">1123</span></span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_B8QFJJ2W" class="item journalArticle">
			<h2>Fatigue as a manifestation of psychosocial distress in a low-income country: a population-based panel study.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Smartt C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Medhin G</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Alem A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Patel V</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Dewey M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Prince M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hanlon C</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>OBJECTIVE: Fatigue is a common complaint worldwide and 
associated with disability and high health service use costs. We tested 
the hypothesis that maternal fatigue would be associated independently 
with maternal common mental disorder ('maternal CMD') in a rural, 
low-income country setting. METHODS: The analysis was conducted using 
data from a population-based cohort located in the Butajira demographic 
surveillance site, Ethiopia. A total of 1065 women were recruited in 
pregnancy and followed up to 2.5 (n = 1009; 94.7%) and 3.5 years 
post-partum (n = 989; 92.9%). Maternal CMD symptoms were measured using a
 locally validated version of the Self-Reporting Questionnaire and 
fatigue was measured using a dichotomised item from the Patient Health 
Questionnaire-15. Physical health indicators included haemoglobin level,
 body mass index and illness episodes. Generalised estimating equations 
were used to conduct hypothesis-driven and exploratory multivariable 
analyses in the panel at 2.5 and 3.5 years. RESULTS: The prevalence of 
maternal fatigue was 8.3% at 2.5 years and 5.5% at 3.5 years 
post-partum. Psychological symptoms of maternal CMD were associated 
independently with complaints of fatigue after adjusting for anaemia, 
body mass index, physical ill health, poverty and other confounding 
variables: adjusted odds ratio (aOR), 1.46; 95% confidence interval 
(CI), 1.28-1.66 for each one point increase in SRQ score. In the 
multivariable model, only psychosocial factors (CMD and stressful life 
events) and self-reported physical ill health were associated 
significantly with complaints of fatigue. CONCLUSION: Complaints of 
fatigue are associated strongly with maternal CMD and other psychosocial
 risk factors in this rural, low-income country setting with a high 
burden of undernutrition and infectious disease. Fatigue should be 
understood as a potential indicator of CMD in primary care to improve 
detection and treatment.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2016-03</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 3
Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>21</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>365-72</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Tropical medicine &amp; international health : TM &amp; IH</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1111/tmi.12658">10.1111/tmi.12658</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>3</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1360-2276 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:31 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:31 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Young Adult</li>
					<li>Risk Factors</li>
					<li>Prevalence</li>
					<li>Middle Aged</li>
					<li>Surveys and Questionnaires</li>
					<li>Adolescent</li>
					<li>Hemoglobins/analysis</li>
					<li>Ethiopia</li>
					<li>Ethiopia/epidemiology</li>
					<li>Body Mass Index</li>
					<li>Developing Countries/*statistics &amp; numerical data</li>
					<li>Health Status</li>
					<li>low-and middle-income countries</li>
					<li>angustia psicosocial</li>
					<li>detresse psychosociale</li>
					<li>DMC materno</li>
					<li>estudio poblacional de paneles</li>
					<li>Ethiopie</li>
					<li>Etiopia</li>
					<li>etude de panel basee sur la population</li>
					<li>fatiga</li>
					<li>fatigue</li>
					<li>Fatigue/epidemiology/*etiology</li>
					<li>maternal CMD</li>
					<li>PFR-PRI</li>
					<li>PIBMs</li>
					<li>population-based panel study</li>
					<li>Pregnancy Complications/epidemiology/psychology</li>
					<li>psychosocial distress</li>
					<li>Stress, Psychological/*complications/epidemiology</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_MDS8HW4Z">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name : </strong><span style="color: rgb(0, 0, 0)"><span style="background-color: rgb(255, 255, 255)">Site not specified</span></span></p>
<p><strong>Location Type : </strong><span style="color: rgb(0, 0, 0)"><span style="background-color: rgb(255, 255, 255)">Surveillance site</span></span></p>
<p><strong>Description : </strong><span style="color: rgb(0, 0, 0)"><span style="background-color: rgb(255, 255, 255)">Butajira District, Gurage Zone, Southern Nations, Nationalities, and Peoples' Region (SNNPR) of Ethiopia</span></span></p>
<p><strong>sample size :</strong> <span style="color: rgb(0, 0, 0)"><span style="background-color: rgb(255, 255, 255)">1065&nbsp;</span></span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_FSNECYXZ" class="item journalArticle">
			<h2>First look: a cluster-randomized trial of ultrasound to improve pregnancy outcomes in low income country settings.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>McClure EM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Nathan RO</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Saleem S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Esamai F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Garces A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chomba E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Tshefu A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Swanson D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mabeya H</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Figuero L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mirza W</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Muyodi D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Franklin H</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Lokangaka A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bidashimwa D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Pasha O</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mwenechanya M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bose CL</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Carlo WA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hambidge KM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Liechty EA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Krebs N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Wallace DD</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Swanson J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Koso-Thomas M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Widmer R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Goldenberg RL</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: In high-resource settings, obstetric ultrasound is
 a standard component of prenatal care used to identify pregnancy 
complications and to establish an accurate gestational age in order to 
improve obstetric care. Whether or not ultrasound use will improve care 
and ultimately pregnancy outcomes in low-resource settings is unknown. 
METHODS/DESIGN: This multi-country cluster randomized trial will assess 
the impact of antenatal ultrasound screening performed by health care 
staff on a composite outcome consisting of maternal mortality and 
maternal near-miss, stillbirth and neonatal mortality in low-resource 
community settings. The trial will utilize an existing research 
infrastructure, the Global Network for Women's and Children's Health 
Research with sites in Pakistan, Kenya, Zambia, Democratic Republic of 
Congo and Guatemala. A maternal and newborn health registry in defined 
geographic areas which documents all pregnancies and their outcomes to 6
 weeks post-delivery will provide population-based rates of maternal 
mortality and morbidity, stillbirth, neonatal mortality and morbidity, 
and health care utilization for study clusters. A total of 58 study 
clusters each with a health center and about 500 births per year will be
 randomized (29 intervention and 29 control). The intervention includes 
training of health workers (e.g., nurses, midwives, clinical officers) 
to perform ultrasound examinations during antenatal care, generally at 
18-22 and at 32-36 weeks for each subject. Women who are identified as 
having a complication of pregnancy will be referred to a hospital for 
appropriate care. Finally, the intervention includes community 
sensitization activities to inform women and their families of the 
availability of ultrasound at the antenatal care clinic and training in 
emergency obstetric and neonatal care at referral facilities. 
DISCUSSION: In summary, our trial will evaluate whether introduction of 
ultrasound during antenatal care improves pregnancy outcomes in rural, 
low-resource settings. The intervention includes training for 
ultrasound-naive providers in basic obstetric ultrasonography and then 
enabling these trainees to use ultrasound to screen for pregnancy 
complications in primary antenatal care clinics and to refer 
appropriately. TRIAL REGISTRATION: Clinicaltrials.gov (NCT # 01990625).</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2014-02</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>14</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>73</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>BMC pregnancy and childbirth</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/1471-2393-14-73">10.1186/1471-2393-14-73</a></td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1471-2393 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Infant, Newborn</li>
					<li>*Pregnancy Outcome</li>
					<li>*Developing Countries</li>
					<li>Gestational Age</li>
					<li>Socioeconomic Factors</li>
					<li>Zambia/epidemiology</li>
					<li>Rural Population</li>
					<li>Cluster Analysis</li>
					<li>Kenya/epidemiology</li>
					<li>Prenatal Care/*methods</li>
					<li>Pakistan/epidemiology</li>
					<li>Maternal Mortality/trends</li>
					<li>Guatemala/epidemiology</li>
					<li>Ultrasonography, Prenatal/*standards</li>
					<li>*Maternal Welfare</li>
					<li>Congo/epidemiology</li>
					<li>Infant Mortality/trends</li>
					<li>Maternal Health Services/*standards</li>
					<li>Midwifery/standards</li>
					<li>Morbidity/trends</li>
					<li>Pregnancy Complications/*diagnostic imaging/epidemiology</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_5MP66GTZ">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location &nbsp;Name</strong> : Names not specified </p>
<p><strong>Location type</strong> : Study Cluster/ Health Facility</p>
<p><strong>Description</strong> : <span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">58 study clusters each with a health center sites in Pakistan, Kenya, Zambia, Democratic Republic of Congo and Guatemala,</span></span></p>
<p><strong>Sample size :</strong></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_FFCQ6D5U" class="item journalArticle">
			<h2>Gestational weight gain during the second and third trimesters 
and adverse pregnancy outcomes, results from a prospective pregnancy 
cohort in urban Tanzania.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Yang J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Wang M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Tobias DK</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Rich-Edwards JW</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Darling AM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Abioye AI</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Pembe AB</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Madzorera I</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Fawzi WW</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Appropriate gestational weight gain (GWG) is 
important for optimal pregnancy outcomes. This study prospectively 
evaluated the associations between GWG during the second and third 
trimesters of pregnancy and adverse pregnancy outcomes in an urban 
Tanzanian pregnancy cohort. METHODS: We used data from a randomized 
clinical trial conducted among pregnant women recruited by 27 weeks of 
gestation in Dar es Salaam, Tanzania (N = 1230). Women's gestational 
weight was measured at baseline and at monthly antenatal visits. Weekly 
GWG rate during the second and third trimesters was calculated and 
characterized as inadequate, adequate, or excessive, in conjunction with
 measured or imputed early-pregnancy BMI status according to the 2009 
Institute of Medicine (IOM) GWG guidelines. We used multivariable 
Poisson regression with a sandwich variance estimator to calculate risk 
ratios (RR) for associations of GWG with low birth weight, preterm 
birth, small for gestational age (SGA), and large for gestational age 
(LGA). Degree of appropriate GWG defined using additional metrics (i.e.,
 percentage of adequacy, z-score) and potential effect modification by 
maternal BMI were additionally evaluated. RESULTS: According to the IOM 
guidelines, 517 (42.0%), 270 (22.0%), and 443 (36.0%) women were 
characterized as having inadequate, adequate, and excessive GWG, 
respectively. Overall, compared to women with adequate GWG, women with 
inadequate GWG had a lower risk of LGA births (RR = 0.54, 95% CI: 
0.36-0.80) and a higher risk of SGA births (RR = 1.32, 95% CI: 
0.95-1.81). Women with inadequate GWG as defined by percentage of GWG 
adequacy had a higher risk of LBW (OR = 1.93, 95% CI: 1.03-3.63). In 
stratified analyses by early-pregnancy BMI, excessive GWG among women 
with normal BMI was associated with a higher risk of preterm birth (RR =
 1.59, 95% CI: 1.03-2.44). CONCLUSIONS: A comparatively high percentage 
of excessive GWG was observed among healthy pregnant women in Tanzania. 
Both inadequate and excessive GWGs were associated with elevated risks 
of poor pregnancy outcomes. Future studies among diverse SSA populations
 are warranted to confirm our findings, and clinical recommendations on 
optimal GWG should be developed to promote healthy GWG in SSA settings. 
TRIAL REGISTRATION: This trial was registered as "Prenatal Iron 
Supplements: Safety and Efficacy in Tanzania" (NCT01119612; 
http://clinicaltrials.gov/show/NCT01119612 ).</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2022-06</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>19</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>140</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Reproductive health</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/s12978-022-01441-7">10.1186/s12978-022-01441-7</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1742-4755 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Infant, Newborn</li>
					<li>Prospective Studies</li>
					<li>Male</li>
					<li>Pregnancy Outcome/epidemiology</li>
					<li>Pregnancy Trimester, Third</li>
					<li>Tanzania</li>
					<li>Tanzania/epidemiology</li>
					<li>*Premature Birth/epidemiology</li>
					<li>*Gestational Weight Gain</li>
					<li>Body Mass Index</li>
					<li>Weight Gain</li>
					<li>Gestational weight gain</li>
					<li>Fetal Growth Retardation</li>
					<li>*Pregnancy Complications/epidemiology</li>
					<li>Adverse birth outcomes</li>
					<li>Institute of Medicine (U.S.)</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_D6AZT9Q6">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location name : </strong></p>
<p>Specific names of clinics and hospitals not given</p>
<p><strong>Location Type: </strong>Health Facilities</p>
<p><strong>Description</strong> :Conducted &nbsp;<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">in health facilities in Dar es Salaam, Tanzania</span></span></p>
<p><strong>Sample size</strong> : 1230</p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_QUMEJ237" class="item journalArticle">
			<h2>Ghana randomized air pollution and health study (GRAPHS): study protocol for a randomized controlled trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Jack DW</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Asante KP</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Wylie BJ</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chillrud SN</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Whyatt RM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ae-Ngibise KA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Quinn AK</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Yawson AK</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Boamah EA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Agyei O</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mujtaba M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kaali S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kinney P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Owusu-Agyei S</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Household air pollution exposure is a major health
 risk, but validated interventions remain elusive. METHODS/DESIGN: The 
Ghana Randomized Air Pollution and Health Study (GRAPHS) is a 
cluster-randomized trial that evaluates the efficacy of clean fuels 
(liquefied petroleum gas, or LPG) and efficient biomass cookstoves in 
the Brong-Ahafo region of central Ghana. We recruit pregnant women into 
LPG, efficient cookstove, and control arms and track birth weight and 
physician-assessed severe pneumonia incidence in the first year of life.
 A woman is eligible to participate if she is in the first or second 
trimester of pregnancy and carrying a live singleton fetus, if she is 
the primary cook, and if she does not smoke. We hypothesize that babies 
born to intervention mothers will weigh more and will have fewer cases 
of physician-assessed severe pneumonia in the first year of life. 
Additionally, an extensive personal air pollution exposure monitoring 
effort opens the way for exposure-response analyses, which we will 
present alongside intention-to-treat analyses. Major funding was 
provided by the National Institute of Environmental Health Sciences, The
 Thrasher Research Fund, and the Global Alliance for Clean Cookstoves. 
DISCUSSION: Household air pollution exposure is a major health risk that
 requires well-tested interventions. GRAPHS will provide important new 
evidence on the efficacy of both efficient biomass cookstoves and LPG, 
and will thus help inform health and energy policies in developing 
countries. TRIAL REGISTRATION: The trial was registered with 
clinicaltrials.gov on 13 April 2011 with the identifier NCT01335490 .</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2015-09</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>16</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>420</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Trials</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/s13063-015-0930-8">10.1186/s13063-015-0930-8</a></td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1745-6215 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:25 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:25 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Incidence</li>
					<li>Pregnancy</li>
					<li>Birth Weight</li>
					<li>Infant, Newborn</li>
					<li>Risk Factors</li>
					<li>Ghana/epidemiology</li>
					<li>Infant</li>
					<li>Time Factors</li>
					<li>Research Design</li>
					<li>*Biomass</li>
					<li>*Housing</li>
					<li>Air Pollution, Indoor/*adverse effects/prevention &amp; control</li>
					<li>Cooking/*instrumentation</li>
					<li>Equipment Design</li>
					<li>Gases</li>
					<li>Inhalation Exposure/*adverse effects/prevention &amp; control</li>
					<li>Petroleum/*adverse effects</li>
					<li>Pneumonia/diagnosis/epidemiology</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_E8HMSXGF">
<div><div data-schema-version="8"><p>Location &nbsp;information</p>
<p><strong>Location Name</strong> : Names not specified</p>
<p><strong>Location Type</strong> :<span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)"> Rural communities&nbsp;&nbsp;</span></span></p>
<p><strong>Description</strong> : <span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">Thirty-five
 rural communities&nbsp;&nbsp; in Kintampo North and South districts, 
Brong-Ahafo region of central Ghana, West Africa.</span></span></p>
<p><strong>Sample size</strong> : <span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">1225&nbsp;</span></span></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_T96Z3STP" class="item journalArticle">
			<h2>Goodstart: a cluster randomised effectiveness trial of an 
integrated, community-based package for maternal and newborn care, with 
prevention of mother-to-child transmission of HIV in a South African 
township.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Tomlinson M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Doherty T</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ijumba P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Jackson D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Lawn J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Persson LA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Lombard C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sanders D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Daviaud E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Nkonki L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Goga A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Rohde S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sitrin D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Colvin M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chopra M</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Progress towards MDG4 for child survival in South 
Africa requires effective prevention of mother-to-child transmission 
(PMTCT) of HIV including increasing exclusive breastfeeding, as well as a
 new focus on reducing neonatal deaths. This necessitates increased 
focus on the pregnancy and early post-natal periods, developing and 
scaling up appropriate models of community-based care, especially to 
reach the peri-urban poor. METHODS: We used a randomised controlled 
trial with 30 clusters (15 in each arm) to evaluate an integrated, 
scalable package providing two pregnancy visits and five post-natal home
 visits delivered by community health workers in Umlazi, Durban, South 
Africa. Primary outcomes were exclusive and appropriate infant feeding 
at 12 weeks post-natally and HIV-free infant survival. RESULTS: At 12 
weeks of infant age, the intervention was effective in almost doubling 
the rate of exclusive breastfeeding (risk ratio 1.92; 95% CI: 1.59-2.33)
 and increasing infant weight and length-for-age z-scores (weight 
difference 0.09; 95% CI: 0.00-0.18, length difference 0.11; 95% CI: 
0.03-0.19). No difference was seen between study arms in HIV-free 
survival. Women in the intervention arm were also more likely to take 
their infant to the clinic within the first week of life (risk ratio 
1.10; 95% CI: 1.04-1.18). CONCLUSIONS: The trial coincided with national
 scale up of ARVs for PMTCT, and this could have diluted the effect of 
the intervention on HIV-free survival. We have demonstrated that 
implementation of a pro-poor integrated PMTCT and maternal, neonatal and
 child health home visiting model is feasible and effective. This trial 
could inform national primary healthcare reengineering strategies in 
favour of home visits. The dose effect on exclusive breastfeeding is 
notable as improving exclusive breastfeeding has been resistant to 
change in other studies targeting urban poor families.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2014-03</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>19</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>256-266</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Tropical medicine &amp; international health : TM &amp; IH</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1111/tmi.12257">10.1111/tmi.12257</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>3</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1360-2276 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Infant, Newborn</li>
					<li>Young Adult</li>
					<li>Poverty</li>
					<li>Child, Preschool</li>
					<li>Infant</li>
					<li>Infectious Disease Transmission, Vertical/*prevention &amp; control</li>
					<li>South Africa</li>
					<li>South Africa/epidemiology</li>
					<li>Adolescent</li>
					<li>Cluster Analysis</li>
					<li>Infant Mortality</li>
					<li>Health Knowledge, Attitudes, Practice</li>
					<li>HIV</li>
					<li>*Community Health Workers</li>
					<li>Outcome Assessment, Health Care</li>
					<li>Program Evaluation</li>
					<li>Survival Rate</li>
					<li>Linear Models</li>
					<li>Breast Feeding/*statistics &amp; numerical data</li>
					<li>newborn</li>
					<li>*Community Health Services</li>
					<li>community health worker</li>
					<li>community-based</li>
					<li>Depression, Postpartum/epidemiology</li>
					<li>HIV Infections/epidemiology/*prevention &amp; control/transmission</li>
					<li>House Calls</li>
					<li>integrated</li>
					<li>Maternal Health Services/*methods</li>
					<li>post-natal care</li>
					<li>prevent mother-to-child transmission (PMTCT)</li>
					<li>primary health care</li>
					<li>Urban Population/statistics &amp; numerical data</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_APRC4A5A">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location Name</strong> : </p>
<p>Umlazi</p>
<p><strong>Location Type</strong> : </p>
<p>Community</p>
<p><strong>Description</strong> : &nbsp;</p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Conducted in Umlazi, a periurban settlement near Durban, KwaZulu-Natal, South Africa.</span></span></p>
<p><strong>Sample size</strong> : 3,957</p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_LTZ2LEUK" class="item journalArticle">
			<h2>Group versus individual antenatal and first year postpartum care:
 Study protocol for a multi-country cluster randomized controlled trial 
in Kenya and Nigeria.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kabue MM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Grenier L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Suhowatsky S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Oyetunji J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ugwa E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Onguti B</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Omanga E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gichangi A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Wambua J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Waka C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Enne J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Don-Aki J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ali M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Buba M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ang'aha J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Iya D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Washika E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mohan D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Smith JM</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>Background: Antenatal care (ANC) in many low- and 
middle-income countries is under-utilized and of sub-optimal quality. 
Group ANC (G-ANC) is an intervention designed to improve the experience 
and provision of ANC for groups of women (cohorts) at similar stages of 
pregnancy. Methods: A two-arm, two-phase, cluster randomized controlled 
trial (cRCT) (non-blinded) is being conducted in Kenya and Nigeria. 
Public health facilities were matched and randomized to either standard 
individual ANC (control) or G-ANC (intervention) prior to enrollment. 
Participants include pregnant women attending first ANC at gestational 
age &lt;24 weeks, health care providers, and sub-national health 
managers. Enrollment ended in June 2017 for both countries. In the 
intervention arm, pregnant women are assigned to cohorts at first ANC 
visit and receive subsequent care together during five meetings 
facilitated by a health care provider (Phase 1). After birth, the same 
cohorts meet four times over 12 months with their babies (Phase 2). Data
 collection was performed through surveys, clinical data extraction, 
focus group discussions, and in-depth interviews. Phase 1 data 
collection ended in January 2018 and Phase 2 concludes in November 2018.
 Intention-to-treat analysis will be used to evaluate primary outcomes 
for Phases 1 and 2: health facility delivery and use of a modern method 
of family planning at 12 months postpartum, respectively. Data analysis 
and reporting of results will be consistent with norms for cRCTs. 
General estimating equation models that account for clustering will be 
employed for primary outcome analyzes. Results: Overall 1,075 and 1,013 
pregnant women were enrolled in Nigeria and Kenya, respectively. Final 
study results will be available in February 2019. Conclusions: This is 
the first cRCT on G-ANC in Africa. It is among the first to examine the 
effects of continuing group care through the first year postpartum. 
Registration: Pan African Clinical Trials Registry PACTR201706002254227 
May 02, 2017.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2018</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>2</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>56</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Gates open research</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.12688/gatesopenres.12867.2">10.12688/gatesopenres.12867.2</a></td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>2572-4754 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:30 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:30 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Nigeria</li>
					<li>Kenya</li>
					<li>experience of care</li>
					<li>facility-based delivery</li>
					<li>Group antenatal care</li>
					<li>health literacy</li>
					<li>postpartum family planning</li>
					<li>self-efficacy</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_ERJGLNND">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name</strong> : </p>
<p><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">Machakos and Kisumu</span></span></p>
<p><strong>Location Type</strong> : </p>
<p><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">Counties </span></span></p>
<p><strong>Description</strong> :</p>
<p> <span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">Machakos and Kisumu Counties in Kenya and in Nasarawa State, Nigeria</span></span></p>
<p><strong>Sample size : 2,088</strong></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_WFYFJ2Z4" class="item journalArticle">
			<h2>Growth effects of exclusive breastfeeding promotion by peer 
counsellors in sub-Saharan Africa: the cluster-randomised PROMISE EBF 
trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Engebretsen IM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Jackson D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Fadnes LT</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Nankabirwa V</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Diallo AH</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Doherty T</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Lombard C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Swanvelder S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Nankunda J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ramokolo V</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sanders D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Wamani H</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Meda N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Tumwine JK</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ekstrom EC</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Van de Perre P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kankasa C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sommerfelt H</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Tylleskar T</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: In this multi-country cluster-randomized 
behavioural intervention trial promoting exclusive breastfeeding (EBF) 
in Africa, we compared growth of infants up to 6 months of age living in
 communities where peer counsellors promoted EBF with growth in those 
infants living in control communities. METHODS: A total of 82 clusters 
in Burkina Faso, Uganda and South Africa were randomised to either the 
intervention or the control arm. Feeding data and anthropometric 
measurements were collected at visits scheduled 3, 6, 12 and 24 weeks 
post-partum. We calculated weight-for-length (WLZ), length-for-age (LAZ)
 and weight-for-age (WAZ) z-scores. Country specific adjusted Least 
Squares Means with 95% confidence intervals (CI) based on a longitudinal
 analysis are reported. Prevalence ratios (PR) for the association 
between peer counselling for EBF and wasting (WLZ &lt; -2), stunting 
(LAZ &lt; -2) and underweight (WAZ &lt; -2) were calculated at each data
 collection point. RESULTS: The study included a total of 2,579 
children. Adjusting for socio-economic status, the mean WLZ at 24 weeks 
were in Burkina Faso -0.20 (95% CI -0.39 to -0.01) and in Uganda -0.23 
(95% CI -0.43 to -0.03) lower in the intervention than in the control 
arm. In South Africa the mean WLZ at 24 weeks was 0.23 (95% CI 0.03 to 
0.43) greater in the intervention than in the control arm. Differences 
in LAZ between the study arms were small and not statistically 
significant. In Uganda, infants in the intervention arm were more likely
 to be wasted compared to those in the control arm at 24 weeks (PR 2.36;
 95% CI 1.11 to 5.00). Differences in wasting in South Africa and 
Burkina Faso and stunting and underweight in all three countries were 
small and not significantly different. CONCLUSIONS: There were small 
differences in mean anthropometric indicators between the intervention 
and control arms in the study, but in Uganda and Burkina Faso, a 
tendency to slightly lower ponderal growth (weight-for-length z-scores) 
was found in the intervention arms. TRIAL REGISTRATION NUMBER: 
ClinicalTrials.gov: NCT00397150.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2014-06</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>14</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>633</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>BMC public health</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/1471-2458-14-633">10.1186/1471-2458-14-633</a></td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1471-2458 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:30 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:30 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Uganda/epidemiology</li>
					<li>Young Adult</li>
					<li>Male</li>
					<li>Prevalence</li>
					<li>Child, Preschool</li>
					<li>Infant</li>
					<li>Postpartum Period</li>
					<li>South Africa/epidemiology</li>
					<li>Counseling</li>
					<li>*Breast Feeding/statistics &amp; numerical data</li>
					<li>*Growth</li>
					<li>*Health Promotion</li>
					<li>*Peer Group</li>
					<li>Body Weight</li>
					<li>Burkina Faso/epidemiology</li>
					<li>Growth Disorders/epidemiology/*prevention &amp; control</li>
					<li>Residence Characteristics</li>
					<li>Thinness/epidemiology/*prevention &amp; control</li>
					<li>Wasting Syndrome/epidemiology/*prevention &amp; control</li>
					<li>Weight Gain</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_LPA8A55P">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name : &nbsp;</strong></p>
<p><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">Banfora, Bungokho, Paarl, Umlazi</span></span></p>
<p><strong>Location Type : </strong></p>
<p>Rural community</p>
<p><strong>Description : </strong></p>
<p><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">82 clusters in Burkina Faso, Uganda and South Africa&nbsp;</span></span></p>
<p><strong>Sample Size :</strong> <span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">&nbsp;2,579</span></span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_98XGFXSZ" class="item journalArticle">
			<h2>HIV self-testing alone or with additional interventions, 
including financial incentives, and linkage to care or prevention among 
male partners of antenatal care clinic attendees in Malawi: An adaptive 
multi-arm, multi-stage cluster randomised trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Choko AT</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Corbett EL</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Stallard N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Maheswaran H</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Lepine A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Johnson CC</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sakala D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kalua T</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kumwenda M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hayes R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Fielding K</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Conventional HIV testing services have been less 
comprehensive in reaching men than in reaching women globally, but HIV 
self-testing (HIVST) appears to be an acceptable alternative. 
Measurement of linkage to post-test services following HIVST remains the
 biggest challenge, yet is the biggest driver of cost-effectiveness. We 
investigated the impact of HIVST alone or with additional interventions 
on the uptake of testing and linkage to care or prevention among male 
partners of antenatal care clinic attendees in a novel adaptive trial. 
METHODS AND FINDINGS: An adaptive multi-arm, 2-stage cluster randomised 
trial was conducted between 8 August 2016 and 30 June 2017, with 
antenatal care clinic (ANC) days (i.e., clusters of women attending on a
 single day) as the unit of randomisation. Recruitment was from 
Ndirande, Bangwe, and Zingwangwa primary health clinics in urban 
Blantyre, Malawi. Women attending an ANC for the first time for their 
current pregnancy (regardless of trimester), 18 years and older, with a 
primary male partner not known to be on ART were enrolled in the trial 
after giving consent. Randomisation was to either the standard of care 
(SOC; with a clinic invitation letter to the male partner) or 1 of 5 
intervention arms: the first arm provided women with 2 HIVST kits for 
their partners; the second and third arms provided 2 HIVST kits along 
with a conditional fixed financial incentive of $3 or $10; the fourth 
arm provided 2 HIVST kits and a 10% chance of receiving $30 in a 
lottery; and the fifth arm provided 2 HIVST kits and a phone call 
reminder for the women's partners. The primary outcome was the 
proportion of male partners who were reported to have tested for HIV and
 linked into care or prevention within 28 days, with referral for 
antiretroviral therapy (ART) or circumcision accordingly. Women were 
interviewed at 28 days about partner testing and adverse events. 
Cluster-level summaries compared each intervention versus SOC using 
eligible women as the denominator (intention-to-treat). Risk ratios were
 adjusted for male partner testing history and recruitment clinic. A 
total of 2,349/3,137 (74.9%) women participated (71 ANC days), with a 
mean age of 24.8 years (SD: 5.4). The majority (2,201/2,233; 98.6%) of 
women were married, 254/2,107 (12.3%) were unable to read and write, and
 1,505/2,247 (67.0%) were not employed. The mean age for male partners 
was 29.6 years (SD: 7.5), only 88/2,200 (4.0%) were unemployed, and 
966/2,210 (43.7%) had never tested for HIV before. Women in the SOC arm 
reported that 17.4% (71/408) of their partners tested for HIV, whereas a
 much higher proportion of partners were reported to have tested for HIV
 in all intervention arms (87.0%-95.4%, p &lt; 0.001 in all 5 
intervention arms). As compared with those who tested in the SOC arm 
(geometric mean 13.0%), higher proportions of partners met the primary 
endpoint in the HIVST + $3 (geometric mean 40.9%, adjusted risk ratio 
[aRR] 3.01 [95% CI 1.63-5.57], p &lt; 0.001), HIVST + $10 (51.7%, aRR 
3.72 [95% CI 1.85-7.48], p &lt; 0.001), and phone reminder (22.3%, aRR 
1.58 [95% CI 1.07-2.33], p = 0.021) arms. In contrast, there was no 
significant increase in partners meeting the primary endpoint in the 
HIVST alone (geometric mean 17.5%, aRR 1.45 [95% CI 0.99-2.13], p = 
0.130) or lottery (18.6%, aRR 1.43 [95% CI 0.96-2.13], p = 0.211) arms. 
The lottery arm was dropped at interim analysis. Overall, 46 male 
partners were confirmed to be HIV positive, 42 (91.3%) of whom initiated
 ART within 28 days; 222 tested HIV negative and were not already 
circumcised, of whom 135 (60.8%) were circumcised as part of the trial. 
No serious adverse events were reported. Costs per male partner who 
attended the clinic with a confirmed HIV test result were $23.73 and 
$28.08 for the HIVST + $3 and HIVST + $10 arms, respectively. Notable 
limitations of the trial included the relatively small number of 
clusters randomised to each arm, proxy reporting of the male partner 
testing outcome, and being unable to evaluate retention in care. 
CONCLUSIONS: In this study, the odds of men's linkage to care or 
prevention increased substantially using conditional fixed financial 
incentives plus partner-delivered HIVST; combinations were potentially 
affordable. TRIAL REGISTRATION: ISRCTN 18421340.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2019-01</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>16</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e1002719</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>PLoS medicine</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1371/journal.pmed.1002719">10.1371/journal.pmed.1002719</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1549-1277 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Malawi/epidemiology</li>
					<li>Pregnancy</li>
					<li>Young Adult</li>
					<li>Male</li>
					<li>*Motivation</li>
					<li>*Continuity of Patient Care</li>
					<li>*Prenatal Care/methods</li>
					<li>*Self Care/methods/psychology</li>
					<li>AIDS Serodiagnosis/*methods</li>
					<li>HIV Infections/*diagnosis/epidemiology/prevention &amp; control/therapy</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_8SE4LTAU">
<div><div data-schema-version="8"><p><strong>Location Information:</strong></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Name:</span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">names of health facilities not frovided</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Type:</span></span></strong></p>
<p><strong><span style="color: black"><span style="background-color: white"> </span></span></strong><span style="color: black"><span style="background-color: white">Health facilities</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Description:</span></span></strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Conducted at three primary health clinics in Blantyre, Malawi</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Sample size : </span></span></strong><span style="color: black"><span style="background-color: white">2349</span></span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_BRXIEKD4" class="item journalArticle">
			<h2>Household fuel use and adverse pregnancy outcomes in a Ghanaian cohort study.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Weber E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Adu-Bonsaffoh K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Vermeulen R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Klipstein-Grobusch K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Grobbee DE</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Browne JL</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Downward GS</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Accruing epidemiological evidence suggests that 
prenatal exposure to emissions from cooking fuel is associated with 
increased risks of adverse maternal and perinatal outcomes including 
hypertensive disorders of pregnancy, low birth weight, stillbirth and 
infant mortality. We aimed to investigate the relationship between 
cooking fuel use and various pregnancy related outcomes in a cohort of 
urban women from the Accra region of Ghana. METHODS: Self-reported 
cooking fuel use was divided into "polluting" (wood, charcoal, crop 
residue and kerosene) and "clean" fuels (liquid petroleum gas and 
electricity) to examine 12 obstetric outcomes in a prospective cohort of
 pregnant women (N = 1010) recruited at &lt; 17 weeks of gestation from 
Accra, Ghana. Logistic and multivariate linear regression analyses 
adjusted for BMI, maternal age, maternal education and socio-economic 
status asset index was conducted. RESULTS: 34% (n = 279) of 819 women 
with outcome data available for analysis used polluting fuel as their 
main cooking fuel. Using polluting cooking fuels was associated with 
perinatal mortality (aOR: 7.6, 95%CI: 1.67-36.0) and an adverse Apgar 
score (&lt; 7) at 5 min (aOR:3.83, 95%CI: (1.44-10.11). The other 
outcomes (miscarriage, post-partum hemorrhage, pre-term birth, low 
birthweight, caesarian section, hypertensive disorders of pregnancy, 
small for gestational age, and Apgar score at 1 min) had 
non-statistically significant findings. CONCLUSIONS: We report an 
increased likelihood of perinatal mortality, and adverse 5-min Apgar 
scores in association with polluting fuel use. Further research 
including details on extent of household fuel use exposure is 
recommended to better quantify the consequences of household fuel use. 
STUDY REGISTRATION: Ghana Service Ethical Review Committee (GHS-ERC #: 
07-9-11).</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2020-02</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 1
Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>17</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>29</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Reproductive health</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/s12978-020-0878-3">10.1186/s12978-020-0878-3</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1742-4755 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:31 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:31 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Pregnancy outcomes</li>
					<li>Perinatal mortality</li>
					<li>Apgar score</li>
					<li>Cooking fuel</li>
					<li>Perinatal outcomes</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_LQRISEQB">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name</strong> : </p>
<p>Facility names</p>
<p><strong>Location Type</strong> : Health Facility</p>
<p><strong>Description</strong> : </p>
<p>Two public hospitals in Accra, capital city of Ghana</p>
<p><strong>sample size</strong> : 1010</p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_T5EG8HJK" class="item journalArticle">
			<h2>Hypertensive disorders in primigravid black South African women: A one-year descriptive analysis.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Moodley J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Onyangunga OA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Maharaj NR</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>OBJECTIVE: To describe the incidence and obstetric and 
perinatal outcomes in primigravid Black South Africans with hypertensive
 disorders of pregnancy (HDP). METHOD: All primigravidae who booked for 
antenatal care were followed up until hospital discharge. Relevant 
clinical and demographic data were collected in structured data forms. 
RESULTS: A total of 5860 primigravidae delivered during the study 
period. Of these, 731 had an HDP, giving an incidence of 12.5%. The 
diagnosis of gestational hypertension was made in 6.7% of all 
primigravidae but was the commonest HDP subcategory (n = 394/731; 
53.9%). On the other hand, mild to moderate preeclampsia or non-severe 
preeclampsia, severe preeclampsia, and eclampsia occurred in 222, 84, 
and 31 of the 5860 primigravidae, respectively. Therefore, 
preeclampsia-eclampsia syndrome occurred in 337/5860 or 5.75% of the 
study population. Severe preeclampsia occurred in 1.43% (84/5860) of the
 primigravidae. The rates of caesarean deliveries in women with 
preeclampsia were approximately 50%. There were no perinatal deaths in 
the gestational hypertension group, but the overall perinatal mortality 
rate in all preeclamptics was 5.9%, in comparison to 2.2% in all 
primigravidae. CONCLUSION: Hypertensive disorders of pregnancy developed
 in 12.5% (n = 731/5860) of primigravidae seen over a one-year period. 
Gestational hypertension comprised the commonest subcategory of the HDP 
and there were no perinatal deaths in this group.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2016-11</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>35</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>529-535</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Hypertension in pregnancy</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1080/10641955.2016.1193190">10.1080/10641955.2016.1193190</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>4</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1064-1955 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Incidence</li>
					<li>Pregnancy</li>
					<li>Young Adult</li>
					<li>Prevalence</li>
					<li>Pregnancy Outcome</li>
					<li>South Africa/epidemiology</li>
					<li>*Parity</li>
					<li>Hypertensive disorders of pregnancy</li>
					<li>*African Continental Ancestry Group</li>
					<li>Hypertension, Pregnancy-Induced/epidemiology/*ethnology</li>
					<li>obstetric outcomes</li>
					<li>primigravidae</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_6HDHPV5V">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location Name</strong> : </p>
<p>Name of facility not supplied</p>
<p><strong>Location Type :</strong> </p>
<p>Health facility</p>
<p><strong>Description :</strong> &nbsp;</p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Conducted in South Africa, specifically among primigravid Black South Africans.</span></span></p>
<p><strong>Sample size :</strong> 731</p>
<p></p>
<p></p>
<p></p>
<p></p>
<p></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_9CCLKL5U" class="item journalArticle">
			<h2>Impact of Mother-Infant Pair Clinics and Short-Text Messaging 
Service (SMS) Reminders on Retention of HIV-Infected Women and 
HIV-Exposed Infants in eMTCT Care in Malawi: A Cluster Randomized Trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mwapasa V</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Joseph J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Tchereni T</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Jousset A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gunda A</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Poor retention of mothers and HIV-exposed infants 
(HEIs) in HIV care threatens efforts to eliminate pediatric HIV. Novel 
strategies are required to address this challenge. We compared 12-month 
maternal and HEI postpartum retention in health facilities implementing 
the following HIV care delivery models: integrated HIV and maternal, 
neonatal, and child health services [mother-infant pair (MIP) clinics], 
MIP clinics plus short-text messaging service (SMS) reminders to prevent
 default (MIP + SMS), and standard of care (SOC). METHODS: From May 2013
 to August 2016, a cluster randomized trial was conducted in rural 
Malawi, which randomized 30 health facilities to the 3 service delivery 
models. HIV+ pregnant women and HEIs were enrolled and followed up to 
monitor compliance with prescheduled visits and retention. Log binomial 
regression, using generalized estimated equation, was used to assess the
 impact of the models on retention. RESULTS: The trial enrolled 461, 
493, and 396 HIV+ pregnant women and 386, 399, and 300 HEIs into the 
MIP, MIP + SMS, and SOC arms, respectively. Compared with the 12-month 
maternal retention rate in the SOC arm (22.2%), the rates were similar 
in the MIP arm [19.3%, risk ratio (RR): 0.85, 95% confidence interval 
(CI): 0.56 to 1.30] and in the MIP + SMS arm (24.9%, RR: 1.08, 95% CI: 
0.87 to 1.35). Compared with the 12-month infant retention rate in the 
SOC arm (9.8%), the rates were similar in the MIP arm (8.0%, RR: 0.89, 
95% CI: 0.31 to 2.58) and in the MIP + SMS arm (19.5%, RR: 1.40, 95% CI:
 0.85 to 2.31). CONCLUSIONS: MIP and MIP + SMS service delivery models 
were ineffective in improving maternal and infant retention in rural 
Malawi.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2017-06</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>75 Suppl 2</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>S123-S131</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Journal of acquired immune deficiency syndromes (1999)</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1097/QAI.0000000000001340">10.1097/QAI.0000000000001340</a></td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1525-4135 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Infant</li>
					<li>Infectious Disease Transmission, Vertical/*prevention &amp; control</li>
					<li>Malawi</li>
					<li>Postpartum Period</li>
					<li>Cluster Analysis</li>
					<li>Anti-HIV Agents/*therapeutic use</li>
					<li>Health Services Accessibility</li>
					<li>*Mothers</li>
					<li>Pregnancy Complications, Infectious/drug therapy/*prevention &amp; control</li>
					<li>*Text Messaging</li>
					<li>HIV Infections/complications/*drug therapy/transmission</li>
					<li>Patient Compliance/*statistics &amp; numerical data</li>
					<li>Standard of Care</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_ZHAGIW6D">
<div><div data-schema-version="8"><p><strong>Location Information:</strong></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Name: </span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">Facility names not specified</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Type: </span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">Health facilities</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Description:</span></span></strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Conducted in Salima and Mangochi districts, located in central and southern Malawi, respectively</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Sample size : &nbsp;1350</span></span></strong></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_SPSQYXDS" class="item journalArticle">
			<h2>Impact of Sulfadoxine-Pyrimethamine Resistance on Effectiveness 
of Intermittent Preventive Therapy for Malaria in Pregnancy at Clearing 
Infections and Preventing Low Birth Weight.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Desai M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gutman J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Taylor SM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Wiegand RE</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Khairallah C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kayentao K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ouma P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Coulibaly SO</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kalilani L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mace KE</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Arinaitwe E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mathanga DP</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Doumbo O</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Otieno K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Edgar D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chaluluka E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kamuliwo M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ades V</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Skarbinski J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Shi YP</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Magnussen P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Meshnick S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ter Kuile FO</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Owing to increasing sulfadoxine-pyrimethamine (SP)
 resistance in sub-Saharan Africa, monitoring the effectiveness of 
intermittent preventive therapy in pregnancy (IPTp) with SP is crucial. 
METHODS: Between 2009 and 2013, both the efficacy of IPTp-SP at clearing
 existing peripheral malaria infections and the effectiveness of IPTp-SP
 at reducing low birth weight (LBW) were assessed among human 
immunodeficiency virus-uninfected participants in 8 sites in 6 
countries. Sites were classified as high, medium, or low resistance 
after measuring parasite mutations conferring SP resistance. An 
individual-level prospective pooled analysis was conducted. RESULTS: 
Among 1222 parasitemic pregnant women, overall polymerase chain 
reaction-uncorrected and -corrected failure rates by day 42 were 21.3% 
and 10.0%, respectively (39.7% and 21.1% in high-resistance areas; 4.9% 
and 1.1% in low-resistance areas). Median time to recurrence decreased 
with increasing prevalence of Pfdhps-K540E. Among 6099 women at 
delivery, IPTp-SP was associated with a 22% reduction in the risk of LBW
 (prevalence ratio [PR], 0.78; 95% confidence interval [CI], .69-.88; P 
&lt; .001). This association was not modified by insecticide-treated net
 use or gravidity, and remained significant in areas with high SP 
resistance (PR, 0.81; 95% CI, .67-.97; P = .02). CONCLUSIONS: The 
efficacy of SP to clear peripheral parasites and prevent new infections 
during pregnancy is compromised in areas with &gt;90% prevalence of 
Pfdhps-K540E. Nevertheless, in these high-resistance areas, IPTp-SP use 
remains associated with increases in birth weight and maternal 
hemoglobin. The effectiveness of IPTp in eastern and southern Africa is 
threatened by further increases in SP resistance and reinforces the need
 to evaluate alternative drugs and strategies for the control of malaria
 in pregnancy.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2016-02</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 3
Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>62</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>323-333</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1093/cid/civ881">10.1093/cid/civ881</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>3</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1058-4838 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:44 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:44 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Infant, Newborn</li>
					<li>Prospective Studies</li>
					<li>Young Adult</li>
					<li>Drug Combinations</li>
					<li>Pregnancy Complications, Infectious/*prevention &amp; control</li>
					<li>*Drug Resistance</li>
					<li>*Infant, Low Birth Weight</li>
					<li>Africa South of the Sahara/epidemiology</li>
					<li>Amino Acid Substitution</li>
					<li>Antimalarials/administration &amp; dosage/*pharmacology</li>
					<li>Dihydropteroate Synthase/genetics</li>
					<li>Drug Therapy/methods</li>
					<li>effectiveness</li>
					<li>intermittent preventive treatment</li>
					<li>malaria in pregnancy</li>
					<li>Malaria/complications/*prevention &amp; control</li>
					<li>Mutant Proteins/genetics</li>
					<li>Plasmodium falciparum/enzymology</li>
					<li>Pyrimethamine/administration &amp; dosage/*pharmacology</li>
					<li>sulfadoxine-pyrimethamine resistance</li>
					<li>Sulfadoxine/administration &amp; dosage/*pharmacology</li>
					<li>Treatment Outcome</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_47S99DIM">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location Name</strong> :</p>
<p> Site Name not specified</p>
<p><strong>Location Type</strong> : </p>
<p>Study Site</p>
<p><strong>Description</strong> :</p>
<p> <span style="color: rgb(42, 42, 42)"><span style="background-color: rgb(255, 255, 255)">8
 sites in 6 countries: 2 countries in West Africa Mali &nbsp;and Burkina
 Faso &nbsp;and 4 in eastern and southern Africa, Mansa, Zambia, 
Machinga District, Malawi, Tororo, Uganda, and western Kenya</span></span></p>
<p><strong>Sample size : </strong>1222</p>
</div></div>
					</li>
				</ul>
				<h3 class="attachments">Attachments</h3>
				<ul class="attachments">
					<li id="item_5W4SJTZ7">Full Text					</li>
				</ul>
			</li>


			<li id="item_LWIXVCBL" class="item journalArticle">
			<h2>Impact of universal home visits on child health in Bauchi State, Nigeria: a stepped wedge cluster randomised controlled trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Omer K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Joga A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Dutse U</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hasan K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Aziz A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ansari U</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gidado Y</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Baba MC</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gamawa AI</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mohammad R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Andersson N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Cockcroft A</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Nigeria is the second biggest contributor to 
global child mortality. Infectious diseases continue to be major 
killers. In Bauchi State, Nigeria, a stepped wedge cluster randomised 
controlled trial tested the health impacts of universal home visits to 
pregnant women and their spouses. We present here the findings related 
to early child health. METHODS: The home visits took place in eight 
wards in Toro Local Government Authority, randomly allocated into four 
waves with a delay of 1 year between waves. Female and male home 
visitors visited all pregnant women and their spouses every 2 months 
during pregnancy, with a follow up visit 12-18 months after the birth. 
They presented and discussed evidence about household prevention and 
management of diarrhoea and immunisation. We compared outcomes among 
children 12-18 months old born to mothers visited during the first year 
of intervention in each wave (intervention group) with those among 
children 12-18 months old pre-intervention in subsequent waves (control 
group). Primary outcomes included prevalence and management of childhood
 diarrhoea and immunisation status, with intermediate outcomes of 
household knowledge and actions. Generalised Estimating Equations (GEE),
 with an exchangeable correlation matrix and ward as cluster, tested the
 significance of differences in outcomes. RESULTS: The analysis included
 1796 intervention and 5109 control children. In GEE models including 
other characteristics of the children, intervention children were less 
likely to have suffered diarrhoea in the last 15 days (Odds Ratio (OR) 
0.40, 95% confidence interval (CI) 0.30-0.53) and more likely to have 
received increased fluids and continued feeding in their last episode of
 diarrhoea (OR 6.06, 95% CI 2.58-14.20). Mothers of intervention 
children were more likely to identify lack of hygiene as a cause of 
diarrhoea (OR 2.24, 95% CI 1.27-3.95) and their households had better 
observed hygiene (OR 3.29, 95% CI 1.45-7.45). Intervention children were
 only slightly more likely to be fully immunised (OR 1.67, 95% CI 
0.78-3.57). CONCLUSIONS: Evidence-based home visits to both parents 
stimulated household actions that improved prevention and management of 
childhood diarrhoea. Such visits could help to improve child health even
 in settings with poor access to quality health services. TRIAL 
REGISTRATION: ISRCTN82954580 . Date: 11/08/2017. Retrospectively 
registered.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2021-10</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>21</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>1085</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>BMC health services research</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/s12913-021-07000-3">10.1186/s12913-021-07000-3</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1472-6963 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Home visits</li>
					<li>Male</li>
					<li>Nigeria/epidemiology</li>
					<li>Infant</li>
					<li>Child health</li>
					<li>Child</li>
					<li>*House Calls</li>
					<li>Parturition</li>
					<li>*Child Health</li>
					<li>Community health workers</li>
					<li>Family Characteristics</li>
					<li>Childhood diarrhoea</li>
					<li>Immunisation</li>
					<li>Stepped wedge cluster randomised controlled trial</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_7HH3AC7V">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name</strong> : </p>
<p>Ward Names </p>
<p><strong>Location Type</strong> : </p>
<p>Ward <span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">units</span></span></p>
<p><strong>Description</strong> : </p>
<p><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">Eight wards (administrative units) of Toro local government area (LGA) of Bauchi state, Nigeria.</span></span></p>
<p><strong>sample size</strong> : <span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">7242</span></span></p>
<p></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_DSN9S9ZY" class="item journalArticle">
			<h2>Impact of universal home visits on maternal and infant outcomes 
in Bauchi state, Nigeria: protocol of a cluster randomized controlled 
trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Cockcroft A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Omer K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gidado Y</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gamawa AI</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Andersson N</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Maternal mortality in Nigeria is one of the 
highest in the world. Access to antenatal care is limited and the 
quality of services is poor in much of the country. Previous research in
 Bauchi State found associations between maternal morbidity and domestic
 violence, heavy work in pregnancy, lack of knowledge about danger 
signs, and lack of spousal communication about pregnancy and childbirth.
 This cluster randomized controlled stepped-wedge trial will test the 
impact of universal home visits to pregnant women and their partners, 
and the added value of video edutainment. METHODS: The trial will take 
place in six wards of Toro Local Government Area in Bauchi State, 
Nigeria, randomly allocated into three waves of two wards each. Home 
visits will begin in wave 1 wards immediately; in wave 2 wards after one
 year; and in wave 3 wards after a further year. In each wave, one ward,
 randomly allocated, will receive video edutainment during the home 
visits. Female home visitors will contact all households in their 
catchment areas of about 300 households, register all pregnant women, 
and visit them every two months during pregnancy, after delivery and one
 year later. They will use android handsets to collect information on 
pregnancy progress, send this to a central server, and discuss with the 
women the evidence about household factors associated with higher 
maternal risks, using video clips in the edutainment wards. Male home 
visitors will contact the partners of the pregnant women and discuss 
with them the same evidence. We will compare outcomes between wave 1 and
 wave 2 wards at about one year, between wave 2 and wave 3 wards at 
about two years, and finally between wards with and without added 
edutainment. Primary outcomes will be complications in pregnancy and 
delivery, and child health at one year. Secondary outcomes include 
knowledge and attitudes, use of health services, knowledge of danger 
signs, and household care of pregnant women. DISCUSSION: Demonstrating 
an impact of home visits and understanding potential mechanisms could 
have important implications for reducing maternal morbidity and 
mortality in other settings with poor access to quality antenatal care 
services. TRIAL REGISTRATION: Registration number: ISRCTN82954580 . 
Registry: ISRCTN. Date of registration: 11 August 2017. Retrospectively 
registered.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2018-07</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>18</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>510</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>BMC health services research</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/s12913-018-3319-z">10.1186/s12913-018-3319-z</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1472-6963 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Infant, Newborn</li>
					<li>Nigeria</li>
					<li>Infant</li>
					<li>Pregnancy Outcome</li>
					<li>Cluster Analysis</li>
					<li>Maternal Mortality</li>
					<li>*House Calls</li>
					<li>Parturition</li>
					<li>Randomized Controlled Trials as Topic</li>
					<li>*Nigeria</li>
					<li>Prenatal Care/*organization &amp; administration</li>
					<li>*Edutainment</li>
					<li>*Home visits</li>
					<li>*Male involvement</li>
					<li>*Maternal and newborn health</li>
					<li>*Randomized controlled trial</li>
					<li>*Stepped-wedge design</li>
					<li>Child Health/statistics &amp; numerical data</li>
					<li>Domestic Violence/statistics &amp; numerical data</li>
					<li>Health Services Accessibility/*organization &amp; administration</li>
					<li>Patient Education as Topic/organization &amp; administration</li>
					<li>Pregnancy Complications/etiology</li>
					<li>Video Recording</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_UMYKC6WZ">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Name: </span></span></strong></p>
<p><strong><span style="color: black"><span style="background-color: white">&nbsp;</span></span></strong><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Toro LGA in Bauchi State</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Type: </span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">Community</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Description: </span></span></strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Conducted in Toro LGA in Bauchi State, Nigeria</span></span></p>
<p><strong>Sample Size</strong>: &nbsp;3690</p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_UIB3N3KL" class="item journalArticle">
			<h2>Implementation and Operational Research: Effect of Integration of
 HIV Care and Treatment Into Antenatal Care Clinics on Mother-to-Child 
HIV Transmission and Maternal Outcomes in Nyanza, Kenya: Results From 
the SHAIP Cluster Randomized Controlled Trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Washington S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Owuor K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Turan JM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Steinfeld RL</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Onono M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Shade SB</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bukusi EA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ackers ML</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Cohen CR</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Many HIV-infected pregnant women identified during
 antenatal care (ANC) do not enroll in long-term HIV care, resulting in 
deterioration of maternal health and continued risk of HIV transmission 
to infants. METHODS: We performed a cluster randomized trial to evaluate
 the effect of integrating HIV care into ANC clinics in rural Kenya. 
Twelve facilities were randomized to provide either integrated services 
(ANC, prevention of mother-to-child transmission, and HIV care delivered
 in the ANC clinic; n = 6 intervention facilities) or standard ANC 
services (including prevention of mother-to-child transmission and 
referral to a separate clinic for HIV care; n = 6 control facilities). 
RESULTS: There were high patient attrition rates over the course of this
 study. Among study participants who enrolled in HIV care, there was 
12-month follow-up data for 256 of 611 (41.8%) women and postpartum data
 for only 325 of 1172 (28%) women. By 9 months of age, 382 of 568 
(67.3%) infants at intervention sites and 338 of 594 (57.0%) at control 
sites had tested for HIV [odds ratio (OR) 1.45, 95% confidence interval 
(CI): 0.71 to 2.82]; 7.3% of infants tested HIV positive at intervention
 sites compared with 8.0% of infants at control sites (OR 0.89, 95% CI: 
0.56 to 1.43). The composite clinical/immunologic progression into AIDS 
was similar in both arms (4.9% vs. 5.1%, OR 0.83, 95% CI: 0.41 to 1.68).
 CONCLUSIONS: Despite the provision of integrated services, patient 
attrition was substantial in both arms, suggesting barriers beyond lack 
of service integration. Integration of HIV services into the ANC clinic 
was not associated with a reduced risk of HIV transmission to infants 
and did not appear to affect short-term maternal health outcomes.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2015-08</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>69</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e164-71</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Journal of acquired immune deficiency syndromes (1999)</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1097/QAI.0000000000000656">10.1097/QAI.0000000000000656</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>5</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1525-4135 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Infant, Newborn</li>
					<li>Young Adult</li>
					<li>Risk Factors</li>
					<li>Infant</li>
					<li>Infectious Disease Transmission, Vertical/*prevention &amp; control</li>
					<li>Treatment Outcome</li>
					<li>Antiretroviral Therapy, Highly Active</li>
					<li>Cluster Analysis</li>
					<li>Kenya/epidemiology</li>
					<li>Odds Ratio</li>
					<li>Prenatal Care/*organization &amp; administration</li>
					<li>Anti-HIV Agents/administration &amp; dosage/*therapeutic use</li>
					<li>Community Health Centers/*organization &amp; administration</li>
					<li>Health Plan Implementation/*organization &amp; administration</li>
					<li>HIV Infections/drug therapy/epidemiology/prevention &amp; control/*transmission</li>
					<li>Maternal-Child Health Centers/organization &amp; administration</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_GDSE5BUM">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Name: &nbsp;</span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">specific names of health facilities not mentioned</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Type:</span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">12 health facilities</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Description: </span></span></strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Conducted in Nyanza Province, Kenya,</span></span></p>
<p><strong>Sample Size</strong>: &nbsp;1172</p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_IWXJFRHI" class="item journalArticle">
			<h2>Implementing comprehensive prevention of mother-to-child 
transmission and HIV prevention for South African couples: study 
protocol for a randomized controlled trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Jones D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Peltzer K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Weiss SM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sifunda S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Dwane N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ramlagan S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Cook R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Matseke G</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Maduna V</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Spence A</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: In rural South Africa, only two-thirds of 
HIV-positive pregnant women seeking antenatal care at community health 
centers took full advantage of 'prevention of mother-to-child 
transmission' (PMTCT) services in 2010. Studies generally support male 
involvement to promote PMTCT, but the nature and impact of that 
involvement is unclear and untested. Additionally, stigma, disclosure 
and intimate partner violence pose significant barriers to PMTCT uptake 
and retention in care, suggesting that male involvement may be 
'necessary, but not sufficient' to reduce infant HIV incidence. This 
study expands on a successful United States President's Emergency Plan 
for AIDS Relief (PEPFAR)-supported PMTCT couples intervention pilot 
study conducted in the Mpumalanga province, targeting HIV-positive 
pregnant women and their partners, the primary objective being to 
determine whether male partner involvement plus a behavioral 
intervention will significantly reduce infant HIV incidence. 
METHODS/DESIGN: The study follows a cluster randomized controlled design
 enrolling two cohorts of HIV-positive pregnant women recruited from 12 
randomly assigned Community Health Centers (CHC) (six experimental, six 
control). The two cohorts will consist of women attending without their 
male partners (n = 720) and women attending with their male partners (n =
 720 couples), in order to determine whether the influence of male 
participation itself, or combined with a behavioral PMTCT intervention, 
can significantly reduce infant HIV infection ante-, peri- and 
postnatally. DISCUSSION: It is our intention to significantly increase 
PMTCT participation from current levels (69%) in the Mpumalanga province
 to between 90 and 95% through engaging women and couples in a 
controlled, six session ante- and postnatal risk-reducing and PMTCT 
promotion intervention addressing barriers to PMTCT (such as stigma, 
disclosure, intimate partner violence, communication, infant feeding 
practices and safer conception) that prevent women and men from 
utilizing treatment opportunities available to them and their infants. 
Based upon the encouraging preliminary results from our pilot study, 
successful CHC adoption of the program could have major public health 
policy implications for containing the epidemic among the most 
vulnerable populations in rural South Africa: HIV-positive pregnant 
women and their infants. TRIAL REGISTRATION: ClinicalTrials.gov 
NCT02085356 (registration date: 10 March 2014).</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2014-10</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>15</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>417</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Trials</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/1745-6215-15-417">10.1186/1745-6215-15-417</a></td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1745-6215 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Incidence</li>
					<li>Pregnancy</li>
					<li>Male</li>
					<li>Infectious Disease Transmission, Vertical/*prevention &amp; control</li>
					<li>Treatment Outcome</li>
					<li>South Africa/epidemiology</li>
					<li>Health Knowledge, Attitudes, Practice</li>
					<li>HIV Infections/epidemiology/*prevention &amp; control/psychology/*transmission</li>
					<li>Spouses/*psychology</li>
					<li>Time Factors</li>
					<li>*Prenatal Care</li>
					<li>Patient Compliance</li>
					<li>Social Support</li>
					<li>Research Design</li>
					<li>*Behavior Therapy</li>
					<li>*Patient Education as Topic</li>
					<li>*Rural Health Services</li>
					<li>Clinical Protocols</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_83RN9Z2A">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Nam</strong>e : </p>
<p>The exact names of the health facilities are not mentioned</p>
<p><strong>Location Type :</strong> </p>
<p>Community Health facilities</p>
<p><strong>Description</strong> : &nbsp;</p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Conducted
 in 12 health centers in two districts the Gert Sibande and Nkangala 
Districts in the Mpumalanga province of South Africa</span></span></p>
<p><strong>Sample size</strong> : 1,440</p>
<p></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_F9FYYM3C" class="item journalArticle">
			<h2>Improved prediction of gestational hypertension by inclusion of 
placental growth factor and pregnancy associated plasma protein-a in a 
sample of Ghanaian women.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Antwi E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Klipstein-Grobusch K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Browne JL</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Schielen PC</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Koram KA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Agyepong IA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Grobbee DE</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: We assessed whether adding the biomarkers 
Pregnancy Associated Plasma Protein-A (PAPP-A) and Placental Growth 
Factor (PlGF) to maternal clinical characteristics improved the 
prediction of a previously developed model for gestational hypertension 
in a cohort of Ghanaian pregnant women. METHODS: This study was nested 
in a prospective cohort of 1010 pregnant women attending antenatal 
clinics in two public hospitals in Accra, Ghana. Pregnant women who were
 normotensive, at a gestational age at recruitment of between 8 and 13 
weeks and provided a blood sample for biomarker analysis were eligible 
for inclusion. From serum, biomarkers PAPP-A and PlGF concentrations 
were measured by the AutoDELFIA immunoassay method and multiple of the 
median (MoM) values corrected for gestational age (PAPP-A and PlGF) and 
maternal weight (PAPP-A) were calculated. To obtain prediction models, 
these biomarkers were included with clinical predictors maternal weight,
 height, diastolic blood pressure, a previous history of gestational 
hypertension, history of hypertension in parents and parity in a 
logistic regression to obtain prediction models. The Area Under the 
Receiver Operating Characteristic Curve (AUC) was used to assess the 
predictive ability of the models. RESULTS: Three hundred and seventy 
three women participated in this study. The area under the curve (AUC) 
of the model with only maternal clinical characteristics was 0.75 
(0.64-0.86) and 0.89(0.73-1.00) for multiparous and primigravid women 
respectively. The AUCs after inclusion of both PAPP-A and PlGF were 0.82
 (0.74-0.89) and 0.95 (0.87-1.00) for multiparous and primigravid women 
respectively. CONCLUSION: Adding the biomarkers PAPP-A and PlGF to 
maternal characteristics to a prediction model for gestational 
hypertension in a cohort of Ghanaian pregnant women improved predictive 
ability. Further research using larger sample sizes in similar settings 
to validate these findings is recommended.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2018-03</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 1
Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>15</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>56</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Reproductive health</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/s12978-018-0492-9">10.1186/s12978-018-0492-9</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1742-4755 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:30 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:30 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Cohort Studies</li>
					<li>Prospective Studies</li>
					<li>Young Adult</li>
					<li>Ghana/epidemiology</li>
					<li>Follow-Up Studies</li>
					<li>Biomarkers</li>
					<li>Risk</li>
					<li>Biomarkers/blood</li>
					<li>Sensitivity and Specificity</li>
					<li>Pregnancy Trimester, First</li>
					<li>Parity</li>
					<li>Early Diagnosis</li>
					<li>Gestational hypertension</li>
					<li>*Maternal Serum Screening Tests</li>
					<li>*Models, Biological</li>
					<li>*Up-Regulation</li>
					<li>Algorithms</li>
					<li>Hypertension, Pregnancy-Induced/blood/*diagnosis/epidemiology</li>
					<li>Hypertensive disorders of pregnancy</li>
					<li>Placenta Growth Factor/*blood</li>
					<li>Prediction model</li>
					<li>Pregnancy-Associated Plasma Protein-A/*analysis</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_LVZXKPU5">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name</strong> :</p>
<p> Facility names not specified</p>
<p><strong>Location Type</strong> : </p>
<p>Health Facility</p>
<p><strong>Description</strong> : </p>
<p><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">Two public hospitals in Accra, capital city of Ghana</span></span></p>
<p><strong>sample size : 1010</strong></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_PAYT92WV" class="item journalArticle">
			<h2>Improving health care facility birth rates in Rorya District, Tanzania: a multiple baseline trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Webber G</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chirangi B</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Magatti N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mallick R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Taljaard M</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Rates of maternal mortality and morbidity in 
Africa remain unacceptably high, as many women deliver at home, without 
access to skilled birth attendants and life-saving medications. In rural
 Tanzania, women face significant barriers accessing health care 
facilities for their deliveries. METHODS: From January 2017 to February 
2019 we conducted a multiple baseline (interrupted time series) trial 
within the four divisions of Rorya District, Tanzania. We collected 
baseline data, then sequentially introduced a complex intervention in 
each of the divisions, in randomized order, over 3 month intervals. We 
allowed for a 6 month transition period to avoid contamination between 
the pre- and post-intervention periods. The intervention included using 
community health workers to educate about safe delivery, distribution of
 birth kits with misoprostol, and a transport subsidy for women living a
 distance from the health care facility. The primary outcome was the 
health facility birth rate, while the secondary outcomes were the rates 
of antenatal and postpartum care and postpartum hemorrhage. Outcomes 
were analyzed using fixed effects segmented logistic regression, 
adjusting for age, marital status, education, and parity. Maternal and 
baby morbidity/mortality were analyzed descriptively. RESULTS: We 
analyzed data from 9565 pregnant women (2634 before and 6913 after the 
intervention was implemented). Facility births increased from 1892 
(71.8%) before to 5895 (85.1%) after implementation of the intervention.
 After accounting for the secular trend, the intervention was associated
 with an immediate increase in the odds of facility births (OR = 1.51, 
95% CI 1.14 to 2.01, p = 0.0045) as well as a small gradual effect (OR =
 1.03 per month, 95% CI 1.00 to 1.07, p = 0.0633). For the secondary 
outcomes, there were no statistically significant immediate changes 
associated with the intervention. Rates of maternal and baby 
morbidity/mortality were low and similar between the pre- and 
post-implementation periods. CONCLUSIONS: Access to health care 
facilities can be improved through implementation of education of the 
population by community health workers about the importance of a health 
care facility birth, provision of birth kits with misoprostol to women 
in late pregnancy, and access to a transport subsidy for delivery for 
women living at a distance from the health facility. CLINICAL TRIALS 
REGISTRATION: NCT03024905 19/01/2017.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2022-01</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 1
Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>22</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>74</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>BMC pregnancy and childbirth</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/s12884-022-04408-5">10.1186/s12884-022-04408-5</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1471-2393 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:27 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:27 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Young Adult</li>
					<li>Infant</li>
					<li>Middle Aged</li>
					<li>Adolescent</li>
					<li>Rural Population</li>
					<li>Tanzania</li>
					<li>Child</li>
					<li>Tanzania/epidemiology</li>
					<li>*Delivery, Obstetric</li>
					<li>Research Design</li>
					<li>Misoprostol</li>
					<li>*Health Services Accessibility</li>
					<li>*Birth Rate</li>
					<li>*Health Facilities</li>
					<li>Birth kits</li>
					<li>Community health worker</li>
					<li>Community Health Workers/education</li>
					<li>Facility birth</li>
					<li>Health Education/*methods</li>
					<li>M-health</li>
					<li>Postnatal Care/trends</li>
					<li>Prenatal Care/trends</li>
					<li>Social Determinants of Health</li>
					<li>Transportation</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_TLESL6MF">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name : </strong></p>
<p><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">Nyancha, Girango, Suba and Luoimbo&nbsp;</span></span></p>
<p><strong>Location Type :</strong></p>
<p>Divisions</p>
<p><strong>Description : </strong><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">&nbsp;</span></span></p>
<p><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">Rorya District consists of four divisions: Nyancha, Girango, Suba and Luoimbo&nbsp;</span></span></p>
<p><strong>sample size :</strong> <span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">9565&nbsp;</span></span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_RIAQVDXR" class="item journalArticle">
			<h2>In Nigeria, Stillbirths And Newborn Deaths Increased During The COVID-19 Pandemic.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Okeke EN</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Abubakar IS</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>De Guttry R</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>The COVID-19 pandemic has put severe pressure on health care 
systems worldwide. Although attention has been focused on COVID-19 
hospitalizations and deaths, some experts have warned about potentially 
devastating secondary health effects. These effects may be most severe 
in low- and middle-income countries with already weak health care 
systems. This study examines the effect of the COVID-19 pandemic on 
early infant deaths, a question that is currently unsettled. We present 
new evidence from Nigeria showing that early infant deaths have 
significantly increased during the pandemic. Using data on the birth 
outcomes of a large and diverse cohort of pregnant women enrolled in a 
prospective study and a quasi-experimental difference-in-differences 
design, we found a 1.1-percentage-point (22 percent) increase and a 
0.72-percentage-point (23 percent) increase, respectively, in 
stillbirths and newborn deaths. Our findings show that the health 
effects of the pandemic extend beyond counted COVID-19 deaths. If these 
findings generalize to other low- and middle-income countries, they may 
indicate that the hard-won gains in child survival made during the past 
two decades are at risk of being reversed amid the ongoing pandemic. 
Policies addressing disruptions to health services delivery and 
providing support to vulnerable groups-specifically to households with 
pregnant women-will be critical as the pandemic continues.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2021-11</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 11
Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>40</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>1797-1805</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Health affairs (Project Hope)</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1377/hlthaff.2021.00659">10.1377/hlthaff.2021.00659</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>11</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>0278-2715 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:29 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:29 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Infant, Newborn</li>
					<li>Prospective Studies</li>
					<li>Nigeria/epidemiology</li>
					<li>Infant</li>
					<li>Child</li>
					<li>*COVID-19</li>
					<li>Stillbirth/epidemiology</li>
					<li>*Pandemics</li>
					<li>SARS-CoV-2</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_A7R6W7LD">
<div><div data-schema-version="8"><p>location Information</p>
<p><strong>Location Name</strong> : </p>
<p>Facility Name not specified</p>
<p><strong>Location Type</strong> : </p>
<p>Health Facility, Region</p>
<p><strong>Description</strong> : </p>
<p>288 primary health facility service areas drawn from four states Kano, Jigawa, Gombe and Akwa Ibom regions of Nigeria</p>
<p><strong>Sample size : </strong><span style="color: rgb(64, 64, 66)"><span style="background-color: rgb(255, 255, 255)">36,607</span></span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_R64AZWH4" class="item journalArticle">
			<h2>Incidence of and socio-biologic risk factors for spontaneous preterm birth in HIV positive Nigerian women.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ezechi OC</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>David AN</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gab-Okafor CV</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ohwodo H</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Oladele DA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kalejaiye OO</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ezeobi PM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gbajabiamila TA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Adu RA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Oke B</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Musa ZA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ekama SO</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ilesanmi O</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Odubela O</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Somefun EO</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Herbertson EC</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Onwujekwe DI</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ujah IA</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Recent studies have identified HIV as a leading 
contributor to preterm delivery and its associated morbidity and 
mortality. However little or no information exists in our sub-region on 
this subject. Identifying the factors associated with preterm delivery 
in HIV positive women in our country and sub-region will not only 
prevent mother to child transmission of HIV virus but will also reduce 
the morbidity and mortality associated with prematurity and low birth 
weight. This study was designed to determine the incidence and risk 
factors for preterm delivery in HIV positive Nigerians. METHOD: The 
required data for this retrospective study was extracted from the data 
base of a cohort study of the outcome of prevention of mother to child 
transmission at the Nigerian Institute of Medical Research, Lagos. Only 
data of women that met the eligibility of spontaneous delivery after 20 
weeks of gestation were included. Ethical approval was obtained from the
 Institution's Ethical Review Board. RESULTS: 181 women out of the 1626 
eligible for inclusion into the study had spontaneous preterm delivery 
(11.1%). The mean birth weight was 3.1 +/- 0.4 kg, with 10.3% having 
LBW. Spontaneous preterm delivery was found to be significantly 
associated with unmarried status (cOR: 1.7;1.52-2.57), baseline CD4 
count &lt;200 cells/mm(3) (cOR: 1.8; 1.16-2.99), presence of 
opportunistic infection at delivery (cOR: 2.2;1.23-3.57), multiple 
pregnancy (cOR 10.4; 4.24 - 26.17), use of PI based triple ARV therapy 
(eOR 10.2; 5.52 - 18.8) in the first trimester (cOR 2.5; 1.77 - 3.52) on
 univariate analysis. However after multivariate analysis controlling 
for potential confounding variables including low birth weight, only 
multiple pregnancy (aOR: 8.6; CI: 6.73 - 12.9), presence of 
opportunistic infection at delivery (aOR: 1.9; CI: 1.1 - 5.7), and 1st 
trimester exposure to PI based triple therapy (aOR: 5.4; CI: 3.4 - 7.8) 
retained their significant association with preterm delivery. 
CONCLUSION: The spontaneous preterm delivery rate among our cohort was 
11.1%. HIV positive women with multiple pregnancies, symptomatic HIV 
infection at delivery and first trimester fetal exposure to PI based 
triple therapy were found to be at risk of spontaneous preterm delivery.
 Early booking and non-use of PI based triple therapy in the first 
trimester will significantly reduce the risk of preterm delivery.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2012-09</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>12</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>93</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>BMC pregnancy and childbirth</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/1471-2393-12-93">10.1186/1471-2393-12-93</a></td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1471-2393 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:44 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:44 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Incidence</li>
					<li>Pregnancy</li>
					<li>Retrospective Studies</li>
					<li>Young Adult</li>
					<li>*Pregnancy Outcome</li>
					<li>Premature Birth/*epidemiology</li>
					<li>Risk Factors</li>
					<li>Nigeria/epidemiology</li>
					<li>Antiretroviral Therapy, Highly Active</li>
					<li>Antirheumatic Agents/therapeutic use</li>
					<li>HIV Seropositivity/drug therapy/*epidemiology</li>
					<li>Pregnancy Complications, Infectious/*epidemiology</li>
					<li>Viral Load</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_XCSZ555D">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name</strong> : </p>
<p><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">Nigerian Institute of Medical Research</span></span></p>
<p><strong>Location Type</strong> : Research Institute</p>
<p><strong>Description</strong> : <span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">Nigerian Institute of Medical Research, Lagos.</span></span></p>
<p><strong>Sample size : </strong><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">1626</span></span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_J2X3LVLF" class="item journalArticle">
			<h2>Incidence of preterm premature rupture of membranes and its 
association with inter-pregnancy interval: a prospective cohort study.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Jena BH</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Biks GA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gete YK</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gelaye KA</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>Preterm premature rupture of membranes is one of the causes of
 premature birth and perinatal deaths, particularly in developing 
countries due to poor access and availability of medical resources to 
manage and sustain the pregnancy to term. Although, several risk factors
 for preterm premature rupture of membranes were identified, its 
association with inter-pregnancy interval was understudied. Therefore, 
we aimed to assess the incidence of preterm premature rupture of 
membranes and its association with inter-pregnancy interval in urban 
South Ethiopia. A community-based prospective cohort study was conducted
 among 2578 pregnant women, and followed until delivery. A generalized 
linear model for binary outcome was applied for the analysis, using a 
95% confidence level and P-value. The incidence of preterm premature 
rupture of membranes was 2%, 95% CI: 2%, 3%. However, the incidence was 
varied across the months of inter-pregnancy intervals 4% (&lt; 18 
months), 2% (18-23 months) and 1% (24-60 months). The risk of preterm 
premature rupture of membranes was nearly three times (ARR = 2.59, 
95%CI: 1.27, 5.29) higher for women with inter-pregnancy intervals &lt; 
18 months than 24-60 months. Inter-pregnancy interval under 18 months 
increases the risk of preterm premature rupture of membranes, 
highlighting the need to improve pregnancy spacing in the community.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2022-04</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>12</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>5714</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Scientific reports</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1038/s41598-022-09743-3">10.1038/s41598-022-09743-3</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>2045-2322 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Incidence</li>
					<li>Pregnancy</li>
					<li>Infant, Newborn</li>
					<li>Prospective Studies</li>
					<li>*Premature Birth/epidemiology</li>
					<li>Birth Intervals</li>
					<li>*Fetal Membranes, Premature Rupture/epidemiology</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_TBB9CDJR">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location Name :</strong> </p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Names of the health facilities are not mentioned.</span></span></p>
<p><strong>Location Type :</strong> </p>
<p>Health facilities</p>
<p><strong>Description :</strong> <span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">conducted in five urban settings (Hossana, Shone, Homecho, Gimbichu, and Jajura) in the Hadiya zone, South Ethiopia.</span></span></p>
<p><strong>Sample Size :</strong> &nbsp;<span style="color: rgb(34, 34, 34)"><span style="background-color: rgb(255, 255, 255)">2578</span></span></p>
<p></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_JXBZCPK5" class="item journalArticle">
			<h2>Inequality in uptake of isoniazid prevention therapy and Mantoux 
test among pregnant women with HIV in the Eastern Cape, South Africa.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Adeniyi OV</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Selanto-Chairman N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Owolabi EO</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ajayi AI</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kayembe DK</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ter Goon D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gordana A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Lambert J</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: HIV-associated tuberculosis (TB) is a major cause 
of death among pregnant women in South Africa. Isoniazid prevention 
therapy (IPT) strategy was implemented in South Africa concurrently with
 life-long antiretroviral therapy (ART) to reduce the TB-associated 
morbidity and mortality in individuals living with HIV. This study 
assessed the extent of the implementation of IPT and the performance of 
the Mantoux test by geographic settings of health facilities and 
residences of pregnant women living with HIV in the Eastern Cape, South 
Africa. METHODS: We conducted a data analysis of 1709 pregnant women 
enrolled in the new electronic database of the prevention of 
mother-to-child transmission programme of the East London Prospective 
Cohort Study. Relevant data on place of residence and antenatal care, 
performance of the Mantoux test and subsequent initiation of IPT were 
obtained. Descriptive and inferential statistics were employed to 
analyse the geographical variations and accessibility to Mantoux test 
and IPT. RESULTS: The analysis shows that Mantoux test was performed on 
803 pregnant women (47%) with significant geographical variation. After 
controlling for relevant covariates, pregnant women who resided in rural
 areas (AOR:0.63; CI: 0.47-0.84) compared to those who resided in urban 
areas were significantly less likely to receive Mantoux test. The rate 
of uptake of IPT was 79% with significant geographic variations. In the 
unadjusted model, rural place of residence (UOR:0.68; CI: 0.49-0.96) was
 independently associated with lower likelihood of uptake of INH 
prophylaxis; however, the effect was not significant after controlling 
for important covariates. CONCLUSIONS: The high uptake rate of isoniazid
 prevention therapy in pregnant women living with HIV at the study sites
 is commendable; however, concerted efforts are needed to address the 
inequality gaps in the roll-out of IPT. Poor performance of Mantoux test
 is a serious concern and requires the attention of TB programme 
managers and other relevant authorities.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2019-10</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>19</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>1407</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>BMC public health</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/s12889-019-7769-y">10.1186/s12889-019-7769-y</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1471-2458 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Prospective Studies</li>
					<li>Young Adult</li>
					<li>Infectious Disease Transmission, Vertical/*prevention &amp; control</li>
					<li>Middle Aged</li>
					<li>South Africa</li>
					<li>Adolescent</li>
					<li>Pregnancy Complications, Infectious/*drug therapy</li>
					<li>HIV Infections/*drug therapy</li>
					<li>*Healthcare Disparities</li>
					<li>HIV-associated tuberculosis</li>
					<li>Isoniazid prevention therapy</li>
					<li>Isoniazid/*therapeutic use</li>
					<li>Mantoux test</li>
					<li>Maternal mortality</li>
					<li>Tuberculin Test/*statistics &amp; numerical data</li>
					<li>Tuberculosis-associated morbidity</li>
					<li>Tuberculosis-associated mortality</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_BTB8AUY7">
<div><div data-schema-version="8"><p><strong>Location Information:</strong></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Name:</span></span></strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Frere Hospital, Cecilia Makiwane Hospital, Bisho Hospital:</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Type: </span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">Health facility</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Description: </span></span></strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Buffalo/Amathole districts in the Eastern Cape Province, South Africa.</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Sample size : 1709</span></span></strong></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_7HZ872RZ" class="item journalArticle">
			<h2>Infant feeding modes and determinants among HIV-1-infected African Women in the Kesho Bora Study.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bork K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Cames C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Cournil A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Musyoka F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ayassou K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Naidu K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mepham S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gichuhi C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Read JS</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gaillard P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>de Vincenzi I</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>OBJECTIVE: To assess breastfeeding modes and determinants in a
 prevention of mother-to-child transmission study. DESIGN: 
HIV-1-infected pregnant women from 5 sites in Burkina Faso, Kenya, and 
South Africa were enrolled in the study that comprised 2 prospective 
cohorts and 1 randomized controlled trial. Women were counseled to 
either breastfeed exclusively up to 6 months or formula feed from birth.
 METHODS: Determinants of breastfeeding initiation and continuation by 3
 months postpartum were investigated using multiple logistic regression 
analysis. Neonatal morbidity was defined as mother-reported fever, 
diarrhea, or vomiting during the first month of life. RESULTS: Among 
1028, 781 women (76%) initiated breastfeeding and 565 of 995 (56%) were 
still breastfeeding at 3 months postpartum (30% exclusively, 18% 
predominantly, and 8% partially). Study site (Durban, Mombasa, and 
Nairobi compared with Bobo-Dioulasso), CD4 cell count (&lt;200 
cells/mm), secondary schooling (compared with none), and emergency 
cesarean delivery (compared with vaginal delivery) were independently 
associated with a lower probability of ever breastfeeding. The odds of 
still breastfeeding by 3 months postpartum (among those breastfeeding by
 1 month) were lower in Mombasa, Nairobi, and Somkhele (compared with 
Bobo-Dioulasso) and among infants with neonatal morbidity [0.60 
(0.37-0.976)]. The odds of exclusive breastfeeding (EBF) by 3 months (if
 EBF by 1 month) were lower in Mombasa and Nairobi, in ill neonates 
[0.54 (0.31-0.93)] and boys [0.51 (0.34-0.77)]. CONCLUSIONS: EBF was of 
short duration, particularly for boys. The importance of neonatal 
morbidity for breastfeeding cessation requires further investigation. 
Infant feeding counseling might need adaptation to better support 
mothers of boys and ill neonates.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2013-01</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 1
Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>62</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>109-18</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Journal of acquired immune deficiency syndromes (1999)</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1097/QAI.0b013e318277005e">10.1097/QAI.0b013e318277005e</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1525-4135 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:35 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:35 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Cohort Studies</li>
					<li>Infant, Newborn</li>
					<li>Prospective Studies</li>
					<li>Male</li>
					<li>Infant</li>
					<li>Infectious Disease Transmission, Vertical/*prevention &amp; control</li>
					<li>South Africa/epidemiology</li>
					<li>Kenya/epidemiology</li>
					<li>HIV-1/*isolation &amp; purification</li>
					<li>Burkina Faso/epidemiology</li>
					<li>Breast Feeding/*statistics &amp; numerical data</li>
					<li>HIV Infections/*epidemiology/*transmission</li>
					<li>Pregnancy Complications, Infectious/epidemiology</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_KNS2SN3D">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location Name :</strong></p>
<ol>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Centre de Sante d'Ahouansori Agu and Hpital Bethesda in Cotonou, Benin</span></span>
</li>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Siaya District Hospital in Siaya, Kenya</span></span>
</li>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Zomba Central Hospital in Zomba, Malawi</span></span>
</li>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Teule Hospital in Muheza, Tanga, Tanzania</span></span>
</li>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">National Institute for Medical Research/Nyamagana District Hospital in Mwanza, Tanzania</span></span>
</li>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Mulanda Health Centre IV in Kampala, Uganda</span></span><strong> </strong>
</li>
</ol>
<p><strong>Location Type : &nbsp;</strong>Health facilities and Communities</p>
<p><strong>Description : </strong><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">&nbsp;5 sites : </span></span></p>
<ol>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Bobo-Dioulasso, Burkina Faso (West Africa)</span></span>
</li>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Nairobi and Mombasa, Kenya (East Africa)</span></span>
</li>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Durban and a rural and semiurban area of</span></span>
</li>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">KwaZulu-Natal (Somkhele), Republic of South Africa.</span></span>
</li>
</ol>
<p><strong>sample size :</strong> <span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">1028</span></span></p>
<p></p>
<p></p>
<p></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_3S4IKSPS" class="item journalArticle">
			<h2>Influenza vaccination of pregnant women and protection of their infants.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Madhi SA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Cutland CL</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kuwanda L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Weinberg A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hugo A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Jones S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Adrian PV</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>van Niekerk N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Treurnicht F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ortiz JR</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Venter M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Violari A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Neuzil KM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Simoes EA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Klugman KP</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Nunes MC</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: There are limited data on the efficacy of 
vaccination against confirmed influenza in pregnant women with and those
 without human immunodeficiency virus (HIV) infection and protection of 
their infants. METHODS: We conducted two double-blind, randomized, 
placebo-controlled trials of trivalent inactivated influenza vaccine 
(IIV3) in South Africa during 2011 in pregnant women infected with HIV 
and during 2011 and 2012 in pregnant women who were not infected. The 
immunogenicity, safety, and efficacy of IIV3 in pregnant women and their
 infants were evaluated until 24 weeks after birth. Immune responses 
were measured with a hemagglutination inhibition (HAI) assay, and 
influenza was diagnosed by means of 
reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assays of 
respiratory samples. RESULTS: The study cohorts included 2116 pregnant 
women who were not infected with HIV and 194 pregnant women who were 
infected with HIV. At 1 month after vaccination, seroconversion rates 
and the proportion of participants with HAI titers of 1:40 or more were 
higher among IIV3 recipients than among placebo recipients in both 
cohorts. Newborns of IIV3 recipients also had higher HAI titers than 
newborns of placebo recipients. The attack rate for RT-PCR-confirmed 
influenza among both HIV-uninfected placebo recipients and their infants
 was 3.6%. The attack rates among HIV-uninfected IIV3 recipients and 
their infants were 1.8% and 1.9%, respectively, and the respective 
vaccine-efficacy rates were 50.4% (95% confidence interval [CI], 14.5 to
 71.2) and 48.8% (95% CI, 11.6 to 70.4). Among HIV-infected women, the 
attack rate for placebo recipients was 17.0% and the rate for IIV3 
recipients was 7.0%; the vaccine-efficacy rate for these IIV3 recipients
 was 57.7% (95% CI, 0.2 to 82.1). CONCLUSIONS: Influenza vaccine was 
immunogenic in HIV-uninfected and HIV-infected pregnant women and 
provided partial protection against confirmed influenza in both groups 
of women and in infants who were not exposed to HIV. (Funded by the Bill
 and Melinda Gates Foundation and others; ClinicalTrials.gov numbers, 
NCT01306669 and NCT01306682.).</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2014-09</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>371</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>918-31</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>The New England journal of medicine</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1056/NEJMoa1401480">10.1056/NEJMoa1401480</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>10</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>0028-4793 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Infant, Newborn</li>
					<li>Young Adult</li>
					<li>Male</li>
					<li>Infant</li>
					<li>South Africa</li>
					<li>Pregnancy Outcome</li>
					<li>Double-Blind Method</li>
					<li>HIV Infections/complications/*immunology</li>
					<li>Infant, Premature</li>
					<li>Influenza Vaccines/*immunology</li>
					<li>Influenza, Human/*prevention &amp; control</li>
					<li>Kaplan-Meier Estimate</li>
					<li>Pregnancy Complications, Infectious/immunology/*prevention &amp; control</li>
					<li>Vaccines, Inactivated/immunology</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_TX8YMLXX">
<div><div data-schema-version="8"><p><strong>LocationInformation</strong></p>
<p><strong>Location Name :</strong> </p>
<p>The exact name of the health facilities are not mentioned</p>
<p><strong>Location Type</strong> : </p>
<p>Health facilities</p>
<p><strong>Description</strong> : </p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Conducted at 4 antenatal clinics in Soweto, South Africa</span></span></p>
<p><strong>Sample size : </strong><span style="color: rgb(77, 77, 77)"><span style="background-color: rgb(255, 255, 255)">2116</span></span></p>
<p></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_62R9BD5T" class="item journalArticle">
			<h2>Intermittent preventive treatment of malaria in pregnancy with 
mefloquine in HIV-negative women: a multicentre randomized controlled 
trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gonzalez R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mombo-Ngoma G</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ouedraogo S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kakolwa MA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Abdulla S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Accrombessi M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Aponte JJ</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Akerey-Diop D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Basra A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Briand V</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Capan M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Cot M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kabanywanyi AM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kleine C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kremsner PG</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Macete E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mackanga JR</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Massougbodgi A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mayor A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Nhacolo A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Pahlavan G</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ramharter M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ruperez M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sevene E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Vala A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Zoleko-Manego R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Menendez C</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Intermittent preventive treatment in pregnancy 
(IPTp) with sulfadoxine-pyrimethamine (SP) is recommended by WHO to 
prevent malaria in African pregnant women. The spread of SP parasite 
resistance has raised concerns regarding long-term use for IPT. 
Mefloquine (MQ) is the most promising of available alternatives to SP 
based on safety profile, long half-life, and high efficacy in Africa. We
 evaluated the safety and efficacy of MQ for IPTp compared to those of 
SP in HIV-negative women. METHODS AND FINDINGS: A total of 4,749 
pregnant women were enrolled in an open-label randomized clinical trial 
conducted in Benin, Gabon, Mozambique, and Tanzania comparing two-dose 
MQ or SP for IPTp and MQ tolerability of two different regimens. The 
study arms were: (1) SP, (2) single dose MQ (15 mg/kg), and (3) 
split-dose MQ in the context of long lasting insecticide treated nets. 
There was no difference on low birth weight prevalence (primary study 
outcome) between groups (360/2,778 [13.0%]) for MQ group and 177/1,398 
(12.7%) for SP group; risk ratio [RR], 1.02 (95% CI 0.86-1.22; p=0.80 in
 the ITT analysis). Women receiving MQ had reduced risks of parasitemia 
(63/1,372 [4.6%] in the SP group and 88/2,737 [3.2%] in the MQ group; 
RR, 0.70 [95% CI 0.51-0.96]; p=0.03) and anemia at delivery (609/1,380 
[44.1%] in the SP group and 1,110/2743 [40.5%] in the MQ group; RR, 0.92
 [95% CI 0.85-0.99]; p=0.03), and reduced incidence of clinical malaria 
(96/551.8 malaria episodes person/year [PYAR] in the SP group and 
130/1,103.2 episodes PYAR in the MQ group; RR, 0.67 [95% CI 0.52-0.88]; 
p=0.004) and all-cause outpatient attendances during pregnancy 
(850/557.8 outpatients visits PYAR in the SP group and 1,480/1,110.1 
visits PYAR in the MQ group; RR, 0.86 [0.78-0.95]; p=0.003). There were 
no differences in the prevalence of placental infection and adverse 
pregnancy outcomes between groups. Tolerability was poorer in the two MQ
 groups compared to SP. The most frequently reported related adverse 
events were dizziness (ranging from 33.9% to 35.5% after dose 1; and 
16.0% to 20.8% after dose 2) and vomiting (30.2% to 31.7%, after dose 1 
and 15.3% to 17.4% after dose 2) with similar proportions in the full 
and split MQ arms. The open-label design is a limitation of the study 
that affects mainly the safety assessment. CONCLUSIONS: Women taking MQ 
IPTp (15 mg/kg) in the context of long lasting insecticide treated nets 
had similar prevalence rates of low birth weight as those taking SP 
IPTp. MQ recipients had less clinical malaria than SP recipients, and 
the pregnancy outcomes and safety profile were similar. MQ had poorer 
tolerability even when splitting the dose over two days. These results 
do not support a change in the current IPTp policy. TRIAL REGISTRATION: 
ClinicalTrials.gov NCT 00811421; Pan African Clinical Trials Registry 
PACTR 2010020001429343 Please see later in the article for the Editors' 
Summary.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2014-09</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 9
Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>11</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e1001733</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>PLoS medicine</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1371/journal.pmed.1001733">10.1371/journal.pmed.1001733</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>9</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1549-1277 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:32 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:32 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Cohort Studies</li>
					<li>Young Adult</li>
					<li>Infant, Low Birth Weight</li>
					<li>Follow-Up Studies</li>
					<li>Africa South of the Sahara/epidemiology</li>
					<li>Treatment Outcome</li>
					<li>Adolescent</li>
					<li>*HIV Infections</li>
					<li>Antimalarials/*administration &amp; dosage</li>
					<li>Insecticide-Treated Bednets/*statistics &amp; numerical data</li>
					<li>Malaria/diagnosis/epidemiology/*prevention &amp; control</li>
					<li>Mefloquine/*administration &amp; dosage</li>
					<li>Pregnancy Complications, Parasitic/diagnosis/epidemiology/*prevention &amp; control</li>
					<li>Preventive Health Services/statistics &amp; numerical data</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_6AZEBKNR">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name</strong> : </p>
<p><span style="color: rgb(32, 32, 32)"><span style="background-color: rgb(255, 255, 255)">Allada, Skou, Attogon ,Lambarn,Fougamou ,Makole, Chamwino, Manhia and Maragra</span></span></p>
<p><strong>Location Type</strong> : </p>
<p>Town</p>
<p><strong>Description</strong> : </p>
<p><span style="color: rgb(32, 32, 32)"><span style="background-color: rgb(255, 255, 255)">Sub-Saharan
 countries: Benin (Allada, Skou, and Attogon), Gabon (Lambarn and 
Fougamou), Tanzania (Makole and Chamwino), and Mozambique (Manhia and 
Maragra).&nbsp;</span></span></p>
<p><strong>Study Participants</strong> : 4749</p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_KYMI2XIS" class="item journalArticle">
			<h2>Intermittent screening and treatment or intermittent preventive 
treatment with dihydroartemisinin-piperaquine versus intermittent 
preventive treatment with sulfadoxine-pyrimethamine for the control of 
malaria during pregnancy in western Kenya: an open-label, three-group, 
randomised controlled superiority trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Desai M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gutman J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>L'lanziva A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Otieno K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Juma E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kariuki S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ouma P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Were V</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Laserson K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Katana A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Williamson J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>ter Kuile FO</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Every year, more than 32 million pregnancies in 
sub-Saharan Africa are at risk of malaria infection and its adverse 
consequences. The effectiveness of the intermittent preventive treatment
 with sulfadoxine-pyrimethamine strategy recommended by WHO is 
threatened by high levels of parasite resistance. We aimed to assess the
 efficacy and safety of two alternative strategies: intermittent 
screening with malaria rapid diagnostic tests and treatment of women who
 test positive with dihydroartemisinin-piperaquine, and intermittent 
preventive treatment with dihydroartemisinin-piperaquine. METHODS: We 
did this open-label, three-group, randomised controlled superiority 
trial at four sites in western Kenya with high malaria transmission and 
sulfadoxine-pyrimethamine resistance. HIV-negative pregnant women 
between 16 and 32 weeks' gestation were randomly assigned (1:1:1), via 
computer-generated permuted-block randomisation (block sizes of three, 
six, and nine), to receive intermittent screening and treatment with 
dihydroartemisinin-piperaquine, intermittent preventive treatment with 
dihydroartemisinin-piperaquine, or intermittent preventive treatment 
with sulfadoxine-pyrimethamine. Study participants, study clinic nurses,
 and the study coordinator were aware of treatment allocation, but 
allocation was concealed from study investigators, delivery unit nurses,
 and laboratory staff. The primary outcome was malaria infection at 
delivery, defined as a composite of peripheral or placental parasitaemia
 detected by placental histology, microscopy, or rapid diagnostic test. 
The primary analysis was by modified intention to treat. This study is 
registered with ClinicalTrials.gov, number NCT01669941. FINDINGS: 
Between Aug 21, 2012, and June 19, 2014, we randomly assigned 1546 women
 to receive intermittent screening and treatment with 
dihydroartemisinin-piperaquine (n=515), intermittent preventive 
treatment with dihydroartemisinin-piperaquine (n=516), or intermittent 
preventive treatment with sulfadoxine-pyrimethamine (n=515); 1368 (88%) 
women comprised the intention-to-treat population for the primary 
endpoint. Prevalence of malaria infection at delivery was lower in the 
intermittent preventive treatment with dihydroartemisinin-piperaquine 
group than in the intermittent preventive treatment with 
sulfadoxine-pyrimethamine group (15 [3%] of 457 women vs 47 [10%] of 459
 women; relative risk 0.32, 95% CI 0.18-0.56; p&lt;0.0001), but not in 
the intermittent screening and treatment with 
dihydroartemisinin-piperaquine group (57 [13%] of 452 women; 1.23, 
0.86-1.77; p=0.26). Compared with intermittent preventive treatment with
 sulfadoxine-pyrimethamine, intermittent preventive treatment with 
dihydroartemisinin-piperaquine was associated with a lower incidence of 
malaria infection during pregnancy (192.0 vs 54.4 events per 100 
person-years; incidence rate ratio [IRR] 0.28, 95% CI 0.22-0.36; 
p&lt;0.0001) and clinical malaria during pregnancy (37.9 vs 6.1 events; 
0.16, 0.08-0.33; p&lt;0.0001), whereas intermittent screening and 
treatment with dihydroartemisinin-piperaquine was associated with a 
higher incidence of malaria infection (232.0 events; 1.21, 1.03-1.41; 
p=0.0177) and clinical malaria (53.4 events; 1.41, 1.00-1.98; p=0.0475).
 We recorded 303 maternal and infant serious adverse events, which were 
least frequent in the intermittent preventive treatment with 
dihydroartemisinin-piperaquine group. INTERPRETATION: At current levels 
of rapid diagnostic test sensitivity, intermittent screening and 
treatment is not a suitable alternative to intermittent preventive 
treatment with sulfadoxine-pyrimethamine in the context of high 
sulfadoxine-pyrimethamine resistance and malaria transmission. However, 
dihydroartemisinin-piperaquine is a promising alternative drug to 
replace sulfadoxine-pyrimethamine for intermittent preventive treatment.
 Future studies should investigate the efficacy, safety, operational 
feasibility, and cost-effectiveness of intermittent preventive treatment
 with dihydroartemisinin-piperaquine. FUNDING: The Malaria in Pregnancy 
Consortium, which is funded through a grant from the Bill &amp; Melinda 
Gates Foundation to the Liverpool School of Tropical Medicine.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2015-12</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>386</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>2507-19</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Lancet (London, England)</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1016/S0140-6736(15)00310-4">10.1016/S0140-6736(15)00310-4</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>10012</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>0140-6736 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Young Adult</li>
					<li>Risk Factors</li>
					<li>Drug Combinations</li>
					<li>Treatment Outcome</li>
					<li>Adolescent</li>
					<li>Antimalarials/*administration &amp; dosage</li>
					<li>Artemisinins/*administration &amp; dosage</li>
					<li>Kenya</li>
					<li>Pyrimethamine/*administration &amp; dosage</li>
					<li>Sulfadoxine/*administration &amp; dosage</li>
					<li>Drug Therapy, Combination</li>
					<li>Malaria/diagnosis/drug therapy/*prevention &amp; control</li>
					<li>Mass Screening/methods</li>
					<li>Pregnancy Complications, Parasitic/diagnosis/drug therapy/*prevention &amp; control</li>
					<li>Prenatal Diagnosis/methods</li>
					<li>Quinolines/*administration &amp; dosage</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_5CVHHRNB">
<div><div data-schema-version="8"><p><strong>Location Information:</strong></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Name:</span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">Specific names of the health facilities not given</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Type:</span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">Health facilities</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Description:</span></span></strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Conducted at four sites in western Kenya</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Sample size : &nbsp;1546</span></span></strong></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_IDY6IEBP" class="item journalArticle">
			<h2>Intermittent Treatment for the Prevention of Malaria during 
Pregnancy in Benin: A Randomized, Open-Label Equivalence Trial Comparing
 Sulfadoxine-Pyrimethamine with Mefloquine</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Julie Bottero Valrie Briand</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BackgroundIn the context of the increasing resistance to 
sulfadoxine-pyrimethamine (SP), we evaluated the efficacy of mefloquine 
(MQ) for intermittent preventive treatment during pregnancy (IPTp)</td>
					</tr>
					<tr>
					<th>URL</th>
						<td><a href="https://academic.oup.com/jid/article/200/6/991/856594?login=false">https://academic.oup.com/jid/article/200/6/991/856594?login=false</a></td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/https://doi.org/10.1086/605474">https://doi.org/10.1086/605474</a></td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>3/5/2024, 2:38:34 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>3/5/2024, 2:40:33 PM</td>
					</tr>
				</tbody></table>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_USNM6SNT">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name</strong> &nbsp; : </p>
<p><span style="color: rgb(42, 42, 42)"><span style="background-color: rgb(255, 255, 255)">Ouidah</span></span></p>
<p><strong>Location Type</strong> : </p>
<p>Town</p>
<p><strong>Description</strong> : &nbsp;</p>
<p><span style="color: rgb(42, 42, 42)"><span style="background-color: rgb(255, 255, 255)">Ouidah, a semirural town in Benin</span></span></p>
<p><strong>Sample size : </strong><span style="color: rgb(42, 42, 42)"><span style="background-color: rgb(239, 242, 247)">1601</span></span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_7769BXWL" class="item journalArticle">
			<h2>International standards for symphysis-fundal height based on 
serial measurements from the Fetal Growth Longitudinal Study of the 
INTERGROWTH-21st Project: prospective cohort study in eight countries.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Papageorghiou AT</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ohuma EO</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gravett MG</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hirst J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>da Silveira MF</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Lambert A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Carvalho M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Jaffer YA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Altman DG</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Noble JA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bertino E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Purwar M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Pang R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Cheikh Ismail L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Victora C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bhutta ZA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kennedy SH</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Villar J</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>OBJECTIVE: To create international symphysis-fundal height 
standards derived from pregnancies of healthy women with good maternal 
and perinatal outcomes. DESIGN: Prospective longitudinal observational 
study. SETTING: Eight geographically diverse urban regions in Brazil, 
China, India, Italy, Kenya, Oman, United Kingdom, and United States. 
PARTICIPANTS: Healthy, well nourished pregnant women enrolled into the 
Fetal Growth Longitudinal Study component of the INTERGROWTH-21(st) 
Project at 9-14 weeks' gestation, and followed up until birth. MAIN 
OUTCOME MEASURES: Symphysis-fundal height was measured every five weeks 
from 14 weeks' gestation until birth using standardised methods and 
dedicated research staff who were blinded to the symphysis-fundal height
 measurements by turning the tape measure so that numbers were not 
visible during examination. The best fitting curve was selected using 
second degree fractional polynomials and further modelled in a 
multilevel framework to account for the longitudinal design of the 
study. RESULTS: Of 13 108 women screened in the first trimester, 4607 
(35.1%) met the study entry criteria. Of the eligible women, 4321 
(93.8%) had pregnancies without major complications and delivered live 
singletons without congenital malformations. The median number of 
symphysis-fundal height measurements was 5.0 (range 1-7); 3976 (92.0%) 
women had four or more measurements. Symphysis-fundal height 
measurements increased almost linearly with gestational age; data were 
used to determine fitted 3rd, 50th, and 97th centile curves, which 
showed excellent agreement with observed values. CONCLUSIONS: This study
 presents international standards to measure symphysis-fundal height as a
 first level screening tool for fetal growth disturbances.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2016-11</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>355</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>i5662</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>BMJ (Clinical research ed.)</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1136/bmj.i5662">10.1136/bmj.i5662</a></td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>0959-8138 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Infant, Newborn</li>
					<li>Prospective Studies</li>
					<li>Male</li>
					<li>Longitudinal Studies</li>
					<li>Gestational Age</li>
					<li>*Anthropometry</li>
					<li>Abdomen/*anatomy &amp; histology</li>
					<li>Fetal Development/*physiology</li>
					<li>Fetal Growth Retardation/diagnosis</li>
					<li>Pubic Symphysis</li>
					<li>Ultrasonography, Prenatal/*standards</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_U72YTI8X">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name</strong> :</p>
<p>Kenya <strong>:</strong> Nairobi (Aga Khan University Hospital, MP Shah Hospital, and Avenue Hospital)</p>
<p>Nairobi &nbsp;<strong>:</strong> <span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Aga Khan University Hospital, MP Shah Hospital, and Avenue Hospital.</span></span></p>
<p><strong>Location Type</strong> : </p>
<p>Health facility</p>
<p><strong>Description</strong> : </p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Conducted between 2009 and 2014 in eight countries, including Brazil, China, India, Italy, Kenya, Oman, the UK, and the USA</span></span></p>
<p><strong>Sample size : <span style="background-color: rgb(255, 212, 0);">&nbsp;</span></strong><span style="background-color: rgb(255, 212, 0);">4239</span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_7ENV7ETA" class="item journalArticle">
			<h2>Introduction of misoprostol for the treatment of incomplete abortion beyond 12 weeks of pregnancy in Benin.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Adisso S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hounkpatin BI</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Komongui GD</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sambieni O</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Perrin RX</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>Improving the care of women who have undergone a spontaneous 
or induced abortion is an important step in reducing abortion-related 
morbidity and mortality. Both the International Federation of Gynecology
 and Obstetrics (FIGO) and the World Health Organization recommend the 
use of manual vacuum aspiration (MVA) and misoprostol rather than sharp 
curettage to treat incomplete abortion. MVA was introduced into the 
public healthcare service in Benin in 2006 and since 2008 misoprostol 
has been available in 3 large maternity hospitals. The present study 
opted to use an oral dose of 800 mug and not to limit to pregnancies of 
up to 12 weeks, but to include women with second trimester abortions. 
After 5 years, results show that around three-quarters of the women 
treated with misoprostol at 13-18 weeks of pregnancy required MVA to 
complete uterine evacuation and approximately one-quarter had severe 
bleeding, confirming that the indication of misoprostol for incomplete 
abortion should be limited to pregnancies of up to 12 weeks.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2014-07</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>126 Suppl 1</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>S36-9</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>International journal of gynaecology and obstetrics: the 
official organ of the International Federation of Gynaecology and 
Obstetrics</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1016/j.ijgo.2014.03.002">10.1016/j.ijgo.2014.03.002</a></td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>0020-7292 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:29 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:29 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Prospective Studies</li>
					<li>Prevention</li>
					<li>World Health Organization</li>
					<li>Benin</li>
					<li>Abortifacient Agents, Nonsteroidal/*administration &amp; dosage/adverse effects</li>
					<li>Abortion, Incomplete/*therapy</li>
					<li>Complications</li>
					<li>FIGO initiative</li>
					<li>Gestational age</li>
					<li>Hospitals, Maternity/statistics &amp; numerical data</li>
					<li>Incomplete abortion</li>
					<li>International Agencies/organization &amp; administration</li>
					<li>Misoprostol</li>
					<li>Misoprostol/*administration &amp; dosage/adverse effects</li>
					<li>Pregnancy Trimesters</li>
					<li>Unsafe abortion</li>
					<li>Vacuum Curettage/*methods</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_X4K8YAIL">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name :</strong></p>
<p> Facility Name not specified</p>
<p><strong>Location Type :</strong></p>
<p>Health Facility</p>
<p><strong>Description</strong> : &nbsp;</p>
<p><span style="color: rgb(0, 0, 0)"><span style="background-color: rgb(255, 255, 255)">Three maternity hospitals in Cotonou, Benin:</span></span></p>
<p><strong>Geo-coordinate</strong> :</p>
<p><span style="color: rgb(0, 0, 0)"><span style="background-color: rgb(255, 255, 255)">Cotonou (</span></span> 6.3703 N latitude and 2.4200 E longitude.)</p>
<p><strong>Sample size : </strong><span style="color: rgb(0, 0, 0)"><span style="background-color: rgb(255, 255, 255)">3139</span></span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_T3G8B6FU" class="item journalArticle">
			<h2>'Landmark' African vaccine trial faces impasse.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Cohen J</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2021-06</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>372</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>1135-1136</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Science (New York, N.Y.)</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1126/science.372.6547.1135">10.1126/science.372.6547.1135</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>6547</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>0036-8075 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Africa South of the Sahara</li>
					<li>Randomized Controlled Trials as Topic</li>
					<li>HIV Infections/complications</li>
					<li>Pregnancy Complications, Infectious/prevention &amp; control</li>
					<li>*COVID-19 Vaccines/immunology</li>
					<li>*SARS-CoV-2/immunology</li>
					<li>*Vaccines, Synthetic/immunology</li>
					<li>2019-nCoV Vaccine mRNA-1273</li>
					<li>BNT162 Vaccine</li>
					<li>Coinfection</li>
					<li>COVID-19/complications/*prevention &amp; control/virology</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_F468ASJB">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name : </strong></p>
<p>names not provided</p>
<p><strong>Location Type :</strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Health facilities, research centers</span></span></p>
<p><strong>Description : </strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">The
 trial is planned to take place in several African countries, including 
South Africa, Eswatini, Botswana, Zimbabwe, Malawi, Zambia, Uganda, and 
Kenya.</span></span></p>
<p><strong>Sample size :</strong> &nbsp;14000</p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_UFC8QHZ8" class="item journalArticle">
			<h2>Linkage to Care, Early Infant Diagnosis, and Perinatal 
Transmission Among Infants Born to HIV-Infected Nigerian Mothers: 
Evidence From the Healthy Beginning Initiative.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Pharr JR</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Obiefune MC</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ezeanolue CO</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Osuji A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ogidi AG</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gbadamosi S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Patel D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Iwelunmor J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Yang W</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ogedegbe G</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ehiri JE</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sam-Agudu NA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ezeanolue EE</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: In 2014, Nigeria accounted for 33% of all new 
childhood HIV infections that occurred among the 22 Global Plan priority
 countries where 80% of HIV-infected women reside. Even with a vertical 
HIV transmission rate of 27%, only 6% of infants born to HIV-infected 
women in Nigeria receive early infant diagnosis (EID). This article 
reports rates of antiretroviral prophylaxis, EID, and mother-to-child 
transmission in a congregation-based Healthy Beginning Initiative (HBI) 
designed to increase HIV testing among pregnant women in southeast 
Nigeria. METHODS: This is a nested cohort study of HIV-exposed infants 
(HEI) within the HBI trial originally designed as a 2-arm cluster 
randomized trial. HIV-infected mothers and infants were followed between
 January 2013 and August 2014. RESULTS: Across both arms of the study, 
72 HIV-infected women delivered 69 live infants (1 set of twins) and 4 
had miscarriages. Of the 69 live-born HEI, HIV status was known for 71% 
(49/69), 16% (11/69) died before sample collection, and 13% (9/69) were 
lost to follow-up. Complete information was available for 84% of HEI 
(58/69), of which 64% (37/58) received antiretroviral prophylaxis. Among
 the 49 infants tested for HIV, 88% (43/49) received EID within 2 months
 and 12% (6/49) received antibody testing after 18 months. The 
mother-to-child transmission rate was 8.2% (4/49). CONCLUSIONS: EID was 
higher and HIV transmission rate was lower among the HBI participants 
compared to reported rates in 2014. However, further progress is needed 
to achieve goals of elimination of infant HIV infection.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2016-08</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>72 Suppl 2</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>S154-60</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Journal of acquired immune deficiency syndromes (1999)</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1097/QAI.0000000000001051">10.1097/QAI.0000000000001051</a></td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1525-4135 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:27 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:27 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Infant, Newborn</li>
					<li>Nigeria</li>
					<li>Infectious Disease Transmission, Vertical/*prevention &amp; control</li>
					<li>Anti-HIV Agents/therapeutic use</li>
					<li>Pregnancy Complications, Infectious/*drug therapy</li>
					<li>Early Diagnosis</li>
					<li>*Evidence-Based Practice</li>
					<li>Comprehensive Health Care</li>
					<li>HIV Infections/diagnosis/drug therapy/*transmission</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_4FFF7ERF">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name</strong> : </p>
<p>Site Names not specified</p>
<p><strong>Location Type</strong> : </p>
<p><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">Church sites</span></span></p>
<p><strong>Description</strong> : </p>
<p><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">40 churches in Enugu State of Nigeria</span></span></p>
<p><strong>sample size</strong> : <span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">3002&nbsp;</span></span></p>
<p></p>
<p></p>
<p></p>
<p></p>
<p></p>
<p></p>
<p><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">&nbsp;</span></span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_XEUHAULF" class="item journalArticle">
			<h2>Low HIV incidence in pregnant and postpartum women receiving a 
community-based combination HIV prevention intervention in a high HIV 
incidence setting in South Africa.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Fatti G</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Shaikh N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Jackson D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Goga A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Nachega JB</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Eley B</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Grimwood A</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Young Southern African women have the highest HIV 
incidence globally. Pregnancy doubles the risk of HIV acquisition 
further, and maternal HIV acquisition contributes significantly to the 
paediatric HIV burden. Little data on combination HIV prevention 
interventions during pregnancy and lactation are available. We measured 
HIV incidence amongst pregnant and postpartum women receiving a 
community-based combination HIV prevention intervention in a high HIV 
incidence setting in South Africa. METHODS: A cohort study that included
 HIV-uninfected pregnant women was performed. Lay community-based 
workers provided individualized HIV prevention counselling and performed
 three-monthly home and clinic-based individual and couples HIV testing.
 Male partners were referred for circumcision, sexually transmitted 
infections or HIV treatment as appropriate. Kaplan-Meier analyses and 
Cox's regression were used to estimate HIV incidence and factors 
associated with HIV acquisition. RESULTS: The 1356 women included 
(median age 22.5 years) received 5289 HIV tests. Eleven new HIV 
infections were detected over 828.3 person-years (PY) of follow-up, with
 an HIV incidence rate of 1.33 infections/100 PY (95% CI: 0.74-2.40). 
Antenatally, the HIV incidence rate was 1.49 infections/100 PY (95% CI: 
0.64-2.93) and postnatally the HIV incidence rate was 1.03 
infections/100 PY (95% CI: 0.33-3.19). 53% of male partners received HIV
 testing and 66% of eligible partners received referral for 
circumcision. Women within known serodiscordant couples, and women with 
newly diagnosed HIV-infected partners, adjusted hazard ratio (aHR) = 
32.7 (95% CI: 3.8-282.2) and aHR = 126.4 (95% CI: 33.8-472.2) had 
substantially increased HIV acquisition, respectively. Women with 
circumcised partners had a reduced risk of incident HIV infection, aHR =
 0.22 (95% CI: 0.03-1.86). CONCLUSIONS: Maternal HIV incidence was 
substantially lower than previous regional studies. Community-based 
combination HIV prevention interventions may reduce high maternal HIV 
incidence in resource-poor settings. Expanded roll-out of home-based 
couples HIV testing and initiating pre-exposure prophylaxis for pregnant
 women within serodiscordant couples is needed in Southern Africa.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2017</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>12</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e0181691</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>PloS one</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1371/journal.pone.0181691">10.1371/journal.pone.0181691</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>7</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1932-6203 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Incidence</li>
					<li>Pregnancy</li>
					<li>Young Adult</li>
					<li>Male</li>
					<li>Postpartum Period</li>
					<li>South Africa/epidemiology</li>
					<li>Adolescent</li>
					<li>Kaplan-Meier Estimate</li>
					<li>Proportional Hazards Models</li>
					<li>Circumcision, Male</li>
					<li>Counseling</li>
					<li>HIV Infections/epidemiology/*prevention &amp; control</li>
					<li>Pregnancy Complications, Infectious/epidemiology/*prevention &amp; control</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_ZY7GCVQV">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name :</strong> T</p>
<p>he exact name of the health facilities are not mentioned</p>
<p><strong>Location Type :</strong> </p>
<p>Health facilities</p>
<p><strong>Descritpion :</strong> </p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Conducted at an urban primary healthcare facility located north of Durban in the eThekwini district, South Africa.</span></span></p>
<p><strong>Sample size :</strong> <span style="color: rgb(32, 32, 32)"><span style="background-color: rgb(255, 255, 255)">1356</span></span></p>
<p></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_WPS34V5J" class="item journalArticle">
			<h2>Low-dose aspirin for the prevention of preterm delivery in 
nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, 
double-blind, placebo-controlled trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hoffman MK</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Goudar SS</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kodkany BS</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Metgud M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Somannavar M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Okitawutshu J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Lokangaka A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Tshefu A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bose CL</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mwapule A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mwenechanya M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chomba E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Carlo WA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chicuy J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Figueroa L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Garces A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Krebs NF</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Jessani S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Zehra F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Saleem S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Goldenberg RL</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kurhe K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Das P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Patel A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hibberd PL</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Achieng E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Nyongesa P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Esamai F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Liechty EA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Goco N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hemingway-Foday J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Moore J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Nolen TL</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>McClure EM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Koso-Thomas M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Miodovnik M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Silver R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Derman RJ</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Preterm birth remains a common cause of neonatal 
mortality, with a disproportionately high burden in low-income and 
middle-income countries. Meta-analyses of low-dose aspirin to prevent 
pre-eclampsia suggest that the incidence of preterm birth might also be 
decreased, particularly if initiated before 16 weeks of gestation. 
METHODS: ASPIRIN was a randomised, multicountry, double-masked, 
placebo-controlled trial of low-dose aspirin (81 mg daily) initiated 
between 6 weeks and 0 days of pregnancy, and 13 weeks and 6 days of 
pregnancy, in nulliparous women with an ultrasound confirming 
gestational age and a singleton viable pregnancy. Participants were 
enrolled at seven community sites in six countries (two sites in India 
and one site each in the Democratic Republic of the Congo, Guatemala, 
Kenya, Pakistan, and Zambia). Participants were randomly assigned (1:1, 
stratified by site) to receive aspirin or placebo tablets of identical 
appearance, via a sequence generated centrally by the data coordinating 
centre at Research Triangle Institute International (Research Triangle 
Park, NC, USA). Treatment was masked to research staff, health 
providers, and patients, and continued until 36 weeks and 7 days of 
gestation or delivery. The primary outcome of incidence of preterm 
birth, defined as the number of deliveries before 37 weeks' gestational 
age, was analysed in randomly assigned women with pregnancy outcomes at 
or after 20 weeks, according to a modified intention-to-treat (mITT) 
protocol. Analyses of our binary primary outcome involved a 
Cochran-Mantel-Haenszel test stratified by site, and generalised linear 
models to obtain relative risk (RR) estimates and associated confidence 
intervals. Serious adverse events were assessed in all women who 
received at least one dose of drug or placebo. This study is registered 
with ClinicalTrials.gov, NCT02409680, and the Clinical Trial 
Registry-India, CTRI/2016/05/006970. FINDINGS: From March 23, 2016 to 
June 30, 2018, 14 361 women were screened for inclusion and 11 976 women
 aged 14-40 years were randomly assigned to receive low-dose aspirin 
(5990 women) or placebo (5986 women). 5780 women in the aspirin group 
and 5764 in the placebo group were evaluable for the primary outcome. 
Preterm birth before 37 weeks occurred in 668 (11.6%) of the women who 
took aspirin and 754 (13.1%) of those who took placebo (RR 0.89 [95% CI 
0.81 to 0.98], p=0.012). In women taking aspirin, we also observed 
significant reductions in perinatal mortality (0.86 [0.73-1.00], 
p=0.048), fetal loss (infant death after 16 weeks' gestation and before 7
 days post partum; 0.86 [0.74-1.00], p=0.039), early preterm delivery 
(&lt;34 weeks; 0.75 [0.61-0.93], p=0.039), and the incidence of women 
who delivered before 34 weeks with hypertensive disorders of pregnancy 
(0.38 [0.17-0.85], p=0.015). Other adverse maternal and neonatal events 
were similar between the two groups. INTERPRETATION: In populations of 
nulliparous women with singleton pregnancies from low-income and 
middle-income countries, low-dose aspirin initiated between 6 weeks and 0
 days of gestation and 13 weeks and 6 days of gestation resulted in a 
reduced incidence of preterm delivery before 37 weeks, and reduced 
perinatal mortality. FUNDING: Eunice Kennedy Shriver National Institute 
of Child Health and Human Development.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2020-01</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>395</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>285-293</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Lancet (London, England)</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1016/S0140-6736(19)32973-3">10.1016/S0140-6736(19)32973-3</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>10220</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>0140-6736 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Young Adult</li>
					<li>Pregnancy Outcome/epidemiology</li>
					<li>Adolescent</li>
					<li>Developing Countries</li>
					<li>Double-Blind Method</li>
					<li>Delivery, Obstetric/statistics &amp; numerical data</li>
					<li>Premature Birth/*epidemiology/prevention &amp; control</li>
					<li>Aspirin/*administration &amp; dosage/adverse effects</li>
					<li>Blood Pressure</li>
					<li>Pre-Eclampsia/*epidemiology/prevention &amp; control</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_JEG6AU8K">
<div><div data-schema-version="8"><p><strong>Location Information:</strong></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Name:</span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">Specific names of the health facilities not given</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Type:</span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">Health facilities</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Description: </span></span></strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Conducted
 at seven community sites in six countries, including two sites in India
 and one site each in the Democratic Republic of the Congo, Guatemala, 
Kenya, Pakistan, and Zambia.</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Sample size : &nbsp;3810</span></span></strong></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_EYI9YEQ5" class="item journalArticle">
			<h2>Low-dose aspirin for the prevention of preterm delivery in 
nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, 
double-blind, placebo-controlled trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hoffman MK</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Goudar SS</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kodkany BS</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Metgud M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Somannavar M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Okitawutshu J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Lokangaka A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Tshefu A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bose CL</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mwapule A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mwenechanya M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chomba E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Carlo WA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chicuy J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Figueroa L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Garces A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Krebs NF</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Jessani S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Zehra F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Saleem S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Goldenberg RL</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kurhe K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Das P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Patel A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hibberd PL</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Achieng E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Nyongesa P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Esamai F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Liechty EA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Goco N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hemingway-Foday J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Moore J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Nolen TL</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>McClure EM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Koso-Thomas M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Miodovnik M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Silver R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Derman RJ</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Preterm birth remains a common cause of neonatal 
mortality, with a disproportionately high burden in low-income and 
middle-income countries. Meta-analyses of low-dose aspirin to prevent 
pre-eclampsia suggest that the incidence of preterm birth might also be 
decreased, particularly if initiated before 16 weeks of gestation. 
METHODS: ASPIRIN was a randomised, multicountry, double-masked, 
placebo-controlled trial of low-dose aspirin (81 mg daily) initiated 
between 6 weeks and 0 days of pregnancy, and 13 weeks and 6 days of 
pregnancy, in nulliparous women with an ultrasound confirming 
gestational age and a singleton viable pregnancy. Participants were 
enrolled at seven community sites in six countries (two sites in India 
and one site each in the Democratic Republic of the Congo, Guatemala, 
Kenya, Pakistan, and Zambia). Participants were randomly assigned (1:1, 
stratified by site) to receive aspirin or placebo tablets of identical 
appearance, via a sequence generated centrally by the data coordinating 
centre at Research Triangle Institute International (Research Triangle 
Park, NC, USA). Treatment was masked to research staff, health 
providers, and patients, and continued until 36 weeks and 7 days of 
gestation or delivery. The primary outcome of incidence of preterm 
birth, defined as the number of deliveries before 37 weeks' gestational 
age, was analysed in randomly assigned women with pregnancy outcomes at 
or after 20 weeks, according to a modified intention-to-treat (mITT) 
protocol. Analyses of our binary primary outcome involved a 
Cochran-Mantel-Haenszel test stratified by site, and generalised linear 
models to obtain relative risk (RR) estimates and associated confidence 
intervals. Serious adverse events were assessed in all women who 
received at least one dose of drug or placebo. This study is registered 
with ClinicalTrials.gov, NCT02409680, and the Clinical Trial 
Registry-India, CTRI/2016/05/006970. FINDINGS: From March 23, 2016 to 
June 30, 2018, 14 361 women were screened for inclusion and 11 976 women
 aged 14-40 years were randomly assigned to receive low-dose aspirin 
(5990 women) or placebo (5986 women). 5780 women in the aspirin group 
and 5764 in the placebo group were evaluable for the primary outcome. 
Preterm birth before 37 weeks occurred in 668 (11.6%) of the women who 
took aspirin and 754 (13.1%) of those who took placebo (RR 0.89 [95% CI 
0.81 to 0.98], p=0.012). In women taking aspirin, we also observed 
significant reductions in perinatal mortality (0.86 [0.73-1.00], 
p=0.048), fetal loss (infant death after 16 weeks' gestation and before 7
 days post partum; 0.86 [0.74-1.00], p=0.039), early preterm delivery 
(&lt;34 weeks; 0.75 [0.61-0.93], p=0.039), and the incidence of women 
who delivered before 34 weeks with hypertensive disorders of pregnancy 
(0.38 [0.17-0.85], p=0.015). Other adverse maternal and neonatal events 
were similar between the two groups. INTERPRETATION: In populations of 
nulliparous women with singleton pregnancies from low-income and 
middle-income countries, low-dose aspirin initiated between 6 weeks and 0
 days of gestation and 13 weeks and 6 days of gestation resulted in a 
reduced incidence of preterm delivery before 37 weeks, and reduced 
perinatal mortality. FUNDING: Eunice Kennedy Shriver National Institute 
of Child Health and Human Development.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2020-01</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 10220
Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>395</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>285-293</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Lancet (London, England)</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1016/S0140-6736(19)32973-3">10.1016/S0140-6736(19)32973-3</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>10220</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>0140-6736 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:30 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:30 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Young Adult</li>
					<li>Pregnancy Outcome/epidemiology</li>
					<li>Adolescent</li>
					<li>Developing Countries</li>
					<li>Double-Blind Method</li>
					<li>Delivery, Obstetric/statistics &amp; numerical data</li>
					<li>Premature Birth/*epidemiology/prevention &amp; control</li>
					<li>Aspirin/*administration &amp; dosage/adverse effects</li>
					<li>Blood Pressure</li>
					<li>Pre-Eclampsia/*epidemiology/prevention &amp; control</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_387QXATQ">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name :</strong> </p>
<p>Names not specified</p>
<p><strong>Location Type: </strong></p>
<p>Community</p>
<p><strong>Description</strong> : <span style="color: rgb(80, 80, 80)"><span style="background-color: rgb(255, 255, 255)">&nbsp;</span></span></p>
<p><span style="color: rgb(80, 80, 80)"><span style="background-color: rgb(255, 255, 255)">Seven
 community sites in six countries (two sites in India and one site each 
in the Democratic Republic of the Congo, Guatemala, Kenya, Pakistan, and
 Zambia)</span></span></p>
<p><strong>Sample size :</strong> <span style="color: rgb(80, 80, 80)"><span style="background-color: rgb(255, 255, 255)">14361</span></span></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_ND3UG6UV" class="item journalArticle">
			<h2>Malaria and gravidity interact to modify maternal haemoglobin concentrations during pregnancy.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ouedraogo S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bodeau-Livinec F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Briand V</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Huynh BT</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Koura GK</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Accrombessi MM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Fievet N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Massougbodji A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Deloron P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Cot M</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Primigravidity is one of the main risk factors for
 both malaria and anaemia. Since the implementation of intermittent 
preventive treatment (IPTp) in sub-Saharan Africa, the relationship 
between anaemia and gravidity and its evolution during pregnancy has 
been little explored. This study aimed to evaluate the impact of 
gravidity on the variation of haemoglobin during pregnancy according to 
the timing of gestation. METHODS: Data from three studies carried out in
 nearby areas in south Benin (Ouidah, Come, Allada) between 2005 and 
2012 were analysed. At inclusion (first antenatal visit, ANV1) women's 
age, area of residence, schooling, gravidity, gestational age, weight 
and height were recorded. Thick blood smears were performed on ANV1, 
second visit (ANV2) and at delivery. In Allada, women's serum ferritin 
and CRP concentrations were also assessed. The impact of gravidity on 
maternal haemoglobin (Hb) was analysed using a logistic or linear 
regression depending on the outcome. The statistical significance was 
set to P &lt; 0.05. RESULTS: In total, data from 3,591 pregnant women 
were analysed. Both univariate and multivariate analyses showed a 
constant association between Hb concentrations and gravidity in the 
three periods of Hb assessment (ANV1, ANV2 and delivery). Mean Hb 
concentration was significantly lower in primigravidae than in 
multigravidae at ANV1 (mean difference = -2.4 g/L, CI 95%: [-3.4, -1.4],
 P &lt; 0.001). Afterwards, there was a significant increase in 
primigravidae only, with a tendency to reversal between primigravidae 
and multigravidae, which was confirmed at delivery (mean difference = 
2.8 g/L, CI 95%: [1.3, 4.2], P &lt; 0.001). The prevalence of malaria 
infection was halved between ANV1 and delivery in primigravidae while it
 decreased by only 38% among multigravidae, who were less prone to 
malaria infection (prevalence at ANV1, 20% and 10% respectively). Iron 
deficiency was more common in multigravidae, and it decreased slightly 
in this group between ANV1 and delivery. CONCLUSION: In a context of 
IPTp, Hb levels improved progressively throughout pregnancy in 
primigravidae, likely as a result of reduction in malaria infection. In 
multigravidae, the improvement was less perceptible and anaemia was 
mainly due to iron deficiency.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2012-10</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>11</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>348</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Malaria journal</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/1475-2875-11-348">10.1186/1475-2875-11-348</a></td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1475-2875 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:34 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:34 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Cohort Studies</li>
					<li>Young Adult</li>
					<li>Benin/epidemiology</li>
					<li>Anemia/*epidemiology</li>
					<li>Antimalarials/therapeutic use</li>
					<li>Hemoglobins/*analysis</li>
					<li>Malaria/*complications/drug therapy/*pathology</li>
					<li>Pregnancy Complications, Infectious/*pathology</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_V7AD5MJU">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name :</strong></p>
<p><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">Ouidah, Com, Allada</span></span></p>
<p><strong>Location Type :</strong></p>
<p><strong> </strong>City</p>
<p><strong>Description :</strong></p>
<p><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">South Benin (Ouidah, Com, Allada)</span></span></p>
<p><strong>Sample Size :</strong> <span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">3,591</span></span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_JL8ZBRXE" class="item journalArticle">
			<h2>Malaria control aimed at the entire population in KwaZulu-Natal negates the need for policies to prevent malaria in pregnancy.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Tsoka-Gwegweni JM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kleinschmidt I</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: South Africa has no policy to prevent malaria in 
pregnancy, despite the adverse effects of the disease in pregnancy. 
However, malaria control measures consisting of indoor residual spraying
 and specific antimalarial treatment have been in place since the 1970s.
 Information on the burden of malaria in pregnancy in South Africa is 
needed to indicate whether a specific policy for malaria prevention in 
pregnancy is necessary. OBJECTIVE: To determine the burden of malaria in
 pregnancy in KwaZulu-Natal (KZN) province, South Africa. METHODS: 
Pregnant women were enrolled at their first antenatal care visit to 
three health facilities in Umkhanyakude health district in northern KZN 
during May 2004 - September 2005 and followed up until delivery. Data 
collection included demographic details, current and previous malaria 
infection during pregnancy, haemoglobin concentrations and birth 
outcomes. RESULTS: Of the 1 406 study participants, more than a quarter 
were younger than 20 years of age, and more than 90% were unemployed and
 unmarried. Although 33.2% of the women were anaemic, this was not 
related to malaria. The prevalence and incidence of malaria were very 
low, and low birth weight was only weakly associated with malaria 
(1/10). CONCLUSION: The low burden of malaria in these pregnant women 
suggests that they have benefited from malaria control strategies in the
 study area. The implication is that additional measures specific for 
malaria prevention in pregnancy are not required. However, ongoing 
monitoring is needed to ensure that malaria prevalence remains low.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2013-01</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: South Africa</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>103</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>172-5</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.7196/samj.6330">10.7196/samj.6330</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>3</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>0256-9574 (Print)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Incidence</li>
					<li>Pregnancy</li>
					<li>Pregnancy Outcome/epidemiology</li>
					<li>Prevalence</li>
					<li>Drug Combinations</li>
					<li>Socioeconomic Factors</li>
					<li>South Africa/epidemiology</li>
					<li>Adolescent</li>
					<li>Outcome Assessment, Health Care</li>
					<li>Antimalarials/therapeutic use</li>
					<li>Pyrimethamine/*therapeutic use</li>
					<li>Sulfadoxine/*therapeutic use</li>
					<li>control</li>
					<li>numerical data</li>
					<li>*Communicable Disease Control/methods/organization &amp; administration/statistics &amp;</li>
					<li>*Insecticides</li>
					<li>*Malaria, Falciparum/drug therapy/epidemiology/prevention &amp; control/transmission</li>
					<li>*Pregnancy Complications, Infectious/drug therapy/epidemiology/prevention &amp;</li>
					<li>Plasmodium falciparum/*drug effects/isolation &amp; purification</li>
					<li>Prenatal Care/methods/statistics &amp; numerical data</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_IUWEN6PL">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name</strong> : </p>
<p>Facility Names not specified</p>
<p><strong>Location Type</strong> : </p>
<p>Health Facility</p>
<p><strong>Description</strong> : T</p>
<p><span style="color: rgb(0, 0, 0)"><span style="background-color: rgb(255, 255, 255)">hree health facilities in Umkhanyakude health district in KwaZulu-Natal (KZN) province, South Africa.</span></span></p>
<p><strong>Sample size : </strong><span style="color: rgb(0, 0, 0)"><span style="background-color: rgb(255, 255, 255)">1 406</span></span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_LH75HLNS" class="item journalArticle">
			<h2>Malaria Infection Is Common and Associated With Perinatal 
Mortality and Preterm Delivery Despite Widespread Use of Chemoprevention
 in Mali: An Observational Study 2010 to 2014.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mahamar A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Andemel N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Swihart B</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sidibe Y</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gaoussou S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Barry A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Traore M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Attaher O</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Dembele AB</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Diarra BS</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Keita S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Dicko A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Duffy PE</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Fried M</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: In malaria-endemic areas, pregnant women and 
especially first-time mothers are more susceptible to Plasmodium 
falciparum. Malaria diagnosis is often missed during pregnancy, because 
many women with placental malaria remain asymptomatic or have 
submicroscopic parasitemia, masking the association between malaria and 
pregnancy outcomes. Severe maternal anemia and low birthweight 
deliveries are well-established sequelae, but few studies have confirmed
 the relationship between malaria infection and severe outcomes like 
perinatal mortality in high transmission zones. METHODS: Pregnant women 
of any gestational age enrolled at antenatal clinic into a longitudinal 
cohort study in Ouelessebougou, Mali, an area of high seasonal malaria 
transmission. Follow-up visits included scheduled and unscheduled visits
 throughout pregnancy. Blood smear microscopy and polymerase chain 
reaction (PCR) analysis were employed to detect both microscopic and 
submicroscopic infections, respectively. Intermittent preventative 
treatment in pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) was 
documented and prompt treatment regardless of symptoms given upon 
malaria diagnosis. RESULTS: Of the 1850 women followed through delivery,
 72.6% of women received 2 or more IPTp-SP doses, 67.2% of women 
experienced at least 1 infection between enrollment up to and including 
delivery. Malaria infection increased the risks of stillbirth (adjusted 
hazard ratio [aHR] 3.87, 95% confidence interval [CI]: 1.18-12.71) and 
preterm delivery (aHR 2.41, 95% CI: 1.35-4.29) in primigravidae, and 
early neonatal death (death within 7 days) in secundigravidae and 
multigravidae (aHR 6.30, 95% CI: 1.41-28.15). CONCLUSIONS: Malaria 
treatment after diagnosis, alongside IPTp-SP, is insufficient to prevent
 malaria-related stillbirth, early neonatal death and preterm delivery 
(PTD). Although IPTp-SP was beneficial in Mali during the study period, 
new tools are needed to improve pregnancy outcomes. CLINICAL TRIALS 
REGISTRATION: NCT01168271.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2021-10</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 8
Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>73</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>1355-1361</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1093/cid/ciab301">10.1093/cid/ciab301</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>8</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1058-4838 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:28 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:28 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Infant, Newborn</li>
					<li>Longitudinal Studies</li>
					<li>Drug Combinations</li>
					<li>*Perinatal Death</li>
					<li>control</li>
					<li>Placenta</li>
					<li>Pyrimethamine/therapeutic use</li>
					<li>Sulfadoxine/therapeutic use</li>
					<li>Mali/epidemiology</li>
					<li>Perinatal Mortality</li>
					<li>*Premature Birth/epidemiology/prevention &amp; control</li>
					<li>*Malaria/drug therapy/epidemiology/prevention &amp; control</li>
					<li>*Antimalarials/therapeutic use</li>
					<li>*early neonatal death</li>
					<li>*intermittent preventative treatment in pregnancy</li>
					<li>*Malaria, Falciparum/drug therapy/epidemiology/prevention &amp; control</li>
					<li>*Pregnancy Complications, Parasitic/drug therapy/epidemiology/prevention &amp;</li>
					<li>*pregnancy malaria</li>
					<li>*preterm delivery</li>
					<li>*stillbirth</li>
					<li>Chemoprevention</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_FMW5HJBN">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name : </strong></p>
<p><span style="color: rgb(42, 42, 42)"><span style="background-color: rgb(255, 255, 255)">Oulessbougou</span></span></p>
<p><strong>Location Type : </strong></p>
<p>Town</p>
<p><strong>Description : &nbsp;</strong></p>
<p><span style="color: rgb(42, 42, 42)"><span style="background-color: rgb(255, 255, 255)">Oulessbougou, Mali, located 80 km south of Bamako</span></span></p>
<p><strong>Sample size : </strong><span style="color: rgb(42, 42, 42)"><span style="background-color: rgb(239, 242, 247)">1850</span></span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_ZEXX7VWD" class="item journalArticle">
			<h2>Male partner circumcision associated with lower Trichomonas 
vaginalis incidence among pregnant and postpartum Kenyan women: a 
prospective cohort study.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Pintye J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Drake AL</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Unger JA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Matemo D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kinuthia J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>McClelland RS</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>John-Stewart G</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>OBJECTIVE: Trichomonas vaginalis is the world's most common 
curable STI and has implications for reproductive health in women. We 
determined incidence and correlates of T. vaginalis in an HIV-uninfected
 peripartum cohort. METHODS: Women participating in a prospective study 
of peripartum HIV acquisition in Western Kenya were enrolled during 
pregnancy and followed until 9 months post partum. T. vaginalis was 
assessed every 1-3 months using wet mount microscopy. Correlates of 
incident T. vaginalis were determined using Cox proportional hazards 
models. RESULTS: Among 1271 women enrolled, median age was 22 years (IQR
 19-27) and gestational age was 22 weeks (IQR 18-26); most (78%) were 
married and had uncircumcised male partners (69%). Prevalent T. 
vaginalis was detected in 81 women (6%) at enrolment. Among women 
without T. vaginalis at enrolment, 112 had T. vaginalis detected during 
1079 person-years of follow-up (10.4 per 100 person-years). After 
adjustment for socio-economic factors, male partner circumcision status,
 pregnancy status and other STIs, T. vaginalis incidence was higher 
during pregnancy than post partum (22.3 vs 7.7 per 100 person-years, 
adjusted HR (aHR) 3.68, 95% CI 1.90 to 7.15, p&lt;0.001). Women with 
circumcised male partners had a 58% lower risk of incident T. vaginalis 
compared with women with uncircumcised partners (aHR 0.42, 95% CI 0.23 
to 0.76, p=0.004). Employed women had lower risk of incident T. 
vaginalis than unemployed women (aHR 0.49, 95% CI 0.31 to 0.79, 
p=0.003); recent STI was associated with increased T. vaginalis risk 
(aHR 2.97, 95% CI 1.49 to 5.94, p=0.002). CONCLUSIONS: T. vaginalis was 
relatively common in this peripartum cohort. Male circumcision may 
confer benefits in preventing T. vaginalis.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2017-03</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>93</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>137-143</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Sexually transmitted infections</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1136/sextrans-2016-052629">10.1136/sextrans-2016-052629</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>2</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1368-4973 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Incidence</li>
					<li>Pregnancy</li>
					<li>Prospective Studies</li>
					<li>Male</li>
					<li>Prevalence</li>
					<li>Postpartum Period</li>
					<li>Kenya/epidemiology</li>
					<li>*Sexual Partners</li>
					<li>*EPIDEMIOLOGY (CLINICAL)</li>
					<li>*PREGNANCY</li>
					<li>*TRICHOMONAS</li>
					<li>*WOMEN</li>
					<li>Circumcision, Male/*statistics &amp; numerical data</li>
					<li>Pregnancy Complications, Infectious/*epidemiology/*prevention &amp; control</li>
					<li>Trichomonas Infections/*epidemiology/*prevention &amp; control</li>
					<li>Trichomonas vaginalis</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_UPC4TZ68">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Name: &nbsp;</span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">Names of health facilities not mentioned</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Type: </span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">health facilities</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Description: </span></span></strong>Western Kenya</p>
<p><strong>Sample Size</strong>: &nbsp;1271</p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_EBPW7S67" class="item journalArticle">
			<h2>Maternal and Infant Lipid-Based Nutritional Supplementation 
Increases Height of Ghanaian Children at 46 Years Only if the Mother 
Was Not Overweight Before Conception</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kumordzie Sika M,Adu-Afarwuah Seth</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Adu-Afarwuah Seth,Arimond Mary</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>October 2018</td>
					</tr>
					<tr>
					<th>URL</th>
						<td><a href="https://doi.org/10.1093/jn/nxz005">https://doi.org/10.1093/jn/nxz005</a></td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>3/8/2024, 11:17:30 AM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>3/8/2024, 11:20:32 AM</td>
					</tr>
				</tbody></table>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_5RPQ9FEZ">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name</strong> : </p>
<p><span style="color: rgb(31, 31, 31)">Yilo and Lower Manya Krobo</span></p>
<p><strong>Location Type</strong> : &nbsp;</p>
<p>District</p>
<p><strong>Description</strong> : </p>
<p><span style="color: rgb(31, 31, 31)">Yilo and Lower Manya Krobo districts of the Eastern Region of Ghana</span></p>
<p><strong>Sample size</strong> : <span style="color: rgb(31, 31, 31)">1320</span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_4HWI4XYX" class="item journalArticle">
			<h2>Maternal and neonatal outcomes after caesarean delivery in the 
African Surgical Outcomes Study: a 7-day prospective observational 
cohort study.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bishop D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Dyer RA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Maswime S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Rodseth RN</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>van Dyk D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kluyts HL</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Tumukunde JT</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Madzimbamuto FD</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Elkhogia AM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ndonga AKN</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ngumi ZWW</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Omigbodun AO</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Amanor-Boadu SD</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Zoumenou E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Basenero A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Munlemvo DM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Youssouf C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ndayisaba G</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Antwi-Kusi A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gobin V</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Forget P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mbwele B</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ndasi H</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Rakotoarison SR</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Samateh AL</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mehyaoui R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Patel-Mujajati U</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sani CM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Esterhuizen TM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Madiba TE</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Pearse RM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Biccard BM</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Maternal and neonatal mortality is high in Africa,
 but few large, prospective studies have been done to investigate the 
risk factors associated with these poor maternal and neonatal outcomes. 
METHODS: A 7-day, international, prospective, observational cohort study
 was done in patients having caesarean delivery in 183 hospitals across 
22 countries in Africa. The inclusion criteria were all consecutive 
patients (aged &gt;/=18 years) admitted to participating centres having 
elective and non-elective caesarean delivery during the 7-day study 
cohort period. To ensure a representative sample, each hospital had to 
provide data for 90% of the eligible patients during the recruitment 
week. The primary outcome was in-hospital maternal mortality and 
complications, which were assessed by local investigators. The study was
 registered on the South African National Health Research Database, 
number KZ_2015RP7_22, and on ClinicalTrials.gov, number NCT03044899. 
FINDINGS: Between February, 2016, and May, 2016, 3792 patients were 
recruited from hospitals across Africa. 3685 were included in the 
postoperative complications analysis (107 missing data) and 3684 were 
included in the maternal mortality analysis (108 missing data). These 
hospitals had a combined number of specialist surgeons, obstetricians, 
and anaesthetists totalling 0.7 per 100 000 population (IQR 0.2-2.0). 
Maternal mortality was 20 (0.5%) of 3684 patients (95% CI 0.3-0.8). 
Complications occurred in 633 (17.4%) of 3636 mothers (16.2-18.6), which
 were predominantly severe intraoperative and postoperative bleeding 
(136 [3.8%] of 3612 mothers). Maternal mortality was independently 
associated with a preoperative presentation of placenta praevia, 
placental abruption, ruptured uterus, antepartum haemorrhage (odds ratio
 4.47 [95% CI 1.46-13.65]), and perioperative severe obstetric 
haemorrhage (5.87 [1.99-17.34]) or anaesthesia complications (11.47 
(1.20-109.20]). Neonatal mortality was 153 (4.4%) of 3506 infants (95% 
CI 3.7-5.0). INTERPRETATION: Maternal mortality after caesarean delivery
 in Africa is 50 times higher than that of high-income countries and is 
driven by peripartum haemorrhage and anaesthesia complications. Neonatal
 mortality is double the global average. Early identification and 
appropriate management of mothers at risk of peripartum haemorrhage 
might improve maternal and neonatal outcomes in Africa. FUNDING: Medical
 Research Council of South Africa.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2019-04</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 4
Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>7</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e513-e522</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>The Lancet. Global health</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1016/S2214-109X(19)30036-1">10.1016/S2214-109X(19)30036-1</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>4</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>2214-109X (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:41 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:41 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>*Pregnancy Complications</li>
					<li>Infant, Newborn</li>
					<li>Prospective Studies</li>
					<li>Risk Factors</li>
					<li>Infant</li>
					<li>South Africa/epidemiology</li>
					<li>Maternal Mortality</li>
					<li>*Infant Mortality</li>
					<li>Postoperative Complications/*epidemiology</li>
					<li>*Treatment Outcome</li>
					<li>Cesarean Section/*adverse effects/*mortality</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_8JFKFMPQ">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name :</strong> &nbsp;<a href="https://www.thelancet.com/cms/10.1016/S2214-109X(19)30036-1/attachment/a20d8bdb-ccc8-4e6f-9a42-3bb58d6baf7b/mmc1.pdf" rel="noopener noreferrer nofollow">https://www.thelancet.com/cms/10.1016/S2214-109X(19)30036-1/attachment/a20d8bdb-ccc8-4e6f-9a42-3bb58d6baf7b/mmc1.pdf</a></p>
<p><strong>Location Type :</strong> &nbsp;Health faciilities</p>
<p><strong>Description </strong></p>
<p>183 hospitals from 22 African countries participated in the ASOS obstetric substudy</p>
<ul>
<li>
<span style="color: var(--primary-text)"><span style="background-color: rgb(255, 255, 255)">Benin (9 hospitals)</span></span>
</li>
<li>
<span style="color: var(--primary-text)"><span style="background-color: rgb(255, 255, 255)">Burundi (6 hospitals)</span></span>
</li>
<li>
<span style="color: var(--primary-text)"><span style="background-color: rgb(255, 255, 255)">Republic of the Congo (1 hospital)</span></span>
</li>
<li>
<span style="color: var(--primary-text)"><span style="background-color: rgb(255, 255, 255)">Democratic Republic of the Congo (16 hospitals)</span></span>
</li>
<li>
<span style="color: var(--primary-text)"><span style="background-color: rgb(255, 255, 255)">Ethiopia (2 hospitals)</span></span>
</li>
<li>
<span style="color: var(--primary-text)"><span style="background-color: rgb(255, 255, 255)">The Gambia (5 hospitals)</span></span>
</li>
<li>
<span style="color: var(--primary-text)"><span style="background-color: rgb(255, 255, 255)">Madagascar (6 hospitals)</span></span>
</li>
<li>
<span style="color: var(--primary-text)"><span style="background-color: rgb(255, 255, 255)">Mali (9 hospitals)</span></span>
</li>
<li>
<span style="color: var(--primary-text)"><span style="background-color: rgb(255, 255, 255)">Niger (1 hospital)</span></span>
</li>
<li>
<span style="color: var(--primary-text)"><span style="background-color: rgb(255, 255, 255)">Tanzania (3 hospitals)</span></span>
</li>
<li>
<span style="color: var(--primary-text)"><span style="background-color: rgb(255, 255, 255)">Uganda (8 hospitals)</span></span>
</li>
<li>
<span style="color: var(--primary-text)"><span style="background-color: rgb(255, 255, 255)">Zimbabwe (19 hospitals)</span></span>
</li>
<li>
<span style="color: var(--primary-text)"><span style="background-color: rgb(255, 255, 255)">Algeria (2 hospitals)</span></span>
</li>
<li>
<span style="color: var(--primary-text)"><span style="background-color: rgb(255, 255, 255)">Cameroon (5 hospitals)</span></span>
</li>
<li>
<span style="color: var(--primary-text)"><span style="background-color: rgb(255, 255, 255)">Ghana (2 hospitals)</span></span>
</li>
<li>
<span style="color: var(--primary-text)"><span style="background-color: rgb(255, 255, 255)">Kenya (5 hospitals)</span></span>
</li>
<li>
<span style="color: var(--primary-text)"><span style="background-color: rgb(255, 255, 255)">Libya (6 hospitals)</span></span>
</li>
<li>
<span style="color: var(--primary-text)"><span style="background-color: rgb(255, 255, 255)">Mauritius (6 hospitals)</span></span>
</li>
<li>
<span style="color: var(--primary-text)"><span style="background-color: rgb(255, 255, 255)">Namibia (15 hospitals)</span></span>
</li>
<li>
<span style="color: var(--primary-text)"><span style="background-color: rgb(255, 255, 255)">Nigeria (10 hospitals)</span></span>
</li>
<li>
<span style="color: var(--primary-text)"><span style="background-color: rgb(255, 255, 255)">South Africa (44 hospitals)</span></span>
</li>
<li>
<span style="color: var(--primary-text)"><span style="background-color: rgb(255, 255, 255)">Zambia (3 hospitals)</span></span><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">.</span></span>
</li>
</ul>
<p><strong>Sample Size : </strong><span style="color: rgb(80, 80, 80)"><span style="background-color: rgb(255, 255, 255)">3792</span></span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_E3LD24N4" class="item journalArticle">
			<h2>Maternal and newborn effects of gestational diabetes mellitus: A prospective cohort study.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Feleke BE</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Feleke TE</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Adane WG</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kassahun MB</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Girma A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Alebachew A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Misgan E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mekonnin AW</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Guadie W</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Engedaw HA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gebeyehu M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Biadglegne F</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Gestational diabetes mellitus (GDM) is a high 
glucose level detected during pregnancy and usually it disappears after 
42 days of post partum. The aim of this research was to assess the 
maternal and newborn effects of GDM in resource limited settings. 
METHODS: A prospective cohort was implemented in the five referral 
hospitals of Amhara region. Data were collected using both primary data 
collection tool and reviewing the patients' charts. Descriptive 
statistics were used to describe the effects of GDM on the pregnancy 
outcomes, fractional regression was used to estimate the proportion of 
weight gain in the first 3 months, Poisson regression was used to 
identify the effects of GDM on the episodes of childhood infectious 
diseases, independent sample t-test was used to estimate the effects of 
GDM on the newborn serum zinc and vitamin D levels. RESULTS: A total of 
3459 women were included with a response rate of 85.56%. Cesarean 
section rate among GDM mother was 40.3% and among GDM free mothers was 
7.1%. In the first 3 months, the weight gains of infant born from GDM 
mothers were 53% higher than infant born from GDM free mothers. GDM 
increases the risk of infectious disease episodes by 4 folds. GDM 
decreases the neonatal serum zinc and vitamin D levels. CONCLUSION: GDM 
increases the maternal complications of pregnancy; GDM significantly 
depletes the newborn micronutrient levels and increase the episodes of 
infectious diseases during the infancy periods.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2022-02</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>16</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>89-95</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Primary care diabetes</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1016/j.pcd.2021.09.007">10.1016/j.pcd.2021.09.007</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1878-0210 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>*birth outcomes</li>
					<li>Cohort Studies</li>
					<li>Infant, Newborn</li>
					<li>Prospective Studies</li>
					<li>Cesarean Section</li>
					<li>Infant</li>
					<li>Ethiopia</li>
					<li>*Diabetes, Gestational/diagnosis/epidemiology</li>
					<li>*Diabetes</li>
					<li>*Diabetes Mellitus</li>
					<li>*Gestational</li>
					<li>*Pregnancy-Induced</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_RJD2QD48">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location Name :</strong> </p>
<p>The exact name of the health facilities are not mentioned</p>
<p><strong>Location Type :</strong> </p>
<p>Health facilities</p>
<p><strong>Descritpion :</strong> </p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">The study was conducted in the five referral hospitals of the Amhara region in Ethiopia</span></span></p>
<p><strong>Sample size :</strong> <span style="color: rgb(80, 80, 80)"><span style="background-color: rgb(255, 255, 255)">3459</span></span></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_JILVMR2K" class="item journalArticle">
			<h2>Maternal body mass index and adverse pregnancy outcomes: A ghanaian cohort study.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Van Der Linden EL</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Browne JL</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Vissers KM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Antwi E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Agyepong IA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Grobbee DE</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Klipstein-Grobusch K</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>OBJECTIVE: To examine the association between maternal weight 
at &lt;17 weeks gestation and maternal and infant outcomes of pregnancy,
 delivery, and the postpartum period in pregnant Ghanaian women. 
METHODS: A prospective cohort study of 1,000 women in Accra, Ghana 
(2012-2014), was conducted. Women were classified as having overweight 
(BMI 25-30) and obesity (BMI &gt;/= 30), and their obstetric and infant 
outcomes were analyzed using multivariate logistic regression. RESULTS: 
The analysis included 824 women, average 28 years (SD 5.1); 313 (31.3%) 
had overweight and 169 (16.9%) obesity. Women with obesity had a 
two-fold increased risk for cesarean sections (RR 2.20, 95% CI 
1.21-4.02) and more than a six-fold higher risk for pregnancy-induced 
hypertension (RR 6.17, 95% CI 2.90-13.13) and chronic hypertension (RR 
6.00, 95% CI 1.40-25.76). Infants of women with overweight or obesity 
were more likely to be macrosomic (RR 2.37, 95% CI 1.13-4.97). 
CONCLUSIONS: The global obesity epidemic has reached women in low- and 
middle-income countries (LMIC) with important adverse consequences for 
maternal and infant health. Antenatal care in LMIC will need to 
anticipate this potential expansion of complications, including the 
development of guidelines for optimal maternity care for pregnant women 
with overweight and obesity.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2016-01</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 1
Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>24</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>215-22</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Obesity (Silver Spring, Md.)</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1002/oby.21210">10.1002/oby.21210</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1930-7381 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:27 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:27 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Cohort Studies</li>
					<li>Ghana</li>
					<li>Infant, Newborn</li>
					<li>Prospective Studies</li>
					<li>Risk Factors</li>
					<li>Pregnancy Outcome/*epidemiology</li>
					<li>*Developing Countries</li>
					<li>Gestational Age</li>
					<li>Hypertension, Pregnancy-Induced/epidemiology</li>
					<li>Infant</li>
					<li>Pregnancy Complications/*epidemiology</li>
					<li>*Body Mass Index</li>
					<li>Obesity/*epidemiology</li>
					<li>Fetal Macrosomia/epidemiology</li>
					<li>Cesarean Section/adverse effects</li>
					<li>Overweight/*epidemiology</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_LQANSA7W">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name</strong> : Facility names not specified</p>
<p><strong>Location Type</strong> : </p>
<p>Health Facility</p>
<p><strong>Description</strong> :</p>
<p> Two public hospitals in Accra, capital city of Ghana</p>
<p><strong>sample size</strong> : 1010</p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_KUYTHY9D" class="item journalArticle">
			<h2>Maternal demographic and antenatal factors, low birth weight and 
preterm birth: findings from the mother and child in the environment 
(MACE) birth cohort, Durban, South Africa.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Jeena PM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Asharam K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mitku AA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Naidoo P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Naidoo RN</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Low birthweight (LBW) and preterm birth (PB) 
remain the leading cause of morbidity and mortality in neonates 
worldwide. The aim of this study was to identify maternal demographic 
and antenatal factors associated with PB and LBW among low 
socio-economic communities. METHODS: Pregnant women (n = 1099) were 
recruited in the first trimester into the Mother and Child in the 
Environment (MACE) birth cohort in Durban, South Africa. Maternal 
factors such as demographic information, health status, residential 
area, occupational, personal and environmental smoking and biomass fuel 
use were obtained through standardised interviews, while clinical status
 was obtained in each trimester and antenatal information on HIV status 
and treatment, syphilis and conditions such as pregnancy induced 
hypertension, diabetes etc. was extracted from the antenatal 
assessments. Key outcomes of interest were preterm birth and low 
birthweight. The latter data was obtained from the clinical assessments 
performed by midwives at delivery. Logistic regression models identified
 factors associated with PB and LBW. RESULTS: Of the 760 live births, 
16.4 and 13.5% were preterm and LBW, respectively. Mothers who delivered
 by caesarean section had an increased odds of having LBW babies 
(Adjusted odds ratio (AOR): 1.7; 95% CI: 1.1-2.7) and PB (AOR: 1.7, 95% 
CI: 1.1-2.7) versus normal vaginal deliveries. Mothers &gt; 30 years 
(AOR: 1.8, 95% CI: 1.1-2.9) and current smokers (AOR: 2.7, 95% CI: 
1.3-5.8) had an increased odds of having PB babies. Compared to younger 
mothers and non-smokers respectively. An effect of PB and LBW was seen 
among mothers with high BMI (25.0-29.9 kg/m(2)) (PB: AOR: 0.5, 95% CI: 
0.3-0.9 and LBW: AOR: 0.5, 0.5, CI: 0.3-0.8), and obese BMI (&gt; 30 
kg/m(2)) (PB: AOR: 0.5, 95% CI: 0.3-0.9 and LBW: AOR: 0.4, CI: 0.2-0.7).
 Maternal HIV (PB AOR: 1.4 and LBW AOR: 1.2) and history of sexually 
transmitted infections (PB AOR: 2.7 and LBW AOR: 4.2) were not 
statistically significant. CONCLUSION: Maternal age, cigarette smoking 
and caesarean delivery were associated with LBW and PB. Findings 
highlight the need of maternal health interventions to improve new-born 
health outcomes.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2020-10</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 1
Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>20</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>628</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>BMC pregnancy and childbirth</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/s12884-020-03328-6">10.1186/s12884-020-03328-6</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1471-2393 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:25 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:25 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Infant, Newborn</li>
					<li>Young Adult</li>
					<li>Risk Factors</li>
					<li>Longitudinal Studies</li>
					<li>*Infant, Low Birth Weight</li>
					<li>South Africa/epidemiology</li>
					<li>Adolescent</li>
					<li>Infant, Premature</li>
					<li>Case-Control Studies</li>
					<li>Mothers/statistics &amp; numerical data</li>
					<li>Cesarean Section/*statistics &amp; numerical data</li>
					<li>*Maternal Age</li>
					<li>Age</li>
					<li>Caesarean delivery</li>
					<li>Cigarette smoking</li>
					<li>Low birthweight</li>
					<li>Premature Birth/*epidemiology/prevention &amp; control</li>
					<li>Preterm birth</li>
					<li>Risk Assessment/statistics &amp; numerical data</li>
					<li>Smoking/*epidemiology</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_7ZFJUR7Z">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name</strong>:</p>
<p> <span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">Durban, South Africa.</span></span></p>
<p><strong>Location Type</strong> :</p>
<p> City</p>
<p><strong>Description</strong> : </p>
<p><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">Durban, South Africa.</span></span></p>
<p><strong>Sample size : 1099</strong></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_QZAE3LQP" class="item journalArticle">
			<h2>Maternal Dietary L-Arginine and Adverse Birth Outcomes in Dar es Salaam, Tanzania.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Darling AM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>McDonald CR</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Urassa WS</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kain KC</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mwiru RS</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Fawzi WW</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>The amino acid arginine is a physiological precursor to nitric
 oxide, which is a key mediator of embryonic survival, fetal growth, and
 pregnancy maintenance. We evaluated the association between consumption
 of the amino acid arginine and the rate of adverse birth outcomes using
 data from a double-blind, randomized, placebo-controlled micronutrient 
supplementation trial among pregnant women in Dar es Salaam, Tanzania 
(2001-2004). Dietary intakes of arginine were assessed using repeated 
24-hour recalls that were administered throughout pregnancy. 
Participants (n = 7,591) were monitored by research midwives throughout 
follow-up to assess pregnancy outcomes. Cubic-restricted splines and 
multivariable log-Poisson regression with empirical standard errors were
 used to estimate the continuous and categorical associations between 
arginine intake and adverse birth outcomes. Compared with women within 
the lowest quintile of arginine intake, those within the highest 
quintile had 0.79 times the risk of preterm birth before 37 weeks (95% 
confidence interval: 0.63, 1.00; P = 0.03). The continuous associations 
of arginine intake with preterm birth before 37 weeks and with preterm 
birth before 34 weeks were characterized by an initial rapid decrease in
 risk with increasing intake (P for nonlinearity &lt; 0.01). Arginine 
intake was not associated with fetal loss or giving birth to infants who
 were born small for their gestational ages. This data suggest that the 
association between dietary arginine intake and preterm birth warrants 
further investigation.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2017-09</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>186</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>603-611</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>American journal of epidemiology</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1093/aje/kwx080">10.1093/aje/kwx080</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>5</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>0002-9262 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Infant, Newborn</li>
					<li>Prospective Studies</li>
					<li>Pregnancy Outcome/*epidemiology</li>
					<li>Tanzania</li>
					<li>Tanzania/epidemiology</li>
					<li>birth outcomes</li>
					<li>pregnancy</li>
					<li>Randomized Controlled Trials as Topic</li>
					<li>Premature Birth/*epidemiology/prevention &amp; control</li>
					<li>*Diet</li>
					<li>arginine</li>
					<li>Arginine/administration &amp; dosage/*physiology</li>
					<li>Dietary Supplements/statistics &amp; numerical data</li>
					<li>Micronutrients/administration &amp; dosage/physiology</li>
					<li>nutrition</li>
					<li>Poisson Distribution</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_Q7582E5W">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location Name</strong> : </p>
<p>The exact name of the clinics are not mentioned</p>
<p><strong>Location Type</strong> : </p>
<p>Health facilities (antenatal clinics)</p>
<p><strong>Description</strong> : </p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Conducted in Dar es Salaam, Tanzania</span></span></p>
<p><strong>Sample size</strong> : <span style="color: rgb(42, 42, 42)"><span style="background-color: rgb(255, 255, 255)">7,591</span></span></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_NUEL8HYW" class="item journalArticle">
			<h2>Maternal exposure to arsenic and mercury and associated risk of 
adverse birth outcomes in small-scale gold mining communities in 
Northern Tanzania.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Nyanza EC</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Dewey D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Manyama M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Martin JW</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hatfield J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bernier FP</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Exposure to arsenic and mercury in artisanal and 
small-scale gold mining (ASGM) communities is an issue that 
predominantly affects low and middle-income countries. Large 
epidemiology studies in these communities are rare, and the impact of 
such exposures on reproductive outcomes are not well understood. 
OBJECTIVE: To examine associations between prenatal maternal arsenic and
 mercury exposure and birth outcomes in both ASGM and non-ASGM 
communities in Northern Tanzania. METHODS: This longitudinal prospective
 study included 961 women (ASGM = 788, non-ASGM = 173) of the original 
cohort of 1056 who were followed until a pregnancy outcome was 
registered. Maternal spot urine samples and dried blood spots were used 
to measure total arsenic (T-As) and total mercury (T-Hg) in the second 
trimester of pregnancy. Data on adverse birth outcomes were collected in
 5 categories: spontaneous abortion, stillbirth, preterm birth, low 
birth weight, and visible congenital anomalies. Mann-Whitney U-tests 
were used to test for differences between median T-As and T-Hg by area 
of residence. Logistic regression models were used to estimate the odds 
of stillbirth and visible congenital anomalies given maternal T-As and 
T-Hg levels. Modified Poisson regressions were used to estimate relative
 risk ratios between maternal T-As and T-Hg levels and composite adverse
 birth outcome, spontaneous abortion, low birth weight, and preterm 
birth. RESULTS: Statistically significant differences were found in 
median T-As (9.6 vs. 6.3 microg/L, Mann-Whitney U-tests, Z = -3.50, p 
&lt; 0.001) and median T-Hg blood concentrations (1.2 vs. 0.70 microg/L,
 Z = -9.88, p-value &lt; 0.001) between women living in ASGM and 
non-ASGM areas respectively. In ASGM areas, the adjusted relative risk 
(aRR) of a composite adverse birth outcome increased with increasing 
T-As (aRR 1.23, 95%CI: 1.14-1.33, p &lt; 0.0001) and T-Hg (aRR 1.17, 
95%CI: 1.1-1.25, p &lt; 0.0001) exposure. Spontaneous abortion (aRR 
1.53, 95%CI: 1.28-1.83), stillbirth (adjusted odds ratio (aOR) 1.97, 
95%CI: 1.45-2.66) and preterm birth (1.17, 95%CI: 1.01-1.36) were 
significantly associated with elevated T-As, whereas elevated T-Hg was 
significantly associated with stillbirth (aOR 2.49, 95%CI: 1.88-3.29) 
and visible congenital anomalies (aOR 2.24, 95%CI: 1.3-3.87). 
CONCLUSION: Over half (54.7%) of women in ASGM areas of Northern 
Tanzania had adverse birth outcomes and the risk of adverse birth 
outcomes was significantly associated with increased prenatal exposure 
to arsenic and mercury.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2020-04</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: Netherlands</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>137</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>105450</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Environment international</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1016/j.envint.2019.105450">10.1016/j.envint.2019.105450</a></td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>0160-4120 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Infant, Newborn</li>
					<li>Prospective Studies</li>
					<li>*Pregnancy Outcome</li>
					<li>Infant, Low Birth Weight</li>
					<li>Stillbirth</li>
					<li>Tanzania</li>
					<li>*Arsenic</li>
					<li>*Arsenic/toxicity</li>
					<li>*Birth outcome</li>
					<li>*Maternal Exposure</li>
					<li>*Mercury</li>
					<li>*Mercury/toxicity</li>
					<li>*Mining</li>
					<li>*Prenatal exposure</li>
					<li>*Preterm birth</li>
					<li>*Spontaneous abortion</li>
					<li>Abortion, Spontaneous</li>
					<li>Congenital Abnormalities</li>
					<li>Environmental Exposure</li>
					<li>Gold</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_IH8WK77H">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location Name</strong> :</p>
<p>The exact name of the health facilities are not mentioned</p>
<p><strong>Location Type</strong> : </p>
<p>Health facilities</p>
<p><strong>Description</strong> : </p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Conducted in two districts in Tanzania: Geita District and Magu District.</span></span></p>
<p><strong>Sample size</strong> : <span style="color: rgb(31, 31, 31)">1078</span></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_MUF5H7KN" class="item journalArticle">
			<h2>Maternal health outcomes among HIV-infected breastfeeding women with high CD4 counts: results of a treatment strategy trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hoffman RM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Angelidou KN</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Brummel SS</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Saidi F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Violari A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Dula D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mave V</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Fairlie L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Theron G</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kamateeka M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chipato T</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chi BH</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Stranix-Chibanda L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Nematadzira T</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Moodley D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bhattacharya D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gupta A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Coletti A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>McIntyre JA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Klingman KL</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chakhtoura N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Shapiro DE</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Fowler MG</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Currier JS</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: IMPAACT PROMISE 1077BF/FF was a randomized study 
of antiretroviral therapy (ART) strategies for pregnant and postpartum 
women with high CD4+ T-cell counts. We describe postpartum outcomes for 
women in the study who were randomized to continue or discontinue ART 
after delivery. METHODS: Women with pre-ART CD4+ cell counts &gt;/=350 
cells/mm(3) who started ART during pregnancy were randomized postpartum 
to continue or discontinue treatment. Women were enrolled from India, 
Malawi, South Africa, Tanzania, Uganda, Zambia, and Zimbabwe. The 
primary outcome was a composite of progression to AIDS-defining illness 
or death. Log-rank tests and Cox regression models assessed treatment 
effects. Incidence rates were calculated per 100 person-years. A post 
hoc analysis evaluated WHO Stage 2/3 events. All analyses were 
intent-to-treat. FINDINGS: 1611 women were enrolled (June 2011-October 
2014) and 95% were breastfeeding. Median age at entry was 27 years, CD4+
 count 728 cells/mm(3) and the majority of women were Black African 
(97%). After a median follow-up of 1.6 years, progression to 
AIDS-defining illness or death was rare and there was no significant 
difference between arms (HR: 0.55; 95%CI 0.14, 2.08, p = 0.37). WHO 
Stage 2/3 events were reduced with continued ART (HR: 0.60; 95%CI 0.39, 
0.90, p = 0.01). The arms did not differ with respect to the rate of 
grade 2, 3, or 4 safety events (p = 0.61). INTERPRETATION: Serious 
clinical events were rare among predominately breastfeeding women with 
high CD4+ cell counts over 18 months after delivery. ART had significant
 benefit in reducing WHO 2/3 events in this population.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2018-12</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>19</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>209-224</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>HIV clinical trials</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1080/15284336.2018.1537327">10.1080/15284336.2018.1537327</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>6</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1528-4336 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>CD4 Lymphocyte Count</li>
					<li>Young Adult</li>
					<li>Breast Feeding</li>
					<li>Postpartum Period</li>
					<li>Treatment Outcome</li>
					<li>*Maternal Health</li>
					<li>Anti-HIV Agents/*therapeutic use</li>
					<li>*Antiretroviral Therapy, Highly Active</li>
					<li>*antiretroviral therapy (ART)</li>
					<li>*HIV and breastfeeding</li>
					<li>*HIV/AIDS</li>
					<li>*postpartum maternal health</li>
					<li>Disease Progression</li>
					<li>HIV Infections/*drug therapy/virology</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_YEZTUJ6I">
<div><div data-schema-version="8"><p><strong>Location Information:</strong></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Name:</span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">Specific names of the health facilities not given</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Type:</span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">Health facilities</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Description: </span></span></strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Conducted in 15 sites in India, Malawi, South Africa, Tanzania, Uganda, Zambia, and Zimbabwe.</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Sample size : &nbsp;3331</span></span></strong></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_53T3M48A" class="item journalArticle">
			<h2>Maternal Highly Active Antiretroviral Therapy and Child HIV-Free Survival in Malawi, 2004-2009.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Schwartz SR</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kumwenda N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kumwenda J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chen S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mofenson LM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Taylor AW</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Fowler MG</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Taha TE</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>OBJECTIVES: Highly active antiretroviral therapy (HAART) 
provision to eligible HIV-infected pregnant and post-partum women is 
critical for optimizing maternal health. We assessed the impact of 
maternal HAART on HIV-free survival of breastfed infants in Malawi. 
METHODS: The post-exposure prophylaxis of infants-Malawi trial 
(2004-2009) enrolled mothers/infants during labor or immediately 
post-partum to evaluate 14-week extended infant antiretroviral 
prophylaxis for preventing HIV transmission through breastfeeding. 
Mothers meeting national HAART guidelines were referred for therapy. 
Child HIV-free survival-survival without HIV infection-was compared by 
maternal HAART status. RESULTS: Overall, 3022 mother-infant pairs 
contributed 4214 infant/person-years (PY) at-risk for HIV infection or 
death, with 532 events (incidence 12.6/100 PY, 95 % confidence interval 
[CI] 11.6-13.7). During follow-up, 349 mothers were HAART initiated; 581
 remained HAART naive with CD4 cell counts &lt;250 cells/mm(3), and 2092
 were never HAART-eligible. By 3 months, 11 % of infants with HAART 
naive mothers (CD4 &lt; 250) were infected with HIV or died versus 7 % 
of infants of HAART-initiated mothers and 4 % of infants of 
HAART-ineligible mothers. Maternal HAART was associated with a 46 % 
reduction in infant HIV infection or death as compared to infants with 
HAART naive mothers (CD4 &lt; 250) (adjusted hazards ratio 0.54, 95 % CI
 0.36-0.81). Among HIV-exposed, uninfected infants, breastfeeding, but 
not HAART, was significantly associated with decreased child mortality. 
CONCLUSIONS: HIV infection and mortality are high during the first 3 
months post-partum in infants of mothers with advanced HIV, and rapid 
maternal HAART initiation can significantly improve HIV-related infant 
outcomes. Clinical Trials Registration This study is registered at 
http://clinicaltrials.gov/ under trial number NCT00115648.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2016-03</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>20</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>542-9</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Maternal and child health journal</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1007/s10995-015-1852-5">10.1007/s10995-015-1852-5</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>3</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1092-7875 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Malawi/epidemiology</li>
					<li>Pregnancy</li>
					<li>CD4 Lymphocyte Count</li>
					<li>Young Adult</li>
					<li>Infant</li>
					<li>Infectious Disease Transmission, Vertical/*prevention &amp; control</li>
					<li>Postpartum Period</li>
					<li>Follow-Up Studies</li>
					<li>Pregnancy Outcome</li>
					<li>Treatment Outcome</li>
					<li>*Breast Feeding</li>
					<li>Prevention of mother-to-child transmission</li>
					<li>Time Factors</li>
					<li>*Antiretroviral Therapy, Highly Active</li>
					<li>Breastfeeding</li>
					<li>Child survival</li>
					<li>Highly active antiretroviral therapy</li>
					<li>HIV Infections/*drug therapy/ethnology/mortality</li>
					<li>HIV-1</li>
					<li>Mothers/statistics &amp; numerical data</li>
					<li>Pregnancy Complications, Infectious/*drug therapy/virology</li>
					<li>Survival Analysis</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_KGGXTKWY">
<div><div data-schema-version="8"><p><strong>Location Information:</strong></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Name: </span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">names of health facilities are not mentioned in the study</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Type: </span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">health facilities</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Description: </span></span></strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">conducted in Malawi.</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Sample size : </span></span></strong><span style="color: black"><span style="background-color: white">3022</span></span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_BUGF4AXY" class="item journalArticle">
			<h2>Maternal HIV viral load testing during pregnancy and postpartum care in Gauteng Province, South Africa.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Moyo F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mazanderani AH</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kufa T</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sherman GG</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Pregnant and breastfeeding women living with HIV 
(WLHIV) are a target population for elimination of mother-to-child 
transmission of HIV (eMTCT). However, there are limited data on maternal
 virological responses during pregnancy and the postpartum period in 
South Africa (SA). OBJECTIVES: To review compliance of viral load (VL) 
testing with national guidelines and suppression rates during pregnancy 
and up to 9 months postpartum among WLHIV delivering in four tertiary 
hospitals in Gauteng Province, SA. METHODS: All women who had a 
point-of-care HIV VL test using Xpert HIV-1 VL (Cepheid, USA) at 
delivery in four tertiary obstetric units in Gauteng between June 2018 
and February 2020 were included. HIV VL tests of eligible women 
performed up to 9 months before and after delivery were extracted from 
the National Health Laboratory Service's Corporate Data Warehouse. 
Proportions of women delivering who had antenatal and postpartum VL 
tests performed and their suppression rates were determined and 
expressed as percentages. RESULTS: Of 4 989 eligible WLHIV (median age 
31.1 years), 917 (18.4%) had a VL performed during the antenatal period;
 of these, 335 (36.5%) had a VL &gt;/=50 copies/mL and 165 (18.0%) a VL 
&gt;/=1 000 copies/mL. At delivery, 1 911 women (38.3%) had a VL 
&gt;/=50 copies/mL and 1 028 (20.6%) a VL &gt;/=1 000 copies/mL. Among 
627 women (12.6%) with a VL test postpartum, 234 (37.3%) had a VL 
&gt;/=50 copies/mL and 93 (14.8%) a VL &gt;/=1 000 copies/mL. Overall, 
having a VL test performed during the antenatal period was associated 
with viral suppression at delivery and receiving a VL test postpartum 
(p&amp;lt;0.001). Women with a VL &gt;/=50 copies/mL at delivery were 
more likely to be younger and to remain virally unsuppressed postpartum 
(p&amp;lt;0.001) compared with women with a VL &amp;lt;50 copies/mL. 
CONCLUSIONS: Fewer than 5% of WLHIV with a VL at the time of delivery 
received VL monitoring during the antenatal and postpartum periods in 
accordance with national guidelines. More than 80% of WLHIV delivering 
had no evidence of VL monitoring during the antenatal period, and they 
were more likely than women who received monitoring during the antenatal
 period to be virally unsuppressed at delivery and to receive no VL 
monitoring postpartum. Women with a high VL at delivery were likely to 
remain virally unsuppressed postpartum. These results emphasise the need
 for closer monitoring of and rapid reaction to high maternal VLs during
 pregnancy, at delivery and postpartum for attainment of eMTCT.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2021-04</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: South Africa</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>111</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>469-473</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.7196/SAMJ.2021.v111i5.15240">10.7196/SAMJ.2021.v111i5.15240</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>5</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>2078-5135 (Electronic)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Young Adult</li>
					<li>Breast Feeding</li>
					<li>Middle Aged</li>
					<li>South Africa</li>
					<li>Prenatal Care</li>
					<li>*Postnatal Care</li>
					<li>Age Factors</li>
					<li>Infectious Disease Transmission, Vertical/prevention &amp; control</li>
					<li>Tertiary Care Centers</li>
					<li>HIV Infections/drug therapy/*epidemiology/virology</li>
					<li>*Viral Load</li>
					<li>Anti-HIV Agents/administration &amp; dosage</li>
					<li>Point-of-Care Testing</li>
					<li>Pregnancy Complications, Infectious/drug therapy/*virology</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_Z4498JQZ">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name : </strong></p>
<p>The name of the 4 tertiary obstetric units were not given</p>
<p><strong>Location Type : </strong></p>
<p>Health facility</p>
<p><strong>Description :</strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Conducted in four tertiary obstetric units in Gauteng, South Africa</span></span></p>
<p><strong>Sample size :</strong> <span style="color: rgb(0, 0, 0)"><span style="background-color: rgb(255, 255, 255)">4 989</span></span></p>
<p></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_MPFP3IUV" class="item journalArticle">
			<h2>Maternal Malaria and Malnutrition (M3) initiative, a pooled birth
 cohort of 13 pregnancy studies in Africa and the Western Pacific.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Unger HW</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Cates JE</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gutman J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Briand V</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Fievet N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Valea I</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Tinto H</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>d'Alessandro U</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Landis SH</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Adu-Afarwuah S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Dewey KG</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ter Kuile F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Dellicour S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ouma P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Slutsker L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Terlouw DJ</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kariuki S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ayisi J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Nahlen B</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Desai M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Madanitsa M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kalilani-Phiri L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ashorn P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Maleta K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mueller I</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Stanisic D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Schmiegelow C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Lusingu J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Westreich D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>van Eijk AM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Meshnick S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Rogerson S</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>PURPOSE: The Maternal Malaria and Malnutrition (M3) initiative
 has pooled together 13 studies with the hope of improving understanding
 of malaria-nutrition interactions during pregnancy and to foster 
collaboration between nutritionists and malariologists. PARTICIPANTS: 
Data were pooled on 14 635 singleton, live birth pregnancies from women 
who had participated in 1 of 13 pregnancy studies. The 13 studies cover 8
 countries in Africa and Papua New Guinea in the Western Pacific 
conducted from 1996 to 2015. FINDINGS TO DATE: Data are available at the
 time of antenatal enrolment of women into their respective parent study
 and at delivery. The data set comprises essential data such as malaria 
infection status, anthropometric assessments of maternal nutritional 
status, presence of anaemia and birth weight, as well as additional 
variables such gestational age at delivery for a subset of women. 
Participating studies are described in detail with regard to setting and
 primary outcome measures, and summarised data are available from each 
contributing cohort. FUTURE PLANS: This pooled birth cohort is the 
largest pregnancy data set to date to permit a more definite evaluation 
of the impact of plausible interactions between poor nutritional status 
and malaria infection in pregnant women on fetal growth and gestational 
length. Given the current comparative lack of large pregnancy cohorts in
 malaria-endemic settings, compilation of suitable pregnancy cohorts is 
likely to provide adequate statistical power to assess malaria-nutrition
 interactions, and could point towards settings where such interactions 
are most relevant. The M3 cohort may thus help to identify pregnant 
women at high risk of adverse outcomes who may benefit from tailored 
intensive antenatal care including nutritional supplements and 
alternative or intensified malaria prevention regimens, and the settings
 in which these interventions would be most effective.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2016-12</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>6</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e012697</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>BMJ open</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1136/bmjopen-2016-012697">10.1136/bmjopen-2016-012697</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>12</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>2044-6055 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>*Pregnancy Complications</li>
					<li>Cohort Studies</li>
					<li>Infant, Newborn</li>
					<li>*pregnancy</li>
					<li>Male</li>
					<li>Prenatal Care</li>
					<li>Africa</li>
					<li>*malaria</li>
					<li>*Nutritional Status</li>
					<li>Malaria/*complications</li>
					<li>*Gestational Age</li>
					<li>*Fetal Development</li>
					<li>*malnutrition</li>
					<li>Datasets as Topic</li>
					<li>Malnutrition/*complications</li>
					<li>Papua New Guinea</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_JWL7KXYA">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Name: &nbsp;</span></span></strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Adama
 Hospital Medical College in Ethiopia, Adama Health Centre, Geda Health 
Centre, and several others across different countries.</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Type: </span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">Health facilities</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Description: </span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">conducted in</span></span></p>
<ol>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Benin</span></span>
</li>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Burkina Faso</span></span>
</li>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Democratic Republic of the Congo</span></span>
</li>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Ghana</span></span>
</li>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Kenya</span></span>
</li>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Malawi</span></span>
</li>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Papua New Guinea</span></span>
</li>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Tanzania</span></span>
</li>
</ol>
<p><strong>Sample Size</strong>: &nbsp;13995</p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_MPZI72L8" class="item journalArticle">
			<h2>Maternal mortality among HIV-infected pregnant women in Tanzania.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Li N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Matchi E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Spiegelman D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chalamilla G</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hertzmank E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sando D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sando MM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Liu E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Muya A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Fawzi W</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>OBJECTIVE: To investigate risk factors for maternal mortality 
among HIV-infected women in Tanzania. DESIGN: Prospective cohort study. 
SETTING: HIV care and treatment clinics in Dar es Salaam, Tanzania. 
POPULATION: HIV-infected pregnant women. METHODS: Data were collected 
for all patients enrolled in an HIV/AIDS care and treatment program. 
Between November 2004 and September 2011, there were 18 917 women 
pregnant at least once during the follow-up. Thirteen percent of these 
women had more than one pregnancy, with 21 645 pregnancies occurring. 
Logistic regression was used to explore the predictors of maternal death
 among these women. MAIN OUTCOME MEASURES: Maternal mortality. RESULTS: 
During the study period, 363 maternal deaths occurred, giving a maternal
 mortality ratio of 1729 [95% confidence interval (CI) 1553-1905] per 
100 000 live births. Being wasted [odds ratio (OR) 3.38, 95% CI 
2.58-4.45] or anemic (OR 2.26, 95% CI 1.70-3.00) was associated with a 
higher risk of maternal mortality. Women who were initiated on 
antiretroviral therapy before their pregnancy had a 55% decreased risk 
of maternal mortality (95% CI 0.29-0.70) compared with women who were 
not. The risk of maternal mortality decreased with the length of time on
 antiretroviral therapy during pregnancy, by 8% for each additional 
month (OR 0.92, 95% CI 0.88-0.96). CONCLUSIONS: Maternal mortality was 
high among HIV-infected women. Initiating women on antiretroviral 
therapy as early as possible and providing nutritional interventions 
during pregnancy should be considered as means to reduce the maternal 
mortality among these women.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2014-05</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>93</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>463-8</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Acta obstetricia et gynecologica Scandinavica</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1111/aogs.12374">10.1111/aogs.12374</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>5</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>0001-6349 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Prospective Studies</li>
					<li>Risk Factors</li>
					<li>Tanzania</li>
					<li>Maternal Mortality</li>
					<li>Time Factors</li>
					<li>Tanzania/epidemiology</li>
					<li>antiretroviral therapy</li>
					<li>Hemoglobins/metabolism</li>
					<li>Maternal mortality</li>
					<li>Anti-Retroviral Agents/therapeutic use</li>
					<li>Maternal Age</li>
					<li>Sub-Saharan Africa</li>
					<li>Anemia/mortality</li>
					<li>Diarrhea/mortality</li>
					<li>HIV Infections/blood/drug therapy/*mortality</li>
					<li>HIV Wasting Syndrome/mortality</li>
					<li>HIV/AIDS</li>
					<li>nutrition status</li>
					<li>Pregnancy Complications, Infectious/blood/drug therapy/*mortality</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_94TSTRRW">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location Name : </strong></p>
<p>Clinics in Dar es Salaam, names o clinics were not given</p>
<p><strong>Location Type :</strong></p>
<p>Health facility</p>
<p><strong>Descritption :</strong> </p>
<p>HIV care and treatment clinics in Dar es Salaam, Tanzania</p>
<p><strong>Sample size : </strong><span style="color: rgb(0, 0, 0)"><span style="background-color: rgb(255, 255, 255)">64&nbsp;296</span></span></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_XS9STRSF" class="item journalArticle">
			<h2>Medication exposure during pregnancy: a pilot pharmacovigilance system using health and demographic surveillance platform.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mosha D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mazuguni F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mrema S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Abdulla S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Genton B</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: There is limited safety information on most drugs 
used during pregnancy. This is especially true for medication against 
tropical diseases because pharmacovigilance systems are not much 
developed in these settings. The aim of the present study was to 
demonstrate feasibility of using Health and Demographic Surveillance 
System (HDSS) as a platform to monitor drug safety in pregnancy. 
METHODS: Pregnant women with gestational age below 20 weeks were 
recruited from Reproductive and Child Health (RCH) clinics or from 
monthly house visits carried out for the HDSS. A structured 
questionnaire was used to interview pregnant women. Participants were 
followed on monthly basis to record any new drug used as well as 
pregnancy outcome. RESULTS: 1089 pregnant women were recruited; 994 
(91.3%) completed the follow-up until delivery. 98% women reported to 
have taken at least one medication during pregnancy, mainly those used 
in antenatal programmes. Other most reported drugs were analgesics 
(24%), antibiotics (17%), and antimalarial (15%), excluding IPTp. 
Artemether-lumefantrine (AL) was the most used antimalarial for treating
 illness by nearly 3/4 compared to other groups of malaria drugs. 
Overall, antimalarial and antibiotic exposures in pregnancy were not 
significantly associated with adverse pregnancy outcome. Iron and folic 
acid supplementation were associated with decreased risk of 
miscarriage/stillbirth (OR 0.1; 0.08-0.3). CONCLUSION: Almost all women 
were exposed to medication during pregnancy. Exposure to iron and folic 
acid had a beneficial effect on pregnancy outcome. HDSS proved to be a 
useful platform to establish a reliable pharmacovigilance system in 
resource-limited countries. Widening drug safety information is 
essential to facilitate evidence based risk-benefit decision for 
treatment during pregnancy, a major challenge with newly marketed 
medicines.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2014-09</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>14</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>322</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>BMC pregnancy and childbirth</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/1471-2393-14-322">10.1186/1471-2393-14-322</a></td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1471-2393 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Prospective Studies</li>
					<li>Young Adult</li>
					<li>Gestational Age</li>
					<li>Infant, Low Birth Weight</li>
					<li>Middle Aged</li>
					<li>Adolescent</li>
					<li>Stillbirth/*epidemiology</li>
					<li>Feasibility Studies</li>
					<li>Tanzania/epidemiology</li>
					<li>Dietary Supplements</li>
					<li>Folic Acid/therapeutic use</li>
					<li>Abortion, Spontaneous/*epidemiology</li>
					<li>Vitamins/therapeutic use</li>
					<li>*Pharmacovigilance</li>
					<li>Anti-Infective Agents/adverse effects/*therapeutic use</li>
					<li>Antitussive Agents/therapeutic use</li>
					<li>Congenital Abnormalities/epidemiology</li>
					<li>Ferrous Compounds/therapeutic use</li>
					<li>Live Birth</li>
					<li>Minerals/therapeutic use</li>
					<li>Population Surveillance/*methods</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_MRLRCG6K">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location Name :</strong> </p>
<p>The exact name of the health facilities are not mentioned</p>
<p><strong>Location Type :</strong> </p>
<p>Health facilities and communities</p>
<p><strong>Description :</strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Conducted in the Rufiji Health and Demographic Surveillance System (HDSS) located in the Coastal region of Eastern Tanzania.</span></span></p>
<p><strong>Sample size :</strong> <span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">1089&nbsp;</span></span></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_GSB3JHK5" class="item journalArticle">
			<h2>Mobile Telephone Follow-Up to Ascertain Birth Outcomes in The Gambia.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Laing S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Remmelzwaal K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Cooper M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>N'Dow J</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>Introduction: In the past decade, mobile telephone use has 
surged in sub-Saharan Africa, creating new opportunities in health care.
 Mobile telephone interventions have been used in controlled trials to 
improve perinatal care, but in this first cohort study of birth outcomes
 from The Gambia, we report the value of mobile telephone follow-up. 
Methods: Between December 2012 and November 2015, 1,611 women entered 
the cohort at their first antenatal visit to be followed through 
pregnancy and beyond. Potential risk factors for adverse birth outcomes 
were measured throughout the pregnancy. As many women left the health 
center within a few hours of delivery, delivered elsewhere, or failed to
 attend the postnatal clinics, mobile telephone follow-up was used to 
identify stillbirths and neonatal deaths at 7 and 28 days. Results: The 
immediate birth outcome was known for 968 women who delivered at the 
health center (60.1%). The known outcomes at birth improved from 60.1% 
to 85.2% following telephone calls to women who delivered elsewhere. The
 known outcomes at 7 days improved from 43.6% to 82.5%, and the known 
outcomes at 28 days improved from 32.8% to 71.5% following a telephone 
call. Conclusions: Previous cohort studies of birth outcomes in 
sub-Saharan Africa have not followed the mothers and babies after 
leaving the birth facility. This cohort is the first to record birth 
outcomes up to 28 days after the birth. Mobile telephone communications 
have made an invaluable contribution in intervention studies. This study
 has shown that mobile telephone follow-up is also an important tool in 
an observational study.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2020-01</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: United States</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Telemedicine journal and e-health : the official journal of the American Telemedicine Association</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1089/tmj.2019.0119">10.1089/tmj.2019.0119</a></td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1530-5627 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>birth outcome</li>
					<li>Gambia</li>
					<li>cohort</li>
					<li>early neonatal death</li>
					<li>mobile telephone</li>
					<li>stillbirth</li>
					<li>telehealth</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_3LSBSV89">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name:</strong> </p>
<p>Name</p>
<p><strong>Location type :</strong> </p>
<p>Health facility/ City</p>
<p><strong>Description :</strong> </p>
<p><span style="color: rgb(41, 43, 44)"><span style="background-color: rgb(255, 255, 255)">Government-supported health center in an urban area of The Gambia</span></span></p>
<p><strong>Sample size :</strong> <span style="color: rgb(41, 43, 44)"><span style="background-color: rgb(255, 255, 255)">1,611</span></span></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_PFY3IT4D" class="item journalArticle">
			<h2>Multiple micronutrient supplementation in Tanzanian infants born 
to HIV-infected mothers: a randomized, double-blind, placebo-controlled 
clinical trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Duggan C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Manji KP</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kupka R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bosch RJ</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Aboud S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kisenge R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Okuma J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Fawzi WW</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Multiple micronutrients (vitamin B complex and 
vitamins C and E) were effective at reducing infectious disease 
morbidity, HIV disease progression, and poor pregnancy outcomes in 
HIV-infected women. OBJECTIVE: The objective was to evaluate whether 
direct supplementation of these micronutrients to HIV-exposed infants 
reduces mortality and morbidity. DESIGN: Infants born to HIV-infected 
women from Dar es Salaam, Tanzania, were randomly assigned to receive 
daily oral supplementation of multiple multivitamins (vitamin B complex 
and vitamins C and E) or placebo from age 6 wk for 24 mo. All-cause 
mortality, hospitalizations, and unscheduled clinic visits were 
recorded. Morbidities were recorded during monthly follow-up visits. All
 mothers received multiple micronutrients throughout the study. RESULTS:
 A total of 1193 infants were randomly assigned to receive 
micronutrients and 1194 to receive placebo. There were 138 child deaths 
in the multivitamin group and 124 deaths in the placebo group (HR: 1.13;
 95% CI: 0.88, 1.44; P = 0.33). Hospitalizations (RR: 0.83; 95% CI: 
0.62, 1.13; P = 0.23), unscheduled clinic visits (RR: 0.97; 95% CI: 
0.85, 1.10; P = 0.59), and maternal reports of diarrhea (RR: 0.97; 0.87,
 1.10; P = 0.64) were not significantly different between the 2 groups. 
Fever (P = 0.02) and vomiting (P = 0.007) were significantly lower in 
the multivitamin group. Among 429 children whose mothers received 
antiretroviral (ARV) therapy, multivitamin use had no effect on 
mortality but was associated with a significant reduction in 
hospitalizations (P = 0.035), episodes of fever (P = 0.005), and 
episodes of fever and cough (P = 0.019). CONCLUSIONS: In the setting of 
maternal micronutrient supplementation, supplementation of HIV-exposed 
infants with vitamin B and vitamins C and E does not reduce mortality. 
Studies of nutrition supplementation in ARV-exposed infants may be 
warranted.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2012-12</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>96</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>1437-46</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>The American journal of clinical nutrition</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.3945/ajcn.112.044263">10.3945/ajcn.112.044263</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>6</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>0002-9165 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>*Dietary Supplements</li>
					<li>*Maternal Nutritional Physiological Phenomena</li>
					<li>Infant, Newborn</li>
					<li>Male</li>
					<li>Infant</li>
					<li>Infectious Disease Transmission, Vertical/*prevention &amp; control</li>
					<li>Double-Blind Method</li>
					<li>Tanzania</li>
					<li>Infant Mortality</li>
					<li>Pregnancy Complications, Infectious/drug therapy</li>
					<li>*Infant Nutritional Physiological Phenomena</li>
					<li>Anti-Retroviral Agents/adverse effects/therapeutic use</li>
					<li>Breast Feeding/adverse effects</li>
					<li>Fever/prevention &amp; control</li>
					<li>HIV Seropositivity/drug therapy/*transmission</li>
					<li>Infection Control/*methods</li>
					<li>Micronutrients/administration &amp; dosage/*therapeutic use</li>
					<li>Poverty Areas</li>
					<li>Vomiting/prevention &amp; control</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_XSZ66XG2">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Locatin Name :</strong> </p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">The names of the 8 clinics were not provided</span></span></p>
<p><strong>Location Type :</strong></p>
<p> Health facility</p>
<p><strong>Description :</strong> </p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Conducted in Dar es Salaam, Tanzania, at 8 antenatal clinics.</span></span></p>
<p><strong>Sample size</strong> : <span style="color: rgb(31, 31, 31)">2387</span></p>
<p></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_CMQCTZUB" class="item journalArticle">
			<h2>No association between antenatal common mental disorders in 
low-obstetric risk women and adverse birth outcomes in their offspring: 
results from the CDS study in Ghana and Cote D'Ivoire.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bindt C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Guo N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bonle MT</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Appiah-Poku J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hinz R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Barthel D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Schoppen S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Feldt T</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Barkmann C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Koffi M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Loag W</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Nguah SB</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Eberhardt KA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Tagbor H</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>N'goran E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ehrhardt S</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Evidence linking common mental disorders (CMD) in 
pregnant women to adverse birth outcomes is inconsistent, and studies 
often failed to control for pregnancy complications. This study aimed to
 explore the association between antenatal depression and anxiety 
symptoms and birth outcomes in a low-obstetric risk sample of 
mother/child dyads in Ghana and Cote d'Ivoire. METHODS: In 2010-2011, a 
prospective cohort of 1030 women in their third trimester in Ghana and 
Cote d'Ivoire was enrolled. Depression and anxiety were assessed in the 
third trimester using the Patient Health Questionnaire depression module
 and the 7-item Generalized Anxiety Disorder scale. 719 mother/child 
dyads were included in the analysis. We constructed multivariate 
regression models to estimate the association between CMD and low birth 
weight (LBW), and preterm birth (PTB) to control for potential 
confounders. RESULTS: The prevalence of depression and anxiety symptoms 
were 28.9% and 14.2% respectively. The mean birth weight was 3172.1g (SD
 440.6) and the prevalence of LBW was 1.7%. The mean gestational age was
 39.6 weeks and the proportion of PTB was 4%. Multivariate linear 
regression revealed no significant association between maternal 
depression (B=52.2, 95% CI -18.2 122.6, p=0.15) or anxiety (B=17.1, 95% 
CI -74.6 108.7, p=0.72) and birth weight. Yet, low socio-economic 
status, female sex of the child, and younger maternal age were 
associated with lower birth weight. Multivariate logistic regression 
suggested no significant association between maternal depression (OR: 
2.1, 95% CI 0.8 5.6, p=0.15) or anxiety (OR: 1.8, 95% CI 0.6 5.5, 
p=0.29) with PTB. CONCLUSIONS: Our data suggests that depression and/or 
anxiety in the 3(rd) trimester of pregnancy are not independent 
predictors of adverse birth outcomes in low obstetric risk women. The 
role of pregnancy complications as confounders or effect modifiers in 
studies of maternal CMD and their impact on birth outcomes should be 
investigated.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2013</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 11
Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>8</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e80711</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>PloS one</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1371/journal.pone.0080711">10.1371/journal.pone.0080711</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>11</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1932-6203 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:45 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:45 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>*Pregnancy Complications</li>
					<li>Prospective Studies</li>
					<li>Young Adult</li>
					<li>Risk Factors</li>
					<li>Prevalence</li>
					<li>Anxiety/epidemiology</li>
					<li>Cote d'Ivoire/epidemiology</li>
					<li>Depression/epidemiology</li>
					<li>Ghana/epidemiology</li>
					<li>Longitudinal Studies</li>
					<li>Mental Disorders/*epidemiology</li>
					<li>Pregnancy Outcome/*epidemiology</li>
					<li>Pregnancy Trimester, Third</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_WAHH4F67">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name : </strong></p>
<p><span style="color: rgb(32, 32, 32)"><span style="background-color: rgb(255, 255, 255)">Komfo Anokye,Abobo</span></span></p>
<p><strong>Location Type : </strong></p>
<p>Health facility</p>
<p><strong>Description : </strong><span style="color: rgb(32, 32, 32)"><span style="background-color: rgb(255, 255, 255)">&nbsp;</span></span></p>
<p><span style="color: rgb(32, 32, 32)"><span style="background-color: rgb(255, 255, 255)">Hospitals,
 the Komfo Anokye Teaching Hospital in Kumasi, Ghana, and the Abobo 
Community Hospital in Abidjan, CteGhana and Cte dIvoire</span></span></p>
<p><strong>sample size :</strong> &nbsp;<span style="color: rgb(32, 32, 32)"><span style="background-color: rgb(255, 255, 255)">1030&nbsp;</span></span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_73B7P24U" class="item journalArticle">
			<h2>Non-inferiority of low-dose compared to standard high-dose 
calcium supplementation in pregnancy: study protocol for two randomized,
 parallel group, non-inferiority trials in India and Tanzania.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Dwarkanath P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Muhihi A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sudfeld CR</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Rani S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Duggan CP</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sando MM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Wylie BJ</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Fernandez R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kinyogoli S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Munk C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Perumal N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Raj JM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Buggi N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Swai N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Thomas T</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Wang M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kurpad AV</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Masanja H</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Pembe AB</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Fawzi WW</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Hypertensive disorders of pregnancy are important 
causes of maternal morbidity and mortality, as well as preterm birth, 
the leading cause of death for children under 5 years globally. The 
World Health Organization currently recommends that pregnant women 
receive high-dose calcium supplementation (1500-2000 mg elemental 
calcium) for prevention of preeclampsia in populations with low dietary 
calcium intake. Trials of low-dose calcium supplementation (&lt; 1000 mg
 elemental calcium/day) during pregnancy have also shown similar 
reductions in the risk of preeclampsia; however, no trials to date have 
directly compared low-dose to the standard high-dose calcium 
supplementation. Our objective is to assess the non-inferiority of 
low-dose as compared to standard high-dose calcium supplementation in 
pregnancy. METHODS/DESIGN: We will conduct two independent trials in 
Bangalore, India (n = 11,000 pregnancies), and Dar es Salaam, Tanzania 
(n = 11,000 pregnancies). The trial designs are individually randomized,
 parallel group, quadruple-blind, non-inferiority trials of low-dose 
calcium supplementation (500 mg elemental calcium/day) as compared to 
standard high-dose calcium supplementation (1500 mg elemental 
calcium/day) among nulliparous pregnant women. Pregnant women will be 
enrolled in the trial before 20 weeks of gestation and will receive the 
randomized calcium regimen from randomization until the time of 
delivery. The co-primary outcomes are (i) preeclampsia and (ii) preterm 
birth; we will test non-inferiority of the primary outcomes for low-dose
 as compared to the standard high-dose supplementation regimen in each 
trial. The trials' secondary outcomes include gestational hypertension, 
severe features of preeclampsia, pregnancy-related death, third 
trimester severe anemia, fetal death, stillbirth, low birthweight, 
small-for-gestational age birth, and infant death. DISCUSSION: The 
trials will provide causal evidence on the non-inferiority of low-dose 
as compared to the standard high-dose supplementation in India and 
Tanzania. A single tablet, low-dose calcium supplementation regimen may 
improve individual-level adherence, reduce programmatic costs, and 
ultimately expand implementation of routine calcium supplementation in 
pregnancy in populations with low dietary calcium intake. TRIAL 
REGISTRATION: ClinicalTrials.gov identifier: NCT03350516 ; registered on
 22 November 2018. Clinical Trials Registry-India identifier: 
CTRI/2018/02/012119 ; registered on 23 February 2018. Tanzania Medicines
 and Medical Devices Authority Trials Registry identifier: 
TFDA0018/CTR/0010/5 ; registered on 20 December 2018.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2021-11</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>22</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>838</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Trials</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/s13063-021-05811-7">10.1186/s13063-021-05811-7</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1745-6215 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Infant, Newborn</li>
					<li>Child, Preschool</li>
					<li>Infant</li>
					<li>Stillbirth</li>
					<li>Tanzania</li>
					<li>Child</li>
					<li>Randomized Controlled Trials as Topic</li>
					<li>India</li>
					<li>Preterm birth</li>
					<li>*Hypertension, Pregnancy-Induced</li>
					<li>*Premature Birth/prevention &amp; control</li>
					<li>Calcium</li>
					<li>Dietary supplements</li>
					<li>Dietary Supplements/adverse effects</li>
					<li>Non-inferiority trial</li>
					<li>Pre-eclampsia</li>
					<li>Pregnancy complications</li>
					<li>Pregnancy-induced hypertension</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_FPVLJWY9">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name</strong> : </p>
<p>Names of health facilities not provided</p>
<p><strong>Location Type</strong> : </p>
<p>Health Facility</p>
<p><strong>Description</strong> : </p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Conducted in two independent trials, one in India and the other in Tanzania</span></span></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">India
 -11 health facilities within the Greater Bengaluru Metropolitan 
Corporation system (referred to as the Bruhat Bengaluru Mahanagar 
Palike).</span></span></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Tanzania ------- conducted in urban Dar es Salaam at 6 health facilities providing antenatal care.</span></span></p>
<p></p>
<p><strong>Sample size</strong> : Tanzania ---= 11000</p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_A2BC3BSP" class="item journalArticle">
			<h2>Nutrient supplementation may adversely affect maternal oral health--a randomised controlled trial in rural Malawi.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Harjunmaa U</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Jarnstedt J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Dewey KG</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ashorn U</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Maleta K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Vosti SA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ashorn P</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>Nutritional supplementation during pregnancy is increasingly 
recommended especially in low-resource settings, but its oral health 
impacts have not been studied. Our aim was to examine whether 
supplementation with multiple micronutrients (MMN) or small-quantity 
lipid-based nutrient supplements affects dental caries development or 
periodontal health in a rural Malawian population. The study was 
embedded in a controlled iLiNS-DYAD trial that enrolled 1391 pregnant 
women &lt;20 gestation weeks. Women were provided with one daily 
iron-folic acid capsule (IFA), one capsule with 18 micronutrients (MMN) 
or one sachet of lipid-based nutrient supplements (LNS) containing 
protein, carbohydrates, essential fatty acids and 21 micronutrients. 
Oral examination of 1024 participants was conducted and panoramic X-ray 
taken within 6 weeks after delivery. The supplement groups were similar 
at baseline in average socio-economic, nutritional and health status. At
 the end of the intervention, the prevalence of caries was 56.7%, 69.1% 
and 63.3% (P = 0.004), and periodontitis 34.9%, 29.8% and 31.2% (P = 
0.338) in the IFA, MMN and LNS groups, respectively. Compared with the 
IFA group, women in the MMN group had 0.60 (0.18-1.02) and in the LNS 
group 0.59 (0.17-1.01) higher mean number of caries lesions. In the 
absence of baseline oral health data, firm conclusions on causality 
cannot be drawn. However, although not confirmatory, the findings are 
consistent with a possibility that provision of MMN or LNS may have 
increased the caries incidence in this target population. Because of the
 potential public health impacts, further research on the association 
between gestational nutrient interventions and oral health in low-income
 settings is needed.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2016-01</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>12</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>99-110</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Maternal &amp; child nutrition</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1111/mcn.12204">10.1111/mcn.12204</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1740-8695 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Incidence</li>
					<li>Malawi/epidemiology</li>
					<li>Pregnancy</li>
					<li>*Maternal Nutritional Physiological Phenomena</li>
					<li>Risk Factors</li>
					<li>Prevalence</li>
					<li>Postpartum Period</li>
					<li>pregnancy</li>
					<li>Intention to Treat Analysis</li>
					<li>*Rural Health</li>
					<li>dental caries</li>
					<li>Dental Caries/epidemiology/*etiology/physiopathology</li>
					<li>Dietary Supplements/*adverse effects</li>
					<li>Lost to Follow-Up</li>
					<li>micronutrient</li>
					<li>Micronutrients/*adverse effects</li>
					<li>nutritional intervention</li>
					<li>oral health</li>
					<li>Outpatient Clinics, Hospital</li>
					<li>periodontal diseases</li>
					<li>Periodontitis/epidemiology/*etiology/physiopathology</li>
					<li>Pregnancy Complications/epidemiology/*etiology/physiopathology</li>
					<li>Severity of Illness Index</li>
					<li>Single-Blind Method</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_3BNUNTYC">
<div><div data-schema-version="8"><p><strong>Location Information:</strong></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Name:</span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">Mangochi hospital, Malindi Hospital, Lingwena and Namwera health centers</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Type:</span></span></strong></p>
<p>Health facilities</p>
<p><strong><span style="color: black"><span style="background-color: white">Description: </span></span></strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Conducted in Mangochi district in southern Malawian.</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Sample size :</span></span></strong><span style="color: black"><span style="background-color: white"> 1391</span></span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_GHN7ENHZ" class="item journalArticle">
			<h2>Optimizing Antiretroviral Therapy (ART) for Maternal and Child Health (MCH): Rationale and Design of the MCH-ART Study.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Myer L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Phillips TK</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Zerbe A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ronan A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hsiao NY</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mellins CA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Remien RH</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Le Roux SM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Brittain K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ciaranello A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Petro G</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>McIntyre JA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Abrams EJ</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Prevention of mother-to-child transmission of HIV 
implementation faces significant challenges globally, particularly in 
the context of universal lifelong antiretroviral therapy (ART) for all 
HIV-infected pregnant women. METHODS: We describe the rationale and 
methods of the Maternal and Child Health-Antiretroviral Therapy 
(MCH-ART) study, an implementation science project examining strategies 
for providing HIV care and treatment to HIV-infected women who initiate 
ART during pregnancy and their HIV-exposed infants. RESULTS: MCH-ART is 
composed of 3 interrelated study designs across the antenatal and 
postnatal periods. Phase 1 is a cross-sectional evaluation of 
consecutive HIV-infected pregnant women seeking antenatal care; phase 2 
is an observational cohort of all women from phase 1 who are eligible 
for initiation of ART following local guidelines; and phase 3 is a 
randomized trial of strategies for delivering ART to breastfeeding women
 from phase 2 during the postpartum period. During each phase, a set of 
study measurement visits is carried out separately from antenatal care 
and ART services; a maximum of 9 visits takes place from the beginning 
of antenatal care through 12 months postpartum. In parallel, in-depth 
interviews are used to examine issues of ART adherence and retention 
qualitatively, and costs and cost-effectiveness of models of care are 
examined. Separate substudies examine health outcomes in HIV-uninfected 
women and their HIV-unexposed infants, and the role of the adherence 
club model for long-term adherence and retention. DISCUSSION: Combining 
observational and experimental components, the MCH-ART study presents a 
novel approach to understand and optimize ART delivery for MCH.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2016-08</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>72 Suppl 2</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>S189-96</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Journal of acquired immune deficiency syndromes (1999)</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1097/QAI.0000000000001056">10.1097/QAI.0000000000001056</a></td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1525-4135 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Infant, Newborn</li>
					<li>Breast Feeding</li>
					<li>Infant</li>
					<li>Infectious Disease Transmission, Vertical/*prevention &amp; control</li>
					<li>Postpartum Period</li>
					<li>Africa South of the Sahara</li>
					<li>Pregnancy Complications, Infectious/*drug therapy</li>
					<li>Anti-HIV Agents/*therapeutic use</li>
					<li>Patient Compliance</li>
					<li>Cross-Sectional Studies</li>
					<li>*Clinical Studies as Topic</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_D8HZ3XCI">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location Name :</strong> </p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Gugulethu Community Health Centre</span></span></p>
<p><strong>Location Type :</strong> </p>
<p>Health facility</p>
<p><strong>Description :</strong> </p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Conducted at the Midwife-Obstetric Unit (MOU) at the Gugulethu Community Health Centre in Cape Town, South Africa</span></span></p>
<p><strong>Sample size :</strong> <span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">1554&nbsp;</span></span></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_6SNB37T7" class="item journalArticle">
			<h2>Optimizing PMTCT efforts by repeat HIV testing during antenatal 
and perinatal care in resource-limited settings: A longitudinal 
assessment of HIV seroconversion.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mushamiri I</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Adudans M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Apat D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ben Amor Y</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Mother to child transmission (MTCT) of HIV remains
 a challenge in resource-limited settings. Central to elimination of 
MTCT is effective Provider Initiated HIV Counseling and Testing (PICT). 
Research has shown that conducting PICT only at the initial antenatal 
care (ANC) visit fails to benefit pregnant women who seroconvert later 
in their pregnancy. This study aimed to determine the most cost 
effective time to perform repeat HIV testing during ANC and perinatal 
care (PNC). METHODS: We studied the repeat HIV testing results of 
pregnant women &gt;/= 18 and adolescent girls aged 15-17 in the Sauri, 
Kenya Millennium Villages Project (MVP) site. Nurses provided HIV 
screening to 1,403 expectant women and 256 adolescent girls following 
the 1st, 2nd, 3rd and 4th ANC visits, at birth and 6 and 14 weeks 
postpartum. RESULTS: Five women seroconverted during the study period 
(incidence proportion 0.41%). One woman seroconverted at the 2nd ANC 
visit, another one at the 3rd, two at the 4th and one at 6 weeks 
post-partum. Of all the women who seroconverted, four reported an HIV 
negative primary partner, while one reported an unknown partner status. 
None of the participants reported condom use during pregnancy. Two of 
the seroconverters vertically transmitted HIV to their babies. The 
results did not suggest a clear pattern of seroconversion during ANC and
 PNC. CONCLUSIONS: The low rates of seroconversion suggest that testing 
pregnant women multiple times during ANC and PNC may not be cost 
effective, but a follow-up test during birth may be protective of the 
newborn.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2020</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>15</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e0233396</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>PloS one</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1371/journal.pone.0233396">10.1371/journal.pone.0233396</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>5</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1932-6203 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Young Adult</li>
					<li>Longitudinal Studies</li>
					<li>Infectious Disease Transmission, Vertical/*prevention &amp; control</li>
					<li>Adolescent</li>
					<li>Cost-Benefit Analysis</li>
					<li>Health Resources</li>
					<li>Kenya</li>
					<li>Pregnancy Complications, Infectious/*diagnosis</li>
					<li>AIDS Serodiagnosis/economics/methods</li>
					<li>HIV Infections/*complications/*prevention &amp; control/transmission</li>
					<li>HIV Seropositivity/*complications/*diagnosis</li>
					<li>Perinatal Care/economics/methods</li>
					<li>Prenatal Care/economics/methods</li>
					<li>Proof of Concept Study</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_RM5FA3B2">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location Name :</strong> </p>
<p>Sauri cluster</p>
<p><strong>Location type :</strong> </p>
<p>Community</p>
<p><strong>Description</strong> : </p>
<p><span style="color: black">Conducted in Sauri cluster, located in Siaya County, Western Kenya</span></p>
<p><strong>Sample size :</strong> <span style="color: rgb(32, 32, 32)"><span style="background-color: rgb(255, 255, 255)">&nbsp;2,100</span></span></p>
<p></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_49TCDF5B" class="item journalArticle">
			<h2>Oxytocin via Uniject (a prefilled single-use injection) versus 
oral misoprostol for prevention of postpartum haemorrhage at the 
community level: a cluster-randomised controlled trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Diop A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Daff B</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sow M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Blum J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Diagne M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sloan NL</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Winikoff B</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Access to injectable uterotonics for management of
 postpartum haemorrhage remains limited in Senegal outside health 
facilities, and misoprostol and oxytocin delivered via Uniject have been
 deemed viable alternatives in community settings. We aimed to compare 
the efficacy of these drugs when delivered by auxiliary midwives at 
maternity huts. METHODS: We did an unmasked cluster-randomised 
controlled trial at maternity huts in three districts in Senegal. 
Maternity huts with auxiliary midwives located 3-21 km from the closest 
referral centre were randomly assigned (1:1; via a computer-generated 
random allocation overseen by Gynuity Health Projects) to either 600 mug
 oral misoprostol or 10 IU oxytocin in Uniject (intramuscular), 
stratified by reported previous year clinic volume (deliveries) and 
geographical location (inland or coastal). Maternity huts that had been 
included in a previous study of misoprostol for prevention of postpartum
 haemorrhage were excluded to prevent contamination. Pregnant women in 
their third trimester were screened for eligibility either during 
community outreach or at home-based prenatal visits. Only women 
delivered by the auxiliary midwives in the maternity huts were eligible 
for the study. Women with known allergies to prostaglandins or pregnancy
 complications were excluded. The primary outcome was mean change in 
haemoglobin concentration measured during the third trimester and after 
delivery. This study was registered with ClinicalTrials.gov, number 
NCT01713153. FINDINGS: 28 maternity hut clusters were randomly 
assigned-14 to the misoprostol group and 14 to the oxytocin group. 
Between June 6, 2012, and Sept 21, 2013, 1820 women were recruited. 647 
women in the misoprostol group and 402 in the oxytocin group received 
study drug and had recorded pre-delivery and post-delivery haemoglobin 
concentrations, and overall 1412 women delivered in the study maternity 
huts. The mean change in haemoglobin concentrations was 3.5 g/L (SD 
16.1) in the misoprostol group and 2.7 g/L (SD 17.8) in the oxytocin 
group. When adjusted for cluster design, the mean difference in 
haemoglobin decreases between groups was not significant (0.3 g/L, 95% 
CI -8.26 to 8.92, p=0.71). Both drugs were well tolerated. Shivering was
 common in the misoprostol group, and nausea in the oxytocin group. 
Postpartum haemorrhage was diagnosed in one woman allocated to oxytocin,
 who was referred and transferred to a higher-level facility for 
additional care, and fully recovered. No other women were transferred. 
INTERPRETATION: In terms of effects on haemoglobin concentrations, 
neither oxytocin nor misoprostol was significantly better than the 
other, and both drugs were safe and efficacious when delivered by 
auxiliary midwives. The programmatic limitations of oxytocin, including 
short shelf life outside the cold chain, mean that misoprostol could be 
more appropriate for community-level prophylaxis of postpartum 
haemorrhage. FUNDING: Bill &amp; Melinda Gates Foundation.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2016-01</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 1
Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>4</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e37-44</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>The Lancet. Global health</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1016/S2214-109X(15)00219-3">10.1016/S2214-109X(15)00219-3</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>2214-109X (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:30 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:30 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Administration, Oral</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Young Adult</li>
					<li>Middle Aged</li>
					<li>Adolescent</li>
					<li>Double-Blind Method</li>
					<li>Community Health Centers</li>
					<li>Misoprostol/*administration &amp; dosage/adverse effects</li>
					<li>Senegal</li>
					<li>Hemoglobins/drug effects</li>
					<li>Home Childbirth</li>
					<li>Injections</li>
					<li>Midwifery/education</li>
					<li>Oxytocics/*administration &amp; dosage/adverse effects</li>
					<li>Oxytocin/*administration &amp; dosage/adverse effects</li>
					<li>Postpartum Hemorrhage/*prevention &amp; control</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_5XEEP95W">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name</strong> : </p>
<p><span style="color: rgb(80, 80, 80)"><span style="background-color: rgb(255, 255, 255)">Thiadiaye, Kolda, and Medina Yero Foula</span></span></p>
<p><strong>Location Type</strong> : </p>
<p>District</p>
<p><strong>Description</strong> : </p>
<p><span style="color: rgb(80, 80, 80)"><span style="background-color: rgb(255, 255, 255)">3 health districts in Senegal (Thiadiaye, Kolda, and Medina Yero Foula)</span></span></p>
<p><strong>Sample size : &nbsp;</strong><span style="color: rgb(80, 80, 80)"><span style="background-color: rgb(255, 255, 255)">1820&nbsp;</span></span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_IJGMMT7E" class="item journalArticle">
			<h2>Partner-delivered HIV self-test kits with and without financial 
incentives in antenatal care and index patients with HIV in Malawi: a 
three-arm, cluster-randomised controlled trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Choko AT</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Fielding K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Johnson CC</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kumwenda MK</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chilongosi R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Baggaley RC</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Nyirenda R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sande LA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Desmond N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hatzold K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Neuman M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Corbett EL</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Secondary distribution of HIV self-testing (HIVST)
 kits by patients attending clinic services to their partners could 
improve the rate of HIV diagnosis. We aimed to investigate whether 
secondary administration of HIVST kits, with or without an additional 
financial incentive, via women receiving antenatal care (ANC) or via 
people newly diagnosed with HIV (ie, index patients) could improve the 
proportion of male partners tested or the number of people newly 
diagnosed with HIV. METHODS: We did a three-arm, open-label, pragmatic, 
cluster-randomised trial of 27 health centres (clusters), eligible if 
they were a government primary health centre providing ANC, HIV testing,
 and ART services, across four districts of Malawi. We recruited women 
(aged &gt;/=18 years) attending their first ANC visit and whose male 
partner was available, not already taking ART, and not already tested 
for HIV during this pregnancy (ANC cohort), and people (aged &gt;/=18 
years) with newly diagnosed HIV during routine clinic HIV testing who 
had at least one sexual contact not already known to be HIV-positive 
(index cohort). Centres were randomly assigned (1:1:1), using a public 
selection of computer-generated random allocations, to enhanced standard
 of care (including an invitation for partners to attend HIV testing 
services), HIVST only, or HIVST plus a US$10 financial incentive for 
retesting. The primary outcome for the ANC cohort was the proportion of 
male partners reportedly tested, as ascertained by interview with women 
in this cohort at day 28. The primary outcome for the index cohort was 
the geometric mean number of new HIV-positive people identified per 
facility within 28 days of enrolment, as measured by observed HIV test 
results. Cluster-level summaries compared intervention with standard of 
care by intention to treat. This trial is registered with 
ClinicalTrials.gov, NCT03705611. FINDINGS: Between Sept 8, 2018, and May
 2, 2019, nine clusters were assigned to each trial arm, resulting in 
4544 eligible women in the ANC cohort (1447 [31.8%] in the standard care
 group, 1465 [32.2%] in the HIVST only group, and 1632 [35.9%] in HIVST 
plus financial incentive group) and 708 eligible patients in the index 
cohort (234 [33.1%] in the standard care group, 169 [23.9%] in the HIVST
 only group, and 305 [42.9%] in the HIVST plus financial incentive 
group). 4461 (98.2%) of 4544 eligible women in the ANC cohort and 645 
(91.1%) of 708 eligible patients in the index cohort were recruited, of 
whom 3378 (75.7%) in the ANC cohort and 439 (68.1%) in the index cohort 
were interviewed after 28 days. In the ANC cohort, the mean proportion 
of reported partner testing per cluster was 35.0% (SD 10.0) in the 
standard care group, 73.0% in HIVST only group (13.1, adjusted risk 
ratio [RR] 1.71, 95% CI 1.48-1.98; p&lt;0.0001), and 65.2% in the HIVST 
plus financial incentive group (11.6, adjusted RR 1.62, 1.45-1.81; 
p&lt;0.0001). In the index cohort, the geometric mean number of new 
HIV-positive sexual partners per cluster was 1.35 (SD 1.62) for the 
standard care group, 1.91 (1.78) for the HIVST only group (incidence 
rate ratio adjusted for number eligible as an offset in the negative 
binomial model 1.65, 95% CI 0.49-5.55; p=0.3370), and 3.20 (3.81) for 
the HIVST plus financial incentive group (3.11, 0.99-9.77; p=0.0440). 
Four self-resolving, temporary marital separations occurred due to 
disagreement in couples regarding HIV self-test kits. INTERPRETATION: 
Although administration of HIVST kits in the ANC cohort, even when 
offered alongside a financial incentive, did not identify significantly 
more male patients with HIV than did standard care, out-of-clinic 
options for HIV testing appear more acceptable to many male partners of 
women with HIV, increasing test uptake. Viewed in the current context, 
this approach might allow continuation of services despite 
COVID-19-related lockdowns. FUNDING: Unitaid, through the Self-Testing 
Africa Initiative.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2021-07</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>9</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e977-e988</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>The Lancet. Global health</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1016/S2214-109X(21)00175-3">10.1016/S2214-109X(21)00175-3</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>7</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>2214-109X (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Malawi/epidemiology</li>
					<li>Pregnancy</li>
					<li>Young Adult</li>
					<li>Male</li>
					<li>Cluster Analysis</li>
					<li>*Prenatal Care</li>
					<li>*Sexual Partners</li>
					<li>*Self-Testing</li>
					<li>HIV Infections/*diagnosis/epidemiology</li>
					<li>HIV Testing/economics/*methods</li>
					<li>Motivation</li>
					<li>Reagent Kits, Diagnostic</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_F2YNR9HH">
<div><div data-schema-version="8"><p><strong>Location Information:</strong></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Name:</span></span></strong></p>
<p><span style="color: black"><span style="background-color: white"> names of health facility not in the article</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Type:</span></span></strong></p>
<p><span style="color: black"><span style="background-color: white"> Health facilities</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Description:</span></span></strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">conducted in Malawi across four districts: Blantyre, Zomba, Thyolo, and Mulanje.</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Sample size : 5252</span></span></strong></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_VMWZTZQC" class="item journalArticle">
			<h2>Perinatal common mental disorders and child survival in Ethiopia.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Adewuya AO</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hanlon C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Medhin G</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Dewey M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Alem A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Worku B</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Prince M</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>AIMS: The study aims to evaluate the impact of perinatal 
common mental disorders (CMDs) on child mortality up to 3.5 years in a 
demographic surveillance site at Butajira, Ethiopia. METHODS: One 
thousand sixty-five eligible women were assessed for CMD in the third 
trimester of pregnancy and at 2 months post-delivery using the 
Self-Reporting Questionnaire. We derived a four-level categorical 
exposure variable for the course of perinatal CMD. The outcome measure 
was child death recorded from 1 month after the postnatal assessment up 
to 3.5 years. Potential confounders and mediators were evaluated. 
RESULTS: The cumulative child mortality rates were 62.6/1000 at 1 year 
and 82.5/1000 at 3.5 years, respectively. Exposure to perinatal CMD did 
not significantly affect child survival at 3.5 years, with results 
showing fully adjusted hazard ratio (HR) and 95% confidence interval 
(95% CI) of 1.85 (0.43, 7.88) for CMD in pregnancy only, 1.47 (0.14, 
15.66) for CMD in postnatal period only and 0.41 (0.02, 7.38) for 
persistent CMD (both in pregnancy and postnatal). Only using soap less 
frequently than daily (HR 5.67, 95% CI 1.58-20.30) and episode of 
malaria in pregnancy (HR 5.02, 95% CI 2.15-11.72) were associated with 
child mortality in multivariable analysis. CONCLUSIONS: Maternal health,
 health behaviours and family structure appear to be the most important 
factors affecting post-neonatal child mortality in this Ethiopian birth 
cohort, with little evidence for an effect of maternal perinatal CMD.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2014-01</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: Australia</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>50</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>57-63</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Journal of paediatrics and child health</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1111/jpc.12411">10.1111/jpc.12411</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1034-4810 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>*Pregnancy Complications</li>
					<li>Young Adult</li>
					<li>Pregnancy Trimester, Third</li>
					<li>Child, Preschool</li>
					<li>Infant</li>
					<li>Adolescent</li>
					<li>*Child Mortality</li>
					<li>*Infant Mortality</li>
					<li>Survival Analysis</li>
					<li>Ethiopia/epidemiology</li>
					<li>*Health Behavior</li>
					<li>*Mental Disorders</li>
					<li>*Puerperal Disorders</li>
					<li>child survival</li>
					<li>common mental disorder</li>
					<li>Family Characteristics</li>
					<li>perinatal</li>
					<li>Proportional Hazards Models</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_FAA78PFL">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name :</strong> </p>
<p>Butajira</p>
<p><strong>Location Type : </strong></p>
<p>Community</p>
<p><strong>Description : </strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Conducted in Butajira,135 km south of Addis Ababa, the capital city of Ethiopia</span></span></p>
<p><strong>Sample size :</strong> &nbsp;1065</p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_YN8F6VGE" class="item journalArticle">
			<h2>Perinatal outcomes after hypertensive disorders in pregnancy in a low resource setting.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Browne JL</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Vissers KM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Antwi E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Srofenyoh EK</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Van der Linden EL</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Agyepong IA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Grobbee DE</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Klipstein-Grobusch K</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>OBJECTIVE: The objective of this study was to evaluate 
perinatal outcomes of pregnancies complicated by hypertensive disorders 
in pregnancy in an urban sub-Saharan African setting. METHODS: A 
prospective cohort study of 1010 women of less than 17 weeks of 
gestation was conducted at two antenatal clinics in Accra, Ghana, 
between July 2012 and March 2014. Information about hypertensive 
disorders was available for analysis on 789 pregnancies. The main 
outcomes were pre-term birth, birthweight, Apgar scores, small for 
gestational age and mortality. Relative risk (RR, 95% confidence 
interval (CI)) for the association between hypertensive disorders of 
pregnancy and perinatal outcomes was assessed using logistic regression 
adjusting for potential confounders. RESULTS: A total of 88.7% of women 
remained normotensive, 7.5% developed pregnancy-induced hypertension, 
2.0% had chronic hypertension, and 1.7% developed (pre-)eclampsia. No 
adverse effects were observed in women with pregnancy-induced 
hypertension. Women with chronic hypertension were more likely to have a
 lower gestational age at delivery (38.0 +/- 2.3 weeks vs. 39.0 +/- 1.9 
weeks, P = 0.04) and higher risk of pre-term delivery (aRR 4.63, 95% CI 
1.35-15.91). Women with pre-eclampsia had emergency Caesarean section 
significantly more often (88.9% vs. 50%, P = 0.04), with a higher risk 
for low birthweight infants (aRR 7.95, 95% CI 1.41-44.80) and a higher 
risk of neonatal death (aRR 18.41, 95% CI 1.20-283.22). CONCLUSION: 
Comparable to high-income countries, in Accra hypertensive disorders 
during pregnancy were associated with increased risk of adverse 
perinatal outcomes necessitating maternal and newborn care.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2015-12</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 12
Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>20</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>1778-86</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Tropical medicine &amp; international health : TM &amp; IH</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1111/tmi.12606">10.1111/tmi.12606</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>12</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1360-2276 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:45 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:45 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Birth Weight</li>
					<li>Infant, Newborn</li>
					<li>Prospective Studies</li>
					<li>Young Adult</li>
					<li>*Pregnancy Outcome</li>
					<li>Prevalence</li>
					<li>Ghana/epidemiology</li>
					<li>*Developing Countries</li>
					<li>*Pre-Eclampsia/epidemiology</li>
					<li>Apgar scores</li>
					<li>Cesarean Section</li>
					<li>Chronic Disease</li>
					<li>chronic hypertension</li>
					<li>Gestational Age</li>
					<li>Hypertension, Pregnancy-Induced/epidemiology</li>
					<li>Hypertension/*complications/epidemiology</li>
					<li>Infant, Low Birth Weight</li>
					<li>Logistic Models</li>
					<li>Perinatal Death/etiology</li>
					<li>perinatal outcome</li>
					<li>Poverty</li>
					<li>pre-eclampsia</li>
					<li>pre-term birth</li>
					<li>pregnancy-induced hypertension</li>
					<li>Premature Birth</li>
					<li>Reference Values</li>
					<li>Urban Population</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_2IV68P53">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name</strong> : </p>
<p>Facility names</p>
<p><strong>Location Type</strong> : </p>
<p>Health Facility </p>
<p><strong>Description</strong> : </p>
<p>Two public hospitals in Accra, capital city of Ghana</p>
<p><strong>sample size</strong> : 1010</p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_GEHB2EMX" class="item journalArticle">
			<h2>Pharmacovigilance for ACTs in Africa (PVACT)</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>PharmD Halidou Tinto</td>
					</tr>
					<tr>
					<th>URL</th>
						<td><a href="https://classic.clinicaltrials.gov/ct2/show/NCT01232530">https://classic.clinicaltrials.gov/ct2/show/NCT01232530</a></td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>3/5/2024, 11:52:58 AM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>3/5/2024, 11:54:50 AM</td>
					</tr>
				</tbody></table>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_QIL8KA85">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name : </strong></p>
<p><span style="color: rgb(0, 0, 0)"><span style="background-color: rgb(255, 255, 255)">Nanoro</span></span></p>
<p><strong>Location Type : </strong></p>
<p>City</p>
<p><strong>Description :</strong></p>
<p>Nanoro, Boulkiemd, Burkina Faso</p>
<p><strong>Sample size : &nbsp;</strong><span style="color: rgb(0, 0, 0)"><span style="background-color: rgb(255, 255, 255)">3176</span></span></p>
<p></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_H84QLIAT" class="item journalArticle">
			<h2>Pilot Outcomes of Maisha: An HIV Stigma Reduction Intervention Developed for Antenatal Care in Tanzania.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Watt MH</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Minja L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Knettel BA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mwamba RN</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Osaki H</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ngocho JS</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kisigo GA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Renju J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Vissoci JRN</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sao SS</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mmbaga BT</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>HIV stigma is a persistent barrier to curbing the spread of 
HIV and improving quality of life for people living with HIV. We 
developed and pilot tested Maisha, an HIV stigma reduction intervention 
in antenatal care (ANC) with two objectives: 1) among individuals living
 with HIV, reduce internalized and anticipated HIV stigma, with 
subsequent improvements in HIV care engagement, and 2) among individuals
 who are HIV-seronegative, reduce HIV stigmatizing attitudes. We 
enrolled and baselined 1039 women and 492 male partners presenting to a 
first ANC appointment and randomized them to standard of care or the 
Maisha intervention. All women living with HIV (WLHIV) and a subset of 
HIV-negative participants completed a 3-month follow-up assessment. 
Participation in the three Maisha sessions was high (99.6%, 92.8%, 
89.3%), and nearly all participants noted satisfaction with the 
intervention content (99.8%) and counselor (99.8%). Among 55 WLHIV, care
 engagement outcomes did not differ by condition. Among 293 HIV-negative
 participants, Maisha participants had significantly greater reductions 
in the moral judgment sub-scale of the stigma attitudes measure (p &lt; 
.001), but not the social distancing subscale. The ANC setting, where 
women and their partners are routinely tested for HIV, is an ideal venue
 for addressing HIV stigma. The Maisha intervention was feasible and 
acceptable, and had an impact on HIV stigma attitudes. A full trial is 
needed to examine impacts on HIV outcomes; modifications to the 
intervention should be considered to reduce social alienation of PLWH.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2021-04</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>25</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>1171-1184</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>AIDS and behavior</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1007/s10461-020-03093-9">10.1007/s10461-020-03093-9</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>4</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1090-7165 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Male</li>
					<li>Tanzania</li>
					<li>HIV</li>
					<li>Social Stigma</li>
					<li>*Prenatal Care</li>
					<li>Infectious Disease Transmission, Vertical/prevention &amp; control</li>
					<li>Antenatal care</li>
					<li>Stigma</li>
					<li>*HIV Infections/prevention &amp; control</li>
					<li>Prevention of mother to child transmission</li>
					<li>Quality of Life</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_U3SPB6KL">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location Name :</strong> </p>
<p><span style="color: var(--tw-prose-bold)">Majengo Health Center and Pasua Health Center)</span></p>
<p><strong>Location Type</strong> : </p>
<p>Healthy Facility</p>
<p><strong><span style="color: var(--tw-prose-bold)">Description: </span></strong></p>
<p><span style="color: var(--tw-prose-bold)">Two government health facilities in Moshi municipality, Tanzania (Majengo Health Center and Pasua Health Center)</span></p>
<p><strong><span style="color: var(--tw-prose-bold)">Sample size : </span></strong><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">&nbsp;</span></span>1039 women and 492 male partners</p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_2JC85YPK" class="item journalArticle">
			<h2>Plasma and breast-milk selenium in HIV-infected Malawian mothers 
are positively associated with infant selenium status but are not 
associated with maternal supplementation: results of the Breastfeeding, 
Antiretrovirals, and Nutrition study.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Flax VL</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bentley ME</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Combs GF Jr</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chasela CS</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kayira D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Tegha G</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kamwendo D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Daza EJ</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Fokar A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kourtis AP</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Jamieson DJ</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>van der Horst CM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Adair LS</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Selenium is found in soils and is essential for 
human antioxidant defense and immune function. In Malawi, low soil 
selenium and dietary intakes coupled with low plasma selenium 
concentrations in HIV infection could have negative consequences for the
 health of HIV-infected mothers and their exclusively breastfed infants.
 OBJECTIVE: We tested the effects of lipid-based nutrient supplements 
(LNS) that contained 1.3 times the Recommended Dietary Allowance of 
sodium selenite and antiretroviral drugs (ARV) on maternal plasma and 
breast-milk selenium concentrations. DESIGN: HIV-infected Malawian 
mothers in the Breastfeeding, Antiretrovirals, and Nutrition study were 
randomly assigned at delivery to receive: LNS, ARV, LNS and ARV, or a 
control. In a subsample of 526 mothers and their uninfected infants, we 
measured plasma and breast-milk selenium concentrations at 2 or 6 
(depending on the availability of infant samples) and 24 wk postpartum. 
RESULTS: Overall, mean (+/- SD) maternal (range: 81.2 +/- 20.4 to 86.2 
+/- 19.9 mug/L) and infant (55.6 +/- 16.3 to 61.0 +/- 15.4 mug/L) plasma
 selenium concentrations increased, whereas breast-milk selenium 
concentrations declined (14.3 +/- 11.5 to 9.8 +/- 7.3 mug/L) from 2 or 6
 to 24 wk postpartum (all P &lt; 0.001). Compared with the highest 
baseline selenium tertile, low and middle tertiles were positively 
associated with a change in maternal plasma or breast-milk selenium from
 2 or 6 to 24 wk postpartum (both P &lt; 0.001). With the use of linear 
regression, we showed that LNS that contained selenium and ARV were not 
associated with changes in maternal plasma and breast-milk selenium, but
 maternal selenium concentrations were positively associated with infant
 plasma selenium at 2 or 6 and 24 wk postpartum (P &lt; 0.001) 
regardless of the study arm. CONCLUSIONS: Selenite supplementation of 
HIV-infected Malawian women was not associated with a change in their 
plasma or breast-milk selenium concentrations. Future research should 
examine effects of more readily incorporated forms of selenium (ie, 
selenomethionine) in HIV-infected breastfeeding women.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2014-04</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>99</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>950-6</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>The American journal of clinical nutrition</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.3945/ajcn.113.073833">10.3945/ajcn.113.073833</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>4</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>0002-9165 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>*Dietary Supplements</li>
					<li>*Maternal Nutritional Physiological Phenomena</li>
					<li>Adult</li>
					<li>Anti-Retroviral Agents/*therapeutic use</li>
					<li>Child Development</li>
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>HIV Infections/blood/drug therapy/*metabolism</li>
					<li>Humans</li>
					<li>Infant</li>
					<li>Lactation/blood/*metabolism</li>
					<li>Malawi</li>
					<li>Milk, Human/*chemistry</li>
					<li>Nutritional Status</li>
					<li>Selenium/blood/deficiency/*metabolism/therapeutic use</li>
					<li>Sodium Selenite/administration &amp; dosage</li>
					<li>Young Adult</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_95PCY92N">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Name: &nbsp;</span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">Names not specified</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Type: </span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">Health facilities</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Description: </span></span></strong></p>
<p><span style="color: rgb(28, 43, 51)"><span style="background-color: rgb(255, 255, 255)">The study was conducted at antenatal clinics in Lilongwe, Malawi</span></span></p>
<p><strong>Sample Size</strong>: &nbsp;2418</p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_GBZUDLWX" class="item journalArticle">
			<h2>Population-based rates, risk factors and consequences of preterm 
births in South-Asia and sub-Saharan Africa: A multi-country prospective
 cohort study.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Preterm birth is the leading cause of neonatal 
deaths in low middle-income countries (LMICs), yet there exists a 
paucity of high-quality data from these countries. Most modelling 
estimates are based on studies using inaccurate methods of gestational 
age assessment. We aimed to fill this gap by measuring the 
population-based burden of preterm birth using early ultrasound dating 
in five countries in South-Asian and sub-Saharan Africa. METHODS: We 
identified women early in pregnancy (&lt;20 weeks based on last 
menstrual period) by home visits every 2-3 months (except in Zambia 
where they were identified at antenatal care clinics) in 5 research 
sites in South-Asia and sub-Saharan Africa between July 2012 and 
September 2016. Trained sonographers performed an ultrasound scan for 
gestational age dating. Women were enrolled if they were 8-19 weeks 
pregnant on ultrasound. Women &lt;8 weeks were rescheduled for repeat 
scans after 4 weeks, and identified women were followed through 
pregnancy until 6 weeks postpartum. Site-specific rates and proportions 
were calculated and a logistic regression model was used to predict the 
risk factors of preterm birth. RESULTS: Preterm birth rates ranged from 
3.2% in Ghana to 15.7% in Pakistan. About 46% of all neonatal deaths 
occurred among preterm infants, 49% in South Asia and 40% in sub-Saharan
 Africa. Fourteen percent of all preterm infants died during the 
neonatal period. The mortality was 37.6% for early preterm babies 
(&lt;34 weeks), 5.9% for late preterm babies (34 to &lt;37 weeks), and 
1.7% for term babies (37 to &lt;42 weeks). Factors associated lower 
gestation at birth included South-Asian region (adjusted mean difference
 (Adj MD) = -6.2 days, 95% confidence interval (CI) = -5.5, -6.9), 
maternal morbidities (Adj MD = -3.4 days, 95% CI = -4.6, -2.2), multiple
 pregnancies (Adj MD = -17.8 days, 95% CI = -19.9,-15.8), adolescent 
pregnancy (Adj MD = -2.7 days, 95% CI = -3.7, -1.6) and lowest wealth 
quintile (Adj MD = -1.3 days, 95% CI = -2.4, -0.3). CONCLUSIONS: Preterm
 birth rates are higher in South Asia than in sub-Saharan Africa and 
contribute to 49% and 40% of all neonatal deaths in the two regions, 
respectively. Adolescent pregnancy and maternal morbidities are 
modifiable risk factors associated with preterm birth.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2022</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: Scotland</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>12</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>04011</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Journal of global health</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.7189/jogh.12.04011">10.7189/jogh.12.04011</a></td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>2047-2978 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:31 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:31 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Ghana</li>
					<li>Infant, Newborn</li>
					<li>Prospective Studies</li>
					<li>Risk Factors</li>
					<li>Infant</li>
					<li>Adolescent</li>
					<li>Pakistan</li>
					<li>Infant, Premature</li>
					<li>*Premature Birth/epidemiology</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_JQNMGAG7">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name</strong> : </p>
<p>South-Asia (Sylhet, Bangladesh, and Karachi, Pakistan), sub-Saharan 
Africa (Kintampo, Ghana; Pemba, Tanzania; and Southern Province, 
Zambia)a</p>
<p><strong>Location Type</strong> : </p>
<p>Community sites</p>
<p><strong>Description</strong> : </p>
<p>Five community sites in South-Asia (Sylhet, Bangladesh, and Karachi, 
Pakistan), sub-Saharan Africa (Kintampo, Ghana; Pemba, Tanzania; and 
Southern Province, Zambia)</p>
<p><strong>sample size</strong> : Ghana (N=976) ,Tanzania (N=2427) ,Zambia (N=981)</p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_ZERTB2TF" class="item journalArticle">
			<h2>Population-based rates, timing, and causes of maternal deaths, 
stillbirths, and neonatal deaths in south Asia and sub-Saharan Africa: a
 multi-country prospective cohort study.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Modelled mortality estimates have been useful for 
health programmes in low-income and middle-income countries. However, 
these estimates are often based on sparse and low-quality data. We aimed
 to generate high quality data about the burden, timing, and causes of 
maternal deaths, stillbirths, and neonatal deaths in south Asia and 
sub-Saharan Africa. METHODS: In this prospective cohort study done in 11
 community-based research sites in south Asia and sub-Saharan Africa, 
between July, 2012, and February, 2016, we conducted population-based 
surveillance of women of reproductive age (15-49 years) to identify 
pregnancies, which were followed up to birth and 42 days post partum. We
 used standard operating procedures, data collection instruments, 
training, and standardisation to harmonise study implementation across 
sites. Verbal autopsies were done for deaths of all women of 
reproductive age, neonatal deaths, and stillbirths. Physicians used 
standardised methods for cause of death assignment. Site-specific rates 
and proportions were pooled at the regional level using a meta-analysis 
approach. FINDINGS: We identified 278 186 pregnancies and 263 563 births
 across the study sites, with outcomes ascertained for 269 630 (96.9%) 
pregnancies, including 8761 (3.2%) that ended in miscarriage or 
abortion. Maternal mortality ratios in sub-Saharan Africa (351 per 100 
000 livebirths, 95% CI 168-732) were similar to those in south Asia (336
 per 100 000 livebirths, 247-458), with far greater variability within 
sites in sub-Saharan Africa. Stillbirth and neonatal mortality rates 
were approximately two times higher in sites in south Asia than in 
sub-Saharan Africa (stillbirths: 35.1 per 1000 births, 95% CI 28.5-43.1 
vs 17.1 per 1000 births, 12.5-25.8; neonatal mortality: 43.0 per 1000 
livebirths, 39.0-47.3 vs 20.1 per 1000 livebirths, 14.6-27.6). 40-45% of
 pregnancy-related deaths, stillbirths, and neonatal deaths occurred 
during labour, delivery, and the 24 h postpartum period in both regions.
 Obstetric haemorrhage, non-obstetric complications, hypertensive 
disorders of pregnancy, and pregnancy-related infections accounted for 
more than three-quarters of maternal deaths and stillbirths. The most 
common causes of neonatal deaths were perinatal asphyxia (40%, 95% CI 
39-42, in south Asia; 34%, 32-36, in sub-Saharan Africa) and severe 
neonatal infections (35%, 34-36, in south Asia; 37%, 34-39 in 
sub-Saharan Africa), followed by complications of preterm birth (19%, 
18-20, in south Asia; 24%, 22-26 in sub-Saharan Africa). INTERPRETATION:
 These results will contribute to improved global estimates of rates, 
timing, and causes of maternal and newborn deaths and stillbirths. Our 
findings imply that programmes in sub-Saharan Africa and south Asia need
 to further intensify their efforts to reduce mortality rates, which 
continue to be high. The focus on improving the quality of maternal 
intrapartum care and immediate newborn care must be further enhanced. 
Efforts to address perinatal asphyxia and newborn infections, as well as
 preterm birth, are critical to achieving survival goals in the 
Sustainable Development Goals era. FUNDING: Bill &amp; Melinda Gates 
Foundation.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2018-12</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>6</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e1297-e1308</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>The Lancet. Global health</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1016/S2214-109X(18)30385-1">10.1016/S2214-109X(18)30385-1</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>12</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>2214-109X (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Infant, Newborn</li>
					<li>Prospective Studies</li>
					<li>Young Adult</li>
					<li>Middle Aged</li>
					<li>Africa South of the Sahara/epidemiology</li>
					<li>Adolescent</li>
					<li>Stillbirth/*epidemiology</li>
					<li>Asia/epidemiology</li>
					<li>*Perinatal Death/etiology</li>
					<li>Maternal Death/*etiology/*statistics &amp; numerical data</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_S7NIPPMI">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Name: &nbsp;</span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">North and south Ubangi, Brong Ahafo</span></span><strong><span style="color: black"><span style="background-color: white">, </span></span></strong><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Western Province, Ifakara, Pemba, Southern Province</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Type: </span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">Community</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Description: </span></span></strong></p>
<ol>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">South Asia:</span></span>
</li>
</ol>
<ul>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Bangladesh (Sylhet)</span></span>
</li>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">India (Haryana, Uttar Pradesh)</span></span>
</li>
<li>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Pakistan (Karachi, Matiari)</span></span></p>
<p></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">2. Sub-Saharan Africa:</span></span></p>
<ul>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Democratic Republic of Congo (North and South Ubangi)</span></span>
</li>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Ghana (Brong Ahafo)</span></span>
</li>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Kenya (Western Province)</span></span>
</li>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Tanzania (Ifakara, Pemba)</span></span>
</li>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Zambia (Southern Province)</span></span>
</li>
</ul>
</li>
</ul>
<p><strong>Sample Size: 117661</strong></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_PQTQADUB" class="item journalArticle">
			<h2>Postpartum depression and child growth in Tanzania: a cohort study.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Holm-Larsen CE</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Madsen FK</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Rogathi JJ</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Manongi R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mushi D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Meyrowitsch DW</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gammeltoft T</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sigalla GN</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Rasch V</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>OBJECTIVE: To examine the association between postpartum 
depression and child growth in a Tanzanian birth cohort. DESIGN: 
Prospective cohort study. SETTING: Moshi, Tanzania. POPULATION: Pregnant
 women over the age of 18 who sought antenatal care at two health 
clinics in Moshi, and the children they were pregnant with, were 
assessed for inclusion in this study. METHODS: The women were 
interviewed twice during pregnancy and three times after birth, the 
final follow up taking place 2-3 years postpartum. Signs of postpartum 
depression were assessed approximately 40 days postpartum with the 
Edinburgh Postnatal Depression Scale. MAIN OUTCOME MEASURES: Child 
growth was assessed with anthropometric measurements at 2-3 years of age
 and expressed as mean z-scores. RESULTS: In all, 1128 mother-child 
pairs were followed throughout the duration of the study. In total, 
12.2% of the mothers showed signs of postpartum depression. Adjusted 
mean height-for-age z-score (HAZ) was significantly lower at 2-3 years 
follow up for children of mothers with postpartum depression than for 
children of mothers without (difference in HAZ: -0.32, 95% CI-0.49 to 
-0.15). Adjusted mean weight-for-height z-score (WHZ) was significantly 
increased for the children exposed to postpartum depression (difference 
in WHZ: 0.21, 95% CI 0.02-0.40), whereas there was no significant 
difference in adjusted weight-for-age z-score (WAZ; difference in WAZ: 
-0.04, 95% CI -0.20 to 0.12). CONCLUSIONS: We found that postpartum 
depressive symptoms predicted decreased linear height in children at 2-3
 years of age and slightly increased weight-for-height. TWEETABLE 
ABSTRACT: Postpartum depression in Tanzanian mothers is associated with 
impaired child growth at 2-3 years of age.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2019-04</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>126</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>590-598</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>BJOG : an international journal of obstetrics and gynaecology</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1111/1471-0528.15495">10.1111/1471-0528.15495</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>5</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1470-0328 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Prospective Studies</li>
					<li>Young Adult</li>
					<li>Male</li>
					<li>Child, Preschool</li>
					<li>Tanzania</li>
					<li>*Child Development</li>
					<li>*Depression, Postpartum</li>
					<li>Child development</li>
					<li>Child of Impaired Parents/*statistics &amp; numerical data</li>
					<li>Growth Charts</li>
					<li>Growth Disorders/*psychology</li>
					<li>maternal depression</li>
					<li>Mothers/*psychology</li>
					<li>nutritional status</li>
					<li>postnatal depression</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_WRDZJT6R">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location Name</strong> :</p>
<p>The exact name of the health facilities are not mentioned</p>
<p><strong>Location Type</strong> : </p>
<p>Health facility</p>
<p><strong>Description</strong> :</p>
<p>Conducted in two health clinics in Moshi, Tanzania..</p>
<p><strong>Sample size</strong> : <span style="color: rgb(0, 0, 0)"><span style="background-color: rgb(255, 255, 255)">1128</span></span></p>
<p></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_G858K7QZ" class="item journalArticle">
			<h2>Pregnancy Outcomes in the Era of Universal Antiretroviral Treatment in Sub-Saharan Africa (POISE Study).</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Dadabhai S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gadama L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chamanga R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kawalazira R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Katumbi C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Makanani B</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Dula D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hua N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Lau B</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mallewa M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Taha TE</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Adverse pregnancy outcomes such as preterm birth 
(PTB), low birth weight (LBW), and small for gestational age (SGA) 
remain major global problems. We compared pregnancy outcomes among 
HIV-infected women receiving antiretroviral treatment (ART) and with CD4
 &gt;/=350 cells, and HIV-uninfected women to assess whether disparities
 associated with HIV infection have been eliminated through use of ART. 
SETTING: Observational study conducted at 5 health facilities in 
Blantyre, Malawi, during 2016-2017. METHODS: HIV-infected women 
receiving the national ART regimen (efavirenz + lamivudine + tenofovir) 
and HIV-uninfected women were consented and enrolled at delivery. Data 
collected included sociodemographic and clinical; gestational age; BW; 
infant/maternal anthropometry; and laboratory results. We defined PTB as
 GA &lt;37 weeks; LBW as BW &lt;2.5 kg; and SGA as BW &lt;10th 
percentile of GA. SGA infants were classified into proportionate and 
disproportionate based on ponderal index. Descriptive, stratified, and 
multivariate logistic and linear regression analyses were used. RESULTS:
 Of 5423 women approached, 614 HIV-infected and 685 HIV-uninfected women
 were enrolled. Rates of PTB, LBW, and SGA were 10.6%, 7.2%, and 17.1% 
among HIV-infected women on ART and 9.5%, 5.0%, and 18.4% among 
HIV-uninfected women, respectively. None of these differences were 
statistically significant in univariate- or multivariate-adjusted 
analyses (P &gt; 0.05). Of 231 SGA infants, 78.8% were proportionate and
 21% were disproportionate. Of the 614 HIV-infected women on ART, 75% 
had undetectable virus at delivery. CONCLUSIONS: ART use has reduced the
 high rates of adverse pregnancy outcomes among HIV-infected women. 
However, the rates remain high irrespective of HIV infection and require
 appropriate interventions.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2019-01</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>80</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>7-14</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Journal of acquired immune deficiency syndromes (1999)</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1097/QAI.0000000000001875">10.1097/QAI.0000000000001875</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1525-4135 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Malawi/epidemiology</li>
					<li>Pregnancy</li>
					<li>Infant, Newborn</li>
					<li>Prospective Studies</li>
					<li>Infectious Disease Transmission, Vertical/*prevention &amp; control</li>
					<li>Pregnancy Outcome</li>
					<li>Socioeconomic Factors</li>
					<li>Anti-Retroviral Agents/*therapeutic use</li>
					<li>control</li>
					<li>Drug Administration Schedule</li>
					<li>HIV Infections/*drug therapy/transmission</li>
					<li>Pregnancy Complications, Infectious/*drug therapy/epidemiology/prevention &amp;</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_JXJ8LVVE">
<div><div data-schema-version="8"><p><strong>Location Information:</strong></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Name:</span></span></strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Queen Elizabeth Central Hospital &nbsp;and the name of the 4 other health centers is not provided</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Type: </span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">Health facilities</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Description:</span></span></strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Conducted
 in Blantyre, Malawi. It took place at the main teaching hospital, the 
Queen Elizabeth Central Hospital (QECH), and at 4 major health centers 
that represent the catchment area for QECH.</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Sample size : 1299</span></span></strong></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_J4V98VJ3" class="item journalArticle">
			<h2>Pregnancy-Related Acute Kidney Injury in Preeclampsia: Risk Factors and Renal Outcomes.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Conti-Ramsden FI</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Nathan HL</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>De Greeff A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hall DR</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Seed PT</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chappell LC</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Shennan AH</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bramham K</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>Preeclampsia is a common cause of acute kidney injury (AKI) in
 low- and middle-income countries, but AKI incidence in preeclampsia, 
its risk factors, and renal outcomes are unknown. A prospective 
observational multicenter study of women admitted with preeclampsia in 
South Africa was conducted. Creatinine concentrations were extracted 
from national laboratory databases for women with maximum creatinine of 
&gt;/=90 mumol/L (&gt;/=1.02 mg/dL). Renal injury and recovery were 
defined by Kidney Disease Improving Global Outcomes creatinine criteria.
 Predefined risk factors, maternal outcomes, and neonatal outcomes were 
compared between AKI stages. Of 1547 women admitted with preeclampsia 
237 (15.3%) met AKI criteria: 6.9% (n=107) stage 1, 4.3% (n=67) stage 2,
 and 4.1% (n=63) stage 3. There was a higher risk of maternal death 
(n=7; relative risk, 4.3; 95% CI, 1.6-11.4) and stillbirth (n=80; 
relative risk, 2.2; 95% CI, 1.8-2.8) in women with AKI compared with 
those without. Perinatal mortality was also increased (89 of 240; 
37.1%). Hypertension in a previous pregnancy was the strongest predictor
 of AKI stage 2 or 3 (odds ratio, 2.24; 95% CI, 1.21-4.17). Renal 
recovery rate reduced with increasing AKI stage. A third of surviving 
women (76 of 230 [33.0%]) had not recovered baseline renal function by 
discharge. Approximately half (39 of 76; 51.3%) of these women had no 
further creatinine testing post-discharge. In summary, AKI was common in
 women with preeclampsia and had high rates of associated maternal and 
perinatal mortality. Only two-thirds of women had confirmed renal 
recovery. History of a previous hypertensive pregnancy was an important 
risk factor.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2019-11</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 5
Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>74</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>1144-1151</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Hypertension (Dallas, Tex. : 1979)</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1161/HYPERTENSIONAHA.119.13089">10.1161/HYPERTENSIONAHA.119.13089</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>5</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>0194-911X (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:28 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:28 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Infant, Newborn</li>
					<li>*pregnancy</li>
					<li>Prospective Studies</li>
					<li>Prevalence</li>
					<li>Risk Assessment</li>
					<li>Poverty</li>
					<li>South Africa</li>
					<li>Follow-Up Studies</li>
					<li>Adolescent</li>
					<li>Developing Countries</li>
					<li>Stillbirth/*epidemiology</li>
					<li>Odds Ratio</li>
					<li>*Perinatal Death</li>
					<li>Survival Analysis</li>
					<li>Pre-Eclampsia/diagnosis/*epidemiology/therapy</li>
					<li>Hospitalization/statistics &amp; numerical data</li>
					<li>Severity of Illness Index</li>
					<li>*acute kidney injury</li>
					<li>*creatinine</li>
					<li>*preeclampsia</li>
					<li>*renal insufficiency, chronic</li>
					<li>Acute Kidney Injury/diagnosis/*epidemiology/therapy</li>
					<li>Comorbidity</li>
					<li>Confidence Intervals</li>
					<li>Creatinine/blood</li>
					<li>Kidney Function Tests</li>
					<li>Maternal Death/*trends</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_64UH4FFX">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name : </strong></p>
<p><span style="color: rgb(0, 0, 0)"><span style="background-color: rgb(255, 255, 255)">Groote Schuur , Tygerberg &nbsp;and Kimberley Hospital</span></span></p>
<p><strong>Location Type : </strong></p>
<p>Health facility</p>
<p><strong>Description : </strong></p>
<p><span style="color: rgb(0, 0, 0)"><span style="background-color: rgb(255, 255, 255)">Tertiary hospital sites (Groote Schuur Hospital, Tygerberg Hospital, and Kimberley Hospital) in South Africa</span></span></p>
<p><strong>Sample Size :</strong> <span style="color: rgb(0, 0, 0)"><span style="background-color: rgb(255, 255, 255)">1547&nbsp;</span></span></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_KWLAETM5" class="item journalArticle">
			<h2>Prenatal nutrition, stimulation, and exposure to punishment are 
associated with early child motor, cognitive, language, and 
socioemotional development in Dar es Salaam, Tanzania.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Pitchik HO</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Fawzi WW</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>McCoy DC</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Darling AM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Abioye AI</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Tesha F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Smith ER</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mugusi F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sudfeld CR</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Despite growing evidence that early life 
experiences and exposures can impact child development, there is limited
 research on how prenatal and early life nutrition and early life 
parenting practices predict specific domains of child development in 
resource-limited settings. This study examines the association between 
prenatal factors, birth outcomes, and early life characteristics with 
motor, cognitive/language, and socioemotional development in Tanzania. 
METHODS: We assessed motor, cognitive/language, and socioemotional 
development among a cohort of 198 children aged 20-39 months in Dar es 
Salaam, Tanzania, whose mothers were previously enrolled in a 
randomized, placebo-controlled trial of prenatal vitamin A and zinc 
supplementation. Linear regression models were used to assess 
standardized mean differences in child development scores for randomized
 prenatal regimen and pregnancy, delivery, and early childhood factors. 
RESULTS: Children born to mothers randomized to prenatal vitamin A had 
significantly lower reported motor scores in minimally adjusted and 
multivariate analyses, -0.29 SD, 95% CI [-0.54, -0.04], p = 0.03, as 
compared with children whose mothers did not receive vitamin A. There 
was no significant effect of randomized prenatal zinc on any development
 domain. Greater caregiver-child stimulation was associated with 0.38 
SD, 95% CI [0.14, 0.63], p &lt; 0.01, better cognitive/language scores, 
whereas children who experienced both verbal and physical punishment had
 0.29 SD, 95% CI [-0.52, -0.05], p = 0.02, lower scores in 
socioemotional development. Maternal completion of primary school was 
associated with higher reported motor and cognitive/language 
development. Further, children of mothers who were &lt;155 cm tall had 
lower cognitive and language scores. CONCLUSION: Prenatal vitamin A 
supplements in a setting with low levels of vitamin A deficiency may not
 provide child development benefits. However, integrated environmental, 
educational, parenting, and stimulation interventions may have large 
positive effects across child development domains in resource-limited 
settings.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2018-11</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>44</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>841-849</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Child: care, health and development</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1111/cch.12605">10.1111/cch.12605</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>6</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>0305-1862 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>*Dietary Supplements</li>
					<li>Male</li>
					<li>Child, Preschool</li>
					<li>Prenatal Exposure Delayed Effects</li>
					<li>Tanzania/epidemiology</li>
					<li>*child development</li>
					<li>Health Surveys</li>
					<li>*developing countries</li>
					<li>*early assessment</li>
					<li>*psychosocial factors</li>
					<li>*randomized trials</li>
					<li>Child Development/*physiology</li>
					<li>Education, Nonprofessional/*organization &amp; administration</li>
					<li>Language Development</li>
					<li>Maternal Nutritional Physiological Phenomena/*physiology</li>
					<li>Mothers/education/*psychology</li>
					<li>Motor Skills/*physiology</li>
					<li>Punishment/*psychology</li>
					<li>Social Environment</li>
					<li>Vitamin A/therapeutic use</li>
					<li>Zinc/therapeutic use</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_UA4SV9GG">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location Name</strong> :</p>
<p>City name - Dar es salaam</p>
<p>Health facility names - not provided</p>
<p><strong>Location Type</strong> : </p>
<p>City, health facility</p>
<p><strong>Description</strong> &nbsp;: &nbsp;</p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Conducted in Dar es Salaam, Tanzania</span></span></p>
<p><strong>Sample size : </strong><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">198</span></span></p>
<p></p>
<p></p>
<p></p>
<p></p>
<p></p>
<p></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_JTM44P5P" class="item journalArticle">
			<h2>PrEP Implementation for Mothers in Antenatal Care (PrIMA): study protocol of a cluster randomised trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Dettinger JC</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kinuthia J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Pintye J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mwongeli N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gomez L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Richardson BA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Barnabas R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Wagner AD</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>O'Malley G</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Baeten JM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>John-Stewart G</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>INTRODUCTION: Women in regions with high HIV prevalence are at
 high risk of HIV acquisition during pregnancy and postpartum, and acute
 maternal HIV contributes a substantial proportion of infant HIV 
infections. Pre-exposure prophylaxis (PrEP) could prevent HIV during 
pregnancy/postpartum; however, identifying women who would most benefit 
from PrEP in this period is challenging. Women may not perceive risk, 
may not know partner HIV status and partners may have external partners 
during this period. PrEP offer in pregnancy could be universal or risk 
guided. METHODS AND ANALYSIS: The PrEP Implementation for Mothers in 
Antenatal Care (PrIMA) study is a cluster randomised trial that aims to 
determine the best model for PrEP implementation in pregnancy, among 
women attending public sector maternal child health clinics in Western 
Kenya (HIV prevalence &gt;25%). Twenty clinics are randomised to either 
universal PrEP offer following standardised counselling ('Universal arm'
 10 clinics) or risk screening with partner self-test option ('Targeted 
arm' 10 clinics). Four thousand women will be enrolled and followed 
through 9-month postpartum. The primary analysis will be intention to 
treat. Outcomes reflect the balance between HIV preventive effectiveness
 and avoiding unnecessary PrEP exposure to women at low risk and 
include: maternal HIV incidence, PrEP uptake, PrEP adherence, PrEP 
duration, 'appropriate' PrEP use (among women with objective evidence of
 potential risk), infant birth outcomes, infant growth and partner 
self-testing uptake. To better understand the feasibility and 
acceptability of the provision of PrEP in these settings, qualitative 
interviews and cost-effectiveness analyses will be conducted. ETHICS AND
 DISSEMINATION: The protocol was approved by the institutional review 
boards at Kenyatta National Hospital and the University of Washington. 
An external advisory panel monitors adverse and social harm events. 
Results will be disseminated through peer-reviewed journals, 
presentations at local and international conferences to national and 
global policy makers, community and participants. TRIAL REGISTRATION 
NUMBER: NCT03070600.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2019-03</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>9</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e025122</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>BMJ open</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1136/bmjopen-2018-025122">10.1136/bmjopen-2018-025122</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>3</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>2044-6055 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>*HIV</li>
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>*pregnancy</li>
					<li>Anti-HIV Agents/*therapeutic use</li>
					<li>HIV Infections/*prevention &amp; control</li>
					<li>Kenya</li>
					<li>Randomized Controlled Trials as Topic</li>
					<li>*cluster randomised trial</li>
					<li>*postpartum period</li>
					<li>*pre-exposure prophylaxis (PrEP)</li>
					<li>Maternal Health/*statistics &amp; numerical data</li>
					<li>Maternal Welfare/*statistics &amp; numerical data</li>
					<li>Pre-Exposure Prophylaxis/*methods</li>
					<li>Prenatal Care/*organization &amp; administration</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_IEYQA7I4">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location Name :</strong> </p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Homa Bay and Siaya</span></span></p>
<p><strong>Location Type :</strong> </p>
<p>Health facilities</p>
<p><strong>Description</strong> : </p>
<p>Conducted in Kenya</p>
<p><strong>Sample size :</strong></p>
<p></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_7Z9I44EZ" class="item journalArticle">
			<h2>Prevalence, associated factors and perinatal outcomes of antepartum depression in Ibadan Nigeria.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Adeoye IA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sogbesan A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Esan O</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Antepartum depression is the most common mental 
health disorder in pregnancy and it is also a risk factor for adverse 
perinatal outcomes. Low and middle income countries like Nigeria bear a 
higher burden of antepartum depression compared with high income 
countries. Prioritizing mental health issues among pregnant women is 
crucial to achieving the Sustainable Development Goals. We determined 
the prevalence, associated factors and perinatal outcomes of antepartum 
depression among pregnant women in Ibadan, Nigeria. METHODS: A 
prospective cohort study was conducted among 1745 pregnant women 
enrolled early in pregnancy (&lt;/= 20 weeks) at four comprehensive 
obstetric facilities within Ibadan metropolis. Antepartum depression was
 ascertained during the third trimester using the Edinburg Postpartum 
Depression Scale &gt;/= 12. The primary exposure was antepartum 
depression and the outcome variables were the perinatal outcomes. The 
associated factors assessed included sociodemographic, obstetric, 
psychological, and lifestyle characteristics. Bi-variate logistic and 
Poisson regression analyses were used to assess the factors and relative
 risk for perinatal outcomes of antepartum depression. RESULTS: The 
prevalence of antepartum depression was 14.1%. The significant factors 
associated with APD after adjusting for confounders were: high income 
(&gt;/= 20, 000) which was protective (AOR) = 0.59; 95% CI: (0.40 - 
0.88); p-value: 0.010] and perceived stress increased the odds of APD in
 a monotonic fashion: moderate stress [AOR = 2.39; 95% CI: (1.01 - 5.7);
 p-value: 0.047], high stress [AOR = 6.43; 95% CI: (2.28 - 18.2); 
p-value: &lt; 0.001]. Preterm delivery was the only significant 
perinatal outcome [Relative Risk (RR) = 1.66; 95% CI (1.14 - 2.39); 
p-value = 0.007]. Depression did not increase the risk of having low 
birth weight babies (p = 0.513), macrosomia (p = 0.894), birth asphyxia 
(p = 0.317), and caesarean section (p = 0.298). CONCLUSIONS: APD was 
prevalent among our study population. The significant factors identified
 in this study can be targeted to reduce the occurrence of APD among 
pregnant women in Nigeria through appropriate social and public health 
interventions which include APD screening, counselling, and the 
provision of emotional support for pregnant women during antenatal care.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2022-03</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 1
Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>22</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>219</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>BMC pregnancy and childbirth</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/s12884-022-04549-7">10.1186/s12884-022-04549-7</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1471-2393 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:45 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:45 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Cohort Studies</li>
					<li>Infant, Newborn</li>
					<li>Prospective Studies</li>
					<li>Nigeria</li>
					<li>Risk Factors</li>
					<li>Antepartum depression</li>
					<li>Birth outcomes</li>
					<li>Depression/*psychology</li>
					<li>Maternal health</li>
					<li>Mental health</li>
					<li>Nigeria/epidemiology</li>
					<li>Pregnancy Complications/*psychology</li>
					<li>Pregnancy Outcome/epidemiology</li>
					<li>Prevalence</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_K5Z9HLEJ">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name</strong> : </p>
<p>Ibadan</p>
<p><strong>Location Type</strong> :</p>
<p> City</p>
<p><strong>Description</strong> : </p>
<p><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">Ibadan, the capital city of Oyo State, southwest, Nigeria.</span></span></p>
<p><strong>Sample size : </strong><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">1745</span></span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_83MKJSAY" class="item journalArticle">
			<h2>Prevalence, seroconversion and mother-to-child transmission of 
dual and triplex infections of HIV, hepatitis B and C viruses among 
pregnant women in Nigeria: study protocol.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Eleje GU</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mbachu II</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ogwaluonye UC</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kalu SO</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Onubogu CU</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Nweje SI</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Uzochukwu CE</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Nwankwo CH</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Fiebai PO</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Loto OM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Akaba GO</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Usman HA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Rabiu A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Egeonu RO</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Igue OE</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Adesoji BA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Jibuaku CH</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Aja PO</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chidozie CP</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ibrahim HS</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Aliyu FE</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Numan AI</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Okoro OD</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Omoruyi SA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Oppah IC</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Anyang UI</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ahmed A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chukwurah SN</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Umeononihu OS</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chukwuanukwu RC</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Umeh EO</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Emeka EA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ogbuagu CN</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Yakasai IA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ezechi OC</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ikechebelu JI</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Nigeria contributes significantly to the global 
burden of HIV, Hepatitis B and C infections, either singly or in 
combinations, despite progress in HIV care regionally and globally. 
Although some limited data on mono infection of HIV, Hepatitis B and C 
virus infections do exists, that of dual and triplex infections, 
including seroconversion and mother-to-child transmission (MTCT) rates 
necessary for planning to address the scourge of infections in pregnancy
 are not available. OBJECTIVES: To determine the seroprevalence, rate of
 new infections, MTCT of dual and triple infections of HIV, Hepatitis B 
and C viruses and associated factors, among pregnant women in Nigeria. 
METHOD: A multicenter prospective cohort study will be conducted in six 
tertiary health facilities randomly selected from the six geopolitical 
zones of Nigeria. All eligible pregnant women are to be tested at 
enrollment after informed consent for HIV, Hepatitis B and C virus 
infections. While those positive for at least two of the infections in 
any combination will be enrolled into the study and followed up to 6 
weeks post-delivery, those negative for the three infections or positive
 for only one of the infections at enrolment will be retested at 
delivery using a rapid diagnostic test. On enrolment into the study 
relevant information, will be obtained, and laboratory test of CD4 
count, liver function test and full blood counts, and prenatal 
ultrasonography will also be obtained/performed. Management of 
mother-newborns pairs will be according to appropriate national 
guidelines. All exposed newborns will be tested for HIV, HBV or HCV 
infection at birth and 6 weeks using PCR technique. The study data will 
be documented on the study case record forms. Data will be managed with 
SPSS for windows version 23. Ethical approval was obtained from National
 Health Research Ethics Committee (NHREC) (NHREC/01/01/2007-23/01/2020).
 CONCLUSION: Pregnant women with multiple of HIV, HBV and HCV infections
 are at increased risk of hepatotoxicity, maternal and perinatal 
morbidity and mortality. Additionally, infected pregnant women transmit 
the virus to their unborn baby even when asymptomatic. Children born 
with any of the infection have significantly poorer quality of life and 
lower five-year survival rate. Unfortunately, the seroconversion and 
MTCT rates of dual or triplex infections among pregnant women in Nigeria
 have not been studied making planning for prevention and subsequent 
elimination of the viruses difficult. The study is expected to fill this
 knowledge gaps. Nigeria joining the rest of the world to eliminate the 
triple infection among children rest on the availability of adequate and
 reliable data generated from appropriately designed, and powered study 
using representative population sample. The establishment of the 
three-in-one study of prevalence, rate of new infection, rate and risk 
factor for MTCT of dual and triple infection of HIV, Hepatitis B and C 
viruses among pregnant women in Nigeria is urgently needed for policy 
development and planning for the improvement of the quality of life of 
mothers and the elimination of childhood triplex infection.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2020-09</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 1
Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>17</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>144</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Reproductive health</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/s12978-020-00995-8">10.1186/s12978-020-00995-8</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1742-4755 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:37 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:37 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Nigeria</li>
					<li>HIV</li>
					<li>Dual infection</li>
					<li>HBV</li>
					<li>HCV</li>
					<li>Multiple infection</li>
					<li>Seroconversion</li>
					<li>Triplex infection</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_62536P28">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name</strong> : </p>
<p>Facility Names</p>
<p><strong>Location Type</strong> : </p>
<p><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">Health facility</span></span></p>
<p><strong>Description</strong> &nbsp;: </p>
<p><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">Six tertiary health facilities from &nbsp;six geopolitical zones of Nigeria</span></span></p>
<p><strong>Sample size :</strong></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_MNS8434F" class="item journalArticle">
			<h2>Probable perinatal depression and social support among women enrolled in Malawi's Option B+ Program: A longitudinal analysis.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bhushan NL</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Stockton MA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Harrington BJ</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>DiPrete BL</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Maliwichi M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Jumbe AN</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kulisewa K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chagomerana MB</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Pence BW</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gaynes BN</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hosseinipour MC</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Malawi's PMTCT Option B+ program has expanded the 
reach of ART services among pregnant and breastfeeding women, but 
retention in lifelong HIV care remains challenging. Given that 
depression can undermine retention, it is important to understand how 
depression changes over the perinatal period, varies across treatment 
and retention groups, and could be buffered by social support. METHODS: 
Data are from an observational study conducted among women enrolled in 
Malawi's PMTCT Option B+ program. We used multilevel generalized linear 
models to estimate the odds of probable depression by time, treatment 
and retention group, and social support. Probable depression was 
assessed with the Edinburgh Postnatal Depression Scale and Patient 
Health Questionnaire-9. RESULTS: Of 468 women, 15% reported probable 
depression at antenatal enrollment and prevalence differed across newly 
diagnosed individuals, second line therapy users, and previous 
defaulters (18%, 21%, 5%, p=0.001). Odds of probable perinatal 
depression decreased over time (OR per month: 0.87, 95% CI: 0.82-0.92) 
but were higher among those newly diagnosed (OR: 3.25, 95% CI: 
1.59-6.65) and on second line therapy (OR: 3.39, 95% CI: 1.44-7.99) as 
compared to previous defaulters. Odds of probable postpartum depression 
were lower for participants with high social support (OR: 0.19, 95% CI: 
0.09-0.39). LIMITATIONS: Lack of diagnostic psychiatric evaluation 
precludes actual diagnosis of depression. CONCLUSIONS: Probable 
depression varied across the perinatal period and across treatment and 
retention groups. Social support was protective for postpartum 
depression among all participants. Depression screening and provision of
 social support should be considered in PMTCT programs.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2022-06</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: Netherlands</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>306</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>200-207</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Journal of affective disorders</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1016/j.jad.2022.03.017">10.1016/j.jad.2022.03.017</a></td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>0165-0327 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>*HIV</li>
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Malawi/epidemiology</li>
					<li>Pregnancy</li>
					<li>Depression/epidemiology</li>
					<li>*Perinatal depression</li>
					<li>Social Support</li>
					<li>Infectious Disease Transmission, Vertical/prevention &amp; control</li>
					<li>*Pregnancy Complications, Infectious</li>
					<li>*HIV Infections/epidemiology</li>
					<li>*Depression, Postpartum/diagnosis/epidemiology/psychology</li>
					<li>*Social support</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_8AHPPGB7">
<div><div data-schema-version="8"><p><strong>Location Information:</strong></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Name:</span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">Specific names of the health facilities not given</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Type:</span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">Health facilities</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Description: </span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">conducted in Lilongwe Malawi</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Sample size : &nbsp;8000</span></span></strong></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_H3EKB3H8" class="item journalArticle">
			<h2>Progression of pregnancy induced diabetes mellitus to type two diabetes mellitus, an ambidirectional cohort study.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Feleke BE</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Feleke TE</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kassahun MB</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Adane WG</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Achenefe D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Genetu A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Nigussie AA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Engedaw HA</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>INTRODUCTION: Diabetes mellitus (DM) is a metabolic disorder 
characterized by elevated level of blood glucose. It affects more than 
422 million people globally. In resource limited settings, the 
progression of gestational diabetes (GDM) to DM was not well 
investigated and this research work was conducted to estimate the 
incidence of DM after GDM and their predictors in resource limited 
settings. METHODS: A retrospective and prospective cohort studies were 
used from January 2010 until December 2019. The data were collected 
using patients chart review, interview and collecting blood sample. 
Initially, baseline data were collected from GDM and GDM free women and 
update data were collected every 3 month. Clinical nurses were used to 
extract the necessary data from medical charts and to collect the data 
using patient interview. Laboratory technologists were used to measure 
the blood glucose level of the study participants. The study was 
conducted in pregnant women presenting themselves in the referral 
hospitals of Amhara regional state. The sample size was calculated using
 Epi-info software. Descriptive statistics were used to describe the 
profile of study participants. Kaplan Meier survival curve and 
life-table were used to estimate the survivals of study participants. 
Incidence density was used to estimate the incidence of DM. Cox 
regression was used to identify the predictors DM. RESULTS: A total of 
4892 women were followed giving for the response rate of 88.62%. The 
mean age of study participants at the start of the study was 28.34 years
 with standard deviation [SD] +/-7.48 years. DM was associated with 
gestational diabetes mellitus [AHR (adjusted hazard ratio); 2.53, 95% 
CI: 2.14-2.99], frequency of breastfeeding [AHR; 0.72, 95% CI: 
0.69-0.74], age [AHR; 1.04, 95% CI: 1.03-1.05], parity [AHR; 1.14, 95% 
CI: 1.07-1.21], regular physical exercise [AHR; 0.45, 95% CI: 
0.37-0.55], family history of DM [AHR; 2.04, 95% CI: 1.76-2.37], 
stillbirth [AHR; 1.67: 95% CI: 1.34-2.07], abortion [AHR; 2.64, 95% CI: 
2.25-3.09]. CONCLUSION: The progression of GDM to DM was very high and 
special follow up should be implemented for women with a history of 
abortion, stillbirth, and family history of DM.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2021-06</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>15</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>596-600</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Primary care diabetes</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1016/j.pcd.2020.11.016">10.1016/j.pcd.2020.11.016</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>3</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1878-0210 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Retrospective Studies</li>
					<li>Cohort Studies</li>
					<li>Prospective Studies</li>
					<li>Risk Factors</li>
					<li>Ethiopia</li>
					<li>*Diabetes Mellitus, Type 2</li>
					<li>*Diabetes, Gestational/diagnosis/epidemiology</li>
					<li>*Glucose intolerance</li>
					<li>*Pregnancy induced diabetes mellitus</li>
					<li>*Progression</li>
					<li>*Type 2 DM</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_PRDI5GZ5">
<div><div data-schema-version="8"><p><strong>Location Information </strong></p>
<p>Location Name: <strong><span style="color: var(--tw-prose-bold)"><span style="background-color: rgb(255, 255, 255)">Bangladesh:</span></span></strong></p>
<ul>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Location: Two sub-districts of Tangail district.</span></span>
</li>
</ul>
<ol>
<li>
<p><strong><span style="color: var(--tw-prose-bold)"><span style="background-color: rgb(255, 255, 255)">India (Belagavi):</span></span></strong></p>
<ul>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Location: Northwestern corner of the southern state of Karnataka.</span></span>
</li>
<li>

</li>
</ul>
</li>
<li>
<p><strong><span style="color: var(--tw-prose-bold)"><span style="background-color: rgb(255, 255, 255)">India (Nagpur):</span></span></strong></p>
<ul>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Location: Within the state of Maharashtra.</span></span>
</li>
<li>

</li>
</ul>
</li>
<li>
<p><strong><span style="color: var(--tw-prose-bold)"><span style="background-color: rgb(255, 255, 255)">Pakistan (Thatta):</span></span></strong></p>
<ul>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Location: Two of five sub-districts within the Thatta district</span></span>
</li>
</ul>
</li>
<li>
<p><strong><span style="color: var(--tw-prose-bold)"><span style="background-color: rgb(255, 255, 255)">Kenya:</span></span></strong></p>
<ul>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Location: Western region of Kenya in the counties of Busia, Bungoma, and Kakamega.</span></span>
</li>
<li>

</li>
</ul>
</li>
<li>
<p><strong><span style="color: var(--tw-prose-bold)"><span style="background-color: rgb(255, 255, 255)">Zambia:</span></span></strong></p>
<ul>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Location: South and east of Lusaka, in four main districts (Kafue, Chilanga, Rufusa, and Chongwe).</span></span>
</li>
<li>

</li>
</ul>
</li>
<li>
<p><strong><span style="color: var(--tw-prose-bold)"><span style="background-color: rgb(255, 255, 255)">Democratic Republic of Congo:</span></span></strong></p>
<ul>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Location: North and South Ubangi Provinces.</span></span>
</li>
</ul>
</li>
</ol>
<p><strong>Location Type :</strong>Health facilities</p>
<p><strong>Description :</strong> <span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">conducted in multiple sites across different sites.</span></span></p>
<ol>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Argentina (Site replaced in 2013)</span></span>
</li>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Guatemala</span></span>
</li>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">India (Belagavi and Nagpur)</span></span>
</li>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Pakistan (Thatta)</span></span>
</li>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Kenya</span></span>
</li>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Zambia</span></span>
</li>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Democratic Republic of Congo</span></span>
</li>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Bangladesh (Joined in 2019)</span></span>
</li>
</ol>
<p><strong>Sample size :</strong> <span style="color: rgb(80, 80, 80)"><span style="background-color: rgb(255, 255, 255)">4892</span></span></p>
<p></p>
<p></p>
<p></p>
<ol>
<li>
<ul>
<li>

</li>
</ul>
</li>
</ol>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_D3YV2ZX2" class="item journalArticle">
			<h2>Quality of care, risk management, and technology in obstetrics to
 reduce hospital-based maternal mortality in Senegal and Mali (QUARITE):
 a cluster-randomised trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Dumont A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Fournier P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Abrahamowicz M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Traore M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Haddad S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Fraser WD</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Maternal mortality is higher in west Africa than 
in most industrialised countries, so the development and validation of 
effective interventions is essential. We did a trial to assess the 
effect of a multifaceted intervention to promote maternity death reviews
 and onsite training in emergency obstetric care in referral hospitals 
with high maternal mortality rates in Senegal and Mali. METHODS: We did a
 pragmatic cluster-randomised controlled trial, with hospitals as the 
units of randomisation and patients as the unit of analysis. 46 public 
first-level and second-level referral hospitals with more than 800 
deliveries a year were enrolled, stratified by country and hospital 
type, and randomly assigned to either the intervention group (n=23) or 
the control group with no external intervention (n=23). All women who 
delivered in each of the participating facilities during the baseline 
and post-intervention periods were included. The intervention, 
implemented over a period of 2 years at the hospital level, consisted of
 an initial interactive workshop and quarterly educational 
clinically-oriented and evidence-based outreach visits focused on 
maternal death reviews and best practices implementation. The primary 
outcome was reduction of risk of hospital-based mortality. Analysis was 
by intention-to-treat and relied on the generalised estimating equations
 extension of the logistic regression model to account for clustering of
 women within hospitals. This study is registered with 
ClinicalTrials.gov, number ISRCTN46950658. FINDINGS: 191,167 patients 
who delivered in the participating hospitals were analysed (95,931 in 
the intervention groups and 95,236 in the control groups). Overall, 
mortality reduction in intervention hospitals was significantly higher 
than in control hospitals (odds ratio [OR] 0.85, 95% CI 0.73-0.98, 
p=0.0299), but this effect was limited to capital and district 
hospitals, which mainly acted as first-level referral hospitals in this 
trial. There was no effect in second-level referral (regional) hospitals
 outside the capitals (OR 1.02, 95% CI 0.79-1.31, p=0.89). No hospitals 
were lost to follow-up. Concrete actions were implemented 
comprehensively to improve quality of care in intervention hospitals. 
INTERPRETATION: Regular visits by a trained external facilitator and 
onsite training can provide health-care professionals with the knowledge
 and confidence to make quality improvement suggestions during audit 
sessions. Maternal death reviews, combined with best practices 
implementation, are effective in reducing hospital-based mortality in 
first-level referral hospitals. Further studies are needed to determine 
whether the benefits of the intervention are generalisable to 
second-level referral hospitals. FUNDING: Canadian Institutes of Health 
Research.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2013-07</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>382</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>146-57</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Lancet (London, England)</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1016/S0140-6736(13)60593-0">10.1016/S0140-6736(13)60593-0</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>9887</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>0140-6736 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Pregnancy Outcome</li>
					<li>Practice Guidelines as Topic</li>
					<li>Cluster Analysis</li>
					<li>Maternal Mortality</li>
					<li>*Quality of Health Care</li>
					<li>Clinical Competence/standards</li>
					<li>Emergency Treatment/*standards</li>
					<li>Health Personnel/education/standards</li>
					<li>Health Workforce</li>
					<li>Hospital Mortality</li>
					<li>Hospitals, District/statistics &amp; numerical data</li>
					<li>Inservice Training</li>
					<li>Mali</li>
					<li>Obstetrics and Gynecology Department, Hospital/statistics &amp; numerical data</li>
					<li>Obstetrics/education/*standards</li>
					<li>Pregnancy Complications/mortality/prevention &amp; control</li>
					<li>Prenatal Care/*standards</li>
					<li>Risk Management/methods</li>
					<li>Senegal</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_E72HBXDD">
<div><div data-schema-version="8"><p><strong>Location Information:</strong></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Name: </span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">Names of health facilities not provided</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Type: </span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">Health facilities</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Description: </span></span></strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Conducted
 in referral hospitals with high maternal mortality rates in Senegal and
 Mali. Specifically, 46 public first-level and second-level referral 
hospitals</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Sample size :191167</span></span></strong></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_DMRDZIPH" class="item journalArticle">
			<h2>Reassessing pregnancy intention and its relation to maternal, 
perinatal and neonatal outcomes in a low-income setting: A cohort study.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hall JA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Barrett G</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Copas A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Phiri T</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Malata A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Stephenson J</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: It is unclear whether unintended pregnancies are 
associated with adverse outcomes. Data are predominantly from 
high-income countries and have methodological limitations, calling the 
findings into question. This research was designed to overcome these 
limitations and assess the relationships between pregnancy intention and
 miscarriage, stillbirth, low birthweight, neonatal death and postnatal 
depression in a low-income country. METHODS: The pregnancy intention of 
4,244 pregnant women in Mchinji District, Malawi, was measured using the
 validated Chichewa version of the London Measure of Unplanned Pregnancy
 (LMUP). Women were re-interviewed postnatally to assess pregnancy 
outcome. Postnatal depression was assessed using the WHO's 
Self-Reporting Questionnaire. Multivariable regressions were conducted, 
with the choice of confounders informed by a pre-existing conceptual 
epidemiological hierarchy. RESULTS: Planned pregnancies are associated 
with a reduced risk of any (adjusted RR 0.90 [95%CI 0.86, 0.95]) or high
 symptoms of depression (adjusted RR 0.76 [95%CI 0.63, 0.91]) compared 
to unplanned pregnancies in rural Malawi. There was no relationship 
between pregnancy intention and the composite measure of miscarriage, 
stillbirth, low birthweight and neonatal death. There was some evidence 
that greater pregnancy intention was associated with reduced adjusted 
risk of stillbirth (0.93 [95%CI 0.87, 1.00]). CONCLUSION: Our study is 
the first to use a psychometrically valid measure of pregnancy 
intention, and to do so antenatally. As pregnancy intention increases, 
the risk of postnatal depression and, possibly, stillbirth decreases. 
This suggests a new, clinical use for the LMUP; identifying women 
antenatally who are at risk of these adverse pregnancy outcomes.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2018</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>13</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e0205487</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>PloS one</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1371/journal.pone.0205487">10.1371/journal.pone.0205487</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>10</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1932-6203 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Cohort Studies</li>
					<li>Infant, Newborn</li>
					<li>Male</li>
					<li>Infant, Low Birth Weight</li>
					<li>Poverty</li>
					<li>Malawi</li>
					<li>Self Report</li>
					<li>Stillbirth</li>
					<li>Adolescent</li>
					<li>Abortion, Spontaneous/*epidemiology</li>
					<li>Perinatal Death</li>
					<li>Depression, Postpartum/*epidemiology</li>
					<li>Pregnancy Outcome/*psychology</li>
					<li>Pregnancy, Unplanned/*psychology</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_B2YX5DFX">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location Name :</strong> </p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Banja la Mtsogolo', a Marie Stopes International Partner, </span></span>the other exact names of the health facilities are not mentioned</p>
<p><strong>Location type</strong> : </p>
<p>Health facility</p>
<p><strong>Description</strong> : </p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Conducted in Mchinji District, a rural district in Malawi</span></span></p>
<p><strong>Sample size</strong> : <span style="color: rgb(32, 32, 32)"><span style="background-color: rgb(255, 255, 255)">4,244</span></span></p>
<p></p>
<p></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_NF4HWVYI" class="item journalArticle">
			<h2>Residual risk of mother-to-child transmission of hepatitis B 
virus infection despite timely birth-dose vaccination in Cameroon (ANRS 
12303): a single-centre, longitudinal observational study.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Shimakawa Y</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Veillon P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Birguel J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Pivert A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sauvage V</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Guillou-Guillemette HL</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Roger S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Njouom R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ducancelle A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Amta P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Huraux JM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Adoukara JP</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Lunel-Fabiani F</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: In sub-Saharan Africa, administration of hepatitis
 B virus (HBV) birth-dose vaccines remains suboptimal. Evidence is 
scarce on whether African countries should focus on increasing vaccine 
coverage or developing strategies incorporating additional measures, 
such as peripartum antiviral prophylaxis to pregnant women at high risk.
 To better inform decision makers, we estimated the residual risk of 
mother-to-child transmission despite HBV birth-dose vaccine in Cameroon.
 METHODS: We did a single-centre, longitudinal observational study. 
Pregnant women were systematically screened for HBV surface antigen 
(HBsAg) at Tokombere District Hospital (Tokombere district, Cameroon). 
Children born to HBsAg-positive mothers in 2009-16 who received the HBV 
birth-dose vaccine and three subsequent doses of pentavalent vaccine at 
6, 10, and 14 weeks were followed up prospectively in 2015-17. In 
children, capillary blood was obtained for HBsAg rapid test and dried 
blood spots to quantify HBV DNA concentrations. Venous blood was also 
collected from HBsAg-positive children. Mother-to-child transmission was
 confirmed by whole-genome sequencing. FINDINGS: Between Jan 31, 2009, 
and Dec 31, 2016, 22 243 (66.8%) of 33 309 pregnant women accepted 
antenatal HBV screening, of whom 3901 (17.5%) were HBsAg positive. 2004 
(51.4%) of 3901 children who were born to HBsAg-positive mothers 
received the HBV birth-dose vaccine, of whom 1800 (89.8%) also completed
 the three-dose pentavalent vaccine. In total, the current analysis 
included 607 children who had a follow-up serosurvey. The prevalence of 
HBsAg was 5.6% in children who received the birth-dose vaccine in less 
than 24 h, 7.0% in those who received it 24-47 h after birth, and 16.7% 
in those who received it 48-96 h after birth (ptrend=0.083). 35 (89.7%) 
of 39 infected children were born to mothers positive for HBV e antigen 
with high HBV DNA of 5.3 log10 IU/mL or more. Whole-genome sequencing of
 HBV in infected mother-child pairs confirmed high identity proportions 
of 99.97-100%. INTERPRETATION: We documented a substantial risk of 
mother-to-child transmission despite timely administration of the HBV 
birth-dose vaccine within 24 h after birth. To reach WHO's elimination 
targets, peripartum antiviral prophylaxis might be required in parts of 
Africa, in addition to increasing coverage of the HBV birth-dose 
vaccine. FUNDING: Agence nationale de recherches sur le sida et les 
hepatites virales (ANRS).</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2022-04</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>10</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e521-e529</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>The Lancet. Global health</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1016/S2214-109X(22)00026-2">10.1016/S2214-109X(22)00026-2</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>4</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>2214-109X (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>control</li>
					<li>Infectious Disease Transmission, Vertical/prevention &amp; control</li>
					<li>Vaccination</li>
					<li>*Pregnancy Complications, Infectious/drug therapy/epidemiology/prevention &amp;</li>
					<li>*Hepatitis B/drug therapy/epidemiology/prevention &amp; control</li>
					<li>Antiviral Agents/therapeutic use</li>
					<li>Cameroon/epidemiology</li>
					<li>DNA, Viral</li>
					<li>Hepatitis B Surface Antigens</li>
					<li>Hepatitis B Vaccines</li>
					<li>Hepatitis B virus</li>
					<li>Vaccines, Combined/therapeutic use</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_T5U4SQXQ">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location Name :</strong> </p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Tokombr District Hospital</span></span></p>
<p><strong>Location Type : </strong></p>
<p>Health facility</p>
<p><strong>Description :</strong> </p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Conducted at the Tokombr District Hospital, the only hospital in the Tokombr district, Cameroon.</span></span></p>
<p><strong>Sample size :</strong> <span style="color: rgb(80, 80, 80)"><span style="background-color: rgb(255, 255, 255)">33309</span></span></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_2RJQP375" class="item journalArticle">
			<h2>Risk of Dysglycemia in Pregnancy amongst Kenyan Women with HIV Infection: A Nested Case-Control Analysis from the STRiDE Study.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Pastakia SD</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kosgei WK</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Christoffersen-Deb A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kiragu B</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hector JN</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Anusu G</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Saravanan P</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>INTRODUCTION: Gestational diabetes is a common complication, 
whose incidence is growing globally. There is a pressing need to obtain 
more data on GDM in low- and middle-income countries, especially amongst
 high-risk populations, as most of the data on GDM comes from 
high-income countries. With the growing awareness of the role HIV plays 
in the progression of noncommunicable diseases and the disproportionate 
HIV burden African countries like Kenya face, investigating the 
potential role HIV plays in increasing dysglycemia amongst pregnant 
women with HIV is an important area of study. METHODS: The STRiDE study 
is one of the largest ever conducted studies of GDM in Kenya. This study
 enrolled pregnant women aged between 16 and 50 who were receiving care 
from public and private sector facilities in Eldoret, Kenya. Within this
 study, women received venous testing for glycosylated hemoglobin 
(HbA1c) and fasting glucose between 8- and 20-week gestational age. At 
their 24-32-week visit, they received a venous 75 g oral glucose 
tolerance test (OGTT). Because of the pressing need to assess the burden
 of GDM within the population of pregnant women with HIV, a nested 
case-control study design was used. Pregnant women with HIV within the 
larger STRiDE cohort were matched to non-HIV-infected women within the 
STRiDE cohort at a 1 : 3 ratio based on body mass index, parity, family 
history of GDM, gestational age, and family history of hypertension. The
 measurements of glucose from the initial visit (fasting glucose and 
HbA1c) and follow-up visit (OGTT) were compared between the two groups 
of HIV+ cases and matched HIV- controls. RESULTS: A total of 83 pregnant
 women with HIV were well matched to 249 non-HIV-infected women from the
 STRiDE cohort with marital status being the only characteristic that 
was statistically significantly different between the two groups. 
Statistically significant differences were not observed in the 
proportion of women who developed GDM, the fasting glucose values, the 
HbA1c, or OGTT measurements between the two groups. Discussion. 
Significant associations were not seen between the different measures of
 glycemic status between pregnant women with and without HIV. While 
significant differences were not seen in this cohort, additional 
investigation is needed to better describe the association of 
dysglycemia with HIV, especially in Kenyan populations with a higher 
prevalence of GDM.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2021</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>2021</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>8830048</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Journal of diabetes research</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1155/2021/8830048">10.1155/2021/8830048</a></td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>2314-6753 (Electronic)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Prospective Studies</li>
					<li>Young Adult</li>
					<li>Risk Factors</li>
					<li>Prevalence</li>
					<li>Risk Assessment</li>
					<li>Middle Aged</li>
					<li>Adolescent</li>
					<li>Biomarkers/blood</li>
					<li>Blood Glucose/*analysis</li>
					<li>Case-Control Studies</li>
					<li>Diabetes, Gestational/blood/diagnosis/*epidemiology</li>
					<li>Glucose Tolerance Test</li>
					<li>Glycated Hemoglobin A/analysis</li>
					<li>HIV Infections/diagnosis/*epidemiology</li>
					<li>Kenya/epidemiology</li>
					<li>Predictive Value of Tests</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_L6ZFQYSB">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong><span style="color: var(--tw-prose-bold)"><span style="background-color: rgb(255, 255, 255)">Location Name:</span></span></strong><span style="background-color: rgb(255, 255, 255)"> </span></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Moi
 Teaching and Referral Hospital (MTRH), Uasin Gishu District Hospital, 
and Langas. Memorial, Reale, and Mediheal hospitals in Eldoret etc</span></span></p>
<p><strong><span style="color: var(--tw-prose-bold)"><span style="background-color: rgb(255, 255, 255)">Location Type:</span></span></strong><span style="background-color: rgb(255, 255, 255)"> &nbsp;</span></p>
<p><span style="background-color: rgb(255, 255, 255)">Health facilities and community</span></p>
<p><strong><span style="color: var(--tw-prose-bold)"><span style="background-color: rgb(255, 255, 255)">Description:</span></span></strong><span style="background-color: rgb(255, 255, 255)"> &nbsp;</span></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Conducted
 in and around Eldoret, Kenya. Patients were recruited from both public 
and private sector settings, including public sector facilities such as 
Moi Teaching and Referral Hospital (MTRH), Uasin Gishu District 
Hospital, and Langas Health Center, as well as private sector facilities
 like Memorial, Reale, and Mediheal hospitals in Eldoret.</span></span></p>
<p><strong><span style="color: var(--tw-prose-bold)"><span style="background-color: rgb(255, 255, 255)">Sample size : 3051</span></span></strong></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_KSRHM6DQ" class="item journalArticle">
			<h2>Safe and efficacious artemisinin-based combination treatments for
 African pregnant women with malaria: a multicentre randomized control 
trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Nambozi M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mulenga M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Halidou T</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Tagbor H</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mwapasa V</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Phiri LK</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kalanda G</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Valea I</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Traore M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mwakazanga D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Claeys Y</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Schurmans C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>De Crop M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Menten J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ravinetto R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Thriemer K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Van Geertruyden JP</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mutabingwa T</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>D'Alessandro U</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Asymptomatic and symptomatic malaria during 
pregnancy has consequences for both mother and her offspring. 
Unfortunately, there is insufficient information on the safety and 
efficacy of most antimalarials in pregnancy. Indeed, clinical trials 
assessing antimalarial treatments systematically exclude pregnancy for 
fear of teratogenicity and embryotoxicity. The little available 
information originates from South East Asia while in sub-Saharan Africa 
such information is still limited and needs to be provided. DESIGN: A 
Phase 3, non-inferiority, multicentre, randomized, open-label clinical 
trial on safety and efficacy of 4 ACT when administered during pregnancy
 was carried out in 4 African countries: Burkina Faso, Ghana, Malawi and
 Zambia. This is a four arm trial using a balanced incomplete block 
design. Pregnant women diagnosed with malaria are randomised to receive 
either amodiaquine-artesunate (AQ-AS), dihydroartemisinin-piperaquine 
(DHA-PQ), artemether-lumefantrine (AL), or mefloquine-artesunate (MQAS).
 They are actively followed up until day 63 post-treatment and then 
monthly until 4-6 weeks post-delivery. The offspring is visited at the 
time of the first birthday. The primary endpoint is treatment failure 
(PCR adjusted) at day 63 and safety profiles. Secondary endpoints 
included PCR unadjusted treatment failure up to day 63, gametocyte 
carriage, Hb changes, placenta malaria, mean birth weight and low birth 
weight. The primary statistical analysis will use the combined data from
 all 4 centres, with adjustment for any centre effects, using an 
additive model for the response rates. This will allow the assessment of
 all 6 possible pair-wise treatment comparisons using all available 
data. DISCUSSION: The strength of this trial is the involvement of 
several African countries, increasing the generalisability of the 
results. In addition, it assesses most ACTs currently available, 
determining their relative '-value-' compared to others. The balanced 
incomplete block design was chosen because using all 4-arms in each site
 would have increased complexity in terms of implementation. Excluding 
HIV-positive pregnant women on antiretroviral drugs may be seen as a 
limitation because of the possible interactions between antiretroviral 
and antimalarial treatments. Nevertheless, the results of this trial 
will provide the evidence base for the formulation of malaria treatment 
policy for pregnant women in sub-Saharan Africa.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2015-01</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>12</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>5</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Reproductive health</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/1742-4755-12-5">10.1186/1742-4755-12-5</a></td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1742-4755 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Ghana</li>
					<li>Infant, Newborn</li>
					<li>Drug Combinations</li>
					<li>Malawi</li>
					<li>Follow-Up Studies</li>
					<li>Prenatal Exposure Delayed Effects</li>
					<li>Malaria/*drug therapy</li>
					<li>Pregnancy Complications, Parasitic/*drug therapy</li>
					<li>Zambia</li>
					<li>Burkina Faso</li>
					<li>Antimalarials/adverse effects/*therapeutic use</li>
					<li>Artemether, Lumefantrine Drug Combination</li>
					<li>Artemisinins/adverse effects/*therapeutic use</li>
					<li>Fetal Development/drug effects</li>
					<li>Amodiaquine/adverse effects/therapeutic use</li>
					<li>Artesunate</li>
					<li>Birth Weight/drug effects</li>
					<li>Ethanolamines/adverse effects/therapeutic use</li>
					<li>Fluorenes/adverse effects/therapeutic use</li>
					<li>Mefloquine/adverse effects/therapeutic use</li>
					<li>Placentation/drug effects</li>
					<li>Quinolines/adverse effects/therapeutic use</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_P9C7AWDR">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p></p>
<p><strong>Location Name</strong> : </p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Burkina Faso: Nanoro and Nazoanga, Ghana: Effiduase, Ejisu, and Juaben , Malawi: Chikwawa , Zambia: Nchelenge</span></span></p>
<p><strong>Location Type </strong>: </p>
<p>Health facility</p>
<p><strong>Description :</strong> </p>
<p>Conducted in 7 sites</p>
<ol>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Burkina Faso: Nanoro and Nazoanga</span></span>
</li>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Ghana: Effiduase, Ejisu, and Juaben</span></span>
</li>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Malawi: Chikwawa</span></span>
</li>
<li>
<span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Zambia: Nchelenge</span></span>
</li>
</ol>
<p><strong>Sample size : </strong>3428</p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_2KVG5N2F" class="item journalArticle">
			<h2>Safety of a killed oral cholera vaccine (Shanchol) in pregnant women in Malawi: an observational cohort study.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ali M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Nelson A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Luquero FJ</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Azman AS</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Debes AK</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>M'bang'ombe MM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Seyama L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kachale E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Zuze K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Malichi D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Zulu F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Msyamboza KP</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kabuluzi S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sack DA</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Pregnancy increases the risk of harmful effects 
from cholera for both mothers and their fetuses. A killed oral cholera 
vaccine, Shanchol (Shantha Biotechnics, Hydrabad, India), can protect 
against the disease for up to 5 years. However, cholera vaccination 
campaigns have often excluded pregnant women because of insufficient 
safety data for use during pregnancy. We did an observational cohort 
study to assess the safety of Shanchol during pregnancy. METHODS: This 
observational cohort study was done in two adjacent districts (Nsanje 
and Chikwawa) in Malawi. Individuals older than 1 year in Nsanje were 
offered oral cholera vaccine during a mass vaccination campaign between 
March 30 and April 30, 2015, but no vaccines were administered in 
Chikwawa. We enrolled women who were exposed to oral cholera vaccine 
during pregnancy in Nsanje district, and women who were pregnant in 
Chikwawa district (and thus not exposed to oral cholera vaccine) during 
the same period. The primary endpoint of our analysis was pregnancy loss
 (spontaneous miscarriage or stillbirth), and the secondary endpoints 
were neonatal deaths and malformations. We evaluated these endpoints 
using log-binomial regression, adjusting for the imbalanced baseline 
characteristics between the groups. This study is registered with 
ClinicalTrials.gov, number NCT02499172. FINDINGS: We recruited 900 women
 exposed to oral cholera vaccine and 899 women not exposed to the 
vaccine between June 16 and Oct 10, 2015, and analysed 835 in each 
group. 361 women exposed to the vaccine and 327 not exposed to the 
vaccine were recruited after their pregnancies had ended. The incidence 
of pregnancy loss was 27.54 (95% CI 18.41-41.23) per 1000 pregnancies 
among those exposed to the vaccine and 21.56 (13.65-34.04) per 1000 
among those not exposed. The adjusted relative risk for pregnancy loss 
among those exposed to oral cholera vaccine was 1.24 (95% CI 0.64-2.43; 
p=0.52) compared with those not exposed to the vaccine. The neonatal 
mortality rate was 11.78 (95% CI 5.92-23.46) per 1000 livebirths for 
infants whose mothers were exposed to oral cholera vaccine versus 8.91 
(4.02-19.77) per 1000 livebirths for infants whose mothers were not 
exposed to the vaccine (crude relative risk 1.32, 95% CI 0.46-3.84; 
p=0.60). Only three newborn babies had malformations, two in the vaccine
 exposure group and one in the no-exposure group, yielding a relative 
risk of 2.00 (95% CI 0.18-22.04; p=0.57), although this estimate is 
unreliable because of the small number of outcomes. INTERPRETATION: Our 
study provides evidence that fetal exposure to oral cholera vaccine 
confers no significantly increased risk of pregnancy loss, neonatal 
mortality, or malformation. These data, along with findings from two 
retrospective studies, support use of oral cholera vaccine in pregnant 
women in cholera-affected regions. FUNDING: Bill &amp; Melinda Gates 
Foundation.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2017-05</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>17</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>538-544</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>The Lancet. Infectious diseases</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1016/S1473-3099(16)30523-0">10.1016/S1473-3099(16)30523-0</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>5</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1473-3099 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Administration, Oral</li>
					<li>Adult</li>
					<li>Cholera Vaccines/*administration &amp; dosage</li>
					<li>Cholera/complications/epidemiology/prevention &amp; control</li>
					<li>Female</li>
					<li>Fetal Death</li>
					<li>Humans</li>
					<li>Incidence</li>
					<li>Malawi/epidemiology</li>
					<li>Mothers</li>
					<li>Pregnancy</li>
					<li>Retrospective Studies</li>
					<li>Safety/*standards</li>
					<li>Vaccines, Inactivated/administration &amp; dosage</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_IAVCTWR7">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location Name</strong> : </p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Nsanje and Chikwawa.</span></span></p>
<p><strong>Location Type</strong> : </p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Communities</span></span></p>
<p><strong>Description</strong> : </p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Conducted in two neighbouring districts in the southern region of Malawi, namely Nsanje and Chikwawa.</span></span></p>
<p><strong>Sample siz</strong>e : 1799</p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_QP524L75" class="item journalArticle">
			<h2>Scheduled Intermittent Screening with Rapid Diagnostic Tests and 
Treatment with Dihydroartemisinin-Piperaquine versus Intermittent 
Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in 
Pregnancy in Malawi: An Open-Label Randomized Controlled Trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Madanitsa M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kalilani L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mwapasa V</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>van Eijk AM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Khairallah C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ali D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Pace C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Smedley J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Thwai KL</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Levitt B</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Wang D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kang'ombe A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Faragher B</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Taylor SM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Meshnick S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ter Kuile FO</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: In Africa, most plasmodium infections during 
pregnancy remain asymptomatic, yet are associated with maternal anemia 
and low birthweight. WHO recommends intermittent preventive therapy in 
pregnancy with sulfadoxine-pyrimethamine (IPTp-SP). However, 
sulfadoxine-pyrimethamine (SP) efficacy is threatened by high-level 
parasite resistance. We conducted a trial to evaluate the efficacy and 
safety of scheduled intermittent screening with malaria rapid diagnostic
 tests (RDTs) and treatment of RDT-positive women with 
dihydroartemisinin-piperaquine (DP) as an alternative strategy to 
IPTp-SP. METHODS AND FINDINGS: This was an open-label, two-arm 
individually randomized superiority trial among HIV-seronegative women 
at three sites in Malawi with high SP resistance. The intervention 
consisted of three or four scheduled visits in the second and third 
trimester, 4 to 6 wk apart. Women in the IPTp-SP arm received SP at each
 visit. Women in the intermittent screening and treatment in pregnancy 
with DP (ISTp-DP) arm were screened for malaria at every visit and 
treated with DP if RDT-positive. The primary outcomes were adverse live 
birth outcome (composite of small for gestational age, low birthweight 
[&lt;2,500 g], or preterm birth [&lt;37 wk]) in paucigravidae (first or 
second pregnancy) and maternal or placental plasmodium infection at 
delivery in multigravidae (third pregnancy or higher). Analysis was by 
intention to treat. Between 21 July 2011 and 18 March 2013, 1,873 women 
were recruited (1,155 paucigravidae and 718 multigravidae). The 
prevalence of adverse live birth outcome was similar in the ISTp-DP 
(29.9%) and IPTp-SP (28.8%) arms (risk difference = 1.08% [95% CI -3.25%
 to 5.41%]; all women: relative risk [RR] = 1.04 [95% CI 0.90-1.20], p =
 0.625; paucigravidae: RR = 1.10 [95% CI 0.92-1.31], p = 0.282; 
multigravidae: RR = 0.92 [95% CI 0.71-1.20], p = 0.543). The prevalence 
of malaria at delivery was higher in the ISTp-DP arm (48.7% versus 
40.8%; risk difference = 7.85%, [95% CI 3.07%-12.63%]; all women: RR = 
1.19 [95% CI 1.07-1.33], p = 0.007; paucigravidae: RR = 1.16 [95% CI 
1.04-1.31], p = 0.011; multigravidae: RR = 1.29 [95% CI 1.02-1.63], p = 
0.037). Fetal loss was more common with ISTp-DP (2.6% versus 1.3%; RR = 
2.06 [95% CI 1.01-4.21], p = 0.046) and highest among non-DP-recipients 
(3.1%) in the ISTp-DP arm. Limitations included the open-label design. 
CONCLUSIONS: Scheduled screening for malaria parasites with the current 
generation of RDTs three to four times during pregnancy as part of 
focused antenatal care was not superior to IPTp-SP in this area with 
high malaria transmission and high SP resistance and was associated with
 higher fetal loss and more malaria at delivery. TRIAL REGISTRATION: Pan
 African Clinical Trials Registry PACTR201103000280319; ISRCTN Registry 
ISRCTN69800930.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2016-09</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>13</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e1002124</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>PLoS medicine</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1371/journal.pmed.1002124">10.1371/journal.pmed.1002124</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>9</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1549-1277 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Young Adult</li>
					<li>Drug Combinations</li>
					<li>Malawi</li>
					<li>Malaria/*prevention &amp; control</li>
					<li>Adolescent</li>
					<li>Pregnancy Complications, Parasitic/*prevention &amp; control</li>
					<li>*Diagnostic Tests, Routine/statistics &amp; numerical data</li>
					<li>Antimalarials/*adverse effects</li>
					<li>Artemisinins/*adverse effects</li>
					<li>Pyrimethamine/*adverse effects</li>
					<li>Quinolines/*adverse effects</li>
					<li>Sulfadoxine/*adverse effects</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_Q8W63BTI">
<div><div data-schema-version="8"><p><strong>Location Inforamtion</strong></p>
<p><strong>Location Name</strong> : </p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Mpemba and Madziabango Health Centers and the Chikwawa District Hospita</span></span></p>
<p><strong>Location Type :</strong> </p>
<p>Health facility</p>
<p><strong>Description :</strong> </p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Conducted at the Mpemba and Madziabango Health Centers and the Chikwawa District Hospital in southern Malawi</span></span></p>
<p><strong>Sample size :</strong> <span style="color: rgb(32, 32, 32)"><span style="background-color: rgb(255, 255, 255)">, 1,873&nbsp;</span></span></p>
<p></p>
<p></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">l</span></span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_ER6R2H9U" class="item journalArticle">
			<h2>Seasonality modifies the effect of a lipid-based nutrient supplement for pregnant rural women on birth length.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Toe LC</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bouckaert KP</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>De Beuf K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Roberfroid D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Meda N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Thas O</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Van Camp J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kolsteren PW</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Huybregts LF</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Maternal nutritional status is a major determinant
 of low birth weight and fluctuates across seasons. Seasonality may 
influence the outcome of prenatal nutrition interventions that aim to 
enhance fetal growth. OBJECTIVE: This study investigated seasonal 
modifications of the efficacy of a randomized controlled prenatal 
nutrition intervention trial in pregnant women to improve fetal growth 
in rural Burkina Faso. METHODS: The second Micronutriments et Sante de 
la Mere et de l'Enfant study compared a lipid-based nutrient supplement 
(LNS) fortified with multiple micronutrients (MMNs) to an MMN 
supplement. Truncated Fourier series were used to characterize 
seasonality in birth outcomes. Models that included the Fourier series 
and newborn and maternal characteristics were used to assess seasonal 
effect modifications of prenatal supplementation on birth outcomes. 
RESULTS: Birth weight, birth length, small for gestational age as a 
proxy for intrauterine growth retardation, and preterm birth were 
significantly related to date of birth and showed important seasonal 
variations. LNSs, which supply energy in addition to MMNs, resulted in a
 significant increase in birth length (+13.5 mm, 95% CI: 6.5, 20.5 mm) 
at the transition from rain to dry season (September to November) 
compared to MMNs alone. CONCLUSIONS: The climatologic and agricultural 
seasonal patterns in Burkina Faso affect the efficacy of prenatal LNSs 
on birth length. In this context, prenatal MMN supplementation programs 
should be complemented by energy supplementation during the annual rain 
season to promote fetal growth. This trial was registered at 
clinicaltrials.gov as NCT00909974.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2015-03</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 3
Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>145</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>634-9</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>The Journal of nutrition</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.3945/jn.114.203448">10.3945/jn.114.203448</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>3</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>0022-3166 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:31 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:31 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>*Dietary Supplements</li>
					<li>*Rural Population</li>
					<li>Young Adult</li>
					<li>Gestational Age</li>
					<li>Logistic Models</li>
					<li>Premature Birth</li>
					<li>Nutritional Status</li>
					<li>*Prenatal Nutritional Physiological Phenomena</li>
					<li>*Birth Weight</li>
					<li>Burkina Faso</li>
					<li>Linear Models</li>
					<li>Fetal Development</li>
					<li>pregnant women</li>
					<li>birth length</li>
					<li>birth weight</li>
					<li>Fetal Growth Retardation</li>
					<li>food supplement</li>
					<li>Micronutrients/*administration &amp; dosage</li>
					<li>premature birth</li>
					<li>seasonal variations</li>
					<li>small for gestational age</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_EQ6J62P3">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name</strong> :</p>
<p>Names not specified</p>
<p><strong>Location Type</strong> : &nbsp;</p>
<p>Health Facility Catchment</p>
<p><strong>Description</strong> : </p>
<p>Catchment area of <span style="color: rgb(31, 31, 31)">2 health centers in the Hound health district of Burkina Faso, West Africa</span></p>
<p><strong>Sample size</strong> : <span style="color: rgb(31, 31, 31)">1296&nbsp;</span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_KCILCG5M" class="item journalArticle">
			<h2>Severe bacterial neonatal infections in Madagascar, Senegal, and Cambodia: A multicentric community-based cohort study.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Huynh BT</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kermorvant-Duchemin E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chheang R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Randrianirina F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Seck A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hariniaina Ratsima E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Andrianirina ZZ</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Diouf JB</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Abdou AY</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Goyet S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ngo V</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Lach S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Pring L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sok T</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Padget M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sarr FD</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Borand L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Garin B</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Collard JM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Herindrainy P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>de Lauzanne A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Vray M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Delarocque-Astagneau E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Guillemot D</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Severe bacterial infections (SBIs) are a leading 
cause of neonatal deaths in low- and middle-income countries (LMICs). 
However, most data came from hospitals, which do not include neonates 
who did not seek care or were treated outside the hospital. Studies from
 the community are scarce, and few among those available were conducted 
with high-quality microbiological techniques. The burden of SBI at the 
community level is therefore largely unknown. We aimed here to describe 
the incidence, etiology, risk factors, and antibiotic resistance 
profiles of community-acquired neonatal SBI in 3 LMICs. METHODS AND 
FINDINGS: The BIRDY study is a prospective multicentric community-based 
mother and child cohort study and was conducted in both urban and rural 
areas in Madagascar (2012 to 2018), Cambodia (2014 to 2018), and Senegal
 (2014 to 2018). All pregnant women within a geographically defined 
population were identified and enrolled. Their neonates were actively 
followed from birth to 28 days to document all episodes of SBI. A total 
of 3,858 pregnant women (2,273 (58.9%) in Madagascar, 814 (21.1%) in 
Cambodia, and 771 (20.0%) in Senegal) were enrolled in the study, and, 
of these, 31.2% were primigravidae. Women enrolled in the urban sites 
represented 39.6% (900/2,273), 45.5% (370/814), and 61.9% (477/771), and
 those enrolled in the rural sites represented 60.4% (1,373/2,273), 
54.5% (444/814), and 38.1% (294/771) of the total in Madagascar, 
Cambodia, and Senegal, respectively. Among the 3,688 recruited newborns,
 49.6% were male and 8.7% were low birth weight (LBW). The incidence of 
possible severe bacterial infection (pSBI; clinical diagnosis based on 
WHO guidelines of the Integrated Management of Childhood Illness) was 
196.3 [95% confidence interval (CI) 176.5 to 218.2], 110.1 [88.3 to 
137.3], and 78.3 [59.5 to 103] per 1,000 live births in Madagascar, 
Cambodia, and Senegal, respectively. The incidence of pSBI differed 
between urban and rural sites in all study countries. In Madagascar, we 
estimated an incidence of 161.0 pSBI per 1,000 live births [133.5 to 
194] in the urban site and 219.0 [192.6 to 249.1] pSBI per 1,000 live 
births in the rural site (p = 0.008). In Cambodia, estimated incidences 
were 141.1 [105.4 to 189.0] and 85.3 [61.0 to 119.4] pSBI per 1,000 live
 births in urban and rural sites, respectively (p = 0.025), while in 
Senegal, we estimated 103.6 [76.0 to 141.2] pSBI and 41.5 [23.0 to 75.0]
 pSBI per 1,000 live births in urban and rural sites, respectively (p = 
0.006). The incidences of culture-confirmed SBI were 15.2 [10.6 to 
21.8], 6.5 [2.7 to 15.6], and 10.2 [4.8 to 21.3] per 1,000 live births 
in Madagascar, Cambodia, and Senegal, respectively, with no difference 
between urban and rural sites in each country. The great majority of 
early-onset infections occurred during the first 3 days of life (72.7%).
 The 3 main pathogens isolated were Klebsiella spp. (11/45, 24.4%), 
Escherichia coli (10/45, 22.2%), and Staphylococcus spp. (11/45, 24.4%).
 Among the 13 gram-positive isolates, 5 were resistant to gentamicin, 
and, among the 29 gram-negative isolates, 13 were resistant to 
gentamicin, with only 1 E. coli out of 10 sensitive to ampicillin. 
Almost one-third of the isolates were resistant to both first-line drugs
 recommended for the management of neonatal sepsis (ampicillin and 
gentamicin). Overall, 38 deaths occurred among neonates with SBI 
(possible and culture-confirmed SBI together). LBW and foul-smelling 
amniotic fluid at delivery were common risk factors for early pSBI in 
all 3 countries. A main limitation of the study was the lack of samples 
from a significant proportion of infants with pBSI including 35 neonatal
 deaths. Without these samples, bacterial infection and resistance 
profiles could not be confirmed. CONCLUSIONS: In this study, we observed
 a high incidence of neonatal SBI, particularly in the first 3 days of 
life, in the community of 3 LMICs. The current treatment for the 
management of neonatal infection is hindered by antimicrobial 
resistance. Our findings suggest that microbiological diagnosis of SBI 
remains a challenge in these settings and support more research on 
causes of neonatal death and the implementation of early interventions 
(e.g., follow-up of at-risk newborns during the first days of life) to 
decrease the burden of neonatal SBI and associated mortality and help 
achieve Sustainable Development Goal 3.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2021-09</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 9
Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>18</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e1003681</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>PLoS medicine</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1371/journal.pmed.1003681">10.1371/journal.pmed.1003681</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>9</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1549-1277 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:43 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:43 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Incidence</li>
					<li>Pregnancy</li>
					<li>Cohort Studies</li>
					<li>Infant, Newborn</li>
					<li>Prospective Studies</li>
					<li>Young Adult</li>
					<li>Male</li>
					<li>Middle Aged</li>
					<li>Adolescent</li>
					<li>Bacterial Infections/diagnosis/*epidemiology/microbiology</li>
					<li>Cambodia/epidemiology</li>
					<li>Infant, Newborn, Diseases</li>
					<li>Madagascar/epidemiology</li>
					<li>Patient Acuity</li>
					<li>Senegal/epidemiology</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_HRYH3SDN">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name : </strong>Antananarivo,Moramanga,Gudiawaye &amp; Sokone</p>
<p><strong>Location Type :</strong></p>
<p><strong> </strong><span style="color: rgb(0, 0, 0)"><span style="background-color: rgb(247, 247, 247)">District</span></span></p>
<p><strong>Description : </strong></p>
<p>Madagascar urban districts of Antananarivo and in the rural city of 
Moramanga . In Senegal district of Gudiawaye, , a city near urban Dakar
 and Sokone, a rural city</p>
<p><strong>Sample Size :</strong> <span style="color: rgb(32, 32, 32)"><span style="background-color: rgb(255, 255, 255)">2,273 (58.9%) in Madagascar, 814 (21.1%) in Cambodia, and 771 (20.0%) in Senegal)&nbsp;</span></span></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_V7YSMUGQ" class="item journalArticle">
			<h2>Sexual Risk among Pregnant Women at Risk of HIV Infection in Cape Town, South Africa: What Does Alcohol Have to Do with It?</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Miller AP</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Shoptaw S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mvududu R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mashele N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Coates TJ</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bekker LG</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Essack Z</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Groenewald C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Petersen Z</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gorbach PM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Myer L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Joseph Davey DL</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>This study examines baseline associations between alcohol use 
and HIV sexual risk among a cohort of HIV-uninfected pregnant women (n =
 1201) residing in a high HIV burdened community in Cape Town, South 
Africa. Alcohol use was measured using a modified version of the Alcohol
 Use Disorder Identification Test (AUDIT). HIV sexual risk was measured 
through a composite variable of four risk factors: diagnosis with a STI,
 self-report of &gt; 1 recent sex partners, partner HIV serostatus 
(unknown or HIV+) and condomless sex at last sex. Any past year alcohol 
use prior to pregnancy was reported by half of participants (50%); 6.0% 
reported alcohol use during pregnancy. Alcohol use prior to pregnancy 
was associated with increased odds of being at high risk of HIV (aOR = 
1.33, 95% CI 1.05-1.68, for 2 risks and aOR = 1.47, 95% CI 0.95-2.27 for
 3 risks). In addition to reducing alcohol use, several other strategies
 to address HIV sexual risk were identified. Evidence-based 
interventions to address alcohol use and other HIV sexual risk behaviors
 during pregnancy in South Africa are desperately needed. Qualitative 
work exploring individual and community level drivers of alcohol use 
among pregnant and breastfeeding women in this setting could support 
development of a culturally tailored intervention to address these 
issues in this population.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2022-06</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: United States</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>AIDS and behavior</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1007/s10461-022-03742-1">10.1007/s10461-022-03742-1</a></td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1090-7165 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Pregnancy</li>
					<li>South Africa</li>
					<li>HIV</li>
					<li>Sub-Saharan Africa</li>
					<li>Alcohol use</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_M3Z274UM">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Name: &nbsp;</span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">a clinic in Gugulethu</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Type:</span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">health facilities</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Description: </span></span></strong></p>
<p><span style="color: #0D0D0D"><span style="background-color: white">Conducted at one public health clinic in Gugulethu,Cape Town, Western Cape, South Africa.</span></span></p>
<p><strong>Sample Size</strong>: &nbsp;1201</p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_R5ND3ESY" class="item journalArticle">
			<h2>Sexually transmitted infection screening to prevent adverse birth
 and newborn outcomes: study protocol for a randomized-controlled 
hybrid-effectiveness trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Medina-Marino A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Cleary S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Muzny CA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Taylor C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Tamhane A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ngwepe P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bezuidenhout C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Facente SN</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mlisana K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Peters RPH</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Klausner JD</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Sexually transmitted infections (STIs) during 
pregnancy are associated with adverse birth outcomes, including preterm 
birth, low birth weight, perinatal death, and congenital infections such
 as increased mother-to-child HIV transmission. Prevalence of STIs among
 pregnant women in South Africa remains high, with most women being 
asymptomatic for their infection(s). Unfortunately, most STIs remain 
undetected and untreated due to standard practice syndromic management 
in accordance with World Health Organization (WHO) guidelines. Although 
lab-based and point-of-care molecular tests are available, optimal 
screening strategies during pregnancy, their health impact, and 
cost-effectiveness are unknown. METHODS: We will implement a 3-arm 
(1:1:1) type-1 hybrid effectiveness-implementation randomized-controlled
 trial (RCT). We will enroll 2500 pregnant women attending their first 
antenatal care (ANC) visit for their current pregnancy at participating 
health facilities in Buffalo City Metro District, Eastern Cape Province,
 South Africa. Participants allocated to arms 1 and 2 (intervention) 
will receive GeneXpert(R) point-of-care diagnostic testing for Neisseria
 gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis, with 
same-day treatment for detected infection(s). Arm 1 will additionally 
receive a test-of-cure 3 weeks post-treatment, while Arm 2 will receive a
 repeat test at 30-34 weeks' gestation. Those allocated to Arm 3 will 
receive syndromic management (standard-of-care). The RE-AIM framework 
will be used to guide collection of implementation indicators to inform 
potential future scale up. Primary outcome measures include (1) 
frequency of adverse birth outcomes among study arms, defined by a 
composite measure of low birth weight and pre-term delivery, and (2) 
change in STI prevalence between baseline and birth outcome among 
intervention arms and compared to standard-of-care. Estimates and 
comparative costs of the different screening strategies relative to 
standard-of-care and the costs of managing adverse birth outcomes will 
be calculated. Cost-effectiveness will be assessed per STI and 
disability-adjusted life year averted. DISCUSSION: This trial is the 
first RCT designed to identify optimal, cost-effective screening 
strategies that decrease the burden of STIs during pregnancy and reduce 
adverse birth outcomes. Demonstrating the impact of diagnostic screening
 and treatment, compared to syndromic management, on birth outcomes will
 provide critical evidence to inform changes to WHO guidelines for 
syndromic management of STIs during pregnancy. TRIAL REGISTRATION: 
ClinicalTrials.gov NCT04446611 . Registered on 25 June 2020.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2022-05</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>23</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>441</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Trials</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/s13063-022-06400-y">10.1186/s13063-022-06400-y</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1745-6215 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Prevalence</li>
					<li>Randomized Controlled Trials as Topic</li>
					<li>Antenatal care</li>
					<li>Preterm birth</li>
					<li>Low birth weight</li>
					<li>*Pregnancy Complications, Infectious/diagnosis/epidemiology/prevention &amp; control</li>
					<li>*Sexually Transmitted Diseases/diagnosis/epidemiology/prevention &amp; control</li>
					<li>*Trichomonas vaginalis</li>
					<li>Chlamydia trachomatis</li>
					<li>Cost-effectiveness</li>
					<li>Neisseria gonorrhoeae</li>
					<li>Sexually transmitted infections</li>
					<li>STI screening</li>
					<li>STIs</li>
					<li>Syndromic management</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_QCV27F8L">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location Name</strong> : </p>
<p>Health facilities within <span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Buffalo City Metro Health District</span></span></p>
<p><strong>Location Type</strong> : </p>
<p>Health facilities</p>
<p><strong>Description</strong> : </p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Conducted in the Buffalo City Metro Health District, Eastern Cape Province, South Africa</span></span></p>
<p><strong>Sample size</strong> : <span style="background-color: rgb(255, 212, 0);">2500</span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_R9UI2IJU" class="item journalArticle">
			<h2>Sexually transmitted infection screening to prevent adverse birth
 and newborn outcomes: study protocol for a randomized-controlled 
hybrid-effectiveness trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Medina-Marino A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Cleary S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Muzny CA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Taylor C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Tamhane A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ngwepe P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bezuidenhout C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Facente SN</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mlisana K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Peters RPH</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Klausner JD</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Sexually transmitted infections (STIs) during 
pregnancy are associated with adverse birth outcomes, including preterm 
birth, low birth weight, perinatal death, and congenital infections such
 as increased mother-to-child HIV transmission. Prevalence of STIs among
 pregnant women in South Africa remains high, with most women being 
asymptomatic for their infection(s). Unfortunately, most STIs remain 
undetected and untreated due to standard practice syndromic management 
in accordance with World Health Organization (WHO) guidelines. Although 
lab-based and point-of-care molecular tests are available, optimal 
screening strategies during pregnancy, their health impact, and 
cost-effectiveness are unknown. METHODS: We will implement a 3-arm 
(1:1:1) type-1 hybrid effectiveness-implementation randomized-controlled
 trial (RCT). We will enroll 2500 pregnant women attending their first 
antenatal care (ANC) visit for their current pregnancy at participating 
health facilities in Buffalo City Metro District, Eastern Cape Province,
 South Africa. Participants allocated to arms 1 and 2 (intervention) 
will receive GeneXpert(R) point-of-care diagnostic testing for Neisseria
 gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis, with 
same-day treatment for detected infection(s). Arm 1 will additionally 
receive a test-of-cure 3 weeks post-treatment, while Arm 2 will receive a
 repeat test at 30-34 weeks' gestation. Those allocated to Arm 3 will 
receive syndromic management (standard-of-care). The RE-AIM framework 
will be used to guide collection of implementation indicators to inform 
potential future scale up. Primary outcome measures include (1) 
frequency of adverse birth outcomes among study arms, defined by a 
composite measure of low birth weight and pre-term delivery, and (2) 
change in STI prevalence between baseline and birth outcome among 
intervention arms and compared to standard-of-care. Estimates and 
comparative costs of the different screening strategies relative to 
standard-of-care and the costs of managing adverse birth outcomes will 
be calculated. Cost-effectiveness will be assessed per STI and 
disability-adjusted life year averted. DISCUSSION: This trial is the 
first RCT designed to identify optimal, cost-effective screening 
strategies that decrease the burden of STIs during pregnancy and reduce 
adverse birth outcomes. Demonstrating the impact of diagnostic screening
 and treatment, compared to syndromic management, on birth outcomes will
 provide critical evidence to inform changes to WHO guidelines for 
syndromic management of STIs during pregnancy. TRIAL REGISTRATION: 
ClinicalTrials.gov NCT04446611 . Registered on 25 June 2020.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2022-05</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 1
Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>23</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>441</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Trials</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/s13063-022-06400-y">10.1186/s13063-022-06400-y</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1745-6215 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:34 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:34 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Prevalence</li>
					<li>Randomized Controlled Trials as Topic</li>
					<li>Antenatal care</li>
					<li>Preterm birth</li>
					<li>Low birth weight</li>
					<li>*Pregnancy Complications, Infectious/diagnosis/epidemiology/prevention &amp; control</li>
					<li>*Sexually Transmitted Diseases/diagnosis/epidemiology/prevention &amp; control</li>
					<li>*Trichomonas vaginalis</li>
					<li>Chlamydia trachomatis</li>
					<li>Cost-effectiveness</li>
					<li>Neisseria gonorrhoeae</li>
					<li>Sexually transmitted infections</li>
					<li>STI screening</li>
					<li>STIs</li>
					<li>Syndromic management</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_X9MAHWTG">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name</strong>:</p>
<p>Facility Name </p>
<p><strong>Location type</strong> : </p>
<p>Health facility</p>
<p><strong>Descriptio</strong>n : </p>
<p><span style="color: rgb(33, 33, 33)"><span style="background-color: rgb(255, 255, 255)">Health facilities in Buffalo City Metro District, Eastern Cape Province, South Africa</span></span></p>
<p><strong>Sample size : </strong><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">2500</span></span></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_FXMPGNCJ" class="item journalArticle">
			<h2>Strengthening intrapartum and immediate newborn care to reduce 
morbidity and mortality of preterm infants born in health facilities in 
Migori County, Kenya and Busoga Region, Uganda: a study protocol for a 
randomized controlled trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Otieno P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Waiswa P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Butrick E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Namazzi G</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Achola K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Santos N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Keating R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Lester F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Walker D</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Preterm birth (birth before 37 weeks of gestation)
 and its complications are the leading contributors to neonatal and 
under-5 mortality. The majority of neonatal deaths in Kenya and Uganda 
occur during the intrapartum and immediate postnatal period. This paper 
describes our study protocol for implementing and evaluating a package 
of facility-based interventions to improve care during this critical 
window. METHODS/DESIGN: This is a pair-matched, cluster randomized 
controlled trial across 20 facilities in Eastern Uganda and Western 
Kenya. The intervention facilities receive four components: (1) 
strengthening of routine data collection and data use activities; (2) 
implementation of the WHO Safe Childbirth Checklist modified for preterm
 birth; (3) PRONTO simulation training and mentoring to strengthen 
intrapartum and immediate newborn care; and (4) support of quality 
improvement teams. The control facilities receive both data 
strengthening and introduction of the modified checklist. The primary 
outcome for this study is 28-day mortality rate among preterm infants. 
The denominator will include all live births and fresh stillbirths 
weighing greater than 1000 g and less than 2500 g; all live births and 
fresh stillbirths weighing between 2501 and 3000 g with a documented 
gestational age less than 37 weeks. DISCUSSION: The results of this 
study will inform interventions to improve personnel and facility 
capacity to respond to preterm labor and delivery, as well as care for 
the preterm infant. TRIAL REGISTRATION: ClinicalTrials.gov, ID: 
NCT03112018 . Registered on 13 April 2017.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2018-06</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>19</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>313</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Trials</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/s13063-018-2696-2">10.1186/s13063-018-2696-2</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1745-6215 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>*Premature Birth</li>
					<li>Infant, Newborn</li>
					<li>Risk Factors</li>
					<li>Gestational Age</li>
					<li>Uganda</li>
					<li>Treatment Outcome</li>
					<li>Time Factors</li>
					<li>Neonatal mortality</li>
					<li>Kenya</li>
					<li>Randomized Controlled Trials as Topic</li>
					<li>Health Facilities</li>
					<li>Perinatal Mortality</li>
					<li>Preterm birth</li>
					<li>Perinatal Death</li>
					<li>Hospital Mortality</li>
					<li>Clinical Competence</li>
					<li>*Infant, Premature</li>
					<li>Quality Improvement</li>
					<li>Checklist</li>
					<li>Delivery of Health Care, Integrated/*methods/standards</li>
					<li>Health Personnel/*education/standards</li>
					<li>Inservice Training/*methods/standards</li>
					<li>Multicenter Studies as Topic</li>
					<li>Patient Care Team</li>
					<li>Perinatal Care/*methods/standards</li>
					<li>Quality improvement</li>
					<li>Simulation training</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_EN2LQD3X">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location Name : </strong></p>
<p>The names of the facilities were not mentioned</p>
<p><strong>Location Type : </strong></p>
<p>Health facility</p>
<p><strong>Description : </strong></p>
<p><span style="color: black">Conducted in 20 facilities in Migori County, Kenya and Busoga Region, Uganda</span></p>
<p><strong>Sample size :</strong></p>
<p></p>
<p></p>
<p></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_YSNKG56H" class="item journalArticle">
			<h2>Submicroscopic Plasmodium falciparum Infections Are Associated With Maternal Anemia, Premature Births, and Low Birth Weight.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Cottrell G</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Moussiliou A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Luty AJ</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Cot M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Fievet N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Massougbodji A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Deloron P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Tuikue Ndam N</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Molecular, as opposed to microscopic, detection 
measures the real prevalence of Plasmodium falciparum infections. Such 
occult infections are common during pregnancy but their impact on 
pregnancy outcomes is unclear. We performed a longitudinal study to 
describe that impact. METHODS: In a cohort of 1037 Beninese pregnant 
women, we used ultrasound to accurately estimate gestational ages. 
Infection with P. falciparum, hemoglobin concentration, use of 
intermittent preventive treatment during pregnancy (IPTp) for malaria, 
and other parameters were recorded during pregnancy. Using multivariate 
analyses, we evaluated the impact of submicroscopic infections on 
maternal anemia, premature birth, and low birth weight. RESULTS: At 
inclusion, polymerase chain reaction (PCR) and microscopy detected 
infection in 40% and 16% of women, respectively. The proportion infected
 declined markedly after 2 doses of IPTp but rebounded to 34% (by PCR) 
at delivery. Submicroscopic infections during pregnancy were associated 
with lower mean hemoglobin irrespective of gravidity, and with increased
 anemia risk in primigravidae (odds ratio [OR], 2.23; 95% confidence 
interval [CI], .98-5.07). Prospectively, submicroscopic infections at 
inclusion were associated with significantly increased risks of low 
birth weight in primigravidae (OR, 6.09; 95% CI, 1.16-31.95) and 
premature births in multigravidae (OR, 2.25; 95% CI, 1.13-4.46). 
CONCLUSIONS: In this detailed longitudinal study, we document the 
deleterious impact of submicroscopic P. falciparum parasitemia during 
pregnancy on multiple pregnancy outcomes. Parasitemia occurs frequently 
during pregnancy, but routine microscopic and rapid diagnostic tests 
fail to detect the vast majority of episodes. Our findings imply caution
 in any revision of the current strategies for prevention of 
pregnancy-associated malaria.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2015-05</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 10
Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>60</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>1481-8</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1093/cid/civ122">10.1093/cid/civ122</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>10</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1058-4838 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:35 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:35 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>*Premature Birth</li>
					<li>Cohort Studies</li>
					<li>Infant, Newborn</li>
					<li>Prospective Studies</li>
					<li>Young Adult</li>
					<li>Longitudinal Studies</li>
					<li>*Infant, Low Birth Weight</li>
					<li>Adolescent</li>
					<li>Benin/epidemiology</li>
					<li>malaria</li>
					<li>pregnancy</li>
					<li>Microscopy</li>
					<li>Plasmodium falciparum</li>
					<li>Polymerase Chain Reaction</li>
					<li>*Pregnancy Complications, Infectious</li>
					<li>Anemia/epidemiology/*etiology</li>
					<li>Diagnostic Tests, Routine/*methods</li>
					<li>Malaria, Falciparum/*complications/epidemiology</li>
					<li>PCR</li>
					<li>submicroscopic</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_RWRZSET9">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name</strong> : </p>
<p><span style="color: rgb(42, 42, 42)"><span style="background-color: rgb(255, 255, 255)">Com</span></span></p>
<p><strong>Location Type</strong> : &nbsp;</p>
<p>District</p>
<p><strong>Description</strong> : &nbsp;</p>
<p><span style="color: rgb(42, 42, 42)"><span style="background-color: rgb(255, 255, 255)">Com district, a semirural area of southern Benin, 70 km west of Cotonou, the commercial capital of Benin</span></span></p>
<p><strong>Sample size : </strong><span style="color: rgb(42, 42, 42)"><span style="background-color: rgb(239, 242, 247)">1037</span></span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_SEQJMLDB" class="item journalArticle">
			<h2>Testing strategies for couple engagement in prevention of 
mother-to-child transmission of HIV and family health in Kenya: study 
protocol for a randomized controlled trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kwena Z</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kimbo L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Darbes LA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hatcher AM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Helova A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Owino G</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Thirumurthy H</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bukusi EA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Braun T</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kilgore M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Pisu M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Tamhane A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Nghiem VT</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Agot K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Neilands TB</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Turan JM</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: HIV-related maternal deaths and HIV infection 
among infants remain unacceptably high across sub-Saharan Africa despite
 increased antenatal care attendance and provision of antiretroviral 
therapy to pregnant women. In the Jamii Bora ("Better Family" in 
Swahili) Study, we seek to test the efficacy of an interdependence 
theory-based couple intervention. The intervention reaches pregnant 
women and male partners through home visits by male-female pairs of lay 
health workers. The aim is to increase access to home-based couples' HIV
 testing and counseling services to improve family health. METHODS: This
 is a three-arm randomized control trial among 1080 pregnant women 15 
years of age or older, living with their male partners, and who have not
 undergone couples' HIV testing and counseling in Kisumu and Migori 
Counties in Kenya. Couples will be randomized into three groups: 
home-based couple visits, HIV self-testing kits for couple use, or 
standard care (male partner clinic invitation letters). Participants 
will be followed up to 18 months postpartum. The study has three aims: 
in aim 1, we will determine the effects of the intervention on our 
primary outcome of couple HIV testing, compared to HIV self-testing kits
 and standard care; in aim 2, we will examine the intervention impact on
 HIV prevention behaviors, facility delivery, and postnatal healthcare 
utilization, as well as secondary health outcomes of maternal viral 
suppression and HIV-free child survival up to 18 months for couples 
living with HIV; and in aim 3, we will compare the cost-effectiveness of
 the home-based couple intervention to the less resource-intensive 
strategies used in the other two study arms. Assessments with couples 
are conducted at baseline, late pregnancy, and at months 3, 6, 12, and 
18 after birth. DISCUSSION: The results from this study will inform 
decision-makers about the cost-effective strategies to engage pregnant 
couples in the prevention of mother-to-child transmission and family 
health, with important downstream benefits for maternal, paternal, and 
infant health. TRIAL REGISTRATION: ClinicalTrials.gov NCT03547739 . 
Registered on May 9, 2018.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2021-01</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>22</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>19</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Trials</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/s13063-020-04956-1">10.1186/s13063-020-04956-1</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1745-6215 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Male</li>
					<li>Infant</li>
					<li>Child</li>
					<li>Kenya</li>
					<li>Randomized Controlled Trials as Topic</li>
					<li>Counseling</li>
					<li>*HIV Infections/diagnosis/prevention &amp; control</li>
					<li>*Infectious Disease Transmission, Vertical/prevention &amp; control</li>
					<li>Antiretroviral therapy (ART)</li>
					<li>Couple home testing and counseling (CHTC)</li>
					<li>Couple relationships</li>
					<li>Family Health</li>
					<li>HIV self-testing kits (HIVST)</li>
					<li>Intimate partner violence (IPV)</li>
					<li>Prevention of mother-to-child transmission (PMTCT)</li>
					<li>Randomized controlled trial (RCT)</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_KWRHCUAW">
<div><div data-schema-version="8"><p><strong>Location Informaation</strong></p>
<p><strong>Location &nbsp;Name :</strong></p>
<p>Kisumu and Migori, the other facilities are not mentioned</p>
<p><strong>Location Type : </strong></p>
<p>Health facility</p>
<p><strong>Description : </strong></p>
<p><span style="color: black">Conducted in 18 Antenatal care health facilities in &nbsp;Kisumu and Migori Counties in Kenya.</span></p>
<p><strong>Sample size :</strong> <span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">1080</span></span></p>
<p></p>
<p></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_KC6P5L8W" class="item journalArticle">
			<h2>Text messaging for maternal and infant retention in prevention of
 mother-to-child HIV transmission services: A pragmatic stepped-wedge 
cluster-randomized trial in Kenya.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Odeny TA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hughes JP</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bukusi EA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Akama E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Geng EH</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Holmes KK</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>McClelland RS</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Timely diagnosis of infant HIV infection is 
essential for antiretroviral therapy (ART) initiation. In a randomized 
controlled trial, we found the Texting Improves Testing (TextIT) 
intervention (a theory-based text messaging system) to be efficacious 
for improving infant HIV testing rates and maternal retention in 
prevention of mother-to-child HIV transmission (PMTCT) programs. Using 
an implementation science approach, we aimed to evaluate real-world 
effectiveness of the intervention. METHODS AND FINDINGS: In a pragmatic,
 cluster-randomized, stepped-wedge trial with 2 time periods of 
observation, we randomly allocated 10 clinics to begin implementing the 
intervention immediately and 10 clinics to begin implementing 6 months 
later. To approximate real-world conditions, inclusion criteria were 
broad. Women at clinics implementing the intervention received up to 14 
text messages during pregnancy and after delivery and had the option to 
respond to text messages, call, or send inquiry text messages to a 
designated clinic phone. The primary outcomes were infant HIV testing 
and maternal retention in care during the first 8 weeks after delivery. 
We used modified Poisson regression with robust variance estimation to 
estimate the relative risk and 95% confidence intervals (CIs). 
Generalized estimating equations were applied on individual-level data 
to account for clustering by site. Between February 2015 and December 
2016, 4,681 women were assessed for study participation, and 2,515 were 
included. Participant characteristics at enrollment did not differ by 
study arm. Overall median age was 27 years (interquartile range [IQR] 
23-30), median gestational age was 30 weeks (IQR 28-34), 99% were 
receiving ART, and 87% who enrolled during intervention phases owned a 
phone. Of 2,326 infants analyzed, 1,466 of 1,613 (90.9%) in the 
intervention group and 609 of 713 (85.4%) in the control group met the 
primary outcome of HIV virologic testing performed before 8 weeks after 
birth (adjusted relative risk [aRR] 1.03; 95% CI 0.97-1.10; P = 0.3). Of
 2,472 women analyzed, 1,548 of 1,725 (90%) in the intervention group 
and 571 of 747 (76%) in the control group met the primary outcome of 
retention in care during the first 8 weeks after delivery (aRR 1.12; 95%
 CI 0.97-1.30; P = 0.1). This study had two main limitations. Staff at 
all facilities were aware of ongoing observation, which may have 
contributed to increased rates of infant HIV testing and maternal 
retention in care at both intervention and control facilities, and 
programmatic initiatives to improve maternal and infant retention in 
care were ongoing at all facilities at the time of this study, which 
likely limited the ability to demonstrate effectiveness of the trial 
intervention. CONCLUSIONS: In this study, a larger proportion of infants
 in the intervention group received HIV testing compared with the 
control group, but the difference was small and not statistically 
significant. There was also a nonsignificant increase in maternal 
postpartum retention in the intervention periods. Despite the lack of a 
significant effect of the intervention, key lessons emerged, both for 
strengthening PMTCT and for implementation research in general. Perhaps 
most important, improving the implementation of usual care may have been
 sufficient to substantially improve infant HIV testing rates. TRIAL 
REGISTRATION: ClinicalTrials.gov Trial Number NCT02350140.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2019-10</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>16</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e1002924</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>PLoS medicine</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1371/journal.pmed.1002924">10.1371/journal.pmed.1002924</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>10</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1549-1277 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Young Adult</li>
					<li>Infectious Disease Transmission, Vertical/*prevention &amp; control</li>
					<li>Treatment Outcome</li>
					<li>Anti-HIV Agents/therapeutic use</li>
					<li>Cluster Analysis</li>
					<li>Pregnancy Complications, Infectious/drug therapy</li>
					<li>Kenya</li>
					<li>*Medication Adherence</li>
					<li>Poisson Distribution</li>
					<li>*Text Messaging</li>
					<li>Health Promotion</li>
					<li>HIV Infections/*drug therapy/*prevention &amp; control/*transmission</li>
					<li>Program Development</li>
					<li>Reminder Systems</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_P7XGSTMF">
<div><div data-schema-version="8"><p><strong>Location information</strong></p>
<p><strong>Location Name :</strong> &nbsp;</p>
<p>Health facilities in Kisimu, Migori and Homa Bay</p>
<p><strong>Location Type :</strong> &nbsp;</p>
<p>Health facilities</p>
<p><strong>Description :</strong> </p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Conducted in the Nyanza region of Kenya, encompassing three counties: Kisumu, Migori, and Homa Bay.</span></span></p>
<p><strong>Sample Size : 2515</strong></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_422NJVLL" class="item journalArticle">
			<h2>The acceptability of intermittent screening and treatment versus 
intermittent preventive treatment during pregnancy: results from a 
qualitative study in Northern Ghana.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Pell C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Menaca A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chatio S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hodgson A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Tagbor H</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Pool R</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Affecting mother and child, malaria during 
pregnancy (MiP) provokes a double morbidity and mortality burden. Within
 a package of interventions to prevent MiP in endemic areas, the WHO 
currently recommends intermittent preventive treatment (IPTp). Concerns 
about anti-malarial resistance have however prompted interest in 
intermittent screening and treating (IST) as an alternative approach to 
IPTp. IST involves screening for malaria infection at scheduled 
antenatal care (ANC) clinic visits and treating malaria cases. In light 
of the need to comprehensively evaluate new interventions prior to roll 
out, this article explores the acceptability of IST with 
artemether-lumefantrine (AL) compared to IPTp with 
sulphadoxine-pyrimethamine (SP) and in Upper East Region, northern 
Ghana. METHODS: Data were collected alongside an open-label, randomized,
 controlled trial of IST-AL and IPTp-SP in Kassena-Nankana District. 
Thirty pregnant women enrolled in the clinical trial participated in six
 focus group discussions. Ten in-depth interviews were carried out with 
clinical trial staff. Observations were also made at the health 
facilities where the clinical trial took place. RESULTS: Trial 
participants were generally willing to endure the discomfort of the 
finger prick necessary for a rapid diagnostic test for malaria and this 
reflected a wider demand for diagnostic techniques. Reports of side 
effects were however linked to both trial anti-malarials. Direct 
complaints about SP were particularly severe with regard to women's 
experience of vomiting. Although the follow-up treatment doses of AL for
 IST were not supervised, based on blister inspection and questioning 
trial, staff were confident about participants' adherence to the 
treatment course. One case of partial adherence to the AL treatment 
course was reported. CONCLUSION: Despite the discomfort of the finger 
prick required to perform the intermittent malaria screening, trial 
participants generally expressed more positive sentiments towards IST-AL
 than IPTp-SP. Nonetheless, questions remain about adherence to a 
multiple dose anti-malarial regimen during pregnancy, particularly in 
endemic areas where MiP is often non-symptomatic. Any implementation of 
IST must be accompanied by appropriate health messages on adherence and 
the necessary training for health staff regarding case management.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2014-11</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>13</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>432</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Malaria journal</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/1475-2875-13-432">10.1186/1475-2875-13-432</a></td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1475-2875 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:31 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:31 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Ghana</li>
					<li>Infant, Newborn</li>
					<li>Young Adult</li>
					<li>Adolescent</li>
					<li>*Patient Acceptance of Health Care</li>
					<li>Interviews as Topic</li>
					<li>Mass Screening/methods</li>
					<li>*Health Services Administration</li>
					<li>Malaria/diagnosis/*drug therapy/*prevention &amp; control</li>
					<li>Pregnancy Complications, Infectious/diagnosis/*drug therapy/*prevention &amp; control</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_E6QMI9FM">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name : </strong></p>
<p><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">Kassena-Nankana</span></span></p>
<p><strong>Location Type : </strong></p>
<p>District</p>
<p><strong>Description : </strong></p>
<p><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">Kassena-Nankana District in Ghana</span></span></p>
<p><strong>sample size :</strong> <span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">5,000&nbsp;</span></span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_PLWRCS2A" class="item journalArticle">
			<h2>The burden of influenza among Kenyan pregnant and postpartum women and their infants, 2015-2020.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Otieno NA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Nyawanda BO</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>McMorrow M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Oneko M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Omollo D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Lidechi S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Widdowson MA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Flannery B</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chaves SS</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Azziz-Baumgartner E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Emukule GO</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: In tropical Africa, data about 
influenza-associated illness burden are needed to assess potential 
benefits of influenza vaccination among pregnant women. We estimated the
 incidence of influenza among pregnant women and their infants in Siaya 
County, Kenya. METHODS: We enrolled women at &lt;31 weeks of gestation 
and conducted weekly follow-up until 6-month postpartum to identify 
acute respiratory illnesses (ARIs). We defined ARI among mothers as 
reported cough, rhinorrhoea or sore throat and among infants as 
maternal-reported cough, difficulty breathing, rhinorrhoea or clinician 
diagnosis of respiratory illness. We collected nasal/nasopharyngeal and 
oropharyngeal swabs from mothers/infants with ARI and tested for 
influenza A and B using molecular assays. We calculated antenatal 
incidence of laboratory-confirmed influenza among mothers and postnatal 
incidence among mothers and infants. RESULTS: During June 2015 to May 
2020, we analysed data from 3,026 pregnant women at a median gestational
 age of 16 weeks (interquartile range [IQR], 13, 18) and followed 2,550 
infants. Incidence of laboratory-confirmed influenza during pregnancy 
(10.3 episodes per 1,000 person-months [95% confidence interval {CI} 
8.6-11.8]) was twofold higher than in the postpartum period (4.0 [95% CI
 2.6-5.5]; p &lt; 0.01). Incidence was significantly higher among human 
immunodeficiency virus (HIV)-infected pregnant women (15.6 [95% CI 
11.0-20.6] vs. 9.1 [95% CI 7.5-10.8]; p &lt; 0.01). Incidence among 
young infants was 4.4 (95% CI 3.0-5.9) and similar among HIV-exposed and
 HIV-unexposed infants. CONCLUSION: Our findings suggest a substantial 
burden of influenza illnesses during pregnancy, with a higher burden 
among HIV-infected mothers. Kenyan authorities should consider the value
 of vaccinating pregnant women, especially if HIV infected.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2022-05</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>16</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>452-461</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Influenza and other respiratory viruses</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1111/irv.12950">10.1111/irv.12950</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>3</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1750-2640 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Infant</li>
					<li>Postpartum Period</li>
					<li>Kenya/epidemiology</li>
					<li>*burden</li>
					<li>*HIV Infections/complications/epidemiology</li>
					<li>*infants</li>
					<li>*influenza</li>
					<li>*Influenza, Human/epidemiology/prevention &amp; control</li>
					<li>*Pregnancy Complications, Infectious/epidemiology</li>
					<li>*pregnant women</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_2MCBKX43">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location Name : </strong></p>
<p>Siaya County Referral Hospital &amp; Bondo sub-County Hospital</p>
<p><strong>Location Type :</strong></p>
<p>Health facility</p>
<p><strong>Description : </strong></p>
<p><span style="color: black">Conducted in Siaya County, Kenya.</span></p>
<p><strong>Sample size : </strong><span style="color: rgb(0, 0, 0)"><span style="background-color: rgb(255, 255, 255)">3,026</span></span></p>
<p></p>
<p></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_LTQ4PAI4" class="item journalArticle">
			<h2>The effect of inter-pregnancy interval on stillbirth in urban South Ethiopia: a community-based prospective cohort study.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Jena BH</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Biks GA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gete YK</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gelaye KA</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Stillbirth is an invisible and poorly understood 
adverse pregnancy outcome that remains a challenge in clinical practice 
in low-resource settings. It is also a key concern in Ethiopia where 
more than half of pregnancies occur shortly after preceding childbirth. 
Whether the interval between pregnancies has an effect on stillbirth or 
not is unclear. Therefore, we aimed to assess the effect of 
inter-pregnancy interval on stillbirth in urban South Ethiopia. METHODS:
 A community-based prospective cohort study was conducted among 2578 
pregnant women and followed until delivery. Baseline data were collected
 at the household level during registration and enrolment. End-line data
 were collected from hospitals during delivery. Exposed groups were 
pregnant women with inter-pregnancy intervals &lt; 18 months and 18-23 
months. Unexposed group contains women with inter-pregnancy intervals 
24-60 months. A generalized linear model for binary outcome was applied,
 using R version 4.0.5 software. Relative risk (RR) was used to estimate
 the effect size with a 95% confidence level. Attributable fraction (AF)
 and population attributable fraction (PAF) were used to report the 
public health impact of exposure. RESULTS: The overall incidence of 
stillbirth was 15 per 1000 total births, (95% CI: 11, 20%). However, the
 incidence was varied across months of inter-pregnancy intervals; 30 
(&lt; 18 months), 8 (18-23 months) and 10 (24-60 months) per 1000 total 
births. The risk of stillbirth was nearly four times (ARR = 3.55, 95%CI:
 1.64, 7.68) higher for women with inter-pregnancy interval &lt; 18 
months as compared to 24-60 months. This means, about 72% (AF = 72, 
95%CI: 39, 87%) of stillbirth among the exposed group (inter-pregnancy 
interval &lt; 18 months category) and 42% (PAF = 42, 95%CI: 23, 50%) of 
stillbirth in the study population were attributed to inter-pregnancy 
interval &lt; 18 months. These could be prevented with an 
inter-pregnancy interval that is at least 18 months or longer. 
CONCLUSIONS: Inter-pregnancy interval under 18 months increases the risk
 of stillbirth in this population in urban South Ethiopia. Interventions
 targeting factors contributing to short inter-pregnancy intervals could
 help in reducing the risk of stillbirth. Improving contraceptive 
utilization in the community could be one of these interventions.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2021-12</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>21</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>847</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>BMC pregnancy and childbirth</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/s12884-021-04325-z">10.1186/s12884-021-04325-z</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1471-2393 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Incidence</li>
					<li>Pregnancy</li>
					<li>Prospective Studies</li>
					<li>Urban Population</li>
					<li>Stillbirth</li>
					<li>Stillbirth/*epidemiology</li>
					<li>Pregnant women</li>
					<li>Ethiopia/epidemiology</li>
					<li>*Birth Intervals</li>
					<li>Cohort</li>
					<li>Inter-pregnancy interval</li>
					<li>Urban South Ethiopia</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_33T7VIUF">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location Name : </strong></p>
<p>Hossana, Shone, Gimbichu, Jajura, and Homecho.</p>
<p><strong>Location type : </strong></p>
<p>Community</p>
<p><strong>Description : </strong></p>
<p>C<span style="color: black">onducted in 5 urban settings within the Hadiya zone, Ethiopia.</span></p>
<p><strong>Sample size :</strong> <span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">2578</span></span></p>
<p></p>
<p></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_A37D2GLQ" class="item journalArticle">
			<h2>The effect of maternal depressive symptoms on infant feeding practices in rural Ethiopia: community based birth cohort study.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Woldetensay YK</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Belachew T</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ghosh S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kantelhardt EJ</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Biesalski HK</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Scherbaum V</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Maternal depression and other psychosocial factors
 have been shown to have adverse consequences on infant feeding 
practices. This study explored the longitudinal relationship of maternal
 depressive symptoms and other selected psychosocial factors with infant
 feeding practices (IFPs) in rural Ethiopia using summary IFP index. 
METHODS: This study uses existing data from the ENGINE birth cohort 
study, conducted from March 2014 to March 2016 in three districts in the
 southwest of Ethiopia. A total of 4680 pregnant women were recruited 
and data were collected once during pregnancy (twice for those in the 
first trimester), at birth, and then every 3 months until the child was 
12 months old. A standardized questionnaire was used to collect data on 
IFPs, maternal depressive symptoms, household food insecurity, intimate 
partner violence (IPV), maternal social support, active social 
participation, and other sociodemographic variables. A composite measure
 of IFP index was computed using 14 WHO recommended infant and young 
child feeding (IYCF) practice indicators. High IFP index indicated best 
practice. Prenatal and postnatal maternal depressive symptoms were 
assessed using the patient health questionnaire (PHQ-9). Linear 
multilevel mixed effects model was fitted to assess longitudinal 
relationship of IFPs with maternal depression and other psychosocial 
factors. RESULTS: Reports of higher postnatal depressive symptoms (ss = -
 1.03, P = 0.001) and IPV (ss = - 0.21, P = 0.001) were associated with 
lower scores on the IFP index. Whereas, reports of better maternal 
social support (ss = 0.11, P = 0.002) and active social participation 
(ss = 0.55, P &lt; 0.001) were associated with higher scores on the IFP 
index. Contrary to expectations, moderate household food insecurity (ss =
 0.84, P = 0.003), severe household food insecurity (ss = 1.03, P = 
0.01) and infant morbidity episodes (ss = 0.63, P = 0.013) were 
associated with higher scores on the IFP index. CONCLUSIONS: Overall, a 
multitude of factors are related to IFPs and hence coordinated, 
multi-sectoral and multi-stakeholder interventions including maternal 
depressive symptoms screening and management are needed to improve 
infant feeding practices.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2021-03</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>16</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>27</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>International breastfeeding journal</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/s13006-021-00375-3">10.1186/s13006-021-00375-3</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1746-4358 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Cohort Studies</li>
					<li>Infant, Newborn</li>
					<li>Infant</li>
					<li>Rural Population</li>
					<li>Child</li>
					<li>Ethiopia/epidemiology</li>
					<li>*Ethiopia</li>
					<li>*Social support</li>
					<li>*Depression, Postpartum/epidemiology/etiology</li>
					<li>*Depression/epidemiology/etiology</li>
					<li>*Household food insecurity</li>
					<li>*Infant feeding practices</li>
					<li>*Intimate partner violence</li>
					<li>*Postnatal depression</li>
					<li>*Prenatal depression</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_6KQWBKKK">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location Name:</strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Woliso district, Tiro-Afeta district, and Gomma district</span></span></p>
<p><strong>Location Type:</strong></p>
<p>Community</p>
<p><strong>Description :</strong><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)"> </span></span></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Conducted in three districts (Woliso, Tiro-Afeta, and Gomma) in the Southwestern part of Ethiopia.</span></span></p>
<p><strong>Sample size : </strong><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">4680</span></span></p>
<p></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_JN2UNLBU" class="item journalArticle">
			<h2>The effects of HIV self-testing kits in increasing uptake of male
 partner testing among pregnant women attending antenatal clinics in 
Kenya: a randomized controlled trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Marwa T</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Karanja S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Osero J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Orago A</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>Introduction: HIV self-testing could add a new approach to 
scaling up HIV testing with potential of being high impact, low cost, 
confidential, and empowering for users. Methods: Pregnant women 
attending antenatal clinics (ANC) and their male partners were recruited
 in 14 clinics in the eastern and central regions of Kenya and randomly 
allocated to intervention or control arms at a ratio of 1:1:1. Arm 1 
received the standard of care, which involved invitation of the male 
partner to the clinic through word of mouth, arm 2 received an improved 
invitation letter, and arm 3 received the same improved letter and, two 
self-testing kits. Analysis was done using adjusted odds ratios (aOR) at
 95% confidence intervals (CI) to calculate and determine effects of HIV
 self-testing in increasing uptake of male partner testing. Results: A 
total of 1410 women and 1033 men were recruited; 86% (1217) women and 
79% (1107) couples were followed up. In arm 3, over 80% (327) of male 
partners took HIV test, compared to only 37% (133) in arm 2 and 28% 
(106) in arm one. There was a statistical significance between arm one 
and two (p-value=0.01) while arm three was statistically significant 
compared to arm two (p-value&lt;0.001). Men in arm three were twelve 
times more likely to test compared to arm one (aOR 12.45 (95% CI 7.35, 
21.08)). Conclusion: Giving ANC mothers test kits and improved male 
invitation letter increased the likelihood of male partner testing by 
twelve times. These results demonstrate that HIV self-test kits could 
complement routine HIV testing methods in the general population.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2019</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: Uganda</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>33</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>213</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>The Pan African medical journal</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.11604/pamj.2019.33.213.14160">10.11604/pamj.2019.33.213.14160</a></td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1937-8688 (ELECTRONIC)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:30 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:30 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Young Adult</li>
					<li>Male</li>
					<li>Adolescent</li>
					<li>randomized controlled trial</li>
					<li>Kenya</li>
					<li>Prenatal Care/*methods</li>
					<li>*Sexual Partners</li>
					<li>ANC mothers</li>
					<li>Diagnostic Tests, Routine</li>
					<li>drivers and barriers</li>
					<li>HIV Infections/*diagnosis</li>
					<li>HIV self-testing</li>
					<li>male involvement</li>
					<li>male partners</li>
					<li>Mass Screening/*methods/statistics &amp; numerical data</li>
					<li>Patient Acceptance of Health Care/statistics &amp; numerical data</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_82D9NLXQ">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name : </strong></p>
<p>Names not specified</p>
<p><strong>Location Type : </strong></p>
<p>Health facilities</p>
<p><strong>Description : </strong></p>
<p><span style="color: rgb(0, 0, 0)"><span style="background-color: rgb(249, 249, 249)">14 clinics in the eastern and central regions of Kenya , </span><span style="background-color: rgb(255, 255, 255)">in Meru, Kiambu, Kitui, Embu and Murang'a counties of Kenya</span></span></p>
<p><strong>Sample Size :</strong> <span style="color: rgb(0, 0, 0)"><span style="background-color: rgb(255, 255, 255)">&nbsp;1217</span></span></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_BJ7JQ8MB" class="item journalArticle">
			<h2>The effects of maternal alcohol consumption during pregnancy on 
adverse fetal outcomes among pregnant women attending antenatal care at 
public health facilities in Gondar town, Northwest Ethiopia: a 
prospective cohort study.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Addila AE</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Azale T</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gete YK</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Yitayal M</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: The teratogenic effect of fetal alcohol exposure 
may lead to actual and potential problems, instantly after birth, at 
infancy; or even later, and mental impairment in life. This study aimed 
to investigate the effects of maternal alcohol consumption during 
pregnancy on adverse fetal outcomes at Gondar town public health 
facilities, Northwest Ethiopia. METHODS: A facility-based prospective 
cohort study was performed among 1778 pregnant women who were booked for
 antenatal care in selected public health facilities from 29 October 
2019 to 7 May 2020 in Gondar town. We used a two-stage random sampling 
technique to recruit and include participants in the cohort. Data were 
collected using the Alcohol Use Disorders Identification Test - 
Consumption (AUDIT-C) standardized and pre-tested questionnaire. 
Multivariable analysis was performed to examine the association between 
reported prenatal alcohol exposure (non-hazardous and hazardous) and 
interested adverse birth outcomes using log-binomial regression 
modeling. The burden of outcomes was reported using the adjusted risk 
ratio and population-attributable risk (PAR). RESULTS: A total of 1686 
pregnant women were included in the analysis, which revealed that the 
incidences of low birth weight, preterm, and stillbirth were 12.63% (95%
 CI: 11.12, 14.31), 6.05% (95% CI: 5.00, 7.29) and 4.27% (95% CI: 3.4, 
5.35), respectively. Non-hazardous and hazardous alcohol consumption 
during pregnancy was significantly associated with low birth weight (ARR
 = 1.50; 95% CI: 1.31, 1.98) and (ARR = 2.34; 95% CI: 1.66, 3.30), 
respectively. Hazardous alcohol consumption during pregnancy was also 
significantly associated with preterm birth (ARR = 2.06; 95% CI: 1.21, 
3.52). The adjusted PAR of low birth weight related to non-hazardous and
 hazardous alcohol drinking during pregnancy was 11.72 and 8.44%, 
respectively. The adjusted PAR of hazardous alcohol consumption was 
6.80% for preterm. CONCLUSIONS: Our findings suggest that there is an 
increasing risk of adverse birth outcomes, particularly preterm delivery
 and low birth weight, with increasing levels of alcohol intake. This 
result showed that the prevention of maternal alcohol use during 
pregnancy has the potential to reduce low birth weight and preterm 
birth. Hence, screening women for alcohol use during antenatal care 
visits and providing advice with rigorous follow-up of women who used 
alcohol may save the fetus from the potential risks of adverse birth 
outcomes.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2021-08</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>16</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>64</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Substance abuse treatment, prevention, and policy</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/s13011-021-00401-x">10.1186/s13011-021-00401-x</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1747-597X (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Cohort Studies</li>
					<li>Infant, Newborn</li>
					<li>Prospective Studies</li>
					<li>Stillbirth</li>
					<li>Pregnant Women</li>
					<li>Prenatal Care</li>
					<li>*Premature Birth/epidemiology</li>
					<li>Ethiopia/epidemiology</li>
					<li>*Adverse health outcomes</li>
					<li>*Alcohol use</li>
					<li>*Alcoholism</li>
					<li>*Ethiopia</li>
					<li>*Pregnant women</li>
					<li>*Prenatal Exposure Delayed Effects</li>
					<li>Alcohol Drinking/adverse effects/epidemiology</li>
					<li>Fetus</li>
					<li>Health Facilities</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_SM768HDG">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location &nbsp; Name :</strong></p>
<p>University of Gondar comprehensive specialized hospital, Gondar polyclinic, Azezo health centre, and Maraki health centre.</p>
<p><strong>Location &nbsp;Type :</strong></p>
<p>Health facility</p>
<p><strong>Description :</strong> </p>
<p><span style="color: black">Conducted in Gondar town, Ethiopia</span></p>
<p><strong>Sample size :</strong> <span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">&nbsp;1778</span></span></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_4MS6VLDF" class="item journalArticle">
			<h2>The global network antenatal corticosteroids trial: impact on stillbirth.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Goldenberg RL</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Thorsten VR</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Althabe F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Saleem S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Garces A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Carlo WA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Pasha O</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chomba E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Goudar S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Esamai F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Krebs NF</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Derman RJ</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Liechty EA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Patel A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hibberd PL</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Buekens PM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Koso-Thomas M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Miodovnik M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Jobe AH</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Wallace DD</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Belizan JM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>McClure EM</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Antenatal corticosteroids are commonly used to 
reduce neonatal mortality, but most research to date has been in 
high-resource settings and few studies have evaluated its impact on 
stillbirth. In the Antenatal Corticosteroids Trial (ACT), a 
multi-country trial to assess impact of a multi-faceted intervention 
including antenatal corticosteroids to reduce neonatal mortality 
associated with preterm birth, we found an overall increase in 28-day 
neonatal mortality and stillbirth associated with the intervention. 
METHODS: The ACT was a cluster-randomized trial conducted in 102 
clusters across 7 research sites in 6 countries (India [2 sites], 
Pakistan, Zambia, Kenya, Guatemala and Argentina), comparing an 
intervention to train birth attendants at all levels of the health 
system to identify women at risk of preterm birth, administer 
corticosteroids and refer women at risk. Because of inadequate 
gestational age dating, the &lt;5(th) percentile birth weight was used 
as a proxy for preterm birth. A pre-specified secondary outcome of the 
trial was stillbirth. RESULTS: After adjusting for the pre-trial 
imbalance in stillbirth rates, the ACT intervention was associated with a
 non-significant increased risk of stillbirth (aRR 1.08, 95 % CI, 
0.99-1.17, p-0.073). Additionally, the stillbirth rate was higher in the
 term births (1.20 95 % CI 1.06-1.37, 0.004) and among those with signs 
of maceration (RR 1.18 (1.04-1.35), p = 0.013) in the intervention vs. 
control clusters. Differences in obstetric care favored the control 
clusters and maternal infection was likely more common in the 
intervention clusters. CONCLUSIONS: In this pragmatic trial, limited 
data were available to identify the causes of the increase in 
stillbirths in the intervention clusters. A higher rate of stillbirth in
 the intervention clusters prior to the trial, differences in obstetric 
care and an increase in maternal infection are potential explanations 
for the observed increase in stillbirths in the intervention clusters 
during the trial. TRIAL REGISTRATION: clinicaltrials.gov (NCT01084096).</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2016-06</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>13</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>68</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Reproductive health</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/s12978-016-0174-4">10.1186/s12978-016-0174-4</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1742-4755 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Gestational Age</li>
					<li>Adrenal Cortex Hormones/*adverse effects/therapeutic use</li>
					<li>Practice Guidelines as Topic</li>
					<li>Premature Birth/*drug therapy</li>
					<li>Stillbirth/*epidemiology</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_LJ63GXQT">
<div><div data-schema-version="8"><p><strong>Location Information:</strong></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Name:</span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">Specific names of the health facilities not given</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Type:</span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">Health facilities</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Description:</span></span></strong></p>
<p><span style="color: var(--tw-prose-body)">Conducted in specified 
geographic clusters across Argentina, Guatemala, Kenya, Zambia, 
Pakistan, and in Belgaum and Nagpur, India.</span></p>
<p><strong><span style="color: black"><span style="background-color: white">Sample size : &nbsp;2301</span></span></strong></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_AQIS2NP6" class="item journalArticle">
			<h2>The hazard of pregnancy loss and stillbirth among women in Kersa, East Ethiopia: a follow up study.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Assefa N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Berhane Y</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Worku A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Tsui A</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Although pregnancy loss causes considerable 
challenge to women's health, population-based studies in rural areas are
 not widely available in low-income countries. This study aims to 
determine the hazard of pregnancy loss and related factors in the rural 
communities of Ethiopia. METHODOLOGY: A prospective community-based 
study was conducted over a period of 1 year. Pregnancy was identified as
 early as possible by a pregnancy urine test. All pregnant women 
identified during the screening were followed up at their home until 
termination of pregnancy or delivery of the neonate. The total follow-up
 time was 7802 'pregnant person months'. A Cox regression analysis was 
done to estimate the hazard of pregnancy loss. RESULT: Out of a total of
 1438 terminated pregnancies, 143 (9.9%) did not end in live birth, 116 
ended due to bleeding and 27 were stillbirths. Whilst the hazard of 
pregnancy loss was low among women with pregnancy interval of two or 
more years [AHR 0.3 (95%CI: 0.15, 0.43)], it was high among women having
 unplanned pregnancy [AHR 2.2 (95% CI: 1.56, 3.11)], among those who 
complained STI like symptoms during the index pregnancy [AHR 4.5 (95% 
CI: 2.79, 7.38)] and among those never received antenatal care [AHR 1.8 
(95% CI: 1.13, 2.73)]. CONCLUSION: Pregnancy loss was higher amongst 
women experienced unplanned pregnancy, complained STI like symptoms and 
women who had not attended antenatal care services. RECOMMENDATION: To 
reduce pregnancy loss in rural Ethiopia expanding and promoting the use 
of family planning, antenatal services and other reproductive health 
care is necessary.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2012-10</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: Netherlands</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>3</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>107-12</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Sexual &amp; reproductive healthcare : official journal of the Swedish Association of Midwives</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1016/j.srhc.2012.06.002">10.1016/j.srhc.2012.06.002</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>3</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1877-5756 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Infant, Newborn</li>
					<li>Prospective Studies</li>
					<li>Young Adult</li>
					<li>Prevalence</li>
					<li>Poverty</li>
					<li>Follow-Up Studies</li>
					<li>Adolescent</li>
					<li>Rural Population</li>
					<li>Stillbirth/*epidemiology</li>
					<li>*Prenatal Care</li>
					<li>Ethiopia/epidemiology</li>
					<li>Proportional Hazards Models</li>
					<li>*Pregnancy, Unplanned</li>
					<li>*Sexually Transmitted Diseases</li>
					<li>Live Birth/*epidemiology</li>
					<li>Uterine Hemorrhage/epidemiology</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_FL9UVHR4">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location Name :</strong></p>
<p><strong> </strong>Kersa distric</p>
<p><strong>Location &nbsp;Type : </strong></p>
<p>Community</p>
<p><strong>Description : </strong></p>
<p>Conducted in Kersa distric, Ethiopia.</p>
<p><strong>Sample size :</strong> <span style="color: rgb(31, 31, 31)">7802&nbsp;</span></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_ZGTEW932" class="item journalArticle">
			<h2>The impact of maternal antenatal treatment with two doses of 
azithromycin and monthly sulphadoxine-pyrimethamine on child weight, 
mid-upper arm circumference and head circumference: A randomized 
controlled trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hallamaa L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Cheung YB</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Luntamo M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ashorn U</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kulmala T</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mangani C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ashorn P</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>AIM: Intermittent preventive treatment in pregnancy (IPTp) 
with azithromycin and monthly sulfadoxine-pyrimethamine increased the 
mean child weight, mid-upper arm and head circumference at four weeks of
 age in a rural low-income setting. Now we assess for how long these 
gains were sustained during 0-5 years of age. METHODS: We enrolled 1320 
pregnant Malawian women in a randomized trial and treated them with two 
doses of sulfadoxine-pyrimethamine (control) or monthly 
sulfadoxine-pyrimethamine as IPTp against malaria, or monthly 
sulfadoxine-pyrimethamine and two doses of azithromycin (AZI-SP) as IPTp
 against malaria and reproductive tract infections. Child weight, 
mid-upper arm circumference, head circumference and weight-for-height 
Z-score were recorded at one, six, 12, 24, 36, 48, and 60 months. 
RESULTS: Throughout follow-up, the mean child weight was approximately 
100 g higher (difference in means 0.12 kg, 95% CI 0.04-0.20, P = 0.003 
at one month; 0.19 kg, 95% CI 0.05-0.33, P = 0.007, at six months), mean
 head circumference 2 mm larger (0.3 cm, 95% CI 0.1 to 0.5, P = 0.004 at
 one month) and the cumulative incidence of underweight by five years of
 age was lower (hazard ratio 0.74, 95% CI 0.60 to 0.90, P = 0.002) in 
the AZI-SP group than in the control group. The 2 mm difference in the 
mean mid-upper arm circumference at one month (0.2 cm, 95% CI 0.0 to 
0.3, P = 0.007) disappeared after three years of age. There was no 
difference in mean weight-for-height Z-score at any time point. 
CONCLUSION: In Malawi, IPTp with azithromycin and monthly 
sulfadoxine-pyrimethamine has a modest, 3-5-year positive impact on 
child weight, mid-upper arm circumference and head circumference, but 
not on weight-for-height Z-score.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2019</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>14</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e0216536</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>PloS one</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1371/journal.pone.0216536">10.1371/journal.pone.0216536</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>5</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1932-6203 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Incidence</li>
					<li>Pregnancy</li>
					<li>Infant, Newborn</li>
					<li>Male</li>
					<li>Child, Preschool</li>
					<li>Drug Combinations</li>
					<li>Infant</li>
					<li>Malawi</li>
					<li>Follow-Up Studies</li>
					<li>Child</li>
					<li>Pregnancy Complications, Infectious/epidemiology/prevention &amp; control</li>
					<li>Malaria/epidemiology/*prevention &amp; control</li>
					<li>Anti-Bacterial Agents/administration &amp; dosage</li>
					<li>Antimalarials/administration &amp; dosage</li>
					<li>Arm/*anatomy &amp; histology</li>
					<li>Azithromycin/*administration &amp; dosage</li>
					<li>Birth Weight/*drug effects</li>
					<li>Head/*anatomy &amp; histology</li>
					<li>Pregnancy Complications, Parasitic/epidemiology/prevention &amp; control</li>
					<li>Pyrimethamine/*administration &amp; dosage</li>
					<li>Respiratory Tract Infections/epidemiology/*prevention &amp; control</li>
					<li>Sulfadoxine/*administration &amp; dosage</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_Z5LDCTBS">
<div><div data-schema-version="8"><p><strong>Location Information:</strong></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Name: </span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">Specific places are not mentioned in the article</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Type:</span></span></strong></p>
<p><strong><span style="color: black"><span style="background-color: white"> </span></span></strong><span style="color: black"><span style="background-color: white">health facilities</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Description: </span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">Conducted in Malaw</span></span><strong><span style="color: black"><span style="background-color: white">i</span></span></strong></p>
<p><strong><span style="color: black"><span style="background-color: white">Sample size :</span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">1320</span></span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_VBJR76EQ" class="item journalArticle">
			<h2>The safe passage study: design, methods, recruitment, and follow-up approach.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Dukes KA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Burd L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Elliott AJ</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Fifer WP</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Folkerth RD</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hankins GD</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hereld D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hoffman HJ</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Myers MM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Odendaal HJ</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Signore C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sullivan LM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Willinger M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Wright C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kinney HC</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: The Safe Passage Study is a large, prospective, 
multidisciplinary study designed to (1) investigate the association 
between prenatal alcohol exposure, sudden infant death syndrome (SIDS), 
and stillbirth, and (2) determine the biological basis of the spectrum 
of phenotypic outcomes from exposure, as modified by environmental and 
genetic factors that increase the risk of stillbirth, SIDS, and in 
surviving children, fetal alcohol spectrum disorders. METHODS: The 
results provided are based on an interim assessment of 6004 women 
enrolled, out of the 12,000 projected, from the Northern Plains, US, and
 Cape Town, South Africa, areas known to be of high risk for maternal 
drinking during pregnancy. Research objectives, study design, and 
descriptive statistics, including consent, recruitment, and retention 
information, are provided. RESULTS: Overall visit compliance is 87%, and
 includes prenatal, delivery/newborn, and postnatal contacts through 1 
year post-delivery. Pregnancy outcome ascertainment is 98% prior to 
medical chart review; less than 2% of women withdraw. Consent for the 
use of DNA and placental tissue exceed 94%, and consent to participate 
in the autopsy portion of the study is 71%. CONCLUSIONS: The Safe 
Passage Study is the first multi-site study of SIDS and stillbirth to 
integrate prospectively collected exposure information with 
multidisciplinary biological information in the same maternal and 
fetal/infant dyad using a common protocol. Essential components of the 
study design and its success are close ties to the community and 
rigorous systems and processes to ensure compliance with the study 
protocol and procedures.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2014-09</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>28</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>455-65</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Paediatric and perinatal epidemiology</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1111/ppe.12136">10.1111/ppe.12136</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>5</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>0269-5022 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Prospective Studies</li>
					<li>Risk Factors</li>
					<li>Infant</li>
					<li>Follow-Up Studies</li>
					<li>South Africa/epidemiology</li>
					<li>United States/epidemiology</li>
					<li>Stillbirth/*epidemiology</li>
					<li>stillbirth</li>
					<li>Alcohol Drinking/*epidemiology</li>
					<li>fetal alcohol spectrum disorders</li>
					<li>Fetal Alcohol Spectrum Disorders/*epidemiology</li>
					<li>PASS</li>
					<li>prenatal alcohol exposure</li>
					<li>Safe Passage Study</li>
					<li>study methodology</li>
					<li>sudden infant death syndrome</li>
					<li>Sudden Infant Death/*epidemiology</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_AH9I4NWU">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location Name : </strong></p>
<p>The exact name of the health facilities are not mentioned</p>
<p><strong>Location Type : </strong></p>
<p>Health facility</p>
<p><strong>Description : </strong></p>
<p>Conducted in Conducted in the Northern Plains, US, and Cape Town, South Africa</p>
<p><strong>Sample size :</strong> <span style="color: rgb(0, 0, 0)"><span style="background-color: rgb(255, 255, 255)">6004&nbsp;</span></span></p>
<p></p>
<p></p>
<p></p>
<p></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_S9MBXF8Y" class="item journalArticle">
			<h2>The Tingathe programme: a pilot intervention using community 
health workers to create a continuum of care in the prevention of mother
 to child transmission of HIV (PMTCT) cascade of services in Malawi</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Maria H Kim Mark W Kline</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.7448/IAS.15.4.17389">10.7448/IAS.15.4.17389</a></td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>3/1/2024, 12:13:52 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>3/1/2024, 12:17:39 PM</td>
					</tr>
				</tbody></table>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_WMEFKRU7">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location &nbsp;Name :</strong></p>
<p><strong> </strong><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Area 25 and Kawale the exact names of the health facilities was not provided</span></span></p>
<p><strong>Location &nbsp;Type : </strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Health facilities and within the community.</span></span></p>
<p><strong>Description : </strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Implemented in Area 25 and Kawale, two peri-urban communities in Lilongwe, Malawi.</span></span></p>
<p><strong>Sample size :</strong> &nbsp;1688</p>
<p></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_RLQ5WYC7" class="item journalArticle">
			<h2>Thoughts of self-harm in early and late pregnancy in urban South 
Africa: Investigating prevalence, predictors and screening options.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Redinger S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Pearson RM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Houle B</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Norris SA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Rochat TJ</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Thoughts of self-harm (TSH) are an important 
marker of mental health risk, and risk for attempted and completed 
suicide. While there is increasing attention being paid to mental health
 problems in pregnancy in South Africa (SA), TSH have received less 
attention despite some cross-sectional studies suggesting that 
prevalence may be high (12 - 39%). There is a dearth of longitudinal 
research to inform prevention and treatment. OBJECTIVES: To examine the 
rates of TSH across pregnancy in a longitudinal SA cohort and to 
investigate factors associated with the onset and persistence of TSH, as
 well as the relationship between TSH, depression and/or anxiety. 
METHODS: Women were enrolled in a prospective pregnancy cohort (S1000) 
in Soweto, SA between 2014 and 2016, and assessed using validated 
screening measures (Edinburgh Postnatal Depression Scale (EPDS) and 
State Trait Anxiety Index short form) in early and later pregnancy. Data
 were available for 649 women. TSH were determined using EPDS item 10. 
Logistic regression and bifactor models were used to determine factors 
associated with TSH across pregnancy. RESULTS: Of the 649 women, 18% 
reported TSH at some stage during their pregnancy. Prevalence of TSH was
 slightly higher in early pregnancy (12.5%) than later in pregnancy 
(11.6%). TSH were associated with a history of mental illness (adjusted 
odds ratio (aOR) 4.17; 95% confidence interval (CI) 1.3 - 13.7; 
p=0.020), concurrent depression (aOR 4.8; 95%CI 2.7 - 8.6; 
p&amp;lt;0.001); marital stress (aOR 1.74; 95% CI 1.0 - 3.0; p=0.040); 
and practical support (aOR 0.43; 95% CI 0.2 - 1.0; p=0.040) using a 
multivariate logistic regression. Bifactor analysis examining depression
 and anxiety scales showed that TSH contributed the highest variance to a
 shared depression and anxiety factor in early pregnancy. Logistic 
regressions showed that early depression was a strong predictor of later
 reports of TSH. CONCLUSIONS: The present study shows that the risk of 
TSH during pregnancy is relatively common, and starts early during 
pregnancy. Screening approaches could be simplified to encourage 
healthcare practitioners working in busy and over-burdened public 
healthcare settings to engage in identifying at-risk women. Efforts in 
improving early identification of mental health risk in pregnancy should
 be matched with strengthening of current treatment and referral 
options. Since practical support and a good marital relationship reduce 
the risk of TSH, these may be important avenues of focus for designing 
interventions.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2021-06</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 7
Place: South Africa</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>111</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>627-634</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.7196/SAMJ.2021.v111i7.15058">10.7196/SAMJ.2021.v111i7.15058</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>7</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>2078-5135 (ELECTRONIC)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:29 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:29 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Risk Factors</li>
					<li>Prevalence</li>
					<li>Longitudinal Studies</li>
					<li>Logistic Models</li>
					<li>South Africa/epidemiology</li>
					<li>Psychiatric Status Rating Scales</li>
					<li>Pregnancy Complications/diagnosis/epidemiology/*psychology</li>
					<li>Mass Screening/*methods</li>
					<li>*Suicidal Ideation</li>
					<li>Anxiety/complications/diagnosis/epidemiology</li>
					<li>Depression/complications/diagnosis/epidemiology</li>
					<li>Pregnancy Trimesters/psychology</li>
					<li>Self-Injurious Behavior/complications/epidemiology/psychology</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_T8Z6ZBUX">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name</strong> : </p>
<p>Soweto</p>
<p><strong>Location Type</strong> :</p>
<p>City</p>
<p><strong>Description</strong> : </p>
<p><span style="color: rgb(0, 0, 0)"><span style="background-color: rgb(255, 255, 255)">Soweto, SA</span></span></p>
<p><strong>Sample Size</strong> : 1055</p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_MIDNWR89" class="item journalArticle">
			<h2>Trial of ready-to-use supplemental food and corn-soy blend in 
pregnant Malawian women with moderate malnutrition: a randomized 
controlled clinical trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Callaghan-Gillespie M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Schaffner AA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Garcia P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Fry J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Eckert R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Malek S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Trehan I</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Thakwalakwa C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Maleta KM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Manary MJ</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Papathakis PC</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>Background: Malnutrition during pregnancy in sub-Saharan 
Africa is associated with poor birth outcomes. Objective: This study 
compared maternal and offspring anthropometry for moderately 
malnourished pregnant women receiving ready-to-use supplemental food 
(RUSF), a fortified corn-soy blend (CSB+) with a daily multiple 
micronutrient antenatal supplement [United Nations International 
Multiple Micronutrient Preparation (UNIMMAP)], or standard of care 
comprising CSB+ and iron and folic acid (IFA). Design: A single-blind 
randomized controlled clinical trial was conducted in southern Malawi 
among 1828 pregnant women with moderate malnutrition, defined as a 
midupper arm circumference (MUAC) &gt;/=20.6 and &lt;/=23.0 cm. Women 
received 1 of 3 dietary treatment regimens that provided approximately 
900 kcal/d and 33-36 g protein/d. Maternal and infant anthropometry were
 followed until the child was 3 mo old. Results: Newborns had a mean 
length-for-age z score of -1.3 +/- 1.2 and 22% were stunted at birth. 
Mothers receiving RUSF had the highest weight gain during 
supplementation (3.4 +/- 2.6, 3.0 +/- 2.2, and 3.2 +/- 2.4 kg for the 
RUSF, CSB+ with UNIMMAP, and CSB+ with IFA groups, respectively; P = 
0.03). Newborn birth weights and lengths were similar across 
intervention groups, but the incidence of newborns with a birth weight 
&lt;2.4 kg (weight-for-age z score &lt;-2) was higher in the CSB+ with 
UNIMMAP group than the other groups (17%, 18%, and 24% for the CSB+ with
 IFA, RUSF, and CSB+ with UNIMMAP groups, respectively; P = 0.02). At 
birth, HIV-exposed newborns had a similar length and weight as newborns 
without HIV exposure, but their head circumference was smaller (34.0 +/-
 1.5 and 34.3 +/- 1.6 cm, respectively; P = 0.02). At 3 mo of age, 
HIV-exposed infants had smaller weights, lengths, and head and arm 
circumferences than infants without HIV exposure. Conclusions: RUSF 
improved maternal weight gain compared with CSB+ with UNIMMAP. The large
 amount of food given and the modest effect on linear growth in newborns
 suggests that stunting in utero is unlikely to be reduced by 
supplemental food alone. This trial was registered at clinicaltrials.gov
 as NCT02120599.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2017-10</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>106</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>1062-1069</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>The American journal of clinical nutrition</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.3945/ajcn.117.157198">10.3945/ajcn.117.157198</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>4</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>0002-9165 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>*Dietary Supplements</li>
					<li>Birth Weight</li>
					<li>Infant, Newborn</li>
					<li>Infant</li>
					<li>Single-Blind Method</li>
					<li>*Food, Fortified</li>
					<li>Malnutrition/*diet therapy</li>
					<li>Pregnancy Complications/*diet therapy</li>
					<li>Soybeans</li>
					<li>Zea mays</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_VPEJFTQD">
<div><div data-schema-version="8"><p><strong>Location Information:</strong></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Name:</span></span></strong><span style="color: black"><span style="background-color: white"> </span></span></p>
<p><span style="color: black"><span style="background-color: white">Names of the health facilities is given in the study</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Type: </span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">Health facility</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Description:</span></span></strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Conducted in 15 antenatal clinics in southern Malawi</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Sample size : 1828</span></span></strong></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_BY8GAYYG" class="item journalArticle">
			<h2>Tuberculosis infection and stillbirth in Ethiopia-A prospective cohort study.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Walles J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Otero LG</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Tesfaye F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Abera A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Jansson M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Balcha TT</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sturegard E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Winqvist N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hansson SR</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bjorkman P</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Tuberculosis is among the leading causes of death 
among infectious diseases. Regions with a high incidence of 
tuberculosis, such as sub-Saharan Africa, are disproportionately 
burdened by stillbirth and other pregnancy complications. Active 
tuberculosis increases the risk of pregnancy complications, but the 
association between latent tuberculosis infection (LTBI) and pregnancy 
outcomes is unknown. We explored the effect of latent tuberculosis 
infection on the risk of stillbirth in women attending antenatal care 
clinics in Ethiopia, a country with &gt;170 000 annual cases of active 
tuberculosis. METHOD: Pregnant women were enrolled from antenatal care 
at three health facilities in Adama, Ethiopia, during 2015-2018, with 
assessment for previous and current active tuberculosis and testing for 
LTBI using QuantiFERON-TB-GOLD-PLUS. Proportions of stillbirth (&gt;/= 
20 weeks of gestation) and neonatal death (&lt; 29 days of birth) were 
compared with respect to categories of maternal tuberculosis infection 
(tuberculosis-uninfected, LTBI, previous-, and current active 
tuberculosis). Multivariable logistic regression was performed for 
stillbirth. RESULTS: Among 1463 participants enrolled, the median age 
was 25 years, 10.2% were HIV-positive, 34.6% were primigravidae, and the
 median gestational age at inclusion was 18 weeks. Four (0.3%) were 
diagnosed with active tuberculosis during pregnancy, 68 (4.6%) reported 
previous treatment for active tuberculosis, 470 (32.1%) had LTBI, and 
921 (63.0%) were tuberculosis-uninfected. Stillbirth was more frequent 
in participants with LTBI compared to tuberculosis-uninfected 
participants, although not reaching statistical significance (19/470, 
4.0% vs 25/921, 2.7%, adjusted [for age, gravidity and HIV serostatus] 
odds ratio 1.38, 95% confidence interval 0.73-2.57, p = 0.30). Rates of 
neonatal death (5/470, 1.1% vs 10/921, 1.1%) were similar between these 
categories. CONCLUSION: Latent tuberculosis infection was not 
significantly associated with stillbirth or neonatal death in this 
cohort. Studies based on larger cohorts and with details on causes of 
stillbirth, as well as other pregnancy outcomes, are needed to further 
investigate this issue.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2022</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>17</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e0261972</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>PloS one</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1371/journal.pone.0261972">10.1371/journal.pone.0261972</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>4</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1932-6203 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>*Pregnancy Complications</li>
					<li>Cohort Studies</li>
					<li>Infant, Newborn</li>
					<li>Prospective Studies</li>
					<li>Stillbirth/epidemiology</li>
					<li>*Perinatal Death</li>
					<li>Ethiopia/epidemiology</li>
					<li>*Latent Tuberculosis/complications/diagnosis/epidemiology</li>
					<li>*Tuberculosis/complications/diagnosis/epidemiology</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_36G5VQFC">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Name: &nbsp;</span></span></strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Adama Hospital Medical College, Adama Health Centre, and Geda Health Centre</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Type:</span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">Health facility</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Description:</span></span></strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">conducted in Adama city, Ethiopia</span></span></p>
<p><strong>Sample Size</strong>: &nbsp;2085</p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_5ZSKQYUR" class="item journalArticle">
			<h2>Understanding biological mechanisms underlying adverse birth 
outcomes in developing countries: protocol for a prospective cohort 
(AMANHI bio-banking) study.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Baqui AH</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Khanam R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Rahman MS</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ahmed A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Rahman HH</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Moin MI</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ahmed S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Jehan F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Nisar I</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hussain A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ilyas M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hotwani A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sajid M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Qureshi S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Zaidi A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sazawal S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ali SM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Deb S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Juma MH</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Dhingra U</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Dutta A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ame SM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hayward C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Rudan I</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Zangenberg M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Russell D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Yoshida S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Polasek O</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Manu A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bahl R</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>Objectives: The AMANHI study aims to seek for biomarkers as 
predictors of important pregnancy-related outcomes, and establish a 
biobank in developing countries for future research as new methods and 
technologies become available. Methods: AMANHI is using harmonised 
protocols to enrol 3000 women in early pregnancies (8-19 weeks of 
gestation) for population-based follow-up in pregnancy up to 42 days 
postpartum in Bangladesh, Pakistan and Tanzania, with collection taking 
place between August 2014 and June 2016. Urine pregnancy tests will be 
used to confirm reported or suspected pregnancies for screening 
ultrasound by trained sonographers to accurately date the pregnancy. 
Trained study field workers will collect very detailed phenotypic and 
epidemiological data from the pregnant woman and her family at scheduled
 home visits during pregnancy (enrolment, 24-28 weeks, 32-36 weeks &amp;
 38+ weeks) and postpartum (days 0-6 or 42-60). Trained phlebotomists 
will collect maternal and umbilical blood samples, centrifuge and obtain
 aliquots of serum, plasma and the buffy coat for storage. They will 
also measure HbA1C and collect a dried spot sample of whole blood. 
Maternal urine samples will also be collected and stored, alongside 
placenta, umbilical cord tissue and membrane samples, which will both be
 frozen and prepared for histology examination. Maternal and newborn 
stool (for microbiota) as well as paternal and newborn saliva samples 
(for DNA extraction) will also be collected. All samples will be stored 
at -80 degrees C in the biobank in each of the three sites. These 
samples will be linked to numerous epidemiological and phenotypic data 
with unique study identification numbers. Importance of the study: 
AMANHI biobank proves that biobanking is feasible to implement in LMICs,
 but recognises that biobank creation is only the first step in 
addressing current global challenges.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2017-12</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 2
Place: Scotland</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>7</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>021202</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Journal of global health</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.7189/jogh.07.021202">10.7189/jogh.07.021202</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>2</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>2047-2978 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:33 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:33 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Prospective Studies</li>
					<li>*Pregnancy Outcome</li>
					<li>*Developing Countries</li>
					<li>Feasibility Studies</li>
					<li>*Biomarkers</li>
					<li>Biological Specimen Banks/*organization &amp; administration</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_NEUVDPCV">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location name : </strong></p>
<p>Disctri /Facility name</p>
<p><strong>Location Type: </strong></p>
<p>District, Health Facilities</p>
<p><strong>Description</strong> : </p>
<p>Tanzania, the study is being carried out in two of the four districts
 or Shehias of Pemba, the smaller of the two islands of the Zanzibar 
archipelago</p>
<p><strong>Sample size</strong> : 1000</p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_6TQM9F9R" class="item journalArticle">
			<h2>Use of a novel supplementary food and measures to control 
inflammation in malnourished pregnant women in Sierra Leone to improve 
birth outcomes: study protocol for a prospective, randomized, controlled
 clinical effectiveness trial.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hendrixson DT</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Koroma AS</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Callaghan-Gillespie M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Weber J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Papathakis P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Manary MJ</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>Background: The negative synergy between poor nutritional 
status and infectious diseases is doubly detrimental in pregnancy. In 
Sierra Leone, maternal malnutrition is amongst the highest in the world,
 while maternal mortality is high at 1320/100,000 live births and 
stunting in under-five is 37.9%, ranked 110/132 worldwide. Maternal 
malnutrition has been associated with preterm birth, 
small-for-gestational age infants, and poor maternal outcomes. Infants 
born prematurely or small-for-gestational age experience higher 
mortality and are at risk for stunting and decreased cognitive 
performance. Nutritional interventions alone during pregnancy may not be
 as effective in the setting of increased inflammation from repeated 
infections. Interventions are needed to improve maternal outcomes and 
reduce stunting in this population. Methods/design: This will be a 
prospective, randomized, controlled clinical effectiveness trial of an 
improved supplementary food plus anti-infective therapies compared to 
standard therapy in malnourished pregnant women. Pregnant women will be 
randomized to receive a low water activity, ready-to-use supplementary 
food plus five anti-infective interventions or the standard of care 
which is 3.5 kg corn/ soy blended flour with 350 mL vegetable oil every 
two weeks. The five anti-infective interventions are 1) 
insecticide-treated mosquito net at the time of enrollment into the 
study, 2) sulfadoxine-pyrimethamine given every 4 weeks, beginning at 
enrollment or at 13 weeks' gestation, whichever is later, 3)azithromycin
 at a dose of 1 g given once at enrollment (after first trimester)and 
again during 28-34 weeks of gestation, 4)single dose 400 mg albendazole 
given in second trimester, and 5) testing and treatment for bacterial 
vaginosis at enrollment and again at 28-34 weeks of gestation. Treatment
 will be provided for the duration of the pregnancy. The primary outcome
 measure will be birth length. Secondary outcomes in the mothers will 
include rates of maternal weight gain and increase in mid-upper arm 
circumference, and time to maternal anthropometric recovery. Secondary 
outcomes in the infants will include birth weight, birth head 
circumference, and linear and ponderal growth. Discussion: Malnutrition 
remains a major problem in the developing world with lasting maternal 
and infant consequences. Maternal malnutrition has been associated with 
intrauterine growth retardation, low birth weight (LBW), pre-term 
delivery and poor cognitive development. Nutritional interventions alone
 have not been successful in reducing stunting. By bundling nutritional 
and anti-infective interventions, we aim to reduce intrauterine growth 
restriction and low birth weight in moderately malnourished pregnant 
women in Sierra Leone. If successful, this bundle can easily be 
implemented by governments or non-governmental organizations. Trial 
registration: Clinicaltrials.gov NCT03079388; Date: March 5, 2017.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2018</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>4</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>15</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>BMC nutrition</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/s40795-018-0218-y">10.1186/s40795-018-0218-y</a></td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>2055-0928 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Pregnancy</li>
					<li>Intrauterine growth restriction</li>
					<li>Legumes</li>
					<li>Low birth weight</li>
					<li>Malnutrition</li>
					<li>RUSF</li>
					<li>Stunting</li>
					<li>Supplementary foods</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_4U4QZDHB">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name</strong> : </p>
<p>Name</p>
<p><strong>Location Type</strong> :</p>
<p>Health facility &amp; District</p>
<p><strong>Description</strong> : </p>
<p>A<span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">ntenatal clinics in rural Pujehun District in southern Sierra Leone and 10 antenatal clinics in the Rural Western Area District</span></span></p>
<p><strong>Sample size : </strong><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">1514&nbsp;</span></span></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_W3JN75UX" class="item journalArticle">
			<h2>Use of antenatal corticosteroids at health facilities and communities in low-and-middle income countries.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Berrueta M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hemingway-Foday J</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Thorsten VR</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Goldenberg RL</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Carlo WA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Garces A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Patel A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Saleem S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Pasha O</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chomba E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hibberd PL</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Krebs NF</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Goudar S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Derman RJ</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Esamai F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Liechty EA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Moore JL</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>McClure EM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Koso-Thomas M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Buekens PM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Belizan JM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Althabe F</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: Antenatal corticosteroids (ACS) for women at high 
risk of preterm birth is an effective intervention to reduce neonatal 
mortality among preterm babies delivered in hospital settings, but has 
not been widely used in low-middle resource settings. We sought to 
assess the rates of ACS use at all levels of health care in low and 
middle income countries (LMIC). METHODS: We assessed rates of ACS in 7 
sites in 6 LMIC participating in the Eunice Kennedy Shriver National 
Institute of Child Health and Human Development's Global Network for 
Women and Children's Health Research Antenatal Corticosteroids Trial 
(ACT), a cluster-randomized trial to assess the feasibility, 
effectiveness, and safety of a multifaceted intervention designed to 
increase the use of ACS. We conducted this analysis using data from the 
control clusters, which did not receive any components of the 
intervention and intended to follow usual care. We included women who 
delivered an infant with a birth weight &lt;5th percentile, a proxy for 
preterm birth, and were enrolled in the Maternal Newborn Health (MNH) 
Registry between October 2011 and March 2014 in all clusters. A survey 
of the site investigators regarding existing policies on ACS in health 
facilities and for health workers in the community was part of pre-trial
 activities. RESULTS: Overall, of 51,523 women delivered in control 
clusters across all sites, the percentage of &lt;5th percentile babies 
ranged from 3.5 % in Kenya to 10.7 % in Pakistan. There was variation 
among the sites in the use of ACS at all hospitals and among those 
hospitals having cesarean section and neonatal care capabilities (bag 
and mask and oxygen or mechanical ventilation). Rates of ACS use for 
&lt;5th percentile babies in all hospitals ranged from 3.8 % in the 
Kenya sites to 44.5 % in the Argentina site, and in hospitals with 
cesarean section and neonatal care capabilities from 0 % in Zambia to 
43.5 % in Argentina. ACS were rarely used in clinic or home deliveries 
at any site. Guidelines for ACS use at all levels of the health system 
were available for most of the sites. CONCLUSION: Our study reports an 
overall low utilization of ACS among mothers of &lt;5th percentile 
infants in hospital and clinic deliveries in LMIC. TRIAL REGISTRATION: 
clinicaltrials.gov ( NCT01084096 ).</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2016-05</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 1
Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>13</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>66</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Reproductive health</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1186/s12978-016-0176-2">10.1186/s12978-016-0176-2</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1742-4755 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:35 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:35 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Birth Weight</li>
					<li>Infant, Newborn</li>
					<li>*Developing Countries</li>
					<li>Infant, Low Birth Weight</li>
					<li>Community Health Centers</li>
					<li>Health Facilities</li>
					<li>Drug Utilization/statistics &amp; numerical data</li>
					<li>Glucocorticoids/*administration &amp; dosage/therapeutic use</li>
					<li>Obstetric Labor, Premature/prevention &amp; control</li>
					<li>Prenatal Care/methods/*statistics &amp; numerical data</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_SVMQAMIL">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name</strong> : </p>
<p>Name</p>
<p><strong>Location Type</strong> : </p>
<p>Clutsers</p>
<p><strong>Descritpion</strong> : </p>
<p><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">Rural
 and semi-urban clusters (geographic areas with about 500 births per 
year) within six countries (Argentina, Guatemala, India [2 sites], 
Pakistan, Kenya, and Zambia</span></span></p>
<p><strong>Sample size</strong> : <span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">51,523&nbsp;</span></span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_KDS63PBC" class="item journalArticle">
			<h2>Vertical transmission of HIV among pregnant women who initially 
had false-negative rapid HIV tests in four South African antenatal 
clinics.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mayaphi SH</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Martin DJ</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Quinn TC</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Stoltz AC</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>INTRODUCTION: There is a risk of mother-to-child transmission 
of HIV (MTCT) during pregnancy and breastfeeding. The aim of this study 
was to assess vertical transmission of HIV among pregnant women who 
initially had false-negative rapid HIV tests in South African antenatal 
care (ANC) clinics. METHODS: Pregnant participants were enrolled in a 
diagnostic study that used nucleic acid amplification testing (NAAT) to 
screen for early HIV infection among individuals who tested negative on 
rapid HIV tests used at the point-of-care (POC) facilities. Participants
 were enrolled from four ANC clinics in the Tshwane district of South 
Africa. All NAAT-positive participants were recalled to the clinics for 
further management. Vertical transmission was assessed among exposed 
infants whose HIV polymerase chain reaction (PCR) results were 
available. RESULTS: This study enrolled 8208 pregnant participants who 
tested negative on rapid HIV tests between 2013 and 2016. Their median 
age was 26 years (interquartile range [IQR]: 23-30). NAAT detected HIV 
infections in 0.6% (n = 49; 95% confidence interval {CI}: 0.5-0.8) of 
all study participants. The distribution of these infections among the 
four clinics ranged from 0.3%- 1.1%, but this was not statistically 
significant (p = 0.07). Forty-seven participants (95.9%) were 
successfully recalled and referred for antiretroviral treatment 
initiation as part of prevention of MTCT (PMTCT). Most women with newly 
diagnosed HIV infection presented for the first ANC visit in the second 
(61.9%, n = 26) and third (31.0%, n = 13) trimesters. HIV PCR results 
were available for thirty-two infants, three of whom tested positive 
(9.4%; 95% CI: 1.98-25.02). CONCLUSIONS: This study showed that 
supplemental HIV testing for pregnant women led to earlier linkage to 
the PMTCT programme. Inaccurate diagnosis of HIV infection at ANC 
clinics is likely to undermine the efforts of eliminating MTCT 
particularly in HIV-endemic settings.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2019</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 12
Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>14</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e0226391</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>PloS one</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1371/journal.pone.0226391">10.1371/journal.pone.0226391</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>12</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1932-6203 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:39 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:39 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Young Adult</li>
					<li>Infant</li>
					<li>South Africa</li>
					<li>Point-of-Care Systems</li>
					<li>Mass Screening</li>
					<li>Anti-HIV Agents/*therapeutic use</li>
					<li>Prenatal Care/methods</li>
					<li>numerical data</li>
					<li>Maternal Age</li>
					<li>Infectious Disease Transmission, Vertical/prevention &amp; control/*statistics &amp;</li>
					<li>Pregnancy Complications, Infectious/drug therapy/*virology</li>
					<li>False Negative Reactions</li>
					<li>HIV Infections/*diagnosis/drug therapy/transmission</li>
					<li>HIV/*genetics</li>
					<li>Nucleic Acid Amplification Techniques</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_SXJSSVT5">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name</strong> : </p>
<p>Facility Name</p>
<p><strong>Location Type</strong> : </p>
<p>Health facility / District</p>
<p><strong>Description</strong> : <span style="color: rgb(32, 32, 32)"><span style="background-color: rgb(255, 255, 255)">&nbsp;</span></span></p>
<p><span style="color: rgb(32, 32, 32)"><span style="background-color: rgb(255, 255, 255)">Four ANC clinics in the Tshwane district of South Africa</span></span></p>
<p><strong>Sample size : </strong><span style="color: rgb(32, 32, 32)"><span style="background-color: rgb(255, 255, 255)">8208&nbsp;</span></span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_MRW63DT6" class="item journalArticle">
			<h2>Viral Suppression and HIV Drug Resistance at 6 Months Among Women
 in Malawi's Option B+ Program: Results From the PURE Malawi Study.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hosseinipour M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Nelson JAE</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Trapence C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Rutstein SE</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kasende F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kayoyo V</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kaunda-Khangamwa B</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Compliment K</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Stanley C</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Cataldo F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>van Lettow M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Rosenberg NE</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Tweya H</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gugsa S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Sampathkumar V</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Schouten E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Eliya M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chimbwandira F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Chiwaula L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kapito-Tembo A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Phiri S</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>BACKGROUND: In 2011, Malawi launched Option B+, a program of 
universal antiretroviral therapy (ART) treatment for pregnant and 
lactating women to optimize maternal health and prevent pediatric HIV 
infection. For optimal outcomes, women need to achieve HIVRNA 
suppression. We report 6-month HIVRNA suppression and HIV drug 
resistance in the PURE study. METHODS: PURE study was a 
cluster-randomized controlled trial evaluating 3 strategies for 
promoting uptake and retention; arm 1: Standard of Care, arm 2: Facility
 Peer Support, and arm 3: Community Peer support. Pregnant and 
breastfeeding mothers were enrolled and followed according to Malawi ART
 guidelines. Dried blood spots for HIVRNA testing were collected at 6 
months. Samples with ART failure (HIVRNA &gt;/=1000 copies/ml) had 
resistance testing. We calculated odds ratios for ART failure using 
generalized estimating equations with a logit link and binomial 
distribution. RESULTS: We enrolled 1269 women across 21 sites in 
Southern and Central Malawi. Most enrolled while pregnant (86%) and were
 WHO stage 1 (95%). At 6 months, 950/1269 (75%) were retained; 833/950 
(88%) had HIVRNA testing conducted, and 699/833 (84%) were suppressed. 
Among those with HIVRNA &gt;/=1000 copies/ml with successful 
amplification (N = 55, 41% of all viral loads &gt; 1000 copies/ml), 
confirmed HIV resistance was found in 35% (19/55), primarily to the 
nonnucleoside reverse transcriptase inhibitor class of drugs. ART 
failure was associated with treatment default but not study arm, age, 
WHO stage, or breastfeeding status. CONCLUSIONS: Virologic suppression 
at 6 months was &lt;90% target, but the observed confirmed resistance 
rates suggest that adherence support should be the primary approach for 
early failure in option B+.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2017-06</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>75 Suppl 2</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>S149-S155</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Journal of acquired immune deficiency syndromes (1999)</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1097/QAI.0000000000001368">10.1097/QAI.0000000000001368</a></td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>1525-4135 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Malawi/epidemiology</li>
					<li>Pregnancy</li>
					<li>Infant, Newborn</li>
					<li>CD4 Lymphocyte Count</li>
					<li>Young Adult</li>
					<li>Breast Feeding</li>
					<li>Infectious Disease Transmission, Vertical/*prevention &amp; control</li>
					<li>Viral Load</li>
					<li>*Maternal-Child Health Services</li>
					<li>Cluster Analysis</li>
					<li>HIV Infections/*drug therapy/prevention &amp; control/transmission</li>
					<li>Anti-HIV Agents/*therapeutic use</li>
					<li>Program Evaluation</li>
					<li>*World Health Organization</li>
					<li>Drug Resistance/*drug effects</li>
					<li>Medication Adherence/statistics &amp; numerical data</li>
					<li>Pregnancy Complications, Infectious/*drug therapy/prevention &amp; control</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_GKZFXJXB">
<div><div data-schema-version="8"><p><strong>Location Information:</strong></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Name:</span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">Specific names of the health facilities not given</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Location Type:</span></span></strong></p>
<p><span style="color: black"><span style="background-color: white">Health facilities</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Description:</span></span></strong></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">conducted in 21 sites in Central and Southern Malawi</span></span></p>
<p><strong><span style="color: black"><span style="background-color: white">Sample size : &nbsp;</span></span></strong><span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">1272</span></span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_CGWU4SNW" class="item journalArticle">
			<h2>Weekly miscarriage rates in a community-based prospective cohort study in rural western Kenya.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Dellicour S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Aol G</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ouma P</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Yan N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Bigogo G</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Hamel MJ</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Burton DC</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Oneko M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Breiman RF</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Slutsker L</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Feikin D</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kariuki S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Odhiambo F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Calip G</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Stergachis A</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Laserson KF</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>ter Kuile FO</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Desai M</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>OBJECTIVE: Information on adverse pregnancy outcomes is 
important to monitor the impact of public health interventions. 
Miscarriage is a challenging end point to ascertain and there is scarce 
information on its rate in low-income countries. The objective was to 
estimate the background rate and cumulative probability of miscarriage 
in rural western Kenya. DESIGN: This was a population-based prospective 
cohort. PARTICIPANTS AND SETTING: Women of childbearing age were 
followed prospectively to identify pregnancies and ascertain their 
outcomes in Siaya County, western Kenya. The cohort study was carried 
out in 33 adjacent villages under health and demographic surveillance. 
OUTCOME MEASURE: Miscarriage. RESULTS: Between 2011 and 2013, among 5536
 women of childbearing age, 1453 pregnancies were detected and 1134 were
 included in the analysis. The cumulative probability was 18.9%. The 
weekly miscarriage rate declined steadily with increasing gestation 
until approximately 20 weeks. Known risk factors for miscarriage such as
 maternal age, gravidity, occupation, household wealth and HIV infection
 were confirmed. CONCLUSIONS: This is the first report of weekly 
miscarriage rates in a rural African setting in the context of high HIV 
and malaria prevalence. Future studies should consider the involvement 
of community health workers to identify the pregnancy cohort of early 
gestation for better data on the actual number of pregnancies and the 
assessment of miscarriage.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2016-04</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>6</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e011088</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>BMJ open</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1136/bmjopen-2016-011088">10.1136/bmjopen-2016-011088</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>4</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>2044-6055 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>*Rural Population</li>
					<li>Prospective Studies</li>
					<li>Young Adult</li>
					<li>Risk Factors</li>
					<li>Prevalence</li>
					<li>*Developing Countries</li>
					<li>Socioeconomic Factors</li>
					<li>Adolescent</li>
					<li>Kenya/epidemiology</li>
					<li>Kenya</li>
					<li>Age Factors</li>
					<li>Pregnancy Complications/epidemiology</li>
					<li>sub-Saharan Africa</li>
					<li>*Abortion, Spontaneous</li>
					<li>Gravidity</li>
					<li>HIV Infections/complications/epidemiology</li>
					<li>Miscarriage</li>
					<li>prospective cohort</li>
					<li>rate</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_FJFZUJNX">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong><span style="color: var(--tw-prose-bold)"><span style="background-color: rgb(255, 255, 255)">Location Name:</span></span></strong><span style="background-color: rgb(255, 255, 255)"> </span></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Siaya County, western Kenya.</span></span></p>
<p><strong><span style="color: var(--tw-prose-bold)"><span style="background-color: rgb(255, 255, 255)">Location Type:</span></span></strong><span style="background-color: rgb(255, 255, 255)"> &nbsp;</span></p>
<p><span style="background-color: rgb(255, 255, 255)">Community</span></p>
<p><strong><span style="color: var(--tw-prose-bold)"><span style="background-color: rgb(255, 255, 255)">Description:</span></span></strong><span style="background-color: rgb(255, 255, 255)"> &nbsp;</span></p>
<p><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Conducted
 in 33 adjacent villages under the Kenya Medical Research 
Institute-Centers for Disease Control and Prevention (KEMRI-CDC) Health 
and Demographic Surveillance System area (KEMRI-CDC HDSS), </span></span><span style="background-color: rgb(255, 255, 255)">in </span><span style="color: rgb(13, 13, 13)"><span style="background-color: rgb(255, 255, 255)">Siaya County, western Kenya.</span></span></p>
<p><strong><span style="color: var(--tw-prose-bold)"><span style="background-color: rgb(255, 255, 255)">Sample size :</span></span></strong><span style="background-color: rgb(255, 255, 255)"> 1453 pregnancies recruited Siaya County, western Kenya</span></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_B7V9I5QH" class="item journalArticle">
			<h2>Weight change during the first week of life and a new method for 
retrospective prediction of birthweight among exclusively breastfed 
newborns.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Mtove G</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Abdul O</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Kullberg F</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Gesase S</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Scheike T</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Andersen FM</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Madanitsa M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Ter Kuile FO</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Alifrangis M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Lusingu JPA</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Minja DTR</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Schmiegelow C</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>INTRODUCTION: Identification of low birthweight and small for 
gestational age is pivotal in clinical management and many research 
studies, but in low-income countries, birthweight is often unavailable 
within 24 h of birth. Newborn weights measured within days after birth 
and knowledge of the growth patterns in the first week of life can help 
estimate the weight at birth retrospectively. This study aimed to 
generate sex-specific prediction maps and weight reference charts for 
the retrospective estimation of birthweight for exclusively breastfed 
newborns in a low-resource setting. MATERIAL AND METHODS: This was a 
prospective cohort study nested in a clinical trial of intermittent 
preventive treatment in pregnancy for malaria with either 
dihydroartemisinin-piperaquine with/without azithromycin or 
sulfadoxine-pyrimethamine in Korogwe District, north-eastern Tanzania 
(Clinicaltrials.gov: NCT03208179). Newborns were weighed at birth or in 
the immediate hours after birth and then daily for 1 week. Reference 
charts, nadir, time to regain weight, and prediction maps were generated
 using nonlinear mixed-effects models fitted to the longitudinal data, 
incorporating interindividual variation as random effects. Predictions 
and prediction standard deviations were computed using a linear 
approximation approach. RESULTS: Between March and December 2019, 513 
live newborns with birthweights measured within 24 h of delivery were 
weighed daily for 1 week. Complete datasets were available from 476 
exclusively breastfed newborns. There was a rapid decline in weight 
shortly after delivery. The average weight loss, time of nadir, and time
 to regain weight were 4.3% (95% confidence interval [CI] 3.8-4.9) at 27
 h (95% CI 24-30) and 105 h (95% CI 91-120) in boys and 4.9% (95% CI 
4.2-5.6) at 28 h (95% CI 23-33) and 114 h (95% CI 93-136) in girls, 
respectively. The data were used to generate prediction maps with 1-h 
time intervals and 0.05 kg weight increments showing the predicted 
birthweights and weight-for-age and weight-change-for-age reference 
charts depicting variation in weight loss from &lt;1 to &gt;10%. 
CONCLUSIONS: The prediction maps and reference charts can be used by 
researchers in low-resource settings to retrospectively estimate 
birthweights using weights collected up to 168 h after delivery, thereby
 maximizing data utilization. Clinical practitioners can also use the 
prediction maps to retrospectively classify newborns as low birthweight 
or small for gestational age.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2022-03</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Number: 3
Place: United States</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>101</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>293-302</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>Acta obstetricia et gynecologica Scandinavica</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1111/aogs.14323">10.1111/aogs.14323</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>3</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>0001-6349 (LINKING)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>2/20/2024, 12:59:27 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>2/20/2024, 12:59:27 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Retrospective Studies</li>
					<li>Birth Weight</li>
					<li>Infant, Newborn</li>
					<li>Prospective Studies</li>
					<li>Male</li>
					<li>*Breast Feeding</li>
					<li>weight</li>
					<li>Newborn</li>
					<li>infants</li>
					<li>*Fetal Growth Retardation</li>
					<li>exclusive breastfeeding</li>
					<li>growth</li>
					<li>weight loss</li>
					<li>Weight Loss</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_D8DX9BV6">
<div><div data-schema-version="8"><p>Location Information</p>
<p><strong>Location Name</strong> :</p>
<p><span style="color: rgb(0, 0, 0)"><span style="background-color: rgb(255, 255, 255)">Korogwe</span></span></p>
<p><strong>Location Type</strong> : </p>
<p>District</p>
<p><strong>Description</strong> : <span style="color: rgb(0, 0, 0)"><span style="background-color: rgb(255, 255, 255)">&nbsp;</span></span></p>
<p><span style="color: rgb(0, 0, 0)"><span style="background-color: rgb(255, 255, 255)">Korogwe District, north-eastern Tanzania</span></span></p>
<p><strong>Sample siz</strong>e :<span style="color: rgb(0, 0, 0)"><span style="background-color: rgb(255, 255, 255)">617&nbsp;</span></span></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>


			<li id="item_HD5HFDEK" class="item journalArticle">
			<h2>What prevents pregnant women from adhering to the continuum of 
maternal care? Evidence on interrelated mechanisms from a cohort study 
in Kenya.</h2>
				<table>
					<tbody><tr>
						<th>Item Type</th>
						<td>Journal Article</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Aksunger N</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>De Sanctis T</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Waiyaiya E</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>van Doeveren R</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>van der Graaf M</td>
					</tr>
					<tr>
						<th class="author">Author</th>
						<td>Janssens W</td>
					</tr>
					<tr>
					<th>Abstract</th>
						<td>OBJECTIVES: To examine the determinants of the continuum of 
maternal care from an integrated perspective, focusing on how key 
components of an adequate journey are interrelated. DESIGN: A 
facility-based prospective cohort study. SETTING: 25 health facilities 
across three counties of Kenya: Nairobi, Kisumu and Kakamega. 
PARTICIPANTS: A total of 5 879 low-income pregnant women aged 13-49 
years. OUTCOME MEASURES: Ordinary least squares, Poisson and logistic 
regression models were employed, to predict three key determinants of 
the continuum of maternal care: (i) the week of enrolment at the clinic 
for antenatal care (ANC), (ii) the total number of ANC visits and (iii) 
utilisation of skilled birth attendance (SBA). The interrelationship 
between the three outcome variables was assessed with structural 
equation modeling. RESULTS: Each week of delayed enrolment in ANC 
reduced the number of ANC visits by 3% (incidence rate ratio=0.967, 95% 
CI 0.965 to 0.969). A higher number of ANC visits increased the relative
 probability of using SBA (odds ratio=1.28, 95% CI 1.22 to 1.34). The 
direct association between late enrolment and SBA was positive (odds 
ratio=1.033, 95% CI 1.02 to 1.04). Predisposing factors (age, household 
head's education), enabling factors (wealth, shorter distance, rural 
area) and need factors (risk level of pregnancy, multigravida) were 
positively associated with adherence to ANC. CONCLUSION: The results 
point towards a domino-effect and underscore the importance of enhancing
 the full continuum of maternal care. A larger number of ANC visits 
increases SBA, while early initiation of the care journey increases the 
number of ANC visits, thereby indirectly supporting SBA as well. These 
beneficial pathways counteract the direct link between enrolment and 
SBA, which is partly driven by pregnant teenagers who both enrol late 
and are at heightened risk of complications, stressing the need for 
specific attention to this vulnerable population.</td>
					</tr>
					<tr>
					<th>Date</th>
						<td>2022-01</td>
					</tr>
					<tr>
					<th>Extra</th>
						<td>Place: England</td>
					</tr>
					<tr>
					<th>Volume</th>
						<td>12</td>
					</tr>
					<tr>
					<th>Pages</th>
						<td>e050670</td>
					</tr>
					<tr>
					<th>Publication</th>
						<td>BMJ open</td>
					</tr>
					<tr>
					<th>DOI</th>
						<td><a href="http://doi.org/10.1136/bmjopen-2021-050670">10.1136/bmjopen-2021-050670</a></td>
					</tr>
					<tr>
					<th>Issue</th>
						<td>1</td>
					</tr>
					<tr>
					<th>ISSN</th>
						<td>2044-6055 (Linking)</td>
					</tr>
					<tr>
					<th>Date Added</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
					<tr>
					<th>Modified</th>
						<td>1/16/2024, 2:27:56 PM</td>
					</tr>
				</tbody></table>
				<h3 class="tags">Tags:</h3>
				<ul class="tags">
					<li>eppi-reviewer4</li>
					<li>Adult</li>
					<li>Female</li>
					<li>Humans</li>
					<li>Pregnancy</li>
					<li>Cohort Studies</li>
					<li>Prospective Studies</li>
					<li>Young Adult</li>
					<li>Middle Aged</li>
					<li>Socioeconomic Factors</li>
					<li>*Maternal Health Services</li>
					<li>Adolescent</li>
					<li>*antenatal</li>
					<li>Kenya</li>
					<li>Parturition</li>
					<li>*health policy</li>
					<li>*Pregnant Women</li>
					<li>*public health</li>
					<li>Prenatal Care/methods</li>
				</ul>
				<h3 class="notes">Notes:</h3>
				<ul class="notes">
					<li id="item_NBW7VAKU">
<div><div data-schema-version="8"><p><strong>Location Information</strong></p>
<p><strong>Location &nbsp;Name : </strong></p>
<p>The exact name of the health facilities are not mentioned</p>
<p><strong>Location &nbsp;Type : </strong></p>
<p>Health facility</p>
<p><strong>Description : </strong></p>
<p>Conducted in 25 health facilities in three counties in Kenya: 
Nairobi, Kisumu, and Kakamega. Nairobi is urbun, Kisumu is periurburn 
and Kakamega is mostly rural.</p>
<p><strong>Sample size :</strong> <span style="color: rgb(51, 51, 51)"><span style="background-color: rgb(255, 255, 255)">5 879</span></span></p>
<p></p>
<p></p>
</div></div>
					</li>
				</ul>
			</li>

		</ul>
	
</body></html>